data_1m5z_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1m5z _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.013 0.435 . . . . 0.0 111.847 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -137.73 122.82 19.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.316 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.43 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 13.6 mt -60.03 137.5 58.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.102 0.477 . . . . 0.0 111.839 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.34 122.04 8.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.173 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.87 135.43 51.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.517 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.37 143.05 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.143 0.496 . . . . 0.0 111.451 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.2 m -134.55 141.42 46.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.784 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.39 -179.63 5.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.08 0.467 . . . . 0.0 111.639 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.42 ' CD2' ' HG2' ' A' ' 97' ' ' LYS . 9.8 m-85 -138.96 125.35 20.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.391 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -94.87 164.94 12.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.997 0.427 . . . . 0.0 111.231 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.37 141.13 48.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.657 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.3 p -60.11 84.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 138.33 -3.68 3.03 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.217 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.6 151.34 29.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.864 0.364 . . . . 0.0 110.989 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -94.91 -10.53 30.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.388 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.83 175.87 13.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.68 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.483 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.6 OUTLIER -94.15 2.1 56.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.619 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.33 18.23 5.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.382 -0.913 . . . . 0.0 113.25 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.569 ' HB2' HG12 ' A' ' 54' ' ' ILE . 39.4 p90 -174.04 134.45 0.45 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 117.035 0.418 . . . . 0.0 111.654 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.403 ' O ' ' N ' ' A' ' 52' ' ' LYS . 67.4 m -92.99 151.3 19.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.088 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.426 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 34.5 m -114.93 167.95 7.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.122 0.487 . . . . 0.0 111.837 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -133.85 140.69 47.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.782 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.13 121.75 18.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.817 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.05 89.65 0.98 Allowed Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 pp -83.36 -2.47 55.82 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 mp -77.17 -13.49 59.94 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.586 ' O ' ' CG ' ' A' ' 47' ' ' LYS . 0.6 OUTLIER -157.88 -83.78 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.001 179.334 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.586 ' CG ' ' O ' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -175.68 134.22 0.29 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.596 0.758 . . . . 0.0 110.233 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.62 -159.19 22.01 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.263 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.426 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 18.8 t -154.82 144.38 13.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.627 0.251 . . . . 0.0 110.852 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.408 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -135.88 151.39 49.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.806 0.336 . . . . 0.0 111.028 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.476 ' HB ' ' OD1' ' A' ' 69' ' ' ASP . 44.7 t -60.49 123.59 13.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.02 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 39' ' ' SER . 0.1 OUTLIER -88.19 -27.54 21.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.169 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -169.68 140.34 2.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.738 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.569 HG12 ' HB2' ' A' ' 38' ' ' PHE . 2.7 mt -119.61 142.9 32.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.002 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -65.37 111.7 6.71 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.732 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 50.0 Cg_exo -55.53 109.17 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.464 2.109 . . . . 0.0 112.485 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 56' ' ' PRO . . . 83.38 38.14 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.367 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.9 -170.41 13.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.171 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.77 -43.62 39.73 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.35 2.033 . . . . 0.0 111.817 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.85 -38.5 95.63 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.428 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -73.59 -32.84 64.32 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.007 0.432 . . . . 0.0 110.196 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 75.3 mt -73.01 -31.84 64.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.682 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.86 -40.92 34.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.362 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.34 8.4 6.49 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.031 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 mt -63.4 115.96 5.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.911 0.386 . . . . 0.0 110.988 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.4 ' CG ' ' HD2' ' A' ' 67' ' ' PRO . 15.2 tttm -107.33 141.56 23.23 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.512 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.596 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 4.1 Cg_exo -39.47 135.75 1.16 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.202 2.601 . . . . 0.0 112.727 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.596 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 78.2 m-85 85.44 -5.31 0.87 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.542 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.476 ' OD1' ' HB ' ' A' ' 51' ' ' VAL . 9.1 p-10 -56.22 85.1 0.01 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.062 0.458 . . . . 0.0 110.885 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 68' ' ' TYR . 42.4 ttt180 -66.66 102.61 0.94 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.476 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.2 mt -54.5 107.28 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.721 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.457 ' HA ' ' CG ' ' A' ' 80' ' ' ARG . 5.5 mt -82.98 -63.48 1.35 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.376 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -121.23 118.24 29.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.07 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.1 t -100.55 120.21 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.249 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.442 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 0.4 OUTLIER 46.36 43.11 11.4 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.671 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.442 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.1 OUTLIER 86.59 -19.37 0.28 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.752 179.534 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.85 120.69 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.875 0.369 . . . . 0.0 111.087 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -70.13 85.94 0.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.419 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 27.9 p -96.51 30.93 2.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.138 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.457 ' CG ' ' HA ' ' A' ' 72' ' ' LEU . 4.6 mtp180 -68.4 -45.73 71.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.008 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -92.0 18.28 8.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.311 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.419 ' CD1' ' HA ' ' A' ' 79' ' ' THR . 3.5 m-30 -82.16 171.81 13.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.883 0.373 . . . . 0.0 110.931 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.07 166.87 11.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.33 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 9.5 p -51.52 -44.62 62.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.256 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 26.2 p -61.13 -20.12 62.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.52 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.5 mp -99.45 -33.37 10.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.868 0.366 . . . . 0.0 111.165 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 44.9 t -77.5 -35.9 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.963 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.534 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 99.0 t -57.65 -52.36 74.9 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.735 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 45.7 Cg_endo -67.56 -44.8 4.04 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.149 1.899 . . . . 0.0 111.8 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 13.1 mt -54.94 -31.64 60.58 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.045 0.45 . . . . 0.0 110.391 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.412 HG22 ' CD1' ' A' ' 98' ' ' LEU . 60.3 mt -72.57 -51.4 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.161 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.84 -3.06 42.7 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.976 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.97 -5.99 22.86 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.414 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 3.3 t -64.82 -14.73 60.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.741 0.305 . . . . 0.0 111.461 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.11 -142.97 16.34 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.663 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -74.65 -5.53 43.57 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.42 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 42.1 mtpt -146.23 151.3 37.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.874 0.369 . . . . 0.0 111.141 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -129.67 97.86 4.65 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.285 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -99.21 117.9 34.71 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.3 pp -150.21 162.89 39.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.262 0.553 . . . . 0.0 112.253 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.1 t -114.1 109.53 28.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.895 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.422 ' CD1' ' HB2' ' A' ' 69' ' ' ASP . 2.6 pp -105.45 169.26 2.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.345 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.7 p -133.42 121.68 22.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.766 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.401 ' HB3' ' HA ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -136.44 147.68 47.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.171 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -74.57 122.67 88.04 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.779 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 C--O 1.25 1.11 0 C-N-CA 122.333 2.022 . . . . 0.0 112.385 -179.912 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.419 ' CG2' ' HB2' ' A' ' 103' ' ' SER . 28.9 m . . . . . 0 C--O 1.23 0.079 0 CA-C-O 121.063 0.458 . . . . 0.0 111.711 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -132.51 122.81 25.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.479 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 13.5 mt -60.01 148.67 34.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.033 0.444 . . . . 0.0 111.651 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.5 122.87 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.221 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -71.51 119.24 15.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.509 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.5 148.17 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.134 0.493 . . . . 0.0 111.493 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.3 m -134.59 106.89 7.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.848 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.461 ' CD1' ' CE1' ' A' ' 38' ' ' PHE . 13.8 mt -101.08 173.66 6.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.24 0.543 . . . . 0.0 112.017 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.425 ' CZ ' ' HD3' ' A' ' 97' ' ' LYS . 6.3 m-85 -132.53 166.15 22.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.329 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -134.08 161.02 36.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.98 0.419 . . . . 0.0 111.29 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.44 148.02 51.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.657 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.4 m -58.05 -25.21 60.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.149 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.77 -14.71 51.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.854 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 5.3 mmt -81.29 145.0 31.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.911 0.386 . . . . 0.0 111.013 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -91.73 -10.15 41.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.24 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -154.13 -167.52 2.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.607 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.513 ' CE2' ' HB2' ' A' ' 98' ' ' LEU . 1.1 m-85 -95.89 24.4 5.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.723 0.297 . . . . 0.0 111.564 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.6 16.81 74.76 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.568 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.484 ' O ' ' CD1' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -172.05 124.42 0.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.192 0.52 . . . . 0.0 111.696 179.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.4 m -89.51 154.04 20.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.807 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.5 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 30.8 m -106.39 165.47 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.554 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -124.25 178.15 5.49 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.144 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -103.81 139.08 39.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.077 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.07 118.51 5.44 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.33 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.53 -28.5 15.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.927 0.394 . . . . 0.0 111.263 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tp -84.7 -7.68 59.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.856 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 47' ' ' LYS . 8.9 mm-40 -150.12 25.44 0.81 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.13 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER 26.26 63.08 0.08 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.012 0.434 . . . . 0.0 112.082 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -149.24 -164.55 11.69 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.499 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.5 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 19.1 t -132.39 132.51 60.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.638 0.256 . . . . 0.0 111.087 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.461 ' CE1' ' NH1' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -133.41 145.86 50.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.289 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 69' ' ' ASP . 58.6 t -49.06 124.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.057 0.456 . . . . 0.0 111.512 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -88.29 -30.6 19.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.002 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -175.88 160.92 2.42 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.386 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.437 HG12 ' HB2' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -128.04 142.7 43.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.978 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -65.26 147.6 98.48 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.415 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 58.6 Cg_endo -71.78 100.08 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.526 2.151 . . . . 0.0 112.391 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 56' ' ' PRO . . . 83.1 29.35 0.09 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.16 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.03 -179.52 32.95 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.401 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.83 -29.52 53.2 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.588 2.192 . . . . 0.0 112.146 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.19 -47.3 86.4 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.201 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.25 -32.84 67.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.12 0.486 . . . . 0.0 109.951 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.3 mt -73.47 -29.14 62.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.358 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.46 -48.49 29.77 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.178 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.88 10.49 3.51 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.446 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.415 ' CD1' ' CD1' ' A' ' 54' ' ' ILE . 1.3 pp -111.44 152.16 27.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.098 0.449 . . . . 0.0 110.93 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.428 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -138.51 179.11 1.4 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.673 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.477 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 74.8 Cg_exo -49.73 144.9 18.95 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.362 2.041 . . . . 0.0 112.353 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.495 ' O ' ' N ' ' A' ' 70' ' ' ARG . 11.6 m-85 90.32 -17.21 0.2 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.433 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.433 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 1.6 m-20 -53.34 83.75 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.007 0.432 . . . . 0.0 110.847 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 68' ' ' TYR . 24.6 ttm-85 -67.92 99.61 0.86 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.987 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.31 107.98 1.48 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.02 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.51 ' HA ' ' CG ' ' A' ' 80' ' ' ARG . 6.5 mt -83.51 -56.31 3.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.467 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -137.06 116.68 12.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.784 0.326 . . . . 0.0 111.516 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.5 t -89.14 109.04 19.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.535 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 75.54 -59.11 0.54 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.18 0.514 . . . . 0.0 110.517 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -167.47 -14.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.221 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.81 129.24 38.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.775 0.321 . . . . 0.0 111.172 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.73 87.23 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.413 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 20.4 p -96.41 26.48 4.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.288 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.51 ' CG ' ' HA ' ' A' ' 72' ' ' LEU . 2.3 tmm_? -74.93 -46.37 36.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.797 0.332 . . . . 0.0 110.698 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -92.49 19.45 7.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.413 ' CD1' ' HA ' ' A' ' 79' ' ' THR . 2.9 m-85 -82.01 171.14 14.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.959 0.409 . . . . 0.0 110.95 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -105.27 158.74 16.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.378 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 23.7 m -51.34 -41.32 60.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.88 0.372 . . . . 0.0 110.724 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 17.3 t -65.24 -21.63 66.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.274 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.478 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 10.1 mp -94.56 -30.06 14.57 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.016 0.436 . . . . 0.0 110.739 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.59 -35.79 19.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.254 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.634 ' HB ' ' HD3' ' A' ' 89' ' ' PRO . 58.1 t -58.92 -50.99 85.03 Favored Pre-proline 0 C--N 1.331 -0.209 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.87 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.634 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.8 Cg_exo -67.3 -48.04 1.92 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.445 2.097 . . . . 0.0 111.465 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.0 mt -54.93 -29.96 57.48 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.886 0.374 . . . . 0.0 110.511 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.436 ' CG2' HD11 ' A' ' 98' ' ' LEU . 48.3 mt -74.19 -46.53 44.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.343 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.81 -3.79 52.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.966 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -94.87 -15.77 23.42 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.432 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 1.4 t -65.15 -16.04 63.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.382 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.08 -141.41 15.6 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.696 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -73.99 -20.38 60.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.683 0.277 . . . . 0.0 111.441 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.425 ' HD3' ' CZ ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -127.73 152.38 47.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.674 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.513 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -135.77 97.76 3.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.778 0.323 . . . . 0.0 111.575 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.97 118.06 30.41 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.6 162.99 37.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.157 0.503 . . . . 0.0 111.968 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.5 t -112.91 109.17 27.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.272 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 2.4 pp -109.17 169.19 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.183 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.419 ' HB2' ' CG2' ' A' ' 20' ' ' VAL . 19.0 p -136.15 107.03 6.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.953 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.11 136.14 53.03 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 0.9 OUTLIER -93.54 131.37 32.59 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.128 178.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 105' ' ' ASN . 8.7 Cg_exo . . . . . 0 C--O 1.249 1.05 0 C-N-CA 122.24 1.96 . . . . 0.0 112.19 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.462 0.128 0 CA-C-O 120.945 0.402 . . . . 0.0 111.629 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -120.32 122.75 41.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.601 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.446 HD21 HD11 ' A' ' 72' ' ' LEU . 14.1 mt -61.86 141.92 57.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.291 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.426 ' HB2' ' CD1' ' A' ' 102' ' ' ILE . 9.9 m-70 -144.15 108.51 4.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.839 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.95 102.5 4.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.39 138.44 38.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.107 0.479 . . . . 0.0 111.828 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.2 m -131.98 106.39 8.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.732 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.42 ' HB2' ' CD1' ' A' ' 36' ' ' PHE . 19.6 mt -98.81 177.1 5.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.978 0.418 . . . . 0.0 111.662 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -136.33 135.89 39.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.315 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -94.64 138.18 32.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.417 . . . . 0.0 111.097 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.54 131.04 54.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.795 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -60.59 84.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.838 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.77 -17.25 1.09 Allowed Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.882 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.09 167.94 19.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.848 0.356 . . . . 0.0 110.836 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -107.39 -10.52 15.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.37 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.44 -169.33 3.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.875 0.369 . . . . 0.0 110.896 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.482 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 1.6 m-85 -103.97 17.74 23.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.493 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.34 14.76 59.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.229 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.496 ' O ' ' CD1' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -173.31 130.62 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.112 0.482 . . . . 0.0 111.127 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.82 160.35 14.68 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.065 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.458 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 26.8 m -115.69 158.86 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.178 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -123.58 167.3 14.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.157 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.2 p30 -73.13 153.26 40.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.661 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.23 96.87 1.01 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.564 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.23 -17.97 22.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 0.0 111.302 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.02 -28.88 25.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.439 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -155.92 51.79 0.55 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.603 -179.734 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 21.62 96.44 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.643 179.49 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.34 -170.88 43.58 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.815 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.458 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 93.7 t -133.08 131.58 58.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.678 0.275 . . . . 0.0 110.671 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -138.59 157.11 46.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.876 0.37 . . . . 0.0 111.237 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.443 ' CG2' ' CD2' ' A' ' 38' ' ' PHE . 43.6 t -65.19 114.92 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.959 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.14 -28.32 17.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.26 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -142.8 156.49 44.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.603 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.473 HD13 ' HB3' ' A' ' 38' ' ' PHE . 1.2 mm -138.54 109.31 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.588 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -64.88 121.8 75.74 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.02 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.93 165.16 2.06 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.46 2.107 . . . . 0.0 112.267 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 35.77 75.34 0.06 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.983 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.93 -171.09 35.87 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.151 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -55.72 -29.75 72.67 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.387 2.058 . . . . 0.0 112.05 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.82 -43.83 16.72 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.578 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -73.77 -32.92 64.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.042 0.448 . . . . 0.0 110.357 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.2 mt -75.27 -32.93 61.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.037 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.4 -46.85 7.78 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.566 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 114.92 25.56 3.86 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.668 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 mt -73.73 141.95 46.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.857 0.361 . . . . 0.0 110.798 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -114.65 156.17 45.15 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.92 66.67 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.63 2.22 . . . . 0.0 112.04 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.413 ' O ' ' HB3' ' A' ' 50' ' ' TYR . 0.7 OUTLIER -178.16 -24.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.572 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.407 ' HB3' ' CG1' ' A' ' 102' ' ' ILE . 4.4 m-20 -44.0 94.96 0.01 OUTLIER 'General case' 0 C--O 1.231 0.082 0 CA-C-O 121.194 0.521 . . . . 0.0 111.277 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 50' ' ' TYR . 20.6 ttp180 -74.95 101.31 4.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.667 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 mp -53.98 107.05 0.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.278 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.446 HD11 HD21 ' A' ' 22' ' ' LEU . 20.0 mt -85.12 -56.14 3.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.059 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -136.35 117.59 14.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.92 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.9 t -102.95 119.06 50.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.88 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 72.11 -61.58 0.49 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.128 0.489 . . . . 0.0 110.563 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -168.07 -18.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.988 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.84 127.29 40.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.826 0.346 . . . . 0.0 111.198 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.69 93.61 0.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.745 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.437 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 14.5 p -95.75 34.41 1.51 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.198 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.412 ' CG ' ' HA ' ' A' ' 72' ' ' LEU . 3.3 mtt180 -67.99 -53.31 26.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.584 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -94.0 25.1 3.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.183 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 79' ' ' THR . 2.5 m-30 -81.43 174.49 11.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.877 0.37 . . . . 0.0 110.805 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.28 161.05 17.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.347 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.437 ' N ' HG22 ' A' ' 49' ' ' VAL . 42.0 t -51.82 -42.96 62.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.894 0.378 . . . . 0.0 110.664 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.4 t -63.54 -19.52 64.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.264 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 mp -96.58 -32.77 12.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.042 0.449 . . . . 0.0 110.647 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.1 t -77.5 -36.01 22.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.9 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.546 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 98.9 t -57.79 -52.2 76.14 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.839 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 41.5 Cg_endo -66.9 -45.4 4.29 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.336 2.024 . . . . 0.0 111.854 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 19.7 mt -54.64 -29.69 53.05 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.985 0.421 . . . . 0.0 110.681 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.445 HG23 ' CD2' ' A' ' 36' ' ' PHE . 70.2 mt -78.19 -48.18 23.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.839 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.19 -3.93 32.8 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.74 -4.21 14.74 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.4 t -64.73 -16.19 62.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.806 0.336 . . . . 0.0 111.367 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.46 -154.26 19.72 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.557 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -73.44 -9.25 58.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.612 0.244 . . . . 0.0 111.404 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -138.87 123.42 18.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.694 0.283 . . . . 0.0 110.743 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.482 ' HB2' ' CE1' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -107.3 97.4 7.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.19 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -98.62 118.23 34.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 pp -147.75 150.81 34.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.084 0.469 . . . . 0.0 111.965 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.6 t -105.43 108.85 25.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.792 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 23' ' ' HIS . 2.5 pp -104.41 169.04 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.048 0.451 . . . . 0.0 111.503 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.71 123.87 20.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.382 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.87 126.9 25.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.255 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -75.24 112.95 20.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.828 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 C--O 1.249 1.04 0 C-N-CA 122.413 2.075 . . . . 0.0 112.252 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 105' ' ' ASN . 29.1 m . . . . . 0 C--O 1.231 0.112 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -97.24 121.82 39.57 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 4.6 pp -100.34 153.14 19.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.266 0.555 . . . . 0.0 112.356 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -148.31 149.66 32.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.281 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.87 103.52 10.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.49 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.4 138.7 23.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.197 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.5 m -130.21 110.2 11.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.364 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.9 mt -106.78 174.87 5.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.027 0.442 . . . . 0.0 111.498 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -127.73 154.97 44.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.593 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -114.25 140.45 48.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.035 0.445 . . . . 0.0 111.321 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 32' ' ' GLY . 10.5 t70 -112.79 134.67 54.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.372 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.8 m -56.86 85.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.052 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 30' ' ' ASP . . . 148.65 -18.41 1.28 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.83 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.16 140.67 34.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 111.028 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.52 -10.58 59.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.263 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.58 -167.58 2.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.918 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.476 ' CE2' ' HB2' ' A' ' 98' ' ' LEU . 4.0 m-85 -99.38 28.25 4.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.293 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.12 21.55 48.99 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.999 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.427 ' CD2' HD13 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -174.38 128.01 0.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.792 0.33 . . . . 0.0 110.833 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.7 m -90.06 150.02 22.26 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.792 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 35.5 m -110.48 171.0 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.697 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.61 144.38 26.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.112 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -72.49 168.24 18.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -105.35 122.59 7.27 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.314 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.15 -23.75 17.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.038 0.447 . . . . 0.0 111.322 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.4 mp -84.28 -39.61 19.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.949 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.538 ' O ' ' O ' ' A' ' 47' ' ' LYS . 7.0 pt-20 -156.2 59.95 0.57 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.058 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.538 ' O ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 32.85 -166.85 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.623 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.77 176.01 42.75 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.534 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.439 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 58.9 t -133.79 132.16 56.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.872 0.367 . . . . 0.0 111.226 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -126.1 -175.11 3.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.372 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.428 HG11 ' CG1' ' A' ' 54' ' ' ILE . 56.0 t -95.77 122.11 46.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.978 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.27 -29.69 19.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.448 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -157.37 154.11 28.38 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.558 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.428 ' CG1' HG11 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -138.25 139.05 42.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.768 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.04 133.42 94.76 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.889 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.435 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 61.1 Cg_endo -72.85 98.05 0.95 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.493 2.129 . . . . 0.0 112.306 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 56' ' ' PRO . . . 82.99 28.77 0.1 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.082 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -106.47 -160.83 22.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.434 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.56 -53.61 6.57 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.586 2.191 . . . . 0.0 112.308 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.06 -39.04 89.05 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.421 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.56 -32.88 64.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.084 0.468 . . . . 0.0 110.21 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 45.3 mt -73.73 -31.41 63.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.686 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.74 -55.59 7.28 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.331 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 139.38 -11.65 3.25 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.04 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.427 HD13 ' CD2' ' A' ' 38' ' ' PHE . 3.3 pp -80.44 135.34 36.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.973 0.416 . . . . 0.0 111.025 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.557 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 6.7 ptmt -120.03 167.52 12.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.397 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.617 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 99.9 Cg_exo -44.62 146.99 1.91 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.459 2.106 . . . . 0.0 112.7 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.617 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 2.2 m-85 82.98 -10.13 1.05 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.671 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.415 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 7.7 m-20 -54.74 88.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.05 0.453 . . . . 0.0 110.854 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 50' ' ' TYR . 12.3 ttm180 -66.83 101.04 0.77 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.02 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.4 mp -56.14 107.89 0.41 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.006 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.413 ' HA ' ' CG ' ' A' ' 80' ' ' ARG . 27.8 mt -82.99 -56.55 3.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.437 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -139.48 137.02 35.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.099 0.475 . . . . 0.0 111.385 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.538 ' O ' ' HB2' ' A' ' 75' ' ' ASN . 31.3 t -107.52 110.45 31.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.345 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.538 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 2.7 m-80 73.28 -58.84 0.58 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.678 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -167.47 -12.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.532 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.411 ' O ' HG12 ' A' ' 77' ' ' VAL . 12.2 p -84.22 133.15 29.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.924 0.393 . . . . 0.0 111.427 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.7 mmt-85 -72.07 89.79 1.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.943 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.42 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 37.7 p -96.28 21.01 9.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.333 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.413 ' CG ' ' HA ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -70.95 -42.53 69.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.885 0.374 . . . . 0.0 110.595 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.16 15.27 13.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.099 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CD1' ' HA ' ' A' ' 79' ' ' THR . 3.1 m-85 -81.92 172.24 13.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.927 0.394 . . . . 0.0 110.977 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -111.88 162.53 15.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.383 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 15.7 p -51.49 -43.67 62.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.759 0.314 . . . . 0.0 110.839 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.43 -22.22 64.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.332 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.467 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 11.0 mp -95.99 -31.0 13.29 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.904 0.383 . . . . 0.0 111.127 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.95 -35.69 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.299 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.623 ' HB ' ' HD3' ' A' ' 89' ' ' PRO . 62.1 t -58.73 -50.9 85.49 Favored Pre-proline 0 C--N 1.33 -0.26 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.913 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.623 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 14.0 Cg_exo -68.9 -44.57 2.62 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.444 2.096 . . . . 0.0 111.6 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 13.6 mt -54.62 -29.41 51.85 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.663 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.413 ' CG2' ' CD1' ' A' ' 98' ' ' LEU . 51.6 mt -78.07 -50.01 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.6 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.91 -4.05 26.06 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.931 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.14 -9.16 18.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.626 0.251 . . . . 0.0 111.581 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -64.8 -16.21 62.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.721 0.296 . . . . 0.0 111.374 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.83 -143.97 16.9 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.635 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -73.7 -10.15 59.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.584 0.231 . . . . 0.0 111.544 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -138.19 155.7 48.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.69 0.281 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.476 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -139.64 97.46 3.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.136 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -96.12 118.71 33.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.019 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pp -150.04 163.92 36.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.142 0.496 . . . . 0.0 112.064 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.2 t -111.97 109.12 27.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.914 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 2.6 pp -100.67 168.65 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.999 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.46 129.72 21.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.545 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.419 ' NE ' ' CG ' ' A' ' 66' ' ' LYS . 10.2 ptt85 -139.7 124.88 18.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.919 0.39 . . . . 0.0 111.616 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 4.1 p30 -69.13 133.94 89.6 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.662 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo . . . . . 0 C--O 1.249 1.065 0 C-N-CA 122.457 2.105 . . . . 0.0 112.337 179.939 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.812 0.339 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -112.35 122.2 47.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.408 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.404 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 14.2 mt -60.81 141.94 56.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.601 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.408 ' CE1' ' O ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -153.24 120.92 5.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.146 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.408 ' O ' ' CE1' ' A' ' 23' ' ' HIS . 2.6 tptp -69.88 124.43 24.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.903 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.4 139.92 50.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.039 0.447 . . . . 0.0 111.121 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 95.0 m -134.34 117.51 16.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.198 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 mp -116.03 167.65 10.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.079 0.466 . . . . 0.0 111.572 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' A' ' 28' ' ' TYR . 2.9 m-85 -135.37 121.92 20.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.175 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -95.11 163.65 13.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.946 0.403 . . . . 0.0 111.262 -179.526 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.99 139.47 41.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.26 85.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.921 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.64 -23.58 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.831 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.91 156.7 27.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.932 0.396 . . . . 0.0 110.961 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -87.71 -10.54 50.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.434 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -155.35 -172.24 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.857 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.482 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -97.87 32.15 2.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.238 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.93 -5.2 63.56 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.286 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' A' ' 53' ' ' ASN . 48.6 p90 -171.31 149.58 2.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.047 0.424 . . . . 0.0 111.739 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.9 m -104.5 133.83 48.71 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.433 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.429 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 33.1 m -93.46 170.8 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.751 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -139.38 162.31 35.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.148 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -83.25 130.31 35.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.709 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.494 ' HA3' ' CZ ' ' A' ' 50' ' ' TYR . . . -103.25 107.52 3.07 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.793 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 mp -94.67 -26.74 16.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.055 0.455 . . . . 0.0 111.03 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 tp -84.51 -6.09 59.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.714 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 47' ' ' LYS . 10.2 mt-10 -152.69 29.78 0.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.922 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 26.99 91.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.149 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.426 ' O ' ' HA3' ' A' ' 43' ' ' GLY . . . 157.9 160.4 10.2 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.273 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.429 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 40.1 t -101.39 133.48 44.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.853 0.359 . . . . 0.0 111.361 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.494 ' CZ ' ' HA3' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -125.42 -177.46 3.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.454 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.412 HG13 ' CD1' ' A' ' 54' ' ' ILE . 37.2 t -89.62 162.2 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.649 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.9 -42.12 0.24 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.011 0.434 . . . . 0.0 110.833 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 67.1 m-80 -123.43 130.49 52.78 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.578 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.425 HG12 ' HB2' ' A' ' 38' ' ' PHE . 1.1 mt -136.49 117.78 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.746 0.308 . . . . 0.0 111.331 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.13 110.54 5.28 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.592 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.11 55.06 0.72 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.589 2.193 . . . . 0.0 112.777 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -173.82 -43.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.927 0.394 . . . . 0.0 111.255 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.9 -152.47 0.96 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.705 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -62.14 -35.26 76.3 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.801 2.334 . . . . 0.0 112.079 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.5 -49.92 66.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.716 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -73.67 -36.18 65.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.061 0.457 . . . . 0.0 110.201 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 33.1 mt -60.83 -29.6 69.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.974 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.92 -51.42 3.8 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.419 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.38 47.71 0.85 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.724 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.41 165.63 11.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.079 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.427 ' O ' ' OD2' ' A' ' 69' ' ' ASP . 12.2 mtmm -132.13 159.57 71.6 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.665 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.453 ' O ' ' CG ' ' A' ' 68' ' ' TYR . 36.7 Cg_endo -65.55 64.43 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.487 2.125 . . . . 0.0 112.254 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.453 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 6.2 m-85 -174.12 -30.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.396 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.471 ' HB2' ' CD1' ' A' ' 102' ' ' ILE . 4.4 p30 -50.25 96.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.453 0.644 . . . . 0.0 110.799 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.421 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 27.6 ttp180 -74.3 104.16 4.96 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.537 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.417 ' CD2' ' CD2' ' A' ' 100' ' ' LEU . 1.1 mt -54.42 108.42 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.027 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.419 ' HB3' ' CG ' ' A' ' 80' ' ' ARG . 5.2 mt -82.9 -66.02 0.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.132 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.32 132.19 53.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.892 0.377 . . . . 0.0 111.163 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.458 ' HA ' ' HB3' ' A' ' 100' ' ' LEU . 29.7 t -104.58 103.85 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.8 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 75.31 -58.61 0.56 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.138 0.494 . . . . 0.0 110.565 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -167.67 -13.76 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.286 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.63 141.04 15.05 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.741 0.305 . . . . 0.0 111.309 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -70.2 128.13 35.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.519 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.426 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 41.6 p -143.76 25.93 1.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.172 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.419 ' CG ' ' HB3' ' A' ' 72' ' ' LEU . 6.9 mtt180 -73.32 -52.78 12.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.59 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -93.74 25.33 3.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.108 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.426 ' CD1' ' HA ' ' A' ' 79' ' ' THR . 2.2 m-85 -81.58 166.37 20.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.897 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -106.03 161.16 14.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.549 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.408 ' N ' HG23 ' A' ' 49' ' ' VAL . 1.9 t -51.69 -42.2 62.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.645 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 23.0 m -62.74 -22.91 66.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.213 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.405 ' HB3' ' CD2' ' A' ' 82' ' ' PHE . 7.9 mp -93.0 -32.93 14.33 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.012 0.434 . . . . 0.0 110.854 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.8 t -77.6 -36.03 22.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.0 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.541 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 77.8 t -54.73 -52.41 70.54 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.732 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 50.3 Cg_endo -68.63 -45.96 2.1 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.233 1.956 . . . . 0.0 111.788 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 27.0 mt -55.48 -32.06 62.53 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.607 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.429 HG21 ' CD1' ' A' ' 98' ' ' LEU . 60.7 mt -75.17 -44.86 42.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.599 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.11 -3.7 43.66 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.949 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -85.03 -15.82 42.84 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.742 0.306 . . . . 0.0 111.723 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.0 m -65.02 -25.01 67.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.982 0.42 . . . . 0.0 111.269 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.92 -61.48 3.74 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.189 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -163.12 16.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.84 105.69 2.21 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -107.39 107.52 18.46 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.0 117.93 35.46 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.458 ' HB3' ' HA ' ' A' ' 74' ' ' VAL . 1.3 pp -150.49 155.96 40.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.262 0.553 . . . . 0.0 112.373 -178.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.5 t -105.44 109.24 27.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.618 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.471 ' CD1' ' HB2' ' A' ' 69' ' ' ASP . 2.8 pp -100.96 169.45 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.189 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.9 102.63 5.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.605 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.409 ' HB3' ' HA ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -111.56 124.3 52.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.073 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.1 148.09 88.66 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.675 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo . . . . . 0 C--O 1.248 1.022 0 C-N-CA 122.606 2.204 . . . . 0.0 112.42 -179.948 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.425 ' CG2' ' HB2' ' A' ' 103' ' ' SER . 18.0 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.851 0.358 . . . . 0.0 111.432 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.58 122.21 28.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.734 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.7 mt -60.95 150.68 32.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.442 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -156.67 110.56 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.986 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -71.4 113.56 8.56 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.53 140.19 44.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.202 0.525 . . . . 0.0 112.099 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.8 m -134.33 106.64 7.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.51 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.424 HD13 ' CE1' ' A' ' 38' ' ' PHE . 23.5 mt -102.79 173.54 6.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.222 0.534 . . . . 0.0 112.143 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 96' ' ' ASN . 8.5 m-85 -134.69 121.82 21.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.245 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.463 ' N ' ' CE1' ' A' ' 36' ' ' PHE . 5.2 tttt -104.26 152.05 22.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.928 0.394 . . . . 0.0 111.346 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -119.62 158.74 25.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.651 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.24 -27.94 64.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.173 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.13 -24.74 51.12 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.73 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 2.9 mmt -81.41 132.7 35.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.907 0.384 . . . . 0.0 111.043 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -78.67 -10.78 59.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.265 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -155.9 -168.82 2.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.639 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.463 ' CE1' ' N ' ' A' ' 29' ' ' LYS . 5.0 m-85 -97.02 29.72 2.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.334 . . . . 0.0 111.178 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.09 24.57 68.61 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.955 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.424 ' CE1' HD13 ' A' ' 27' ' ' LEU . 1.4 p90 -174.44 117.3 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.047 0.451 . . . . 0.0 111.427 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -88.9 146.44 24.93 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.872 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.457 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 34.4 m -108.62 171.07 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.656 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -137.81 156.89 47.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.14 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -72.38 144.34 48.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.693 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.419 ' HA3' ' CZ ' ' A' ' 50' ' ' TYR . . . -119.93 108.26 1.44 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.612 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 pp -94.14 -27.28 16.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.976 0.417 . . . . 0.0 110.985 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.4 -3.33 58.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.371 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 47' ' ' LYS . 7.2 mt-10 -152.97 27.6 0.53 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.675 -0.238 . . . . 0.0 110.981 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER 27.09 91.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.251 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.9 -154.37 25.3 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.479 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.457 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 21.3 t -142.11 139.31 30.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.36 . . . . 0.0 110.942 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -126.68 177.73 6.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.509 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 69' ' ' ASP . 61.4 t -86.46 123.29 39.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.182 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -88.13 -29.34 20.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.782 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -168.33 149.99 5.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.246 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.417 HD11 ' CD1' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -129.26 132.73 66.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.184 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -65.56 125.22 89.23 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.54 140.38 83.24 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.388 2.059 . . . . 0.0 112.547 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 40.8 32.34 0.15 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.991 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -101.66 -167.96 27.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.955 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.57 -34.27 98.72 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.313 2.009 . . . . 0.0 111.721 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.28 -44.67 42.34 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.427 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -71.98 -32.76 67.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.99 0.424 . . . . 0.0 109.942 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.1 mt -72.11 -29.24 63.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.443 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.37 -57.93 5.32 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.326 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.49 -20.83 1.69 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.449 -0.881 . . . . 0.0 113.091 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.417 ' CD1' HD11 ' A' ' 54' ' ' ILE . 3.1 pp -73.83 134.04 43.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.944 0.402 . . . . 0.0 111.0 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.478 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 15.1 mttt -120.74 167.63 12.51 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.607 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.657 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 99.9 Cg_exo -43.24 145.98 1.22 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.539 2.159 . . . . 0.0 112.606 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.657 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 4.3 m-85 83.21 -10.01 1.03 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.665 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.451 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 4.3 m-20 -54.61 87.06 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.972 0.415 . . . . 0.0 110.817 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 68' ' ' TYR . 31.2 ttp180 -66.93 97.51 0.49 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.7 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.405 ' CD2' ' CD2' ' A' ' 100' ' ' LEU . 2.9 mt -55.58 107.39 0.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.127 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.46 ' HA ' HD21 ' A' ' 72' ' ' LEU . 23.8 mt -84.25 -65.92 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.121 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -122.57 140.97 52.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.027 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.3 t -124.69 112.63 32.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.055 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.463 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 5.1 m120 64.64 33.33 10.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.934 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.463 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 2.6 t-80 86.72 -14.89 0.47 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.611 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 36.7 t -83.27 138.65 18.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.828 0.346 . . . . 0.0 111.061 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -69.55 130.88 43.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.687 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.445 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 30.3 p -144.24 27.97 1.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.061 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.417 ' CG ' ' HB3' ' A' ' 72' ' ' LEU . 30.5 mtp180 -83.14 -42.5 17.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.627 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.11 10.31 27.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.041 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.493 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 3.1 m-85 -80.28 -176.45 5.63 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.959 0.409 . . . . 0.0 110.84 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -128.5 169.3 14.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.309 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 53.3 t -51.18 -45.58 61.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.746 0.307 . . . . 0.0 110.755 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.28 -18.45 63.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.107 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -95.5 -37.97 10.65 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.216 0.531 . . . . 0.0 111.04 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.03 -35.46 23.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.536 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.663 ' HB ' ' HD3' ' A' ' 89' ' ' PRO . 89.8 t -57.53 -51.79 79.11 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.694 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.663 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 18.3 Cg_exo -65.67 -44.38 8.35 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.248 1.966 . . . . 0.0 111.181 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.442 HD13 ' CE2' ' A' ' 82' ' ' PHE . 52.7 mt -54.57 -32.08 57.88 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.04 0.447 . . . . 0.0 110.526 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.421 ' HA ' HD11 ' A' ' 98' ' ' LEU . 61.9 mt -73.29 -49.65 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.55 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.17 -2.69 32.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.796 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -93.32 -13.2 28.46 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.413 ' OG ' ' HG ' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -63.8 -27.63 69.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.05 0.453 . . . . 0.0 110.746 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.8 -53.3 0.82 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.865 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 6.7 m120 -165.6 -34.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.956 0.408 . . . . 0.0 110.403 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -104.71 108.7 20.3 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.248 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -101.93 97.35 7.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.708 -179.243 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -100.45 118.32 36.42 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.405 ' CD2' ' CD2' ' A' ' 71' ' ' LEU . 1.3 pp -148.1 159.51 43.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.226 0.536 . . . . 0.0 112.239 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.3 t -111.14 109.14 27.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.014 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.5 pp -104.19 169.6 2.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.38 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.425 ' HB2' ' CG2' ' A' ' 20' ' ' VAL . 9.0 p -143.19 125.4 15.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.332 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -144.99 137.16 25.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.986 0.422 . . . . 0.0 111.421 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -62.57 132.21 94.37 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.743 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 122.422 2.082 . . . . 0.0 112.284 -179.959 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.86 0.362 . . . . 0.0 111.531 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -116.0 122.39 45.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.647 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 15.4 mt -62.27 137.64 58.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.479 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.406 ' NE2' ' CG2' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -149.04 127.42 12.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.273 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -71.53 133.69 45.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.622 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.406 ' CG2' ' NE2' ' A' ' 23' ' ' HIS . 0.2 OUTLIER -135.87 147.72 28.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.949 0.404 . . . . 0.0 111.327 -179.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.7 m -134.4 118.4 17.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.135 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.414 HD11 ' CZ ' ' A' ' 38' ' ' PHE . 3.8 mt -110.11 168.77 9.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.959 0.409 . . . . 0.0 111.678 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -134.87 132.66 38.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.573 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -102.02 165.11 11.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.943 0.402 . . . . 0.0 111.254 -179.683 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -144.14 141.68 30.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.687 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -55.87 -23.11 29.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.299 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.5 -13.11 56.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.996 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -80.28 155.15 27.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.916 0.389 . . . . 0.0 111.197 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -100.99 -10.64 20.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.215 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -155.08 -174.62 5.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.588 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -97.46 32.55 2.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.27 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.99 1.08 90.2 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.009 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.469 ' O ' ' CD1' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -172.14 135.29 0.77 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.004 0.43 . . . . 0.0 111.43 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.9 m -96.32 148.23 22.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.51 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.424 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 33.9 m -104.15 169.07 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.674 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -141.42 167.01 23.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.999 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -80.58 153.28 28.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.839 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.01 115.48 2.45 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.505 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.3 tt -94.31 -28.65 15.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.015 0.436 . . . . 0.0 111.148 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 mp -83.9 -55.9 3.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.781 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.4 mt-10 -89.78 17.11 6.95 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.431 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER 30.03 88.46 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.883 0.373 . . . . 0.0 111.934 -179.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.22 -141.99 7.26 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.515 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.424 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 39.5 t -145.47 138.24 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.916 0.389 . . . . 0.0 110.988 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -131.1 179.44 6.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.416 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.419 ' CG2' ' CD2' ' A' ' 38' ' ' PHE . 47.9 t -87.65 123.6 40.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.017 0.437 . . . . 0.0 111.287 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.74 -31.33 18.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.225 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -157.23 154.96 30.02 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.401 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.424 ' CD1' ' CB ' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -135.45 123.85 38.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.102 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -65.6 122.8 82.34 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.825 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.23 152.41 31.46 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.397 2.065 . . . . 0.0 112.439 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 38.65 33.94 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.007 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -118.79 -162.47 12.12 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.164 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.11 -54.33 5.61 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.5 2.133 . . . . 0.0 112.245 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.94 -33.15 86.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.717 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -73.71 -32.76 64.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.928 0.394 . . . . 0.0 110.409 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -74.1 -29.8 62.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.997 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -86.83 -34.83 10.67 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.463 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.2 32.83 3.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.518 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.424 ' CB ' ' CD1' ' A' ' 54' ' ' ILE . 11.4 mt -81.59 138.54 35.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.775 0.321 . . . . 0.0 111.042 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -126.32 160.58 56.96 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.715 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.436 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 78.1 Cg_exo -50.45 142.13 31.05 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.638 2.226 . . . . 0.0 112.332 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.436 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 18.4 m-85 85.44 -3.86 0.86 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.33 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.416 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 4.7 m-20 -53.19 89.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.056 0.455 . . . . 0.0 110.806 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 68' ' ' TYR . 69.0 ttt180 -76.99 111.64 12.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.999 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.26 107.79 4.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.734 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.467 HD22 ' HG2' ' A' ' 80' ' ' ARG . 1.7 mt -83.48 -19.5 35.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.963 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.06 152.68 1.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.011 0.434 . . . . 0.0 111.528 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -124.0 112.6 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.611 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.3 m120 76.25 -58.19 0.54 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.107 0.48 . . . . 0.0 110.569 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -167.06 -14.22 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.134 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.78 136.28 23.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-O 120.752 0.311 . . . . 0.0 111.116 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -69.65 143.2 53.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.674 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.435 ' HA ' ' CG ' ' A' ' 82' ' ' PHE . 64.2 p -146.07 18.39 1.41 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.657 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.467 ' HG2' HD22 ' A' ' 72' ' ' LEU . 11.3 mtm180 -65.77 -51.66 57.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.895 0.379 . . . . 0.0 110.425 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -93.75 20.96 6.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.227 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.435 ' CG ' ' HA ' ' A' ' 79' ' ' THR . 2.3 m-30 -81.32 169.18 17.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.797 0.332 . . . . 0.0 110.823 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -109.76 160.33 16.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.668 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 24.8 p -51.87 -31.44 28.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.906 0.384 . . . . 0.0 110.713 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -21.67 62.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.196 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.612 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 5.7 mp -98.38 -30.23 12.69 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.084 0.469 . . . . 0.0 110.819 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.8 t -79.74 -35.98 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.451 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.598 ' CG1' ' HD3' ' A' ' 89' ' ' PRO . 5.0 p -64.22 -39.82 46.79 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.667 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.612 ' HD2' ' C ' ' A' ' 86' ' ' LEU . 73.4 Cg_endo -74.37 -46.73 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.662 1.575 . . . . 0.0 111.227 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 81.5 mt -56.58 -28.35 60.04 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.108 0.48 . . . . 0.0 110.263 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.534 HG21 HD13 ' A' ' 98' ' ' LEU . 33.2 mt -75.92 -49.15 26.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.631 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.78 -2.56 47.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.064 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.64 -12.54 17.64 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.417 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -65.38 -14.3 60.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.698 0.285 . . . . 0.0 111.419 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.67 -145.15 17.77 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.609 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -73.56 -15.91 61.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.581 0.229 . . . . 0.0 111.393 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -125.98 139.68 53.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.798 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.534 HD13 HG21 ' A' ' 91' ' ' ILE . 0.4 OUTLIER -130.61 97.14 4.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.123 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -98.34 118.6 35.36 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.7 pp -146.86 158.79 44.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.224 0.535 . . . . 0.0 112.24 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.5 t -113.76 109.66 29.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.104 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 2.0 pp -108.78 169.56 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.372 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.406 ' OG ' ' HG ' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -130.54 127.84 39.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.859 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.03 141.43 34.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.934 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -71.42 135.78 84.06 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.766 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 C--O 1.248 1.003 0 C-N-CA 122.392 2.061 . . . . 0.0 112.252 -179.994 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.464 0.232 0 CA-C-O 120.927 0.394 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -119.16 122.54 42.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.52 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.416 HD21 HD12 ' A' ' 72' ' ' LEU . 13.3 mt -60.72 135.46 57.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.499 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -143.83 112.05 6.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.726 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 111.31 7.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.191 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.66 139.55 44.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.122 0.487 . . . . 0.0 111.553 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.5 m -133.02 106.74 7.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.97 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 mp -99.16 174.0 6.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.961 0.41 . . . . 0.0 111.902 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -131.33 140.16 49.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.332 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -109.22 165.21 11.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.952 0.406 . . . . 0.0 111.422 -179.559 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.65 137.22 53.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.681 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -59.25 85.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.138 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.06 14.36 2.75 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.163 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -81.68 166.88 19.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.89 0.345 . . . . 0.0 110.807 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -92.52 -24.29 18.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.152 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -157.79 -167.89 2.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.755 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -103.6 31.05 4.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.892 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.45 0.06 80.06 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.085 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.428 ' CE2' HG22 ' A' ' 51' ' ' VAL . 18.4 p90 -172.41 153.74 3.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.985 0.392 . . . . 0.0 111.461 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.9 p -119.03 148.01 43.48 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.552 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.429 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 30.5 m -113.35 157.6 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.474 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -114.14 177.54 4.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.208 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.79 160.86 21.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.27 115.29 2.49 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.389 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.61 -35.23 12.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.11 0.481 . . . . 0.0 111.191 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 tp -84.26 -53.78 5.25 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.055 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.4 mm-40 -90.53 16.37 9.09 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.558 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 46' ' ' GLU . 3.5 mmtt 29.05 82.91 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 174.97 -150.87 11.52 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.492 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.429 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 88.8 t -138.38 139.83 40.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.824 0.345 . . . . 0.0 110.914 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -139.51 162.72 34.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.605 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.428 HG22 ' CE2' ' A' ' 38' ' ' PHE . 50.1 t -62.36 162.0 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.592 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.8 pttt -147.0 -35.36 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 0.0 111.579 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 15.6 m-80 -144.49 139.03 28.02 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.981 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.425 HG12 ' HB2' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -132.95 133.97 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.0 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -65.89 142.4 98.06 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.913 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 55' ' ' ARG . 34.7 Cg_exo -57.66 127.19 24.35 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.544 2.162 . . . . 0.0 112.531 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 43.28 30.79 0.33 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.875 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.92 -159.48 32.52 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.935 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -51.87 -55.92 3.44 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.312 2.008 . . . . 0.0 111.876 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.93 -38.66 86.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.671 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -73.37 -32.63 64.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.967 0.413 . . . . 0.0 110.183 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.6 mt -77.32 -30.39 54.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.842 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.28 -56.67 6.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.426 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.97 33.23 0.93 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.656 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.7 pp -118.5 132.06 56.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 110.905 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.467 ' CB ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -117.87 169.51 7.53 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.783 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 1.6 Cg_endo -44.63 146.14 2.35 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.646 2.231 . . . . 0.0 112.239 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.486 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 8.5 m-85 91.14 -21.13 0.11 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.095 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -53.75 85.49 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.166 0.508 . . . . 0.0 110.669 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -68.49 105.91 2.37 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.195 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mp -63.07 107.9 1.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.425 ' HA ' ' CG ' ' A' ' 80' ' ' ARG . 10.0 mt -83.38 -65.85 0.96 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.17 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -119.38 126.82 52.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.157 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.1 t -109.62 107.1 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.712 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 74.65 -58.59 0.58 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.139 0.495 . . . . 0.0 110.537 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -167.22 -18.02 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.951 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.36 125.27 40.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-O 120.792 0.329 . . . . 0.0 111.129 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.65 84.36 0.45 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.649 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.415 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 17.7 p -94.62 43.94 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.17 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.425 ' CG ' ' HA ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -80.99 -47.02 14.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.646 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -92.93 21.29 5.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.055 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 79' ' ' THR . 3.2 m-85 -81.69 170.82 15.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.702 0.287 . . . . 0.0 110.954 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -106.26 160.26 15.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.404 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 7.4 p -51.76 -42.12 62.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 110.694 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.7 m -63.44 -23.28 67.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.236 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.448 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -93.63 -31.13 14.6 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.906 0.384 . . . . 0.0 110.95 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.7 t -79.62 -35.95 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.359 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.628 ' HB ' ' HD3' ' A' ' 89' ' ' PRO . 95.1 t -57.14 -50.84 85.86 Favored Pre-proline 0 C--N 1.331 -0.219 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.938 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.628 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 12.0 Cg_exo -70.43 -47.14 0.77 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.509 2.14 . . . . 0.0 111.512 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.437 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 44.8 mt -53.92 -30.75 47.62 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.517 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.444 HG22 ' CD2' ' A' ' 36' ' ' PHE . 63.9 mt -78.28 -42.04 26.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.505 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.41 -4.69 40.94 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.437 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 10.3 pt-20 -107.38 -3.44 19.58 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.418 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 6.9 t -64.38 -15.99 61.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.801 0.334 . . . . 0.0 111.411 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.5 -144.61 17.41 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.592 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.39 -10.67 59.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.55 0.214 . . . . 0.0 111.425 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -140.76 157.29 45.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.813 0.34 . . . . 0.0 110.97 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -138.33 97.2 3.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.033 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.14 118.23 31.25 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.37 164.03 35.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.257 0.551 . . . . 0.0 112.025 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.405 HG11 ' CD2' ' A' ' 22' ' ' LEU . 48.4 t -115.79 108.93 26.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.103 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.5 pp -101.82 169.27 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.409 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.17 122.18 15.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.676 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -133.48 138.66 46.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.153 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -80.93 154.5 72.91 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.7 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo . . . . . 0 C--O 1.25 1.092 0 C-N-CA 122.497 2.131 . . . . 0.0 112.304 179.94 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.4 m . . . . . 0 CA--C 1.527 0.074 0 CA-C-O 120.814 0.34 . . . . 0.0 111.748 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -123.45 122.38 38.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.597 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.401 HD22 HD13 ' A' ' 72' ' ' LEU . 15.5 mt -62.63 138.99 58.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.712 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -145.09 120.82 10.52 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.677 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.13 113.2 11.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.42 139.84 42.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.144 0.497 . . . . 0.0 111.849 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.7 m -134.03 106.43 7.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.955 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.42 HD23 ' CD2' ' A' ' 38' ' ' PHE . 2.3 mp -99.91 168.41 9.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.919 0.39 . . . . 0.0 111.483 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 96' ' ' ASN . 4.9 m-85 -124.92 143.95 50.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.748 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -104.83 159.45 15.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.113 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -129.97 140.97 50.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.92 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.7 p -57.97 -28.73 64.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.064 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.47 -22.53 46.99 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.683 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 18.0 mmm -81.0 162.44 23.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.369 . . . . 0.0 110.959 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.84 -10.56 15.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.325 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.63 -166.97 2.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.798 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 7.5 m-85 -97.46 32.75 2.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.201 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 48.39 40.63 23.44 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.209 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.615 ' HB2' ' CD1' ' A' ' 54' ' ' ILE . 0.1 OUTLIER -174.65 116.37 0.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.076 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.43 155.19 19.37 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 121.112 0.482 . . . . 0.0 112.155 -177.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.423 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 34.1 m -116.1 169.86 6.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.07 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -129.51 176.74 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.87 0.367 . . . . 0.0 111.358 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.8 140.76 30.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.764 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.71 103.57 1.65 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.521 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 mp -94.17 -31.54 14.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.184 0.516 . . . . 0.0 110.828 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.28 -3.91 58.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.506 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 47' ' ' LYS . 11.2 mt-10 -153.07 27.01 0.53 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.098 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 26.99 95.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 159.99 -155.46 26.58 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.435 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.423 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 80.5 t -141.76 138.01 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.328 . . . . 0.0 111.042 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.45 ' CD1' ' HG3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -134.43 165.09 25.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.41 179.835 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.425 HG12 ' CD1' ' A' ' 54' ' ' ILE . 3.8 t -63.84 162.76 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.625 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.4 -36.97 0.28 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.028 0.442 . . . . 0.0 111.325 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 2.0 m-80 -140.24 145.21 37.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.326 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.615 ' CD1' ' HB2' ' A' ' 38' ' ' PHE . 5.0 mm -134.92 119.07 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.907 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.56 131.98 94.93 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.714 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.469 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 67.1 Cg_endo -74.0 121.82 7.22 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.491 2.127 . . . . 0.0 112.443 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 56' ' ' PRO . . . 87.77 -20.8 0.19 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.73 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.16 -170.74 30.87 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.415 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -51.93 -25.77 22.82 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.529 2.153 . . . . 0.0 112.247 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.47 -45.83 88.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.367 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -73.55 -33.03 64.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.947 0.403 . . . . 0.0 110.3 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.3 mt -62.07 -37.97 87.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.821 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.16 -52.05 5.45 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.38 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.35 44.99 1.91 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.611 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.43 HD11 ' CG ' ' A' ' 38' ' ' PHE . 0.5 OUTLIER -111.56 126.21 54.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.928 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.8 mttp -75.12 164.69 59.58 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.107 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.62 64.78 3.83 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.767 2.311 . . . . 0.0 112.366 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.436 ' O ' ' N ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -176.32 -25.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.527 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.487 ' HA ' ' HB2' ' A' ' 104' ' ' ARG . 71.1 m-20 -39.56 90.84 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.455 0.645 . . . . 0.0 111.852 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.45 ' HG3' ' CD1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -67.63 99.3 0.77 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.644 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.72 111.68 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.527 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.453 ' HA ' ' CG ' ' A' ' 80' ' ' ARG . 6.5 mt -82.97 -44.82 14.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.693 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.6 142.37 32.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.762 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.8 t -129.85 152.04 36.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.88 0.371 . . . . 0.0 111.492 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.0 m120 40.21 31.85 0.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.98 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 76.01 42.98 0.18 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.845 0.355 . . . . 0.0 110.898 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 72.8 t -152.15 152.95 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.05 129.06 38.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.73 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.43 HG22 ' CE2' ' A' ' 82' ' ' PHE . 66.8 p -144.47 28.14 1.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.017 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.453 ' CG ' ' HA ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -83.74 -44.95 13.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.736 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -92.28 15.77 13.03 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.34 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.43 ' CE2' HG22 ' A' ' 79' ' ' THR . 5.5 m-30 -81.85 167.53 18.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.872 0.368 . . . . 0.0 110.903 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.81 162.05 14.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.455 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.421 ' N ' HG22 ' A' ' 49' ' ' VAL . 22.9 p -51.8 -38.64 56.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.762 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 16.1 p -65.89 -24.6 66.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.4 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.483 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -93.4 -29.2 15.71 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.012 0.434 . . . . 0.0 110.913 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.0 -35.57 20.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.311 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.643 ' HB ' ' HD3' ' A' ' 89' ' ' PRO . 94.1 t -58.79 -51.16 83.82 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.791 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.643 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 17.0 Cg_exo -67.11 -44.54 4.94 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.555 2.17 . . . . 0.0 111.428 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.462 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 8.0 mt -54.07 -30.99 50.39 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.072 0.463 . . . . 0.0 110.431 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.498 ' HA ' HD11 ' A' ' 98' ' ' LEU . 71.6 mt -79.08 -48.86 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.128 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.5 -4.16 28.78 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.462 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -103.39 8.19 38.07 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.41 -39.43 93.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.227 0.537 . . . . 0.0 110.238 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.59 -47.28 1.11 Allowed Glycine 0 C--N 1.32 -0.36 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.009 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -166.35 -36.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.682 0.277 . . . . 0.0 111.388 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -123.49 114.47 20.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.428 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -100.99 97.58 8.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.548 -179.256 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -95.91 118.12 31.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 pp -146.44 156.04 43.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.993 0.425 . . . . 0.0 111.892 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.5 t -106.34 109.37 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.26 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.432 ' HB ' ' HB3' ' A' ' 69' ' ' ASP . 2.6 pp -106.28 170.12 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.46 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.5 130.78 22.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.787 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.487 ' HB2' ' HA ' ' A' ' 69' ' ' ASP . 0.6 OUTLIER -148.03 139.73 23.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.919 0.39 . . . . 0.0 111.123 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.403 ' N ' ' HG2' ' A' ' 104' ' ' ARG . 1.4 p-10 -79.48 120.88 81.82 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.397 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo . . . . . 0 C--O 1.248 0.999 0 C-N-CA 122.324 2.016 . . . . 0.0 112.232 -179.812 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.7 m . . . . . 0 C--O 1.231 0.098 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.76 122.32 38.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.324 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.0 mt -60.46 149.16 35.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.089 0.471 . . . . 0.0 111.759 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.5 117.91 3.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.193 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -70.73 131.97 44.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.85 141.32 45.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 0.0 111.229 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.1 m -134.63 109.48 8.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.237 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.1 mt -107.15 166.49 10.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.015 0.436 . . . . 0.0 111.726 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -121.03 147.08 46.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.491 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.14 155.1 17.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.939 0.4 . . . . 0.0 111.124 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.04 156.53 23.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.828 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.4 t -68.27 82.59 0.24 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.026 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.41 21.95 5.32 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.725 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.77 124.62 29.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 0.0 110.817 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -72.13 -10.9 60.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.343 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.33 -175.14 5.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.726 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -106.9 29.82 6.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.844 0.354 . . . . 0.0 111.115 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.3 7.47 72.86 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.623 -0.798 . . . . 0.0 113.114 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.466 ' HB2' HG12 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -171.6 148.69 2.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.038 0.419 . . . . 0.0 111.608 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 52' ' ' LYS . 2.4 m -117.84 144.57 45.28 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.594 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.428 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 27.1 m -112.39 165.61 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.775 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -129.6 161.59 30.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.051 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.4 p-10 -72.49 167.37 20.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.89 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.74 126.26 8.4 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.354 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.47 0.14 55.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.49 0.186 . . . . 0.0 111.422 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 93.0 mt -154.05 19.7 0.51 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.501 0.191 . . . . 0.0 111.355 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.463 ' O ' ' C ' ' A' ' 47' ' ' LYS . 81.8 mm-40 -155.36 22.24 0.42 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.196 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER 24.82 50.22 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.433 0.458 . . . . 0.0 112.129 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.25 -166.21 11.63 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.535 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.428 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 72.2 t -135.22 139.7 46.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.889 0.376 . . . . 0.0 111.219 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.51 153.99 47.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.507 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.452 HG12 ' CD1' ' A' ' 54' ' ' ILE . 51.4 t -57.07 162.21 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.616 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 39' ' ' SER . 0.1 OUTLIER -142.85 -34.13 0.44 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.876 0.369 . . . . 0.0 111.591 -179.419 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 37.2 m-80 -144.28 123.95 13.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.466 HG12 ' HB2' ' A' ' 38' ' ' PHE . 1.1 mt -123.57 123.25 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.268 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.95 117.36 44.84 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.411 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.48 56.4 2.18 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.468 2.112 . . . . 0.0 112.599 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -173.04 -51.63 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.143 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.86 -170.48 0.29 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.654 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.35 -31.87 58.99 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.626 2.217 . . . . 0.0 112.36 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.83 -51.58 56.14 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.575 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -73.48 -33.01 64.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.958 0.408 . . . . 0.0 110.396 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 90.1 mt -59.38 -41.64 89.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.031 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.1 -50.93 6.47 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.543 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.26 42.56 0.35 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.442 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.42 ' CB ' ' CD1' ' A' ' 54' ' ' ILE . 19.3 mt -91.42 147.54 22.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.783 0.325 . . . . 0.0 110.845 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.23 161.88 55.01 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 50.9 Cg_exo -53.82 147.92 39.43 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.596 2.197 . . . . 0.0 112.154 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.465 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 4.8 m-85 88.62 -12.55 0.42 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.229 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.435 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 1.1 m-20 -52.88 85.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.93 0.395 . . . . 0.0 110.965 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 68' ' ' TYR . 21.2 ttm180 -74.04 95.12 2.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.462 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 mt -56.26 112.24 1.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.429 HD21 ' CG ' ' A' ' 80' ' ' ARG . 4.9 mt -81.2 -64.0 1.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.64 140.53 46.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.095 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.411 ' O ' ' CG1' ' A' ' 77' ' ' VAL . 24.3 t -118.6 116.16 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.002 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.461 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 0.2 OUTLIER 68.74 28.25 5.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.613 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.461 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER 85.81 -7.03 0.82 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.648 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.411 ' CG1' ' O ' ' A' ' 74' ' ' VAL . 4.6 p -83.97 134.61 26.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 120.818 0.342 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.4 mtt85 -70.56 118.2 13.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.95 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.428 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 30.6 p -145.47 35.94 1.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.429 ' CG ' HD21 ' A' ' 72' ' ' LEU . 1.6 ttp180 -75.87 -48.74 20.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.817 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -92.82 25.58 3.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.063 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.428 ' CD1' ' HA ' ' A' ' 79' ' ' THR . 2.4 m-85 -81.75 170.08 16.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.957 0.408 . . . . 0.0 110.861 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.21 159.09 16.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.272 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 6.5 p -51.38 -41.53 60.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 110.726 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.2 m -63.36 -24.57 67.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.164 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.47 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 10.9 mp -91.09 -30.29 16.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.012 0.434 . . . . 0.0 110.847 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.7 t -79.3 -35.82 17.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.28 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.642 ' HB ' ' HD3' ' A' ' 89' ' ' PRO . 68.0 t -55.3 -51.3 80.95 Favored Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.696 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 14.5 Cg_exo -68.33 -46.53 2.03 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.39 2.06 . . . . 0.0 111.294 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 15.4 mt -54.65 -29.38 52.2 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.008 0.433 . . . . 0.0 110.421 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.448 HG23 ' CD1' ' A' ' 98' ' ' LEU . 47.7 mt -73.91 -51.56 23.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.205 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.39 -2.74 36.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.884 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -92.15 -7.47 48.34 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 t -64.59 -16.51 62.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.873 0.368 . . . . 0.0 111.609 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.56 -52.68 3.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.687 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -165.98 -45.75 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.75 0.309 . . . . 0.0 110.985 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -101.04 107.22 18.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.475 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.484 ' HB2' ' CE1' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -95.96 97.84 9.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.579 -179.428 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -101.34 118.2 36.49 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 pp -147.87 163.56 36.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.105 0.478 . . . . 0.0 112.088 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.85 109.4 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.217 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -103.95 169.37 2.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.216 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 71.5 p -126.29 107.63 10.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.555 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.42 113.45 25.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.345 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.72 158.76 49.23 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.935 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 C--O 1.25 1.108 0 C-N-CA 122.578 2.185 . . . . 0.0 112.394 -179.908 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.49 ' HA ' ' N ' ' A' ' 105' ' ' ASN . 28.5 m . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 120.974 0.416 . . . . 0.0 111.493 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -139.45 122.5 16.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.91 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.401 ' CD2' HD13 ' A' ' 72' ' ' LEU . 11.9 mt -59.74 136.47 58.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.082 0.468 . . . . 0.0 111.667 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.438 ' CE1' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -152.47 119.07 5.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.127 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.16 130.45 42.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.68 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.438 HG11 ' CE1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -131.45 140.83 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.071 0.462 . . . . 0.0 111.343 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.9 m -134.41 106.92 7.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.944 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 mt -106.88 174.46 5.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.002 0.43 . . . . 0.0 111.543 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' A' ' 96' ' ' ASN . 42.5 m-85 -123.07 165.67 16.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.693 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -128.34 120.68 27.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.852 0.358 . . . . 0.0 111.437 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.41 128.32 35.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.464 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.14 -29.22 0.87 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.751 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.32 -38.36 8.42 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.847 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.82 146.7 28.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.877 0.37 . . . . 0.0 111.206 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -103.04 -33.29 9.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.286 0.565 . . . . 0.0 110.603 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.35 152.64 23.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.285 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.503 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 0.8 OUTLIER -91.13 15.19 12.22 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.569 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.08 23.54 57.01 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.39 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.457 ' CE1' HG22 ' A' ' 51' ' ' VAL . 6.5 p90 -174.15 119.82 0.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.179 0.49 . . . . 0.0 111.549 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.1 m -91.88 154.14 19.06 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.631 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.434 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 24.1 m -112.17 170.93 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.011 0.434 . . . . 0.0 111.688 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -139.09 164.36 29.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.021 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -72.79 154.85 40.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.911 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.99 109.13 0.95 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.394 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.7 mt -94.28 -25.41 17.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.432 . . . . 0.0 111.182 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.9 tp -83.81 -6.71 59.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.532 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 47' ' ' LYS . 5.2 mt-10 -153.1 27.39 0.52 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.935 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER 26.54 78.48 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.127 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.02 -152.0 9.51 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.475 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.434 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 23.8 t -144.49 138.42 23.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.875 0.369 . . . . 0.0 111.264 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -130.61 174.37 9.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.313 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.488 ' HB ' ' OD1' ' A' ' 69' ' ' ASP . 58.3 t -78.72 122.89 34.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.039 0.447 . . . . 0.0 111.255 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.408 ' HG3' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -89.1 -29.53 19.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.777 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.408 ' ND2' ' HG3' ' A' ' 52' ' ' LYS . 38.7 m-80 -157.59 155.3 29.92 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.35 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -137.85 130.7 41.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.561 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.38 127.4 92.14 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.873 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -56.49 140.02 88.46 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.454 2.103 . . . . 0.0 112.367 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 39.27 33.35 0.09 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.931 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.6 -161.75 21.32 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.259 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -57.6 -42.9 55.7 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.366 2.044 . . . . 0.0 112.147 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.87 -44.98 90.93 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.787 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.37 -32.62 64.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.028 0.442 . . . . 0.0 110.405 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.2 mt -67.54 -30.93 70.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.737 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.8 -38.6 13.46 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.395 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.53 31.52 1.64 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.565 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.423 HD12 ' CE2' ' A' ' 38' ' ' PHE . 28.4 mt -83.7 123.24 29.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.859 0.362 . . . . 0.0 111.021 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -113.88 138.59 22.83 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.55 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 77.6 Cg_exo -40.44 139.87 1.07 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.933 2.422 . . . . 0.0 113.144 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 48.9 m-85 88.7 -13.12 0.4 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.64 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.488 ' OD1' ' HB ' ' A' ' 51' ' ' VAL . 8.4 p-10 -55.99 85.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.064 0.459 . . . . 0.0 110.562 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.45 ' N ' ' O ' ' A' ' 68' ' ' TYR . 10.1 ttm180 -66.58 118.15 9.77 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.87 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 mt -72.5 112.07 8.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.286 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 80' ' ' ARG . 5.0 mp -84.67 -67.07 0.82 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -115.5 110.42 19.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.433 ' HA ' ' HB3' ' A' ' 100' ' ' LEU . 46.6 t -102.75 143.05 15.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.874 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 0.5 OUTLIER 46.58 29.58 0.95 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.29 -179.687 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.456 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER 85.9 -19.1 0.32 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.773 179.658 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.0 t -83.98 136.0 23.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.818 0.342 . . . . 0.0 111.203 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -69.15 116.57 9.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.252 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.466 ' HB ' ' CD2' ' A' ' 82' ' ' PHE . 32.2 p -141.53 38.77 1.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.412 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -69.87 -46.57 65.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.589 179.679 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -94.38 27.81 2.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.44 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.466 ' CD2' ' HB ' ' A' ' 79' ' ' THR . 2.5 m-30 -81.09 176.3 9.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.811 0.338 . . . . 0.0 110.657 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -108.26 158.79 17.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.511 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 5.3 p -51.56 -41.88 61.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 110.654 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 37.3 m -63.15 -21.74 66.4 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.08 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.48 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 7.7 mp -96.48 -33.16 11.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.002 0.429 . . . . 0.0 111.022 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.8 t -77.61 -36.05 22.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.374 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.652 ' HB ' ' HD3' ' A' ' 89' ' ' PRO . 93.3 t -58.54 -51.29 82.89 Favored Pre-proline 0 C--N 1.33 -0.241 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.79 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.652 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.5 Cg_exo -67.32 -40.93 10.01 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.334 2.023 . . . . 0.0 111.528 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.426 HD13 ' CE2' ' A' ' 82' ' ' PHE . 25.3 mt -54.55 -33.88 60.89 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.027 0.441 . . . . 0.0 110.763 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.411 HG23 ' CD1' ' A' ' 98' ' ' LEU . 25.0 mt -78.34 -44.33 26.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.125 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.22 -2.75 49.95 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.81 6.66 34.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.436 ' HB2' ' HG ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -63.39 -35.1 79.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.371 0.605 . . . . 0.0 110.253 179.481 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.85 -41.87 2.21 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.719 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 6.1 m-80 -166.82 -35.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.511 0.196 . . . . 0.0 111.328 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp -122.76 131.58 53.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.692 0.282 . . . . 0.0 110.942 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.503 ' HB2' ' CE1' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -120.62 97.49 5.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.433 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -96.36 118.4 32.81 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.433 ' HB3' ' HA ' ' A' ' 74' ' ' VAL . 2.6 pp -150.22 162.52 40.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.342 0.592 . . . . 0.0 112.451 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.0 t -114.17 109.1 27.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.699 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 69' ' ' ASP . 2.6 pp -104.07 169.45 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.465 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.73 112.39 11.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.766 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.63 133.42 43.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.001 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.49 ' N ' ' HA ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -62.71 152.01 82.91 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.77 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 C--O 1.248 1.023 0 C-N-CA 122.568 2.179 . . . . 0.0 112.273 -179.927 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.461 0.122 0 CA-C-O 121.01 0.433 . . . . 0.0 112.139 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -121.53 122.45 39.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.393 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.7 mt -60.87 140.65 57.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.313 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -146.52 106.62 4.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.936 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -71.44 109.49 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.047 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.89 141.26 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.115 0.484 . . . . 0.0 111.8 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 95.5 m -133.06 106.63 7.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.866 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.8 mt -105.21 -177.59 3.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.933 0.397 . . . . 0.0 111.608 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.417 ' CD2' ' HG2' ' A' ' 97' ' ' LYS . 16.2 m-85 -135.83 153.59 51.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.529 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -116.1 164.77 13.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.031 0.444 . . . . 0.0 111.423 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -106.16 152.9 22.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.672 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.25 -28.8 29.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.338 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.49 36.71 2.05 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.644 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.4 ttt -81.68 149.14 28.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.748 0.308 . . . . 0.0 110.926 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -96.04 -10.91 27.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.204 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -156.82 176.11 13.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.646 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -102.36 27.07 7.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.168 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.62 5.24 84.64 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.263 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.462 ' CD2' ' CG2' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -173.03 141.67 1.0 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.017 0.437 . . . . 0.0 111.475 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.5 m -107.72 153.42 22.96 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.352 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.434 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 32.6 m -118.58 164.97 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.393 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -132.73 141.66 48.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.08 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -55.98 164.88 1.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.112 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.79 140.56 16.42 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.339 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.72 -58.33 2.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.108 0.48 . . . . 0.0 111.423 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.13 -41.98 16.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.726 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 47' ' ' LYS . 18.0 mt-10 -88.4 10.68 19.17 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.616 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 26.36 78.2 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -169.54 -139.16 2.65 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.488 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.434 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 41.7 t -155.8 138.41 6.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.602 0.239 . . . . 0.0 111.109 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.76 156.48 47.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.829 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.462 ' CG2' ' CD2' ' A' ' 38' ' ' PHE . 62.0 t -64.03 121.17 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.989 0.423 . . . . 0.0 111.249 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.97 -30.64 17.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.181 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -160.34 154.99 23.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.503 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.435 HG12 ' HB2' ' A' ' 38' ' ' PHE . 1.1 mt -133.44 125.94 51.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.1 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.51 114.7 16.81 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.71 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 50.1 Cg_exo -53.62 125.07 17.4 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.293 1.996 . . . . 0.0 112.185 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.478 ' CB ' ' O ' ' A' ' 56' ' ' PRO . . . 89.14 -28.88 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.586 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.86 -179.66 1.27 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.472 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -51.69 -34.6 54.42 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.601 2.201 . . . . 0.0 112.293 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.97 -46.71 94.04 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.592 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.42 -32.71 64.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.983 0.42 . . . . 0.0 110.357 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.4 mt -63.02 -32.76 74.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.897 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -86.44 -46.63 5.17 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.55 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.81 33.89 0.96 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.765 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.417 ' CB ' ' CD1' ' A' ' 54' ' ' ILE . 24.6 mt -73.85 145.94 44.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.775 0.321 . . . . 0.0 110.859 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.411 ' CD ' ' NH1' ' A' ' 104' ' ' ARG . 11.5 mttm -125.64 159.16 62.22 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.968 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.423 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 15.7 Cg_endo -56.96 141.6 93.72 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.76 2.306 . . . . 0.0 112.13 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.546 ' O ' ' N ' ' A' ' 70' ' ' ARG . 31.5 m-85 84.42 0.62 0.9 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.245 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.442 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 3.2 m-20 -52.97 80.33 0.0 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.976 0.417 . . . . 0.0 110.733 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.546 ' N ' ' O ' ' A' ' 68' ' ' TYR . 41.0 ttp180 -66.82 103.86 1.21 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.148 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.404 ' HG ' HG21 ' A' ' 102' ' ' ILE . 3.5 mp -63.2 107.39 1.04 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.809 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.427 ' HA ' ' HG3' ' A' ' 80' ' ' ARG . 8.2 mt -84.98 -67.23 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 0.0 111.155 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -116.21 112.85 22.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.073 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.402 ' CG1' HD22 ' A' ' 98' ' ' LEU . 40.9 t -103.71 125.28 58.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.963 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.459 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 1.1 m-80 45.69 36.9 2.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.398 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.459 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.4 OUTLIER 87.49 -22.66 0.14 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.736 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.0 t -83.39 134.9 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.321 . . . . 0.0 111.141 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -69.38 136.01 51.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.403 ' HA ' ' CG ' ' A' ' 82' ' ' PHE . 76.2 p -144.91 25.02 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.179 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.427 ' HG3' ' HA ' ' A' ' 72' ' ' LEU . 3.4 mtm180 -71.98 -48.45 44.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.883 0.373 . . . . 0.0 110.62 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -92.59 16.03 12.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.363 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.422 ' CE2' HD22 ' A' ' 86' ' ' LEU . 3.3 m-85 -82.05 176.41 9.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.86 0.362 . . . . 0.0 110.818 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.87 160.46 18.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.559 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 6.4 p -51.62 -34.82 39.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.725 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 96.0 m -70.15 -21.69 63.05 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.223 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.601 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 0.5 OUTLIER -97.59 -32.32 11.85 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 111.014 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.413 HG21 ' HB ' ' A' ' 49' ' ' VAL . 46.3 t -79.92 -35.94 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.453 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.618 ' CG1' ' HD3' ' A' ' 89' ' ' PRO . 3.7 p -61.87 -41.2 75.53 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.606 -0.437 . . . . 0.0 111.439 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.618 ' HD3' ' CG1' ' A' ' 88' ' ' VAL . 72.3 Cg_endo -74.55 -45.55 0.32 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 121.806 1.67 . . . . 0.0 111.316 178.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.417 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 36.3 mt -54.48 -29.38 49.84 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.347 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.438 HG21 ' CD2' ' A' ' 36' ' ' PHE . 62.2 mt -78.45 -47.12 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.55 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.63 -3.97 31.37 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.417 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -112.26 -0.64 15.41 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.764 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.404 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 16.5 m -64.79 -16.41 63.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.834 0.35 . . . . 0.0 111.139 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.91 -148.37 18.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.586 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -73.5 -8.52 56.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.616 0.246 . . . . 0.0 111.419 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.417 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -140.96 147.85 39.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.737 0.303 . . . . 0.0 110.863 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -132.13 97.45 4.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.219 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.53 118.3 31.18 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.412 ' CD1' ' CG2' ' A' ' 102' ' ' ILE . 1.9 pp -149.85 154.93 39.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.168 0.509 . . . . 0.0 112.096 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.5 t -111.53 109.16 27.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.954 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 70' ' ' ARG . 2.7 pp -105.82 166.1 3.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.01 0.433 . . . . 0.0 111.596 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.7 p -134.12 129.09 35.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.551 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.442 ' HG3' ' HB2' ' A' ' 68' ' ' TYR . 6.0 ttp180 -127.74 135.78 50.61 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.033 0.444 . . . . 0.0 111.48 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -96.82 111.59 57.93 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.404 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.236 1.958 . . . . 0.0 112.356 -179.86 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 105' ' ' ASN . 35.2 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.002 0.429 . . . . 0.0 111.929 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.54 122.05 45.22 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.581 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 4.4 pp -100.33 153.15 19.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.199 0.523 . . . . 0.0 112.264 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.452 ' CD2' ' CD1' ' A' ' 102' ' ' ILE . 20.9 p80 -144.9 152.22 39.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.698 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -78.55 104.25 9.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.448 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.22 144.62 11.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.364 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.4 m -135.09 106.42 6.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.84 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 mp -105.36 175.18 5.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.033 0.444 . . . . 0.0 111.357 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.451 ' N ' ' CD1' ' A' ' 28' ' ' TYR . 1.5 m-85 -131.51 155.88 46.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.248 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -118.46 149.77 40.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.914 0.388 . . . . 0.0 111.322 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.15 152.85 31.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.741 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.2 m -63.62 -26.25 68.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.257 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.26 1.75 46.96 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.08 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 3.3 mmt -81.78 124.57 29.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.896 0.379 . . . . 0.0 110.976 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.03 -10.77 59.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.365 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -155.59 -167.92 2.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.641 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -105.46 17.49 23.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.559 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.19 7.15 65.91 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.531 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.499 ' HB2' HG12 ' A' ' 54' ' ' ILE . 25.6 p90 -173.62 145.79 1.24 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.26 0.53 . . . . 0.0 111.716 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.75 146.68 41.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.191 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.437 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 34.6 m -105.31 171.02 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.662 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -131.08 178.13 6.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.948 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -89.98 129.0 36.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.808 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.12 100.5 2.36 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.272 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.3 -24.05 17.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.964 0.411 . . . . 0.0 111.176 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.52 -10.98 57.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.32 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 47' ' ' LYS . 3.0 mt-10 -153.36 33.51 0.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.968 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 25.24 91.42 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.173 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 173.13 -162.76 34.19 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.42 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.463 HG21 ' N ' ' A' ' 84' ' ' CYS . 64.8 t -139.4 132.1 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.79 0.329 . . . . 0.0 110.749 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -131.87 163.39 28.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.74 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.408 HG22 ' CD2' ' A' ' 38' ' ' PHE . 66.7 t -72.37 122.57 25.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.747 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -87.39 -31.0 20.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.422 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -162.67 145.72 11.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.486 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.499 HG12 ' HB2' ' A' ' 38' ' ' PHE . 1.4 mt -127.48 133.59 67.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.943 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.08 144.49 99.07 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.814 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.23 144.03 45.32 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.516 2.144 . . . . 0.0 112.373 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 39.06 33.83 0.09 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.976 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -109.97 -168.14 19.85 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.39 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.2 -39.71 70.94 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.513 2.142 . . . . 0.0 112.152 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.39 -36.08 50.73 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.609 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -73.51 -32.83 64.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.027 0.441 . . . . 0.0 110.258 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.0 mt -77.28 -30.68 54.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.804 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.02 -47.81 29.54 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.369 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.46 35.27 1.01 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.554 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.447 ' CD1' ' CE1' ' A' ' 38' ' ' PHE . 13.2 mt -91.1 124.0 34.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.785 0.326 . . . . 0.0 110.998 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.24 156.1 35.66 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.831 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.447 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 53.6 Cg_exo -51.8 136.27 50.79 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.52 2.146 . . . . 0.0 112.227 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.448 ' O ' ' N ' ' A' ' 70' ' ' ARG . 9.9 m-85 85.5 7.49 0.4 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.004 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -53.56 85.84 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.044 0.449 . . . . 0.0 110.993 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 68' ' ' TYR . 28.6 ttt85 -72.31 96.86 1.91 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.629 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 mp -53.33 107.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.104 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.442 ' HA ' ' CG ' ' A' ' 80' ' ' ARG . 3.2 mp -82.17 -62.37 1.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.376 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -133.79 130.01 37.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.874 0.369 . . . . 0.0 111.281 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.403 ' O ' ' CG1' ' A' ' 77' ' ' VAL . 20.1 t -113.66 112.95 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.809 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 5.4 m-80 66.54 30.27 8.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.636 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.467 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 1.6 t-80 87.21 -12.12 0.53 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.892 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.403 ' CG1' ' O ' ' A' ' 74' ' ' VAL . 4.3 p -84.13 143.08 12.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.893 0.378 . . . . 0.0 111.06 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 mtp85 -70.08 125.47 26.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.424 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 52.8 p -146.39 19.69 1.36 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.348 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.442 ' CG ' ' HA ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -66.23 -52.96 42.7 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.953 0.406 . . . . 0.0 110.623 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -94.77 29.33 2.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.239 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.448 ' CE2' ' CD2' ' A' ' 86' ' ' LEU . 1.8 m-30 -80.97 171.79 14.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.858 0.361 . . . . 0.0 110.82 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -107.26 157.62 17.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.499 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.463 ' N ' HG21 ' A' ' 49' ' ' VAL . 5.7 p -51.49 -38.52 54.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.929 0.395 . . . . 0.0 110.445 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 18.9 m -65.67 -21.56 66.56 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.054 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.462 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -95.4 -32.12 13.07 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.094 0.474 . . . . 0.0 110.605 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.0 t -78.26 -35.79 20.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.303 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.635 ' HB ' ' HD3' ' A' ' 89' ' ' PRO . 93.7 t -58.67 -51.01 84.92 Favored Pre-proline 0 C--N 1.331 -0.23 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.975 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.635 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.0 Cg_exo -68.01 -45.64 2.87 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.477 2.118 . . . . 0.0 111.634 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.408 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 36.6 mt -54.5 -30.25 52.82 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.998 0.428 . . . . 0.0 110.574 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.43 ' HA ' ' CD1' ' A' ' 98' ' ' LEU . 70.9 mt -79.17 -49.55 19.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.079 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.48 -2.59 29.56 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.408 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -102.07 -1.14 32.26 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.203 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.406 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -64.82 -30.87 71.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.185 0.516 . . . . 0.0 110.768 179.719 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.38 -63.09 0.84 Allowed Glycine 0 C--N 1.322 -0.248 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.252 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.416 ' HA ' ' CB ' ' A' ' 29' ' ' LYS . 18.8 p30 -162.71 18.29 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.528 0.204 . . . . 0.0 111.3 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.429 ' HE2' ' CE2' ' A' ' 28' ' ' TYR . 3.8 ttmt -161.8 116.77 1.97 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -116.16 98.87 6.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.897 -179.141 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -98.52 117.98 34.18 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 pp -151.69 164.74 36.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.167 0.508 . . . . 0.0 112.097 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.5 t -107.5 109.97 30.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.942 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 2.4 pp -100.44 153.75 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.22 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.53 127.3 52.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.496 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.21 129.88 11.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.996 0.427 . . . . 0.0 111.682 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 3.4 p30 -62.78 158.23 53.58 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.785 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 122.531 2.154 . . . . 0.0 112.289 -179.951 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 105' ' ' ASN . 19.6 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.073 0.463 . . . . 0.0 112.171 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -106.92 124.51 49.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 4.7 pp -105.07 153.51 21.38 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -145.85 156.41 43.54 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.597 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.19 110.64 18.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.25 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.421 ' CG1' ' HG ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -111.75 146.14 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.596 -179.271 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.6 m -134.21 106.64 7.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.314 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 mp -93.53 174.76 7.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.947 0.403 . . . . 0.0 111.561 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.421 ' CD1' ' HG3' ' A' ' 97' ' ' LYS . 81.1 m-85 -132.3 141.44 48.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.171 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -116.25 163.14 16.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.878 0.37 . . . . 0.0 111.418 -179.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.75 140.13 52.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.749 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 90.3 p -61.75 84.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.055 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 123.86 19.67 2.69 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.075 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.79 167.88 18.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.778 0.323 . . . . 0.0 110.8 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -97.52 -18.36 19.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.207 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.62 -171.25 3.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.667 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -108.71 19.21 19.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.301 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.87 0.46 42.15 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.066 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.485 ' HB2' HG12 ' A' ' 54' ' ' ILE . 14.4 p90 -172.85 145.01 1.39 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.943 0.402 . . . . 0.0 111.453 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.1 m -98.19 138.5 35.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.172 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . 35.8 m -93.74 171.07 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.698 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -136.3 178.19 7.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.093 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.57 131.33 45.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.738 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.43 ' HA3' ' CZ ' ' A' ' 50' ' ' TYR . . . -104.0 108.96 3.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.528 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -94.48 -25.15 17.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.001 0.429 . . . . 0.0 111.069 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.94 -7.36 59.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.592 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 47' ' ' LYS . 5.2 mt-10 -153.17 25.22 0.54 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.168 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 27.38 80.86 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -170.22 -156.39 11.15 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.695 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.403 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 95.2 t -137.68 131.24 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.806 0.336 . . . . 0.0 111.044 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.43 ' CZ ' ' HA3' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -128.56 172.41 11.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.246 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.418 HG22 ' CE1' ' A' ' 38' ' ' PHE . 88.7 t -90.77 123.68 43.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.83 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -86.99 -30.73 21.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.362 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -161.76 144.9 12.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.652 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.485 HG12 ' HB2' ' A' ' 38' ' ' PHE . 1.7 mt -126.08 135.84 62.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.996 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.6 mtt180 -65.37 143.87 98.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.724 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.09 143.22 35.65 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.501 2.134 . . . . 0.0 112.481 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 39.57 33.77 0.13 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.894 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.56 -159.24 13.3 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.265 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.79 -53.79 6.22 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.477 2.118 . . . . 0.0 112.033 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.22 -33.81 87.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.683 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -73.59 -32.61 64.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.982 0.42 . . . . 0.0 110.321 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 75.1 mt -75.12 -33.8 61.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.787 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.73 -54.1 10.6 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.392 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.26 33.23 1.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.701 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.423 HD21 ' CE2' ' A' ' 38' ' ' PHE . 1.7 mp -88.06 115.77 25.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.866 0.365 . . . . 0.0 110.884 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -81.37 159.86 66.39 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.552 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 13.0 Cg_endo -56.14 132.54 52.58 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.575 2.183 . . . . 0.0 112.332 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.427 ' O ' ' N ' ' A' ' 70' ' ' ARG . 0.3 OUTLIER 84.16 3.15 0.82 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.599 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.417 ' HB2' ' CD1' ' A' ' 102' ' ' ILE . 6.0 p-10 -54.43 87.61 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.174 0.512 . . . . 0.0 110.858 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 68' ' ' TYR . 4.2 ttp180 -66.99 109.55 3.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.862 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.402 ' CD2' HD22 ' A' ' 100' ' ' LEU . 4.0 mp -58.78 118.27 5.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.226 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.426 ' HA ' ' HG3' ' A' ' 80' ' ' ARG . 40.5 mt -82.77 -65.18 1.04 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.871 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -131.73 128.43 38.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.025 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.33 136.31 44.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.009 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.45 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 23.8 m120 50.18 32.01 5.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.332 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.45 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.3 OUTLIER 85.88 -14.79 0.52 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.77 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.2 t -83.75 136.94 21.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.843 0.354 . . . . 0.0 111.14 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -69.46 125.36 26.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.741 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.467 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 17.1 p -144.5 32.01 1.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.123 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.426 ' HG3' ' HA ' ' A' ' 72' ' ' LEU . 14.0 mtp180 -65.33 -52.03 56.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.43 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.69 28.54 2.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.049 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.467 ' CD1' ' HA ' ' A' ' 79' ' ' THR . 1.8 m-30 -80.8 167.51 19.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.724 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -107.83 161.53 14.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.46 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.81 -40.66 60.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.924 0.393 . . . . 0.0 110.68 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.5 m -63.09 -23.03 67.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.205 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.475 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 10.0 mp -94.17 -32.09 13.86 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.027 0.441 . . . . 0.0 110.864 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.9 t -78.44 -35.86 19.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.222 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.643 ' HB ' ' HD3' ' A' ' 89' ' ' PRO . 97.3 t -57.41 -51.25 83.13 Favored Pre-proline 0 C--N 1.331 -0.199 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.788 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.643 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.9 Cg_exo -66.61 -48.38 2.26 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.475 2.117 . . . . 0.0 111.32 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.4 mt -54.94 -27.99 47.74 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.967 0.413 . . . . 0.0 110.427 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.47 HG21 HD13 ' A' ' 98' ' ' LEU . 27.8 mt -75.84 -48.12 30.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.799 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.2 -3.09 40.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.091 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -89.8 -11.41 42.21 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.422 ' HB2' ' HG ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -64.66 -27.01 68.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.005 0.431 . . . . 0.0 111.208 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.59 -59.6 3.31 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.423 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -164.24 20.41 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.523 0.201 . . . . 0.0 111.383 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.421 ' HG3' ' CD1' ' A' ' 28' ' ' TYR . 14.1 ttpt -165.55 113.03 0.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.7 0.286 . . . . 0.0 110.234 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.47 HD13 HG21 ' A' ' 91' ' ' ILE . 1.7 mt -109.03 102.19 11.2 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -97.32 118.12 33.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.402 HD22 ' CD2' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -152.67 159.16 43.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.267 0.556 . . . . 0.0 112.416 -178.403 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.5 t -105.99 109.33 27.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.455 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 2.6 pp -100.87 162.33 3.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.015 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.425 ' CB ' ' HB3' ' A' ' 22' ' ' LEU . 3.2 p -146.26 130.19 17.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.687 0.28 . . . . 0.0 111.145 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.408 ' HD2' ' O ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -144.96 145.8 31.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.958 0.408 . . . . 0.0 111.409 179.508 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 6.1 p30 -70.04 127.01 92.67 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.748 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.248 1.001 0 C-N-CA 122.42 2.08 . . . . 0.0 112.247 179.989 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.886 0.374 . . . . 0.0 111.478 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -135.23 122.38 21.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.613 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 16.0 mt -62.6 136.58 57.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.472 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 -142.86 119.72 11.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.87 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -75.34 110.93 10.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.28 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.9 140.88 37.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.072 0.463 . . . . 0.0 111.508 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.4 m -133.65 106.79 7.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.02 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.0 mt -98.3 179.56 4.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.172 0.511 . . . . 0.0 111.8 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.416 ' CD1' ' HG2' ' A' ' 97' ' ' LYS . 95.2 m-85 -135.69 136.1 40.61 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.366 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -99.33 165.14 11.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.968 0.413 . . . . 0.0 111.3 -179.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -119.8 131.1 55.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.784 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.82 84.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.126 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.26 -40.67 0.51 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.36 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.63 164.26 21.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 0.0 110.907 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.91 -28.52 9.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.072 0.463 . . . . 0.0 110.922 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -84.8 168.74 14.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.707 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -119.11 29.15 7.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.084 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.07 4.21 67.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.117 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.426 ' CD1' HG21 ' A' ' 51' ' ' VAL . 8.8 p90 -174.33 138.56 0.56 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.981 0.39 . . . . 0.0 111.545 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 52' ' ' LYS . 7.3 m -99.79 148.1 24.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.183 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.41 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 33.0 m -111.8 163.36 8.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.919 0.39 . . . . 0.0 111.588 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -135.08 172.22 13.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.908 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -84.18 163.62 19.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.935 0.397 . . . . 0.0 111.145 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.55 121.98 6.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.322 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.69 6.27 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.53 -38.77 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.072 0.463 . . . . 0.0 111.482 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 47' ' ' LYS . 11.8 mm-40 -88.85 18.14 5.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.561 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 46' ' ' GLU . 12.5 mmtt 27.76 78.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.971 0.415 . . . . 0.0 112.106 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.09 -163.51 35.84 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.473 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.41 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 46.8 t -130.0 138.93 52.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 110.914 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.51 165.64 25.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.795 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.426 HG21 ' CD1' ' A' ' 38' ' ' PHE . 58.9 t -72.35 121.18 22.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.02 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 39' ' ' SER . 0.4 OUTLIER -87.53 -31.05 20.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.865 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -158.12 152.63 24.68 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.447 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.409 HG12 ' HB2' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -133.21 141.53 44.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.029 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.12 117.22 37.43 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.749 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.64 134.2 52.5 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.512 2.141 . . . . 0.0 112.504 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 42.83 31.25 0.3 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.834 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -109.39 -160.88 19.22 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.749 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -50.64 -62.06 0.46 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.49 2.126 . . . . 0.0 111.785 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.9 -35.04 66.58 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.884 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -73.19 -32.83 65.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.051 0.453 . . . . 0.0 110.201 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.5 mt -73.2 -27.41 61.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.56 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.54 -51.66 7.12 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.348 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 134.95 -8.02 4.48 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.021 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.406 HD23 ' CE2' ' A' ' 38' ' ' PHE . 4.0 mp -56.76 128.85 38.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.368 . . . . 0.0 111.114 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -116.6 167.24 10.93 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 69.7 Cg_exo -50.92 137.3 43.79 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.654 2.236 . . . . 0.0 112.368 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.437 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 10.8 m-85 85.02 4.1 0.62 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.232 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.4 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -52.5 89.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.947 0.403 . . . . 0.0 110.81 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 68' ' ' TYR . 9.3 ttt180 -77.85 95.59 4.76 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.787 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 mp -55.0 107.01 0.26 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.873 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.462 HD22 ' HG2' ' A' ' 80' ' ' ARG . 4.4 mt -83.98 -63.05 1.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.835 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -120.49 117.56 27.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.41 ' O ' ' CG1' ' A' ' 77' ' ' VAL . 24.6 t -108.15 109.62 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.163 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.491 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 1.7 m-80 64.24 33.59 11.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.669 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.491 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 3.3 t60 89.73 -17.94 0.21 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.92 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 77' ' ' VAL . 6.4 p -83.69 130.08 36.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.992 0.425 . . . . 0.0 111.125 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.78 89.24 0.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.415 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.422 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 17.3 p -96.76 26.26 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.809 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.462 ' HG2' HD22 ' A' ' 72' ' ' LEU . 10.5 mtp-105 -63.32 -53.03 59.13 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.985 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.35 24.16 4.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.402 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.422 ' CD1' ' HA ' ' A' ' 79' ' ' THR . 2.3 m-85 -81.8 166.48 19.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.852 0.358 . . . . 0.0 110.76 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -106.08 160.9 14.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.554 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.405 ' N ' HG23 ' A' ' 49' ' ' VAL . 11.3 t -51.69 -41.98 61.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.69 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.3 m -63.07 -22.43 66.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.098 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.6 mp -94.02 -32.93 13.61 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.99 0.424 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.4 t -77.57 -36.79 23.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.134 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.544 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 87.5 t -55.61 -52.19 73.97 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.793 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 48.7 Cg_endo -68.44 -45.81 2.36 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.191 1.927 . . . . 0.0 111.835 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 28.2 mt -54.78 -30.71 57.49 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.964 0.412 . . . . 0.0 110.725 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.486 ' CG2' HD13 ' A' ' 98' ' ' LEU . 61.3 mt -76.14 -48.37 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.367 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.69 -3.06 39.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.804 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -92.99 -4.55 52.45 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.418 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -63.52 -29.83 71.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.232 0.539 . . . . 0.0 110.903 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.8 -41.67 2.82 Favored Glycine 0 C--N 1.322 -0.227 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.761 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -166.23 -41.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 111.133 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.416 ' HG2' ' CD1' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -112.9 126.91 55.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.719 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.486 HD13 ' CG2' ' A' ' 91' ' ' ILE . 0.6 OUTLIER -115.85 97.48 6.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.626 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.27 118.16 31.18 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.59 156.44 42.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.142 0.496 . . . . 0.0 112.175 -178.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.1 t -114.32 109.04 27.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.794 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 2.4 pp -104.99 165.56 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.337 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.5 p -126.84 126.55 43.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.738 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -152.27 138.77 18.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.072 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -62.94 154.11 77.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.698 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo . . . . . 0 C--O 1.249 1.025 0 C-N-CA 122.61 2.207 . . . . 0.0 112.324 -179.855 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.444 ' CG2' ' HB3' ' A' ' 103' ' ' SER . 16.5 m . . . . . 0 C--O 1.23 0.035 0 CA-C-O 120.969 0.414 . . . . 0.0 111.566 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -122.38 122.99 40.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.567 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.421 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 14.4 mt -60.33 147.52 40.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.057 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.433 ' CE1' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -157.55 116.57 3.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.368 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.31 121.02 20.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.79 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.433 HG23 ' CE1' ' A' ' 23' ' ' HIS . 0.1 OUTLIER -118.24 145.54 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.296 -179.769 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.2 m -134.56 106.82 7.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.965 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.01 173.34 6.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.997 0.427 . . . . 0.0 111.692 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 28' ' ' TYR . 3.1 m-85 -123.19 156.05 35.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.519 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -111.22 160.37 17.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.912 0.387 . . . . 0.0 111.236 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.82 142.26 50.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.865 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.6 t -56.13 -30.46 62.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.022 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.29 38.17 3.4 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.399 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 5.4 mmt -157.25 110.85 2.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.785 0.326 . . . . 0.0 110.835 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -74.07 -28.81 61.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.087 0.47 . . . . 0.0 110.931 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -85.03 177.99 7.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.651 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.488 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -118.98 29.36 7.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.119 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.7 8.46 85.98 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.688 -0.767 . . . . 0.0 113.332 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 54' ' ' ILE . 20.3 p90 -172.73 127.48 0.5 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 117.171 0.486 . . . . 0.0 111.395 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.06 149.89 20.83 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.013 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.6 m -122.15 150.74 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.303 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.67 178.11 4.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.08 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -94.87 168.18 10.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.015 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -96.88 109.78 3.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.065 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.46 7.11 46.7 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.15 0.47 0.45 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -158.17 31.45 0.25 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.642 0.258 . . . . 0.0 111.298 179.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER 28.59 90.77 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.97 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -175.35 -159.44 21.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.364 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 99.6 t -150.53 137.56 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.94 0.4 . . . . 0.0 111.17 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.8 163.75 30.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.348 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.49 ' HB ' ' OD1' ' A' ' 69' ' ' ASP . 58.3 t -70.68 123.85 25.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.994 0.426 . . . . 0.0 111.262 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.99 -29.76 19.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.636 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -172.16 160.07 5.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.256 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -126.67 138.41 54.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.839 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -64.16 154.67 81.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.284 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.442 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 65.4 Cg_endo -73.71 102.4 1.5 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.684 2.256 . . . . 0.0 112.433 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 56' ' ' PRO . . . 84.58 -6.51 0.99 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.686 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.84 175.87 6.08 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.518 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -46.68 -45.8 19.23 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.71 2.273 . . . . 0.0 112.536 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.08 -41.1 92.39 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.433 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.24 -32.72 64.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.035 0.445 . . . . 0.0 110.032 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.75 -32.13 69.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.515 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.25 -57.55 5.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.16 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.97 38.37 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.895 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.85 127.02 55.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.74 0.305 . . . . 0.0 110.825 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -96.76 162.06 24.44 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.565 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 9.2 Cg_endo -52.32 154.49 11.15 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.743 2.295 . . . . 0.0 112.208 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.472 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 8.0 m-85 90.29 -22.25 0.11 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.368 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.49 ' OD1' ' HB ' ' A' ' 51' ' ' VAL . 10.3 p-10 -55.26 87.75 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.203 0.525 . . . . 0.0 110.453 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -66.74 119.99 12.75 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.734 -179.624 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 mt -68.79 110.74 4.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.303 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.421 ' CD1' ' CD2' ' A' ' 22' ' ' LEU . 3.4 mp -82.74 -58.01 3.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.179 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -129.98 134.29 47.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.965 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.2 t -117.28 108.51 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.005 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.443 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 33.2 m120 64.24 36.27 9.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 50.0 m-70 86.35 -15.94 0.44 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.516 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.0 t -83.66 139.11 18.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.813 0.34 . . . . 0.0 111.013 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.87 122.82 20.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.631 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.463 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 28.0 p -143.08 28.22 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.95 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.418 ' CG ' ' HA ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -72.29 -53.01 13.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.425 179.704 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -94.9 25.96 3.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.069 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.463 ' CD1' ' HA ' ' A' ' 79' ' ' THR . 2.4 m-30 -80.85 171.4 15.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.778 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -108.01 159.94 16.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.479 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 23.8 p -51.51 -42.11 61.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.88 0.371 . . . . 0.0 110.543 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.07 -21.73 66.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.191 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.47 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 8.0 mp -95.31 -31.31 13.51 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.935 0.397 . . . . 0.0 110.819 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.1 t -79.37 -35.72 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.221 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.618 ' HB ' ' HD3' ' A' ' 89' ' ' PRO . 88.8 t -58.18 -50.71 86.59 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.835 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.618 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 13.0 Cg_exo -69.62 -44.43 2.18 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.472 2.115 . . . . 0.0 111.626 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 15.5 mt -54.99 -33.32 62.46 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.694 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.435 HG22 ' CD2' ' A' ' 36' ' ' PHE . 80.4 mt -75.32 -45.87 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.629 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.66 -3.76 36.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.928 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -101.19 -12.12 18.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.659 0.266 . . . . 0.0 111.686 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.8 m -64.76 -15.67 61.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.502 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.97 -143.69 17.21 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.571 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -73.73 -7.52 52.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.547 0.213 . . . . 0.0 111.4 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.7 mtpt -137.49 151.73 48.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.612 0.244 . . . . 0.0 110.592 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.488 ' HB2' ' CE1' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -137.73 97.49 3.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.772 0.32 . . . . 0.0 111.382 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.7 118.17 31.3 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 pp -145.16 157.43 44.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.132 0.492 . . . . 0.0 112.079 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.7 t -110.53 109.25 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.919 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.414 ' CD1' ' HB2' ' A' ' 69' ' ' ASP . 2.6 pp -105.9 169.21 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.074 0.464 . . . . 0.0 111.641 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.444 ' HB3' ' CG2' ' A' ' 20' ' ' VAL . 0.5 OUTLIER -131.84 114.51 14.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.488 179.589 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.411 ' HB3' ' HA ' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -140.82 131.99 26.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.923 0.392 . . . . 0.0 111.642 -179.561 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -65.65 119.86 63.74 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.595 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--O 1.25 1.078 0 C-N-CA 122.339 2.026 . . . . 0.0 112.376 -179.935 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.928 0.394 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -111.08 122.36 47.68 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.516 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 4.4 pp -106.83 153.3 22.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.26 0.552 . . . . 0.0 112.37 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.426 ' NE2' HD13 ' A' ' 102' ' ' ILE . 28.7 p80 -149.28 143.46 25.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.561 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.51 112.26 14.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.486 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.21 153.46 8.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.57 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.4 m -134.09 122.1 22.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.824 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.2 175.16 5.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.293 0.568 . . . . 0.0 111.986 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.437 ' CD1' ' HG2' ' A' ' 97' ' ' LYS . 27.7 m-85 -139.3 124.63 19.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.911 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.43 ' HG3' ' CE2' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -94.84 147.81 22.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.073 0.463 . . . . 0.0 111.431 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -123.41 153.82 39.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.682 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 p -64.64 -24.49 67.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.26 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.62 -0.22 55.43 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.156 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.94 130.42 35.07 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.824 0.345 . . . . 0.0 111.043 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -80.35 -10.74 59.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.16 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -155.93 -164.78 1.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.412 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.451 ' CD2' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -106.01 25.59 10.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 111.482 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.48 -1.17 75.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.74 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.427 ' CE2' HD23 ' A' ' 65' ' ' LEU . 7.9 p90 -172.24 147.76 2.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.334 0.567 . . . . 0.0 111.895 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 p -108.89 137.71 46.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.242 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.45 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 22.6 m -99.23 161.12 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.519 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -125.19 171.11 10.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.153 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -82.01 136.01 35.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.968 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.26 103.43 2.07 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.337 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -94.31 -28.81 15.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.093 0.473 . . . . 0.0 111.287 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 15.0 mt -83.85 -5.63 59.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.375 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 47' ' ' LYS . 11.9 mt-10 -153.07 28.1 0.52 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.941 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.4 OUTLIER 27.38 91.2 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.107 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.92 -153.16 21.73 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.582 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.45 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 16.6 t -145.97 139.0 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.72 0.295 . . . . 0.0 110.931 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -136.93 156.19 48.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.118 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.403 ' CG2' ' HB2' ' A' ' 69' ' ' ASP . 87.6 t -67.63 117.94 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.536 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -87.39 -30.77 20.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.042 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -157.39 147.51 20.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.524 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.415 HG12 ' HB2' ' A' ' 38' ' ' PHE . 1.3 mt -125.1 125.35 69.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.955 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.6 ttt85 -65.33 111.62 6.5 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.05 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.4 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 32.4 Cg_exo -58.34 123.48 13.71 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.476 2.117 . . . . 0.0 112.19 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 56' ' ' PRO . . . 81.34 83.35 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.097 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 167.78 -152.54 21.02 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.531 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.61 -36.78 91.56 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.646 2.231 . . . . 0.0 112.2 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.09 -47.81 43.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.722 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.57 -32.95 64.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.056 0.455 . . . . 0.0 110.515 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.4 mt -71.26 -30.87 66.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.993 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.86 -38.66 15.38 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.663 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.44 29.24 6.38 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.427 HD23 ' CE2' ' A' ' 38' ' ' PHE . 1.2 mp -78.27 131.88 37.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.893 0.378 . . . . 0.0 110.784 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -98.4 165.05 15.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.841 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.417 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 28.1 Cg_endo -62.68 138.96 72.67 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.411 2.074 . . . . 0.0 112.115 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.417 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER 82.96 11.1 0.53 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.347 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.403 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 5.6 m-20 -53.74 88.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.931 0.396 . . . . 0.0 111.162 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 103' ' ' SER . 5.5 ttt85 -73.0 94.34 1.86 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.372 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.416 ' CD1' ' CG1' ' A' ' 87' ' ' VAL . 11.3 mt -50.86 107.51 0.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.998 0.428 . . . . 0.0 111.175 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.413 ' HA ' ' CG ' ' A' ' 80' ' ' ARG . 16.0 mt -82.62 -65.33 1.02 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.946 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -133.79 138.86 45.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.5 t -109.69 106.81 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.931 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 75.37 -59.37 0.54 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.078 0.466 . . . . 0.0 110.613 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -167.29 -11.22 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.414 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.9 p -85.41 125.3 40.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.712 0.292 . . . . 0.0 111.242 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 -69.55 123.8 22.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.424 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.431 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 14.2 p -143.17 32.75 1.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.91 0.386 . . . . 0.0 111.21 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.413 ' CG ' ' HA ' ' A' ' 72' ' ' LEU . 37.0 mtp180 -66.01 -52.49 48.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.636 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.24 30.35 1.95 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.112 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.443 ' CD2' ' HB3' ' A' ' 86' ' ' LEU . 1.6 m-30 -80.9 174.25 11.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.41 . . . . 0.0 110.742 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.09 158.47 17.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.439 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 22.6 p -51.35 -41.66 60.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.914 0.388 . . . . 0.0 110.815 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.56 -22.47 66.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.131 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.443 ' HB3' ' CD2' ' A' ' 82' ' ' PHE . 8.9 mp -93.02 -33.44 14.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.165 0.507 . . . . 0.0 110.875 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.416 ' CG1' ' CD1' ' A' ' 71' ' ' LEU . 59.7 t -77.18 -36.02 23.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.165 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.542 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 78.5 t -55.45 -52.25 73.27 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.819 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 54.4 Cg_endo -69.19 -43.22 3.28 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.281 1.987 . . . . 0.0 111.904 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 15.9 mt -54.6 -31.61 57.3 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.967 0.413 . . . . 0.0 110.787 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.451 HG23 ' CD2' ' A' ' 36' ' ' PHE . 70.3 mt -78.8 -47.45 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.854 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.5 -3.96 30.9 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.08 -4.2 16.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.606 0.241 . . . . 0.0 111.593 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.6 p -64.08 -18.2 64.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.907 0.384 . . . . 0.0 111.133 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.85 -144.81 17.55 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.415 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -73.91 -8.24 55.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.615 0.245 . . . . 0.0 111.466 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.437 ' HG2' ' CD1' ' A' ' 28' ' ' TYR . 10.4 mtpt -144.33 147.57 33.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.678 0.275 . . . . 0.0 111.034 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -124.77 97.58 5.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 0.0 111.078 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -95.04 118.78 32.43 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.2 169.36 21.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.251 0.548 . . . . 0.0 112.333 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 25.0 t -118.44 109.35 26.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.549 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 2.2 pp -102.58 154.56 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.429 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 3.4 t -130.15 125.72 35.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.452 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.42 126.23 10.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.005 0.431 . . . . 0.0 111.791 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.39 140.05 78.97 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.459 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 C--O 1.249 1.028 0 C-N-CA 122.323 2.015 . . . . 0.0 112.302 -179.902 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.808 0.337 . . . . 0.0 111.462 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.39 122.55 47.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.629 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.1 mt -62.44 144.3 56.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.304 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -152.41 110.59 3.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.806 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -72.99 106.26 4.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.112 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.7 141.02 26.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.04 0.448 . . . . 0.0 111.57 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.9 m -132.64 106.75 7.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.144 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.5 mp -101.06 177.6 4.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.046 0.45 . . . . 0.0 111.613 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.418 ' CD2' ' HG2' ' A' ' 97' ' ' LYS . 11.7 m-85 -138.89 133.51 32.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.437 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -94.84 161.88 13.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.971 0.415 . . . . 0.0 111.173 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -124.4 130.9 53.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.802 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 61.3 p -60.04 84.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.4 -13.49 1.4 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.893 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.94 174.64 11.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.769 0.319 . . . . 0.0 110.923 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.82 -10.73 13.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.48 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -155.66 -176.58 6.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.977 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -98.15 31.99 2.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.008 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.85 15.66 79.54 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.973 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.461 ' HB2' HG12 ' A' ' 54' ' ' ILE . 4.1 p90 -173.47 119.22 0.3 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 110.962 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -93.62 149.66 21.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.824 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.452 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 23.7 m -108.33 167.94 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.244 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.08 171.32 11.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.096 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -88.14 137.31 32.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.098 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.86 114.58 4.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.403 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tp -94.38 -31.05 14.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.068 0.461 . . . . 0.0 111.251 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.96 -54.88 4.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.892 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.7 mm-40 -90.55 17.99 6.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.473 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 29.83 89.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.79 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.1 -144.53 8.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.601 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.452 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 38.8 t -146.7 140.74 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 0.0 111.021 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.1 159.99 40.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.608 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.438 HG22 ' CE1' ' A' ' 38' ' ' PHE . 59.8 t -62.97 123.63 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.982 0.42 . . . . 0.0 111.031 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -88.58 -35.38 16.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.98 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -162.55 143.59 10.14 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.273 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.461 HG12 ' HB2' ' A' ' 38' ' ' PHE . 1.2 mt -129.57 133.92 64.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.979 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.44 137.56 96.65 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.687 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.431 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 72.8 Cg_endo -75.03 107.59 2.52 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.498 2.132 . . . . 0.0 112.495 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 56' ' ' PRO . . . 83.54 28.95 0.08 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.268 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -114.5 -161.64 13.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.305 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -50.65 -53.55 6.95 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.493 2.129 . . . . 0.0 112.199 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.01 -38.38 89.0 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.476 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.3 -32.81 64.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.05 0.452 . . . . 0.0 110.273 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.6 -30.8 67.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.687 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.99 -53.4 6.27 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.28 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.45 35.13 0.88 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.787 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.418 HD13 ' CG ' ' A' ' 38' ' ' PHE . 0.3 OUTLIER -113.64 141.87 46.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.843 0.354 . . . . 0.0 110.958 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -121.93 163.04 33.83 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.684 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.552 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 1.4 Cg_endo -44.51 144.28 3.31 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.824 2.35 . . . . 0.0 112.3 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.552 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 93.8 m-85 85.3 -7.82 0.86 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.41 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.425 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 5.4 m-20 -54.41 86.65 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.151 0.5 . . . . 0.0 110.591 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 68' ' ' TYR . 22.2 ttm180 -66.82 109.15 2.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.292 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 mp -66.61 107.92 2.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.796 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.431 ' HG ' ' CG ' ' A' ' 80' ' ' ARG . 5.2 mp -83.75 -37.51 22.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.509 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.81 145.58 18.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.868 0.366 . . . . 0.0 111.087 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.11 109.75 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.791 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 75.46 -57.46 0.59 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.072 0.463 . . . . 0.0 110.695 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -167.19 -14.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.263 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.5 t -85.62 128.47 39.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-O 120.797 0.332 . . . . 0.0 111.098 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -69.31 127.07 31.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.515 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.435 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 16.8 p -142.69 32.44 1.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.031 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.431 ' CG ' ' HG ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -67.95 -48.39 66.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.303 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.15 24.21 4.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.077 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 79' ' ' THR . 2.1 m-30 -81.13 173.87 12.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.802 0.334 . . . . 0.0 110.823 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.32 159.59 16.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.327 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 19.6 t -51.48 -42.1 61.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.824 0.345 . . . . 0.0 110.713 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.6 t -62.61 -21.64 65.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.18 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.473 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 8.3 mp -95.64 -32.57 12.72 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.023 0.44 . . . . 0.0 110.978 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.9 t -78.29 -35.7 19.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.331 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.64 ' HB ' ' HD3' ' A' ' 89' ' ' PRO . 91.9 t -58.27 -51.27 82.99 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.833 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.64 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.3 Cg_exo -67.55 -44.86 3.99 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.349 2.033 . . . . 0.0 111.47 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 18.1 mt -54.74 -29.38 53.51 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.697 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.444 HG21 ' CD2' ' A' ' 36' ' ' PHE . 50.1 mt -78.08 -48.43 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.796 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.37 -4.32 32.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.97 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -99.3 -12.94 19.89 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.716 0.293 . . . . 0.0 111.576 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -15.97 62.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.383 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.03 -144.11 17.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.649 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -73.72 -7.1 50.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.418 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -138.58 141.67 39.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.772 0.32 . . . . 0.0 110.657 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -130.6 97.33 4.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.263 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -98.47 118.11 34.41 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pp -145.91 163.2 35.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.12 0.486 . . . . 0.0 111.849 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.5 t -113.51 109.11 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.168 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -103.75 168.95 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.088 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.2 p -142.39 120.24 11.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.716 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.5 ptt85 -128.34 130.32 47.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.176 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -65.85 157.42 79.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.852 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo . . . . . 0 C--O 1.249 1.054 0 C-N-CA 122.54 2.16 . . . . 0.0 112.224 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.2 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.814 0.34 . . . . 0.0 111.476 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -125.55 122.69 37.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.675 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 15.1 mt -61.19 152.91 27.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.411 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -157.15 109.9 2.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.024 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.45 112.99 9.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.078 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.429 ' CG1' ' HG ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -121.92 143.4 34.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.142 0.496 . . . . 0.0 111.932 -178.898 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.1 m -134.0 106.4 7.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.811 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.445 HD21 ' CD1' ' A' ' 38' ' ' PHE . 4.4 mp -94.34 174.88 6.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.278 0.561 . . . . 0.0 112.04 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -137.4 121.63 18.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.222 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 6.1 tttm -112.04 152.98 27.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.958 0.408 . . . . 0.0 111.263 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -102.52 138.86 38.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.867 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.0 m -51.35 -26.34 7.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.31 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.72 -38.15 21.06 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.615 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 9.2 mmm -81.76 158.14 24.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.91 0.386 . . . . 0.0 110.936 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.68 -30.89 8.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.114 0.483 . . . . 0.0 110.92 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.99 172.03 11.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.713 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.445 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -119.14 32.07 6.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.802 0.335 . . . . 0.0 111.105 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.1 6.59 86.24 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.283 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.445 ' CD1' HD21 ' A' ' 27' ' ' LEU . 14.1 p90 -172.5 123.15 0.46 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.159 0.479 . . . . 0.0 111.393 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -95.1 145.81 24.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.536 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.421 ' HB ' HG12 ' A' ' 49' ' ' VAL . 33.5 m -110.49 159.67 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.281 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.97 178.06 4.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -90.7 161.22 15.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.128 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.5 128.63 8.28 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.239 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.44 -58.07 2.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.289 0.566 . . . . 0.0 111.398 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.58 -43.51 15.59 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.61 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 47' ' ' LYS . 2.1 mt-10 -87.7 9.77 20.42 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.749 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER 27.71 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.73 -152.8 19.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.468 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.421 HG12 ' HB ' ' A' ' 40' ' ' VAL . 59.7 t -142.65 138.39 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.761 0.315 . . . . 0.0 111.052 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.13 167.91 20.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.52 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.429 HG22 ' CE2' ' A' ' 38' ' ' PHE . 47.2 t -71.64 122.04 23.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.979 0.419 . . . . 0.0 111.368 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -89.52 -32.68 17.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.785 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -164.79 153.89 12.9 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.187 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.423 ' CD1' ' HB2' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -130.95 133.62 62.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.15 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.87 127.02 92.82 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.459 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 32.3 Cg_exo -58.34 114.22 1.89 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.418 2.079 . . . . 0.0 112.44 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 56' ' ' PRO . . . 86.64 -14.67 0.48 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.951 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.63 -176.6 2.25 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.371 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.71 -32.48 97.0 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.521 2.148 . . . . 0.0 111.998 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.51 -38.87 96.32 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.321 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.58 -32.68 64.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.987 0.422 . . . . 0.0 110.019 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.4 mt -75.2 -34.99 61.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.833 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.42 -57.78 7.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.42 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 125.59 42.62 0.31 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.752 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.429 ' HG ' ' CG1' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -104.56 122.83 46.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.857 0.361 . . . . 0.0 110.918 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.84 162.04 20.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.772 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 6.9 Cg_endo -49.15 137.46 29.63 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.972 2.448 . . . . 0.0 112.156 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 46.6 m-85 85.32 -1.52 0.82 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.17 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.4 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -53.08 88.23 0.0 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.943 0.401 . . . . 0.0 110.735 179.507 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 68' ' ' TYR . 44.3 ttp180 -76.8 102.12 6.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.035 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.17 115.33 2.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.838 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.48 ' HA ' ' CG ' ' A' ' 80' ' ' ARG . 2.8 mt -82.49 -64.44 1.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 0.0 111.135 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -133.12 109.59 9.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.369 . . . . 0.0 111.174 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.4 t -89.41 123.69 41.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.903 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 14.8 m-80 46.11 40.0 6.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.449 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.47 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 1.5 t-80 87.6 -21.92 0.16 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.823 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.0 t -82.37 129.52 37.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.721 0.296 . . . . 0.0 111.151 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -68.86 135.14 50.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.434 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 30.1 p -144.89 29.87 1.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.058 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.48 ' CG ' ' HA ' ' A' ' 72' ' ' LEU . 8.8 mtp-105 -72.83 -53.2 12.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.696 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.19 21.69 5.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.148 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.434 ' CD1' ' HA ' ' A' ' 79' ' ' THR . 2.8 m-85 -81.27 169.44 17.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.872 0.367 . . . . 0.0 110.875 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -108.51 157.94 18.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.245 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 8.0 p -51.39 -38.37 53.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.0 110.676 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -66.97 -21.45 65.96 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.222 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.421 HD23 ' CD2' ' A' ' 82' ' ' PHE . 1.0 OUTLIER -92.33 -32.31 15.03 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.003 0.43 . . . . 0.0 110.571 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.417 HG22 ' CB ' ' A' ' 49' ' ' VAL . 94.3 t -77.05 -35.68 23.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.982 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.532 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 84.4 t -55.35 -52.64 69.9 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.817 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 49.3 Cg_endo -68.4 -43.22 4.48 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.205 1.937 . . . . 0.0 111.704 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.451 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 11.0 mt -53.97 -33.71 57.71 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.298 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.488 ' HA ' HD11 ' A' ' 98' ' ' LEU . 80.3 mt -78.92 -41.88 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.842 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.64 -5.55 38.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.36 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 4.5 pt-20 -98.38 -3.26 37.35 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.704 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.6 p -63.68 -31.03 72.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.232 0.539 . . . . 0.0 110.666 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.46 -48.9 1.88 Allowed Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.818 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -166.24 -39.48 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.744 0.307 . . . . 0.0 111.111 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -111.75 112.96 25.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.191 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.488 HD11 ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -103.9 98.07 7.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.559 -179.111 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -95.94 118.5 32.69 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 pp -146.43 164.18 33.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.273 0.559 . . . . 0.0 111.978 -178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.0 t -119.22 109.36 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.147 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 2.5 pp -101.68 168.78 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.115 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.11 128.16 15.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.674 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.22 147.56 30.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.983 0.421 . . . . 0.0 111.329 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -62.38 143.2 95.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.829 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo . . . . . 0 C--O 1.248 0.996 0 C-N-CA 122.514 2.142 . . . . 0.0 112.217 -179.958 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.983 0.42 . . . . 0.0 111.672 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.51 122.88 38.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.351 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 13.7 mt -60.53 147.0 42.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.584 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -151.46 107.51 3.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.825 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.44 118.4 13.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.19 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.25 141.58 45.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.076 0.465 . . . . 0.0 111.799 -179.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 95.9 m -134.38 106.64 7.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.778 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.1 mt -100.04 171.99 7.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.018 0.437 . . . . 0.0 111.774 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -123.52 137.25 54.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.34 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 1.5 tttt -95.24 162.91 13.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.033 0.444 . . . . 0.0 111.299 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -131.33 128.18 39.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.741 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.63 -27.16 6.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.248 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.08 26.93 20.6 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.504 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.87 140.09 13.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 110.892 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -96.57 -21.85 17.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.992 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -84.79 170.83 12.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.761 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.47 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -119.03 23.9 11.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.32 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.24 9.63 67.03 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.334 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 54' ' ' ILE . 0.1 OUTLIER -173.72 138.93 0.68 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.128 0.464 . . . . 0.0 111.627 179.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.8 m -99.35 154.69 18.0 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.596 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.467 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 35.0 m -116.34 159.23 16.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.42 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -117.98 178.31 4.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.047 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.09 144.8 26.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.194 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.2 115.45 5.05 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.242 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.29 -45.66 7.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.157 0.503 . . . . 0.0 111.343 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -84.66 4.79 30.83 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.897 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.465 ' O ' ' C ' ' A' ' 47' ' ' LYS . 27.0 mt-10 -153.85 22.92 0.51 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.522 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 24.09 79.84 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -171.69 -157.4 13.51 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.365 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.467 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 35.7 t -143.48 139.38 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.872 0.367 . . . . 0.0 111.15 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.81 168.57 19.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.359 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.438 HG21 ' CE2' ' A' ' 38' ' ' PHE . 72.2 t -74.21 121.54 25.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.793 0.33 . . . . 0.0 111.142 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.52 -31.55 17.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.29 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -163.5 162.96 24.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.27 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -134.27 136.98 52.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.49 123.88 84.24 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.26 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 31.9 Cg_exo -58.5 105.99 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.525 2.15 . . . . 0.0 112.19 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 56' ' ' PRO . . . 82.35 28.56 0.13 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.111 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.21 -173.39 24.23 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.276 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.87 -42.21 45.15 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.453 2.102 . . . . 0.0 112.171 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.23 -36.43 93.22 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.445 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.63 -32.96 64.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.062 0.458 . . . . 0.0 110.404 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.81 -34.43 75.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.992 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.05 -46.69 5.82 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.627 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.14 34.79 0.86 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.581 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.411 ' HB2' ' CD1' ' A' ' 54' ' ' ILE . 45.1 mt -75.81 133.49 40.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.738 0.304 . . . . 0.0 110.917 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -117.87 155.81 50.58 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.893 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.531 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 12.3 Cg_endo -55.69 146.42 65.77 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.621 2.214 . . . . 0.0 112.18 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.531 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 85.4 m-85 84.64 -5.39 0.99 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.384 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.401 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 7.0 m-20 -53.97 85.56 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.98 0.419 . . . . 0.0 110.774 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 68' ' ' TYR . 59.3 ttt180 -71.41 101.13 2.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.06 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.93 107.76 0.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.938 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.463 ' HA ' ' CG ' ' A' ' 80' ' ' ARG . 9.0 mt -82.39 -65.53 1.0 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.869 0.366 . . . . 0.0 110.881 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -119.56 127.5 53.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.892 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.9 104.68 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.101 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.468 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 1.2 m-20 64.71 36.94 7.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.725 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.468 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 2.8 t60 87.66 -14.68 0.42 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.503 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.63 114.06 23.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.8 0.333 . . . . 0.0 111.005 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -69.01 87.09 0.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.812 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.428 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 15.8 p -95.95 32.08 1.98 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.115 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.463 ' CG ' ' HA ' ' A' ' 72' ' ' LEU . 36.2 mtp180 -66.28 -53.15 40.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.814 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -93.52 22.71 5.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.185 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.428 ' CD1' ' HA ' ' A' ' 79' ' ' THR . 2.8 m-85 -82.01 167.94 18.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.951 0.405 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -106.99 160.87 15.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.383 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 4.3 t -51.59 -41.35 61.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.666 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 10.0 p -62.56 -23.91 67.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.07 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.467 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 0.6 OUTLIER -94.12 -30.93 14.39 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.946 0.403 . . . . 0.0 110.972 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.3 t -78.89 -35.9 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.265 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.643 ' HB ' ' HD3' ' A' ' 89' ' ' PRO . 91.6 t -57.76 -51.02 84.79 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.865 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . 0.643 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 14.3 Cg_exo -68.96 -46.19 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.425 2.083 . . . . 0.0 111.517 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 33.3 mt -54.91 -33.09 61.74 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.986 0.422 . . . . 0.0 110.546 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.427 HG21 ' CD1' ' A' ' 98' ' ' LEU . 62.6 mt -73.25 -46.76 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.477 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.57 -3.9 36.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.848 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.18 -7.23 22.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.656 0.265 . . . . 0.0 111.497 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.8 p -64.52 -16.59 62.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.355 . . . . 0.0 111.347 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.26 -144.0 16.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.217 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -74.38 -8.81 57.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.569 0.223 . . . . 0.0 111.452 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -142.1 141.84 32.75 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.784 0.326 . . . . 0.0 110.959 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.47 ' HB2' ' CE1' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -119.56 97.12 5.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.242 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -92.0 118.37 30.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pp -151.85 162.17 41.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.324 0.583 . . . . 0.0 112.093 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.1 t -121.49 109.02 23.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.946 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 2.4 pp -100.95 169.3 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.349 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.4 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -145.58 128.26 16.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.579 179.666 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.0 151.74 35.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.012 0.434 . . . . 0.0 111.478 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -62.68 115.1 14.6 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.971 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.249 1.054 0 C-N-CA 122.508 2.139 . . . . 0.0 112.267 -179.992 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.431 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 16' ' ' SER . 28.0 Cg_exo -62.21 -13.47 32.35 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.498 2.132 . . . . 0.0 112.667 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.489 ' HB ' ' HD3' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -163.0 -55.98 0.01 OUTLIER Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.476 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.489 ' HD3' ' HB ' ' A' ' 18' ' ' THR . 87.5 Cg_exo -47.72 95.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.326 2.017 . . . . 0.0 112.559 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.4 m -50.0 170.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.847 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -137.73 122.82 19.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.316 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.43 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 13.6 mt -60.03 137.5 58.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.102 0.477 . . . . 0.0 111.839 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -149.34 122.04 8.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.173 179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.87 135.43 51.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.517 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.37 143.05 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.143 0.496 . . . . 0.0 111.451 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.2 m -134.55 141.42 46.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.784 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.39 -179.63 5.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.08 0.467 . . . . 0.0 111.639 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.42 ' CD2' ' HG2' ' A' ' 97' ' ' LYS . 9.8 m-85 -138.96 125.35 20.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.391 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -94.87 164.94 12.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.997 0.427 . . . . 0.0 111.231 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.37 141.13 48.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.657 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.3 p -60.11 84.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 138.33 -3.68 3.03 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.217 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.6 151.34 29.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.864 0.364 . . . . 0.0 110.989 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -94.91 -10.53 30.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.388 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.83 175.87 13.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.68 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.483 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.6 OUTLIER -94.15 2.1 56.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.619 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.33 18.23 5.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.382 -0.913 . . . . 0.0 113.25 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.569 ' HB2' HG12 ' A' ' 54' ' ' ILE . 39.4 p90 -174.04 134.45 0.45 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 117.035 0.418 . . . . 0.0 111.654 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.403 ' O ' ' N ' ' A' ' 52' ' ' LYS . 67.4 m -92.99 151.3 19.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.088 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.426 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 34.5 m -114.93 167.95 7.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.122 0.487 . . . . 0.0 111.837 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -133.85 140.69 47.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.782 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.13 121.75 18.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.817 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.05 89.65 0.98 Allowed Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 pp -83.36 -2.47 55.82 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 mp -77.17 -13.49 59.94 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.586 ' O ' ' CG ' ' A' ' 47' ' ' LYS . 0.6 OUTLIER -157.88 -83.78 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.001 179.334 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.586 ' CG ' ' O ' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -175.68 134.22 0.29 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.596 0.758 . . . . 0.0 110.233 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.62 -159.19 22.01 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.263 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.426 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 18.8 t -154.82 144.38 13.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.627 0.251 . . . . 0.0 110.852 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.408 ' N ' HG13 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -135.88 151.39 49.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.806 0.336 . . . . 0.0 111.028 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.476 ' HB ' ' OD1' ' A' ' 69' ' ' ASP . 44.7 t -60.49 123.59 13.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.02 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 39' ' ' SER . 0.1 OUTLIER -88.19 -27.54 21.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.169 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -169.68 140.34 2.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.738 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.569 HG12 ' HB2' ' A' ' 38' ' ' PHE . 2.7 mt -119.61 142.9 32.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.002 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -65.37 111.7 6.71 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.732 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 50.0 Cg_exo -55.53 109.17 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.464 2.109 . . . . 0.0 112.485 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 56' ' ' PRO . . . 83.38 38.14 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.367 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.9 -170.41 13.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.171 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.77 -43.62 39.73 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.35 2.033 . . . . 0.0 111.817 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.85 -38.5 95.63 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.428 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -73.59 -32.84 64.32 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.007 0.432 . . . . 0.0 110.196 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 75.3 mt -73.01 -31.84 64.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.682 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.86 -40.92 34.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.362 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.34 8.4 6.49 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.031 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.2 mt -63.4 115.96 5.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.911 0.386 . . . . 0.0 110.988 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.4 ' CG ' ' HD2' ' A' ' 67' ' ' PRO . 15.2 tttm -107.33 141.56 23.23 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.512 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.596 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 4.1 Cg_exo -39.47 135.75 1.16 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.202 2.601 . . . . 0.0 112.727 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.596 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 78.2 m-85 85.44 -5.31 0.87 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.542 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.476 ' OD1' ' HB ' ' A' ' 51' ' ' VAL . 9.1 p-10 -56.22 85.1 0.01 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.062 0.458 . . . . 0.0 110.885 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 68' ' ' TYR . 42.4 ttt180 -66.66 102.61 0.94 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.476 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.2 mt -54.5 107.28 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.721 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.457 ' HA ' ' CG ' ' A' ' 80' ' ' ARG . 5.5 mt -82.98 -63.48 1.35 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.376 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -121.23 118.24 29.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.07 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 27.1 t -100.55 120.21 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.249 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.442 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 0.4 OUTLIER 46.36 43.11 11.4 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.671 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.442 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.1 OUTLIER 86.59 -19.37 0.28 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.752 179.534 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.85 120.69 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.875 0.369 . . . . 0.0 111.087 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -70.13 85.94 0.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.419 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 27.9 p -96.51 30.93 2.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.138 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.457 ' CG ' ' HA ' ' A' ' 72' ' ' LEU . 4.6 mtp180 -68.4 -45.73 71.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.008 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -92.0 18.28 8.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.311 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.419 ' CD1' ' HA ' ' A' ' 79' ' ' THR . 3.5 m-30 -82.16 171.81 13.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.883 0.373 . . . . 0.0 110.931 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.07 166.87 11.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.33 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 9.5 p -51.52 -44.62 62.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.256 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 26.2 p -61.13 -20.12 62.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.52 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.5 mp -99.45 -33.37 10.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.868 0.366 . . . . 0.0 111.165 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 44.9 t -77.5 -35.9 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.963 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.534 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 99.0 t -57.65 -52.36 74.9 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.735 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 45.7 Cg_endo -67.56 -44.8 4.04 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.149 1.899 . . . . 0.0 111.8 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 13.1 mt -54.94 -31.64 60.58 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.045 0.45 . . . . 0.0 110.391 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.412 HG22 ' CD1' ' A' ' 98' ' ' LEU . 60.3 mt -72.57 -51.4 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.161 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.84 -3.06 42.7 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.976 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.97 -5.99 22.86 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.414 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 3.3 t -64.82 -14.73 60.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.741 0.305 . . . . 0.0 111.461 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.11 -142.97 16.34 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.663 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -74.65 -5.53 43.57 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.42 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 42.1 mtpt -146.23 151.3 37.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.874 0.369 . . . . 0.0 111.141 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -129.67 97.86 4.65 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.285 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -99.21 117.9 34.71 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.3 pp -150.21 162.89 39.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.262 0.553 . . . . 0.0 112.253 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.1 t -114.1 109.53 28.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.895 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.422 ' CD1' ' HB2' ' A' ' 69' ' ' ASP . 2.6 pp -105.45 169.26 2.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.345 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.7 p -133.42 121.68 22.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.766 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.401 ' HB3' ' HA ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -136.44 147.68 47.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.171 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -74.57 122.67 88.04 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.779 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 C--O 1.25 1.11 0 C-N-CA 122.333 2.022 . . . . 0.0 112.385 -179.912 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.447 ' N ' ' HD2' ' A' ' 17' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 16' ' ' SER . 23.6 Cg_endo -61.79 -179.32 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.283 1.989 . . . . 0.0 112.128 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.503 ' CG2' ' HD2' ' A' ' 19' ' ' PRO . 24.8 m 59.03 146.06 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.156 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.503 ' HD2' ' CG2' ' A' ' 18' ' ' THR . 71.9 Cg_exo -50.72 178.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.597 2.198 . . . . 0.0 112.638 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.419 ' CG2' ' HB2' ' A' ' 103' ' ' SER . 28.9 m -46.07 170.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.711 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -132.51 122.81 25.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.479 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 13.5 mt -60.01 148.67 34.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.033 0.444 . . . . 0.0 111.651 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.5 122.87 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.221 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -71.51 119.24 15.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.509 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -117.5 148.17 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.134 0.493 . . . . 0.0 111.493 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.3 m -134.59 106.89 7.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.848 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.461 ' CD1' ' CE1' ' A' ' 38' ' ' PHE . 13.8 mt -101.08 173.66 6.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.24 0.543 . . . . 0.0 112.017 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.425 ' CZ ' ' HD3' ' A' ' 97' ' ' LYS . 6.3 m-85 -132.53 166.15 22.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.329 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -134.08 161.02 36.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.98 0.419 . . . . 0.0 111.29 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.44 148.02 51.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.657 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.4 m -58.05 -25.21 60.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.149 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.77 -14.71 51.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.854 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 5.3 mmt -81.29 145.0 31.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.911 0.386 . . . . 0.0 111.013 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -91.73 -10.15 41.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.24 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -154.13 -167.52 2.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.607 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.513 ' CE2' ' HB2' ' A' ' 98' ' ' LEU . 1.1 m-85 -95.89 24.4 5.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.723 0.297 . . . . 0.0 111.564 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.6 16.81 74.76 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.568 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.484 ' O ' ' CD1' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -172.05 124.42 0.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.192 0.52 . . . . 0.0 111.696 179.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.4 m -89.51 154.04 20.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.807 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.5 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 30.8 m -106.39 165.47 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.554 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -124.25 178.15 5.49 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.144 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -103.81 139.08 39.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.077 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.07 118.51 5.44 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.33 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.53 -28.5 15.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.927 0.394 . . . . 0.0 111.263 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tp -84.7 -7.68 59.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.856 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 47' ' ' LYS . 8.9 mm-40 -150.12 25.44 0.81 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.13 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER 26.26 63.08 0.08 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.012 0.434 . . . . 0.0 112.082 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -149.24 -164.55 11.69 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.499 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.5 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 19.1 t -132.39 132.51 60.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.638 0.256 . . . . 0.0 111.087 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.461 ' CE1' ' NH1' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -133.41 145.86 50.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.289 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 69' ' ' ASP . 58.6 t -49.06 124.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.057 0.456 . . . . 0.0 111.512 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -88.29 -30.6 19.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.002 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -175.88 160.92 2.42 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.386 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.437 HG12 ' HB2' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -128.04 142.7 43.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.978 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -65.26 147.6 98.48 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.415 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 58.6 Cg_endo -71.78 100.08 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.526 2.151 . . . . 0.0 112.391 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 56' ' ' PRO . . . 83.1 29.35 0.09 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.16 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.03 -179.52 32.95 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.401 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.83 -29.52 53.2 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.588 2.192 . . . . 0.0 112.146 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.19 -47.3 86.4 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.201 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.25 -32.84 67.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.12 0.486 . . . . 0.0 109.951 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.3 mt -73.47 -29.14 62.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.358 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.46 -48.49 29.77 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.178 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.88 10.49 3.51 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.446 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.415 ' CD1' ' CD1' ' A' ' 54' ' ' ILE . 1.3 pp -111.44 152.16 27.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.098 0.449 . . . . 0.0 110.93 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.428 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -138.51 179.11 1.4 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.673 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.477 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 74.8 Cg_exo -49.73 144.9 18.95 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.362 2.041 . . . . 0.0 112.353 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.495 ' O ' ' N ' ' A' ' 70' ' ' ARG . 11.6 m-85 90.32 -17.21 0.2 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.433 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.433 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 1.6 m-20 -53.34 83.75 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.007 0.432 . . . . 0.0 110.847 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 68' ' ' TYR . 24.6 ttm-85 -67.92 99.61 0.86 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.987 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.31 107.98 1.48 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.02 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.51 ' HA ' ' CG ' ' A' ' 80' ' ' ARG . 6.5 mt -83.51 -56.31 3.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.467 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -137.06 116.68 12.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.784 0.326 . . . . 0.0 111.516 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.5 t -89.14 109.04 19.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.535 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 75.54 -59.11 0.54 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.18 0.514 . . . . 0.0 110.517 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -167.47 -14.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.221 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.81 129.24 38.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.775 0.321 . . . . 0.0 111.172 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.73 87.23 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.413 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 20.4 p -96.41 26.48 4.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.288 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.51 ' CG ' ' HA ' ' A' ' 72' ' ' LEU . 2.3 tmm_? -74.93 -46.37 36.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.797 0.332 . . . . 0.0 110.698 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -92.49 19.45 7.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.413 ' CD1' ' HA ' ' A' ' 79' ' ' THR . 2.9 m-85 -82.01 171.14 14.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.959 0.409 . . . . 0.0 110.95 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -105.27 158.74 16.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.378 179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 23.7 m -51.34 -41.32 60.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.88 0.372 . . . . 0.0 110.724 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 17.3 t -65.24 -21.63 66.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.274 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.478 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 10.1 mp -94.56 -30.06 14.57 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.016 0.436 . . . . 0.0 110.739 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.59 -35.79 19.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.254 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.634 ' HB ' ' HD3' ' A' ' 89' ' ' PRO . 58.1 t -58.92 -50.99 85.03 Favored Pre-proline 0 C--N 1.331 -0.209 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.87 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.634 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.8 Cg_exo -67.3 -48.04 1.92 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.445 2.097 . . . . 0.0 111.465 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 11.0 mt -54.93 -29.96 57.48 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.886 0.374 . . . . 0.0 110.511 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.436 ' CG2' HD11 ' A' ' 98' ' ' LEU . 48.3 mt -74.19 -46.53 44.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.343 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.81 -3.79 52.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.966 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -94.87 -15.77 23.42 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.432 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 1.4 t -65.15 -16.04 63.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.382 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.08 -141.41 15.6 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.696 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -73.99 -20.38 60.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.683 0.277 . . . . 0.0 111.441 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.425 ' HD3' ' CZ ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -127.73 152.38 47.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.674 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.513 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -135.77 97.76 3.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.778 0.323 . . . . 0.0 111.575 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.97 118.06 30.41 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -146.6 162.99 37.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.157 0.503 . . . . 0.0 111.968 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.5 t -112.91 109.17 27.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.272 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 2.4 pp -109.17 169.19 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.183 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.419 ' HB2' ' CG2' ' A' ' 20' ' ' VAL . 19.0 p -136.15 107.03 6.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.953 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.11 136.14 53.03 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.443 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 0.9 OUTLIER -93.54 131.37 32.59 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.128 178.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 105' ' ' ASN . 8.7 Cg_exo . . . . . 0 C--O 1.249 1.05 0 C-N-CA 122.24 1.96 . . . . 0.0 112.19 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.4 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.543 0.211 . . . . 0.0 111.442 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.4 ' CD ' ' N ' ' A' ' 16' ' ' SER . 69.6 Cg_exo -50.79 -32.19 35.95 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.405 2.07 . . . . 0.0 112.451 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.51 ' HB ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -169.14 -52.98 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.309 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.51 ' HD3' ' HB ' ' A' ' 18' ' ' THR . 51.1 Cg_exo -54.08 120.4 7.89 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.242 1.961 . . . . 0.0 112.344 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 m -44.27 161.23 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.629 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -120.32 122.75 41.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.601 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.446 HD21 HD11 ' A' ' 72' ' ' LEU . 14.1 mt -61.86 141.92 57.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.291 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.426 ' HB2' ' CD1' ' A' ' 102' ' ' ILE . 9.9 m-70 -144.15 108.51 4.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.839 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.95 102.5 4.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.39 138.44 38.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.107 0.479 . . . . 0.0 111.828 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.2 m -131.98 106.39 8.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.732 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.42 ' HB2' ' CD1' ' A' ' 36' ' ' PHE . 19.6 mt -98.81 177.1 5.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.978 0.418 . . . . 0.0 111.662 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -136.33 135.89 39.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.315 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -94.64 138.18 32.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.417 . . . . 0.0 111.097 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.54 131.04 54.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.795 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -60.59 84.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.838 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.77 -17.25 1.09 Allowed Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.882 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.09 167.94 19.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.848 0.356 . . . . 0.0 110.836 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -107.39 -10.52 15.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.37 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.44 -169.33 3.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.875 0.369 . . . . 0.0 110.896 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.482 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 1.6 m-85 -103.97 17.74 23.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.493 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.34 14.76 59.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.229 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.496 ' O ' ' CD1' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -173.31 130.62 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.112 0.482 . . . . 0.0 111.127 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.82 160.35 14.68 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.065 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.458 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 26.8 m -115.69 158.86 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.178 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -123.58 167.3 14.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.157 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.2 p30 -73.13 153.26 40.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.661 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.23 96.87 1.01 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.564 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.23 -17.97 22.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 0.0 111.302 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.02 -28.88 25.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.439 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.455 ' O ' ' C ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -155.92 51.79 0.55 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.603 -179.734 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 21.62 96.44 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.643 179.49 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.34 -170.88 43.58 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.815 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.458 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 93.7 t -133.08 131.58 58.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.678 0.275 . . . . 0.0 110.671 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -138.59 157.11 46.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.876 0.37 . . . . 0.0 111.237 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.443 ' CG2' ' CD2' ' A' ' 38' ' ' PHE . 43.6 t -65.19 114.92 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.959 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.14 -28.32 17.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.26 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -142.8 156.49 44.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.603 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.473 HD13 ' HB3' ' A' ' 38' ' ' PHE . 1.2 mm -138.54 109.31 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.588 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -64.88 121.8 75.74 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.02 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.93 165.16 2.06 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.46 2.107 . . . . 0.0 112.267 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 35.77 75.34 0.06 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.983 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.93 -171.09 35.87 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.151 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -55.72 -29.75 72.67 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.387 2.058 . . . . 0.0 112.05 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -76.82 -43.83 16.72 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.578 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -73.77 -32.92 64.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.042 0.448 . . . . 0.0 110.357 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.2 mt -75.27 -32.93 61.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.037 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.4 -46.85 7.78 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.566 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 114.92 25.56 3.86 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.668 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 mt -73.73 141.95 46.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.857 0.361 . . . . 0.0 110.798 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -114.65 156.17 45.15 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.92 66.67 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.63 2.22 . . . . 0.0 112.04 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.413 ' O ' ' HB3' ' A' ' 50' ' ' TYR . 0.7 OUTLIER -178.16 -24.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.572 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.407 ' HB3' ' CG1' ' A' ' 102' ' ' ILE . 4.4 m-20 -44.0 94.96 0.01 OUTLIER 'General case' 0 C--O 1.231 0.082 0 CA-C-O 121.194 0.521 . . . . 0.0 111.277 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 50' ' ' TYR . 20.6 ttp180 -74.95 101.31 4.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.667 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 mp -53.98 107.05 0.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.278 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.446 HD11 HD21 ' A' ' 22' ' ' LEU . 20.0 mt -85.12 -56.14 3.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.059 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -136.35 117.59 14.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.92 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.9 t -102.95 119.06 50.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.88 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 72.11 -61.58 0.49 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.128 0.489 . . . . 0.0 110.563 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.2 t-160 -168.07 -18.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.988 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.84 127.29 40.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.826 0.346 . . . . 0.0 111.198 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.69 93.61 0.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.745 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.437 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 14.5 p -95.75 34.41 1.51 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.198 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.412 ' CG ' ' HA ' ' A' ' 72' ' ' LEU . 3.3 mtt180 -67.99 -53.31 26.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.584 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -94.0 25.1 3.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.183 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.437 ' CD1' ' HA ' ' A' ' 79' ' ' THR . 2.5 m-30 -81.43 174.49 11.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.877 0.37 . . . . 0.0 110.805 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.28 161.05 17.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.347 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.437 ' N ' HG22 ' A' ' 49' ' ' VAL . 42.0 t -51.82 -42.96 62.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.894 0.378 . . . . 0.0 110.664 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.4 t -63.54 -19.52 64.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.264 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 3.2 mp -96.58 -32.77 12.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.042 0.449 . . . . 0.0 110.647 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.1 t -77.5 -36.01 22.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.9 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.546 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 98.9 t -57.79 -52.2 76.14 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.839 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 41.5 Cg_endo -66.9 -45.4 4.29 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.336 2.024 . . . . 0.0 111.854 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 19.7 mt -54.64 -29.69 53.05 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.985 0.421 . . . . 0.0 110.681 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.445 HG23 ' CD2' ' A' ' 36' ' ' PHE . 70.2 mt -78.19 -48.18 23.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.839 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.19 -3.93 32.8 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.74 -4.21 14.74 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.4 t -64.73 -16.19 62.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.806 0.336 . . . . 0.0 111.367 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.46 -154.26 19.72 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.557 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -73.44 -9.25 58.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.612 0.244 . . . . 0.0 111.404 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -138.87 123.42 18.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.694 0.283 . . . . 0.0 110.743 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.482 ' HB2' ' CE1' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -107.3 97.4 7.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.19 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -98.62 118.23 34.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 pp -147.75 150.81 34.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.084 0.469 . . . . 0.0 111.965 -178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.6 t -105.43 108.85 25.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.792 178.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.426 ' CD1' ' HB2' ' A' ' 23' ' ' HIS . 2.5 pp -104.41 169.04 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.048 0.451 . . . . 0.0 111.503 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.71 123.87 20.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.382 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.87 126.9 25.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.255 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -75.24 112.95 20.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.828 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 C--O 1.249 1.04 0 C-N-CA 122.413 2.075 . . . . 0.0 112.252 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.67 0.272 . . . . 0.0 111.368 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.08 -47.62 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.448 2.099 . . . . 0.0 112.343 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.51 ' HB ' ' CD ' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -167.49 -60.38 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.216 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.51 ' CD ' ' HB ' ' A' ' 18' ' ' THR . 5.7 Cg_endo -47.69 125.41 11.09 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.593 2.195 . . . . 0.0 112.333 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 105' ' ' ASN . 29.1 m -42.78 131.13 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.15 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -97.24 121.82 39.57 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.563 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 4.6 pp -100.34 153.14 19.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.266 0.555 . . . . 0.0 112.356 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -148.31 149.66 32.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.281 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.87 103.52 10.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.49 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.4 138.7 23.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.197 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.5 m -130.21 110.2 11.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.364 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.9 mt -106.78 174.87 5.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.027 0.442 . . . . 0.0 111.498 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -127.73 154.97 44.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.593 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -114.25 140.45 48.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.035 0.445 . . . . 0.0 111.321 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 32' ' ' GLY . 10.5 t70 -112.79 134.67 54.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.372 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.8 m -56.86 85.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.052 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 30' ' ' ASP . . . 148.65 -18.41 1.28 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.83 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.16 140.67 34.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 111.028 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.52 -10.58 59.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.263 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.58 -167.58 2.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.918 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.476 ' CE2' ' HB2' ' A' ' 98' ' ' LEU . 4.0 m-85 -99.38 28.25 4.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.293 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.12 21.55 48.99 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.999 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.427 ' CD2' HD13 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -174.38 128.01 0.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.792 0.33 . . . . 0.0 110.833 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.7 m -90.06 150.02 22.26 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.792 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 35.5 m -110.48 171.0 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.697 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.61 144.38 26.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.112 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -72.49 168.24 18.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -105.35 122.59 7.27 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.314 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.15 -23.75 17.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.038 0.447 . . . . 0.0 111.322 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.4 mp -84.28 -39.61 19.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.949 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.538 ' O ' ' O ' ' A' ' 47' ' ' LYS . 7.0 pt-20 -156.2 59.95 0.57 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.058 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.538 ' O ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 32.85 -166.85 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.623 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.77 176.01 42.75 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.534 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.439 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 58.9 t -133.79 132.16 56.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.872 0.367 . . . . 0.0 111.226 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.472 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -126.1 -175.11 3.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.372 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.428 HG11 ' CG1' ' A' ' 54' ' ' ILE . 56.0 t -95.77 122.11 46.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.978 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.27 -29.69 19.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.448 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -157.37 154.11 28.38 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.558 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.428 ' CG1' HG11 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -138.25 139.05 42.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.768 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.04 133.42 94.76 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.889 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.435 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 61.1 Cg_endo -72.85 98.05 0.95 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.493 2.129 . . . . 0.0 112.306 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 56' ' ' PRO . . . 82.99 28.77 0.1 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.082 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -106.47 -160.83 22.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.434 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.56 -53.61 6.57 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.586 2.191 . . . . 0.0 112.308 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.06 -39.04 89.05 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.421 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.56 -32.88 64.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.084 0.468 . . . . 0.0 110.21 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 45.3 mt -73.73 -31.41 63.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.686 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.74 -55.59 7.28 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.331 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 139.38 -11.65 3.25 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.04 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.427 HD13 ' CD2' ' A' ' 38' ' ' PHE . 3.3 pp -80.44 135.34 36.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.973 0.416 . . . . 0.0 111.025 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.557 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 6.7 ptmt -120.03 167.52 12.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.397 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.617 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 99.9 Cg_exo -44.62 146.99 1.91 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.459 2.106 . . . . 0.0 112.7 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.617 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 2.2 m-85 82.98 -10.13 1.05 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.671 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.415 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 7.7 m-20 -54.74 88.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.05 0.453 . . . . 0.0 110.854 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.452 ' HA ' ' HA ' ' A' ' 50' ' ' TYR . 12.3 ttm180 -66.83 101.04 0.77 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.02 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.4 mp -56.14 107.89 0.41 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.006 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.413 ' HA ' ' CG ' ' A' ' 80' ' ' ARG . 27.8 mt -82.99 -56.55 3.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.437 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -139.48 137.02 35.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.099 0.475 . . . . 0.0 111.385 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.538 ' O ' ' HB2' ' A' ' 75' ' ' ASN . 31.3 t -107.52 110.45 31.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.345 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.538 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 2.7 m-80 73.28 -58.84 0.58 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.678 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -167.47 -12.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.532 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.411 ' O ' HG12 ' A' ' 77' ' ' VAL . 12.2 p -84.22 133.15 29.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.924 0.393 . . . . 0.0 111.427 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.7 mmt-85 -72.07 89.79 1.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.943 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.42 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 37.7 p -96.28 21.01 9.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.333 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.413 ' CG ' ' HA ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -70.95 -42.53 69.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.885 0.374 . . . . 0.0 110.595 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.16 15.27 13.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.099 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.42 ' CD1' ' HA ' ' A' ' 79' ' ' THR . 3.1 m-85 -81.92 172.24 13.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.927 0.394 . . . . 0.0 110.977 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -111.88 162.53 15.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.383 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 15.7 p -51.49 -43.67 62.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.759 0.314 . . . . 0.0 110.839 -179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.43 -22.22 64.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.332 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.467 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 11.0 mp -95.99 -31.0 13.29 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.904 0.383 . . . . 0.0 111.127 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.4 t -78.95 -35.69 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.299 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.623 ' HB ' ' HD3' ' A' ' 89' ' ' PRO . 62.1 t -58.73 -50.9 85.49 Favored Pre-proline 0 C--N 1.33 -0.26 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.913 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.623 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 14.0 Cg_exo -68.9 -44.57 2.62 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.444 2.096 . . . . 0.0 111.6 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 13.6 mt -54.62 -29.41 51.85 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.663 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.413 ' CG2' ' CD1' ' A' ' 98' ' ' LEU . 51.6 mt -78.07 -50.01 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.6 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.91 -4.05 26.06 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.931 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.14 -9.16 18.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.626 0.251 . . . . 0.0 111.581 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -64.8 -16.21 62.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.721 0.296 . . . . 0.0 111.374 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.83 -143.97 16.9 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.635 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -73.7 -10.15 59.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.584 0.231 . . . . 0.0 111.544 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -138.19 155.7 48.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.69 0.281 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.476 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -139.64 97.46 3.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.136 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -96.12 118.71 33.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.019 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pp -150.04 163.92 36.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.142 0.496 . . . . 0.0 112.064 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 38.2 t -111.97 109.12 27.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.914 178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.563 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 2.6 pp -100.67 168.65 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.999 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.46 129.72 21.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.545 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.419 ' NE ' ' CG ' ' A' ' 66' ' ' LYS . 10.2 ptt85 -139.7 124.88 18.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.919 0.39 . . . . 0.0 111.616 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 4.1 p30 -69.13 133.94 89.6 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.662 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo . . . . . 0 C--O 1.249 1.065 0 C-N-CA 122.457 2.105 . . . . 0.0 112.337 179.939 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.841 0.353 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.82 -1.89 11.09 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.972 2.448 . . . . 0.0 112.647 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.521 ' CG2' ' HD2' ' A' ' 19' ' ' PRO . 21.8 m -157.14 143.86 13.34 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.123 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.521 ' HD2' ' CG2' ' A' ' 18' ' ' THR . 1.7 Cg_endo -42.37 168.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.084 2.523 . . . . 0.0 112.538 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.7 m -48.98 144.52 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.634 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -112.35 122.2 47.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.408 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.404 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 14.2 mt -60.81 141.94 56.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.601 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.408 ' CE1' ' O ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -153.24 120.92 5.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.146 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.408 ' O ' ' CE1' ' A' ' 23' ' ' HIS . 2.6 tptp -69.88 124.43 24.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.903 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.4 139.92 50.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.039 0.447 . . . . 0.0 111.121 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 95.0 m -134.34 117.51 16.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.198 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 mp -116.03 167.65 10.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.079 0.466 . . . . 0.0 111.572 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' A' ' 28' ' ' TYR . 2.9 m-85 -135.37 121.92 20.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.175 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -95.11 163.65 13.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.946 0.403 . . . . 0.0 111.262 -179.526 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.99 139.47 41.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.26 85.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.921 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.64 -23.58 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.831 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.91 156.7 27.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.932 0.396 . . . . 0.0 110.961 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -87.71 -10.54 50.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.434 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -155.35 -172.24 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.857 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.482 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -97.87 32.15 2.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.238 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.93 -5.2 63.56 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.286 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.505 ' HA ' ' O ' ' A' ' 53' ' ' ASN . 48.6 p90 -171.31 149.58 2.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.047 0.424 . . . . 0.0 111.739 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.9 m -104.5 133.83 48.71 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.433 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.429 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 33.1 m -93.46 170.8 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.751 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -139.38 162.31 35.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.148 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -83.25 130.31 35.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.709 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.494 ' HA3' ' CZ ' ' A' ' 50' ' ' TYR . . . -103.25 107.52 3.07 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.793 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 mp -94.67 -26.74 16.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.055 0.455 . . . . 0.0 111.03 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 tp -84.51 -6.09 59.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.714 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 47' ' ' LYS . 10.2 mt-10 -152.69 29.78 0.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.922 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 26.99 91.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.149 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.426 ' O ' ' HA3' ' A' ' 43' ' ' GLY . . . 157.9 160.4 10.2 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.273 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.429 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 40.1 t -101.39 133.48 44.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.853 0.359 . . . . 0.0 111.361 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.494 ' CZ ' ' HA3' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -125.42 -177.46 3.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.454 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.412 HG13 ' CD1' ' A' ' 54' ' ' ILE . 37.2 t -89.62 162.2 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.649 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.9 -42.12 0.24 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.011 0.434 . . . . 0.0 110.833 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 67.1 m-80 -123.43 130.49 52.78 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.578 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.425 HG12 ' HB2' ' A' ' 38' ' ' PHE . 1.1 mt -136.49 117.78 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.746 0.308 . . . . 0.0 111.331 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.13 110.54 5.28 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.592 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.11 55.06 0.72 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.589 2.193 . . . . 0.0 112.777 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -173.82 -43.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.927 0.394 . . . . 0.0 111.255 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.9 -152.47 0.96 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.705 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_exo -62.14 -35.26 76.3 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.801 2.334 . . . . 0.0 112.079 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.5 -49.92 66.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.716 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -73.67 -36.18 65.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.061 0.457 . . . . 0.0 110.201 179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 33.1 mt -60.83 -29.6 69.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.974 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.92 -51.42 3.8 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.419 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.38 47.71 0.85 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.724 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.41 165.63 11.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.079 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.427 ' O ' ' OD2' ' A' ' 69' ' ' ASP . 12.2 mtmm -132.13 159.57 71.6 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.665 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.453 ' O ' ' CG ' ' A' ' 68' ' ' TYR . 36.7 Cg_endo -65.55 64.43 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.487 2.125 . . . . 0.0 112.254 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.453 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 6.2 m-85 -174.12 -30.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.396 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.471 ' HB2' ' CD1' ' A' ' 102' ' ' ILE . 4.4 p30 -50.25 96.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.453 0.644 . . . . 0.0 110.799 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.421 ' HB2' ' CD1' ' A' ' 50' ' ' TYR . 27.6 ttp180 -74.3 104.16 4.96 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.537 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.417 ' CD2' ' CD2' ' A' ' 100' ' ' LEU . 1.1 mt -54.42 108.42 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.027 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.419 ' HB3' ' CG ' ' A' ' 80' ' ' ARG . 5.2 mt -82.9 -66.02 0.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.132 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.32 132.19 53.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.892 0.377 . . . . 0.0 111.163 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.458 ' HA ' ' HB3' ' A' ' 100' ' ' LEU . 29.7 t -104.58 103.85 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.8 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 75.31 -58.61 0.56 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.138 0.494 . . . . 0.0 110.565 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -167.67 -13.76 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.286 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.63 141.04 15.05 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.741 0.305 . . . . 0.0 111.309 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -70.2 128.13 35.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.519 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.426 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 41.6 p -143.76 25.93 1.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.172 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.419 ' CG ' ' HB3' ' A' ' 72' ' ' LEU . 6.9 mtt180 -73.32 -52.78 12.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.59 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -93.74 25.33 3.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.108 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.426 ' CD1' ' HA ' ' A' ' 79' ' ' THR . 2.2 m-85 -81.58 166.37 20.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.897 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -106.03 161.16 14.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.549 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.408 ' N ' HG23 ' A' ' 49' ' ' VAL . 1.9 t -51.69 -42.2 62.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.645 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 23.0 m -62.74 -22.91 66.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.213 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.405 ' HB3' ' CD2' ' A' ' 82' ' ' PHE . 7.9 mp -93.0 -32.93 14.33 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.012 0.434 . . . . 0.0 110.854 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.8 t -77.6 -36.03 22.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.0 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.541 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 77.8 t -54.73 -52.41 70.54 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.732 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 50.3 Cg_endo -68.63 -45.96 2.1 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.233 1.956 . . . . 0.0 111.788 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 27.0 mt -55.48 -32.06 62.53 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.607 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.429 HG21 ' CD1' ' A' ' 98' ' ' LEU . 60.7 mt -75.17 -44.86 42.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.599 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.11 -3.7 43.66 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.949 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -85.03 -15.82 42.84 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.742 0.306 . . . . 0.0 111.723 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 2.0 m -65.02 -25.01 67.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.982 0.42 . . . . 0.0 111.269 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.92 -61.48 3.74 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.189 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 24.3 p30 -163.12 16.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.84 105.69 2.21 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -107.39 107.52 18.46 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.941 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.0 117.93 35.46 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.458 ' HB3' ' HA ' ' A' ' 74' ' ' VAL . 1.3 pp -150.49 155.96 40.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.262 0.553 . . . . 0.0 112.373 -178.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.5 t -105.44 109.24 27.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.618 178.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.471 ' CD1' ' HB2' ' A' ' 69' ' ' ASP . 2.8 pp -100.96 169.45 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.189 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.9 102.63 5.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.605 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.409 ' HB3' ' HA ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -111.56 124.3 52.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.073 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.1 148.09 88.66 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.675 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo . . . . . 0 C--O 1.248 1.022 0 C-N-CA 122.606 2.204 . . . . 0.0 112.42 -179.948 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.458 ' CB ' ' HD2' ' A' ' 17' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.627 0.251 . . . . 0.0 111.093 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.458 ' HD2' ' CB ' ' A' ' 16' ' ' SER . 1.3 Cg_endo -43.08 -41.06 9.27 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.137 2.558 . . . . 0.0 113.179 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.499 ' CB ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -86.48 -56.76 0.35 Allowed Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.499 ' HD3' ' CB ' ' A' ' 18' ' ' THR . 7.0 Cg_exo -73.34 90.93 0.87 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.698 2.265 . . . . 0.0 112.561 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.425 ' CG2' ' HB2' ' A' ' 103' ' ' SER . 18.0 m -46.89 170.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.432 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.58 122.21 28.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.734 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.7 mt -60.95 150.68 32.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.442 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 17.1 m-70 -156.67 110.56 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.986 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -71.4 113.56 8.56 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.53 140.19 44.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.202 0.525 . . . . 0.0 112.099 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.8 m -134.33 106.64 7.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.51 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.424 HD13 ' CE1' ' A' ' 38' ' ' PHE . 23.5 mt -102.79 173.54 6.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.222 0.534 . . . . 0.0 112.143 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 96' ' ' ASN . 8.5 m-85 -134.69 121.82 21.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.245 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.463 ' N ' ' CE1' ' A' ' 36' ' ' PHE . 5.2 tttt -104.26 152.05 22.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.928 0.394 . . . . 0.0 111.346 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -119.62 158.74 25.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.651 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.24 -27.94 64.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.173 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.13 -24.74 51.12 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.73 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 2.9 mmt -81.41 132.7 35.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.907 0.384 . . . . 0.0 111.043 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -78.67 -10.78 59.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.265 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -155.9 -168.82 2.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.639 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.463 ' CE1' ' N ' ' A' ' 29' ' ' LYS . 5.0 m-85 -97.02 29.72 2.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.334 . . . . 0.0 111.178 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.09 24.57 68.61 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.955 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.424 ' CE1' HD13 ' A' ' 27' ' ' LEU . 1.4 p90 -174.44 117.3 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.047 0.451 . . . . 0.0 111.427 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -88.9 146.44 24.93 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.872 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.457 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 34.4 m -108.62 171.07 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.656 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -137.81 156.89 47.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.14 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -72.38 144.34 48.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.693 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.419 ' HA3' ' CZ ' ' A' ' 50' ' ' TYR . . . -119.93 108.26 1.44 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.612 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 pp -94.14 -27.28 16.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.976 0.417 . . . . 0.0 110.985 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.4 -3.33 58.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.371 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 47' ' ' LYS . 7.2 mt-10 -152.97 27.6 0.53 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.675 -0.238 . . . . 0.0 110.981 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER 27.09 91.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.251 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.9 -154.37 25.3 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.479 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.457 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 21.3 t -142.11 139.31 30.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.36 . . . . 0.0 110.942 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.1 OUTLIER -126.68 177.73 6.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.509 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 69' ' ' ASP . 61.4 t -86.46 123.29 39.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.182 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -88.13 -29.34 20.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.782 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -168.33 149.99 5.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.246 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.417 HD11 ' CD1' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -129.26 132.73 66.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.184 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -65.56 125.22 89.23 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.54 140.38 83.24 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.388 2.059 . . . . 0.0 112.547 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 40.8 32.34 0.15 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.991 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -101.66 -167.96 27.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.955 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.57 -34.27 98.72 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.313 2.009 . . . . 0.0 111.721 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.28 -44.67 42.34 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.427 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -71.98 -32.76 67.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.99 0.424 . . . . 0.0 109.942 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.1 mt -72.11 -29.24 63.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.443 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.37 -57.93 5.32 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.326 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.49 -20.83 1.69 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.449 -0.881 . . . . 0.0 113.091 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.417 ' CD1' HD11 ' A' ' 54' ' ' ILE . 3.1 pp -73.83 134.04 43.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.944 0.402 . . . . 0.0 111.0 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.478 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 15.1 mttt -120.74 167.63 12.51 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.607 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.657 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 99.9 Cg_exo -43.24 145.98 1.22 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.539 2.159 . . . . 0.0 112.606 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.657 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 4.3 m-85 83.21 -10.01 1.03 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.665 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.451 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 4.3 m-20 -54.61 87.06 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.972 0.415 . . . . 0.0 110.817 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 68' ' ' TYR . 31.2 ttp180 -66.93 97.51 0.49 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.7 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.405 ' CD2' ' CD2' ' A' ' 100' ' ' LEU . 2.9 mt -55.58 107.39 0.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.127 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.46 ' HA ' HD21 ' A' ' 72' ' ' LEU . 23.8 mt -84.25 -65.92 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.121 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -122.57 140.97 52.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.027 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.3 t -124.69 112.63 32.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.055 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.463 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 5.1 m120 64.64 33.33 10.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.934 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.463 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 2.6 t-80 86.72 -14.89 0.47 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.611 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 36.7 t -83.27 138.65 18.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.828 0.346 . . . . 0.0 111.061 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -69.55 130.88 43.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.687 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.445 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 30.3 p -144.24 27.97 1.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.061 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.417 ' CG ' ' HB3' ' A' ' 72' ' ' LEU . 30.5 mtp180 -83.14 -42.5 17.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.627 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.11 10.31 27.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.041 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.493 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 3.1 m-85 -80.28 -176.45 5.63 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.959 0.409 . . . . 0.0 110.84 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -128.5 169.3 14.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.309 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 53.3 t -51.18 -45.58 61.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.746 0.307 . . . . 0.0 110.755 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.28 -18.45 63.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.107 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -95.5 -37.97 10.65 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.216 0.531 . . . . 0.0 111.04 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.6 t -77.03 -35.46 23.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.536 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.663 ' HB ' ' HD3' ' A' ' 89' ' ' PRO . 89.8 t -57.53 -51.79 79.11 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.694 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.663 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 18.3 Cg_exo -65.67 -44.38 8.35 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.248 1.966 . . . . 0.0 111.181 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.442 HD13 ' CE2' ' A' ' 82' ' ' PHE . 52.7 mt -54.57 -32.08 57.88 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.04 0.447 . . . . 0.0 110.526 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.421 ' HA ' HD11 ' A' ' 98' ' ' LEU . 61.9 mt -73.29 -49.65 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.55 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.17 -2.69 32.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.796 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -93.32 -13.2 28.46 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.413 ' OG ' ' HG ' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -63.8 -27.63 69.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.05 0.453 . . . . 0.0 110.746 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.8 -53.3 0.82 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.865 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 6.7 m120 -165.6 -34.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.956 0.408 . . . . 0.0 110.403 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -104.71 108.7 20.3 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.248 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -101.93 97.35 7.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.708 -179.243 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -100.45 118.32 36.42 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.405 ' CD2' ' CD2' ' A' ' 71' ' ' LEU . 1.3 pp -148.1 159.51 43.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.226 0.536 . . . . 0.0 112.239 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.3 t -111.14 109.14 27.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.014 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.5 pp -104.19 169.6 2.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.38 -179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.425 ' HB2' ' CG2' ' A' ' 20' ' ' VAL . 9.0 p -143.19 125.4 15.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.332 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -144.99 137.16 25.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.986 0.422 . . . . 0.0 111.421 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -62.57 132.21 94.37 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.743 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 122.422 2.082 . . . . 0.0 112.284 -179.959 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.441 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 59.0 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.663 0.268 . . . . 0.0 111.5 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 16' ' ' SER . 35.8 Cg_endo -67.8 -80.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.326 2.017 . . . . 0.0 112.593 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.434 ' CG2' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -55.34 154.05 12.38 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.21 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.434 ' HD2' ' CG2' ' A' ' 18' ' ' THR . 32.1 Cg_exo -59.2 -144.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.792 2.328 . . . . 0.0 111.971 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.9 m -45.24 144.59 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.86 0.362 . . . . 0.0 111.531 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -116.0 122.39 45.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.647 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 15.4 mt -62.27 137.64 58.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.479 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.406 ' NE2' ' CG2' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -149.04 127.42 12.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.273 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -71.53 133.69 45.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.622 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.406 ' CG2' ' NE2' ' A' ' 23' ' ' HIS . 0.2 OUTLIER -135.87 147.72 28.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.949 0.404 . . . . 0.0 111.327 -179.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.7 m -134.4 118.4 17.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.135 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.414 HD11 ' CZ ' ' A' ' 38' ' ' PHE . 3.8 mt -110.11 168.77 9.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.959 0.409 . . . . 0.0 111.678 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -134.87 132.66 38.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.573 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -102.02 165.11 11.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.943 0.402 . . . . 0.0 111.254 -179.683 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -144.14 141.68 30.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.687 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -55.87 -23.11 29.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.299 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.5 -13.11 56.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.996 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -80.28 155.15 27.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.916 0.389 . . . . 0.0 111.197 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -100.99 -10.64 20.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.215 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -155.08 -174.62 5.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.588 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -97.46 32.55 2.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.27 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.99 1.08 90.2 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.009 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.469 ' O ' ' CD1' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -172.14 135.29 0.77 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.004 0.43 . . . . 0.0 111.43 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.9 m -96.32 148.23 22.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.51 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.424 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 33.9 m -104.15 169.07 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.674 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -141.42 167.01 23.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.999 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -80.58 153.28 28.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.839 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.01 115.48 2.45 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.505 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.3 tt -94.31 -28.65 15.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.015 0.436 . . . . 0.0 111.148 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 mp -83.9 -55.9 3.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.781 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.4 mt-10 -89.78 17.11 6.95 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.431 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER 30.03 88.46 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.883 0.373 . . . . 0.0 111.934 -179.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.22 -141.99 7.26 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.515 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.424 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 39.5 t -145.47 138.24 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.916 0.389 . . . . 0.0 110.988 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.419 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -131.1 179.44 6.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.416 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.419 ' CG2' ' CD2' ' A' ' 38' ' ' PHE . 47.9 t -87.65 123.6 40.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.017 0.437 . . . . 0.0 111.287 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.74 -31.33 18.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.225 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -157.23 154.96 30.02 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.401 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.424 ' CD1' ' CB ' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -135.45 123.85 38.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.102 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -65.6 122.8 82.34 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.825 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.23 152.41 31.46 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.397 2.065 . . . . 0.0 112.439 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 38.65 33.94 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.007 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -118.79 -162.47 12.12 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.164 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -49.11 -54.33 5.61 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.5 2.133 . . . . 0.0 112.245 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.94 -33.15 86.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.717 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -73.71 -32.76 64.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.928 0.394 . . . . 0.0 110.409 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -74.1 -29.8 62.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.997 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -86.83 -34.83 10.67 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.463 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.2 32.83 3.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.518 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.424 ' CB ' ' CD1' ' A' ' 54' ' ' ILE . 11.4 mt -81.59 138.54 35.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.775 0.321 . . . . 0.0 111.042 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -126.32 160.58 56.96 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.715 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.436 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 78.1 Cg_exo -50.45 142.13 31.05 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.638 2.226 . . . . 0.0 112.332 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.436 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 18.4 m-85 85.44 -3.86 0.86 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.33 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.416 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 4.7 m-20 -53.19 89.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.056 0.455 . . . . 0.0 110.806 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 68' ' ' TYR . 69.0 ttt180 -76.99 111.64 12.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.999 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.26 107.79 4.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.734 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.467 HD22 ' HG2' ' A' ' 80' ' ' ARG . 1.7 mt -83.48 -19.5 35.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.963 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.06 152.68 1.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.011 0.434 . . . . 0.0 111.528 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -124.0 112.6 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.611 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 8.3 m120 76.25 -58.19 0.54 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.107 0.48 . . . . 0.0 110.569 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -167.06 -14.22 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.134 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.78 136.28 23.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-O 120.752 0.311 . . . . 0.0 111.116 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -69.65 143.2 53.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.674 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.435 ' HA ' ' CG ' ' A' ' 82' ' ' PHE . 64.2 p -146.07 18.39 1.41 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.657 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.467 ' HG2' HD22 ' A' ' 72' ' ' LEU . 11.3 mtm180 -65.77 -51.66 57.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.895 0.379 . . . . 0.0 110.425 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -93.75 20.96 6.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.227 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.435 ' CG ' ' HA ' ' A' ' 79' ' ' THR . 2.3 m-30 -81.32 169.18 17.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.797 0.332 . . . . 0.0 110.823 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -109.76 160.33 16.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.668 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 24.8 p -51.87 -31.44 28.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.906 0.384 . . . . 0.0 110.713 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -21.67 62.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.196 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.612 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 5.7 mp -98.38 -30.23 12.69 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.084 0.469 . . . . 0.0 110.819 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.8 t -79.74 -35.98 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.451 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.598 ' CG1' ' HD3' ' A' ' 89' ' ' PRO . 5.0 p -64.22 -39.82 46.79 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.667 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.612 ' HD2' ' C ' ' A' ' 86' ' ' LEU . 73.4 Cg_endo -74.37 -46.73 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.662 1.575 . . . . 0.0 111.227 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 81.5 mt -56.58 -28.35 60.04 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.108 0.48 . . . . 0.0 110.263 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.534 HG21 HD13 ' A' ' 98' ' ' LEU . 33.2 mt -75.92 -49.15 26.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.631 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.78 -2.56 47.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.064 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.64 -12.54 17.64 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.417 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -65.38 -14.3 60.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.698 0.285 . . . . 0.0 111.419 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.67 -145.15 17.77 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.609 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -73.56 -15.91 61.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.581 0.229 . . . . 0.0 111.393 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -125.98 139.68 53.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.798 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.534 HD13 HG21 ' A' ' 91' ' ' ILE . 0.4 OUTLIER -130.61 97.14 4.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.123 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -98.34 118.6 35.36 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.7 pp -146.86 158.79 44.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.224 0.535 . . . . 0.0 112.24 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 18.5 t -113.76 109.66 29.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.104 178.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 2.0 pp -108.78 169.56 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.372 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.406 ' OG ' ' HG ' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -130.54 127.84 39.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.859 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.03 141.43 34.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.934 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -71.42 135.78 84.06 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.766 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 C--O 1.248 1.003 0 C-N-CA 122.392 2.061 . . . . 0.0 112.252 -179.994 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.762 0.315 . . . . 0.0 111.232 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.36 109.65 2.65 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.449 2.099 . . . . 0.0 112.092 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.544 ' CG2' ' HD2' ' A' ' 19' ' ' PRO . 31.3 m 59.82 150.08 0.08 OUTLIER Pre-proline 0 N--CA 1.453 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.504 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 18' ' ' THR . 72.6 Cg_exo -52.78 -147.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.652 2.235 . . . . 0.0 112.572 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.0 m -36.98 153.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.927 0.394 . . . . 0.0 112.053 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -119.16 122.54 42.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.52 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.416 HD21 HD12 ' A' ' 72' ' ' LEU . 13.3 mt -60.72 135.46 57.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.499 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -143.83 112.05 6.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.726 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 111.31 7.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.191 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.66 139.55 44.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.122 0.487 . . . . 0.0 111.553 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.5 m -133.02 106.74 7.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.97 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 mp -99.16 174.0 6.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.961 0.41 . . . . 0.0 111.902 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -131.33 140.16 49.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.332 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -109.22 165.21 11.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.952 0.406 . . . . 0.0 111.422 -179.559 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.65 137.22 53.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.681 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -59.25 85.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.138 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.06 14.36 2.75 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.163 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -81.68 166.88 19.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.89 0.345 . . . . 0.0 110.807 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -92.52 -24.29 18.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.152 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -157.79 -167.89 2.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.755 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -103.6 31.05 4.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.892 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.45 0.06 80.06 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.085 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.428 ' CE2' HG22 ' A' ' 51' ' ' VAL . 18.4 p90 -172.41 153.74 3.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.985 0.392 . . . . 0.0 111.461 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.9 p -119.03 148.01 43.48 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.552 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.429 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 30.5 m -113.35 157.6 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.474 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -114.14 177.54 4.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.208 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.79 160.86 21.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.27 115.29 2.49 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.389 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.61 -35.23 12.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.11 0.481 . . . . 0.0 111.191 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 tp -84.26 -53.78 5.25 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.055 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.4 mm-40 -90.53 16.37 9.09 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.558 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 46' ' ' GLU . 3.5 mmtt 29.05 82.91 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 174.97 -150.87 11.52 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.492 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.429 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 88.8 t -138.38 139.83 40.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.824 0.345 . . . . 0.0 110.914 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -139.51 162.72 34.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.605 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.428 HG22 ' CE2' ' A' ' 38' ' ' PHE . 50.1 t -62.36 162.0 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.592 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 16.8 pttt -147.0 -35.36 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 0.0 111.579 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.408 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 15.6 m-80 -144.49 139.03 28.02 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.981 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.425 HG12 ' HB2' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -132.95 133.97 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.0 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -65.89 142.4 98.06 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.913 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 55' ' ' ARG . 34.7 Cg_exo -57.66 127.19 24.35 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.544 2.162 . . . . 0.0 112.531 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 43.28 30.79 0.33 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.875 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.92 -159.48 32.52 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.935 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -51.87 -55.92 3.44 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.312 2.008 . . . . 0.0 111.876 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.93 -38.66 86.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.671 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -73.37 -32.63 64.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.967 0.413 . . . . 0.0 110.183 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.6 mt -77.32 -30.39 54.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.842 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.28 -56.67 6.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.426 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.97 33.23 0.93 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.656 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.7 pp -118.5 132.06 56.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 110.905 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.467 ' CB ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -117.87 169.51 7.53 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.783 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 1.6 Cg_endo -44.63 146.14 2.35 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.646 2.231 . . . . 0.0 112.239 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.486 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 8.5 m-85 91.14 -21.13 0.11 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.095 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -53.75 85.49 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.166 0.508 . . . . 0.0 110.669 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -68.49 105.91 2.37 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.195 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 mp -63.07 107.9 1.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.425 ' HA ' ' CG ' ' A' ' 80' ' ' ARG . 10.0 mt -83.38 -65.85 0.96 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.17 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -119.38 126.82 52.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.157 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.1 t -109.62 107.1 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.712 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 74.65 -58.59 0.58 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.139 0.495 . . . . 0.0 110.537 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -167.22 -18.02 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.951 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.36 125.27 40.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-O 120.792 0.329 . . . . 0.0 111.129 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.65 84.36 0.45 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.649 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.415 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 17.7 p -94.62 43.94 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.17 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.425 ' CG ' ' HA ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -80.99 -47.02 14.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.646 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -92.93 21.29 5.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.055 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.415 ' CD1' ' HA ' ' A' ' 79' ' ' THR . 3.2 m-85 -81.69 170.82 15.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.702 0.287 . . . . 0.0 110.954 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -106.26 160.26 15.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.404 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 7.4 p -51.76 -42.12 62.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 110.694 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.7 m -63.44 -23.28 67.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.236 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.448 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -93.63 -31.13 14.6 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.906 0.384 . . . . 0.0 110.95 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.7 t -79.62 -35.95 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.359 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.628 ' HB ' ' HD3' ' A' ' 89' ' ' PRO . 95.1 t -57.14 -50.84 85.86 Favored Pre-proline 0 C--N 1.331 -0.219 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.938 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.628 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 12.0 Cg_exo -70.43 -47.14 0.77 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.509 2.14 . . . . 0.0 111.512 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.437 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 44.8 mt -53.92 -30.75 47.62 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.517 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.444 HG22 ' CD2' ' A' ' 36' ' ' PHE . 63.9 mt -78.28 -42.04 26.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.505 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.41 -4.69 40.94 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.437 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 10.3 pt-20 -107.38 -3.44 19.58 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.418 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 6.9 t -64.38 -15.99 61.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.801 0.334 . . . . 0.0 111.411 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.5 -144.61 17.41 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.592 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.39 -10.67 59.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.55 0.214 . . . . 0.0 111.425 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -140.76 157.29 45.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.813 0.34 . . . . 0.0 110.97 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -138.33 97.2 3.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.033 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.14 118.23 31.25 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 pp -148.37 164.03 35.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.257 0.551 . . . . 0.0 112.025 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.405 HG11 ' CD2' ' A' ' 22' ' ' LEU . 48.4 t -115.79 108.93 26.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.103 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.5 pp -101.82 169.27 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.409 -179.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.17 122.18 15.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.676 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -133.48 138.66 46.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.153 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -80.93 154.5 72.91 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.7 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo . . . . . 0 C--O 1.25 1.092 0 C-N-CA 122.497 2.131 . . . . 0.0 112.304 179.94 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.455 ' CB ' ' HD2' ' A' ' 106' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.602 0.239 . . . . 0.0 111.042 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.62 -23.36 25.44 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.304 2.003 . . . . 0.0 111.93 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.463 ' HB ' ' HD3' ' A' ' 19' ' ' PRO . 1.1 m 176.98 -50.95 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.624 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.463 ' HD3' ' HB ' ' A' ' 18' ' ' THR . 34.2 Cg_exo -58.17 92.73 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.405 2.07 . . . . 0.0 112.446 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.4 m -47.34 170.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.748 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -123.45 122.38 38.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.597 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.401 HD22 HD13 ' A' ' 72' ' ' LEU . 15.5 mt -62.63 138.99 58.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.712 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -145.09 120.82 10.52 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.677 179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.13 113.2 11.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.42 139.84 42.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.144 0.497 . . . . 0.0 111.849 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.7 m -134.03 106.43 7.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.955 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.42 HD23 ' CD2' ' A' ' 38' ' ' PHE . 2.3 mp -99.91 168.41 9.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.919 0.39 . . . . 0.0 111.483 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 96' ' ' ASN . 4.9 m-85 -124.92 143.95 50.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.748 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -104.83 159.45 15.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.113 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -129.97 140.97 50.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.92 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.7 p -57.97 -28.73 64.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.064 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.47 -22.53 46.99 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.683 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 18.0 mmm -81.0 162.44 23.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.369 . . . . 0.0 110.959 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.84 -10.56 15.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.325 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.63 -166.97 2.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.798 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 7.5 m-85 -97.46 32.75 2.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.201 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 48.39 40.63 23.44 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.209 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.615 ' HB2' ' CD1' ' A' ' 54' ' ' ILE . 0.1 OUTLIER -174.65 116.37 0.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.076 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.43 155.19 19.37 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 121.112 0.482 . . . . 0.0 112.155 -177.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.423 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 34.1 m -116.1 169.86 6.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.07 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -129.51 176.74 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.87 0.367 . . . . 0.0 111.358 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.8 140.76 30.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.764 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.71 103.57 1.65 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.521 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 mp -94.17 -31.54 14.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.184 0.516 . . . . 0.0 110.828 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.28 -3.91 58.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.506 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.42 ' O ' ' C ' ' A' ' 47' ' ' LYS . 11.2 mt-10 -153.07 27.01 0.53 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.098 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 26.99 95.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 159.99 -155.46 26.58 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.435 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.423 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 80.5 t -141.76 138.01 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.328 . . . . 0.0 111.042 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.45 ' CD1' ' HG3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -134.43 165.09 25.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.41 179.835 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.425 HG12 ' CD1' ' A' ' 54' ' ' ILE . 3.8 t -63.84 162.76 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.625 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -145.4 -36.97 0.28 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.028 0.442 . . . . 0.0 111.325 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.515 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 2.0 m-80 -140.24 145.21 37.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.326 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.615 ' CD1' ' HB2' ' A' ' 38' ' ' PHE . 5.0 mm -134.92 119.07 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.907 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.56 131.98 94.93 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.714 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.469 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 67.1 Cg_endo -74.0 121.82 7.22 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.491 2.127 . . . . 0.0 112.443 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.469 ' CB ' ' O ' ' A' ' 56' ' ' PRO . . . 87.77 -20.8 0.19 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.73 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.16 -170.74 30.87 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.415 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -51.93 -25.77 22.82 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.529 2.153 . . . . 0.0 112.247 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.47 -45.83 88.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.367 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -73.55 -33.03 64.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.947 0.403 . . . . 0.0 110.3 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 57.3 mt -62.07 -37.97 87.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.821 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.16 -52.05 5.45 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.38 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.35 44.99 1.91 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.611 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.43 HD11 ' CG ' ' A' ' 38' ' ' PHE . 0.5 OUTLIER -111.56 126.21 54.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.928 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.8 mttp -75.12 164.69 59.58 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.107 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.62 64.78 3.83 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.767 2.311 . . . . 0.0 112.366 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.436 ' O ' ' N ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -176.32 -25.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.527 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.487 ' HA ' ' HB2' ' A' ' 104' ' ' ARG . 71.1 m-20 -39.56 90.84 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.455 0.645 . . . . 0.0 111.852 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.45 ' HG3' ' CD1' ' A' ' 50' ' ' TYR . 0.2 OUTLIER -67.63 99.3 0.77 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.644 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.72 111.68 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.527 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.453 ' HA ' ' CG ' ' A' ' 80' ' ' ARG . 6.5 mt -82.97 -44.82 14.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.693 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.6 142.37 32.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.762 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.8 t -129.85 152.04 36.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.88 0.371 . . . . 0.0 111.492 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.0 m120 40.21 31.85 0.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.98 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 76.01 42.98 0.18 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.845 0.355 . . . . 0.0 110.898 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 72.8 t -152.15 152.95 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.05 129.06 38.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.73 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.43 HG22 ' CE2' ' A' ' 82' ' ' PHE . 66.8 p -144.47 28.14 1.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.017 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.453 ' CG ' ' HA ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -83.74 -44.95 13.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.736 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -92.28 15.77 13.03 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.34 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.43 ' CE2' HG22 ' A' ' 79' ' ' THR . 5.5 m-30 -81.85 167.53 18.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.872 0.368 . . . . 0.0 110.903 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.81 162.05 14.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.455 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.421 ' N ' HG22 ' A' ' 49' ' ' VAL . 22.9 p -51.8 -38.64 56.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.762 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 16.1 p -65.89 -24.6 66.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.4 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.483 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -93.4 -29.2 15.71 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.012 0.434 . . . . 0.0 110.913 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.0 -35.57 20.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.311 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.643 ' HB ' ' HD3' ' A' ' 89' ' ' PRO . 94.1 t -58.79 -51.16 83.82 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.791 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.643 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 17.0 Cg_exo -67.11 -44.54 4.94 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.555 2.17 . . . . 0.0 111.428 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.462 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 8.0 mt -54.07 -30.99 50.39 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.072 0.463 . . . . 0.0 110.431 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.498 ' HA ' HD11 ' A' ' 98' ' ' LEU . 71.6 mt -79.08 -48.86 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.128 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.5 -4.16 28.78 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.462 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -103.39 8.19 38.07 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.41 -39.43 93.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.227 0.537 . . . . 0.0 110.238 179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.59 -47.28 1.11 Allowed Glycine 0 C--N 1.32 -0.36 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.009 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -166.35 -36.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.682 0.277 . . . . 0.0 111.388 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -123.49 114.47 20.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.428 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -100.99 97.58 8.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.548 -179.256 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -95.91 118.12 31.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.1 pp -146.44 156.04 43.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.993 0.425 . . . . 0.0 111.892 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.5 t -106.34 109.37 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.26 179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.432 ' HB ' ' HB3' ' A' ' 69' ' ' ASP . 2.6 pp -106.28 170.12 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.46 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.5 130.78 22.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.787 179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.487 ' HB2' ' HA ' ' A' ' 69' ' ' ASP . 0.6 OUTLIER -148.03 139.73 23.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.919 0.39 . . . . 0.0 111.123 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.403 ' N ' ' HG2' ' A' ' 104' ' ' ARG . 1.4 p-10 -79.48 120.88 81.82 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.397 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.455 ' HD2' ' CB ' ' A' ' 16' ' ' SER . 20.9 Cg_exo . . . . . 0 C--O 1.248 0.999 0 C-N-CA 122.324 2.016 . . . . 0.0 112.232 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.422 ' CB ' ' HD3' ' A' ' 17' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 120.557 0.218 . . . . 0.0 111.556 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.422 ' HD3' ' CB ' ' A' ' 16' ' ' SER . 5.5 Cg_exo -74.36 49.36 2.03 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.705 2.27 . . . . 0.0 112.55 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.427 ' CB ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -169.77 -51.91 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.136 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.427 ' HD3' ' CB ' ' A' ' 18' ' ' THR . 2.4 Cg_endo -85.72 24.28 0.77 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.119 2.546 . . . . 0.0 112.875 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.7 m -42.94 135.69 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.76 122.32 38.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.324 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.0 mt -60.46 149.16 35.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.089 0.471 . . . . 0.0 111.759 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.5 117.91 3.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.193 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -70.73 131.97 44.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.85 141.32 45.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 0.0 111.229 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.1 m -134.63 109.48 8.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.237 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.1 mt -107.15 166.49 10.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.015 0.436 . . . . 0.0 111.726 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -121.03 147.08 46.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.491 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.14 155.1 17.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.939 0.4 . . . . 0.0 111.124 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.04 156.53 23.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.828 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.4 t -68.27 82.59 0.24 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.026 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.41 21.95 5.32 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.725 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.77 124.62 29.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 0.0 110.817 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -72.13 -10.9 60.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.343 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.33 -175.14 5.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.726 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -106.9 29.82 6.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.844 0.354 . . . . 0.0 111.115 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.3 7.47 72.86 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.623 -0.798 . . . . 0.0 113.114 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.466 ' HB2' HG12 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -171.6 148.69 2.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.038 0.419 . . . . 0.0 111.608 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 52' ' ' LYS . 2.4 m -117.84 144.57 45.28 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.594 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.428 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 27.1 m -112.39 165.61 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.775 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -129.6 161.59 30.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.051 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.4 p-10 -72.49 167.37 20.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.89 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.74 126.26 8.4 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.354 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.47 0.14 55.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.49 0.186 . . . . 0.0 111.422 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 93.0 mt -154.05 19.7 0.51 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.501 0.191 . . . . 0.0 111.355 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.463 ' O ' ' C ' ' A' ' 47' ' ' LYS . 81.8 mm-40 -155.36 22.24 0.42 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.196 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER 24.82 50.22 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.433 0.458 . . . . 0.0 112.129 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.25 -166.21 11.63 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.535 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.428 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 72.2 t -135.22 139.7 46.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.889 0.376 . . . . 0.0 111.219 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.51 153.99 47.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.507 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.452 HG12 ' CD1' ' A' ' 54' ' ' ILE . 51.4 t -57.07 162.21 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.616 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.446 ' N ' ' O ' ' A' ' 39' ' ' SER . 0.1 OUTLIER -142.85 -34.13 0.44 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.876 0.369 . . . . 0.0 111.591 -179.419 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 37.2 m-80 -144.28 123.95 13.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.466 HG12 ' HB2' ' A' ' 38' ' ' PHE . 1.1 mt -123.57 123.25 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.268 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.95 117.36 44.84 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.411 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.48 56.4 2.18 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.468 2.112 . . . . 0.0 112.599 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -173.04 -51.63 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.143 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.86 -170.48 0.29 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.654 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -53.35 -31.87 58.99 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.626 2.217 . . . . 0.0 112.36 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.83 -51.58 56.14 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.575 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -73.48 -33.01 64.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.958 0.408 . . . . 0.0 110.396 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 90.1 mt -59.38 -41.64 89.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.031 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.1 -50.93 6.47 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.543 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.26 42.56 0.35 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.442 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.42 ' CB ' ' CD1' ' A' ' 54' ' ' ILE . 19.3 mt -91.42 147.54 22.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.783 0.325 . . . . 0.0 110.845 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.23 161.88 55.01 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 50.9 Cg_exo -53.82 147.92 39.43 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.596 2.197 . . . . 0.0 112.154 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.465 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 4.8 m-85 88.62 -12.55 0.42 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.229 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.435 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 1.1 m-20 -52.88 85.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.93 0.395 . . . . 0.0 110.965 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.457 ' N ' ' O ' ' A' ' 68' ' ' TYR . 21.2 ttm180 -74.04 95.12 2.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.462 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 mt -56.26 112.24 1.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.429 HD21 ' CG ' ' A' ' 80' ' ' ARG . 4.9 mt -81.2 -64.0 1.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.64 140.53 46.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.095 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.411 ' O ' ' CG1' ' A' ' 77' ' ' VAL . 24.3 t -118.6 116.16 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.002 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.461 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 0.2 OUTLIER 68.74 28.25 5.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.613 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.461 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER 85.81 -7.03 0.82 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.648 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.411 ' CG1' ' O ' ' A' ' 74' ' ' VAL . 4.6 p -83.97 134.61 26.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 120.818 0.342 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.4 mtt85 -70.56 118.2 13.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.95 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.428 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 30.6 p -145.47 35.94 1.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.429 ' CG ' HD21 ' A' ' 72' ' ' LEU . 1.6 ttp180 -75.87 -48.74 20.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.817 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -92.82 25.58 3.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.063 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.428 ' CD1' ' HA ' ' A' ' 79' ' ' THR . 2.4 m-85 -81.75 170.08 16.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.957 0.408 . . . . 0.0 110.861 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.21 159.09 16.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.272 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 6.5 p -51.38 -41.53 60.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 110.726 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.2 m -63.36 -24.57 67.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.164 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.47 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 10.9 mp -91.09 -30.29 16.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.012 0.434 . . . . 0.0 110.847 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 65.7 t -79.3 -35.82 17.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.28 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.642 ' HB ' ' HD3' ' A' ' 89' ' ' PRO . 68.0 t -55.3 -51.3 80.95 Favored Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.696 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.642 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 14.5 Cg_exo -68.33 -46.53 2.03 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.39 2.06 . . . . 0.0 111.294 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 15.4 mt -54.65 -29.38 52.2 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.008 0.433 . . . . 0.0 110.421 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.448 HG23 ' CD1' ' A' ' 98' ' ' LEU . 47.7 mt -73.91 -51.56 23.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.205 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.39 -2.74 36.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.884 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -92.15 -7.47 48.34 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 1.5 t -64.59 -16.51 62.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.873 0.368 . . . . 0.0 111.609 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.56 -52.68 3.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.687 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -165.98 -45.75 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.75 0.309 . . . . 0.0 110.985 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -101.04 107.22 18.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.475 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.484 ' HB2' ' CE1' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -95.96 97.84 9.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.579 -179.428 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -101.34 118.2 36.49 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.3 pp -147.87 163.56 36.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.105 0.478 . . . . 0.0 112.088 -178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.85 109.4 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.217 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.4 pp -103.95 169.37 2.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.216 -179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 71.5 p -126.29 107.63 10.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.555 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.42 113.45 25.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.345 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.407 ' HB3' ' O ' ' A' ' 16' ' ' SER . 0.7 OUTLIER -62.72 158.76 49.23 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.935 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 C--O 1.25 1.108 0 C-N-CA 122.578 2.185 . . . . 0.0 112.394 -179.908 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.787 0.327 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.49 -66.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.593 2.195 . . . . 0.0 112.208 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.425 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -67.82 147.91 98.52 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.096 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 18' ' ' THR . 17.0 Cg_exo -67.04 -8.85 23.01 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.692 2.261 . . . . 0.0 112.682 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.49 ' HA ' ' N ' ' A' ' 105' ' ' ASN . 28.5 m -158.95 168.0 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 120.974 0.416 . . . . 0.0 111.493 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -139.45 122.5 16.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.91 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.401 ' CD2' HD13 ' A' ' 72' ' ' LEU . 11.9 mt -59.74 136.47 58.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.082 0.468 . . . . 0.0 111.667 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.438 ' CE1' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -152.47 119.07 5.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.127 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.16 130.45 42.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.68 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.438 HG11 ' CE1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -131.45 140.83 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.071 0.462 . . . . 0.0 111.343 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.9 m -134.41 106.92 7.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.944 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 mt -106.88 174.46 5.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.002 0.43 . . . . 0.0 111.543 -179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' A' ' 96' ' ' ASN . 42.5 m-85 -123.07 165.67 16.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.693 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -128.34 120.68 27.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.852 0.358 . . . . 0.0 111.437 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.41 128.32 35.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.464 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.14 -29.22 0.87 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.751 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.32 -38.36 8.42 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.847 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.82 146.7 28.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.877 0.37 . . . . 0.0 111.206 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -103.04 -33.29 9.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.286 0.565 . . . . 0.0 110.603 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.35 152.64 23.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.285 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.503 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 0.8 OUTLIER -91.13 15.19 12.22 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.569 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.08 23.54 57.01 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.39 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.457 ' CE1' HG22 ' A' ' 51' ' ' VAL . 6.5 p90 -174.15 119.82 0.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.179 0.49 . . . . 0.0 111.549 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.1 m -91.88 154.14 19.06 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.631 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.434 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 24.1 m -112.17 170.93 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.011 0.434 . . . . 0.0 111.688 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -139.09 164.36 29.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.021 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -72.79 154.85 40.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.911 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.99 109.13 0.95 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.394 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.7 mt -94.28 -25.41 17.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.432 . . . . 0.0 111.182 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.9 tp -83.81 -6.71 59.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.532 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 47' ' ' LYS . 5.2 mt-10 -153.1 27.39 0.52 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.935 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER 26.54 78.48 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.127 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.02 -152.0 9.51 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.475 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.434 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 23.8 t -144.49 138.42 23.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.875 0.369 . . . . 0.0 111.264 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -130.61 174.37 9.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.313 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.488 ' HB ' ' OD1' ' A' ' 69' ' ' ASP . 58.3 t -78.72 122.89 34.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.039 0.447 . . . . 0.0 111.255 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.408 ' HG3' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -89.1 -29.53 19.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.777 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.408 ' ND2' ' HG3' ' A' ' 52' ' ' LYS . 38.7 m-80 -157.59 155.3 29.92 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.35 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -137.85 130.7 41.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.561 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -64.38 127.4 92.14 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.873 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -56.49 140.02 88.46 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.454 2.103 . . . . 0.0 112.367 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 39.27 33.35 0.09 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.931 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.6 -161.75 21.32 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.259 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -57.6 -42.9 55.7 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.366 2.044 . . . . 0.0 112.147 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.87 -44.98 90.93 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.787 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.37 -32.62 64.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.028 0.442 . . . . 0.0 110.405 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.2 mt -67.54 -30.93 70.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.737 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.8 -38.6 13.46 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.395 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.53 31.52 1.64 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.565 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.423 HD12 ' CE2' ' A' ' 38' ' ' PHE . 28.4 mt -83.7 123.24 29.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.859 0.362 . . . . 0.0 111.021 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -113.88 138.59 22.83 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.55 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 77.6 Cg_exo -40.44 139.87 1.07 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.933 2.422 . . . . 0.0 113.144 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 48.9 m-85 88.7 -13.12 0.4 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.64 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.488 ' OD1' ' HB ' ' A' ' 51' ' ' VAL . 8.4 p-10 -55.99 85.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.064 0.459 . . . . 0.0 110.562 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.45 ' N ' ' O ' ' A' ' 68' ' ' TYR . 10.1 ttm180 -66.58 118.15 9.77 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.87 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 mt -72.5 112.07 8.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.286 -179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 80' ' ' ARG . 5.0 mp -84.67 -67.07 0.82 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -115.5 110.42 19.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.433 ' HA ' ' HB3' ' A' ' 100' ' ' LEU . 46.6 t -102.75 143.05 15.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.874 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 0.5 OUTLIER 46.58 29.58 0.95 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.29 -179.687 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.456 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER 85.9 -19.1 0.32 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.773 179.658 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.0 t -83.98 136.0 23.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.818 0.342 . . . . 0.0 111.203 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -69.15 116.57 9.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.252 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.466 ' HB ' ' CD2' ' A' ' 82' ' ' PHE . 32.2 p -141.53 38.77 1.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.412 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -69.87 -46.57 65.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.589 179.679 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -94.38 27.81 2.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.44 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.466 ' CD2' ' HB ' ' A' ' 79' ' ' THR . 2.5 m-30 -81.09 176.3 9.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.811 0.338 . . . . 0.0 110.657 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -108.26 158.79 17.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.511 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 5.3 p -51.56 -41.88 61.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 110.654 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 37.3 m -63.15 -21.74 66.4 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.08 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.48 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 7.7 mp -96.48 -33.16 11.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.002 0.429 . . . . 0.0 111.022 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 37.8 t -77.61 -36.05 22.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.374 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.652 ' HB ' ' HD3' ' A' ' 89' ' ' PRO . 93.3 t -58.54 -51.29 82.89 Favored Pre-proline 0 C--N 1.33 -0.241 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.79 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.652 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.5 Cg_exo -67.32 -40.93 10.01 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.334 2.023 . . . . 0.0 111.528 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.426 HD13 ' CE2' ' A' ' 82' ' ' PHE . 25.3 mt -54.55 -33.88 60.89 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.027 0.441 . . . . 0.0 110.763 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.411 HG23 ' CD1' ' A' ' 98' ' ' LEU . 25.0 mt -78.34 -44.33 26.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.125 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.22 -2.75 49.95 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.81 6.66 34.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.436 ' HB2' ' HG ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -63.39 -35.1 79.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.371 0.605 . . . . 0.0 110.253 179.481 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.85 -41.87 2.21 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.719 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 6.1 m-80 -166.82 -35.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.511 0.196 . . . . 0.0 111.328 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp -122.76 131.58 53.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.692 0.282 . . . . 0.0 110.942 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.503 ' HB2' ' CE1' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -120.62 97.49 5.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.433 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -96.36 118.4 32.81 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.433 ' HB3' ' HA ' ' A' ' 74' ' ' VAL . 2.6 pp -150.22 162.52 40.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.342 0.592 . . . . 0.0 112.451 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.0 t -114.17 109.1 27.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.699 178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 69' ' ' ASP . 2.6 pp -104.07 169.45 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.465 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.73 112.39 11.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.766 179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.63 133.42 43.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.001 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.49 ' N ' ' HA ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -62.71 152.01 82.91 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.77 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 C--O 1.248 1.023 0 C-N-CA 122.568 2.179 . . . . 0.0 112.273 -179.927 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.3 m . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 120.755 0.312 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.74 -74.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.407 2.072 . . . . 0.0 112.559 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.481 ' HB ' ' CD ' ' A' ' 19' ' ' PRO . 1.3 m -167.99 -58.98 0.01 OUTLIER Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.004 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.481 ' CD ' ' HB ' ' A' ' 18' ' ' THR . 11.4 Cg_endo -54.43 127.15 24.75 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.223 1.949 . . . . 0.0 112.22 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.7 m -40.48 160.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.139 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -121.53 122.45 39.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.393 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.7 mt -60.87 140.65 57.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.313 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -146.52 106.62 4.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.936 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -71.44 109.49 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.047 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.89 141.26 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.115 0.484 . . . . 0.0 111.8 -179.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 95.5 m -133.06 106.63 7.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.866 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 7.8 mt -105.21 -177.59 3.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.933 0.397 . . . . 0.0 111.608 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.417 ' CD2' ' HG2' ' A' ' 97' ' ' LYS . 16.2 m-85 -135.83 153.59 51.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.529 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -116.1 164.77 13.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.031 0.444 . . . . 0.0 111.423 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -106.16 152.9 22.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.672 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.25 -28.8 29.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.338 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.49 36.71 2.05 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.644 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.4 ttt -81.68 149.14 28.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.748 0.308 . . . . 0.0 110.926 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -96.04 -10.91 27.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.204 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -156.82 176.11 13.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.646 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -102.36 27.07 7.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.168 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 85.62 5.24 84.64 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.263 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.462 ' CD2' ' CG2' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -173.03 141.67 1.0 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.017 0.437 . . . . 0.0 111.475 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.5 m -107.72 153.42 22.96 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.352 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.434 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 32.6 m -118.58 164.97 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.393 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -132.73 141.66 48.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.08 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -55.98 164.88 1.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.112 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.79 140.56 16.42 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.339 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.72 -58.33 2.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.108 0.48 . . . . 0.0 111.423 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.13 -41.98 16.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.726 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 47' ' ' LYS . 18.0 mt-10 -88.4 10.68 19.17 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.616 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 26.36 78.2 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -169.54 -139.16 2.65 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.488 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.434 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 41.7 t -155.8 138.41 6.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.602 0.239 . . . . 0.0 111.109 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.76 156.48 47.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.829 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.462 ' CG2' ' CD2' ' A' ' 38' ' ' PHE . 62.0 t -64.03 121.17 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.989 0.423 . . . . 0.0 111.249 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.97 -30.64 17.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.181 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -160.34 154.99 23.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.503 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.435 HG12 ' HB2' ' A' ' 38' ' ' PHE . 1.1 mt -133.44 125.94 51.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.1 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.51 114.7 16.81 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.71 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 50.1 Cg_exo -53.62 125.07 17.4 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.293 1.996 . . . . 0.0 112.185 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.478 ' CB ' ' O ' ' A' ' 56' ' ' PRO . . . 89.14 -28.88 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.586 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.86 -179.66 1.27 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.472 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_exo -51.69 -34.6 54.42 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.601 2.201 . . . . 0.0 112.293 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.97 -46.71 94.04 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.592 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.42 -32.71 64.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.983 0.42 . . . . 0.0 110.357 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.4 mt -63.02 -32.76 74.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.897 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -86.44 -46.63 5.17 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.55 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.81 33.89 0.96 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.765 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.417 ' CB ' ' CD1' ' A' ' 54' ' ' ILE . 24.6 mt -73.85 145.94 44.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.775 0.321 . . . . 0.0 110.859 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.411 ' CD ' ' NH1' ' A' ' 104' ' ' ARG . 11.5 mttm -125.64 159.16 62.22 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.968 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.423 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 15.7 Cg_endo -56.96 141.6 93.72 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.76 2.306 . . . . 0.0 112.13 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.546 ' O ' ' N ' ' A' ' 70' ' ' ARG . 31.5 m-85 84.42 0.62 0.9 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.245 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.442 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 3.2 m-20 -52.97 80.33 0.0 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.976 0.417 . . . . 0.0 110.733 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.546 ' N ' ' O ' ' A' ' 68' ' ' TYR . 41.0 ttp180 -66.82 103.86 1.21 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.148 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.404 ' HG ' HG21 ' A' ' 102' ' ' ILE . 3.5 mp -63.2 107.39 1.04 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.809 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.427 ' HA ' ' HG3' ' A' ' 80' ' ' ARG . 8.2 mt -84.98 -67.23 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 0.0 111.155 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -116.21 112.85 22.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.073 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.402 ' CG1' HD22 ' A' ' 98' ' ' LEU . 40.9 t -103.71 125.28 58.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.963 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.459 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 1.1 m-80 45.69 36.9 2.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.398 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.459 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.4 OUTLIER 87.49 -22.66 0.14 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.736 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.0 t -83.39 134.9 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.321 . . . . 0.0 111.141 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -69.38 136.01 51.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.403 ' HA ' ' CG ' ' A' ' 82' ' ' PHE . 76.2 p -144.91 25.02 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.179 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.427 ' HG3' ' HA ' ' A' ' 72' ' ' LEU . 3.4 mtm180 -71.98 -48.45 44.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.883 0.373 . . . . 0.0 110.62 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -92.59 16.03 12.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.363 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.422 ' CE2' HD22 ' A' ' 86' ' ' LEU . 3.3 m-85 -82.05 176.41 9.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.86 0.362 . . . . 0.0 110.818 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.87 160.46 18.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.559 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 6.4 p -51.62 -34.82 39.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.725 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 96.0 m -70.15 -21.69 63.05 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.223 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.601 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 0.5 OUTLIER -97.59 -32.32 11.85 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 111.014 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.413 HG21 ' HB ' ' A' ' 49' ' ' VAL . 46.3 t -79.92 -35.94 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.453 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.618 ' CG1' ' HD3' ' A' ' 89' ' ' PRO . 3.7 p -61.87 -41.2 75.53 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.606 -0.437 . . . . 0.0 111.439 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.618 ' HD3' ' CG1' ' A' ' 88' ' ' VAL . 72.3 Cg_endo -74.55 -45.55 0.32 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 121.806 1.67 . . . . 0.0 111.316 178.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.417 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 36.3 mt -54.48 -29.38 49.84 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.347 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.438 HG21 ' CD2' ' A' ' 36' ' ' PHE . 62.2 mt -78.45 -47.12 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.55 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.63 -3.97 31.37 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.417 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -112.26 -0.64 15.41 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.764 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.404 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 16.5 m -64.79 -16.41 63.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.834 0.35 . . . . 0.0 111.139 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.91 -148.37 18.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.586 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -73.5 -8.52 56.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.616 0.246 . . . . 0.0 111.419 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.417 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -140.96 147.85 39.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.737 0.303 . . . . 0.0 110.863 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -132.13 97.45 4.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.219 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.53 118.3 31.18 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.077 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.412 ' CD1' ' CG2' ' A' ' 102' ' ' ILE . 1.9 pp -149.85 154.93 39.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.168 0.509 . . . . 0.0 112.096 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 23.5 t -111.53 109.16 27.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.954 178.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.424 ' HA ' ' O ' ' A' ' 70' ' ' ARG . 2.7 pp -105.82 166.1 3.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.01 0.433 . . . . 0.0 111.596 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.7 p -134.12 129.09 35.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.551 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.442 ' HG3' ' HB2' ' A' ' 68' ' ' TYR . 6.0 ttp180 -127.74 135.78 50.61 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.033 0.444 . . . . 0.0 111.48 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -96.82 111.59 57.93 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.404 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.236 1.958 . . . . 0.0 112.356 -179.86 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.657 0.265 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.97 -18.92 45.42 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.682 2.255 . . . . 0.0 112.315 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.474 ' CG2' ' HD2' ' A' ' 19' ' ' PRO . 5.3 m -150.14 145.8 19.26 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.696 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HD2' ' CG2' ' A' ' 18' ' ' THR . 52.8 Cg_exo -53.16 -171.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.394 2.062 . . . . 0.0 112.138 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 105' ' ' ASN . 35.2 m -45.51 129.77 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.929 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.54 122.05 45.22 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.581 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 4.4 pp -100.33 153.15 19.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.199 0.523 . . . . 0.0 112.264 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.452 ' CD2' ' CD1' ' A' ' 102' ' ' ILE . 20.9 p80 -144.9 152.22 39.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.698 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -78.55 104.25 9.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.448 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.22 144.62 11.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.364 -179.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.4 m -135.09 106.42 6.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.84 179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 mp -105.36 175.18 5.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.033 0.444 . . . . 0.0 111.357 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.451 ' N ' ' CD1' ' A' ' 28' ' ' TYR . 1.5 m-85 -131.51 155.88 46.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.248 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.436 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -118.46 149.77 40.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.914 0.388 . . . . 0.0 111.322 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.15 152.85 31.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.741 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.2 m -63.62 -26.25 68.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.257 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.26 1.75 46.96 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.08 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 3.3 mmt -81.78 124.57 29.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.896 0.379 . . . . 0.0 110.976 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.03 -10.77 59.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.365 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -155.59 -167.92 2.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.641 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.455 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -105.46 17.49 23.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.559 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.19 7.15 65.91 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.531 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.499 ' HB2' HG12 ' A' ' 54' ' ' ILE . 25.6 p90 -173.62 145.79 1.24 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.26 0.53 . . . . 0.0 111.716 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.75 146.68 41.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.191 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.437 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 34.6 m -105.31 171.02 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.662 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -131.08 178.13 6.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.948 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -89.98 129.0 36.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.808 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.12 100.5 2.36 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.272 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.3 -24.05 17.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.964 0.411 . . . . 0.0 111.176 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.52 -10.98 57.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.32 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 47' ' ' LYS . 3.0 mt-10 -153.36 33.51 0.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.968 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 25.24 91.42 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.173 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 173.13 -162.76 34.19 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.42 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.463 HG21 ' N ' ' A' ' 84' ' ' CYS . 64.8 t -139.4 132.1 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.79 0.329 . . . . 0.0 110.749 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -131.87 163.39 28.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.74 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.408 HG22 ' CD2' ' A' ' 38' ' ' PHE . 66.7 t -72.37 122.57 25.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.747 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -87.39 -31.0 20.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.422 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -162.67 145.72 11.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.486 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.499 HG12 ' HB2' ' A' ' 38' ' ' PHE . 1.4 mt -127.48 133.59 67.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.943 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.08 144.49 99.07 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.814 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.23 144.03 45.32 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.516 2.144 . . . . 0.0 112.373 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 39.06 33.83 0.09 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.976 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -109.97 -168.14 19.85 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.39 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.2 -39.71 70.94 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.513 2.142 . . . . 0.0 112.152 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.39 -36.08 50.73 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.609 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -73.51 -32.83 64.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.027 0.441 . . . . 0.0 110.258 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.0 mt -77.28 -30.68 54.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.804 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.02 -47.81 29.54 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.369 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.46 35.27 1.01 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.554 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.447 ' CD1' ' CE1' ' A' ' 38' ' ' PHE . 13.2 mt -91.1 124.0 34.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.785 0.326 . . . . 0.0 110.998 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.24 156.1 35.66 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.831 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.447 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 53.6 Cg_exo -51.8 136.27 50.79 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.52 2.146 . . . . 0.0 112.227 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.448 ' O ' ' N ' ' A' ' 70' ' ' ARG . 9.9 m-85 85.5 7.49 0.4 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.004 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -53.56 85.84 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.044 0.449 . . . . 0.0 110.993 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 68' ' ' TYR . 28.6 ttt85 -72.31 96.86 1.91 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.629 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 mp -53.33 107.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.104 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.442 ' HA ' ' CG ' ' A' ' 80' ' ' ARG . 3.2 mp -82.17 -62.37 1.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.376 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -133.79 130.01 37.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.874 0.369 . . . . 0.0 111.281 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.403 ' O ' ' CG1' ' A' ' 77' ' ' VAL . 20.1 t -113.66 112.95 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.809 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 5.4 m-80 66.54 30.27 8.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.636 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.467 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 1.6 t-80 87.21 -12.12 0.53 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.892 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.403 ' CG1' ' O ' ' A' ' 74' ' ' VAL . 4.3 p -84.13 143.08 12.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.893 0.378 . . . . 0.0 111.06 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 mtp85 -70.08 125.47 26.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.424 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 52.8 p -146.39 19.69 1.36 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.348 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.442 ' CG ' ' HA ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -66.23 -52.96 42.7 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.953 0.406 . . . . 0.0 110.623 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -94.77 29.33 2.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.239 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.448 ' CE2' ' CD2' ' A' ' 86' ' ' LEU . 1.8 m-30 -80.97 171.79 14.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.858 0.361 . . . . 0.0 110.82 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -107.26 157.62 17.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.499 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.463 ' N ' HG21 ' A' ' 49' ' ' VAL . 5.7 p -51.49 -38.52 54.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.929 0.395 . . . . 0.0 110.445 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 18.9 m -65.67 -21.56 66.56 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.054 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.462 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -95.4 -32.12 13.07 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.094 0.474 . . . . 0.0 110.605 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.0 t -78.26 -35.79 20.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.303 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.635 ' HB ' ' HD3' ' A' ' 89' ' ' PRO . 93.7 t -58.67 -51.01 84.92 Favored Pre-proline 0 C--N 1.331 -0.23 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.975 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.635 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.0 Cg_exo -68.01 -45.64 2.87 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.477 2.118 . . . . 0.0 111.634 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.408 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 36.6 mt -54.5 -30.25 52.82 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.998 0.428 . . . . 0.0 110.574 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.43 ' HA ' ' CD1' ' A' ' 98' ' ' LEU . 70.9 mt -79.17 -49.55 19.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.079 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.48 -2.59 29.56 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.408 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -102.07 -1.14 32.26 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.203 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.406 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -64.82 -30.87 71.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.185 0.516 . . . . 0.0 110.768 179.719 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.38 -63.09 0.84 Allowed Glycine 0 C--N 1.322 -0.248 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.252 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.416 ' HA ' ' CB ' ' A' ' 29' ' ' LYS . 18.8 p30 -162.71 18.29 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.528 0.204 . . . . 0.0 111.3 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.429 ' HE2' ' CE2' ' A' ' 28' ' ' TYR . 3.8 ttmt -161.8 116.77 1.97 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -116.16 98.87 6.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.897 -179.141 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -98.52 117.98 34.18 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.2 pp -151.69 164.74 36.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.167 0.508 . . . . 0.0 112.097 -178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.5 t -107.5 109.97 30.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.942 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.581 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 2.4 pp -100.44 153.75 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.22 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.53 127.3 52.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.496 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.21 129.88 11.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.996 0.427 . . . . 0.0 111.682 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 3.4 p30 -62.78 158.23 53.58 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.785 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 122.531 2.154 . . . . 0.0 112.289 -179.951 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 120.765 0.317 . . . . 0.0 111.401 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.401 ' O ' ' OG1' ' A' ' 18' ' ' THR . 14.2 Cg_exo -68.55 -68.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.745 2.296 . . . . 0.0 112.203 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.44 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 1.8 m -179.05 -61.67 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.665 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 18' ' ' THR . 13.8 Cg_endo -56.79 126.57 22.67 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.567 2.178 . . . . 0.0 112.335 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 105' ' ' ASN . 19.6 m -45.86 144.71 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.171 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -106.92 124.51 49.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.566 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 4.7 pp -105.07 153.51 21.38 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -145.85 156.41 43.54 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.597 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.19 110.64 18.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.25 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.421 ' CG1' ' HG ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -111.75 146.14 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.596 -179.271 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.6 m -134.21 106.64 7.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.314 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 mp -93.53 174.76 7.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.947 0.403 . . . . 0.0 111.561 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.421 ' CD1' ' HG3' ' A' ' 97' ' ' LYS . 81.1 m-85 -132.3 141.44 48.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.171 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -116.25 163.14 16.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.878 0.37 . . . . 0.0 111.418 -179.69 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.75 140.13 52.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.749 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 90.3 p -61.75 84.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.055 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 123.86 19.67 2.69 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.075 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.79 167.88 18.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.778 0.323 . . . . 0.0 110.8 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -97.52 -18.36 19.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.207 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.62 -171.25 3.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.667 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.463 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -108.71 19.21 19.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.301 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.87 0.46 42.15 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.066 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.485 ' HB2' HG12 ' A' ' 54' ' ' ILE . 14.4 p90 -172.85 145.01 1.39 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.943 0.402 . . . . 0.0 111.453 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.1 m -98.19 138.5 35.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.172 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 51' ' ' VAL . 35.8 m -93.74 171.07 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.698 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -136.3 178.19 7.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.093 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.57 131.33 45.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.738 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.43 ' HA3' ' CZ ' ' A' ' 50' ' ' TYR . . . -104.0 108.96 3.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.528 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -94.48 -25.15 17.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.001 0.429 . . . . 0.0 111.069 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.94 -7.36 59.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.592 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 47' ' ' LYS . 5.2 mt-10 -153.17 25.22 0.54 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.168 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 27.38 80.86 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -170.22 -156.39 11.15 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.695 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.403 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 95.2 t -137.68 131.24 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.806 0.336 . . . . 0.0 111.044 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.43 ' CZ ' ' HA3' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -128.56 172.41 11.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.246 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.418 HG22 ' CE1' ' A' ' 38' ' ' PHE . 88.7 t -90.77 123.68 43.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.83 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -86.99 -30.73 21.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.362 -179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -161.76 144.9 12.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.652 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.485 HG12 ' HB2' ' A' ' 38' ' ' PHE . 1.7 mt -126.08 135.84 62.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.996 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.6 mtt180 -65.37 143.87 98.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.724 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.09 143.22 35.65 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.501 2.134 . . . . 0.0 112.481 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 39.57 33.77 0.13 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.894 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.56 -159.24 13.3 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.265 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.79 -53.79 6.22 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.477 2.118 . . . . 0.0 112.033 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.22 -33.81 87.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.683 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -73.59 -32.61 64.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.982 0.42 . . . . 0.0 110.321 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 75.1 mt -75.12 -33.8 61.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.787 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.73 -54.1 10.6 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.392 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.26 33.23 1.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.701 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.423 HD21 ' CE2' ' A' ' 38' ' ' PHE . 1.7 mp -88.06 115.77 25.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.866 0.365 . . . . 0.0 110.884 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -81.37 159.86 66.39 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.552 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.407 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 13.0 Cg_endo -56.14 132.54 52.58 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.575 2.183 . . . . 0.0 112.332 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.427 ' O ' ' N ' ' A' ' 70' ' ' ARG . 0.3 OUTLIER 84.16 3.15 0.82 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.599 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.417 ' HB2' ' CD1' ' A' ' 102' ' ' ILE . 6.0 p-10 -54.43 87.61 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.174 0.512 . . . . 0.0 110.858 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 68' ' ' TYR . 4.2 ttp180 -66.99 109.55 3.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.862 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.402 ' CD2' HD22 ' A' ' 100' ' ' LEU . 4.0 mp -58.78 118.27 5.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.226 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.426 ' HA ' ' HG3' ' A' ' 80' ' ' ARG . 40.5 mt -82.77 -65.18 1.04 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.871 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -131.73 128.43 38.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.025 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.33 136.31 44.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.009 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.45 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 23.8 m120 50.18 32.01 5.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.332 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.45 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.3 OUTLIER 85.88 -14.79 0.52 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.77 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.2 t -83.75 136.94 21.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.843 0.354 . . . . 0.0 111.14 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -69.46 125.36 26.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.741 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.467 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 17.1 p -144.5 32.01 1.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.123 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.426 ' HG3' ' HA ' ' A' ' 72' ' ' LEU . 14.0 mtp180 -65.33 -52.03 56.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.43 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.69 28.54 2.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.049 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.467 ' CD1' ' HA ' ' A' ' 79' ' ' THR . 1.8 m-30 -80.8 167.51 19.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.724 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -107.83 161.53 14.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.46 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -51.81 -40.66 60.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.924 0.393 . . . . 0.0 110.68 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.5 m -63.09 -23.03 67.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.205 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.475 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 10.0 mp -94.17 -32.09 13.86 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.027 0.441 . . . . 0.0 110.864 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.9 t -78.44 -35.86 19.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.222 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.643 ' HB ' ' HD3' ' A' ' 89' ' ' PRO . 97.3 t -57.41 -51.25 83.13 Favored Pre-proline 0 C--N 1.331 -0.199 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.788 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.643 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.9 Cg_exo -66.61 -48.38 2.26 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.475 2.117 . . . . 0.0 111.32 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 37.4 mt -54.94 -27.99 47.74 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.967 0.413 . . . . 0.0 110.427 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.47 HG21 HD13 ' A' ' 98' ' ' LEU . 27.8 mt -75.84 -48.12 30.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.799 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.2 -3.09 40.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.091 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -89.8 -11.41 42.21 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.422 ' HB2' ' HG ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -64.66 -27.01 68.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.005 0.431 . . . . 0.0 111.208 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.59 -59.6 3.31 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.423 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -164.24 20.41 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.523 0.201 . . . . 0.0 111.383 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.421 ' HG3' ' CD1' ' A' ' 28' ' ' TYR . 14.1 ttpt -165.55 113.03 0.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.7 0.286 . . . . 0.0 110.234 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.47 HD13 HG21 ' A' ' 91' ' ' ILE . 1.7 mt -109.03 102.19 11.2 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -97.32 118.12 33.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.402 HD22 ' CD2' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -152.67 159.16 43.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.267 0.556 . . . . 0.0 112.416 -178.403 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.5 t -105.99 109.33 27.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.455 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.566 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 2.6 pp -100.87 162.33 3.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.015 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.425 ' CB ' ' HB3' ' A' ' 22' ' ' LEU . 3.2 p -146.26 130.19 17.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.687 0.28 . . . . 0.0 111.145 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.408 ' HD2' ' O ' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -144.96 145.8 31.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.958 0.408 . . . . 0.0 111.409 179.508 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 6.1 p30 -70.04 127.01 92.67 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.748 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.248 1.001 0 C-N-CA 122.42 2.08 . . . . 0.0 112.247 179.989 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.415 ' N ' ' HD2' ' A' ' 17' ' ' PRO . 2.4 m . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 16' ' ' SER . 47.3 Cg_endo -68.56 -38.89 10.17 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.489 2.126 . . . . 0.0 112.114 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.42 ' CG2' ' HD2' ' A' ' 19' ' ' PRO . 2.9 m -54.42 145.43 37.85 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.989 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.42 ' HD2' ' CG2' ' A' ' 18' ' ' THR . 46.3 Cg_exo -56.49 -164.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.45 2.1 . . . . 0.0 112.182 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 m -54.15 167.13 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.478 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -135.23 122.38 21.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.613 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 16.0 mt -62.6 136.58 57.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.472 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 -142.86 119.72 11.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.87 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -75.34 110.93 10.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.28 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.9 140.88 37.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.072 0.463 . . . . 0.0 111.508 -179.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.4 m -133.65 106.79 7.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.02 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 38.0 mt -98.3 179.56 4.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.172 0.511 . . . . 0.0 111.8 -179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.416 ' CD1' ' HG2' ' A' ' 97' ' ' LYS . 95.2 m-85 -135.69 136.1 40.61 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.366 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -99.33 165.14 11.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.968 0.413 . . . . 0.0 111.3 -179.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -119.8 131.1 55.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.784 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.82 84.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.126 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.26 -40.67 0.51 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.36 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.63 164.26 21.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 0.0 110.907 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.91 -28.52 9.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.072 0.463 . . . . 0.0 110.922 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -84.8 168.74 14.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.707 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -119.11 29.15 7.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.084 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.07 4.21 67.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.117 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.426 ' CD1' HG21 ' A' ' 51' ' ' VAL . 8.8 p90 -174.33 138.56 0.56 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.981 0.39 . . . . 0.0 111.545 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 52' ' ' LYS . 7.3 m -99.79 148.1 24.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.183 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.41 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 33.0 m -111.8 163.36 8.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.919 0.39 . . . . 0.0 111.588 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -135.08 172.22 13.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.908 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -84.18 163.62 19.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.935 0.397 . . . . 0.0 111.145 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.55 121.98 6.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.322 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.69 6.27 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.53 -38.77 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.072 0.463 . . . . 0.0 111.482 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 47' ' ' LYS . 11.8 mm-40 -88.85 18.14 5.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.561 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 46' ' ' GLU . 12.5 mmtt 27.76 78.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.971 0.415 . . . . 0.0 112.106 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.09 -163.51 35.84 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.473 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.41 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 46.8 t -130.0 138.93 52.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 110.914 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.51 165.64 25.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.795 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.426 HG21 ' CD1' ' A' ' 38' ' ' PHE . 58.9 t -72.35 121.18 22.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.02 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 39' ' ' SER . 0.4 OUTLIER -87.53 -31.05 20.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.865 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -158.12 152.63 24.68 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.447 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.409 HG12 ' HB2' ' A' ' 38' ' ' PHE . 1.0 OUTLIER -133.21 141.53 44.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.029 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.12 117.22 37.43 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.749 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.64 134.2 52.5 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.512 2.141 . . . . 0.0 112.504 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 42.83 31.25 0.3 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.834 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -109.39 -160.88 19.22 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.749 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -50.64 -62.06 0.46 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.49 2.126 . . . . 0.0 111.785 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.9 -35.04 66.58 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.884 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -73.19 -32.83 65.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.051 0.453 . . . . 0.0 110.201 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 27.5 mt -73.2 -27.41 61.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.56 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.54 -51.66 7.12 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.348 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 134.95 -8.02 4.48 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.021 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.406 HD23 ' CE2' ' A' ' 38' ' ' PHE . 4.0 mp -56.76 128.85 38.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.368 . . . . 0.0 111.114 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -116.6 167.24 10.93 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 69.7 Cg_exo -50.92 137.3 43.79 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.654 2.236 . . . . 0.0 112.368 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.437 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 10.8 m-85 85.02 4.1 0.62 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.232 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.4 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -52.5 89.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.947 0.403 . . . . 0.0 110.81 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 68' ' ' TYR . 9.3 ttt180 -77.85 95.59 4.76 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.787 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 mp -55.0 107.01 0.26 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.873 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.462 HD22 ' HG2' ' A' ' 80' ' ' ARG . 4.4 mt -83.98 -63.05 1.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.835 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -120.49 117.56 27.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.41 ' O ' ' CG1' ' A' ' 77' ' ' VAL . 24.6 t -108.15 109.62 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.163 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.491 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 1.7 m-80 64.24 33.59 11.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.669 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.491 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 3.3 t60 89.73 -17.94 0.21 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.92 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.46 ' O ' HG12 ' A' ' 77' ' ' VAL . 6.4 p -83.69 130.08 36.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.992 0.425 . . . . 0.0 111.125 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.78 89.24 0.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.415 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.422 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 17.3 p -96.76 26.26 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.809 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.462 ' HG2' HD22 ' A' ' 72' ' ' LEU . 10.5 mtp-105 -63.32 -53.03 59.13 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.985 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.35 24.16 4.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.402 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.422 ' CD1' ' HA ' ' A' ' 79' ' ' THR . 2.3 m-85 -81.8 166.48 19.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.852 0.358 . . . . 0.0 110.76 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -106.08 160.9 14.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.554 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.405 ' N ' HG23 ' A' ' 49' ' ' VAL . 11.3 t -51.69 -41.98 61.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.69 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.3 m -63.07 -22.43 66.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.098 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.6 mp -94.02 -32.93 13.61 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.99 0.424 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.4 t -77.57 -36.79 23.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.134 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.544 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 87.5 t -55.61 -52.19 73.97 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.793 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 48.7 Cg_endo -68.44 -45.81 2.36 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.191 1.927 . . . . 0.0 111.835 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 28.2 mt -54.78 -30.71 57.49 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.964 0.412 . . . . 0.0 110.725 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.486 ' CG2' HD13 ' A' ' 98' ' ' LEU . 61.3 mt -76.14 -48.37 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.367 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.69 -3.06 39.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.804 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -92.99 -4.55 52.45 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.418 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -63.52 -29.83 71.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.232 0.539 . . . . 0.0 110.903 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.8 -41.67 2.82 Favored Glycine 0 C--N 1.322 -0.227 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.761 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -166.23 -41.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 111.133 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.416 ' HG2' ' CD1' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -112.9 126.91 55.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.719 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.486 HD13 ' CG2' ' A' ' 91' ' ' ILE . 0.6 OUTLIER -115.85 97.48 6.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.626 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.27 118.16 31.18 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.59 156.44 42.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.142 0.496 . . . . 0.0 112.175 -178.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.1 t -114.32 109.04 27.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.794 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 2.4 pp -104.99 165.56 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.337 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.5 p -126.84 126.55 43.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.738 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -152.27 138.77 18.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.072 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -62.94 154.11 77.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.698 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo . . . . . 0 C--O 1.249 1.025 0 C-N-CA 122.61 2.207 . . . . 0.0 112.324 -179.855 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.9 t . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.749 0.309 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.89 163.97 35.4 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.496 2.13 . . . . 0.0 112.133 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.466 ' HB ' ' HD3' ' A' ' 19' ' ' PRO . 11.3 m -51.45 -58.73 9.74 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.202 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.466 ' HD3' ' HB ' ' A' ' 18' ' ' THR . 58.0 Cg_endo -70.53 139.34 37.35 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.419 2.079 . . . . 0.0 112.321 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.444 ' CG2' ' HB3' ' A' ' 103' ' ' SER . 16.5 m -46.13 169.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.566 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -122.38 122.99 40.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.567 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.421 ' CD2' ' CD1' ' A' ' 72' ' ' LEU . 14.4 mt -60.33 147.52 40.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.057 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.433 ' CE1' HG23 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -157.55 116.57 3.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.368 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.31 121.02 20.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.79 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.433 HG23 ' CE1' ' A' ' 23' ' ' HIS . 0.1 OUTLIER -118.24 145.54 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.296 -179.769 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.2 m -134.56 106.82 7.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.965 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.01 173.34 6.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.997 0.427 . . . . 0.0 111.692 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 28' ' ' TYR . 3.1 m-85 -123.19 156.05 35.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.519 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -111.22 160.37 17.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.912 0.387 . . . . 0.0 111.236 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.82 142.26 50.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.865 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.6 t -56.13 -30.46 62.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.022 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.29 38.17 3.4 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.399 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 5.4 mmt -157.25 110.85 2.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.785 0.326 . . . . 0.0 110.835 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -74.07 -28.81 61.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.087 0.47 . . . . 0.0 110.931 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -85.03 177.99 7.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.651 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.488 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -118.98 29.36 7.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.119 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.7 8.46 85.98 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.688 -0.767 . . . . 0.0 113.332 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 54' ' ' ILE . 20.3 p90 -172.73 127.48 0.5 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 117.171 0.486 . . . . 0.0 111.395 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.06 149.89 20.83 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.013 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 31.6 m -122.15 150.74 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.303 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.67 178.11 4.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.08 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -94.87 168.18 10.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.015 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -96.88 109.78 3.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.065 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.46 7.11 46.7 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.15 0.47 0.45 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -158.17 31.45 0.25 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.642 0.258 . . . . 0.0 111.298 179.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER 28.59 90.77 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.97 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -175.35 -159.44 21.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.364 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 99.6 t -150.53 137.56 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.94 0.4 . . . . 0.0 111.17 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.8 163.75 30.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.348 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.49 ' HB ' ' OD1' ' A' ' 69' ' ' ASP . 58.3 t -70.68 123.85 25.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.994 0.426 . . . . 0.0 111.262 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.99 -29.76 19.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.636 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -172.16 160.07 5.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.256 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.452 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -126.67 138.41 54.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.839 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -64.16 154.67 81.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.284 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.442 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 65.4 Cg_endo -73.71 102.4 1.5 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.684 2.256 . . . . 0.0 112.433 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 56' ' ' PRO . . . 84.58 -6.51 0.99 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.686 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.84 175.87 6.08 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.518 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -46.68 -45.8 19.23 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.71 2.273 . . . . 0.0 112.536 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.08 -41.1 92.39 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.433 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.24 -32.72 64.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.035 0.445 . . . . 0.0 110.032 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.75 -32.13 69.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.515 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.25 -57.55 5.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.16 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.97 38.37 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.895 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.85 127.02 55.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.74 0.305 . . . . 0.0 110.825 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -96.76 162.06 24.44 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.565 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 9.2 Cg_endo -52.32 154.49 11.15 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.743 2.295 . . . . 0.0 112.208 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.472 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 8.0 m-85 90.29 -22.25 0.11 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.368 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.49 ' OD1' ' HB ' ' A' ' 51' ' ' VAL . 10.3 p-10 -55.26 87.75 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.203 0.525 . . . . 0.0 110.453 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -66.74 119.99 12.75 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.734 -179.624 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.3 mt -68.79 110.74 4.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.303 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.421 ' CD1' ' CD2' ' A' ' 22' ' ' LEU . 3.4 mp -82.74 -58.01 3.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.179 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -129.98 134.29 47.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.965 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.2 t -117.28 108.51 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.005 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.443 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 33.2 m120 64.24 36.27 9.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 50.0 m-70 86.35 -15.94 0.44 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.516 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.0 t -83.66 139.11 18.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.813 0.34 . . . . 0.0 111.013 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.87 122.82 20.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.631 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.463 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 28.0 p -143.08 28.22 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.95 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.418 ' CG ' ' HA ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -72.29 -53.01 13.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.425 179.704 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -94.9 25.96 3.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.069 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.463 ' CD1' ' HA ' ' A' ' 79' ' ' THR . 2.4 m-30 -80.85 171.4 15.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.778 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -108.01 159.94 16.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.479 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 23.8 p -51.51 -42.11 61.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.88 0.371 . . . . 0.0 110.543 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.07 -21.73 66.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.191 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.47 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 8.0 mp -95.31 -31.31 13.51 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.935 0.397 . . . . 0.0 110.819 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.1 t -79.37 -35.72 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.221 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.618 ' HB ' ' HD3' ' A' ' 89' ' ' PRO . 88.8 t -58.18 -50.71 86.59 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.835 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.618 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 13.0 Cg_exo -69.62 -44.43 2.18 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.472 2.115 . . . . 0.0 111.626 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 15.5 mt -54.99 -33.32 62.46 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.694 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.435 HG22 ' CD2' ' A' ' 36' ' ' PHE . 80.4 mt -75.32 -45.87 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.629 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.66 -3.76 36.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.928 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -101.19 -12.12 18.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.659 0.266 . . . . 0.0 111.686 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.8 m -64.76 -15.67 61.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.502 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.97 -143.69 17.21 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.571 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -73.73 -7.52 52.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.547 0.213 . . . . 0.0 111.4 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.7 mtpt -137.49 151.73 48.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.612 0.244 . . . . 0.0 110.592 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.488 ' HB2' ' CE1' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -137.73 97.49 3.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.772 0.32 . . . . 0.0 111.382 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.7 118.17 31.3 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 pp -145.16 157.43 44.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.132 0.492 . . . . 0.0 112.079 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.7 t -110.53 109.25 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.919 178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.414 ' CD1' ' HB2' ' A' ' 69' ' ' ASP . 2.6 pp -105.9 169.21 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.074 0.464 . . . . 0.0 111.641 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.444 ' HB3' ' CG2' ' A' ' 20' ' ' VAL . 0.5 OUTLIER -131.84 114.51 14.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.488 179.589 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.411 ' HB3' ' HA ' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -140.82 131.99 26.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.923 0.392 . . . . 0.0 111.642 -179.561 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -65.65 119.86 63.74 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.595 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--O 1.25 1.078 0 C-N-CA 122.339 2.026 . . . . 0.0 112.376 -179.935 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.427 ' HA ' ' CG ' ' A' ' 106' ' ' PRO . 3.9 m . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.693 0.283 . . . . 0.0 111.294 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.82 146.42 48.04 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.633 2.222 . . . . 0.0 112.32 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.55 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 89.4 m -51.4 -51.1 72.19 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.635 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 18' ' ' THR . 37.6 Cg_endo -66.34 125.67 14.36 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.222 1.948 . . . . 0.0 112.448 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.5 m -45.63 150.77 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.946 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -111.08 122.36 47.68 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.516 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 4.4 pp -106.83 153.3 22.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.26 0.552 . . . . 0.0 112.37 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.426 ' NE2' HD13 ' A' ' 102' ' ' ILE . 28.7 p80 -149.28 143.46 25.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.561 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.51 112.26 14.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.486 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.21 153.46 8.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.57 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 98.4 m -134.09 122.1 22.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.824 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -108.2 175.16 5.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.293 0.568 . . . . 0.0 111.986 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.437 ' CD1' ' HG2' ' A' ' 97' ' ' LYS . 27.7 m-85 -139.3 124.63 19.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.911 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.43 ' HG3' ' CE2' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -94.84 147.81 22.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.073 0.463 . . . . 0.0 111.431 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -123.41 153.82 39.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.682 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 p -64.64 -24.49 67.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.26 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.62 -0.22 55.43 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.156 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.94 130.42 35.07 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.824 0.345 . . . . 0.0 111.043 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -80.35 -10.74 59.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.16 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -155.93 -164.78 1.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.412 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.451 ' CD2' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -106.01 25.59 10.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 111.482 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.48 -1.17 75.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.74 179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.427 ' CE2' HD23 ' A' ' 65' ' ' LEU . 7.9 p90 -172.24 147.76 2.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.334 0.567 . . . . 0.0 111.895 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 p -108.89 137.71 46.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.242 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.45 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 22.6 m -99.23 161.12 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.519 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -125.19 171.11 10.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.153 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -82.01 136.01 35.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.968 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.26 103.43 2.07 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.337 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -94.31 -28.81 15.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.093 0.473 . . . . 0.0 111.287 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 15.0 mt -83.85 -5.63 59.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.375 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 47' ' ' LYS . 11.9 mt-10 -153.07 28.1 0.52 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.941 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.4 OUTLIER 27.38 91.2 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.107 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.92 -153.16 21.73 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.582 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.45 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 16.6 t -145.97 139.0 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.72 0.295 . . . . 0.0 110.931 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -136.93 156.19 48.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.118 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.403 ' CG2' ' HB2' ' A' ' 69' ' ' ASP . 87.6 t -67.63 117.94 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.536 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -87.39 -30.77 20.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.042 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -157.39 147.51 20.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.524 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.415 HG12 ' HB2' ' A' ' 38' ' ' PHE . 1.3 mt -125.1 125.35 69.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.955 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.6 ttt85 -65.33 111.62 6.5 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.05 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.4 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 32.4 Cg_exo -58.34 123.48 13.71 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.476 2.117 . . . . 0.0 112.19 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 56' ' ' PRO . . . 81.34 83.35 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.097 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 167.78 -152.54 21.02 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.531 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.61 -36.78 91.56 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.646 2.231 . . . . 0.0 112.2 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.09 -47.81 43.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.722 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.57 -32.95 64.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.056 0.455 . . . . 0.0 110.515 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.4 mt -71.26 -30.87 66.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.993 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.86 -38.66 15.38 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.663 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.44 29.24 6.38 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.427 HD23 ' CE2' ' A' ' 38' ' ' PHE . 1.2 mp -78.27 131.88 37.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.893 0.378 . . . . 0.0 110.784 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -98.4 165.05 15.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.841 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.417 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 28.1 Cg_endo -62.68 138.96 72.67 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.411 2.074 . . . . 0.0 112.115 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.417 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER 82.96 11.1 0.53 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.347 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.403 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 5.6 m-20 -53.74 88.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.931 0.396 . . . . 0.0 111.162 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 103' ' ' SER . 5.5 ttt85 -73.0 94.34 1.86 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.372 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.416 ' CD1' ' CG1' ' A' ' 87' ' ' VAL . 11.3 mt -50.86 107.51 0.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.998 0.428 . . . . 0.0 111.175 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.413 ' HA ' ' CG ' ' A' ' 80' ' ' ARG . 16.0 mt -82.62 -65.33 1.02 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.946 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -133.79 138.86 45.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.5 t -109.69 106.81 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.931 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 75.37 -59.37 0.54 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.078 0.466 . . . . 0.0 110.613 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -167.29 -11.22 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.414 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.9 p -85.41 125.3 40.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.712 0.292 . . . . 0.0 111.242 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 -69.55 123.8 22.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.424 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.431 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 14.2 p -143.17 32.75 1.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.91 0.386 . . . . 0.0 111.21 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.413 ' CG ' ' HA ' ' A' ' 72' ' ' LEU . 37.0 mtp180 -66.01 -52.49 48.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.636 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.24 30.35 1.95 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.112 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.443 ' CD2' ' HB3' ' A' ' 86' ' ' LEU . 1.6 m-30 -80.9 174.25 11.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.41 . . . . 0.0 110.742 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.09 158.47 17.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.439 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 22.6 p -51.35 -41.66 60.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.914 0.388 . . . . 0.0 110.815 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.56 -22.47 66.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.131 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.443 ' HB3' ' CD2' ' A' ' 82' ' ' PHE . 8.9 mp -93.02 -33.44 14.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.165 0.507 . . . . 0.0 110.875 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.416 ' CG1' ' CD1' ' A' ' 71' ' ' LEU . 59.7 t -77.18 -36.02 23.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.165 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.542 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 78.5 t -55.45 -52.25 73.27 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.819 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 54.4 Cg_endo -69.19 -43.22 3.28 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.281 1.987 . . . . 0.0 111.904 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 15.9 mt -54.6 -31.61 57.3 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.967 0.413 . . . . 0.0 110.787 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.451 HG23 ' CD2' ' A' ' 36' ' ' PHE . 70.3 mt -78.8 -47.45 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.854 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.5 -3.96 30.9 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.08 -4.2 16.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.606 0.241 . . . . 0.0 111.593 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.6 p -64.08 -18.2 64.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.907 0.384 . . . . 0.0 111.133 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.85 -144.81 17.55 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.415 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -73.91 -8.24 55.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.615 0.245 . . . . 0.0 111.466 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.437 ' HG2' ' CD1' ' A' ' 28' ' ' TYR . 10.4 mtpt -144.33 147.57 33.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.678 0.275 . . . . 0.0 111.034 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -124.77 97.58 5.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 0.0 111.078 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -95.04 118.78 32.43 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -150.2 169.36 21.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.251 0.548 . . . . 0.0 112.333 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.407 ' O ' ' HG ' ' A' ' 72' ' ' LEU . 25.0 t -118.44 109.35 26.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.549 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 2.2 pp -102.58 154.56 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.429 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 3.4 t -130.15 125.72 35.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.452 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.42 126.23 10.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.005 0.431 . . . . 0.0 111.791 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.39 140.05 78.97 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.459 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.427 ' CG ' ' HA ' ' A' ' 16' ' ' SER . 74.1 Cg_endo . . . . . 0 C--O 1.249 1.028 0 C-N-CA 122.323 2.015 . . . . 0.0 112.302 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.756 0.312 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -71.23 -70.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.813 2.342 . . . . 0.0 112.116 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.9 m -75.73 145.28 78.14 Favored Pre-proline 0 N--CA 1.452 -0.337 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.004 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.67 -160.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.419 2.079 . . . . 0.0 112.095 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -52.5 146.22 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.462 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.39 122.55 47.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.629 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 14.1 mt -62.44 144.3 56.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.304 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 80.5 m-70 -152.41 110.59 3.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.806 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -72.99 106.26 4.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.112 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.7 141.02 26.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.04 0.448 . . . . 0.0 111.57 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.9 m -132.64 106.75 7.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.144 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.5 mp -101.06 177.6 4.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.046 0.45 . . . . 0.0 111.613 -179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.418 ' CD2' ' HG2' ' A' ' 97' ' ' LYS . 11.7 m-85 -138.89 133.51 32.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.437 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.471 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -94.84 161.88 13.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.971 0.415 . . . . 0.0 111.173 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -124.4 130.9 53.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.802 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 61.3 p -60.04 84.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.4 -13.49 1.4 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.893 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.94 174.64 11.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.769 0.319 . . . . 0.0 110.923 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.82 -10.73 13.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.48 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -155.66 -176.58 6.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.977 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.5 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -98.15 31.99 2.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.008 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.85 15.66 79.54 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.973 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.461 ' HB2' HG12 ' A' ' 54' ' ' ILE . 4.1 p90 -173.47 119.22 0.3 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 110.962 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -93.62 149.66 21.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.824 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.452 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 23.7 m -108.33 167.94 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.244 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -127.08 171.32 11.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.096 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -88.14 137.31 32.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.098 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.86 114.58 4.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.403 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tp -94.38 -31.05 14.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.068 0.461 . . . . 0.0 111.251 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.96 -54.88 4.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.892 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.7 mm-40 -90.55 17.99 6.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.473 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 29.83 89.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.79 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.1 -144.53 8.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.601 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.452 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 38.8 t -146.7 140.74 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 0.0 111.021 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.1 159.99 40.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.608 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.438 HG22 ' CE1' ' A' ' 38' ' ' PHE . 59.8 t -62.97 123.63 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.982 0.42 . . . . 0.0 111.031 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -88.58 -35.38 16.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.98 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -162.55 143.59 10.14 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.273 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.461 HG12 ' HB2' ' A' ' 38' ' ' PHE . 1.2 mt -129.57 133.92 64.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.979 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.44 137.56 96.65 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.687 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.431 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 72.8 Cg_endo -75.03 107.59 2.52 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.498 2.132 . . . . 0.0 112.495 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.431 ' CB ' ' O ' ' A' ' 56' ' ' PRO . . . 83.54 28.95 0.08 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.268 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -114.5 -161.64 13.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.305 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -50.65 -53.55 6.95 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.493 2.129 . . . . 0.0 112.199 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.01 -38.38 89.0 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.476 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.3 -32.81 64.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.05 0.452 . . . . 0.0 110.273 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.6 -30.8 67.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.687 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.99 -53.4 6.27 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.28 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.45 35.13 0.88 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.787 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.418 HD13 ' CG ' ' A' ' 38' ' ' PHE . 0.3 OUTLIER -113.64 141.87 46.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.843 0.354 . . . . 0.0 110.958 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -121.93 163.04 33.83 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.684 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.552 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 1.4 Cg_endo -44.51 144.28 3.31 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.824 2.35 . . . . 0.0 112.3 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.552 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 93.8 m-85 85.3 -7.82 0.86 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.41 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.425 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 5.4 m-20 -54.41 86.65 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.151 0.5 . . . . 0.0 110.591 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 68' ' ' TYR . 22.2 ttm180 -66.82 109.15 2.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.292 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 mp -66.61 107.92 2.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.796 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.431 ' HG ' ' CG ' ' A' ' 80' ' ' ARG . 5.2 mp -83.75 -37.51 22.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.509 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.81 145.58 18.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.868 0.366 . . . . 0.0 111.087 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.11 109.75 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.791 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 75.46 -57.46 0.59 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.072 0.463 . . . . 0.0 110.695 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -167.19 -14.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.263 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.5 t -85.62 128.47 39.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-O 120.797 0.332 . . . . 0.0 111.098 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -69.31 127.07 31.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.515 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.435 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 16.8 p -142.69 32.44 1.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.031 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.431 ' CG ' ' HG ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -67.95 -48.39 66.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.303 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.15 24.21 4.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.077 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.435 ' CD1' ' HA ' ' A' ' 79' ' ' THR . 2.1 m-30 -81.13 173.87 12.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.802 0.334 . . . . 0.0 110.823 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.32 159.59 16.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.327 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 19.6 t -51.48 -42.1 61.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.824 0.345 . . . . 0.0 110.713 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.6 t -62.61 -21.64 65.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.18 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.473 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 8.3 mp -95.64 -32.57 12.72 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.023 0.44 . . . . 0.0 110.978 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.9 t -78.29 -35.7 19.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.331 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.64 ' HB ' ' HD3' ' A' ' 89' ' ' PRO . 91.9 t -58.27 -51.27 82.99 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.833 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.64 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.3 Cg_exo -67.55 -44.86 3.99 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.349 2.033 . . . . 0.0 111.47 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 18.1 mt -54.74 -29.38 53.51 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.697 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.444 HG21 ' CD2' ' A' ' 36' ' ' PHE . 50.1 mt -78.08 -48.43 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.796 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.37 -4.32 32.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.97 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -99.3 -12.94 19.89 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.716 0.293 . . . . 0.0 111.576 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -15.97 62.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.383 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.03 -144.11 17.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.649 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -73.72 -7.1 50.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.418 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -138.58 141.67 39.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.772 0.32 . . . . 0.0 110.657 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -130.6 97.33 4.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.263 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -98.47 118.11 34.41 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pp -145.91 163.2 35.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.12 0.486 . . . . 0.0 111.849 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.5 t -113.51 109.11 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.168 179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 2.6 pp -103.75 168.95 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.088 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 54.2 p -142.39 120.24 11.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.716 179.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.5 ptt85 -128.34 130.32 47.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.176 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -65.85 157.42 79.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.852 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo . . . . . 0 C--O 1.249 1.054 0 C-N-CA 122.54 2.16 . . . . 0.0 112.224 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.552 0.215 . . . . 0.0 111.539 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.8 52.83 4.51 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.561 2.174 . . . . 0.0 112.563 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.46 ' HB ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -168.86 -52.05 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.963 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.46 ' HD3' ' HB ' ' A' ' 18' ' ' THR . 6.2 Cg_exo -78.36 84.63 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.841 2.361 . . . . 0.0 112.346 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.2 m -46.08 168.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.476 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -125.55 122.69 37.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.675 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.401 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 15.1 mt -61.19 152.91 27.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.411 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -157.15 109.9 2.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.024 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.45 112.99 9.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.078 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.429 ' CG1' ' HG ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -121.92 143.4 34.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.142 0.496 . . . . 0.0 111.932 -178.898 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.1 m -134.0 106.4 7.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.811 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.445 HD21 ' CD1' ' A' ' 38' ' ' PHE . 4.4 mp -94.34 174.88 6.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.278 0.561 . . . . 0.0 112.04 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -137.4 121.63 18.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.222 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 6.1 tttm -112.04 152.98 27.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.958 0.408 . . . . 0.0 111.263 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -102.52 138.86 38.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.867 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.0 m -51.35 -26.34 7.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.31 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.72 -38.15 21.06 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.615 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 9.2 mmm -81.76 158.14 24.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.91 0.386 . . . . 0.0 110.936 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.68 -30.89 8.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.114 0.483 . . . . 0.0 110.92 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.99 172.03 11.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.713 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.445 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -119.14 32.07 6.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.802 0.335 . . . . 0.0 111.105 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.1 6.59 86.24 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.283 179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.445 ' CD1' HD21 ' A' ' 27' ' ' LEU . 14.1 p90 -172.5 123.15 0.46 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.159 0.479 . . . . 0.0 111.393 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -95.1 145.81 24.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.536 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.421 ' HB ' HG12 ' A' ' 49' ' ' VAL . 33.5 m -110.49 159.67 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.281 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -116.97 178.06 4.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -90.7 161.22 15.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.128 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.5 128.63 8.28 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.239 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.44 -58.07 2.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.289 0.566 . . . . 0.0 111.398 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.58 -43.51 15.59 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.61 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 47' ' ' LYS . 2.1 mt-10 -87.7 9.77 20.42 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.749 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER 27.71 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.73 -152.8 19.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.468 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.421 HG12 ' HB ' ' A' ' 40' ' ' VAL . 59.7 t -142.65 138.39 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.761 0.315 . . . . 0.0 111.052 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.13 167.91 20.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.52 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.429 HG22 ' CE2' ' A' ' 38' ' ' PHE . 47.2 t -71.64 122.04 23.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.979 0.419 . . . . 0.0 111.368 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -89.52 -32.68 17.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.785 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -164.79 153.89 12.9 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.187 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.423 ' CD1' ' HB2' ' A' ' 65' ' ' LEU . 0.9 OUTLIER -130.95 133.62 62.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.15 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.87 127.02 92.82 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.459 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 32.3 Cg_exo -58.34 114.22 1.89 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.418 2.079 . . . . 0.0 112.44 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.459 ' CB ' ' O ' ' A' ' 56' ' ' PRO . . . 86.64 -14.67 0.48 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.951 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.63 -176.6 2.25 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.371 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.71 -32.48 97.0 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.521 2.148 . . . . 0.0 111.998 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.51 -38.87 96.32 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.321 179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.58 -32.68 64.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.987 0.422 . . . . 0.0 110.019 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.4 mt -75.2 -34.99 61.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.833 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.42 -57.78 7.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.42 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 125.59 42.62 0.31 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.752 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.429 ' HG ' ' CG1' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -104.56 122.83 46.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.857 0.361 . . . . 0.0 110.918 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.84 162.04 20.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.772 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.467 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 6.9 Cg_endo -49.15 137.46 29.63 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.972 2.448 . . . . 0.0 112.156 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 46.6 m-85 85.32 -1.52 0.82 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.17 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.4 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -53.08 88.23 0.0 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.943 0.401 . . . . 0.0 110.735 179.507 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.429 ' N ' ' O ' ' A' ' 68' ' ' TYR . 44.3 ttp180 -76.8 102.12 6.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.035 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.17 115.33 2.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.838 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.48 ' HA ' ' CG ' ' A' ' 80' ' ' ARG . 2.8 mt -82.49 -64.44 1.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 0.0 111.135 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -133.12 109.59 9.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.369 . . . . 0.0 111.174 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.4 t -89.41 123.69 41.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.903 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 14.8 m-80 46.11 40.0 6.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.449 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.47 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 1.5 t-80 87.6 -21.92 0.16 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.823 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.0 t -82.37 129.52 37.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.721 0.296 . . . . 0.0 111.151 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -68.86 135.14 50.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.434 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 30.1 p -144.89 29.87 1.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.058 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.48 ' CG ' ' HA ' ' A' ' 72' ' ' LEU . 8.8 mtp-105 -72.83 -53.2 12.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.696 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.19 21.69 5.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.148 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.434 ' CD1' ' HA ' ' A' ' 79' ' ' THR . 2.8 m-85 -81.27 169.44 17.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.872 0.367 . . . . 0.0 110.875 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -108.51 157.94 18.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.245 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 8.0 p -51.39 -38.37 53.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.0 110.676 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -66.97 -21.45 65.96 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.222 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.421 HD23 ' CD2' ' A' ' 82' ' ' PHE . 1.0 OUTLIER -92.33 -32.31 15.03 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.003 0.43 . . . . 0.0 110.571 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.417 HG22 ' CB ' ' A' ' 49' ' ' VAL . 94.3 t -77.05 -35.68 23.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.982 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.532 ' N ' ' HD2' ' A' ' 89' ' ' PRO . 84.4 t -55.35 -52.64 69.9 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.817 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 49.3 Cg_endo -68.4 -43.22 4.48 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.205 1.937 . . . . 0.0 111.704 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.451 ' HA ' ' HG2' ' A' ' 93' ' ' GLU . 11.0 mt -53.97 -33.71 57.71 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.298 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.488 ' HA ' HD11 ' A' ' 98' ' ' LEU . 80.3 mt -78.92 -41.88 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.842 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.64 -5.55 38.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.36 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.451 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 4.5 pt-20 -98.38 -3.26 37.35 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.704 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.6 p -63.68 -31.03 72.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.232 0.539 . . . . 0.0 110.666 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.46 -48.9 1.88 Allowed Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.818 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -166.24 -39.48 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.744 0.307 . . . . 0.0 111.111 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -111.75 112.96 25.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.191 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.488 HD11 ' HA ' ' A' ' 91' ' ' ILE . 0.2 OUTLIER -103.9 98.07 7.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.559 -179.111 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -95.94 118.5 32.69 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.4 pp -146.43 164.18 33.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.273 0.559 . . . . 0.0 111.978 -178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 26.0 t -119.22 109.36 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.147 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 2.5 pp -101.68 168.78 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.115 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.11 128.16 15.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.674 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.22 147.56 30.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.983 0.421 . . . . 0.0 111.329 -179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -62.38 143.2 95.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.829 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo . . . . . 0 C--O 1.248 0.996 0 C-N-CA 122.514 2.142 . . . . 0.0 112.217 -179.958 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.416 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.613 0.244 . . . . 0.0 111.469 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 16' ' ' SER . 85.2 Cg_endo -83.38 50.93 3.41 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.512 2.141 . . . . 0.0 112.66 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 m 178.76 -61.93 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.479 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -70.46 107.19 1.94 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.425 2.083 . . . . 0.0 112.231 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.7 m -45.95 160.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.672 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.51 122.88 38.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.351 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.408 ' HA ' ' O ' ' A' ' 102' ' ' ILE . 13.7 mt -60.53 147.0 42.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.584 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -151.46 107.51 3.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.825 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.44 118.4 13.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.19 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -126.25 141.58 45.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.076 0.465 . . . . 0.0 111.799 -179.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 95.9 m -134.38 106.64 7.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.778 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.1 mt -100.04 171.99 7.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.018 0.437 . . . . 0.0 111.774 -179.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -123.52 137.25 54.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.34 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 1.5 tttt -95.24 162.91 13.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.033 0.444 . . . . 0.0 111.299 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -131.33 128.18 39.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.741 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.63 -27.16 6.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.248 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.08 26.93 20.6 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.504 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.87 140.09 13.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 110.892 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -96.57 -21.85 17.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.992 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -84.79 170.83 12.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.761 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.47 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -119.03 23.9 11.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.32 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.24 9.63 67.03 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.334 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 54' ' ' ILE . 0.1 OUTLIER -173.72 138.93 0.68 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.128 0.464 . . . . 0.0 111.627 179.781 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.8 m -99.35 154.69 18.0 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.596 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.467 ' HB ' ' CG1' ' A' ' 49' ' ' VAL . 35.0 m -116.34 159.23 16.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.42 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -117.98 178.31 4.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.047 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.09 144.8 26.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.194 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.2 115.45 5.05 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.242 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.29 -45.66 7.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.157 0.503 . . . . 0.0 111.343 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -84.66 4.79 30.83 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.897 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.465 ' O ' ' C ' ' A' ' 47' ' ' LYS . 27.0 mt-10 -153.85 22.92 0.51 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.522 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 24.09 79.84 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -171.69 -157.4 13.51 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.365 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.467 ' CG1' ' HB ' ' A' ' 40' ' ' VAL . 35.7 t -143.48 139.38 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.872 0.367 . . . . 0.0 111.15 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.81 168.57 19.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.359 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.438 HG21 ' CE2' ' A' ' 38' ' ' PHE . 72.2 t -74.21 121.54 25.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.793 0.33 . . . . 0.0 111.142 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.52 -31.55 17.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.29 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -163.5 162.96 24.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.27 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -134.27 136.98 52.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.49 123.88 84.24 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.26 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.429 ' O ' ' CB ' ' A' ' 57' ' ' ALA . 31.9 Cg_exo -58.5 105.99 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.525 2.15 . . . . 0.0 112.19 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.429 ' CB ' ' O ' ' A' ' 56' ' ' PRO . . . 82.35 28.56 0.13 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.111 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.21 -173.39 24.23 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.276 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.87 -42.21 45.15 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.453 2.102 . . . . 0.0 112.171 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.23 -36.43 93.22 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.445 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.63 -32.96 64.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.062 0.458 . . . . 0.0 110.404 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.81 -34.43 75.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.992 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.05 -46.69 5.82 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.627 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.14 34.79 0.86 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.581 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.411 ' HB2' ' CD1' ' A' ' 54' ' ' ILE . 45.1 mt -75.81 133.49 40.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.738 0.304 . . . . 0.0 110.917 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -117.87 155.81 50.58 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.893 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.531 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 12.3 Cg_endo -55.69 146.42 65.77 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.621 2.214 . . . . 0.0 112.18 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.531 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 85.4 m-85 84.64 -5.39 0.99 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.384 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.401 ' HB2' ' CG2' ' A' ' 51' ' ' VAL . 7.0 m-20 -53.97 85.56 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.98 0.419 . . . . 0.0 110.774 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 68' ' ' TYR . 59.3 ttt180 -71.41 101.13 2.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.06 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.93 107.76 0.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.938 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.463 ' HA ' ' CG ' ' A' ' 80' ' ' ARG . 9.0 mt -82.39 -65.53 1.0 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.869 0.366 . . . . 0.0 110.881 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -119.56 127.5 53.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.892 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.9 104.68 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.101 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.468 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 1.2 m-20 64.71 36.94 7.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.725 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.468 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 2.8 t60 87.66 -14.68 0.42 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.503 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.63 114.06 23.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.8 0.333 . . . . 0.0 111.005 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -69.01 87.09 0.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.812 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.428 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 15.8 p -95.95 32.08 1.98 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.115 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.463 ' CG ' ' HA ' ' A' ' 72' ' ' LEU . 36.2 mtp180 -66.28 -53.15 40.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.814 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -93.52 22.71 5.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.185 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.428 ' CD1' ' HA ' ' A' ' 79' ' ' THR . 2.8 m-85 -82.01 167.94 18.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.951 0.405 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -106.99 160.87 15.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.383 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 4.3 t -51.59 -41.35 61.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.666 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 10.0 p -62.56 -23.91 67.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.07 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.467 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 0.6 OUTLIER -94.12 -30.93 14.39 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.946 0.403 . . . . 0.0 110.972 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.3 t -78.89 -35.9 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.265 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.643 ' HB ' ' HD3' ' A' ' 89' ' ' PRO . 91.6 t -57.76 -51.02 84.79 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.865 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.643 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 14.3 Cg_exo -68.96 -46.19 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.425 2.083 . . . . 0.0 111.517 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 33.3 mt -54.91 -33.09 61.74 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.986 0.422 . . . . 0.0 110.546 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.427 HG21 ' CD1' ' A' ' 98' ' ' LEU . 62.6 mt -73.25 -46.76 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.477 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.57 -3.9 36.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.848 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.18 -7.23 22.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.656 0.265 . . . . 0.0 111.497 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.8 p -64.52 -16.59 62.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.355 . . . . 0.0 111.347 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.26 -144.0 16.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.217 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -74.38 -8.81 57.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.569 0.223 . . . . 0.0 111.452 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -142.1 141.84 32.75 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.784 0.326 . . . . 0.0 110.959 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.47 ' HB2' ' CE1' ' A' ' 36' ' ' PHE . 0.2 OUTLIER -119.56 97.12 5.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.242 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -92.0 118.37 30.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.6 pp -151.85 162.17 41.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.324 0.583 . . . . 0.0 112.093 -178.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 39.1 t -121.49 109.02 23.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.946 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 2.4 pp -100.95 169.3 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.349 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.4 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.3 OUTLIER -145.58 128.26 16.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.579 179.666 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.0 151.74 35.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.012 0.434 . . . . 0.0 111.478 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -62.68 115.1 14.6 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.971 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.249 1.054 0 C-N-CA 122.508 2.139 . . . . 0.0 112.267 -179.992 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.013 0.435 . . . . 0.0 111.847 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -137.73 122.82 19.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.316 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.078 HD21 HD12 ' A' ' 72' ' ' LEU . 13.6 mt -60.03 137.5 58.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.102 0.477 . . . . 0.0 111.839 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -149.34 122.04 8.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.173 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.67 ' HD2' HG22 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -68.87 135.43 51.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.517 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.724 HG11 ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -137.37 143.05 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.143 0.496 . . . . 0.0 111.451 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.853 HG23 ' OD1' ' A' ' 99' ' ' ASP . 97.2 m -134.55 141.42 46.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.784 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.691 HD21 HD11 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -138.39 -179.63 5.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.08 0.467 . . . . 0.0 111.639 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.439 ' CD2' ' HG2' ' A' ' 97' ' ' LYS . 9.8 m-85 -138.96 125.35 20.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.391 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -94.87 164.94 12.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.997 0.427 . . . . 0.0 111.231 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.37 141.13 48.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.657 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.3 p -60.11 84.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 138.33 -3.68 3.03 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.217 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.6 151.34 29.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.864 0.364 . . . . 0.0 110.989 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -94.91 -10.53 30.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.388 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.83 175.87 13.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.68 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.861 ' CD2' HD12 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -94.15 2.1 56.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.619 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.33 18.23 5.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.382 -0.913 . . . . 0.0 113.25 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.69 ' HB3' HG23 ' A' ' 54' ' ' ILE . 39.4 p90 -174.04 134.45 0.45 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 117.035 0.418 . . . . 0.0 111.654 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.403 ' O ' ' N ' ' A' ' 52' ' ' LYS . 67.4 m -92.99 151.3 19.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.088 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.731 ' HB ' HG12 ' A' ' 49' ' ' VAL . 34.5 m -114.93 167.95 7.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.122 0.487 . . . . 0.0 111.837 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.506 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -133.85 140.69 47.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.782 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.13 121.75 18.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.817 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.422 ' HA3' ' CZ ' ' A' ' 50' ' ' TYR . . . -77.05 89.65 0.98 Allowed Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 pp -83.36 -2.47 55.82 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.54 ' H ' HD12 ' A' ' 45' ' ' LEU . 4.9 mp -77.17 -13.49 59.94 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.586 ' O ' ' CG ' ' A' ' 47' ' ' LYS . 0.6 OUTLIER -157.88 -83.78 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.001 179.334 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.586 ' CG ' ' O ' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -175.68 134.22 0.29 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.596 0.758 . . . . 0.0 110.233 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.62 -159.19 22.01 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.263 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.731 HG12 ' HB ' ' A' ' 40' ' ' VAL . 18.8 t -154.82 144.38 13.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.627 0.251 . . . . 0.0 110.852 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.422 ' CZ ' ' HA3' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -135.88 151.39 49.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.806 0.336 . . . . 0.0 111.028 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.623 HG22 ' CE1' ' A' ' 38' ' ' PHE . 44.7 t -60.49 123.59 13.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.02 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 39' ' ' SER . 0.1 OUTLIER -88.19 -27.54 21.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.169 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -169.68 140.34 2.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.738 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.69 HG23 ' HB3' ' A' ' 38' ' ' PHE . 2.7 mt -119.61 142.9 32.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.002 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -65.37 111.7 6.71 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.732 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.604 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 50.0 Cg_exo -55.53 109.17 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.464 2.109 . . . . 0.0 112.485 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 83.38 38.14 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.367 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.9 -170.41 13.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.171 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.415 ' HB2' ' O ' ' A' ' 36' ' ' PHE . 72.2 Cg_exo -49.77 -43.62 39.73 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.35 2.033 . . . . 0.0 111.817 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.46 ' HA2' HD12 ' A' ' 65' ' ' LEU . . . -64.85 -38.5 95.63 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.428 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -73.59 -32.84 64.32 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.007 0.432 . . . . 0.0 110.196 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 75.3 mt -73.01 -31.84 64.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.682 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.86 -40.92 34.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.362 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.34 8.4 6.49 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.031 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.724 ' HG ' HG11 ' A' ' 25' ' ' VAL . 1.2 mt -63.4 115.96 5.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.911 0.386 . . . . 0.0 110.988 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -107.33 141.56 23.23 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.512 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.598 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 4.1 Cg_exo -39.47 135.75 1.16 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.202 2.601 . . . . 0.0 112.727 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.598 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 78.2 m-85 85.44 -5.31 0.87 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.542 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.817 ' CB ' HD13 ' A' ' 102' ' ' ILE . 9.1 p-10 -56.22 85.1 0.01 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.062 0.458 . . . . 0.0 110.885 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.563 ' O ' HD23 ' A' ' 72' ' ' LEU . 42.4 ttt180 -66.66 102.61 0.94 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.476 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.92 HD22 HD22 ' A' ' 100' ' ' LEU . 3.2 mt -54.5 107.28 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.721 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.078 HD12 HD21 ' A' ' 22' ' ' LEU . 5.5 mt -82.98 -63.48 1.35 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.376 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -121.23 118.24 29.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.07 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.647 HG23 ' OG1' ' A' ' 79' ' ' THR . 27.1 t -100.55 120.21 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.249 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.442 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 0.7 OUTLIER 46.36 43.11 11.4 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.671 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.442 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.1 OUTLIER 86.59 -19.37 0.28 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.752 179.534 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.85 120.69 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.875 0.369 . . . . 0.0 111.087 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -70.13 85.94 0.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.671 HG21 HD13 ' A' ' 90' ' ' LEU . 27.9 p -96.51 30.93 2.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.138 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.664 ' HG2' HD22 ' A' ' 72' ' ' LEU . 4.6 mtp180 -68.4 -45.73 71.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.008 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -92.0 18.28 8.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.311 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.609 ' HE2' HD11 ' A' ' 90' ' ' LEU . 3.5 m-30 -82.16 171.81 13.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.883 0.373 . . . . 0.0 110.931 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.806 ' OD1' HD13 ' A' ' 86' ' ' LEU . 0.4 OUTLIER -114.07 166.87 11.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.33 179.357 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.809 ' O ' HG23 ' A' ' 88' ' ' VAL . 9.5 p -51.52 -44.62 62.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.256 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 26.2 p -61.13 -20.12 62.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.52 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.806 HD13 ' OD1' ' A' ' 83' ' ' ASP . 7.5 mp -99.45 -33.37 10.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.868 0.366 . . . . 0.0 111.165 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 83' ' ' ASP . 44.9 t -77.5 -35.9 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.963 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 84' ' ' CYS . 99.0 t -57.65 -52.36 74.9 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.735 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 45.7 Cg_endo -67.56 -44.8 4.04 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.149 1.899 . . . . 0.0 111.8 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.671 HD13 HG21 ' A' ' 79' ' ' THR . 13.1 mt -54.94 -31.64 60.58 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.045 0.45 . . . . 0.0 110.391 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.612 ' HA ' HD11 ' A' ' 98' ' ' LEU . 60.3 mt -72.57 -51.4 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.161 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.84 -3.06 42.7 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.976 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.97 -5.99 22.86 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.422 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 3.3 t -64.82 -14.73 60.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.741 0.305 . . . . 0.0 111.461 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.11 -142.97 16.34 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.663 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -74.65 -5.53 43.57 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.439 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 42.1 mtpt -146.23 151.3 37.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.874 0.369 . . . . 0.0 111.141 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.861 HD12 ' CD2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -129.67 97.86 4.65 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.285 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.853 ' OD1' HG23 ' A' ' 26' ' ' THR . 6.1 m-20 -99.21 117.9 34.71 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.92 HD22 HD22 ' A' ' 71' ' ' LEU . 2.3 pp -150.21 162.89 39.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.262 0.553 . . . . 0.0 112.253 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.916 HG12 HD22 ' A' ' 22' ' ' LEU . 15.1 t -114.1 109.53 28.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.895 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.848 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.6 pp -105.45 169.26 2.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.345 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.7 p -133.42 121.68 22.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.766 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.419 ' HB3' ' HA ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -136.44 147.68 47.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.171 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -74.57 122.67 88.04 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.779 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 C--O 1.25 1.11 0 C-N-CA 122.333 2.022 . . . . 0.0 112.385 -179.912 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.419 ' CG2' ' HB2' ' A' ' 103' ' ' SER . 28.9 m . . . . . 0 C--O 1.23 0.079 0 CA-C-O 121.063 0.458 . . . . 0.0 111.711 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -132.51 122.81 25.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.479 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.949 HD21 ' CD1' ' A' ' 72' ' ' LEU . 13.5 mt -60.01 148.67 34.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.033 0.444 . . . . 0.0 111.651 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.5 122.87 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.221 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -71.51 119.24 15.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.509 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.598 HG11 ' HB3' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -117.5 148.17 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.134 0.493 . . . . 0.0 111.493 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.3 m -134.59 106.89 7.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.848 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.099 HD11 HD21 ' A' ' 65' ' ' LEU . 13.8 mt -101.08 173.66 6.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.24 0.543 . . . . 0.0 112.017 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.443 ' CZ ' ' HD3' ' A' ' 97' ' ' LYS . 6.3 m-85 -132.53 166.15 22.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.329 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -134.08 161.02 36.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.98 0.419 . . . . 0.0 111.29 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.44 148.02 51.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.657 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.4 m -58.05 -25.21 60.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.149 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.77 -14.71 51.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.854 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 5.3 mmt -81.29 145.0 31.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.911 0.386 . . . . 0.0 111.013 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -91.73 -10.15 41.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.24 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -154.13 -167.52 2.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.607 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.526 ' CE2' ' HB2' ' A' ' 98' ' ' LEU . 1.1 m-85 -95.89 24.4 5.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.723 0.297 . . . . 0.0 111.564 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.631 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 80.6 16.81 74.76 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.568 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.507 ' CE2' HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -172.05 124.42 0.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.192 0.52 . . . . 0.0 111.696 179.473 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.4 m -89.51 154.04 20.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.807 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.678 ' HB ' HG12 ' A' ' 49' ' ' VAL . 30.8 m -106.39 165.47 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.554 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.782 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -124.25 178.15 5.49 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.144 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -103.81 139.08 39.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.077 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.07 118.51 5.44 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.33 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.53 -28.5 15.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.927 0.394 . . . . 0.0 111.263 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tp -84.7 -7.68 59.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.856 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 47' ' ' LYS . 8.9 mm-40 -150.12 25.44 0.81 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.13 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER 26.26 63.08 0.08 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.012 0.434 . . . . 0.0 112.082 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -149.24 -164.55 11.69 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.499 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.782 HG13 ' O ' ' A' ' 41' ' ' ALA . 19.1 t -132.39 132.51 60.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.638 0.256 . . . . 0.0 111.087 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.461 ' CE1' ' NH1' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -133.41 145.86 50.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.289 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.507 HG22 ' CE2' ' A' ' 38' ' ' PHE . 58.6 t -49.06 124.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.057 0.456 . . . . 0.0 111.512 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.714 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 5.9 tptt -88.29 -30.6 19.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.002 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -175.88 160.92 2.42 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.386 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -128.04 142.7 43.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.978 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -65.26 147.6 98.48 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.592 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 58.6 Cg_endo -71.78 100.08 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.526 2.151 . . . . 0.0 112.391 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 83.1 29.35 0.09 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.16 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.03 -179.52 32.95 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.401 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.83 -29.52 53.2 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.588 2.192 . . . . 0.0 112.146 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.656 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . -64.19 -47.3 86.4 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.201 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.25 -32.84 67.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.12 0.486 . . . . 0.0 109.951 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.3 mt -73.47 -29.14 62.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.358 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.444 ' HA3' HD23 ' A' ' 27' ' ' LEU . . . -71.46 -48.49 29.77 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.178 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.88 10.49 3.51 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.446 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.099 HD21 HD11 ' A' ' 27' ' ' LEU . 1.3 pp -111.44 152.16 27.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.098 0.449 . . . . 0.0 110.93 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.428 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -138.51 179.11 1.4 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.673 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.477 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 74.8 Cg_exo -49.73 144.9 18.95 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.362 2.041 . . . . 0.0 112.353 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.495 ' O ' ' N ' ' A' ' 70' ' ' ARG . 11.6 m-85 90.32 -17.21 0.2 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.433 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.653 ' CG ' HD13 ' A' ' 102' ' ' ILE . 1.6 m-20 -53.34 83.75 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.007 0.432 . . . . 0.0 110.847 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.569 ' HD2' HD21 ' A' ' 72' ' ' LEU . 24.6 ttm-85 -67.92 99.61 0.86 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.987 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.031 HD23 HD13 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -64.31 107.98 1.48 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.02 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.949 ' CD1' HD21 ' A' ' 22' ' ' LEU . 6.5 mt -83.51 -56.31 3.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.467 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -137.06 116.68 12.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.784 0.326 . . . . 0.0 111.516 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.59 HG23 ' OG1' ' A' ' 79' ' ' THR . 22.5 t -89.14 109.04 19.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.535 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 75.54 -59.11 0.54 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.18 0.514 . . . . 0.0 110.517 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -167.47 -14.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.221 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.81 129.24 38.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.775 0.321 . . . . 0.0 111.172 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.73 87.23 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.59 ' OG1' HG23 ' A' ' 74' ' ' VAL . 20.4 p -96.41 26.48 4.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.288 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.761 ' CG ' HD22 ' A' ' 72' ' ' LEU . 2.3 tmm_? -74.93 -46.37 36.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.797 0.332 . . . . 0.0 110.698 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -92.49 19.45 7.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.627 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.9 m-85 -82.01 171.14 14.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.959 0.409 . . . . 0.0 110.95 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.481 ' O ' HG23 ' A' ' 87' ' ' VAL . 7.0 t70 -105.27 158.74 16.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.378 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.898 ' O ' HG23 ' A' ' 88' ' ' VAL . 23.7 m -51.34 -41.32 60.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.88 0.372 . . . . 0.0 110.724 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 17.3 t -65.24 -21.63 66.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.274 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.729 ' O ' HD12 ' A' ' 90' ' ' LEU . 10.1 mp -94.56 -30.06 14.57 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.016 0.436 . . . . 0.0 110.739 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.61 HG12 ' CD1' ' A' ' 91' ' ' ILE . 48.7 t -78.59 -35.79 19.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.254 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 84' ' ' CYS . 58.1 t -58.92 -50.99 85.03 Favored Pre-proline 0 C--N 1.331 -0.209 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.87 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.652 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.8 Cg_exo -67.3 -48.04 1.92 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.445 2.097 . . . . 0.0 111.465 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.729 HD12 ' O ' ' A' ' 86' ' ' LEU . 11.0 mt -54.93 -29.96 57.48 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.886 0.374 . . . . 0.0 110.511 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.803 ' HA ' HD11 ' A' ' 98' ' ' LEU . 48.3 mt -74.19 -46.53 44.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.343 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.81 -3.79 52.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.966 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -94.87 -15.77 23.42 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.445 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 1.4 t -65.15 -16.04 63.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.382 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.08 -141.41 15.6 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.696 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -73.99 -20.38 60.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.683 0.277 . . . . 0.0 111.441 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.443 ' HD3' ' CZ ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -127.73 152.38 47.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.674 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.982 HD22 HD23 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -135.77 97.76 3.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.778 0.323 . . . . 0.0 111.575 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.97 118.06 30.41 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 1.031 HD13 HD23 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -146.6 162.99 37.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.157 0.503 . . . . 0.0 111.968 -178.915 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.881 HG12 HD22 ' A' ' 22' ' ' LEU . 24.5 t -112.91 109.17 27.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.272 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.653 HD13 ' CG ' ' A' ' 69' ' ' ASP . 2.4 pp -109.17 169.19 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.183 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.419 ' HB2' ' CG2' ' A' ' 20' ' ' VAL . 19.0 p -136.15 107.03 6.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.953 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.11 136.14 53.03 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 0.9 OUTLIER -93.54 131.37 32.59 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.128 178.817 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 105' ' ' ASN . 8.7 Cg_exo . . . . . 0 C--O 1.249 1.05 0 C-N-CA 122.24 1.96 . . . . 0.0 112.19 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.431 HG21 ' HB3' ' A' ' 103' ' ' SER . 27.4 m . . . . . 0 N--CA 1.462 0.128 0 CA-C-O 120.945 0.402 . . . . 0.0 111.629 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -120.32 122.75 41.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.601 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.723 HD22 HG12 ' A' ' 101' ' ' VAL . 14.1 mt -61.86 141.92 57.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.291 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.483 ' HB2' HD11 ' A' ' 102' ' ' ILE . 9.9 m-70 -144.15 108.51 4.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.839 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.95 102.5 4.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.607 HG23 HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -110.39 138.44 38.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.107 0.479 . . . . 0.0 111.828 -179.011 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.2 m -131.98 106.39 8.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.732 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.686 HD21 HD11 ' A' ' 65' ' ' LEU . 19.6 mt -98.81 177.1 5.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.978 0.418 . . . . 0.0 111.662 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -136.33 135.89 39.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.315 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -94.64 138.18 32.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.417 . . . . 0.0 111.097 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.54 131.04 54.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.795 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -60.59 84.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.838 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.77 -17.25 1.09 Allowed Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.882 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.09 167.94 19.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.848 0.356 . . . . 0.0 110.836 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -107.39 -10.52 15.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.37 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.44 -169.33 3.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.875 0.369 . . . . 0.0 110.896 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 1.6 m-85 -103.97 17.74 23.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.493 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.34 14.76 59.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.229 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.808 ' HB3' HD13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -173.31 130.62 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.112 0.482 . . . . 0.0 111.127 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.82 160.35 14.68 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.065 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.539 HG11 HD13 ' A' ' 71' ' ' LEU . 26.8 m -115.69 158.86 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.178 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' A' ' 52' ' ' LYS . . . -123.58 167.3 14.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.157 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.2 p30 -73.13 153.26 40.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.661 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -109.23 96.87 1.01 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.564 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.403 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -94.23 -17.97 22.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 0.0 111.302 179.881 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.691 HD12 ' HG2' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -85.02 -28.88 25.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.439 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.691 ' HG2' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -155.92 51.79 0.55 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.603 -179.734 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 21.62 96.44 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.643 179.49 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.34 -170.88 43.58 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.815 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 82' ' ' PHE . 93.7 t -133.08 131.58 58.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.678 0.275 . . . . 0.0 110.671 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.437 ' HB3' ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -138.59 157.11 46.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.876 0.37 . . . . 0.0 111.237 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.443 ' CG2' ' CD2' ' A' ' 38' ' ' PHE . 43.6 t -65.19 114.92 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.959 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -92.14 -28.32 17.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.26 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -142.8 156.49 44.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.603 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.808 HD13 ' HB3' ' A' ' 38' ' ' PHE . 1.2 mm -138.54 109.31 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.588 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -64.88 121.8 75.74 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.02 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.93 165.16 2.06 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.46 2.107 . . . . 0.0 112.267 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 35.77 75.34 0.06 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.983 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.93 -171.09 35.87 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.151 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.452 ' O ' HD22 ' A' ' 27' ' ' LEU . 46.8 Cg_exo -55.72 -29.75 72.67 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.387 2.058 . . . . 0.0 112.05 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.605 ' HA2' HD12 ' A' ' 65' ' ' LEU . . . -76.82 -43.83 16.72 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.578 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -73.77 -32.92 64.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.042 0.448 . . . . 0.0 110.357 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.2 mt -75.27 -32.93 61.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.037 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.4 -46.85 7.78 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.566 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 114.92 25.56 3.86 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.668 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.686 HD11 HD21 ' A' ' 27' ' ' LEU . 3.6 mt -73.73 141.95 46.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.857 0.361 . . . . 0.0 110.798 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -114.65 156.17 45.15 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.92 66.67 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.63 2.22 . . . . 0.0 112.04 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.437 ' O ' ' HB3' ' A' ' 50' ' ' TYR . 0.7 OUTLIER -178.16 -24.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.572 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.675 ' CB ' HD13 ' A' ' 102' ' ' ILE . 4.4 m-20 -44.0 94.96 0.01 OUTLIER 'General case' 0 C--O 1.231 0.082 0 CA-C-O 121.194 0.521 . . . . 0.0 111.277 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 50' ' ' TYR . 20.6 ttp180 -74.95 101.31 4.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.667 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.788 ' CD2' HD22 ' A' ' 100' ' ' LEU . 2.5 mp -53.98 107.05 0.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.278 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.693 HD11 ' HB2' ' A' ' 103' ' ' SER . 20.0 mt -85.12 -56.14 3.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.059 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -136.35 117.59 14.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.92 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.9 t -102.95 119.06 50.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.88 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.11 -61.58 0.49 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.128 0.489 . . . . 0.0 110.563 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.416 ' H ' ' H ' ' A' ' 77' ' ' VAL . 7.2 t-160 -168.07 -18.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.988 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.425 ' O ' HG23 ' A' ' 79' ' ' THR . 21.4 t -84.84 127.29 40.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.826 0.346 . . . . 0.0 111.198 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.69 93.61 0.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.745 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.49 HG21 HD13 ' A' ' 90' ' ' LEU . 14.5 p -95.75 34.41 1.51 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.198 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.52 ' HG2' HD22 ' A' ' 72' ' ' LEU . 3.3 mtt180 -67.99 -53.31 26.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.584 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -94.0 25.1 3.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.183 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.729 ' O ' HG23 ' A' ' 49' ' ' VAL . 2.5 m-30 -81.43 174.49 11.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.877 0.37 . . . . 0.0 110.805 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.51 ' C ' HG21 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -113.28 161.05 17.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.347 179.597 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.849 ' O ' HG23 ' A' ' 88' ' ' VAL . 42.0 t -51.82 -42.96 62.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.894 0.378 . . . . 0.0 110.664 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.4 t -63.54 -19.52 64.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.264 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.596 ' O ' HD12 ' A' ' 90' ' ' LEU . 3.2 mp -96.58 -32.77 12.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.042 0.449 . . . . 0.0 110.647 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.63 HG21 HG11 ' A' ' 49' ' ' VAL . 58.1 t -77.5 -36.01 22.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.9 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 84' ' ' CYS . 98.9 t -57.79 -52.2 76.14 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.839 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 41.5 Cg_endo -66.9 -45.4 4.29 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.336 2.024 . . . . 0.0 111.854 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.689 HD11 ' HE2' ' A' ' 82' ' ' PHE . 19.7 mt -54.64 -29.69 53.05 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.985 0.421 . . . . 0.0 110.681 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.913 HG23 ' CD1' ' A' ' 98' ' ' LEU . 70.2 mt -78.19 -48.18 23.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.839 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.19 -3.93 32.8 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.41 ' CG ' ' HA ' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -111.74 -4.21 14.74 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.489 ' OG ' HD23 ' A' ' 98' ' ' LEU . 2.4 t -64.73 -16.19 62.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.806 0.336 . . . . 0.0 111.367 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.46 -154.26 19.72 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.557 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -73.44 -9.25 58.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.612 0.244 . . . . 0.0 111.404 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -138.87 123.42 18.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.694 0.283 . . . . 0.0 110.743 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.913 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -107.3 97.4 7.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.19 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -98.62 118.23 34.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.788 HD22 ' CD2' ' A' ' 71' ' ' LEU . 1.9 pp -147.75 150.81 34.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.084 0.469 . . . . 0.0 111.965 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.723 HG12 HD22 ' A' ' 22' ' ' LEU . 11.6 t -105.43 108.85 25.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.792 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.768 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.5 pp -104.41 169.04 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.048 0.451 . . . . 0.0 111.503 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.693 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -137.71 123.87 20.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.382 179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.87 126.9 25.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.255 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -75.24 112.95 20.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.828 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 C--O 1.249 1.04 0 C-N-CA 122.413 2.075 . . . . 0.0 112.252 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 105' ' ' ASN . 29.1 m . . . . . 0 C--O 1.231 0.112 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -97.24 121.82 39.57 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.628 HD13 ' CG1' ' A' ' 101' ' ' VAL . 4.6 pp -100.34 153.14 19.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.266 0.555 . . . . 0.0 112.356 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -148.31 149.66 32.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.281 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.87 103.52 10.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.49 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.827 HG11 ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -100.4 138.7 23.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.197 -179.669 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.5 m -130.21 110.2 11.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.364 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.994 HD11 HD21 ' A' ' 65' ' ' LEU . 57.9 mt -106.78 174.87 5.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.027 0.442 . . . . 0.0 111.498 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -127.73 154.97 44.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.593 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -114.25 140.45 48.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.035 0.445 . . . . 0.0 111.321 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 32' ' ' GLY . 10.5 t70 -112.79 134.67 54.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.372 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.8 m -56.86 85.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.052 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 30' ' ' ASP . . . 148.65 -18.41 1.28 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.83 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.16 140.67 34.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 111.028 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.52 -10.58 59.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.263 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.58 -167.58 2.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.918 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 98' ' ' LEU . 4.0 m-85 -99.38 28.25 4.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.293 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.12 21.55 48.99 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.999 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.622 ' CD2' HD13 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -174.38 128.01 0.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.792 0.33 . . . . 0.0 110.833 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.7 m -90.06 150.02 22.26 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.792 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 35.5 m -110.48 171.0 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.697 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.61 144.38 26.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.112 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -72.49 168.24 18.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -105.35 122.59 7.27 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.314 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.15 -23.75 17.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.038 0.447 . . . . 0.0 111.322 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.4 mp -84.28 -39.61 19.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.949 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.538 ' O ' ' O ' ' A' ' 47' ' ' LYS . 7.0 pt-20 -156.2 59.95 0.57 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.058 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.538 ' O ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 32.85 -166.85 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.623 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.77 176.01 42.75 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.534 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.655 HG21 ' CG2' ' A' ' 87' ' ' VAL . 58.9 t -133.79 132.16 56.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.872 0.367 . . . . 0.0 111.226 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -126.1 -175.11 3.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.372 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.472 HG11 HD11 ' A' ' 54' ' ' ILE . 56.0 t -95.77 122.11 46.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.978 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.27 -29.69 19.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.448 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -157.37 154.11 28.38 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.558 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.601 ' CD1' HD12 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -138.25 139.05 42.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.768 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.04 133.42 94.76 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.889 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.606 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 61.1 Cg_endo -72.85 98.05 0.95 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.493 2.129 . . . . 0.0 112.306 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 82.99 28.77 0.1 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.082 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -106.47 -160.83 22.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.434 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.56 -53.61 6.57 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.586 2.191 . . . . 0.0 112.308 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.06 -39.04 89.05 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.421 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.56 -32.88 64.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.084 0.468 . . . . 0.0 110.21 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 45.3 mt -73.73 -31.41 63.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.686 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.74 -55.59 7.28 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.331 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 139.38 -11.65 3.25 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.04 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.994 HD21 HD11 ' A' ' 27' ' ' LEU . 3.3 pp -80.44 135.34 36.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.973 0.416 . . . . 0.0 111.025 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.587 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 6.7 ptmt -120.03 167.52 12.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.397 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.641 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 99.9 Cg_exo -44.62 146.99 1.91 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.459 2.106 . . . . 0.0 112.7 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.641 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 2.2 m-85 82.98 -10.13 1.05 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.671 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.614 ' CG ' HD13 ' A' ' 102' ' ' ILE . 7.7 m-20 -54.74 88.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.05 0.453 . . . . 0.0 110.854 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 50' ' ' TYR . 12.3 ttm180 -66.83 101.04 0.77 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.02 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.758 HD23 HD22 ' A' ' 100' ' ' LEU . 3.4 mp -56.14 107.89 0.41 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.006 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.625 HD22 ' CG ' ' A' ' 80' ' ' ARG . 27.8 mt -82.99 -56.55 3.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.437 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -139.48 137.02 35.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.099 0.475 . . . . 0.0 111.385 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.545 ' O ' ' HB2' ' A' ' 75' ' ' ASN . 31.3 t -107.52 110.45 31.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.345 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.545 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 5.4 m120 73.28 -58.84 0.58 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.678 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -167.47 -12.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.532 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.721 HG13 HG23 ' A' ' 79' ' ' THR . 12.2 p -84.22 133.15 29.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.924 0.393 . . . . 0.0 111.427 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.7 mmt-85 -72.07 89.79 1.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.943 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.721 HG23 HG13 ' A' ' 77' ' ' VAL . 37.7 p -96.28 21.01 9.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.333 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.625 ' CG ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -70.95 -42.53 69.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.885 0.374 . . . . 0.0 110.595 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.16 15.27 13.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.099 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.707 ' HE2' HD11 ' A' ' 90' ' ' LEU . 3.1 m-85 -81.92 172.24 13.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.927 0.394 . . . . 0.0 110.977 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.415 ' O ' HG23 ' A' ' 87' ' ' VAL . 20.3 t0 -111.88 162.53 15.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.383 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.894 ' O ' HG23 ' A' ' 88' ' ' VAL . 15.7 p -51.49 -43.67 62.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.759 0.314 . . . . 0.0 110.839 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.43 -22.22 64.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.332 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.55 ' O ' HD12 ' A' ' 90' ' ' LEU . 11.0 mp -95.99 -31.0 13.29 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.904 0.383 . . . . 0.0 111.127 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.655 ' CG2' HG21 ' A' ' 49' ' ' VAL . 59.4 t -78.95 -35.69 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.299 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.894 HG23 ' O ' ' A' ' 84' ' ' CYS . 62.1 t -58.73 -50.9 85.49 Favored Pre-proline 0 C--N 1.33 -0.26 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.913 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 14.0 Cg_exo -68.9 -44.57 2.62 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.444 2.096 . . . . 0.0 111.6 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.707 HD11 ' HE2' ' A' ' 82' ' ' PHE . 13.6 mt -54.62 -29.41 51.85 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.663 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.936 HG23 ' CD1' ' A' ' 98' ' ' LEU . 51.6 mt -78.07 -50.01 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.6 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.91 -4.05 26.06 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.931 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.14 -9.16 18.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.626 0.251 . . . . 0.0 111.581 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -64.8 -16.21 62.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.721 0.296 . . . . 0.0 111.374 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.83 -143.97 16.9 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.635 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -73.7 -10.15 59.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.584 0.231 . . . . 0.0 111.544 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -138.19 155.7 48.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.69 0.281 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.936 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -139.64 97.46 3.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.136 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -96.12 118.71 33.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.019 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.856 HD23 HD22 ' A' ' 98' ' ' LEU . 1.6 pp -150.04 163.92 36.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.142 0.496 . . . . 0.0 112.064 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.628 ' CG1' HD13 ' A' ' 22' ' ' LEU . 38.2 t -111.97 109.12 27.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.914 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.661 HG23 ' CD1' ' A' ' 100' ' ' LEU . 2.6 pp -100.67 168.65 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.999 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.578 ' HB3' HD11 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -142.46 129.72 21.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.545 179.321 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.419 ' NE ' ' CG ' ' A' ' 66' ' ' LYS . 10.2 ptt85 -139.7 124.88 18.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.919 0.39 . . . . 0.0 111.616 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.469 ' N ' HG12 ' A' ' 20' ' ' VAL . 2.0 p-10 -69.13 133.94 89.6 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.662 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo . . . . . 0 C--O 1.249 1.065 0 C-N-CA 122.457 2.105 . . . . 0.0 112.337 179.939 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.812 0.339 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -112.35 122.2 47.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.408 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.122 HD21 HD12 ' A' ' 72' ' ' LEU . 14.2 mt -60.81 141.94 56.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.601 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.537 ' CD2' HD11 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -153.24 120.92 5.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.146 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.705 ' HD2' HG22 ' A' ' 101' ' ' VAL . 2.6 tptp -69.88 124.43 24.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.903 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.649 HG11 ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -126.4 139.92 50.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.039 0.447 . . . . 0.0 111.121 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 95.0 m -134.34 117.51 16.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.198 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.733 HD21 HD11 ' A' ' 65' ' ' LEU . 2.6 mp -116.03 167.65 10.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.079 0.466 . . . . 0.0 111.572 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' A' ' 28' ' ' TYR . 2.9 m-85 -135.37 121.92 20.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.175 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -95.11 163.65 13.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.946 0.403 . . . . 0.0 111.262 -179.526 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.99 139.47 41.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.26 85.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.921 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.64 -23.58 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.831 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.91 156.7 27.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.932 0.396 . . . . 0.0 110.961 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -87.71 -10.54 50.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.434 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -155.35 -172.24 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.857 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -97.87 32.15 2.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.238 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.427 ' HA3' ' H ' ' A' ' 60' ' ' GLY . . . 96.93 -5.2 63.56 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.286 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.52 ' HD2' HG13 ' A' ' 51' ' ' VAL . 48.6 p90 -171.31 149.58 2.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.047 0.424 . . . . 0.0 111.739 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.9 m -104.5 133.83 48.71 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.433 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.659 ' HB ' HG12 ' A' ' 49' ' ' VAL . 33.1 m -93.46 170.8 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.751 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.744 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -139.38 162.31 35.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.148 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -83.25 130.31 35.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.709 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.516 ' HA3' ' CZ ' ' A' ' 50' ' ' TYR . . . -103.25 107.52 3.07 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.793 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 mp -94.67 -26.74 16.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.055 0.455 . . . . 0.0 111.03 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 tp -84.51 -6.09 59.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.714 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 47' ' ' LYS . 10.2 mt-10 -152.69 29.78 0.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.922 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 26.99 91.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.149 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.42 ' O ' ' HA3' ' A' ' 43' ' ' GLY . . . 157.9 160.4 10.2 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.273 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.744 HG13 ' O ' ' A' ' 41' ' ' ALA . 40.1 t -101.39 133.48 44.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.853 0.359 . . . . 0.0 111.361 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.516 ' CZ ' ' HA3' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -125.42 -177.46 3.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.454 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.867 HG11 HD11 ' A' ' 54' ' ' ILE . 37.2 t -89.62 162.2 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.649 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.516 ' N ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -144.9 -42.12 0.24 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.011 0.434 . . . . 0.0 110.833 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 34.3 m120 -123.43 130.49 52.78 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.578 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.867 HD11 HG11 ' A' ' 51' ' ' VAL . 1.1 mt -136.49 117.78 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.746 0.308 . . . . 0.0 111.331 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.13 110.54 5.28 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.592 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.445 ' HA ' ' HB2' ' A' ' 61' ' ' ASP . 16.5 Cg_exo -68.11 55.06 0.72 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.589 2.193 . . . . 0.0 112.777 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -173.82 -43.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.927 0.394 . . . . 0.0 111.255 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.9 -152.47 0.96 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.705 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.733 ' O ' HD23 ' A' ' 27' ' ' LEU . 28.7 Cg_exo -62.14 -35.26 76.3 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.801 2.334 . . . . 0.0 112.079 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.522 ' O ' HD12 ' A' ' 65' ' ' LEU . . . -56.5 -49.92 66.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.716 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 6.2 t70 -73.67 -36.18 65.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.061 0.457 . . . . 0.0 110.201 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 33.1 mt -60.83 -29.6 69.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.974 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.92 -51.42 3.8 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.419 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.38 47.71 0.85 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.724 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.733 HD11 HD21 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -106.41 165.63 11.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.079 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 68' ' ' TYR . 12.2 mtmm -132.13 159.57 71.6 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.665 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.453 ' O ' ' CG ' ' A' ' 68' ' ' TYR . 36.7 Cg_endo -65.55 64.43 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.487 2.125 . . . . 0.0 112.254 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.453 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 6.2 m-85 -174.12 -30.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.396 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.709 ' HB2' HD13 ' A' ' 102' ' ' ILE . 4.4 p30 -50.25 96.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.453 0.644 . . . . 0.0 110.799 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.605 ' O ' HD23 ' A' ' 72' ' ' LEU . 27.6 ttp180 -74.3 104.16 4.96 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.537 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.05 HD23 HD13 ' A' ' 100' ' ' LEU . 1.1 mt -54.42 108.42 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.027 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.122 HD12 HD21 ' A' ' 22' ' ' LEU . 5.2 mt -82.9 -66.02 0.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.132 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.32 132.19 53.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.892 0.377 . . . . 0.0 111.163 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.518 HG23 ' OG1' ' A' ' 79' ' ' THR . 29.7 t -104.58 103.85 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.8 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 75.31 -58.61 0.56 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.138 0.494 . . . . 0.0 110.565 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -167.67 -13.76 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.286 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.63 141.04 15.05 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.741 0.305 . . . . 0.0 111.309 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -70.2 128.13 35.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.519 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.518 ' OG1' HG23 ' A' ' 74' ' ' VAL . 41.6 p -143.76 25.93 1.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.172 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.731 ' HE ' HD13 ' A' ' 72' ' ' LEU . 6.9 mtt180 -73.32 -52.78 12.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.59 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -93.74 25.33 3.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.108 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.699 ' CE2' HD11 ' A' ' 90' ' ' LEU . 2.2 m-85 -81.58 166.37 20.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.897 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.526 ' C ' HG21 ' A' ' 49' ' ' VAL . 15.6 t70 -106.03 161.16 14.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.549 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.863 ' O ' HG23 ' A' ' 88' ' ' VAL . 1.9 t -51.69 -42.2 62.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.645 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 23.0 m -62.74 -22.91 66.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.213 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.574 ' O ' HD12 ' A' ' 90' ' ' LEU . 7.9 mp -93.0 -32.93 14.33 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.012 0.434 . . . . 0.0 110.854 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.6 HG12 ' CD1' ' A' ' 91' ' ' ILE . 58.8 t -77.6 -36.03 22.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.0 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 84' ' ' CYS . 77.8 t -54.73 -52.41 70.54 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.732 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 50.3 Cg_endo -68.63 -45.96 2.1 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.233 1.956 . . . . 0.0 111.788 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.699 HD11 ' CE2' ' A' ' 82' ' ' PHE . 27.0 mt -55.48 -32.06 62.53 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.607 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.912 ' HA ' HD11 ' A' ' 98' ' ' LEU . 60.7 mt -75.17 -44.86 42.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.599 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.11 -3.7 43.66 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.949 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -85.03 -15.82 42.84 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.742 0.306 . . . . 0.0 111.723 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.407 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 2.0 m -65.02 -25.01 67.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.982 0.42 . . . . 0.0 111.269 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.92 -61.48 3.74 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.189 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 29' ' ' LYS . 24.3 p30 -163.12 16.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.84 105.69 2.21 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.912 HD11 ' HA ' ' A' ' 91' ' ' ILE . 0.9 OUTLIER -107.39 107.52 18.46 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.941 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.0 117.93 35.46 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 1.05 HD13 HD23 ' A' ' 71' ' ' LEU . 1.3 pp -150.49 155.96 40.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.262 0.553 . . . . 0.0 112.373 -178.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.871 HG12 HD22 ' A' ' 22' ' ' LEU . 18.5 t -105.44 109.24 27.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.618 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.862 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.8 pp -100.96 169.45 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.189 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.9 102.63 5.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.605 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.426 ' HB3' ' HA ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -111.56 124.3 52.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.073 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -73.1 148.09 88.66 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.675 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo . . . . . 0 C--O 1.248 1.022 0 C-N-CA 122.606 2.204 . . . . 0.0 112.42 -179.948 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 103' ' ' SER . 18.0 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.851 0.358 . . . . 0.0 111.432 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.58 122.21 28.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.734 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.84 HD22 HG12 ' A' ' 101' ' ' VAL . 14.7 mt -60.95 150.68 32.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.442 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.512 ' HB2' HD11 ' A' ' 102' ' ' ILE . 17.1 m-70 -156.67 110.56 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.986 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -71.4 113.56 8.56 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.792 HG11 ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -119.53 140.19 44.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.202 0.525 . . . . 0.0 112.099 -178.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.8 m -134.33 106.64 7.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.51 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.078 HD11 HD21 ' A' ' 65' ' ' LEU . 23.5 mt -102.79 173.54 6.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.222 0.534 . . . . 0.0 112.143 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 96' ' ' ASN . 8.5 m-85 -134.69 121.82 21.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.245 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.463 ' N ' ' CE1' ' A' ' 36' ' ' PHE . 5.2 tttt -104.26 152.05 22.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.928 0.394 . . . . 0.0 111.346 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -119.62 158.74 25.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.651 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.24 -27.94 64.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.173 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.13 -24.74 51.12 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.73 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 2.9 mmt -81.41 132.7 35.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.907 0.384 . . . . 0.0 111.043 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -78.67 -10.78 59.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.265 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -155.9 -168.82 2.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.639 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.463 ' CE1' ' N ' ' A' ' 29' ' ' LYS . 5.0 m-85 -97.02 29.72 2.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.334 . . . . 0.0 111.178 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.09 24.57 68.61 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.955 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.522 ' CD2' HD13 ' A' ' 65' ' ' LEU . 1.4 p90 -174.44 117.3 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.047 0.451 . . . . 0.0 111.427 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -88.9 146.44 24.93 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.872 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.721 ' HB ' HG12 ' A' ' 49' ' ' VAL . 34.4 m -108.62 171.07 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.656 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.693 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -137.81 156.89 47.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.14 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -72.38 144.34 48.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.693 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.438 ' HA3' ' CZ ' ' A' ' 50' ' ' TYR . . . -119.93 108.26 1.44 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.612 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 pp -94.14 -27.28 16.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.976 0.417 . . . . 0.0 110.985 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.4 -3.33 58.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.371 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 47' ' ' LYS . 7.2 mt-10 -152.97 27.6 0.53 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.675 -0.238 . . . . 0.0 110.981 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER 27.09 91.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.251 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.9 -154.37 25.3 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.479 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.721 HG12 ' HB ' ' A' ' 40' ' ' VAL . 21.3 t -142.11 139.31 30.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.36 . . . . 0.0 110.942 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.438 ' CZ ' ' HA3' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -126.68 177.73 6.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.509 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.502 HG11 HD11 ' A' ' 54' ' ' ILE . 61.4 t -86.46 123.29 39.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.182 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -88.13 -29.34 20.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.782 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -168.33 149.99 5.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.246 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.614 ' CD1' HD12 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -129.26 132.73 66.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.184 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -65.56 125.22 89.23 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.54 140.38 83.24 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.388 2.059 . . . . 0.0 112.547 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 40.8 32.34 0.15 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.991 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -101.66 -167.96 27.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.955 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.572 ' O ' HD22 ' A' ' 27' ' ' LEU . 18.0 Cg_endo -58.57 -34.27 98.72 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.313 2.009 . . . . 0.0 111.721 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.28 -44.67 42.34 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.427 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -71.98 -32.76 67.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.99 0.424 . . . . 0.0 109.942 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.1 mt -72.11 -29.24 63.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.443 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.37 -57.93 5.32 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.326 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.49 -20.83 1.69 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.449 -0.881 . . . . 0.0 113.091 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.078 HD21 HD11 ' A' ' 27' ' ' LEU . 3.1 pp -73.83 134.04 43.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.944 0.402 . . . . 0.0 111.0 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.488 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 15.1 mttt -120.74 167.63 12.51 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.607 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.677 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 99.9 Cg_exo -43.24 145.98 1.22 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.539 2.159 . . . . 0.0 112.606 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.677 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 4.3 m-85 83.21 -10.01 1.03 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.665 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.537 ' CG ' HD13 ' A' ' 102' ' ' ILE . 4.3 m-20 -54.61 87.06 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.972 0.415 . . . . 0.0 110.817 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.435 ' HD3' ' CE1' ' A' ' 50' ' ' TYR . 31.2 ttp180 -66.93 97.51 0.49 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.7 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.931 ' HA ' HG22 ' A' ' 102' ' ' ILE . 2.9 mt -55.58 107.39 0.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.127 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.788 HD12 HD21 ' A' ' 22' ' ' LEU . 23.8 mt -84.25 -65.92 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.121 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -122.57 140.97 52.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.027 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.555 HG12 ' OD1' ' A' ' 75' ' ' ASN . 41.3 t -124.69 112.63 32.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.055 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.555 ' OD1' HG12 ' A' ' 74' ' ' VAL . 5.1 m120 64.64 33.33 10.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.934 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.463 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 2.6 t-80 86.72 -14.89 0.47 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.611 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 36.7 t -83.27 138.65 18.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.828 0.346 . . . . 0.0 111.061 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -69.55 130.88 43.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.687 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.486 ' CG2' HD13 ' A' ' 90' ' ' LEU . 30.3 p -144.24 27.97 1.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.061 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.599 ' HG2' HD22 ' A' ' 72' ' ' LEU . 30.5 mtp180 -83.14 -42.5 17.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.627 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.11 10.31 27.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.041 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.617 ' CE2' HD11 ' A' ' 90' ' ' LEU . 3.1 m-85 -80.28 -176.45 5.63 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.959 0.409 . . . . 0.0 110.84 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -128.5 169.3 14.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.309 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.821 ' O ' HG23 ' A' ' 88' ' ' VAL . 53.3 t -51.18 -45.58 61.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.746 0.307 . . . . 0.0 110.755 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.28 -18.45 63.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.107 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.616 HD12 ' CD2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -95.5 -37.97 10.65 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.216 0.531 . . . . 0.0 111.04 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.48 HG11 HD13 ' A' ' 71' ' ' LEU . 46.6 t -77.03 -35.46 23.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.536 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 84' ' ' CYS . 89.8 t -57.53 -51.79 79.11 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.694 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.674 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 18.3 Cg_exo -65.67 -44.38 8.35 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.248 1.966 . . . . 0.0 111.181 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.617 HD11 ' CE2' ' A' ' 82' ' ' PHE . 52.7 mt -54.57 -32.08 57.88 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.04 0.447 . . . . 0.0 110.526 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.921 HG23 ' CD1' ' A' ' 98' ' ' LEU . 61.9 mt -73.29 -49.65 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.55 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.17 -2.69 32.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.796 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -93.32 -13.2 28.46 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.423 ' OG ' ' HG ' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -63.8 -27.63 69.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.05 0.453 . . . . 0.0 110.746 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.8 -53.3 0.82 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.865 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 6.7 m120 -165.6 -34.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.956 0.408 . . . . 0.0 110.403 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -104.71 108.7 20.3 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.248 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.921 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -101.93 97.35 7.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.708 -179.243 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -100.45 118.32 36.42 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.862 HD22 HD22 ' A' ' 71' ' ' LEU . 1.3 pp -148.1 159.51 43.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.226 0.536 . . . . 0.0 112.239 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.84 HG12 HD22 ' A' ' 22' ' ' LEU . 16.3 t -111.14 109.14 27.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.014 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.931 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.5 pp -104.19 169.6 2.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.38 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.714 ' OG ' HD21 ' A' ' 72' ' ' LEU . 9.0 p -143.19 125.4 15.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.332 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -144.99 137.16 25.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.986 0.422 . . . . 0.0 111.421 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -62.57 132.21 94.37 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.743 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 122.422 2.082 . . . . 0.0 112.284 -179.959 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 103' ' ' SER . 32.9 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.86 0.362 . . . . 0.0 111.531 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -116.0 122.39 45.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.647 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.83 HD22 HG12 ' A' ' 101' ' ' VAL . 15.4 mt -62.27 137.64 58.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.479 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.864 ' CE1' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -149.04 127.42 12.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.273 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -71.53 133.69 45.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.622 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.864 HG22 ' CE1' ' A' ' 23' ' ' HIS . 0.2 OUTLIER -135.87 147.72 28.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.949 0.404 . . . . 0.0 111.327 -179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.509 HG23 ' OD1' ' A' ' 99' ' ' ASP . 94.7 m -134.4 118.4 17.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.135 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.792 HD21 HD12 ' A' ' 65' ' ' LEU . 3.8 mt -110.11 168.77 9.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.959 0.409 . . . . 0.0 111.678 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -134.87 132.66 38.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.573 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -102.02 165.11 11.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.943 0.402 . . . . 0.0 111.254 -179.683 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.485 ' HB2' ' HE1' ' A' ' 33' ' ' MET . 13.3 t0 -144.14 141.68 30.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.687 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -55.87 -23.11 29.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.299 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.5 -13.11 56.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.996 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.485 ' HE1' ' HB2' ' A' ' 30' ' ' ASP . 0.1 OUTLIER -80.28 155.15 27.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.916 0.389 . . . . 0.0 111.197 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -100.99 -10.64 20.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.215 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -155.08 -174.62 5.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.588 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.684 ' CD2' HD12 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -97.46 32.55 2.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.27 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.99 1.08 90.2 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.009 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.469 ' O ' ' CD1' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -172.14 135.29 0.77 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.004 0.43 . . . . 0.0 111.43 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.9 m -96.32 148.23 22.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.51 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.527 ' HB ' HG12 ' A' ' 49' ' ' VAL . 33.9 m -104.15 169.07 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.674 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.757 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -141.42 167.01 23.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.999 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -80.58 153.28 28.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.839 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.01 115.48 2.45 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.505 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.547 ' O ' HD23 ' A' ' 44' ' ' LEU . 7.3 tt -94.31 -28.65 15.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.015 0.436 . . . . 0.0 111.148 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 mp -83.9 -55.9 3.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.781 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.4 mt-10 -89.78 17.11 6.95 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.431 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER 30.03 88.46 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.883 0.373 . . . . 0.0 111.934 -179.763 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.22 -141.99 7.26 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.515 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.757 HG13 ' O ' ' A' ' 41' ' ' ALA . 39.5 t -145.47 138.24 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.916 0.389 . . . . 0.0 110.988 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -131.1 179.44 6.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.416 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.461 HG11 HD11 ' A' ' 54' ' ' ILE . 47.9 t -87.65 123.6 40.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.017 0.437 . . . . 0.0 111.287 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.525 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -88.74 -31.33 18.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.225 -179.815 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -157.23 154.96 30.02 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.401 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.461 HD11 HG11 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -135.45 123.85 38.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.102 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -65.6 122.8 82.34 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.825 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.23 152.41 31.46 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.397 2.065 . . . . 0.0 112.439 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 38.65 33.94 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.007 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -118.79 -162.47 12.12 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.164 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.466 ' C ' HD23 ' A' ' 27' ' ' LEU . 71.8 Cg_exo -49.11 -54.33 5.61 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.5 2.133 . . . . 0.0 112.245 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.764 ' HA2' HD12 ' A' ' 65' ' ' LEU . . . -63.94 -33.15 86.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.717 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -73.71 -32.76 64.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.928 0.394 . . . . 0.0 110.409 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -74.1 -29.8 62.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.997 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -86.83 -34.83 10.67 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.463 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.2 32.83 3.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.518 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.792 HD12 HD21 ' A' ' 27' ' ' LEU . 11.4 mt -81.59 138.54 35.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.775 0.321 . . . . 0.0 111.042 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -126.32 160.58 56.96 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.715 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.436 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 78.1 Cg_exo -50.45 142.13 31.05 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.638 2.226 . . . . 0.0 112.332 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.436 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 18.4 m-85 85.44 -3.86 0.86 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.33 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.607 ' OD2' HD23 ' A' ' 65' ' ' LEU . 4.7 m-20 -53.19 89.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.056 0.455 . . . . 0.0 110.806 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 68' ' ' TYR . 69.0 ttt180 -76.99 111.64 12.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.999 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.858 ' HA ' HG22 ' A' ' 102' ' ' ILE . 0.9 OUTLIER -71.26 107.79 4.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.734 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.77 HD12 HD21 ' A' ' 22' ' ' LEU . 1.7 mt -83.48 -19.5 35.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.963 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.06 152.68 1.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.011 0.434 . . . . 0.0 111.528 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.483 HG12 ' OD1' ' A' ' 75' ' ' ASN . 40.2 t -124.0 112.6 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.611 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.483 ' OD1' HG12 ' A' ' 74' ' ' VAL . 8.3 m120 76.25 -58.19 0.54 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.107 0.48 . . . . 0.0 110.569 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.411 ' H ' ' H ' ' A' ' 77' ' ' VAL . 1.6 m-70 -167.06 -14.22 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.134 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.411 ' H ' ' H ' ' A' ' 76' ' ' HIS . 21.6 t -84.78 136.28 23.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-O 120.752 0.311 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -69.65 143.2 53.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.674 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.441 ' HA ' ' CG ' ' A' ' 82' ' ' PHE . 64.2 p -146.07 18.39 1.41 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.657 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.533 ' HG2' HD13 ' A' ' 72' ' ' LEU . 11.3 mtm180 -65.77 -51.66 57.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.895 0.379 . . . . 0.0 110.425 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -93.75 20.96 6.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.227 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.602 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.3 m-30 -81.32 169.18 17.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.797 0.332 . . . . 0.0 110.823 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 87' ' ' VAL . 2.4 t70 -109.76 160.33 16.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.668 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 24.8 p -51.87 -31.44 28.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.906 0.384 . . . . 0.0 110.713 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -21.67 62.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.196 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.618 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 5.7 mp -98.38 -30.23 12.69 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.084 0.469 . . . . 0.0 110.819 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.663 ' CG1' HD13 ' A' ' 71' ' ' LEU . 39.8 t -79.74 -35.98 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.451 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.77 HG12 ' HD3' ' A' ' 89' ' ' PRO . 5.0 p -64.22 -39.82 46.79 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.667 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.77 ' HD3' HG12 ' A' ' 88' ' ' VAL . 73.4 Cg_endo -74.37 -46.73 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.662 1.575 . . . . 0.0 111.227 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.602 HD11 ' HE2' ' A' ' 82' ' ' PHE . 81.5 mt -56.58 -28.35 60.04 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.108 0.48 . . . . 0.0 110.263 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.582 ' HA ' HD11 ' A' ' 98' ' ' LEU . 33.2 mt -75.92 -49.15 26.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.631 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.78 -2.56 47.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.064 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.64 -12.54 17.64 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.427 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -65.38 -14.3 60.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.698 0.285 . . . . 0.0 111.419 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.67 -145.15 17.77 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.609 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -73.56 -15.91 61.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.581 0.229 . . . . 0.0 111.393 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -125.98 139.68 53.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.798 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.684 HD12 ' CD2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -130.61 97.14 4.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.123 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.509 ' OD1' HG23 ' A' ' 26' ' ' THR . 2.5 m-20 -98.34 118.6 35.36 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.788 HD22 ' CD2' ' A' ' 71' ' ' LEU . 2.7 pp -146.86 158.79 44.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.224 0.535 . . . . 0.0 112.24 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.83 HG12 HD22 ' A' ' 22' ' ' LEU . 18.5 t -113.76 109.66 29.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.104 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.858 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.0 pp -108.78 169.56 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.372 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.415 ' N ' HD12 ' A' ' 102' ' ' ILE . 0.3 OUTLIER -130.54 127.84 39.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.859 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.03 141.43 34.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.934 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -71.42 135.78 84.06 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.766 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 C--O 1.248 1.003 0 C-N-CA 122.392 2.061 . . . . 0.0 112.252 -179.994 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.464 0.232 0 CA-C-O 120.927 0.394 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -119.16 122.54 42.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.52 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.762 HD22 HG12 ' A' ' 101' ' ' VAL . 13.3 mt -60.72 135.46 57.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.499 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.533 ' HB2' HD11 ' A' ' 102' ' ' ILE . 40.2 m-70 -143.83 112.05 6.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.726 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 111.31 7.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.191 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.714 HG11 ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -117.66 139.55 44.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.122 0.487 . . . . 0.0 111.553 -179.185 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.5 m -133.02 106.74 7.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.97 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.917 HD21 HD21 ' A' ' 65' ' ' LEU . 2.4 mp -99.16 174.0 6.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.961 0.41 . . . . 0.0 111.902 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -131.33 140.16 49.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.332 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -109.22 165.21 11.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.952 0.406 . . . . 0.0 111.422 -179.559 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.65 137.22 53.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.681 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -59.25 85.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.138 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.06 14.36 2.75 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.163 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -81.68 166.88 19.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.89 0.345 . . . . 0.0 110.807 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -92.52 -24.29 18.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.152 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -157.79 -167.89 2.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.755 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -103.6 31.05 4.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.892 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.45 0.06 80.06 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.085 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.439 ' HB2' HG12 ' A' ' 54' ' ' ILE . 18.4 p90 -172.41 153.74 3.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.985 0.392 . . . . 0.0 111.461 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.9 p -119.03 148.01 43.48 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.552 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.725 HG11 ' CD1' ' A' ' 71' ' ' LEU . 30.5 m -113.35 157.6 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.474 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.505 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -114.14 177.54 4.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.208 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.79 160.86 21.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.27 115.29 2.49 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.389 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.545 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -94.61 -35.23 12.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.11 0.481 . . . . 0.0 111.191 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 tp -84.26 -53.78 5.25 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.055 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.4 mm-40 -90.53 16.37 9.09 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.558 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 46' ' ' GLU . 3.5 mmtt 29.05 82.91 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 174.97 -150.87 11.52 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.492 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 82' ' ' PHE . 88.8 t -138.38 139.83 40.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.824 0.345 . . . . 0.0 110.914 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -139.51 162.72 34.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.605 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.634 ' HA ' HG12 ' A' ' 40' ' ' VAL . 50.1 t -62.36 162.0 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.592 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.529 ' N ' HG12 ' A' ' 51' ' ' VAL . 16.8 pttt -147.0 -35.36 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 0.0 111.579 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.416 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 15.6 m-80 -144.49 139.03 28.02 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.981 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.646 HD11 HD12 ' A' ' 65' ' ' LEU . 1.0 OUTLIER -132.95 133.97 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.0 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.431 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -65.89 142.4 98.06 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.913 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 55' ' ' ARG . 34.7 Cg_exo -57.66 127.19 24.35 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.544 2.162 . . . . 0.0 112.531 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 43.28 30.79 0.33 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.875 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.92 -159.48 32.52 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.935 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -51.87 -55.92 3.44 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.312 2.008 . . . . 0.0 111.876 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.404 ' HA2' ' CD2' ' A' ' 27' ' ' LEU . . . -56.93 -38.66 86.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.671 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -73.37 -32.63 64.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.967 0.413 . . . . 0.0 110.183 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.6 mt -77.32 -30.39 54.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.842 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.28 -56.67 6.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.426 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.97 33.23 0.93 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.656 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.917 HD21 HD21 ' A' ' 27' ' ' LEU . 1.7 pp -118.5 132.06 56.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 110.905 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.469 ' CB ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -117.87 169.51 7.53 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.783 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 1.6 Cg_endo -44.63 146.14 2.35 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.646 2.231 . . . . 0.0 112.239 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.486 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 8.5 m-85 91.14 -21.13 0.11 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.095 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.684 ' CG ' HD13 ' A' ' 102' ' ' ILE . 7.2 m-20 -53.75 85.49 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.166 0.508 . . . . 0.0 110.669 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -68.49 105.91 2.37 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.195 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.725 ' CD1' HG11 ' A' ' 40' ' ' VAL . 1.9 mp -63.07 107.9 1.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.758 HD22 ' CG ' ' A' ' 80' ' ' ARG . 10.0 mt -83.38 -65.85 0.96 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.17 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -119.38 126.82 52.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.157 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.611 HG23 ' OG1' ' A' ' 79' ' ' THR . 43.1 t -109.62 107.1 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.712 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 74.65 -58.59 0.58 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.139 0.495 . . . . 0.0 110.537 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -167.22 -18.02 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.951 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 79' ' ' THR . 21.5 t -85.36 125.27 40.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-O 120.792 0.329 . . . . 0.0 111.129 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.65 84.36 0.45 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.649 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.611 ' OG1' HG23 ' A' ' 74' ' ' VAL . 17.7 p -94.62 43.94 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.17 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.758 ' CG ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -80.99 -47.02 14.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.646 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -92.93 21.29 5.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.055 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.591 ' HE2' HD11 ' A' ' 90' ' ' LEU . 3.2 m-85 -81.69 170.82 15.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.702 0.287 . . . . 0.0 110.954 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.423 ' C ' HG21 ' A' ' 49' ' ' VAL . 2.6 m-20 -106.26 160.26 15.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.404 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.885 ' O ' HG23 ' A' ' 88' ' ' VAL . 7.4 p -51.76 -42.12 62.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 110.694 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.7 m -63.44 -23.28 67.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.236 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.471 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -93.63 -31.13 14.6 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.906 0.384 . . . . 0.0 110.95 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.739 HG12 ' CD1' ' A' ' 91' ' ' ILE . 60.7 t -79.62 -35.95 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.359 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 84' ' ' CYS . 95.1 t -57.14 -50.84 85.86 Favored Pre-proline 0 C--N 1.331 -0.219 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.938 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.639 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 12.0 Cg_exo -70.43 -47.14 0.77 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.509 2.14 . . . . 0.0 111.512 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.591 HD11 ' HE2' ' A' ' 82' ' ' PHE . 44.8 mt -53.92 -30.75 47.62 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.517 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.942 HG23 ' CD1' ' A' ' 98' ' ' LEU . 63.9 mt -78.28 -42.04 26.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.505 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.41 -4.69 40.94 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.454 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 10.3 pt-20 -107.38 -3.44 19.58 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.432 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 6.9 t -64.38 -15.99 61.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.801 0.334 . . . . 0.0 111.411 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.5 -144.61 17.41 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.592 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.39 -10.67 59.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.55 0.214 . . . . 0.0 111.425 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -140.76 157.29 45.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.813 0.34 . . . . 0.0 110.97 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.942 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -138.33 97.2 3.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.033 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.14 118.23 31.25 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.825 HD23 HD22 ' A' ' 98' ' ' LEU . 1.1 pp -148.37 164.03 35.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.257 0.551 . . . . 0.0 112.025 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.762 HG12 HD22 ' A' ' 22' ' ' LEU . 48.4 t -115.79 108.93 26.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.103 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.684 HD13 ' CG ' ' A' ' 69' ' ' ASP . 2.5 pp -101.82 169.27 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.409 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.17 122.18 15.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.676 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.404 ' CG ' ' HB2' ' A' ' 68' ' ' TYR . 7.6 tmm_? -133.48 138.66 46.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.153 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -80.93 154.5 72.91 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.7 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo . . . . . 0 C--O 1.25 1.092 0 C-N-CA 122.497 2.131 . . . . 0.0 112.304 179.94 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.528 HG21 ' HB3' ' A' ' 103' ' ' SER . 11.4 m . . . . . 0 CA--C 1.527 0.074 0 CA-C-O 120.814 0.34 . . . . 0.0 111.748 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -123.45 122.38 38.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.597 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.939 HD21 HD12 ' A' ' 72' ' ' LEU . 15.5 mt -62.63 138.99 58.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.712 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.611 ' HB2' HD11 ' A' ' 102' ' ' ILE . 11.0 m-70 -145.09 120.82 10.52 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.677 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.13 113.2 11.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.465 HG21 HG12 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -117.42 139.84 42.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.144 0.497 . . . . 0.0 111.849 -179.041 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.7 m -134.03 106.43 7.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.955 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.053 HD21 HD21 ' A' ' 65' ' ' LEU . 2.3 mp -99.91 168.41 9.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.919 0.39 . . . . 0.0 111.483 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 96' ' ' ASN . 4.9 m-85 -124.92 143.95 50.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.748 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -104.83 159.45 15.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.113 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -129.97 140.97 50.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.92 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.7 p -57.97 -28.73 64.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.064 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.47 -22.53 46.99 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.683 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 18.0 mmm -81.0 162.44 23.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.369 . . . . 0.0 110.959 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.84 -10.56 15.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.325 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.63 -166.97 2.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.798 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.51 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 7.5 m-85 -97.46 32.75 2.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.201 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 48.39 40.63 23.44 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.209 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.902 ' HB2' HD13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -174.65 116.37 0.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.076 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.43 155.19 19.37 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 121.112 0.482 . . . . 0.0 112.155 -177.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.769 HG11 HD11 ' A' ' 71' ' ' LEU . 34.1 m -116.1 169.86 6.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.07 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.856 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . . . -129.51 176.74 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.87 0.367 . . . . 0.0 111.358 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.8 140.76 30.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.764 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.71 103.57 1.65 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.521 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 mp -94.17 -31.54 14.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.184 0.516 . . . . 0.0 110.828 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.498 HD12 ' HG3' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -84.28 -3.91 58.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.506 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.498 ' HG3' HD12 ' A' ' 45' ' ' LEU . 11.2 mt-10 -153.07 27.01 0.53 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.098 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 26.99 95.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 159.99 -155.46 26.58 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.435 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.744 HG13 ' O ' ' A' ' 41' ' ' ALA . 80.5 t -141.76 138.01 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.328 . . . . 0.0 111.042 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.462 ' CD1' ' HG3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -134.43 165.09 25.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.41 179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.08 HG11 HD11 ' A' ' 54' ' ' ILE . 3.8 t -63.84 162.76 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.625 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.856 ' HE2' ' HB2' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -145.4 -36.97 0.28 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.028 0.442 . . . . 0.0 111.325 -179.403 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.557 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 2.6 m120 -140.24 145.21 37.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.326 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 1.08 HD11 HG11 ' A' ' 51' ' ' VAL . 5.0 mm -134.92 119.07 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.907 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.56 131.98 94.93 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.714 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.621 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 67.1 Cg_endo -74.0 121.82 7.22 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.491 2.127 . . . . 0.0 112.443 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 87.77 -20.8 0.19 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.73 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.16 -170.74 30.87 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.415 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.672 ' HA ' HD12 ' A' ' 62' ' ' LEU . 55.1 Cg_exo -51.93 -25.77 22.82 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.529 2.153 . . . . 0.0 112.247 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.406 ' HA3' HG23 ' A' ' 54' ' ' ILE . . . -65.47 -45.83 88.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.367 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -73.55 -33.03 64.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.947 0.403 . . . . 0.0 110.3 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.672 HD12 ' HA ' ' A' ' 59' ' ' PRO . 57.3 mt -62.07 -37.97 87.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.821 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.16 -52.05 5.45 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.38 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.35 44.99 1.91 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.611 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.053 HD21 HD21 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -111.56 126.21 54.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.928 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.8 mttp -75.12 164.69 59.58 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.107 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.62 64.78 3.83 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.767 2.311 . . . . 0.0 112.366 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.463 ' HB3' ' HG3' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -176.32 -25.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.527 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.727 ' CG ' HD13 ' A' ' 102' ' ' ILE . 71.1 m-20 -39.56 90.84 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.455 0.645 . . . . 0.0 111.852 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.574 ' O ' HD23 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -67.63 99.3 0.77 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.644 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.005 HD23 HD13 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -56.72 111.68 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.527 -179.518 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.939 HD12 HD21 ' A' ' 22' ' ' LEU . 6.5 mt -82.97 -44.82 14.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.693 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.6 142.37 32.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.762 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.599 HG23 ' OG1' ' A' ' 79' ' ' THR . 47.8 t -129.85 152.04 36.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.88 0.371 . . . . 0.0 111.492 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.0 m120 40.21 31.85 0.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.98 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 76.01 42.98 0.18 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.845 0.355 . . . . 0.0 110.898 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 72.8 t -152.15 152.95 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.05 129.06 38.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.73 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.599 ' OG1' HG23 ' A' ' 74' ' ' VAL . 66.8 p -144.47 28.14 1.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.017 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.694 ' CG ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -83.74 -44.95 13.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.736 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -92.28 15.77 13.03 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.34 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.555 ' CD2' HG22 ' A' ' 79' ' ' THR . 5.5 m-30 -81.85 167.53 18.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.872 0.368 . . . . 0.0 110.903 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.534 ' O ' HG23 ' A' ' 87' ' ' VAL . 0.9 OUTLIER -106.81 162.05 14.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.455 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.893 ' O ' HG23 ' A' ' 88' ' ' VAL . 22.9 p -51.8 -38.64 56.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.762 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 16.1 p -65.89 -24.6 66.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.4 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.727 ' O ' HD12 ' A' ' 90' ' ' LEU . 0.1 OUTLIER -93.4 -29.2 15.71 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.012 0.434 . . . . 0.0 110.913 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.661 HG21 ' HB ' ' A' ' 49' ' ' VAL . 45.0 t -78.0 -35.57 20.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.311 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 84' ' ' CYS . 94.1 t -58.79 -51.16 83.82 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.791 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.649 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 17.0 Cg_exo -67.11 -44.54 4.94 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.555 2.17 . . . . 0.0 111.428 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 86' ' ' LEU . 8.0 mt -54.07 -30.99 50.39 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.072 0.463 . . . . 0.0 110.431 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.628 HG23 HD12 ' A' ' 98' ' ' LEU . 71.6 mt -79.08 -48.86 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.128 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.5 -4.16 28.78 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.485 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -103.39 8.19 38.07 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.413 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 0.9 OUTLIER -64.41 -39.43 93.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.227 0.537 . . . . 0.0 110.238 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.59 -47.28 1.11 Allowed Glycine 0 C--N 1.32 -0.36 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.009 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.426 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -166.35 -36.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.682 0.277 . . . . 0.0 111.388 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -123.49 114.47 20.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.428 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.628 HD12 HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -100.99 97.58 8.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.548 -179.256 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -95.91 118.12 31.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 1.005 HD13 HD23 ' A' ' 71' ' ' LEU . 1.1 pp -146.44 156.04 43.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.993 0.425 . . . . 0.0 111.892 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.878 HG12 HD22 ' A' ' 22' ' ' LEU . 16.5 t -106.34 109.37 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.26 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.727 HD13 ' CG ' ' A' ' 69' ' ' ASP . 2.6 pp -106.28 170.12 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.46 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.528 ' HB3' HG21 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -142.5 130.78 22.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.787 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' A' ' 69' ' ' ASP . 0.6 OUTLIER -148.03 139.73 23.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.919 0.39 . . . . 0.0 111.123 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 6.2 p30 -79.48 120.88 81.82 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.397 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 105' ' ' ASN . 20.9 Cg_exo . . . . . 0 C--O 1.248 0.999 0 C-N-CA 122.324 2.016 . . . . 0.0 112.232 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.442 HG21 ' OG ' ' A' ' 103' ' ' SER . 6.7 m . . . . . 0 C--O 1.231 0.098 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.76 122.32 38.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.324 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.917 HD21 ' CD1' ' A' ' 72' ' ' LEU . 14.0 mt -60.46 149.16 35.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.089 0.471 . . . . 0.0 111.759 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.5 117.91 3.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.193 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -70.73 131.97 44.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.903 HG11 ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -132.85 141.32 45.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 0.0 111.229 -179.683 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.1 m -134.63 109.48 8.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.237 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.767 HD21 HD11 ' A' ' 65' ' ' LEU . 8.1 mt -107.15 166.49 10.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.015 0.436 . . . . 0.0 111.726 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -121.03 147.08 46.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.491 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.14 155.1 17.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.939 0.4 . . . . 0.0 111.124 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.04 156.53 23.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.828 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.4 t -68.27 82.59 0.24 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.026 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.41 21.95 5.32 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.725 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.77 124.62 29.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 0.0 110.817 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -72.13 -10.9 60.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.343 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.33 -175.14 5.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.726 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.568 ' CD2' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -106.9 29.82 6.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.844 0.354 . . . . 0.0 111.115 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.3 7.47 72.86 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.623 -0.798 . . . . 0.0 113.114 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.484 ' HB2' HG12 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -171.6 148.69 2.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.038 0.419 . . . . 0.0 111.608 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 52' ' ' LYS . 2.4 m -117.84 144.57 45.28 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.594 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 51' ' ' VAL . 27.1 m -112.39 165.61 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.775 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.765 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . . . -129.6 161.59 30.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.051 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.4 p-10 -72.49 167.37 20.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.89 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.74 126.26 8.4 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.354 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.47 0.14 55.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.49 0.186 . . . . 0.0 111.422 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 93.0 mt -154.05 19.7 0.51 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.501 0.191 . . . . 0.0 111.355 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.463 ' O ' ' C ' ' A' ' 47' ' ' LYS . 81.8 mm-40 -155.36 22.24 0.42 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.196 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER 24.82 50.22 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.433 0.458 . . . . 0.0 112.129 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.25 -166.21 11.63 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.535 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.618 HG12 ' HB ' ' A' ' 40' ' ' VAL . 72.2 t -135.22 139.7 46.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.889 0.376 . . . . 0.0 111.219 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.51 153.99 47.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.507 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.711 ' HA ' HG12 ' A' ' 40' ' ' VAL . 51.4 t -57.07 162.21 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.616 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.765 ' HE2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -142.85 -34.13 0.44 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.876 0.369 . . . . 0.0 111.591 -179.419 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 37.2 m-80 -144.28 123.95 13.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.661 HD11 HG11 ' A' ' 51' ' ' VAL . 1.1 mt -123.57 123.25 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.268 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.95 117.36 44.84 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.411 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.418 ' HA ' ' HB2' ' A' ' 61' ' ' ASP . 58.1 Cg_endo -71.48 56.4 2.18 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.468 2.112 . . . . 0.0 112.599 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -173.04 -51.63 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.143 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.86 -170.48 0.29 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.654 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.509 ' HA ' HD12 ' A' ' 62' ' ' LEU . 50.0 Cg_exo -53.35 -31.87 58.99 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.626 2.217 . . . . 0.0 112.36 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.83 -51.58 56.14 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.575 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.418 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 7.5 t70 -73.48 -33.01 64.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.958 0.408 . . . . 0.0 110.396 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 59' ' ' PRO . 90.1 mt -59.38 -41.64 89.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.031 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.1 -50.93 6.47 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.543 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.26 42.56 0.35 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.442 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.903 ' CD2' HG11 ' A' ' 25' ' ' VAL . 19.3 mt -91.42 147.54 22.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.783 0.325 . . . . 0.0 110.845 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.23 161.88 55.01 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 50.9 Cg_exo -53.82 147.92 39.43 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.596 2.197 . . . . 0.0 112.154 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.465 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 4.8 m-85 88.62 -12.55 0.42 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.229 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.594 ' CG ' HD13 ' A' ' 102' ' ' ILE . 1.1 m-20 -52.88 85.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.93 0.395 . . . . 0.0 110.965 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.599 ' O ' HD23 ' A' ' 72' ' ' LEU . 21.2 ttm180 -74.04 95.12 2.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.462 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.973 HD23 HD13 ' A' ' 100' ' ' LEU . 1.7 mt -56.26 112.24 1.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.917 ' CD1' HD21 ' A' ' 22' ' ' LEU . 4.9 mt -81.2 -64.0 1.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.64 140.53 46.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.095 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.896 ' O ' HG12 ' A' ' 77' ' ' VAL . 24.3 t -118.6 116.16 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.002 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.461 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 0.2 OUTLIER 68.74 28.25 5.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.613 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.461 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER 85.81 -7.03 0.82 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.648 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.896 HG12 ' O ' ' A' ' 74' ' ' VAL . 4.6 p -83.97 134.61 26.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 120.818 0.342 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.4 mtt85 -70.56 118.2 13.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.95 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.692 HG23 HG13 ' A' ' 77' ' ' VAL . 30.6 p -145.47 35.94 1.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.668 ' CG ' HD22 ' A' ' 72' ' ' LEU . 1.6 ttp180 -75.87 -48.74 20.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.817 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -92.82 25.58 3.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.063 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.723 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.4 m-85 -81.75 170.08 16.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.957 0.408 . . . . 0.0 110.861 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.21 159.09 16.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.272 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.889 ' O ' HG23 ' A' ' 88' ' ' VAL . 6.5 p -51.38 -41.53 60.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 110.726 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.2 m -63.36 -24.57 67.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.164 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.615 ' O ' HD12 ' A' ' 90' ' ' LEU . 10.9 mp -91.09 -30.29 16.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.012 0.434 . . . . 0.0 110.847 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.464 HG12 ' CD1' ' A' ' 91' ' ' ILE . 65.7 t -79.3 -35.82 17.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.28 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 84' ' ' CYS . 68.0 t -55.3 -51.3 80.95 Favored Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.696 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.656 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 14.5 Cg_exo -68.33 -46.53 2.03 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.39 2.06 . . . . 0.0 111.294 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.723 HD11 ' HE2' ' A' ' 82' ' ' PHE . 15.4 mt -54.65 -29.38 52.2 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.008 0.433 . . . . 0.0 110.421 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.639 HG23 ' CD1' ' A' ' 98' ' ' LEU . 47.7 mt -73.91 -51.56 23.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.205 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.39 -2.74 36.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.884 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -92.15 -7.47 48.34 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.413 ' HB2' ' HG ' ' A' ' 98' ' ' LEU . 1.5 t -64.59 -16.51 62.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.873 0.368 . . . . 0.0 111.609 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.56 -52.68 3.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.687 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -165.98 -45.75 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.75 0.309 . . . . 0.0 110.985 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -101.04 107.22 18.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.475 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.639 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.9 OUTLIER -95.96 97.84 9.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.579 -179.428 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -101.34 118.2 36.49 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.973 HD13 HD23 ' A' ' 71' ' ' LEU . 1.3 pp -147.87 163.56 36.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.105 0.478 . . . . 0.0 112.088 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.892 HG12 HD22 ' A' ' 22' ' ' LEU . 21.7 t -114.85 109.4 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.217 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.808 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.4 pp -103.95 169.37 2.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.216 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.442 ' OG ' HG21 ' A' ' 20' ' ' VAL . 71.5 p -126.29 107.63 10.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.555 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.42 113.45 25.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.345 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.72 158.76 49.23 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.935 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 C--O 1.25 1.108 0 C-N-CA 122.578 2.185 . . . . 0.0 112.394 -179.908 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.499 ' HA ' ' N ' ' A' ' 105' ' ' ASN . 28.5 m . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 120.974 0.416 . . . . 0.0 111.493 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -139.45 122.5 16.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.91 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.825 HD22 HG12 ' A' ' 101' ' ' VAL . 11.9 mt -59.74 136.47 58.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.082 0.468 . . . . 0.0 111.667 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.568 ' CE1' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -152.47 119.07 5.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.127 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.16 130.45 42.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.68 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.568 HG13 ' CE1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -131.45 140.83 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.071 0.462 . . . . 0.0 111.343 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.9 m -134.41 106.92 7.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.944 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.016 HD11 HD11 ' A' ' 65' ' ' LEU . 2.6 mt -106.88 174.46 5.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.002 0.43 . . . . 0.0 111.543 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 96' ' ' ASN . 42.5 m-85 -123.07 165.67 16.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.693 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -128.34 120.68 27.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.852 0.358 . . . . 0.0 111.437 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.41 128.32 35.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.464 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.14 -29.22 0.87 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.751 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.32 -38.36 8.42 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.847 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.82 146.7 28.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.877 0.37 . . . . 0.0 111.206 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -103.04 -33.29 9.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.286 0.565 . . . . 0.0 110.603 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.35 152.64 23.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.285 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.518 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 0.8 OUTLIER -91.13 15.19 12.22 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.569 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.08 23.54 57.01 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.39 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.603 ' CD1' HG22 ' A' ' 51' ' ' VAL . 6.5 p90 -174.15 119.82 0.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.179 0.49 . . . . 0.0 111.549 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.1 m -91.88 154.14 19.06 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.631 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.712 ' HB ' HG12 ' A' ' 49' ' ' VAL . 24.1 m -112.17 170.93 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.011 0.434 . . . . 0.0 111.688 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.754 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -139.09 164.36 29.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.021 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -72.79 154.85 40.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.911 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.99 109.13 0.95 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.394 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.7 mt -94.28 -25.41 17.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.432 . . . . 0.0 111.182 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.9 tp -83.81 -6.71 59.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.532 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 47' ' ' LYS . 5.2 mt-10 -153.1 27.39 0.52 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.935 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER 26.54 78.48 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.127 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.02 -152.0 9.51 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.475 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 41' ' ' ALA . 23.8 t -144.49 138.42 23.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.875 0.369 . . . . 0.0 111.264 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -130.61 174.37 9.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.313 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.603 HG22 ' CD1' ' A' ' 38' ' ' PHE . 58.3 t -78.72 122.89 34.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.039 0.447 . . . . 0.0 111.255 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.558 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -89.1 -29.53 19.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.777 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -157.59 155.3 29.92 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.35 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.539 HD13 ' CB ' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -137.85 130.7 41.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.561 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.407 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -64.38 127.4 92.14 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.873 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 55' ' ' ARG . 43.6 Cg_exo -56.49 140.02 88.46 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.454 2.103 . . . . 0.0 112.367 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 39.27 33.35 0.09 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.931 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.6 -161.75 21.32 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.259 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -57.6 -42.9 55.7 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.366 2.044 . . . . 0.0 112.147 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.661 ' HA2' HD12 ' A' ' 65' ' ' LEU . . . -65.87 -44.98 90.93 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.787 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.37 -32.62 64.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.028 0.442 . . . . 0.0 110.405 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.2 mt -67.54 -30.93 70.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.737 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.8 -38.6 13.46 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.395 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.53 31.52 1.64 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.565 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.016 HD11 HD11 ' A' ' 27' ' ' LEU . 28.4 mt -83.7 123.24 29.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.859 0.362 . . . . 0.0 111.021 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -113.88 138.59 22.83 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.55 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 77.6 Cg_exo -40.44 139.87 1.07 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.933 2.422 . . . . 0.0 113.144 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 48.9 m-85 88.7 -13.12 0.4 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.64 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.801 ' CB ' HD13 ' A' ' 102' ' ' ILE . 8.4 p-10 -55.99 85.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.064 0.459 . . . . 0.0 110.562 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.45 ' N ' ' O ' ' A' ' 68' ' ' TYR . 10.1 ttm180 -66.58 118.15 9.77 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.87 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.762 ' CD2' HD22 ' A' ' 100' ' ' LEU . 1.1 mt -72.5 112.07 8.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.286 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.618 HD23 ' HG3' ' A' ' 80' ' ' ARG . 5.0 mp -84.67 -67.07 0.82 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -115.5 110.42 19.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.456 ' HA ' ' HB3' ' A' ' 100' ' ' LEU . 46.6 t -102.75 143.05 15.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.874 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 0.5 OUTLIER 46.58 29.58 0.95 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.29 -179.687 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.456 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER 85.9 -19.1 0.32 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.773 179.658 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.0 t -83.98 136.0 23.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.818 0.342 . . . . 0.0 111.203 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -69.15 116.57 9.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.252 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.626 HG22 ' CE2' ' A' ' 82' ' ' PHE . 32.2 p -141.53 38.77 1.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.412 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.618 ' HG3' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -69.87 -46.57 65.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.589 179.679 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -94.38 27.81 2.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.44 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.626 ' CE2' HG22 ' A' ' 79' ' ' THR . 2.5 m-30 -81.09 176.3 9.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.811 0.338 . . . . 0.0 110.657 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.517 ' O ' HG23 ' A' ' 87' ' ' VAL . 3.6 t70 -108.26 158.79 17.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.511 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.841 ' O ' HG23 ' A' ' 88' ' ' VAL . 5.3 p -51.56 -41.88 61.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 110.654 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 37.3 m -63.15 -21.74 66.4 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.08 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.501 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 7.7 mp -96.48 -33.16 11.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.002 0.429 . . . . 0.0 111.022 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.642 HG21 ' HB ' ' A' ' 49' ' ' VAL . 37.8 t -77.61 -36.05 22.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.374 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 84' ' ' CYS . 93.3 t -58.54 -51.29 82.89 Favored Pre-proline 0 C--N 1.33 -0.241 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.79 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.666 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.5 Cg_exo -67.32 -40.93 10.01 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.334 2.023 . . . . 0.0 111.528 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.595 HD13 HG21 ' A' ' 79' ' ' THR . 25.3 mt -54.55 -33.88 60.89 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.027 0.441 . . . . 0.0 110.763 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.879 ' HA ' HD11 ' A' ' 98' ' ' LEU . 25.0 mt -78.34 -44.33 26.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.125 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.22 -2.75 49.95 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.423 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -104.81 6.66 34.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.445 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -63.39 -35.1 79.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.371 0.605 . . . . 0.0 110.253 179.481 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.85 -41.87 2.21 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.719 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 6.1 m-80 -166.82 -35.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.511 0.196 . . . . 0.0 111.328 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp -122.76 131.58 53.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.692 0.282 . . . . 0.0 110.942 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.879 HD11 ' HA ' ' A' ' 91' ' ' ILE . 0.5 OUTLIER -120.62 97.49 5.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.433 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -96.36 118.4 32.81 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.762 HD22 ' CD2' ' A' ' 71' ' ' LEU . 2.6 pp -150.22 162.52 40.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.342 0.592 . . . . 0.0 112.451 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.825 HG12 HD22 ' A' ' 22' ' ' LEU . 25.0 t -114.17 109.1 27.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.699 178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.801 HD13 ' CB ' ' A' ' 69' ' ' ASP . 2.6 pp -104.07 169.45 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.465 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.438 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -133.73 112.39 11.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.766 179.656 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.63 133.42 43.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.001 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.499 ' N ' ' HA ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -62.71 152.01 82.91 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.77 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 C--O 1.248 1.023 0 C-N-CA 122.568 2.179 . . . . 0.0 112.273 -179.927 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.461 0.122 0 CA-C-O 121.01 0.433 . . . . 0.0 112.139 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -121.53 122.45 39.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.393 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.838 HD22 HG12 ' A' ' 101' ' ' VAL . 13.7 mt -60.87 140.65 57.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.313 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.478 ' HB2' HD11 ' A' ' 102' ' ' ILE . 53.7 m-70 -146.52 106.62 4.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.936 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -71.44 109.49 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.047 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.429 HG11 ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -114.89 141.26 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.115 0.484 . . . . 0.0 111.8 -179.079 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.551 HG23 ' OD1' ' A' ' 99' ' ' ASP . 95.5 m -133.06 106.63 7.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.866 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 1.122 HD11 HD11 ' A' ' 65' ' ' LEU . 7.8 mt -105.21 -177.59 3.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.933 0.397 . . . . 0.0 111.608 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.444 ' CD2' ' HG2' ' A' ' 97' ' ' LYS . 16.2 m-85 -135.83 153.59 51.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.529 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -116.1 164.77 13.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.031 0.444 . . . . 0.0 111.423 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -106.16 152.9 22.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.672 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.25 -28.8 29.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.338 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.49 36.71 2.05 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.644 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.4 ttt -81.68 149.14 28.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.748 0.308 . . . . 0.0 110.926 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -96.04 -10.91 27.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.204 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -156.82 176.11 13.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.646 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -102.36 27.07 7.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.168 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 85.62 5.24 84.64 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.263 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.78 ' CD2' HD13 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -173.03 141.67 1.0 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.017 0.437 . . . . 0.0 111.475 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.5 m -107.72 153.42 22.96 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.352 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.742 HG11 ' CD1' ' A' ' 71' ' ' LEU . 32.6 m -118.58 164.97 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.393 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -132.73 141.66 48.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.08 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -55.98 164.88 1.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.112 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.79 140.56 16.42 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.339 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.72 -58.33 2.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.108 0.48 . . . . 0.0 111.423 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.13 -41.98 16.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.726 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 47' ' ' LYS . 18.0 mt-10 -88.4 10.68 19.17 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.616 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 26.36 78.2 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -169.54 -139.16 2.65 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.488 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.698 HG12 ' HB ' ' A' ' 40' ' ' VAL . 41.7 t -155.8 138.41 6.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.602 0.239 . . . . 0.0 111.109 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.76 156.48 47.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.829 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.468 ' CG2' ' HB2' ' A' ' 69' ' ' ASP . 62.0 t -64.03 121.17 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.989 0.423 . . . . 0.0 111.249 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.97 -30.64 17.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.181 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -160.34 154.99 23.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.503 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.455 HG23 ' HB3' ' A' ' 38' ' ' PHE . 1.1 mt -133.44 125.94 51.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.1 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.51 114.7 16.81 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.71 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.636 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 50.1 Cg_exo -53.62 125.07 17.4 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.293 1.996 . . . . 0.0 112.185 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 89.14 -28.88 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.586 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.86 -179.66 1.27 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.472 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.46 ' O ' HD22 ' A' ' 27' ' ' LEU . 58.4 Cg_exo -51.69 -34.6 54.42 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.601 2.201 . . . . 0.0 112.293 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.635 ' HA2' HD12 ' A' ' 65' ' ' LEU . . . -60.97 -46.71 94.04 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.592 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.42 -32.71 64.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.983 0.42 . . . . 0.0 110.357 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.4 mt -63.02 -32.76 74.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.897 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -86.44 -46.63 5.17 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.55 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.81 33.89 0.96 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.765 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.122 HD11 HD11 ' A' ' 27' ' ' LEU . 24.6 mt -73.85 145.94 44.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.775 0.321 . . . . 0.0 110.859 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.411 ' CD ' ' NH1' ' A' ' 104' ' ' ARG . 11.5 mttm -125.64 159.16 62.22 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.968 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.423 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 15.7 Cg_endo -56.96 141.6 93.72 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.76 2.306 . . . . 0.0 112.13 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.546 ' O ' ' N ' ' A' ' 70' ' ' ARG . 31.5 m-85 84.42 0.62 0.9 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.245 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.55 ' CG ' HD13 ' A' ' 102' ' ' ILE . 3.2 m-20 -52.97 80.33 0.0 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.976 0.417 . . . . 0.0 110.733 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.546 ' N ' ' O ' ' A' ' 68' ' ' TYR . 41.0 ttp180 -66.82 103.86 1.21 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.148 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.823 ' HA ' HG22 ' A' ' 102' ' ' ILE . 3.5 mp -63.2 107.39 1.04 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.809 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.668 HD22 ' HG2' ' A' ' 80' ' ' ARG . 8.2 mt -84.98 -67.23 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 0.0 111.155 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -116.21 112.85 22.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.073 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.607 HG23 ' OG1' ' A' ' 79' ' ' THR . 40.9 t -103.71 125.28 58.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.963 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.459 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 2.4 m120 45.69 36.9 2.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.398 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.459 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.4 OUTLIER 87.49 -22.66 0.14 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.736 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.0 t -83.39 134.9 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.321 . . . . 0.0 111.141 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -69.38 136.01 51.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.607 ' OG1' HG23 ' A' ' 74' ' ' VAL . 76.2 p -144.91 25.02 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.179 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.668 ' HG2' HD22 ' A' ' 72' ' ' LEU . 3.4 mtm180 -71.98 -48.45 44.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.883 0.373 . . . . 0.0 110.62 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -92.59 16.03 12.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.363 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.41 ' CG ' ' HA ' ' A' ' 79' ' ' THR . 3.3 m-85 -82.05 176.41 9.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.86 0.362 . . . . 0.0 110.818 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.87 160.46 18.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.559 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 6.4 p -51.62 -34.82 39.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.725 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 96.0 m -70.15 -21.69 63.05 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.223 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.609 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 0.5 OUTLIER -97.59 -32.32 11.85 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 111.014 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.543 HG11 HD13 ' A' ' 71' ' ' LEU . 46.3 t -79.92 -35.94 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.453 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.836 HG12 ' HD3' ' A' ' 89' ' ' PRO . 3.7 p -61.87 -41.2 75.53 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.606 -0.437 . . . . 0.0 111.439 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.836 ' HD3' HG12 ' A' ' 88' ' ' VAL . 72.3 Cg_endo -74.55 -45.55 0.32 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 121.806 1.67 . . . . 0.0 111.316 178.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 86' ' ' LEU . 36.3 mt -54.48 -29.38 49.84 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.347 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.939 HG23 ' CD1' ' A' ' 98' ' ' LEU . 62.2 mt -78.45 -47.12 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.55 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.63 -3.97 31.37 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -112.26 -0.64 15.41 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.764 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.418 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 16.5 m -64.79 -16.41 63.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.834 0.35 . . . . 0.0 111.139 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.91 -148.37 18.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.586 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -73.5 -8.52 56.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.616 0.246 . . . . 0.0 111.419 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.444 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -140.96 147.85 39.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.737 0.303 . . . . 0.0 110.863 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.939 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -132.13 97.45 4.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.219 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.551 ' OD1' HG23 ' A' ' 26' ' ' THR . 0.4 OUTLIER -93.53 118.3 31.18 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.077 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.752 HD23 HD22 ' A' ' 98' ' ' LEU . 1.9 pp -149.85 154.93 39.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.168 0.509 . . . . 0.0 112.096 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.838 HG12 HD22 ' A' ' 22' ' ' LEU . 23.5 t -111.53 109.16 27.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.954 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.823 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.7 pp -105.82 166.1 3.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.01 0.433 . . . . 0.0 111.596 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.7 p -134.12 129.09 35.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.551 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.468 ' HG3' ' HB2' ' A' ' 68' ' ' TYR . 6.0 ttp180 -127.74 135.78 50.61 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.033 0.444 . . . . 0.0 111.48 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -96.82 111.59 57.93 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.404 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.236 1.958 . . . . 0.0 112.356 -179.86 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 105' ' ' ASN . 35.2 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.002 0.429 . . . . 0.0 111.929 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.54 122.05 45.22 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.727 HD13 ' CG1' ' A' ' 101' ' ' VAL . 4.4 pp -100.33 153.15 19.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.199 0.523 . . . . 0.0 112.264 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.829 ' CE1' HD11 ' A' ' 102' ' ' ILE . 54.1 p-80 -144.9 152.22 39.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.698 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -78.55 104.25 9.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.448 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.52 HG22 ' CD2' ' A' ' 23' ' ' HIS . 0.1 OUTLIER -99.22 144.62 11.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.364 -179.525 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.419 HG23 ' OD2' ' A' ' 99' ' ' ASP . 96.4 m -135.09 106.42 6.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.84 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.804 HD21 ' CD1' ' A' ' 65' ' ' LEU . 1.1 mp -105.36 175.18 5.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.033 0.444 . . . . 0.0 111.357 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.451 ' N ' ' CD1' ' A' ' 28' ' ' TYR . 1.5 m-85 -131.51 155.88 46.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.248 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -118.46 149.77 40.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.914 0.388 . . . . 0.0 111.322 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.15 152.85 31.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.741 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.2 m -63.62 -26.25 68.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.257 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.26 1.75 46.96 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.08 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 3.3 mmt -81.78 124.57 29.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.896 0.379 . . . . 0.0 110.976 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.03 -10.77 59.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.365 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -155.59 -167.92 2.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.641 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.526 ' CD2' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -105.46 17.49 23.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.559 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 91.19 7.15 65.91 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.531 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.571 ' CD2' HG22 ' A' ' 51' ' ' VAL . 25.6 p90 -173.62 145.79 1.24 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.26 0.53 . . . . 0.0 111.716 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.75 146.68 41.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.191 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.493 HG11 ' CD1' ' A' ' 71' ' ' LEU . 34.6 m -105.31 171.02 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.662 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -131.08 178.13 6.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.948 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -89.98 129.0 36.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.808 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.12 100.5 2.36 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.272 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.3 -24.05 17.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.964 0.411 . . . . 0.0 111.176 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.52 -10.98 57.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.32 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 47' ' ' LYS . 3.0 mt-10 -153.36 33.51 0.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.968 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 25.24 91.42 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.173 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 173.13 -162.76 34.19 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.42 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 82' ' ' PHE . 64.8 t -139.4 132.1 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.79 0.329 . . . . 0.0 110.749 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -131.87 163.39 28.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.74 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.571 HG22 ' CD2' ' A' ' 38' ' ' PHE . 66.7 t -72.37 122.57 25.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.747 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -87.39 -31.0 20.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.422 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -162.67 145.72 11.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.486 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.57 HG23 ' HB3' ' A' ' 38' ' ' PHE . 1.4 mt -127.48 133.59 67.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.943 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.08 144.49 99.07 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.814 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.23 144.03 45.32 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.516 2.144 . . . . 0.0 112.373 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 39.06 33.83 0.09 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.976 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -109.97 -168.14 19.85 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.39 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.406 ' O ' HD23 ' A' ' 27' ' ' LEU . 54.2 Cg_exo -52.2 -39.71 70.94 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.513 2.142 . . . . 0.0 112.152 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.39 -36.08 50.73 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.609 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -73.51 -32.83 64.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.027 0.441 . . . . 0.0 110.258 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.0 mt -77.28 -30.68 54.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.804 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.02 -47.81 29.54 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.369 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.46 35.27 1.01 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.554 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.804 ' CD1' HD21 ' A' ' 27' ' ' LEU . 13.2 mt -91.1 124.0 34.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.785 0.326 . . . . 0.0 110.998 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.24 156.1 35.66 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.831 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.447 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 53.6 Cg_exo -51.8 136.27 50.79 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.52 2.146 . . . . 0.0 112.227 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.448 ' O ' ' N ' ' A' ' 70' ' ' ARG . 9.9 m-85 85.5 7.49 0.4 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.004 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.778 ' OD1' HD13 ' A' ' 102' ' ' ILE . 3.8 m-20 -53.56 85.84 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.044 0.449 . . . . 0.0 110.993 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 68' ' ' TYR . 28.6 ttt85 -72.31 96.86 1.91 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.629 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.823 ' CD2' HD22 ' A' ' 100' ' ' LEU . 1.2 mp -53.33 107.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.104 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.736 HD11 ' HB2' ' A' ' 103' ' ' SER . 3.2 mp -82.17 -62.37 1.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.376 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -133.79 130.01 37.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.874 0.369 . . . . 0.0 111.281 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.927 ' O ' HG12 ' A' ' 77' ' ' VAL . 20.1 t -113.66 112.95 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.809 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 5.4 m-80 66.54 30.27 8.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.636 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.467 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 1.6 t-80 87.21 -12.12 0.53 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.892 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.927 HG12 ' O ' ' A' ' 74' ' ' VAL . 4.3 p -84.13 143.08 12.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.893 0.378 . . . . 0.0 111.06 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 mtp85 -70.08 125.47 26.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.527 HG23 HG13 ' A' ' 77' ' ' VAL . 52.8 p -146.39 19.69 1.36 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.348 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.504 ' HG3' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -66.23 -52.96 42.7 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.953 0.406 . . . . 0.0 110.623 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -94.77 29.33 2.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.239 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.855 ' O ' HG23 ' A' ' 49' ' ' VAL . 1.8 m-30 -80.97 171.79 14.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.858 0.361 . . . . 0.0 110.82 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.575 ' C ' HG21 ' A' ' 49' ' ' VAL . 2.4 m-20 -107.26 157.62 17.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.499 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.843 ' O ' HG23 ' A' ' 88' ' ' VAL . 5.7 p -51.49 -38.52 54.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.929 0.395 . . . . 0.0 110.445 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 18.9 m -65.67 -21.56 66.56 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.054 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.729 HD22 ' CE2' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -95.4 -32.12 13.07 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.094 0.474 . . . . 0.0 110.605 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.698 HG11 HD13 ' A' ' 71' ' ' LEU . 39.0 t -78.26 -35.79 20.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.303 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 84' ' ' CYS . 93.7 t -58.67 -51.01 84.92 Favored Pre-proline 0 C--N 1.331 -0.23 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.975 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.643 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.0 Cg_exo -68.01 -45.64 2.87 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.477 2.118 . . . . 0.0 111.634 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.618 HD11 ' HE2' ' A' ' 82' ' ' PHE . 36.6 mt -54.5 -30.25 52.82 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.998 0.428 . . . . 0.0 110.574 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.929 ' HA ' HD11 ' A' ' 98' ' ' LEU . 70.9 mt -79.17 -49.55 19.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.079 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.48 -2.59 29.56 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.431 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -102.07 -1.14 32.26 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.203 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.418 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -64.82 -30.87 71.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.185 0.516 . . . . 0.0 110.768 179.719 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.38 -63.09 0.84 Allowed Glycine 0 C--N 1.322 -0.248 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.252 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.432 ' HA ' ' CB ' ' A' ' 29' ' ' LYS . 18.8 p30 -162.71 18.29 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.528 0.204 . . . . 0.0 111.3 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.439 ' HE2' ' CE2' ' A' ' 28' ' ' TYR . 3.8 ttmt -161.8 116.77 1.97 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.929 HD11 ' HA ' ' A' ' 91' ' ' ILE . 1.0 OUTLIER -116.16 98.87 6.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.897 -179.141 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.419 ' OD2' HG23 ' A' ' 26' ' ' THR . 1.9 m-20 -98.52 117.98 34.18 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.844 HD23 HD22 ' A' ' 98' ' ' LEU . 1.2 pp -151.69 164.74 36.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.167 0.508 . . . . 0.0 112.097 -178.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.727 ' CG1' HD13 ' A' ' 22' ' ' LEU . 15.5 t -107.5 109.97 30.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.942 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.829 HD11 ' CE1' ' A' ' 23' ' ' HIS . 2.4 pp -100.44 153.75 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.22 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.736 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -119.53 127.3 52.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.496 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.21 129.88 11.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.996 0.427 . . . . 0.0 111.682 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.8 p-10 -62.78 158.23 53.58 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.785 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 122.531 2.154 . . . . 0.0 112.289 -179.951 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.701 HG12 ' N ' ' A' ' 105' ' ' ASN . 19.6 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.073 0.463 . . . . 0.0 112.171 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.42 ' HG3' ' NH1' ' A' ' 104' ' ' ARG . 11.3 pt-20 -106.92 124.51 49.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.793 HD22 ' CD1' ' A' ' 72' ' ' LEU . 4.7 pp -105.07 153.51 21.38 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -145.85 156.41 43.54 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.597 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.19 110.64 18.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.25 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.905 HG11 ' HG ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -111.75 146.14 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.596 -179.271 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.6 m -134.21 106.64 7.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.314 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.633 HD11 HD21 ' A' ' 65' ' ' LEU . 3.3 mp -93.53 174.76 7.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.947 0.403 . . . . 0.0 111.561 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.433 ' CD1' ' HG3' ' A' ' 97' ' ' LYS . 81.1 m-85 -132.3 141.44 48.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.171 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -116.25 163.14 16.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.878 0.37 . . . . 0.0 111.418 -179.69 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.75 140.13 52.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.749 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 90.3 p -61.75 84.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.055 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 123.86 19.67 2.69 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.075 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.79 167.88 18.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.778 0.323 . . . . 0.0 110.8 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -97.52 -18.36 19.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.207 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.62 -171.25 3.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.667 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.807 ' CD2' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -108.71 19.21 19.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.301 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 104.87 0.46 42.15 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.066 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.579 ' HB3' HG23 ' A' ' 54' ' ' ILE . 14.4 p90 -172.85 145.01 1.39 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.943 0.402 . . . . 0.0 111.453 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.1 m -98.19 138.5 35.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.172 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.49 HG23 ' SG ' ' A' ' 84' ' ' CYS . 35.8 m -93.74 171.07 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.698 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . . . -136.3 178.19 7.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.093 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.57 131.33 45.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.738 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.449 ' HA3' ' CZ ' ' A' ' 50' ' ' TYR . . . -104.0 108.96 3.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.528 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -94.48 -25.15 17.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.001 0.429 . . . . 0.0 111.069 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -83.94 -7.36 59.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.592 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 47' ' ' LYS . 5.2 mt-10 -153.17 25.22 0.54 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.168 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 27.38 80.86 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -170.22 -156.39 11.15 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.695 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.537 ' HB ' HG21 ' A' ' 87' ' ' VAL . 95.2 t -137.68 131.24 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.806 0.336 . . . . 0.0 111.044 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.449 ' CZ ' ' HA3' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -128.56 172.41 11.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.246 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.539 HG11 HG12 ' A' ' 54' ' ' ILE . 88.7 t -90.77 123.68 43.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.83 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 3.7 ptpp? -86.99 -30.73 21.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.362 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -161.76 144.9 12.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.652 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.597 HD12 ' O ' ' A' ' 65' ' ' LEU . 1.7 mt -126.08 135.84 62.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.996 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.6 mtt180 -65.37 143.87 98.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.724 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.09 143.22 35.65 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.501 2.134 . . . . 0.0 112.481 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 39.57 33.77 0.13 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.894 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.56 -159.24 13.3 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.265 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.79 -53.79 6.22 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.477 2.118 . . . . 0.0 112.033 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.22 -33.81 87.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.683 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -73.59 -32.61 64.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.982 0.42 . . . . 0.0 110.321 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 75.1 mt -75.12 -33.8 61.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.787 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.73 -54.1 10.6 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.392 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.26 33.23 1.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.701 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.905 ' HG ' HG11 ' A' ' 25' ' ' VAL . 1.7 mp -88.06 115.77 25.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.866 0.365 . . . . 0.0 110.884 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -81.37 159.86 66.39 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.552 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.426 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 13.0 Cg_endo -56.14 132.54 52.58 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.575 2.183 . . . . 0.0 112.332 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.427 ' O ' ' N ' ' A' ' 70' ' ' ARG . 0.3 OUTLIER 84.16 3.15 0.82 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.599 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.637 ' HB2' HD13 ' A' ' 102' ' ' ILE . 6.0 p-10 -54.43 87.61 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.174 0.512 . . . . 0.0 110.858 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 68' ' ' TYR . 4.2 ttp180 -66.99 109.55 3.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.862 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.004 HD23 HD13 ' A' ' 100' ' ' LEU . 4.0 mp -58.78 118.27 5.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.226 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.793 ' CD1' HD22 ' A' ' 22' ' ' LEU . 40.5 mt -82.77 -65.18 1.04 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.871 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -131.73 128.43 38.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.025 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.33 136.31 44.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.009 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.45 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 23.8 m120 50.18 32.01 5.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.332 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.45 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.3 OUTLIER 85.88 -14.79 0.52 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.77 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.2 t -83.75 136.94 21.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.843 0.354 . . . . 0.0 111.14 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -69.46 125.36 26.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.741 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.496 HG21 HD13 ' A' ' 90' ' ' LEU . 17.1 p -144.5 32.01 1.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.123 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.549 ' HG2' HD22 ' A' ' 72' ' ' LEU . 14.0 mtp180 -65.33 -52.03 56.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.43 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.69 28.54 2.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.049 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.695 ' HE2' HD11 ' A' ' 90' ' ' LEU . 1.8 m-30 -80.8 167.51 19.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.724 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -107.83 161.53 14.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.46 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.851 ' O ' HG23 ' A' ' 88' ' ' VAL . 0.8 OUTLIER -51.81 -40.66 60.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.924 0.393 . . . . 0.0 110.68 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.5 m -63.09 -23.03 67.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.205 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.51 ' O ' HD12 ' A' ' 90' ' ' LEU . 10.0 mp -94.17 -32.09 13.86 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.027 0.441 . . . . 0.0 110.864 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.537 HG21 ' HB ' ' A' ' 49' ' ' VAL . 52.9 t -78.44 -35.86 19.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.222 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 84' ' ' CYS . 97.3 t -57.41 -51.25 83.13 Favored Pre-proline 0 C--N 1.331 -0.199 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.788 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.651 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.9 Cg_exo -66.61 -48.38 2.26 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.475 2.117 . . . . 0.0 111.32 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.695 HD11 ' HE2' ' A' ' 82' ' ' PHE . 37.4 mt -54.94 -27.99 47.74 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.967 0.413 . . . . 0.0 110.427 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.955 ' HA ' HD11 ' A' ' 98' ' ' LEU . 27.8 mt -75.84 -48.12 30.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.799 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.2 -3.09 40.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.091 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -89.8 -11.41 42.21 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.428 ' HB2' ' HG ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -64.66 -27.01 68.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.005 0.431 . . . . 0.0 111.208 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.59 -59.6 3.31 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.423 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.413 ' HA ' ' CB ' ' A' ' 29' ' ' LYS . 9.0 p30 -164.24 20.41 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.523 0.201 . . . . 0.0 111.383 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.433 ' HG3' ' CD1' ' A' ' 28' ' ' TYR . 14.1 ttpt -165.55 113.03 0.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.7 0.286 . . . . 0.0 110.234 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.955 HD11 ' HA ' ' A' ' 91' ' ' ILE . 1.7 mt -109.03 102.19 11.2 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -97.32 118.12 33.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 1.004 HD13 HD23 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -152.67 159.16 43.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.267 0.556 . . . . 0.0 112.416 -178.403 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.625 ' CG1' HD13 ' A' ' 22' ' ' LEU . 15.5 t -105.99 109.33 27.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.455 178.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.705 HG23 HD12 ' A' ' 100' ' ' LEU . 2.6 pp -100.87 162.33 3.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.015 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.441 ' HB3' HD11 ' A' ' 72' ' ' LEU . 3.2 p -146.26 130.19 17.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.687 0.28 . . . . 0.0 111.145 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.42 ' NH1' ' HG3' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -144.96 145.8 31.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.958 0.408 . . . . 0.0 111.409 179.508 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.701 ' N ' HG12 ' A' ' 20' ' ' VAL . 3.3 p-10 -70.04 127.01 92.67 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.748 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.248 1.001 0 C-N-CA 122.42 2.08 . . . . 0.0 112.247 179.989 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.886 0.374 . . . . 0.0 111.478 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -135.23 122.38 21.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.613 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.047 HD21 HD12 ' A' ' 72' ' ' LEU . 16.0 mt -62.6 136.58 57.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.472 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 -142.86 119.72 11.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.87 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -75.34 110.93 10.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.28 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.71 HG11 ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -116.9 140.88 37.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.072 0.463 . . . . 0.0 111.508 -179.262 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.4 m -133.65 106.79 7.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.02 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.719 HD11 HD13 ' A' ' 65' ' ' LEU . 38.0 mt -98.3 179.56 4.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.172 0.511 . . . . 0.0 111.8 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.437 ' CD1' ' HG2' ' A' ' 97' ' ' LYS . 95.2 m-85 -135.69 136.1 40.61 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.366 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.451 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -99.33 165.14 11.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.968 0.413 . . . . 0.0 111.3 -179.662 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -119.8 131.1 55.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.784 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.82 84.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.126 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.26 -40.67 0.51 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.36 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.63 164.26 21.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 0.0 110.907 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.91 -28.52 9.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.072 0.463 . . . . 0.0 110.922 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -84.8 168.74 14.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.707 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.609 ' CD2' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -119.11 29.15 7.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.084 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.522 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 92.07 4.21 67.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.117 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.77 ' CE2' HD22 ' A' ' 65' ' ' LEU . 8.8 p90 -174.33 138.56 0.56 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.981 0.39 . . . . 0.0 111.545 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 52' ' ' LYS . 7.3 m -99.79 148.1 24.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.183 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.605 ' HB ' HG12 ' A' ' 49' ' ' VAL . 33.0 m -111.8 163.36 8.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.919 0.39 . . . . 0.0 111.588 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.782 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -135.08 172.22 13.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.908 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -84.18 163.62 19.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.935 0.397 . . . . 0.0 111.145 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.55 121.98 6.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.322 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.69 6.27 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.53 -38.77 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.072 0.463 . . . . 0.0 111.482 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 47' ' ' LYS . 11.8 mm-40 -88.85 18.14 5.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.561 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 46' ' ' GLU . 12.5 mmtt 27.76 78.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.971 0.415 . . . . 0.0 112.106 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.09 -163.51 35.84 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.473 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.782 HG13 ' O ' ' A' ' 41' ' ' ALA . 46.8 t -130.0 138.93 52.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 110.914 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -136.51 165.64 25.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.795 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.508 HG11 HD11 ' A' ' 54' ' ' ILE . 58.9 t -72.35 121.18 22.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.02 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 39' ' ' SER . 0.4 OUTLIER -87.53 -31.05 20.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.865 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -158.12 152.63 24.68 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.447 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.522 HG23 ' O ' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -133.21 141.53 44.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.029 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.12 117.22 37.43 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.749 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.64 134.2 52.5 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.512 2.141 . . . . 0.0 112.504 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 42.83 31.25 0.3 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.834 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -109.39 -160.88 19.22 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.749 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -50.64 -62.06 0.46 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.49 2.126 . . . . 0.0 111.785 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.9 -35.04 66.58 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.884 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -73.19 -32.83 65.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.051 0.453 . . . . 0.0 110.201 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 62' ' ' LEU . 27.5 mt -73.2 -27.41 61.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.56 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.54 -51.66 7.12 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.348 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 134.95 -8.02 4.48 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.021 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.77 HD22 ' CE2' ' A' ' 38' ' ' PHE . 4.0 mp -56.76 128.85 38.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.368 . . . . 0.0 111.114 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -116.6 167.24 10.93 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 69.7 Cg_exo -50.92 137.3 43.79 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.654 2.236 . . . . 0.0 112.368 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.437 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 10.8 m-85 85.02 4.1 0.62 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.232 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.528 ' CG ' HD13 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -52.5 89.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.947 0.403 . . . . 0.0 110.81 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.612 ' O ' HD23 ' A' ' 72' ' ' LEU . 9.3 ttt180 -77.85 95.59 4.76 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.787 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.018 HD23 HD13 ' A' ' 100' ' ' LEU . 1.2 mp -55.0 107.01 0.26 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.873 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.047 HD12 HD21 ' A' ' 22' ' ' LEU . 4.4 mt -83.98 -63.05 1.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.835 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -120.49 117.56 27.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.951 ' O ' HG12 ' A' ' 77' ' ' VAL . 24.6 t -108.15 109.62 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.163 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.491 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 1.7 m-80 64.24 33.59 11.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.669 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.491 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 3.3 t60 89.73 -17.94 0.21 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.92 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.951 HG12 ' O ' ' A' ' 74' ' ' VAL . 6.4 p -83.69 130.08 36.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.992 0.425 . . . . 0.0 111.125 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.78 89.24 0.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.415 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.687 HG23 HG13 ' A' ' 77' ' ' VAL . 17.3 p -96.76 26.26 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.809 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.652 ' HG2' HD22 ' A' ' 72' ' ' LEU . 10.5 mtp-105 -63.32 -53.03 59.13 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.985 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.35 24.16 4.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.402 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.693 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.3 m-85 -81.8 166.48 19.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.852 0.358 . . . . 0.0 110.76 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.557 ' C ' HG21 ' A' ' 49' ' ' VAL . 33.6 m-20 -106.08 160.9 14.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.554 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.841 ' O ' HG23 ' A' ' 88' ' ' VAL . 11.3 t -51.69 -41.98 61.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.69 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.3 m -63.07 -22.43 66.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.098 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.536 ' O ' HD12 ' A' ' 90' ' ' LEU . 6.6 mp -94.02 -32.93 13.61 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.99 0.424 . . . . 0.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.732 HG11 HD13 ' A' ' 71' ' ' LEU . 48.4 t -77.57 -36.79 23.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.134 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 84' ' ' CYS . 87.5 t -55.61 -52.19 73.97 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.793 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 48.7 Cg_endo -68.44 -45.81 2.36 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.191 1.927 . . . . 0.0 111.835 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.693 HD11 ' HE2' ' A' ' 82' ' ' PHE . 28.2 mt -54.78 -30.71 57.49 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.964 0.412 . . . . 0.0 110.725 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.809 HG23 ' CD1' ' A' ' 98' ' ' LEU . 61.3 mt -76.14 -48.37 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.367 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.69 -3.06 39.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.804 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -92.99 -4.55 52.45 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.433 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -63.52 -29.83 71.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.232 0.539 . . . . 0.0 110.903 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.8 -41.67 2.82 Favored Glycine 0 C--N 1.322 -0.227 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.761 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -166.23 -41.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 111.133 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.437 ' HG2' ' CD1' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -112.9 126.91 55.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.719 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.809 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.6 OUTLIER -115.85 97.48 6.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.626 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.27 118.16 31.18 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 1.018 HD13 HD23 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -148.59 156.44 42.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.142 0.496 . . . . 0.0 112.175 -178.929 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.899 HG12 HD22 ' A' ' 22' ' ' LEU . 17.1 t -114.32 109.04 27.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.794 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.883 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.4 pp -104.99 165.56 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.337 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.5 p -126.84 126.55 43.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.738 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -152.27 138.77 18.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.072 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -62.94 154.11 77.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.698 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo . . . . . 0 C--O 1.249 1.025 0 C-N-CA 122.61 2.207 . . . . 0.0 112.324 -179.855 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.719 HG21 ' HB3' ' A' ' 103' ' ' SER . 16.5 m . . . . . 0 C--O 1.23 0.035 0 CA-C-O 120.969 0.414 . . . . 0.0 111.566 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -122.38 122.99 40.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.567 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.801 ' CD2' HD13 ' A' ' 72' ' ' LEU . 14.4 mt -60.33 147.52 40.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.057 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.67 ' CE1' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -157.55 116.57 3.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.368 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.31 121.02 20.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.79 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.877 HG11 HD22 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -118.24 145.54 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.296 -179.769 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.2 m -134.56 106.82 7.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.965 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.01 173.34 6.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.997 0.427 . . . . 0.0 111.692 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 28' ' ' TYR . 3.1 m-85 -123.19 156.05 35.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.519 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -111.22 160.37 17.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.912 0.387 . . . . 0.0 111.236 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.82 142.26 50.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.865 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.6 t -56.13 -30.46 62.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.022 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.29 38.17 3.4 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.399 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 5.4 mmt -157.25 110.85 2.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.785 0.326 . . . . 0.0 110.835 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -74.07 -28.81 61.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.087 0.47 . . . . 0.0 110.931 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -85.03 177.99 7.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.651 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.502 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -118.98 29.36 7.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.119 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.613 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 82.7 8.46 85.98 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.688 -0.767 . . . . 0.0 113.332 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.511 ' CE2' HG22 ' A' ' 51' ' ' VAL . 20.3 p90 -172.73 127.48 0.5 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 117.171 0.486 . . . . 0.0 111.395 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.06 149.89 20.83 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.013 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.757 HG11 HD11 ' A' ' 71' ' ' LEU . 31.6 m -122.15 150.74 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.303 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.761 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -107.67 178.11 4.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.08 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -94.87 168.18 10.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.015 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -96.88 109.78 3.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.065 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.554 ' O ' HD22 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -94.46 7.11 46.7 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.554 HD22 ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -150.15 0.47 0.45 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -179.304 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -158.17 31.45 0.25 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.642 0.258 . . . . 0.0 111.298 179.738 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER 28.59 90.77 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.97 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -175.35 -159.44 21.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.364 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 41' ' ' ALA . 99.6 t -150.53 137.56 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.94 0.4 . . . . 0.0 111.17 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.8 163.75 30.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.348 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.629 ' HA ' HG12 ' A' ' 40' ' ' VAL . 58.3 t -70.68 123.85 25.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.994 0.426 . . . . 0.0 111.262 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.99 -29.76 19.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.636 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -172.16 160.07 5.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.256 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.613 HG23 ' O ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -126.67 138.41 54.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.839 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -64.16 154.67 81.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.284 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.614 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 65.4 Cg_endo -73.71 102.4 1.5 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.684 2.256 . . . . 0.0 112.433 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 84.58 -6.51 0.99 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.686 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.84 175.87 6.08 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.518 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -46.68 -45.8 19.23 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.71 2.273 . . . . 0.0 112.536 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.425 ' HA2' HD21 ' A' ' 65' ' ' LEU . . . -57.08 -41.1 92.39 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.433 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.24 -32.72 64.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.035 0.445 . . . . 0.0 110.032 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.75 -32.13 69.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.515 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.25 -57.55 5.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.16 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.97 38.37 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.895 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.877 HD22 HG11 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -110.85 127.02 55.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.74 0.305 . . . . 0.0 110.825 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -96.76 162.06 24.44 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.565 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 9.2 Cg_endo -52.32 154.49 11.15 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.743 2.295 . . . . 0.0 112.208 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.472 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 8.0 m-85 90.29 -22.25 0.11 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.368 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.767 ' HB2' HD13 ' A' ' 102' ' ' ILE . 10.3 p-10 -55.26 87.75 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.203 0.525 . . . . 0.0 110.453 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -66.74 119.99 12.75 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.734 -179.624 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.757 HD11 HG11 ' A' ' 40' ' ' VAL . 1.3 mt -68.79 110.74 4.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.303 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.801 HD13 ' CD2' ' A' ' 22' ' ' LEU . 3.4 mp -82.74 -58.01 3.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.179 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -129.98 134.29 47.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.965 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.805 HG23 ' OG1' ' A' ' 79' ' ' THR . 28.2 t -117.28 108.51 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.005 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.443 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 33.2 m120 64.24 36.27 9.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 17.7 m80 86.35 -15.94 0.44 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.516 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.0 t -83.66 139.11 18.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.813 0.34 . . . . 0.0 111.013 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.87 122.82 20.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.631 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.805 ' OG1' HG23 ' A' ' 74' ' ' VAL . 28.0 p -143.08 28.22 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.95 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.594 ' HG3' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -72.29 -53.01 13.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.425 179.704 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -94.9 25.96 3.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.069 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.692 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.4 m-30 -80.85 171.4 15.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.778 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 87' ' ' VAL . 1.2 m-20 -108.01 159.94 16.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.479 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.878 ' O ' HG23 ' A' ' 88' ' ' VAL . 23.8 p -51.51 -42.11 61.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.88 0.371 . . . . 0.0 110.543 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.07 -21.73 66.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.191 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.603 ' O ' HD12 ' A' ' 90' ' ' LEU . 8.0 mp -95.31 -31.31 13.51 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.935 0.397 . . . . 0.0 110.819 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.656 HG11 ' CD1' ' A' ' 71' ' ' LEU . 48.1 t -79.37 -35.72 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.221 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 84' ' ' CYS . 88.8 t -58.18 -50.71 86.59 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.835 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 13.0 Cg_exo -69.62 -44.43 2.18 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.472 2.115 . . . . 0.0 111.626 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.692 HD11 ' HE2' ' A' ' 82' ' ' PHE . 15.5 mt -54.99 -33.32 62.46 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.694 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.9 HG23 ' CD1' ' A' ' 98' ' ' LEU . 80.4 mt -75.32 -45.87 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.629 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.66 -3.76 36.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.928 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -101.19 -12.12 18.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.659 0.266 . . . . 0.0 111.686 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.8 m -64.76 -15.67 61.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.502 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.97 -143.69 17.21 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.571 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -73.73 -7.52 52.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.547 0.213 . . . . 0.0 111.4 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.7 mtpt -137.49 151.73 48.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.612 0.244 . . . . 0.0 110.592 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.9 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -137.73 97.49 3.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.772 0.32 . . . . 0.0 111.382 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.7 118.17 31.3 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.74 HD23 HD22 ' A' ' 98' ' ' LEU . 1.4 pp -145.16 157.43 44.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.132 0.492 . . . . 0.0 112.079 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.776 HG12 HD22 ' A' ' 22' ' ' LEU . 16.7 t -110.53 109.25 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.919 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.767 HD13 ' HB2' ' A' ' 69' ' ' ASP . 2.6 pp -105.9 169.21 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.074 0.464 . . . . 0.0 111.641 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.791 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -131.84 114.51 14.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.488 179.589 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.422 ' HB3' ' HA ' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -140.82 131.99 26.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.923 0.392 . . . . 0.0 111.642 -179.561 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.408 ' N ' HG12 ' A' ' 20' ' ' VAL . 6.5 m-20 -65.65 119.86 63.74 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.595 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--O 1.25 1.078 0 C-N-CA 122.339 2.026 . . . . 0.0 112.376 -179.935 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.928 0.394 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -111.08 122.36 47.68 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.578 HD13 ' CG1' ' A' ' 101' ' ' VAL . 4.4 pp -106.83 153.3 22.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.26 0.552 . . . . 0.0 112.37 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.677 ' NE2' HD11 ' A' ' 102' ' ' ILE . 28.7 p80 -149.28 143.46 25.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.561 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.51 112.26 14.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.486 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.803 HG11 ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -107.21 153.46 8.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.57 -179.462 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.857 HG23 ' OD1' ' A' ' 99' ' ' ASP . 98.4 m -134.09 122.1 22.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.824 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.705 HD21 ' CD1' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -108.2 175.16 5.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.293 0.568 . . . . 0.0 111.986 -178.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.465 ' CD1' ' HG2' ' A' ' 97' ' ' LYS . 27.7 m-85 -139.3 124.63 19.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.911 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.42 ' HG3' ' CE2' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -94.84 147.81 22.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.073 0.463 . . . . 0.0 111.431 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -123.41 153.82 39.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.682 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 p -64.64 -24.49 67.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.26 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.62 -0.22 55.43 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.156 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.94 130.42 35.07 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.824 0.345 . . . . 0.0 111.043 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -80.35 -10.74 59.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.16 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -155.93 -164.78 1.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.412 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.586 ' O ' HD22 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -106.01 25.59 10.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 111.482 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.606 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 91.48 -1.17 75.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.74 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.575 ' CD1' HG22 ' A' ' 51' ' ' VAL . 7.9 p90 -172.24 147.76 2.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.334 0.567 . . . . 0.0 111.895 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 p -108.89 137.71 46.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.242 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.749 ' HB ' HG12 ' A' ' 49' ' ' VAL . 22.6 m -99.23 161.12 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.519 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.772 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -125.19 171.11 10.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.153 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -82.01 136.01 35.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.968 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.26 103.43 2.07 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.337 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -94.31 -28.81 15.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.093 0.473 . . . . 0.0 111.287 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 45' ' ' LEU . 15.0 mt -83.85 -5.63 59.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.375 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 47' ' ' LYS . 11.9 mt-10 -153.07 28.1 0.52 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.941 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.4 OUTLIER 27.38 91.2 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.107 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.92 -153.16 21.73 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.582 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.772 HG13 ' O ' ' A' ' 41' ' ' ALA . 16.6 t -145.97 139.0 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.72 0.295 . . . . 0.0 110.931 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -136.93 156.19 48.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.118 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.575 HG22 ' CD1' ' A' ' 38' ' ' PHE . 87.6 t -67.63 117.94 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.536 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -87.39 -30.77 20.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.042 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -157.39 147.51 20.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.524 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 37' ' ' GLY . 1.3 mt -125.1 125.35 69.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.955 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.6 ttt85 -65.33 111.62 6.5 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.05 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.589 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 32.4 Cg_exo -58.34 123.48 13.71 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.476 2.117 . . . . 0.0 112.19 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 81.34 83.35 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.097 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 167.78 -152.54 21.02 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.531 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.55 ' C ' HD23 ' A' ' 27' ' ' LEU . 32.2 Cg_exo -59.61 -36.78 91.56 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.646 2.231 . . . . 0.0 112.2 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.09 -47.81 43.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.722 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.57 -32.95 64.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.056 0.455 . . . . 0.0 110.515 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.4 mt -71.26 -30.87 66.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.993 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.86 -38.66 15.38 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.663 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.44 29.24 6.38 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.803 ' HG ' HG11 ' A' ' 25' ' ' VAL . 1.2 mp -78.27 131.88 37.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.893 0.378 . . . . 0.0 110.784 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -98.4 165.05 15.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.841 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 28.1 Cg_endo -62.68 138.96 72.67 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.411 2.074 . . . . 0.0 112.115 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER 82.96 11.1 0.53 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.347 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.578 ' OD1' HD13 ' A' ' 102' ' ' ILE . 5.6 m-20 -53.74 88.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.931 0.396 . . . . 0.0 111.162 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.449 ' HB3' ' O ' ' A' ' 103' ' ' SER . 5.5 ttt85 -73.0 94.34 1.86 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.372 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.919 HD12 ' CG1' ' A' ' 87' ' ' VAL . 11.3 mt -50.86 107.51 0.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.998 0.428 . . . . 0.0 111.175 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.749 HD11 ' HB2' ' A' ' 103' ' ' SER . 16.0 mt -82.62 -65.33 1.02 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.946 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -133.79 138.86 45.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.49 ' O ' HG12 ' A' ' 77' ' ' VAL . 16.5 t -109.69 106.81 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.931 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 75.37 -59.37 0.54 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.078 0.466 . . . . 0.0 110.613 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.401 ' H ' ' H ' ' A' ' 77' ' ' VAL . 0.2 OUTLIER -167.29 -11.22 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.414 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 74' ' ' VAL . 12.9 p -85.41 125.3 40.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.712 0.292 . . . . 0.0 111.242 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 -69.55 123.8 22.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.424 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.639 HG21 HD13 ' A' ' 90' ' ' LEU . 14.2 p -143.17 32.75 1.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.91 0.386 . . . . 0.0 111.21 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.434 ' HG3' ' CA ' ' A' ' 72' ' ' LEU . 37.0 mtp180 -66.01 -52.49 48.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.636 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.24 30.35 1.95 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.112 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.699 ' HE2' HD11 ' A' ' 90' ' ' LEU . 1.6 m-30 -80.9 174.25 11.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.41 . . . . 0.0 110.742 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.09 158.47 17.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.439 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.848 ' O ' HG23 ' A' ' 88' ' ' VAL . 22.6 p -51.35 -41.66 60.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.914 0.388 . . . . 0.0 110.815 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.56 -22.47 66.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.131 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.55 ' O ' HD12 ' A' ' 90' ' ' LEU . 8.9 mp -93.02 -33.44 14.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.165 0.507 . . . . 0.0 110.875 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.919 ' CG1' HD12 ' A' ' 71' ' ' LEU . 59.7 t -77.18 -36.02 23.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.165 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 84' ' ' CYS . 78.5 t -55.45 -52.25 73.27 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.819 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 54.4 Cg_endo -69.19 -43.22 3.28 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.281 1.987 . . . . 0.0 111.904 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.699 HD11 ' HE2' ' A' ' 82' ' ' PHE . 15.9 mt -54.6 -31.61 57.3 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.967 0.413 . . . . 0.0 110.787 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.938 HG23 ' CD1' ' A' ' 98' ' ' LEU . 70.3 mt -78.8 -47.45 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.854 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.5 -3.96 30.9 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.08 -4.2 16.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.606 0.241 . . . . 0.0 111.593 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.6 p -64.08 -18.2 64.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.907 0.384 . . . . 0.0 111.133 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.85 -144.81 17.55 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.415 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -73.91 -8.24 55.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.615 0.245 . . . . 0.0 111.466 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.465 ' HG2' ' CD1' ' A' ' 28' ' ' TYR . 10.4 mtpt -144.33 147.57 33.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.678 0.275 . . . . 0.0 111.034 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.938 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -124.77 97.58 5.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 0.0 111.078 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.857 ' OD1' HG23 ' A' ' 26' ' ' THR . 6.0 m-20 -95.04 118.78 32.43 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.838 HD22 HD22 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -150.2 169.36 21.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.251 0.548 . . . . 0.0 112.333 -178.663 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.635 HG12 HD12 ' A' ' 72' ' ' LEU . 25.0 t -118.44 109.35 26.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.549 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.677 HD11 ' NE2' ' A' ' 23' ' ' HIS . 2.2 pp -102.58 154.56 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.429 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.749 ' HB2' HD11 ' A' ' 72' ' ' LEU . 3.4 t -130.15 125.72 35.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.452 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.42 126.23 10.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.005 0.431 . . . . 0.0 111.791 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.39 140.05 78.97 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.459 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 C--O 1.249 1.028 0 C-N-CA 122.323 2.015 . . . . 0.0 112.302 -179.902 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.447 HG12 ' OD1' ' A' ' 105' ' ' ASN . 27.5 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.808 0.337 . . . . 0.0 111.462 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.39 122.55 47.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.629 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.793 HD22 HG12 ' A' ' 101' ' ' VAL . 14.1 mt -62.44 144.3 56.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.304 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.537 ' HB2' HD11 ' A' ' 102' ' ' ILE . 80.5 m-70 -152.41 110.59 3.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.806 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -72.99 106.26 4.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.112 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.594 HG11 ' CD2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -109.7 141.02 26.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.04 0.448 . . . . 0.0 111.57 -179.263 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.9 m -132.64 106.75 7.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.144 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.58 HD21 HD21 ' A' ' 65' ' ' LEU . 1.5 mp -101.06 177.6 4.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.046 0.45 . . . . 0.0 111.613 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.442 ' CD2' ' HG2' ' A' ' 97' ' ' LYS . 11.7 m-85 -138.89 133.51 32.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.437 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -94.84 161.88 13.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.971 0.415 . . . . 0.0 111.173 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -124.4 130.9 53.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.802 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 61.3 p -60.04 84.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.4 -13.49 1.4 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.893 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.94 174.64 11.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.769 0.319 . . . . 0.0 110.923 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.82 -10.73 13.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.48 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -155.66 -176.58 6.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.977 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.51 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -98.15 31.99 2.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.008 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.85 15.66 79.54 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.973 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.65 ' CD2' HD11 ' A' ' 65' ' ' LEU . 4.1 p90 -173.47 119.22 0.3 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 110.962 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -93.62 149.66 21.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.824 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.686 ' HB ' HG12 ' A' ' 49' ' ' VAL . 23.7 m -108.33 167.94 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.244 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.813 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -127.08 171.32 11.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.096 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -88.14 137.31 32.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.098 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.86 114.58 4.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.403 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tp -94.38 -31.05 14.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.068 0.461 . . . . 0.0 111.251 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.96 -54.88 4.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.892 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.7 mm-40 -90.55 17.99 6.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.473 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 29.83 89.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.79 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.1 -144.53 8.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.601 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.813 HG13 ' O ' ' A' ' 41' ' ' ALA . 38.8 t -146.7 140.74 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 0.0 111.021 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.1 159.99 40.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.608 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.792 HG11 HD11 ' A' ' 54' ' ' ILE . 59.8 t -62.97 123.63 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.982 0.42 . . . . 0.0 111.031 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.49 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 2.0 tptp -88.58 -35.38 16.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.98 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -162.55 143.59 10.14 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.273 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.792 HD11 HG11 ' A' ' 51' ' ' VAL . 1.2 mt -129.57 133.92 64.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.979 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.44 137.56 96.65 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.687 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.585 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 72.8 Cg_endo -75.03 107.59 2.52 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.498 2.132 . . . . 0.0 112.495 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 83.54 28.95 0.08 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.268 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -114.5 -161.64 13.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.305 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -50.65 -53.55 6.95 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.493 2.129 . . . . 0.0 112.199 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.01 -38.38 89.0 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.476 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.3 -32.81 64.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.05 0.452 . . . . 0.0 110.273 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.6 -30.8 67.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.687 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.99 -53.4 6.27 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.28 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.45 35.13 0.88 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.787 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.65 HD11 ' CD2' ' A' ' 38' ' ' PHE . 0.3 OUTLIER -113.64 141.87 46.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.843 0.354 . . . . 0.0 110.958 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -121.93 163.04 33.83 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.684 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.551 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 1.4 Cg_endo -44.51 144.28 3.31 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.824 2.35 . . . . 0.0 112.3 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.551 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 93.8 m-85 85.3 -7.82 0.86 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.41 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.708 ' CG ' HD13 ' A' ' 102' ' ' ILE . 5.4 m-20 -54.41 86.65 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.151 0.5 . . . . 0.0 110.591 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.613 ' O ' HD12 ' A' ' 72' ' ' LEU . 22.2 ttm180 -66.82 109.15 2.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.292 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.562 ' CD2' HD22 ' A' ' 100' ' ' LEU . 1.8 mp -66.61 107.92 2.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.796 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.719 HD11 ' HB3' ' A' ' 103' ' ' SER . 5.2 mp -83.75 -37.51 22.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.509 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.81 145.58 18.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.868 0.366 . . . . 0.0 111.087 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.812 HG12 ' OD1' ' A' ' 75' ' ' ASN . 21.5 t -115.11 109.75 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.791 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.812 ' OD1' HG12 ' A' ' 74' ' ' VAL . 1.0 OUTLIER 75.46 -57.46 0.59 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.072 0.463 . . . . 0.0 110.695 -179.699 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -167.19 -14.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.263 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.5 t -85.62 128.47 39.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-O 120.797 0.332 . . . . 0.0 111.098 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -69.31 127.07 31.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.515 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.784 HG21 HD13 ' A' ' 90' ' ' LEU . 16.8 p -142.69 32.44 1.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.031 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.444 ' CG ' ' HG ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -67.95 -48.39 66.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.303 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.15 24.21 4.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.077 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.613 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.1 m-30 -81.13 173.87 12.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.802 0.334 . . . . 0.0 110.823 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.32 159.59 16.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.327 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.853 ' O ' HG23 ' A' ' 88' ' ' VAL . 19.6 t -51.48 -42.1 61.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.824 0.345 . . . . 0.0 110.713 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.6 t -62.61 -21.64 65.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.18 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 90' ' ' LEU . 8.3 mp -95.64 -32.57 12.72 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.023 0.44 . . . . 0.0 110.978 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.619 HG12 HD11 ' A' ' 91' ' ' ILE . 50.9 t -78.29 -35.7 19.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.331 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 84' ' ' CYS . 91.9 t -58.27 -51.27 82.99 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.833 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.645 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.3 Cg_exo -67.55 -44.86 3.99 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.349 2.033 . . . . 0.0 111.47 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.784 HD13 HG21 ' A' ' 79' ' ' THR . 18.1 mt -54.74 -29.38 53.51 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.697 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.95 HG23 ' CD1' ' A' ' 98' ' ' LEU . 50.1 mt -78.08 -48.43 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.796 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.37 -4.32 32.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.97 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -99.3 -12.94 19.89 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.716 0.293 . . . . 0.0 111.576 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -15.97 62.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.383 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.03 -144.11 17.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.649 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -73.72 -7.1 50.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.442 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -138.58 141.67 39.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.772 0.32 . . . . 0.0 110.657 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.95 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -130.6 97.33 4.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.263 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -98.47 118.11 34.41 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.935 HD23 HD22 ' A' ' 98' ' ' LEU . 1.6 pp -145.91 163.2 35.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.12 0.486 . . . . 0.0 111.849 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.793 HG12 HD22 ' A' ' 22' ' ' LEU . 25.5 t -113.51 109.11 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.168 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.708 HD13 ' CG ' ' A' ' 69' ' ' ASP . 2.6 pp -103.75 168.95 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.088 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.719 ' HB3' HD11 ' A' ' 72' ' ' LEU . 54.2 p -142.39 120.24 11.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.716 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.5 ptt85 -128.34 130.32 47.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.176 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . 0.447 ' OD1' HG12 ' A' ' 20' ' ' VAL . 14.8 m120 -65.85 157.42 79.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.852 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo . . . . . 0 C--O 1.249 1.054 0 C-N-CA 122.54 2.16 . . . . 0.0 112.224 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.424 HG23 ' OG ' ' A' ' 103' ' ' SER . 30.2 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.814 0.34 . . . . 0.0 111.476 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -125.55 122.69 37.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.675 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 1.081 HD21 HD12 ' A' ' 72' ' ' LEU . 15.1 mt -61.19 152.91 27.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.411 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.447 ' HB2' HD11 ' A' ' 102' ' ' ILE . 20.5 m-70 -157.15 109.9 2.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.024 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.545 ' CD ' HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -72.45 112.99 9.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.078 179.596 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.942 HG11 ' HG ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -121.92 143.4 34.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.142 0.496 . . . . 0.0 111.932 -178.898 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.1 m -134.0 106.4 7.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.811 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.538 HD11 HD11 ' A' ' 65' ' ' LEU . 4.4 mp -94.34 174.88 6.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.278 0.561 . . . . 0.0 112.04 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 96' ' ' ASN . 24.8 m-85 -137.4 121.63 18.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.222 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 6.1 tttm -112.04 152.98 27.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.958 0.408 . . . . 0.0 111.263 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.409 ' N ' ' HG2' ' A' ' 29' ' ' LYS . 19.6 t0 -102.52 138.86 38.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.867 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.0 m -51.35 -26.34 7.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.31 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.72 -38.15 21.06 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.615 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 9.2 mmm -81.76 158.14 24.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.91 0.386 . . . . 0.0 110.936 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.68 -30.89 8.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.114 0.483 . . . . 0.0 110.92 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.99 172.03 11.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.713 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.476 ' CD2' HG22 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -119.14 32.07 6.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.802 0.335 . . . . 0.0 111.105 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.401 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 77.1 6.59 86.24 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.283 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.481 ' HD2' HG13 ' A' ' 51' ' ' VAL . 14.1 p90 -172.5 123.15 0.46 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.159 0.479 . . . . 0.0 111.393 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -95.1 145.81 24.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.536 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.668 HG11 HD11 ' A' ' 71' ' ' LEU . 33.5 m -110.49 159.67 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.281 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.796 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -116.97 178.06 4.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -90.7 161.22 15.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.128 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.5 128.63 8.28 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.239 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.44 -58.07 2.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.289 0.566 . . . . 0.0 111.398 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.58 -43.51 15.59 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.61 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 47' ' ' LYS . 2.1 mt-10 -87.7 9.77 20.42 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.749 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER 27.71 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.73 -152.8 19.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.468 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.796 HG13 ' O ' ' A' ' 41' ' ' ALA . 59.7 t -142.65 138.39 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.761 0.315 . . . . 0.0 111.052 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.13 167.91 20.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.52 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.512 HG11 HD11 ' A' ' 54' ' ' ILE . 47.2 t -71.64 122.04 23.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.979 0.419 . . . . 0.0 111.368 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -89.52 -32.68 17.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.785 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -164.79 153.89 12.9 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.187 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.512 HD11 HG11 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -130.95 133.62 62.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.15 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.87 127.02 92.82 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.627 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 32.3 Cg_exo -58.34 114.22 1.89 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.418 2.079 . . . . 0.0 112.44 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 86.64 -14.67 0.48 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.951 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.63 -176.6 2.25 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.371 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.71 -32.48 97.0 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.521 2.148 . . . . 0.0 111.998 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.516 ' HA2' HD21 ' A' ' 27' ' ' LEU . . . -64.51 -38.87 96.32 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.321 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.58 -32.68 64.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.987 0.422 . . . . 0.0 110.019 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.4 mt -75.2 -34.99 61.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.833 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.42 -57.78 7.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.42 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 125.59 42.62 0.31 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.752 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.942 ' HG ' HG11 ' A' ' 25' ' ' VAL . 0.9 OUTLIER -104.56 122.83 46.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.857 0.361 . . . . 0.0 110.918 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.84 162.04 20.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.772 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 6.9 Cg_endo -49.15 137.46 29.63 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.972 2.448 . . . . 0.0 112.156 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 46.6 m-85 85.32 -1.52 0.82 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.17 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.608 ' CG ' HD13 ' A' ' 102' ' ' ILE . 0.9 OUTLIER -53.08 88.23 0.0 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.943 0.401 . . . . 0.0 110.735 179.507 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.57 ' O ' HD23 ' A' ' 72' ' ' LEU . 44.3 ttp180 -76.8 102.12 6.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.035 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.745 HD23 HD13 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -56.17 115.33 2.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.838 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.081 HD12 HD21 ' A' ' 22' ' ' LEU . 2.8 mt -82.49 -64.44 1.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 0.0 111.135 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -133.12 109.59 9.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.369 . . . . 0.0 111.174 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.553 HG13 ' HB3' ' A' ' 100' ' ' LEU . 23.4 t -89.41 123.69 41.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.903 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 4.4 m120 46.11 40.0 6.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.449 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.47 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 1.5 t-80 87.6 -21.92 0.16 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.823 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.0 t -82.37 129.52 37.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.721 0.296 . . . . 0.0 111.151 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -68.86 135.14 50.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.447 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 30.1 p -144.89 29.87 1.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.058 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.649 ' HG2' HD22 ' A' ' 72' ' ' LEU . 8.8 mtp-105 -72.83 -53.2 12.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.696 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.19 21.69 5.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.148 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.747 ' CE2' HD11 ' A' ' 90' ' ' LEU . 2.8 m-85 -81.27 169.44 17.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.872 0.367 . . . . 0.0 110.875 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -108.51 157.94 18.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.245 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.867 ' O ' HG23 ' A' ' 88' ' ' VAL . 8.0 p -51.39 -38.37 53.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.0 110.676 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -66.97 -21.45 65.96 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.222 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.63 HD23 ' CD2' ' A' ' 82' ' ' PHE . 1.0 OUTLIER -92.33 -32.31 15.03 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.003 0.43 . . . . 0.0 110.571 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.485 HG12 ' CD1' ' A' ' 91' ' ' ILE . 94.3 t -77.05 -35.68 23.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.982 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 84' ' ' CYS . 84.4 t -55.35 -52.64 69.9 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.817 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 49.3 Cg_endo -68.4 -43.22 4.48 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.205 1.937 . . . . 0.0 111.704 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.747 HD11 ' CE2' ' A' ' 82' ' ' PHE . 11.0 mt -53.97 -33.71 57.71 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.298 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.948 HG23 ' CD1' ' A' ' 98' ' ' LEU . 80.3 mt -78.92 -41.88 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.842 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.64 -5.55 38.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.36 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 4.5 pt-20 -98.38 -3.26 37.35 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.704 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.6 p -63.68 -31.03 72.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.232 0.539 . . . . 0.0 110.666 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.46 -48.9 1.88 Allowed Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.818 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 6.1 p30 -166.24 -39.48 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.744 0.307 . . . . 0.0 111.111 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -111.75 112.96 25.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.191 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.948 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -103.9 98.07 7.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.559 -179.111 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -95.94 118.5 32.69 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.745 HD13 HD23 ' A' ' 71' ' ' LEU . 1.4 pp -146.43 164.18 33.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.273 0.559 . . . . 0.0 111.978 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.892 HG12 HD22 ' A' ' 22' ' ' LEU . 26.0 t -119.22 109.36 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.147 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.733 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.5 pp -101.68 168.78 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.115 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.424 ' OG ' HG23 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -146.11 128.16 15.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.674 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.403 ' N ' ' HB ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -147.22 147.56 30.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.983 0.421 . . . . 0.0 111.329 -179.811 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -62.38 143.2 95.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.829 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo . . . . . 0 C--O 1.248 0.996 0 C-N-CA 122.514 2.142 . . . . 0.0 112.217 -179.958 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.983 0.42 . . . . 0.0 111.672 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.51 122.88 38.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.351 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.915 HD21 HD12 ' A' ' 72' ' ' LEU . 13.7 mt -60.53 147.0 42.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.584 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.468 ' HB2' HD11 ' A' ' 102' ' ' ILE . 15.1 m-70 -151.46 107.51 3.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.825 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.44 118.4 13.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.19 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.503 HG11 ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -126.25 141.58 45.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.076 0.465 . . . . 0.0 111.799 -179.223 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 95.9 m -134.38 106.64 7.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.778 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.929 HD11 HD11 ' A' ' 65' ' ' LEU . 17.1 mt -100.04 171.99 7.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.018 0.437 . . . . 0.0 111.774 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -123.52 137.25 54.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.34 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 1.5 tttt -95.24 162.91 13.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.033 0.444 . . . . 0.0 111.299 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -131.33 128.18 39.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.741 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.63 -27.16 6.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.248 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.08 26.93 20.6 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.504 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.87 140.09 13.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 110.892 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -96.57 -21.85 17.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.992 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -84.79 170.83 12.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.761 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -119.03 23.9 11.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.32 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 89.24 9.63 67.03 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.334 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.644 ' CD2' HD13 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -173.72 138.93 0.68 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.128 0.464 . . . . 0.0 111.627 179.781 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.8 m -99.35 154.69 18.0 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.596 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.639 ' HB ' HG12 ' A' ' 49' ' ' VAL . 35.0 m -116.34 159.23 16.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.42 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.825 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -117.98 178.31 4.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.047 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.09 144.8 26.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.194 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.2 115.45 5.05 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.242 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.29 -45.66 7.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.157 0.503 . . . . 0.0 111.343 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 45' ' ' LEU . 2.0 mm? -84.66 4.79 30.83 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.897 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.465 ' O ' ' C ' ' A' ' 47' ' ' LYS . 27.0 mt-10 -153.85 22.92 0.51 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.522 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 24.09 79.84 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -171.69 -157.4 13.51 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.365 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.825 HG13 ' O ' ' A' ' 41' ' ' ALA . 35.7 t -143.48 139.38 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.872 0.367 . . . . 0.0 111.15 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.81 168.57 19.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.359 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.513 HG22 ' CE2' ' A' ' 38' ' ' PHE . 72.2 t -74.21 121.54 25.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.793 0.33 . . . . 0.0 111.142 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -89.52 -31.55 17.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.29 -179.865 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -163.5 162.96 24.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.27 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -134.27 136.98 52.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.49 123.88 84.24 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.26 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.6 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 31.9 Cg_exo -58.5 105.99 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.525 2.15 . . . . 0.0 112.19 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 82.35 28.56 0.13 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.111 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.21 -173.39 24.23 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.276 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.444 ' C ' HD22 ' A' ' 27' ' ' LEU . 78.0 Cg_exo -49.87 -42.21 45.15 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.453 2.102 . . . . 0.0 112.171 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.583 ' HA2' HD21 ' A' ' 27' ' ' LEU . . . -64.23 -36.43 93.22 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.445 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.63 -32.96 64.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.062 0.458 . . . . 0.0 110.404 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.81 -34.43 75.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.992 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.05 -46.69 5.82 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.627 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.14 34.79 0.86 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.581 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.929 HD11 HD11 ' A' ' 27' ' ' LEU . 45.1 mt -75.81 133.49 40.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.738 0.304 . . . . 0.0 110.917 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -117.87 155.81 50.58 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.893 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.529 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 12.3 Cg_endo -55.69 146.42 65.77 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.621 2.214 . . . . 0.0 112.18 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.529 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 85.4 m-85 84.64 -5.39 0.99 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.384 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.531 ' CG ' HD13 ' A' ' 102' ' ' ILE . 7.0 m-20 -53.97 85.56 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.98 0.419 . . . . 0.0 110.774 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 68' ' ' TYR . 59.3 ttt180 -71.41 101.13 2.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.06 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.956 HD23 HD13 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -58.93 107.76 0.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.938 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.915 HD12 HD21 ' A' ' 22' ' ' LEU . 9.0 mt -82.39 -65.53 1.0 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.869 0.366 . . . . 0.0 110.881 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -119.56 127.5 53.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.892 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.9 104.68 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.101 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.468 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 1.2 m-20 64.71 36.94 7.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.725 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.468 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 2.8 t60 87.66 -14.68 0.42 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.503 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 79' ' ' THR . 21.4 t -83.63 114.06 23.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.8 0.333 . . . . 0.0 111.005 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -69.01 87.09 0.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.812 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 77' ' ' VAL . 15.8 p -95.95 32.08 1.98 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.115 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.73 ' HG2' HD22 ' A' ' 72' ' ' LEU . 36.2 mtp180 -66.28 -53.15 40.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.814 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -93.52 22.71 5.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.185 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.661 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.8 m-85 -82.01 167.94 18.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.951 0.405 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 87' ' ' VAL . 2.2 m-20 -106.99 160.87 15.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.383 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.873 ' O ' HG23 ' A' ' 88' ' ' VAL . 4.3 t -51.59 -41.35 61.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.666 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 10.0 p -62.56 -23.91 67.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.07 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.495 ' O ' HD12 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -94.12 -30.93 14.39 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.946 0.403 . . . . 0.0 110.972 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.517 HG12 ' CD1' ' A' ' 91' ' ' ILE . 41.3 t -78.89 -35.9 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.265 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 84' ' ' CYS . 91.6 t -57.76 -51.02 84.79 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.865 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . 0.65 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 14.3 Cg_exo -68.96 -46.19 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.425 2.083 . . . . 0.0 111.517 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.661 HD11 ' HE2' ' A' ' 82' ' ' PHE . 33.3 mt -54.91 -33.09 61.74 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.986 0.422 . . . . 0.0 110.546 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.856 HG23 ' CD1' ' A' ' 98' ' ' LEU . 62.6 mt -73.25 -46.76 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.477 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.57 -3.9 36.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.848 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.18 -7.23 22.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.656 0.265 . . . . 0.0 111.497 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.408 ' OG ' ' HG ' ' A' ' 98' ' ' LEU . 4.8 p -64.52 -16.59 62.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.355 . . . . 0.0 111.347 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.26 -144.0 16.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.217 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -74.38 -8.81 57.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.569 0.223 . . . . 0.0 111.452 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -142.1 141.84 32.75 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.784 0.326 . . . . 0.0 110.959 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.894 HD22 HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -119.56 97.12 5.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.242 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -92.0 118.37 30.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.956 HD13 HD23 ' A' ' 71' ' ' LEU . 1.6 pp -151.85 162.17 41.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.324 0.583 . . . . 0.0 112.093 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.854 HG12 HD22 ' A' ' 22' ' ' LEU . 39.1 t -121.49 109.02 23.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.946 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.879 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.4 pp -100.95 169.3 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.349 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.58 128.26 16.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.579 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.0 151.74 35.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.012 0.434 . . . . 0.0 111.478 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -62.68 115.1 14.6 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.971 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.249 1.054 0 C-N-CA 122.508 2.139 . . . . 0.0 112.267 -179.992 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.431 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 16' ' ' SER . 28.0 Cg_exo -62.21 -13.47 32.35 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.498 2.132 . . . . 0.0 112.667 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.521 ' HB ' ' HD3' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -163.0 -55.98 0.01 OUTLIER Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.476 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.521 ' HD3' ' HB ' ' A' ' 18' ' ' THR . 87.5 Cg_exo -47.72 95.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.326 2.017 . . . . 0.0 112.559 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.4 m -50.0 170.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.847 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -137.73 122.82 19.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.316 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.078 HD21 HD12 ' A' ' 72' ' ' LEU . 13.6 mt -60.03 137.5 58.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.102 0.477 . . . . 0.0 111.839 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.507 ' CD2' ' O ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -149.34 122.04 8.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.173 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.67 ' HD2' HG22 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -68.87 135.43 51.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.517 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.724 HG11 ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -137.37 143.05 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.143 0.496 . . . . 0.0 111.451 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.853 HG23 ' OD1' ' A' ' 99' ' ' ASP . 97.2 m -134.55 141.42 46.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.784 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.691 HD21 HD11 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -138.39 -179.63 5.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.08 0.467 . . . . 0.0 111.639 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.439 ' CD2' ' HG2' ' A' ' 97' ' ' LYS . 9.8 m-85 -138.96 125.35 20.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.391 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -94.87 164.94 12.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.997 0.427 . . . . 0.0 111.231 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.37 141.13 48.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.657 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.3 p -60.11 84.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 138.33 -3.68 3.03 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.217 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.6 151.34 29.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.864 0.364 . . . . 0.0 110.989 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -94.91 -10.53 30.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.388 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.83 175.87 13.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.68 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.861 ' CD2' HD12 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -94.15 2.1 56.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.619 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.33 18.23 5.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.382 -0.913 . . . . 0.0 113.25 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.69 ' HB3' HG23 ' A' ' 54' ' ' ILE . 39.4 p90 -174.04 134.45 0.45 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 117.035 0.418 . . . . 0.0 111.654 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.403 ' O ' ' N ' ' A' ' 52' ' ' LYS . 67.4 m -92.99 151.3 19.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.088 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.731 ' HB ' HG12 ' A' ' 49' ' ' VAL . 34.5 m -114.93 167.95 7.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.122 0.487 . . . . 0.0 111.837 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.506 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -133.85 140.69 47.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.782 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.13 121.75 18.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.817 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.422 ' HA3' ' CZ ' ' A' ' 50' ' ' TYR . . . -77.05 89.65 0.98 Allowed Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 pp -83.36 -2.47 55.82 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.54 ' H ' HD12 ' A' ' 45' ' ' LEU . 4.9 mp -77.17 -13.49 59.94 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.586 ' O ' ' CG ' ' A' ' 47' ' ' LYS . 0.6 OUTLIER -157.88 -83.78 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.001 179.334 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.586 ' CG ' ' O ' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -175.68 134.22 0.29 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.596 0.758 . . . . 0.0 110.233 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.62 -159.19 22.01 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.263 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.731 HG12 ' HB ' ' A' ' 40' ' ' VAL . 18.8 t -154.82 144.38 13.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.627 0.251 . . . . 0.0 110.852 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.422 ' CZ ' ' HA3' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -135.88 151.39 49.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.806 0.336 . . . . 0.0 111.028 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.623 HG22 ' CE1' ' A' ' 38' ' ' PHE . 44.7 t -60.49 123.59 13.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.02 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 39' ' ' SER . 0.1 OUTLIER -88.19 -27.54 21.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.169 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -169.68 140.34 2.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.738 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.69 HG23 ' HB3' ' A' ' 38' ' ' PHE . 2.7 mt -119.61 142.9 32.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.002 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -65.37 111.7 6.71 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.732 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.604 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 50.0 Cg_exo -55.53 109.17 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.464 2.109 . . . . 0.0 112.485 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 83.38 38.14 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.367 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.9 -170.41 13.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.171 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.415 ' HB2' ' O ' ' A' ' 36' ' ' PHE . 72.2 Cg_exo -49.77 -43.62 39.73 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.35 2.033 . . . . 0.0 111.817 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.46 ' HA2' HD12 ' A' ' 65' ' ' LEU . . . -64.85 -38.5 95.63 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.428 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -73.59 -32.84 64.32 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.007 0.432 . . . . 0.0 110.196 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 75.3 mt -73.01 -31.84 64.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.682 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.86 -40.92 34.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.362 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.34 8.4 6.49 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.031 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.724 ' HG ' HG11 ' A' ' 25' ' ' VAL . 1.2 mt -63.4 115.96 5.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.911 0.386 . . . . 0.0 110.988 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -107.33 141.56 23.23 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.512 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.598 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 4.1 Cg_exo -39.47 135.75 1.16 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.202 2.601 . . . . 0.0 112.727 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.598 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 78.2 m-85 85.44 -5.31 0.87 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.542 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.817 ' CB ' HD13 ' A' ' 102' ' ' ILE . 9.1 p-10 -56.22 85.1 0.01 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.062 0.458 . . . . 0.0 110.885 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.563 ' O ' HD23 ' A' ' 72' ' ' LEU . 42.4 ttt180 -66.66 102.61 0.94 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.476 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.92 HD22 HD22 ' A' ' 100' ' ' LEU . 3.2 mt -54.5 107.28 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.721 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.078 HD12 HD21 ' A' ' 22' ' ' LEU . 5.5 mt -82.98 -63.48 1.35 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.376 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -121.23 118.24 29.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.07 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.647 HG23 ' OG1' ' A' ' 79' ' ' THR . 27.1 t -100.55 120.21 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.249 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.442 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 0.7 OUTLIER 46.36 43.11 11.4 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.671 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.442 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.1 OUTLIER 86.59 -19.37 0.28 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.752 179.534 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.85 120.69 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.875 0.369 . . . . 0.0 111.087 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -70.13 85.94 0.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.671 HG21 HD13 ' A' ' 90' ' ' LEU . 27.9 p -96.51 30.93 2.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.138 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.664 ' HG2' HD22 ' A' ' 72' ' ' LEU . 4.6 mtp180 -68.4 -45.73 71.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.008 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -92.0 18.28 8.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.311 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.609 ' HE2' HD11 ' A' ' 90' ' ' LEU . 3.5 m-30 -82.16 171.81 13.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.883 0.373 . . . . 0.0 110.931 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.806 ' OD1' HD13 ' A' ' 86' ' ' LEU . 0.4 OUTLIER -114.07 166.87 11.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.33 179.357 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.809 ' O ' HG23 ' A' ' 88' ' ' VAL . 9.5 p -51.52 -44.62 62.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.256 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 26.2 p -61.13 -20.12 62.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.52 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.806 HD13 ' OD1' ' A' ' 83' ' ' ASP . 7.5 mp -99.45 -33.37 10.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.868 0.366 . . . . 0.0 111.165 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 83' ' ' ASP . 44.9 t -77.5 -35.9 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.963 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 84' ' ' CYS . 99.0 t -57.65 -52.36 74.9 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.735 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 45.7 Cg_endo -67.56 -44.8 4.04 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.149 1.899 . . . . 0.0 111.8 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.671 HD13 HG21 ' A' ' 79' ' ' THR . 13.1 mt -54.94 -31.64 60.58 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.045 0.45 . . . . 0.0 110.391 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.612 ' HA ' HD11 ' A' ' 98' ' ' LEU . 60.3 mt -72.57 -51.4 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.161 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.84 -3.06 42.7 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.976 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.97 -5.99 22.86 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.422 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 3.3 t -64.82 -14.73 60.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.741 0.305 . . . . 0.0 111.461 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.11 -142.97 16.34 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.663 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -74.65 -5.53 43.57 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.439 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 42.1 mtpt -146.23 151.3 37.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.874 0.369 . . . . 0.0 111.141 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.861 HD12 ' CD2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -129.67 97.86 4.65 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.285 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.853 ' OD1' HG23 ' A' ' 26' ' ' THR . 6.1 m-20 -99.21 117.9 34.71 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.92 HD22 HD22 ' A' ' 71' ' ' LEU . 2.3 pp -150.21 162.89 39.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.262 0.553 . . . . 0.0 112.253 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.916 HG12 HD22 ' A' ' 22' ' ' LEU . 15.1 t -114.1 109.53 28.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.895 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.848 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.6 pp -105.45 169.26 2.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.345 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.7 p -133.42 121.68 22.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.766 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.419 ' HB3' ' HA ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -136.44 147.68 47.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.171 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -74.57 122.67 88.04 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.779 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 C--O 1.25 1.11 0 C-N-CA 122.333 2.022 . . . . 0.0 112.385 -179.912 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.456 ' N ' ' HD2' ' A' ' 17' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 16' ' ' SER . 23.6 Cg_endo -61.79 -179.32 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.283 1.989 . . . . 0.0 112.128 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.522 ' CG2' ' HD2' ' A' ' 19' ' ' PRO . 24.8 m 59.03 146.06 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.156 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.522 ' HD2' ' CG2' ' A' ' 18' ' ' THR . 71.9 Cg_exo -50.72 178.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.597 2.198 . . . . 0.0 112.638 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.419 ' CG2' ' HB2' ' A' ' 103' ' ' SER . 28.9 m -46.07 170.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.711 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -132.51 122.81 25.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.479 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.949 HD21 ' CD1' ' A' ' 72' ' ' LEU . 13.5 mt -60.01 148.67 34.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.033 0.444 . . . . 0.0 111.651 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.5 122.87 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.221 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -71.51 119.24 15.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.509 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.598 HG11 ' HB3' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -117.5 148.17 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.134 0.493 . . . . 0.0 111.493 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.3 m -134.59 106.89 7.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.848 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.099 HD11 HD21 ' A' ' 65' ' ' LEU . 13.8 mt -101.08 173.66 6.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.24 0.543 . . . . 0.0 112.017 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.443 ' CZ ' ' HD3' ' A' ' 97' ' ' LYS . 6.3 m-85 -132.53 166.15 22.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.329 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -134.08 161.02 36.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.98 0.419 . . . . 0.0 111.29 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.44 148.02 51.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.657 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.4 m -58.05 -25.21 60.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.149 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.77 -14.71 51.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.854 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 5.3 mmt -81.29 145.0 31.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.911 0.386 . . . . 0.0 111.013 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -91.73 -10.15 41.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.24 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -154.13 -167.52 2.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.607 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.526 ' CE2' ' HB2' ' A' ' 98' ' ' LEU . 1.1 m-85 -95.89 24.4 5.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.723 0.297 . . . . 0.0 111.564 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.631 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 80.6 16.81 74.76 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.568 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.507 ' CE2' HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -172.05 124.42 0.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.192 0.52 . . . . 0.0 111.696 179.473 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.4 m -89.51 154.04 20.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.807 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.678 ' HB ' HG12 ' A' ' 49' ' ' VAL . 30.8 m -106.39 165.47 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.554 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.782 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -124.25 178.15 5.49 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.144 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -103.81 139.08 39.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.077 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.07 118.51 5.44 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.33 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.53 -28.5 15.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.927 0.394 . . . . 0.0 111.263 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tp -84.7 -7.68 59.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.856 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 47' ' ' LYS . 8.9 mm-40 -150.12 25.44 0.81 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.13 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER 26.26 63.08 0.08 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.012 0.434 . . . . 0.0 112.082 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -149.24 -164.55 11.69 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.499 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.782 HG13 ' O ' ' A' ' 41' ' ' ALA . 19.1 t -132.39 132.51 60.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.638 0.256 . . . . 0.0 111.087 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.461 ' CE1' ' NH1' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -133.41 145.86 50.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.289 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.507 HG22 ' CE2' ' A' ' 38' ' ' PHE . 58.6 t -49.06 124.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.057 0.456 . . . . 0.0 111.512 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.714 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 5.9 tptt -88.29 -30.6 19.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.002 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -175.88 160.92 2.42 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.386 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -128.04 142.7 43.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.978 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -65.26 147.6 98.48 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.592 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 58.6 Cg_endo -71.78 100.08 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.526 2.151 . . . . 0.0 112.391 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 83.1 29.35 0.09 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.16 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.03 -179.52 32.95 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.401 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.83 -29.52 53.2 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.588 2.192 . . . . 0.0 112.146 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.656 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . -64.19 -47.3 86.4 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.201 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.25 -32.84 67.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.12 0.486 . . . . 0.0 109.951 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.3 mt -73.47 -29.14 62.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.358 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.444 ' HA3' HD23 ' A' ' 27' ' ' LEU . . . -71.46 -48.49 29.77 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.178 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.88 10.49 3.51 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.446 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.099 HD21 HD11 ' A' ' 27' ' ' LEU . 1.3 pp -111.44 152.16 27.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.098 0.449 . . . . 0.0 110.93 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.428 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -138.51 179.11 1.4 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.673 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.477 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 74.8 Cg_exo -49.73 144.9 18.95 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.362 2.041 . . . . 0.0 112.353 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.495 ' O ' ' N ' ' A' ' 70' ' ' ARG . 11.6 m-85 90.32 -17.21 0.2 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.433 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.653 ' CG ' HD13 ' A' ' 102' ' ' ILE . 1.6 m-20 -53.34 83.75 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.007 0.432 . . . . 0.0 110.847 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.569 ' HD2' HD21 ' A' ' 72' ' ' LEU . 24.6 ttm-85 -67.92 99.61 0.86 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.987 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.031 HD23 HD13 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -64.31 107.98 1.48 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.02 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.949 ' CD1' HD21 ' A' ' 22' ' ' LEU . 6.5 mt -83.51 -56.31 3.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.467 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -137.06 116.68 12.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.784 0.326 . . . . 0.0 111.516 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.59 HG23 ' OG1' ' A' ' 79' ' ' THR . 22.5 t -89.14 109.04 19.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.535 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 75.54 -59.11 0.54 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.18 0.514 . . . . 0.0 110.517 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -167.47 -14.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.221 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.81 129.24 38.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.775 0.321 . . . . 0.0 111.172 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.73 87.23 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.59 ' OG1' HG23 ' A' ' 74' ' ' VAL . 20.4 p -96.41 26.48 4.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.288 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.761 ' CG ' HD22 ' A' ' 72' ' ' LEU . 2.3 tmm_? -74.93 -46.37 36.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.797 0.332 . . . . 0.0 110.698 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -92.49 19.45 7.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.627 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.9 m-85 -82.01 171.14 14.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.959 0.409 . . . . 0.0 110.95 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.481 ' O ' HG23 ' A' ' 87' ' ' VAL . 7.0 t70 -105.27 158.74 16.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.378 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.898 ' O ' HG23 ' A' ' 88' ' ' VAL . 23.7 m -51.34 -41.32 60.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.88 0.372 . . . . 0.0 110.724 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 17.3 t -65.24 -21.63 66.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.274 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.729 ' O ' HD12 ' A' ' 90' ' ' LEU . 10.1 mp -94.56 -30.06 14.57 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.016 0.436 . . . . 0.0 110.739 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.61 HG12 ' CD1' ' A' ' 91' ' ' ILE . 48.7 t -78.59 -35.79 19.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.254 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 84' ' ' CYS . 58.1 t -58.92 -50.99 85.03 Favored Pre-proline 0 C--N 1.331 -0.209 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.87 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.652 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.8 Cg_exo -67.3 -48.04 1.92 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.445 2.097 . . . . 0.0 111.465 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.729 HD12 ' O ' ' A' ' 86' ' ' LEU . 11.0 mt -54.93 -29.96 57.48 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.886 0.374 . . . . 0.0 110.511 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.803 ' HA ' HD11 ' A' ' 98' ' ' LEU . 48.3 mt -74.19 -46.53 44.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.343 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.81 -3.79 52.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.966 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -94.87 -15.77 23.42 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.445 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 1.4 t -65.15 -16.04 63.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.382 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.08 -141.41 15.6 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.696 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -73.99 -20.38 60.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.683 0.277 . . . . 0.0 111.441 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.443 ' HD3' ' CZ ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -127.73 152.38 47.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.674 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.982 HD22 HD23 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -135.77 97.76 3.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.778 0.323 . . . . 0.0 111.575 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.97 118.06 30.41 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 1.031 HD13 HD23 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -146.6 162.99 37.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.157 0.503 . . . . 0.0 111.968 -178.915 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.881 HG12 HD22 ' A' ' 22' ' ' LEU . 24.5 t -112.91 109.17 27.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.272 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.653 HD13 ' CG ' ' A' ' 69' ' ' ASP . 2.4 pp -109.17 169.19 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.183 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.419 ' HB2' ' CG2' ' A' ' 20' ' ' VAL . 19.0 p -136.15 107.03 6.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.953 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.11 136.14 53.03 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 0.9 OUTLIER -93.54 131.37 32.59 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.128 178.817 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 105' ' ' ASN . 8.7 Cg_exo . . . . . 0 C--O 1.249 1.05 0 C-N-CA 122.24 1.96 . . . . 0.0 112.19 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.401 ' CB ' ' HD3' ' A' ' 17' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.543 0.211 . . . . 0.0 111.442 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.401 ' HD3' ' CB ' ' A' ' 16' ' ' SER . 69.6 Cg_exo -50.79 -32.19 35.95 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.405 2.07 . . . . 0.0 112.451 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.53 ' HB ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -169.14 -52.98 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.309 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.53 ' HD3' ' HB ' ' A' ' 18' ' ' THR . 51.1 Cg_exo -54.08 120.4 7.89 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.242 1.961 . . . . 0.0 112.344 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.431 HG21 ' HB3' ' A' ' 103' ' ' SER . 27.4 m -44.27 161.23 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.629 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -120.32 122.75 41.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.601 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.723 HD22 HG12 ' A' ' 101' ' ' VAL . 14.1 mt -61.86 141.92 57.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.291 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.483 ' HB2' HD11 ' A' ' 102' ' ' ILE . 9.9 m-70 -144.15 108.51 4.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.839 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.95 102.5 4.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.607 HG23 HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -110.39 138.44 38.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.107 0.479 . . . . 0.0 111.828 -179.011 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.2 m -131.98 106.39 8.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.732 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.686 HD21 HD11 ' A' ' 65' ' ' LEU . 19.6 mt -98.81 177.1 5.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.978 0.418 . . . . 0.0 111.662 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -136.33 135.89 39.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.315 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -94.64 138.18 32.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.417 . . . . 0.0 111.097 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.54 131.04 54.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.795 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -60.59 84.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.838 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.77 -17.25 1.09 Allowed Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.882 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.09 167.94 19.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.848 0.356 . . . . 0.0 110.836 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -107.39 -10.52 15.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.37 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.44 -169.33 3.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.875 0.369 . . . . 0.0 110.896 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 1.6 m-85 -103.97 17.74 23.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.493 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.34 14.76 59.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.229 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.808 ' HB3' HD13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -173.31 130.62 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.112 0.482 . . . . 0.0 111.127 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.82 160.35 14.68 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.065 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.539 HG11 HD13 ' A' ' 71' ' ' LEU . 26.8 m -115.69 158.86 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.178 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' A' ' 52' ' ' LYS . . . -123.58 167.3 14.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.157 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.2 p30 -73.13 153.26 40.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.661 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -109.23 96.87 1.01 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.564 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.403 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -94.23 -17.97 22.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 0.0 111.302 179.881 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.691 HD12 ' HG2' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -85.02 -28.88 25.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.439 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.691 ' HG2' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -155.92 51.79 0.55 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.603 -179.734 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 21.62 96.44 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.643 179.49 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.34 -170.88 43.58 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.815 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 82' ' ' PHE . 93.7 t -133.08 131.58 58.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.678 0.275 . . . . 0.0 110.671 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.437 ' HB3' ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -138.59 157.11 46.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.876 0.37 . . . . 0.0 111.237 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.443 ' CG2' ' CD2' ' A' ' 38' ' ' PHE . 43.6 t -65.19 114.92 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.959 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -92.14 -28.32 17.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.26 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -142.8 156.49 44.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.603 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.808 HD13 ' HB3' ' A' ' 38' ' ' PHE . 1.2 mm -138.54 109.31 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.588 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -64.88 121.8 75.74 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.02 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.93 165.16 2.06 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.46 2.107 . . . . 0.0 112.267 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 35.77 75.34 0.06 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.983 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.93 -171.09 35.87 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.151 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.452 ' O ' HD22 ' A' ' 27' ' ' LEU . 46.8 Cg_exo -55.72 -29.75 72.67 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.387 2.058 . . . . 0.0 112.05 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.605 ' HA2' HD12 ' A' ' 65' ' ' LEU . . . -76.82 -43.83 16.72 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.578 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -73.77 -32.92 64.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.042 0.448 . . . . 0.0 110.357 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.2 mt -75.27 -32.93 61.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.037 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.4 -46.85 7.78 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.566 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 114.92 25.56 3.86 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.668 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.686 HD11 HD21 ' A' ' 27' ' ' LEU . 3.6 mt -73.73 141.95 46.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.857 0.361 . . . . 0.0 110.798 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -114.65 156.17 45.15 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.92 66.67 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.63 2.22 . . . . 0.0 112.04 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.437 ' O ' ' HB3' ' A' ' 50' ' ' TYR . 0.7 OUTLIER -178.16 -24.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.572 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.675 ' CB ' HD13 ' A' ' 102' ' ' ILE . 4.4 m-20 -44.0 94.96 0.01 OUTLIER 'General case' 0 C--O 1.231 0.082 0 CA-C-O 121.194 0.521 . . . . 0.0 111.277 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 50' ' ' TYR . 20.6 ttp180 -74.95 101.31 4.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.667 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.788 ' CD2' HD22 ' A' ' 100' ' ' LEU . 2.5 mp -53.98 107.05 0.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.278 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.693 HD11 ' HB2' ' A' ' 103' ' ' SER . 20.0 mt -85.12 -56.14 3.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.059 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -136.35 117.59 14.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.92 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.9 t -102.95 119.06 50.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.88 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.11 -61.58 0.49 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.128 0.489 . . . . 0.0 110.563 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.416 ' H ' ' H ' ' A' ' 77' ' ' VAL . 7.2 t-160 -168.07 -18.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.988 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.425 ' O ' HG23 ' A' ' 79' ' ' THR . 21.4 t -84.84 127.29 40.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.826 0.346 . . . . 0.0 111.198 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.69 93.61 0.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.745 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.49 HG21 HD13 ' A' ' 90' ' ' LEU . 14.5 p -95.75 34.41 1.51 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.198 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.52 ' HG2' HD22 ' A' ' 72' ' ' LEU . 3.3 mtt180 -67.99 -53.31 26.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.584 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -94.0 25.1 3.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.183 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.729 ' O ' HG23 ' A' ' 49' ' ' VAL . 2.5 m-30 -81.43 174.49 11.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.877 0.37 . . . . 0.0 110.805 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.51 ' C ' HG21 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -113.28 161.05 17.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.347 179.597 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.849 ' O ' HG23 ' A' ' 88' ' ' VAL . 42.0 t -51.82 -42.96 62.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.894 0.378 . . . . 0.0 110.664 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.4 t -63.54 -19.52 64.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.264 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.596 ' O ' HD12 ' A' ' 90' ' ' LEU . 3.2 mp -96.58 -32.77 12.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.042 0.449 . . . . 0.0 110.647 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.63 HG21 HG11 ' A' ' 49' ' ' VAL . 58.1 t -77.5 -36.01 22.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.9 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 84' ' ' CYS . 98.9 t -57.79 -52.2 76.14 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.839 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 41.5 Cg_endo -66.9 -45.4 4.29 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.336 2.024 . . . . 0.0 111.854 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.689 HD11 ' HE2' ' A' ' 82' ' ' PHE . 19.7 mt -54.64 -29.69 53.05 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.985 0.421 . . . . 0.0 110.681 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.913 HG23 ' CD1' ' A' ' 98' ' ' LEU . 70.2 mt -78.19 -48.18 23.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.839 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.19 -3.93 32.8 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.41 ' CG ' ' HA ' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -111.74 -4.21 14.74 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.489 ' OG ' HD23 ' A' ' 98' ' ' LEU . 2.4 t -64.73 -16.19 62.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.806 0.336 . . . . 0.0 111.367 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.46 -154.26 19.72 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.557 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -73.44 -9.25 58.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.612 0.244 . . . . 0.0 111.404 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -138.87 123.42 18.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.694 0.283 . . . . 0.0 110.743 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.913 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -107.3 97.4 7.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.19 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -98.62 118.23 34.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.788 HD22 ' CD2' ' A' ' 71' ' ' LEU . 1.9 pp -147.75 150.81 34.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.084 0.469 . . . . 0.0 111.965 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.723 HG12 HD22 ' A' ' 22' ' ' LEU . 11.6 t -105.43 108.85 25.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.792 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.768 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.5 pp -104.41 169.04 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.048 0.451 . . . . 0.0 111.503 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.693 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -137.71 123.87 20.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.382 179.69 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.87 126.9 25.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.255 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -75.24 112.95 20.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.828 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 C--O 1.249 1.04 0 C-N-CA 122.413 2.075 . . . . 0.0 112.252 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.67 0.272 . . . . 0.0 111.368 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.08 -47.62 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.448 2.099 . . . . 0.0 112.343 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.559 ' HB ' ' CD ' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -167.49 -60.38 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.216 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.559 ' CD ' ' HB ' ' A' ' 18' ' ' THR . 5.7 Cg_endo -47.69 125.41 11.09 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.593 2.195 . . . . 0.0 112.333 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 105' ' ' ASN . 29.1 m -42.78 131.13 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.15 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -97.24 121.82 39.57 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.628 HD13 ' CG1' ' A' ' 101' ' ' VAL . 4.6 pp -100.34 153.14 19.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.266 0.555 . . . . 0.0 112.356 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -148.31 149.66 32.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.281 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.87 103.52 10.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.49 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.827 HG11 ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -100.4 138.7 23.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.197 -179.669 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.5 m -130.21 110.2 11.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.364 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.994 HD11 HD21 ' A' ' 65' ' ' LEU . 57.9 mt -106.78 174.87 5.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.027 0.442 . . . . 0.0 111.498 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -127.73 154.97 44.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.593 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -114.25 140.45 48.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.035 0.445 . . . . 0.0 111.321 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 32' ' ' GLY . 10.5 t70 -112.79 134.67 54.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.372 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.8 m -56.86 85.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.052 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 30' ' ' ASP . . . 148.65 -18.41 1.28 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.83 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.16 140.67 34.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 111.028 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.52 -10.58 59.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.263 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.58 -167.58 2.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.918 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 98' ' ' LEU . 4.0 m-85 -99.38 28.25 4.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.293 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.12 21.55 48.99 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.999 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.622 ' CD2' HD13 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -174.38 128.01 0.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.792 0.33 . . . . 0.0 110.833 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.7 m -90.06 150.02 22.26 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.792 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 35.5 m -110.48 171.0 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.697 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.61 144.38 26.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.112 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -72.49 168.24 18.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -105.35 122.59 7.27 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.314 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.15 -23.75 17.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.038 0.447 . . . . 0.0 111.322 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.4 mp -84.28 -39.61 19.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.949 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.538 ' O ' ' O ' ' A' ' 47' ' ' LYS . 7.0 pt-20 -156.2 59.95 0.57 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.058 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.538 ' O ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 32.85 -166.85 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.623 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.77 176.01 42.75 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.534 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.655 HG21 ' CG2' ' A' ' 87' ' ' VAL . 58.9 t -133.79 132.16 56.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.872 0.367 . . . . 0.0 111.226 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -126.1 -175.11 3.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.372 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.472 HG11 HD11 ' A' ' 54' ' ' ILE . 56.0 t -95.77 122.11 46.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.978 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.27 -29.69 19.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.448 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -157.37 154.11 28.38 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.558 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.601 ' CD1' HD12 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -138.25 139.05 42.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.768 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.04 133.42 94.76 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.889 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.606 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 61.1 Cg_endo -72.85 98.05 0.95 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.493 2.129 . . . . 0.0 112.306 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 82.99 28.77 0.1 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.082 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -106.47 -160.83 22.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.434 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.56 -53.61 6.57 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.586 2.191 . . . . 0.0 112.308 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.06 -39.04 89.05 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.421 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.56 -32.88 64.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.084 0.468 . . . . 0.0 110.21 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 45.3 mt -73.73 -31.41 63.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.686 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.74 -55.59 7.28 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.331 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 139.38 -11.65 3.25 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.04 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.994 HD21 HD11 ' A' ' 27' ' ' LEU . 3.3 pp -80.44 135.34 36.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.973 0.416 . . . . 0.0 111.025 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.587 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 6.7 ptmt -120.03 167.52 12.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.397 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.641 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 99.9 Cg_exo -44.62 146.99 1.91 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.459 2.106 . . . . 0.0 112.7 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.641 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 2.2 m-85 82.98 -10.13 1.05 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.671 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.614 ' CG ' HD13 ' A' ' 102' ' ' ILE . 7.7 m-20 -54.74 88.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.05 0.453 . . . . 0.0 110.854 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 50' ' ' TYR . 12.3 ttm180 -66.83 101.04 0.77 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.02 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.758 HD23 HD22 ' A' ' 100' ' ' LEU . 3.4 mp -56.14 107.89 0.41 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.006 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.625 HD22 ' CG ' ' A' ' 80' ' ' ARG . 27.8 mt -82.99 -56.55 3.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.437 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -139.48 137.02 35.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.099 0.475 . . . . 0.0 111.385 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.545 ' O ' ' HB2' ' A' ' 75' ' ' ASN . 31.3 t -107.52 110.45 31.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.345 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.545 ' HB2' ' O ' ' A' ' 74' ' ' VAL . 5.4 m120 73.28 -58.84 0.58 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.678 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -167.47 -12.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.532 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.721 HG13 HG23 ' A' ' 79' ' ' THR . 12.2 p -84.22 133.15 29.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.924 0.393 . . . . 0.0 111.427 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.7 mmt-85 -72.07 89.79 1.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.943 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.721 HG23 HG13 ' A' ' 77' ' ' VAL . 37.7 p -96.28 21.01 9.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.333 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.625 ' CG ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -70.95 -42.53 69.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.885 0.374 . . . . 0.0 110.595 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.16 15.27 13.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.099 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.707 ' HE2' HD11 ' A' ' 90' ' ' LEU . 3.1 m-85 -81.92 172.24 13.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.927 0.394 . . . . 0.0 110.977 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.415 ' O ' HG23 ' A' ' 87' ' ' VAL . 20.3 t0 -111.88 162.53 15.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.383 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.894 ' O ' HG23 ' A' ' 88' ' ' VAL . 15.7 p -51.49 -43.67 62.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.759 0.314 . . . . 0.0 110.839 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.43 -22.22 64.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.332 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.55 ' O ' HD12 ' A' ' 90' ' ' LEU . 11.0 mp -95.99 -31.0 13.29 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.904 0.383 . . . . 0.0 111.127 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.655 ' CG2' HG21 ' A' ' 49' ' ' VAL . 59.4 t -78.95 -35.69 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.299 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.894 HG23 ' O ' ' A' ' 84' ' ' CYS . 62.1 t -58.73 -50.9 85.49 Favored Pre-proline 0 C--N 1.33 -0.26 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.913 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 14.0 Cg_exo -68.9 -44.57 2.62 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.444 2.096 . . . . 0.0 111.6 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.707 HD11 ' HE2' ' A' ' 82' ' ' PHE . 13.6 mt -54.62 -29.41 51.85 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.663 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.936 HG23 ' CD1' ' A' ' 98' ' ' LEU . 51.6 mt -78.07 -50.01 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.6 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.91 -4.05 26.06 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.931 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.14 -9.16 18.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.626 0.251 . . . . 0.0 111.581 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -64.8 -16.21 62.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.721 0.296 . . . . 0.0 111.374 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.83 -143.97 16.9 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.635 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -73.7 -10.15 59.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.584 0.231 . . . . 0.0 111.544 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -138.19 155.7 48.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.69 0.281 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.936 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -139.64 97.46 3.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.136 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -96.12 118.71 33.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.019 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.856 HD23 HD22 ' A' ' 98' ' ' LEU . 1.6 pp -150.04 163.92 36.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.142 0.496 . . . . 0.0 112.064 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.628 ' CG1' HD13 ' A' ' 22' ' ' LEU . 38.2 t -111.97 109.12 27.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.914 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.661 HG23 ' CD1' ' A' ' 100' ' ' LEU . 2.6 pp -100.67 168.65 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.999 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.578 ' HB3' HD11 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -142.46 129.72 21.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.545 179.321 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.419 ' NE ' ' CG ' ' A' ' 66' ' ' LYS . 10.2 ptt85 -139.7 124.88 18.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.919 0.39 . . . . 0.0 111.616 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.469 ' N ' HG12 ' A' ' 20' ' ' VAL . 2.0 p-10 -69.13 133.94 89.6 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.662 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo . . . . . 0 C--O 1.249 1.065 0 C-N-CA 122.457 2.105 . . . . 0.0 112.337 179.939 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.841 0.353 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.4 ' HD2' ' HG2' ' A' ' 106' ' ' PRO . 7.6 Cg_exo -72.82 -1.89 11.09 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.972 2.448 . . . . 0.0 112.647 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.506 ' CG2' ' HD2' ' A' ' 19' ' ' PRO . 21.8 m -157.14 143.86 13.34 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.123 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.506 ' HD2' ' CG2' ' A' ' 18' ' ' THR . 1.7 Cg_endo -42.37 168.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.084 2.523 . . . . 0.0 112.538 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.7 m -48.98 144.52 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.634 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -112.35 122.2 47.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.408 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.122 HD21 HD12 ' A' ' 72' ' ' LEU . 14.2 mt -60.81 141.94 56.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.601 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.537 ' CD2' HD11 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -153.24 120.92 5.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.146 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.705 ' HD2' HG22 ' A' ' 101' ' ' VAL . 2.6 tptp -69.88 124.43 24.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.903 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.649 HG11 ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -126.4 139.92 50.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.039 0.447 . . . . 0.0 111.121 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 95.0 m -134.34 117.51 16.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.198 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.733 HD21 HD11 ' A' ' 65' ' ' LEU . 2.6 mp -116.03 167.65 10.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.079 0.466 . . . . 0.0 111.572 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' A' ' 28' ' ' TYR . 2.9 m-85 -135.37 121.92 20.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.175 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -95.11 163.65 13.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.946 0.403 . . . . 0.0 111.262 -179.526 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.99 139.47 41.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.26 85.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.921 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.64 -23.58 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.831 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.91 156.7 27.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.932 0.396 . . . . 0.0 110.961 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -87.71 -10.54 50.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.434 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -155.35 -172.24 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.857 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -97.87 32.15 2.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.238 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.427 ' HA3' ' H ' ' A' ' 60' ' ' GLY . . . 96.93 -5.2 63.56 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.286 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.52 ' HD2' HG13 ' A' ' 51' ' ' VAL . 48.6 p90 -171.31 149.58 2.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.047 0.424 . . . . 0.0 111.739 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.9 m -104.5 133.83 48.71 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.433 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.659 ' HB ' HG12 ' A' ' 49' ' ' VAL . 33.1 m -93.46 170.8 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.751 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.744 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -139.38 162.31 35.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.148 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -83.25 130.31 35.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.709 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.516 ' HA3' ' CZ ' ' A' ' 50' ' ' TYR . . . -103.25 107.52 3.07 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.793 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 mp -94.67 -26.74 16.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.055 0.455 . . . . 0.0 111.03 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 tp -84.51 -6.09 59.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.714 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 47' ' ' LYS . 10.2 mt-10 -152.69 29.78 0.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.922 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 26.99 91.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.149 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.42 ' O ' ' HA3' ' A' ' 43' ' ' GLY . . . 157.9 160.4 10.2 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.273 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.744 HG13 ' O ' ' A' ' 41' ' ' ALA . 40.1 t -101.39 133.48 44.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.853 0.359 . . . . 0.0 111.361 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.516 ' CZ ' ' HA3' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -125.42 -177.46 3.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.454 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.867 HG11 HD11 ' A' ' 54' ' ' ILE . 37.2 t -89.62 162.2 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.649 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.516 ' N ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -144.9 -42.12 0.24 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.011 0.434 . . . . 0.0 110.833 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 34.3 m120 -123.43 130.49 52.78 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.578 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.867 HD11 HG11 ' A' ' 51' ' ' VAL . 1.1 mt -136.49 117.78 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.746 0.308 . . . . 0.0 111.331 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.13 110.54 5.28 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.592 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.445 ' HA ' ' HB2' ' A' ' 61' ' ' ASP . 16.5 Cg_exo -68.11 55.06 0.72 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.589 2.193 . . . . 0.0 112.777 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -173.82 -43.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.927 0.394 . . . . 0.0 111.255 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.9 -152.47 0.96 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.705 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.733 ' O ' HD23 ' A' ' 27' ' ' LEU . 28.7 Cg_exo -62.14 -35.26 76.3 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.801 2.334 . . . . 0.0 112.079 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.522 ' O ' HD12 ' A' ' 65' ' ' LEU . . . -56.5 -49.92 66.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.716 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 6.2 t70 -73.67 -36.18 65.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.061 0.457 . . . . 0.0 110.201 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 33.1 mt -60.83 -29.6 69.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.974 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.92 -51.42 3.8 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.419 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.38 47.71 0.85 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.724 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.733 HD11 HD21 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -106.41 165.63 11.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.079 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 68' ' ' TYR . 12.2 mtmm -132.13 159.57 71.6 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.665 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.453 ' O ' ' CG ' ' A' ' 68' ' ' TYR . 36.7 Cg_endo -65.55 64.43 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.487 2.125 . . . . 0.0 112.254 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.453 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 6.2 m-85 -174.12 -30.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.396 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.709 ' HB2' HD13 ' A' ' 102' ' ' ILE . 4.4 p30 -50.25 96.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.453 0.644 . . . . 0.0 110.799 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.605 ' O ' HD23 ' A' ' 72' ' ' LEU . 27.6 ttp180 -74.3 104.16 4.96 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.537 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.05 HD23 HD13 ' A' ' 100' ' ' LEU . 1.1 mt -54.42 108.42 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.027 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.122 HD12 HD21 ' A' ' 22' ' ' LEU . 5.2 mt -82.9 -66.02 0.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.132 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.32 132.19 53.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.892 0.377 . . . . 0.0 111.163 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.518 HG23 ' OG1' ' A' ' 79' ' ' THR . 29.7 t -104.58 103.85 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.8 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 75.31 -58.61 0.56 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.138 0.494 . . . . 0.0 110.565 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -167.67 -13.76 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.286 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.63 141.04 15.05 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.741 0.305 . . . . 0.0 111.309 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -70.2 128.13 35.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.519 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.518 ' OG1' HG23 ' A' ' 74' ' ' VAL . 41.6 p -143.76 25.93 1.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.172 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.731 ' HE ' HD13 ' A' ' 72' ' ' LEU . 6.9 mtt180 -73.32 -52.78 12.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.59 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -93.74 25.33 3.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.108 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.699 ' CE2' HD11 ' A' ' 90' ' ' LEU . 2.2 m-85 -81.58 166.37 20.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.897 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.526 ' C ' HG21 ' A' ' 49' ' ' VAL . 15.6 t70 -106.03 161.16 14.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.549 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.863 ' O ' HG23 ' A' ' 88' ' ' VAL . 1.9 t -51.69 -42.2 62.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.645 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 23.0 m -62.74 -22.91 66.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.213 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.574 ' O ' HD12 ' A' ' 90' ' ' LEU . 7.9 mp -93.0 -32.93 14.33 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.012 0.434 . . . . 0.0 110.854 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.6 HG12 ' CD1' ' A' ' 91' ' ' ILE . 58.8 t -77.6 -36.03 22.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.0 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 84' ' ' CYS . 77.8 t -54.73 -52.41 70.54 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.732 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 50.3 Cg_endo -68.63 -45.96 2.1 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.233 1.956 . . . . 0.0 111.788 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.699 HD11 ' CE2' ' A' ' 82' ' ' PHE . 27.0 mt -55.48 -32.06 62.53 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.607 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.912 ' HA ' HD11 ' A' ' 98' ' ' LEU . 60.7 mt -75.17 -44.86 42.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.599 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.11 -3.7 43.66 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.949 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -85.03 -15.82 42.84 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.742 0.306 . . . . 0.0 111.723 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.407 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 2.0 m -65.02 -25.01 67.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.982 0.42 . . . . 0.0 111.269 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.92 -61.48 3.74 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.189 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 29' ' ' LYS . 24.3 p30 -163.12 16.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.84 105.69 2.21 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.912 HD11 ' HA ' ' A' ' 91' ' ' ILE . 0.9 OUTLIER -107.39 107.52 18.46 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.0 117.93 35.46 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 1.05 HD13 HD23 ' A' ' 71' ' ' LEU . 1.3 pp -150.49 155.96 40.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.262 0.553 . . . . 0.0 112.373 -178.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.871 HG12 HD22 ' A' ' 22' ' ' LEU . 18.5 t -105.44 109.24 27.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.618 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.862 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.8 pp -100.96 169.45 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.189 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.9 102.63 5.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.605 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.426 ' HB3' ' HA ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -111.56 124.3 52.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.073 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -73.1 148.09 88.66 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.675 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.4 ' HG2' ' HD2' ' A' ' 17' ' ' PRO . 90.4 Cg_endo . . . . . 0 C--O 1.248 1.022 0 C-N-CA 122.606 2.204 . . . . 0.0 112.42 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.46 ' CB ' ' HD2' ' A' ' 17' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.627 0.251 . . . . 0.0 111.093 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 16' ' ' SER . 1.3 Cg_endo -43.08 -41.06 9.27 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.137 2.558 . . . . 0.0 113.179 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.501 ' CB ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -86.48 -56.76 0.35 Allowed Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.501 ' HD3' ' CB ' ' A' ' 18' ' ' THR . 7.0 Cg_exo -73.34 90.93 0.87 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.698 2.265 . . . . 0.0 112.561 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 103' ' ' SER . 18.0 m -46.89 170.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.432 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.58 122.21 28.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.734 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.84 HD22 HG12 ' A' ' 101' ' ' VAL . 14.7 mt -60.95 150.68 32.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.442 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.512 ' HB2' HD11 ' A' ' 102' ' ' ILE . 17.1 m-70 -156.67 110.56 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.986 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -71.4 113.56 8.56 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.792 HG11 ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -119.53 140.19 44.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.202 0.525 . . . . 0.0 112.099 -178.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.8 m -134.33 106.64 7.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.51 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.078 HD11 HD21 ' A' ' 65' ' ' LEU . 23.5 mt -102.79 173.54 6.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.222 0.534 . . . . 0.0 112.143 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 96' ' ' ASN . 8.5 m-85 -134.69 121.82 21.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.245 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.463 ' N ' ' CE1' ' A' ' 36' ' ' PHE . 5.2 tttt -104.26 152.05 22.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.928 0.394 . . . . 0.0 111.346 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -119.62 158.74 25.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.651 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.24 -27.94 64.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.173 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.13 -24.74 51.12 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.73 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 2.9 mmt -81.41 132.7 35.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.907 0.384 . . . . 0.0 111.043 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -78.67 -10.78 59.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.265 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -155.9 -168.82 2.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.639 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.463 ' CE1' ' N ' ' A' ' 29' ' ' LYS . 5.0 m-85 -97.02 29.72 2.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.334 . . . . 0.0 111.178 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.09 24.57 68.61 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.955 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.522 ' CD2' HD13 ' A' ' 65' ' ' LEU . 1.4 p90 -174.44 117.3 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.047 0.451 . . . . 0.0 111.427 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -88.9 146.44 24.93 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.872 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.721 ' HB ' HG12 ' A' ' 49' ' ' VAL . 34.4 m -108.62 171.07 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.656 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.693 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -137.81 156.89 47.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.14 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -72.38 144.34 48.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.693 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.438 ' HA3' ' CZ ' ' A' ' 50' ' ' TYR . . . -119.93 108.26 1.44 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.612 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 pp -94.14 -27.28 16.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.976 0.417 . . . . 0.0 110.985 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.4 -3.33 58.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.371 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 47' ' ' LYS . 7.2 mt-10 -152.97 27.6 0.53 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.675 -0.238 . . . . 0.0 110.981 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER 27.09 91.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.251 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.9 -154.37 25.3 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.479 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.721 HG12 ' HB ' ' A' ' 40' ' ' VAL . 21.3 t -142.11 139.31 30.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.36 . . . . 0.0 110.942 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.438 ' CZ ' ' HA3' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -126.68 177.73 6.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.509 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.502 HG11 HD11 ' A' ' 54' ' ' ILE . 61.4 t -86.46 123.29 39.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.182 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -88.13 -29.34 20.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.782 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -168.33 149.99 5.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.246 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.614 ' CD1' HD12 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -129.26 132.73 66.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.184 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -65.56 125.22 89.23 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.54 140.38 83.24 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.388 2.059 . . . . 0.0 112.547 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 40.8 32.34 0.15 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.991 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -101.66 -167.96 27.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.955 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.572 ' O ' HD22 ' A' ' 27' ' ' LEU . 18.0 Cg_endo -58.57 -34.27 98.72 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.313 2.009 . . . . 0.0 111.721 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.28 -44.67 42.34 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.427 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -71.98 -32.76 67.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.99 0.424 . . . . 0.0 109.942 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.1 mt -72.11 -29.24 63.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.443 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.37 -57.93 5.32 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.326 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.49 -20.83 1.69 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.449 -0.881 . . . . 0.0 113.091 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.078 HD21 HD11 ' A' ' 27' ' ' LEU . 3.1 pp -73.83 134.04 43.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.944 0.402 . . . . 0.0 111.0 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.488 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 15.1 mttt -120.74 167.63 12.51 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.607 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.677 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 99.9 Cg_exo -43.24 145.98 1.22 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.539 2.159 . . . . 0.0 112.606 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.677 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 4.3 m-85 83.21 -10.01 1.03 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.665 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.537 ' CG ' HD13 ' A' ' 102' ' ' ILE . 4.3 m-20 -54.61 87.06 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.972 0.415 . . . . 0.0 110.817 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.435 ' HD3' ' CE1' ' A' ' 50' ' ' TYR . 31.2 ttp180 -66.93 97.51 0.49 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.7 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.931 ' HA ' HG22 ' A' ' 102' ' ' ILE . 2.9 mt -55.58 107.39 0.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.127 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.788 HD12 HD21 ' A' ' 22' ' ' LEU . 23.8 mt -84.25 -65.92 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.121 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -122.57 140.97 52.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.027 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.555 HG12 ' OD1' ' A' ' 75' ' ' ASN . 41.3 t -124.69 112.63 32.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.055 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.555 ' OD1' HG12 ' A' ' 74' ' ' VAL . 5.1 m120 64.64 33.33 10.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.934 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.463 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 2.6 t-80 86.72 -14.89 0.47 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.611 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 36.7 t -83.27 138.65 18.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.828 0.346 . . . . 0.0 111.061 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -69.55 130.88 43.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.687 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.486 ' CG2' HD13 ' A' ' 90' ' ' LEU . 30.3 p -144.24 27.97 1.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.061 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.599 ' HG2' HD22 ' A' ' 72' ' ' LEU . 30.5 mtp180 -83.14 -42.5 17.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.627 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.11 10.31 27.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.041 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.617 ' CE2' HD11 ' A' ' 90' ' ' LEU . 3.1 m-85 -80.28 -176.45 5.63 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.959 0.409 . . . . 0.0 110.84 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -128.5 169.3 14.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.309 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.821 ' O ' HG23 ' A' ' 88' ' ' VAL . 53.3 t -51.18 -45.58 61.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.746 0.307 . . . . 0.0 110.755 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.28 -18.45 63.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.107 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.616 HD12 ' CD2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -95.5 -37.97 10.65 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.216 0.531 . . . . 0.0 111.04 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.48 HG11 HD13 ' A' ' 71' ' ' LEU . 46.6 t -77.03 -35.46 23.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.536 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 84' ' ' CYS . 89.8 t -57.53 -51.79 79.11 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.694 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.674 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 18.3 Cg_exo -65.67 -44.38 8.35 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.248 1.966 . . . . 0.0 111.181 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.617 HD11 ' CE2' ' A' ' 82' ' ' PHE . 52.7 mt -54.57 -32.08 57.88 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.04 0.447 . . . . 0.0 110.526 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.921 HG23 ' CD1' ' A' ' 98' ' ' LEU . 61.9 mt -73.29 -49.65 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.55 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.17 -2.69 32.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.796 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -93.32 -13.2 28.46 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.423 ' OG ' ' HG ' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -63.8 -27.63 69.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.05 0.453 . . . . 0.0 110.746 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.8 -53.3 0.82 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.865 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 6.7 m120 -165.6 -34.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.956 0.408 . . . . 0.0 110.403 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -104.71 108.7 20.3 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.248 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.921 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -101.93 97.35 7.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.708 -179.243 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -100.45 118.32 36.42 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.862 HD22 HD22 ' A' ' 71' ' ' LEU . 1.3 pp -148.1 159.51 43.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.226 0.536 . . . . 0.0 112.239 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.84 HG12 HD22 ' A' ' 22' ' ' LEU . 16.3 t -111.14 109.14 27.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.014 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.931 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.5 pp -104.19 169.6 2.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.38 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.714 ' OG ' HD21 ' A' ' 72' ' ' LEU . 9.0 p -143.19 125.4 15.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.332 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -144.99 137.16 25.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.986 0.422 . . . . 0.0 111.421 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.424 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 2.1 p-10 -62.57 132.21 94.37 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.743 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 122.422 2.082 . . . . 0.0 112.284 -179.959 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.441 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 59.0 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.663 0.268 . . . . 0.0 111.5 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 16' ' ' SER . 35.8 Cg_endo -67.8 -80.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.326 2.017 . . . . 0.0 112.593 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.943 HG22 ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -55.34 154.05 12.38 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.21 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.943 ' HD2' HG22 ' A' ' 18' ' ' THR . 32.1 Cg_exo -59.2 -144.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.792 2.328 . . . . 0.0 111.971 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 103' ' ' SER . 32.9 m -45.24 144.59 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.86 0.362 . . . . 0.0 111.531 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -116.0 122.39 45.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.647 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.83 HD22 HG12 ' A' ' 101' ' ' VAL . 15.4 mt -62.27 137.64 58.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.479 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.864 ' CE1' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -149.04 127.42 12.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.273 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -71.53 133.69 45.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.622 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.864 HG22 ' CE1' ' A' ' 23' ' ' HIS . 0.2 OUTLIER -135.87 147.72 28.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.949 0.404 . . . . 0.0 111.327 -179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.509 HG23 ' OD1' ' A' ' 99' ' ' ASP . 94.7 m -134.4 118.4 17.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.135 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.792 HD21 HD12 ' A' ' 65' ' ' LEU . 3.8 mt -110.11 168.77 9.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.959 0.409 . . . . 0.0 111.678 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -134.87 132.66 38.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.573 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -102.02 165.11 11.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.943 0.402 . . . . 0.0 111.254 -179.683 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.485 ' HB2' ' HE1' ' A' ' 33' ' ' MET . 13.3 t0 -144.14 141.68 30.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.687 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -55.87 -23.11 29.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.299 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.5 -13.11 56.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.996 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.485 ' HE1' ' HB2' ' A' ' 30' ' ' ASP . 0.1 OUTLIER -80.28 155.15 27.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.916 0.389 . . . . 0.0 111.197 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -100.99 -10.64 20.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.215 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -155.08 -174.62 5.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.588 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.684 ' CD2' HD12 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -97.46 32.55 2.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.27 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.99 1.08 90.2 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.009 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.469 ' O ' ' CD1' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -172.14 135.29 0.77 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.004 0.43 . . . . 0.0 111.43 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.9 m -96.32 148.23 22.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.51 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.527 ' HB ' HG12 ' A' ' 49' ' ' VAL . 33.9 m -104.15 169.07 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.674 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.757 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -141.42 167.01 23.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.999 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -80.58 153.28 28.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.839 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.01 115.48 2.45 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.505 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.547 ' O ' HD23 ' A' ' 44' ' ' LEU . 7.3 tt -94.31 -28.65 15.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.015 0.436 . . . . 0.0 111.148 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 mp -83.9 -55.9 3.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.781 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.4 mt-10 -89.78 17.11 6.95 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.431 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER 30.03 88.46 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.883 0.373 . . . . 0.0 111.934 -179.763 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.22 -141.99 7.26 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.515 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.757 HG13 ' O ' ' A' ' 41' ' ' ALA . 39.5 t -145.47 138.24 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.916 0.389 . . . . 0.0 110.988 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -131.1 179.44 6.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.416 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.461 HG11 HD11 ' A' ' 54' ' ' ILE . 47.9 t -87.65 123.6 40.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.017 0.437 . . . . 0.0 111.287 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.525 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -88.74 -31.33 18.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.225 -179.815 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -157.23 154.96 30.02 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.401 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.461 HD11 HG11 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -135.45 123.85 38.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.102 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -65.6 122.8 82.34 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.825 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.23 152.41 31.46 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.397 2.065 . . . . 0.0 112.439 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 38.65 33.94 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.007 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -118.79 -162.47 12.12 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.164 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.466 ' C ' HD23 ' A' ' 27' ' ' LEU . 71.8 Cg_exo -49.11 -54.33 5.61 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.5 2.133 . . . . 0.0 112.245 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.764 ' HA2' HD12 ' A' ' 65' ' ' LEU . . . -63.94 -33.15 86.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.717 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -73.71 -32.76 64.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.928 0.394 . . . . 0.0 110.409 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -74.1 -29.8 62.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.997 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -86.83 -34.83 10.67 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.463 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.2 32.83 3.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.518 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.792 HD12 HD21 ' A' ' 27' ' ' LEU . 11.4 mt -81.59 138.54 35.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.775 0.321 . . . . 0.0 111.042 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -126.32 160.58 56.96 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.715 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.436 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 78.1 Cg_exo -50.45 142.13 31.05 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.638 2.226 . . . . 0.0 112.332 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.436 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 18.4 m-85 85.44 -3.86 0.86 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.33 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.607 ' OD2' HD23 ' A' ' 65' ' ' LEU . 4.7 m-20 -53.19 89.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.056 0.455 . . . . 0.0 110.806 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 68' ' ' TYR . 69.0 ttt180 -76.99 111.64 12.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.999 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.858 ' HA ' HG22 ' A' ' 102' ' ' ILE . 0.9 OUTLIER -71.26 107.79 4.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.734 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.77 HD12 HD21 ' A' ' 22' ' ' LEU . 1.7 mt -83.48 -19.5 35.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.963 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.06 152.68 1.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.011 0.434 . . . . 0.0 111.528 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.483 HG12 ' OD1' ' A' ' 75' ' ' ASN . 40.2 t -124.0 112.6 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.611 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.483 ' OD1' HG12 ' A' ' 74' ' ' VAL . 8.3 m120 76.25 -58.19 0.54 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.107 0.48 . . . . 0.0 110.569 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.411 ' H ' ' H ' ' A' ' 77' ' ' VAL . 1.6 m-70 -167.06 -14.22 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.134 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.411 ' H ' ' H ' ' A' ' 76' ' ' HIS . 21.6 t -84.78 136.28 23.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-O 120.752 0.311 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -69.65 143.2 53.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.674 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.441 ' HA ' ' CG ' ' A' ' 82' ' ' PHE . 64.2 p -146.07 18.39 1.41 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.657 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.533 ' HG2' HD13 ' A' ' 72' ' ' LEU . 11.3 mtm180 -65.77 -51.66 57.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.895 0.379 . . . . 0.0 110.425 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -93.75 20.96 6.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.227 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.602 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.3 m-30 -81.32 169.18 17.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.797 0.332 . . . . 0.0 110.823 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 87' ' ' VAL . 2.4 t70 -109.76 160.33 16.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.668 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 24.8 p -51.87 -31.44 28.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.906 0.384 . . . . 0.0 110.713 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -21.67 62.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.196 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.618 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 5.7 mp -98.38 -30.23 12.69 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.084 0.469 . . . . 0.0 110.819 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.663 ' CG1' HD13 ' A' ' 71' ' ' LEU . 39.8 t -79.74 -35.98 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.451 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.77 HG12 ' HD3' ' A' ' 89' ' ' PRO . 5.0 p -64.22 -39.82 46.79 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.667 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.77 ' HD3' HG12 ' A' ' 88' ' ' VAL . 73.4 Cg_endo -74.37 -46.73 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.662 1.575 . . . . 0.0 111.227 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.602 HD11 ' HE2' ' A' ' 82' ' ' PHE . 81.5 mt -56.58 -28.35 60.04 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.108 0.48 . . . . 0.0 110.263 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.582 ' HA ' HD11 ' A' ' 98' ' ' LEU . 33.2 mt -75.92 -49.15 26.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.631 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.78 -2.56 47.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.064 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.64 -12.54 17.64 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.427 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -65.38 -14.3 60.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.698 0.285 . . . . 0.0 111.419 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.67 -145.15 17.77 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.609 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -73.56 -15.91 61.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.581 0.229 . . . . 0.0 111.393 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -125.98 139.68 53.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.798 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.684 HD12 ' CD2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -130.61 97.14 4.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.123 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.509 ' OD1' HG23 ' A' ' 26' ' ' THR . 2.5 m-20 -98.34 118.6 35.36 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.788 HD22 ' CD2' ' A' ' 71' ' ' LEU . 2.7 pp -146.86 158.79 44.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.224 0.535 . . . . 0.0 112.24 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.83 HG12 HD22 ' A' ' 22' ' ' LEU . 18.5 t -113.76 109.66 29.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.104 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.858 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.0 pp -108.78 169.56 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.372 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.415 ' N ' HD12 ' A' ' 102' ' ' ILE . 0.3 OUTLIER -130.54 127.84 39.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.859 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.03 141.43 34.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.934 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -71.42 135.78 84.06 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.766 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 C--O 1.248 1.003 0 C-N-CA 122.392 2.061 . . . . 0.0 112.252 -179.994 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.406 ' HA ' ' CG ' ' A' ' 106' ' ' PRO . 13.0 t . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.762 0.315 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.36 109.65 2.65 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.449 2.099 . . . . 0.0 112.092 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.571 ' CG2' ' HD2' ' A' ' 19' ' ' PRO . 31.3 m 59.82 150.08 0.08 OUTLIER Pre-proline 0 N--CA 1.453 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.504 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.571 ' HD2' ' CG2' ' A' ' 18' ' ' THR . 72.6 Cg_exo -52.78 -147.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.652 2.235 . . . . 0.0 112.572 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.0 m -36.98 153.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.927 0.394 . . . . 0.0 112.053 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -119.16 122.54 42.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.52 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.762 HD22 HG12 ' A' ' 101' ' ' VAL . 13.3 mt -60.72 135.46 57.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.499 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.533 ' HB2' HD11 ' A' ' 102' ' ' ILE . 40.2 m-70 -143.83 112.05 6.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.726 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 111.31 7.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.191 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.714 HG11 ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -117.66 139.55 44.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.122 0.487 . . . . 0.0 111.553 -179.185 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.5 m -133.02 106.74 7.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.97 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.917 HD21 HD21 ' A' ' 65' ' ' LEU . 2.4 mp -99.16 174.0 6.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.961 0.41 . . . . 0.0 111.902 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -131.33 140.16 49.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.332 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -109.22 165.21 11.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.952 0.406 . . . . 0.0 111.422 -179.559 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.65 137.22 53.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.681 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -59.25 85.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.138 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.06 14.36 2.75 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.163 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -81.68 166.88 19.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.89 0.345 . . . . 0.0 110.807 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -92.52 -24.29 18.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.152 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -157.79 -167.89 2.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.755 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -103.6 31.05 4.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.892 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.45 0.06 80.06 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.085 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.439 ' HB2' HG12 ' A' ' 54' ' ' ILE . 18.4 p90 -172.41 153.74 3.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.985 0.392 . . . . 0.0 111.461 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.9 p -119.03 148.01 43.48 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.552 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.725 HG11 ' CD1' ' A' ' 71' ' ' LEU . 30.5 m -113.35 157.6 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.474 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.505 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -114.14 177.54 4.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.208 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.79 160.86 21.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.27 115.29 2.49 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.389 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.545 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.4 OUTLIER -94.61 -35.23 12.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.11 0.481 . . . . 0.0 111.191 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 tp -84.26 -53.78 5.25 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.055 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.4 mm-40 -90.53 16.37 9.09 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.558 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 46' ' ' GLU . 3.5 mmtt 29.05 82.91 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 174.97 -150.87 11.52 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.492 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 82' ' ' PHE . 88.8 t -138.38 139.83 40.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.824 0.345 . . . . 0.0 110.914 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.482 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -139.51 162.72 34.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.605 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.634 ' HA ' HG12 ' A' ' 40' ' ' VAL . 50.1 t -62.36 162.0 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.592 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.529 ' N ' HG12 ' A' ' 51' ' ' VAL . 16.8 pttt -147.0 -35.36 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 0.0 111.579 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.416 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 15.6 m-80 -144.49 139.03 28.02 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.981 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.646 HD11 HD12 ' A' ' 65' ' ' LEU . 1.0 OUTLIER -132.95 133.97 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.0 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.431 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -65.89 142.4 98.06 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.913 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 55' ' ' ARG . 34.7 Cg_exo -57.66 127.19 24.35 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.544 2.162 . . . . 0.0 112.531 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 43.28 30.79 0.33 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.875 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.92 -159.48 32.52 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.935 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -51.87 -55.92 3.44 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.312 2.008 . . . . 0.0 111.876 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.404 ' HA2' ' CD2' ' A' ' 27' ' ' LEU . . . -56.93 -38.66 86.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.671 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -73.37 -32.63 64.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.967 0.413 . . . . 0.0 110.183 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.6 mt -77.32 -30.39 54.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.842 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.28 -56.67 6.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.426 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.97 33.23 0.93 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.656 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.917 HD21 HD21 ' A' ' 27' ' ' LEU . 1.7 pp -118.5 132.06 56.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 110.905 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.469 ' CB ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -117.87 169.51 7.53 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.783 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 1.6 Cg_endo -44.63 146.14 2.35 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.646 2.231 . . . . 0.0 112.239 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.486 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 8.5 m-85 91.14 -21.13 0.11 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.095 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.684 ' CG ' HD13 ' A' ' 102' ' ' ILE . 7.2 m-20 -53.75 85.49 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.166 0.508 . . . . 0.0 110.669 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -68.49 105.91 2.37 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.195 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.725 ' CD1' HG11 ' A' ' 40' ' ' VAL . 1.9 mp -63.07 107.9 1.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.758 HD22 ' CG ' ' A' ' 80' ' ' ARG . 10.0 mt -83.38 -65.85 0.96 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.17 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -119.38 126.82 52.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.157 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.611 HG23 ' OG1' ' A' ' 79' ' ' THR . 43.1 t -109.62 107.1 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.712 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 74.65 -58.59 0.58 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.139 0.495 . . . . 0.0 110.537 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -167.22 -18.02 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.951 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 79' ' ' THR . 21.5 t -85.36 125.27 40.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-O 120.792 0.329 . . . . 0.0 111.129 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.65 84.36 0.45 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.649 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.611 ' OG1' HG23 ' A' ' 74' ' ' VAL . 17.7 p -94.62 43.94 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.17 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.758 ' CG ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -80.99 -47.02 14.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.646 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -92.93 21.29 5.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.055 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.591 ' HE2' HD11 ' A' ' 90' ' ' LEU . 3.2 m-85 -81.69 170.82 15.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.702 0.287 . . . . 0.0 110.954 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.423 ' C ' HG21 ' A' ' 49' ' ' VAL . 2.6 m-20 -106.26 160.26 15.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.404 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.885 ' O ' HG23 ' A' ' 88' ' ' VAL . 7.4 p -51.76 -42.12 62.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 110.694 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.7 m -63.44 -23.28 67.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.236 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.471 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -93.63 -31.13 14.6 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.906 0.384 . . . . 0.0 110.95 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.739 HG12 ' CD1' ' A' ' 91' ' ' ILE . 60.7 t -79.62 -35.95 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.359 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 84' ' ' CYS . 95.1 t -57.14 -50.84 85.86 Favored Pre-proline 0 C--N 1.331 -0.219 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.938 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.639 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 12.0 Cg_exo -70.43 -47.14 0.77 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.509 2.14 . . . . 0.0 111.512 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.591 HD11 ' HE2' ' A' ' 82' ' ' PHE . 44.8 mt -53.92 -30.75 47.62 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.517 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.942 HG23 ' CD1' ' A' ' 98' ' ' LEU . 63.9 mt -78.28 -42.04 26.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.505 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.41 -4.69 40.94 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.454 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 10.3 pt-20 -107.38 -3.44 19.58 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.432 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 6.9 t -64.38 -15.99 61.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.801 0.334 . . . . 0.0 111.411 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.5 -144.61 17.41 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.592 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.39 -10.67 59.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.55 0.214 . . . . 0.0 111.425 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -140.76 157.29 45.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.813 0.34 . . . . 0.0 110.97 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.942 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -138.33 97.2 3.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.033 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.14 118.23 31.25 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.825 HD23 HD22 ' A' ' 98' ' ' LEU . 1.1 pp -148.37 164.03 35.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.257 0.551 . . . . 0.0 112.025 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.762 HG12 HD22 ' A' ' 22' ' ' LEU . 48.4 t -115.79 108.93 26.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.103 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.684 HD13 ' CG ' ' A' ' 69' ' ' ASP . 2.5 pp -101.82 169.27 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.409 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.17 122.18 15.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.676 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.404 ' CG ' ' HB2' ' A' ' 68' ' ' TYR . 7.6 tmm_? -133.48 138.66 46.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.153 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -80.93 154.5 72.91 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.7 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.406 ' CG ' ' HA ' ' A' ' 16' ' ' SER . 64.6 Cg_endo . . . . . 0 C--O 1.25 1.092 0 C-N-CA 122.497 2.131 . . . . 0.0 112.304 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.486 ' CB ' ' HD2' ' A' ' 106' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.602 0.239 . . . . 0.0 111.042 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.62 -23.36 25.44 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.304 2.003 . . . . 0.0 111.93 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.551 ' HB ' ' HD3' ' A' ' 19' ' ' PRO . 1.1 m 176.98 -50.95 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.624 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.551 ' HD3' ' HB ' ' A' ' 18' ' ' THR . 34.2 Cg_exo -58.17 92.73 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.405 2.07 . . . . 0.0 112.446 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.528 HG21 ' HB3' ' A' ' 103' ' ' SER . 11.4 m -47.34 170.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.748 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -123.45 122.38 38.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.597 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.939 HD21 HD12 ' A' ' 72' ' ' LEU . 15.5 mt -62.63 138.99 58.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.712 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.611 ' HB2' HD11 ' A' ' 102' ' ' ILE . 11.0 m-70 -145.09 120.82 10.52 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.677 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.13 113.2 11.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.465 HG21 HG12 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -117.42 139.84 42.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.144 0.497 . . . . 0.0 111.849 -179.041 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.7 m -134.03 106.43 7.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.955 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.053 HD21 HD21 ' A' ' 65' ' ' LEU . 2.3 mp -99.91 168.41 9.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.919 0.39 . . . . 0.0 111.483 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 96' ' ' ASN . 4.9 m-85 -124.92 143.95 50.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.748 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -104.83 159.45 15.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.113 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -129.97 140.97 50.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.92 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.7 p -57.97 -28.73 64.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.064 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.47 -22.53 46.99 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.683 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 18.0 mmm -81.0 162.44 23.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.369 . . . . 0.0 110.959 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.84 -10.56 15.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.325 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.63 -166.97 2.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.798 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.51 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 7.5 m-85 -97.46 32.75 2.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.201 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 48.39 40.63 23.44 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.209 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.902 ' HB2' HD13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -174.65 116.37 0.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.076 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.43 155.19 19.37 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 121.112 0.482 . . . . 0.0 112.155 -177.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.769 HG11 HD11 ' A' ' 71' ' ' LEU . 34.1 m -116.1 169.86 6.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.07 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.856 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . . . -129.51 176.74 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.87 0.367 . . . . 0.0 111.358 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.8 140.76 30.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.764 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.71 103.57 1.65 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.521 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 mp -94.17 -31.54 14.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.184 0.516 . . . . 0.0 110.828 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.498 HD12 ' HG3' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -84.28 -3.91 58.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.506 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.498 ' HG3' HD12 ' A' ' 45' ' ' LEU . 11.2 mt-10 -153.07 27.01 0.53 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.098 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 26.99 95.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 159.99 -155.46 26.58 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.435 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.744 HG13 ' O ' ' A' ' 41' ' ' ALA . 80.5 t -141.76 138.01 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.328 . . . . 0.0 111.042 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.462 ' CD1' ' HG3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -134.43 165.09 25.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.41 179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.08 HG11 HD11 ' A' ' 54' ' ' ILE . 3.8 t -63.84 162.76 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.625 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.856 ' HE2' ' HB2' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -145.4 -36.97 0.28 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.028 0.442 . . . . 0.0 111.325 -179.403 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.557 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 2.6 m120 -140.24 145.21 37.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.326 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 1.08 HD11 HG11 ' A' ' 51' ' ' VAL . 5.0 mm -134.92 119.07 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.907 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.56 131.98 94.93 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.714 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.621 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 67.1 Cg_endo -74.0 121.82 7.22 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.491 2.127 . . . . 0.0 112.443 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 87.77 -20.8 0.19 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.73 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.16 -170.74 30.87 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.415 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.672 ' HA ' HD12 ' A' ' 62' ' ' LEU . 55.1 Cg_exo -51.93 -25.77 22.82 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.529 2.153 . . . . 0.0 112.247 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' HA3' HG23 ' A' ' 54' ' ' ILE . . . -65.47 -45.83 88.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.367 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -73.55 -33.03 64.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.947 0.403 . . . . 0.0 110.3 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.672 HD12 ' HA ' ' A' ' 59' ' ' PRO . 57.3 mt -62.07 -37.97 87.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.821 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.16 -52.05 5.45 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.38 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.35 44.99 1.91 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.611 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.053 HD21 HD21 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -111.56 126.21 54.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.928 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.8 mttp -75.12 164.69 59.58 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.107 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.62 64.78 3.83 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.767 2.311 . . . . 0.0 112.366 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.463 ' HB3' ' HG3' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -176.32 -25.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.527 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.727 ' CG ' HD13 ' A' ' 102' ' ' ILE . 71.1 m-20 -39.56 90.84 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.455 0.645 . . . . 0.0 111.852 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.574 ' O ' HD23 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -67.63 99.3 0.77 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.644 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.005 HD23 HD13 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -56.72 111.68 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.527 -179.518 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.939 HD12 HD21 ' A' ' 22' ' ' LEU . 6.5 mt -82.97 -44.82 14.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.693 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.6 142.37 32.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.762 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.599 HG23 ' OG1' ' A' ' 79' ' ' THR . 47.8 t -129.85 152.04 36.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.88 0.371 . . . . 0.0 111.492 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.0 m120 40.21 31.85 0.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.98 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 76.01 42.98 0.18 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.845 0.355 . . . . 0.0 110.898 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 72.8 t -152.15 152.95 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.05 129.06 38.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.73 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.599 ' OG1' HG23 ' A' ' 74' ' ' VAL . 66.8 p -144.47 28.14 1.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.017 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.694 ' CG ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -83.74 -44.95 13.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.736 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -92.28 15.77 13.03 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.34 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.555 ' CD2' HG22 ' A' ' 79' ' ' THR . 5.5 m-30 -81.85 167.53 18.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.872 0.368 . . . . 0.0 110.903 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.534 ' O ' HG23 ' A' ' 87' ' ' VAL . 0.9 OUTLIER -106.81 162.05 14.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.455 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.893 ' O ' HG23 ' A' ' 88' ' ' VAL . 22.9 p -51.8 -38.64 56.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.762 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 16.1 p -65.89 -24.6 66.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.4 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.727 ' O ' HD12 ' A' ' 90' ' ' LEU . 0.1 OUTLIER -93.4 -29.2 15.71 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.012 0.434 . . . . 0.0 110.913 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.661 HG21 ' HB ' ' A' ' 49' ' ' VAL . 45.0 t -78.0 -35.57 20.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.311 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 84' ' ' CYS . 94.1 t -58.79 -51.16 83.82 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.791 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.649 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 17.0 Cg_exo -67.11 -44.54 4.94 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.555 2.17 . . . . 0.0 111.428 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 86' ' ' LEU . 8.0 mt -54.07 -30.99 50.39 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.072 0.463 . . . . 0.0 110.431 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.628 HG23 HD12 ' A' ' 98' ' ' LEU . 71.6 mt -79.08 -48.86 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.128 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.5 -4.16 28.78 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.485 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -103.39 8.19 38.07 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.413 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 0.9 OUTLIER -64.41 -39.43 93.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.227 0.537 . . . . 0.0 110.238 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.59 -47.28 1.11 Allowed Glycine 0 C--N 1.32 -0.36 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.009 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.426 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -166.35 -36.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.682 0.277 . . . . 0.0 111.388 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -123.49 114.47 20.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.428 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.628 HD12 HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -100.99 97.58 8.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.548 -179.256 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -95.91 118.12 31.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 1.005 HD13 HD23 ' A' ' 71' ' ' LEU . 1.1 pp -146.44 156.04 43.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.993 0.425 . . . . 0.0 111.892 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.878 HG12 HD22 ' A' ' 22' ' ' LEU . 16.5 t -106.34 109.37 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.26 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.727 HD13 ' CG ' ' A' ' 69' ' ' ASP . 2.6 pp -106.28 170.12 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.46 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.528 ' HB3' HG21 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -142.5 130.78 22.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.787 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' A' ' 69' ' ' ASP . 0.6 OUTLIER -148.03 139.73 23.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.919 0.39 . . . . 0.0 111.123 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 6.2 p30 -79.48 120.88 81.82 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.397 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' A' ' 16' ' ' SER . 20.9 Cg_exo . . . . . 0 C--O 1.248 0.999 0 C-N-CA 122.324 2.016 . . . . 0.0 112.232 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.419 ' CB ' ' HD3' ' A' ' 17' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 120.557 0.218 . . . . 0.0 111.556 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.419 ' HD3' ' CB ' ' A' ' 16' ' ' SER . 5.5 Cg_exo -74.36 49.36 2.03 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.705 2.27 . . . . 0.0 112.55 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.433 ' HB ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -169.77 -51.91 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.136 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.433 ' HD3' ' HB ' ' A' ' 18' ' ' THR . 2.4 Cg_endo -85.72 24.28 0.77 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.119 2.546 . . . . 0.0 112.875 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.442 HG21 ' OG ' ' A' ' 103' ' ' SER . 6.7 m -42.94 135.69 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.76 122.32 38.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.324 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.917 HD21 ' CD1' ' A' ' 72' ' ' LEU . 14.0 mt -60.46 149.16 35.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.089 0.471 . . . . 0.0 111.759 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.5 117.91 3.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.193 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -70.73 131.97 44.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.903 HG11 ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -132.85 141.32 45.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 0.0 111.229 -179.683 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.1 m -134.63 109.48 8.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.237 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.767 HD21 HD11 ' A' ' 65' ' ' LEU . 8.1 mt -107.15 166.49 10.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.015 0.436 . . . . 0.0 111.726 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -121.03 147.08 46.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.491 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.14 155.1 17.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.939 0.4 . . . . 0.0 111.124 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.04 156.53 23.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.828 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.4 t -68.27 82.59 0.24 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.026 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.41 21.95 5.32 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.725 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.77 124.62 29.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 0.0 110.817 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -72.13 -10.9 60.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.343 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.33 -175.14 5.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.726 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.568 ' CD2' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -106.9 29.82 6.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.844 0.354 . . . . 0.0 111.115 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.3 7.47 72.86 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.623 -0.798 . . . . 0.0 113.114 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.484 ' HB2' HG12 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -171.6 148.69 2.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.038 0.419 . . . . 0.0 111.608 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 52' ' ' LYS . 2.4 m -117.84 144.57 45.28 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.594 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 51' ' ' VAL . 27.1 m -112.39 165.61 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.775 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.765 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . . . -129.6 161.59 30.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.051 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.4 p-10 -72.49 167.37 20.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.89 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.74 126.26 8.4 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.354 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.47 0.14 55.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.49 0.186 . . . . 0.0 111.422 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 93.0 mt -154.05 19.7 0.51 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.501 0.191 . . . . 0.0 111.355 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.463 ' O ' ' C ' ' A' ' 47' ' ' LYS . 81.8 mm-40 -155.36 22.24 0.42 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.196 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER 24.82 50.22 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.433 0.458 . . . . 0.0 112.129 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.25 -166.21 11.63 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.535 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.618 HG12 ' HB ' ' A' ' 40' ' ' VAL . 72.2 t -135.22 139.7 46.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.889 0.376 . . . . 0.0 111.219 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.51 153.99 47.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.507 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.711 ' HA ' HG12 ' A' ' 40' ' ' VAL . 51.4 t -57.07 162.21 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.616 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.765 ' HE2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -142.85 -34.13 0.44 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.876 0.369 . . . . 0.0 111.591 -179.419 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 37.2 m-80 -144.28 123.95 13.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.661 HD11 HG11 ' A' ' 51' ' ' VAL . 1.1 mt -123.57 123.25 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.268 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.95 117.36 44.84 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.411 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.418 ' HA ' ' HB2' ' A' ' 61' ' ' ASP . 58.1 Cg_endo -71.48 56.4 2.18 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.468 2.112 . . . . 0.0 112.599 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -173.04 -51.63 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.143 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.86 -170.48 0.29 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.654 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.509 ' HA ' HD12 ' A' ' 62' ' ' LEU . 50.0 Cg_exo -53.35 -31.87 58.99 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.626 2.217 . . . . 0.0 112.36 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.83 -51.58 56.14 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.575 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.418 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 7.5 t70 -73.48 -33.01 64.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.958 0.408 . . . . 0.0 110.396 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 59' ' ' PRO . 90.1 mt -59.38 -41.64 89.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.031 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.1 -50.93 6.47 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.543 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.26 42.56 0.35 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.442 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.903 ' CD2' HG11 ' A' ' 25' ' ' VAL . 19.3 mt -91.42 147.54 22.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.783 0.325 . . . . 0.0 110.845 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.23 161.88 55.01 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 50.9 Cg_exo -53.82 147.92 39.43 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.596 2.197 . . . . 0.0 112.154 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.465 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 4.8 m-85 88.62 -12.55 0.42 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.229 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.594 ' CG ' HD13 ' A' ' 102' ' ' ILE . 1.1 m-20 -52.88 85.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.93 0.395 . . . . 0.0 110.965 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.599 ' O ' HD23 ' A' ' 72' ' ' LEU . 21.2 ttm180 -74.04 95.12 2.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.462 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.973 HD23 HD13 ' A' ' 100' ' ' LEU . 1.7 mt -56.26 112.24 1.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.917 ' CD1' HD21 ' A' ' 22' ' ' LEU . 4.9 mt -81.2 -64.0 1.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.64 140.53 46.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.095 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.896 ' O ' HG12 ' A' ' 77' ' ' VAL . 24.3 t -118.6 116.16 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.002 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.461 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 0.2 OUTLIER 68.74 28.25 5.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.613 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.461 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER 85.81 -7.03 0.82 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.648 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.896 HG12 ' O ' ' A' ' 74' ' ' VAL . 4.6 p -83.97 134.61 26.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 120.818 0.342 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.4 mtt85 -70.56 118.2 13.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.95 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.692 HG23 HG13 ' A' ' 77' ' ' VAL . 30.6 p -145.47 35.94 1.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.668 ' CG ' HD22 ' A' ' 72' ' ' LEU . 1.6 ttp180 -75.87 -48.74 20.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.817 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -92.82 25.58 3.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.063 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.723 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.4 m-85 -81.75 170.08 16.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.957 0.408 . . . . 0.0 110.861 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.21 159.09 16.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.272 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.889 ' O ' HG23 ' A' ' 88' ' ' VAL . 6.5 p -51.38 -41.53 60.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 110.726 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.2 m -63.36 -24.57 67.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.164 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.615 ' O ' HD12 ' A' ' 90' ' ' LEU . 10.9 mp -91.09 -30.29 16.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.012 0.434 . . . . 0.0 110.847 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.464 HG12 ' CD1' ' A' ' 91' ' ' ILE . 65.7 t -79.3 -35.82 17.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.28 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 84' ' ' CYS . 68.0 t -55.3 -51.3 80.95 Favored Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.696 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.656 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 14.5 Cg_exo -68.33 -46.53 2.03 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.39 2.06 . . . . 0.0 111.294 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.723 HD11 ' HE2' ' A' ' 82' ' ' PHE . 15.4 mt -54.65 -29.38 52.2 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.008 0.433 . . . . 0.0 110.421 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.639 HG23 ' CD1' ' A' ' 98' ' ' LEU . 47.7 mt -73.91 -51.56 23.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.205 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.39 -2.74 36.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.884 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -92.15 -7.47 48.34 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.413 ' HB2' ' HG ' ' A' ' 98' ' ' LEU . 1.5 t -64.59 -16.51 62.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.873 0.368 . . . . 0.0 111.609 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.56 -52.68 3.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.687 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -165.98 -45.75 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.75 0.309 . . . . 0.0 110.985 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -101.04 107.22 18.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.475 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.639 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.9 OUTLIER -95.96 97.84 9.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.579 -179.428 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -101.34 118.2 36.49 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.973 HD13 HD23 ' A' ' 71' ' ' LEU . 1.3 pp -147.87 163.56 36.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.105 0.478 . . . . 0.0 112.088 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.892 HG12 HD22 ' A' ' 22' ' ' LEU . 21.7 t -114.85 109.4 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.217 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.808 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.4 pp -103.95 169.37 2.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.216 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.442 ' OG ' HG21 ' A' ' 20' ' ' VAL . 71.5 p -126.29 107.63 10.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.555 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.42 113.45 25.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.345 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 16' ' ' SER . 7.5 p30 -62.72 158.76 49.23 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.935 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 C--O 1.25 1.108 0 C-N-CA 122.578 2.185 . . . . 0.0 112.394 -179.908 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.787 0.327 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.49 -66.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.593 2.195 . . . . 0.0 112.208 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.573 HG22 ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -67.82 147.91 98.52 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.096 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.573 ' HD2' HG22 ' A' ' 18' ' ' THR . 17.0 Cg_exo -67.04 -8.85 23.01 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.692 2.261 . . . . 0.0 112.682 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.499 ' HA ' ' N ' ' A' ' 105' ' ' ASN . 28.5 m -158.95 168.0 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 120.974 0.416 . . . . 0.0 111.493 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -139.45 122.5 16.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.91 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.825 HD22 HG12 ' A' ' 101' ' ' VAL . 11.9 mt -59.74 136.47 58.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.082 0.468 . . . . 0.0 111.667 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.568 ' CE1' HG13 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -152.47 119.07 5.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.127 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.16 130.45 42.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.68 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.568 HG13 ' CE1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -131.45 140.83 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.071 0.462 . . . . 0.0 111.343 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.9 m -134.41 106.92 7.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.944 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.016 HD11 HD11 ' A' ' 65' ' ' LEU . 2.6 mt -106.88 174.46 5.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.002 0.43 . . . . 0.0 111.543 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 96' ' ' ASN . 42.5 m-85 -123.07 165.67 16.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.693 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -128.34 120.68 27.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.852 0.358 . . . . 0.0 111.437 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.41 128.32 35.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.464 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.14 -29.22 0.87 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.751 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.32 -38.36 8.42 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.847 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.82 146.7 28.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.877 0.37 . . . . 0.0 111.206 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -103.04 -33.29 9.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.286 0.565 . . . . 0.0 110.603 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.35 152.64 23.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.285 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.518 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 0.8 OUTLIER -91.13 15.19 12.22 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.569 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.08 23.54 57.01 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.39 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.603 ' CD1' HG22 ' A' ' 51' ' ' VAL . 6.5 p90 -174.15 119.82 0.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.179 0.49 . . . . 0.0 111.549 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.1 m -91.88 154.14 19.06 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.631 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.712 ' HB ' HG12 ' A' ' 49' ' ' VAL . 24.1 m -112.17 170.93 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.011 0.434 . . . . 0.0 111.688 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.754 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -139.09 164.36 29.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.021 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -72.79 154.85 40.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.911 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.99 109.13 0.95 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.394 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.7 mt -94.28 -25.41 17.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.432 . . . . 0.0 111.182 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.9 tp -83.81 -6.71 59.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.532 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 47' ' ' LYS . 5.2 mt-10 -153.1 27.39 0.52 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.935 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER 26.54 78.48 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.127 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.02 -152.0 9.51 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.475 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 41' ' ' ALA . 23.8 t -144.49 138.42 23.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.875 0.369 . . . . 0.0 111.264 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -130.61 174.37 9.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.313 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.603 HG22 ' CD1' ' A' ' 38' ' ' PHE . 58.3 t -78.72 122.89 34.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.039 0.447 . . . . 0.0 111.255 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.558 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -89.1 -29.53 19.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.777 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.1 m120 -157.59 155.3 29.92 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.35 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.539 HD13 ' CB ' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -137.85 130.7 41.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.561 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.407 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -64.38 127.4 92.14 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.873 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 55' ' ' ARG . 43.6 Cg_exo -56.49 140.02 88.46 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.454 2.103 . . . . 0.0 112.367 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 39.27 33.35 0.09 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.931 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.6 -161.75 21.32 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.259 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -57.6 -42.9 55.7 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.366 2.044 . . . . 0.0 112.147 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.661 ' HA2' HD12 ' A' ' 65' ' ' LEU . . . -65.87 -44.98 90.93 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.787 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.37 -32.62 64.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.028 0.442 . . . . 0.0 110.405 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.2 mt -67.54 -30.93 70.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.737 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.8 -38.6 13.46 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.395 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.53 31.52 1.64 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.565 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.016 HD11 HD11 ' A' ' 27' ' ' LEU . 28.4 mt -83.7 123.24 29.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.859 0.362 . . . . 0.0 111.021 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -113.88 138.59 22.83 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.55 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 77.6 Cg_exo -40.44 139.87 1.07 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.933 2.422 . . . . 0.0 113.144 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 48.9 m-85 88.7 -13.12 0.4 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.64 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.801 ' CB ' HD13 ' A' ' 102' ' ' ILE . 8.4 p-10 -55.99 85.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.064 0.459 . . . . 0.0 110.562 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.45 ' N ' ' O ' ' A' ' 68' ' ' TYR . 10.1 ttm180 -66.58 118.15 9.77 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.87 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.762 ' CD2' HD22 ' A' ' 100' ' ' LEU . 1.1 mt -72.5 112.07 8.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.286 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.618 HD23 ' HG3' ' A' ' 80' ' ' ARG . 5.0 mp -84.67 -67.07 0.82 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -115.5 110.42 19.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.456 ' HA ' ' HB3' ' A' ' 100' ' ' LEU . 46.6 t -102.75 143.05 15.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.874 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 0.5 OUTLIER 46.58 29.58 0.95 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.29 -179.687 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.456 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER 85.9 -19.1 0.32 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.773 179.658 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.0 t -83.98 136.0 23.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.818 0.342 . . . . 0.0 111.203 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -69.15 116.57 9.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.252 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.626 HG22 ' CE2' ' A' ' 82' ' ' PHE . 32.2 p -141.53 38.77 1.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.412 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.618 ' HG3' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -69.87 -46.57 65.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.589 179.679 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -94.38 27.81 2.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.44 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.626 ' CE2' HG22 ' A' ' 79' ' ' THR . 2.5 m-30 -81.09 176.3 9.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.811 0.338 . . . . 0.0 110.657 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.517 ' O ' HG23 ' A' ' 87' ' ' VAL . 3.6 t70 -108.26 158.79 17.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.511 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.841 ' O ' HG23 ' A' ' 88' ' ' VAL . 5.3 p -51.56 -41.88 61.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 110.654 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 37.3 m -63.15 -21.74 66.4 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.08 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.501 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 7.7 mp -96.48 -33.16 11.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.002 0.429 . . . . 0.0 111.022 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.642 HG21 ' HB ' ' A' ' 49' ' ' VAL . 37.8 t -77.61 -36.05 22.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.374 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 84' ' ' CYS . 93.3 t -58.54 -51.29 82.89 Favored Pre-proline 0 C--N 1.33 -0.241 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.79 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.666 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.5 Cg_exo -67.32 -40.93 10.01 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.334 2.023 . . . . 0.0 111.528 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.595 HD13 HG21 ' A' ' 79' ' ' THR . 25.3 mt -54.55 -33.88 60.89 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.027 0.441 . . . . 0.0 110.763 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.879 ' HA ' HD11 ' A' ' 98' ' ' LEU . 25.0 mt -78.34 -44.33 26.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.125 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.22 -2.75 49.95 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.423 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -104.81 6.66 34.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.445 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -63.39 -35.1 79.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.371 0.605 . . . . 0.0 110.253 179.481 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.85 -41.87 2.21 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.719 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 6.1 m-80 -166.82 -35.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.511 0.196 . . . . 0.0 111.328 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp -122.76 131.58 53.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.692 0.282 . . . . 0.0 110.942 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.879 HD11 ' HA ' ' A' ' 91' ' ' ILE . 0.5 OUTLIER -120.62 97.49 5.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.433 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -96.36 118.4 32.81 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.762 HD22 ' CD2' ' A' ' 71' ' ' LEU . 2.6 pp -150.22 162.52 40.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.342 0.592 . . . . 0.0 112.451 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.825 HG12 HD22 ' A' ' 22' ' ' LEU . 25.0 t -114.17 109.1 27.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.699 178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.801 HD13 ' CB ' ' A' ' 69' ' ' ASP . 2.6 pp -104.07 169.45 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.465 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.438 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -133.73 112.39 11.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.766 179.656 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.63 133.42 43.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.001 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.499 ' N ' ' HA ' ' A' ' 20' ' ' VAL . 2.2 p30 -62.71 152.01 82.91 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.77 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 C--O 1.248 1.023 0 C-N-CA 122.568 2.179 . . . . 0.0 112.273 -179.927 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.3 m . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 120.755 0.312 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.74 -74.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.407 2.072 . . . . 0.0 112.559 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.544 ' HB ' ' CD ' ' A' ' 19' ' ' PRO . 1.3 m -167.99 -58.98 0.01 OUTLIER Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.004 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.544 ' CD ' ' HB ' ' A' ' 18' ' ' THR . 11.4 Cg_endo -54.43 127.15 24.75 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.223 1.949 . . . . 0.0 112.22 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.7 m -40.48 160.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.139 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -121.53 122.45 39.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.393 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.838 HD22 HG12 ' A' ' 101' ' ' VAL . 13.7 mt -60.87 140.65 57.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.313 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.478 ' HB2' HD11 ' A' ' 102' ' ' ILE . 53.7 m-70 -146.52 106.62 4.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.936 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -71.44 109.49 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.047 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.429 HG11 ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -114.89 141.26 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.115 0.484 . . . . 0.0 111.8 -179.079 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.551 HG23 ' OD1' ' A' ' 99' ' ' ASP . 95.5 m -133.06 106.63 7.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.866 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 1.122 HD11 HD11 ' A' ' 65' ' ' LEU . 7.8 mt -105.21 -177.59 3.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.933 0.397 . . . . 0.0 111.608 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.444 ' CD2' ' HG2' ' A' ' 97' ' ' LYS . 16.2 m-85 -135.83 153.59 51.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.529 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -116.1 164.77 13.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.031 0.444 . . . . 0.0 111.423 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -106.16 152.9 22.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.672 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.25 -28.8 29.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.338 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.49 36.71 2.05 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.644 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.4 ttt -81.68 149.14 28.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.748 0.308 . . . . 0.0 110.926 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -96.04 -10.91 27.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.204 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -156.82 176.11 13.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.646 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -102.36 27.07 7.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.168 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 85.62 5.24 84.64 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.263 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.78 ' CD2' HD13 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -173.03 141.67 1.0 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.017 0.437 . . . . 0.0 111.475 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.5 m -107.72 153.42 22.96 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.352 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.742 HG11 ' CD1' ' A' ' 71' ' ' LEU . 32.6 m -118.58 164.97 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.393 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -132.73 141.66 48.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.08 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -55.98 164.88 1.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.112 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.79 140.56 16.42 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.339 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.72 -58.33 2.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.108 0.48 . . . . 0.0 111.423 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.13 -41.98 16.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.726 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 47' ' ' LYS . 18.0 mt-10 -88.4 10.68 19.17 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.616 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 26.36 78.2 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -169.54 -139.16 2.65 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.488 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.698 HG12 ' HB ' ' A' ' 40' ' ' VAL . 41.7 t -155.8 138.41 6.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.602 0.239 . . . . 0.0 111.109 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.76 156.48 47.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.829 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.468 ' CG2' ' HB2' ' A' ' 69' ' ' ASP . 62.0 t -64.03 121.17 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.989 0.423 . . . . 0.0 111.249 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.97 -30.64 17.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.181 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -160.34 154.99 23.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.503 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.455 HG23 ' HB3' ' A' ' 38' ' ' PHE . 1.1 mt -133.44 125.94 51.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.1 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.51 114.7 16.81 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.71 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.636 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 50.1 Cg_exo -53.62 125.07 17.4 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.293 1.996 . . . . 0.0 112.185 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 89.14 -28.88 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.586 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.86 -179.66 1.27 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.472 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.46 ' O ' HD22 ' A' ' 27' ' ' LEU . 58.4 Cg_exo -51.69 -34.6 54.42 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.601 2.201 . . . . 0.0 112.293 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.635 ' HA2' HD12 ' A' ' 65' ' ' LEU . . . -60.97 -46.71 94.04 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.592 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.42 -32.71 64.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.983 0.42 . . . . 0.0 110.357 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.4 mt -63.02 -32.76 74.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.897 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -86.44 -46.63 5.17 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.55 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.81 33.89 0.96 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.765 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.122 HD11 HD11 ' A' ' 27' ' ' LEU . 24.6 mt -73.85 145.94 44.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.775 0.321 . . . . 0.0 110.859 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.411 ' CD ' ' NH1' ' A' ' 104' ' ' ARG . 11.5 mttm -125.64 159.16 62.22 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.968 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.423 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 15.7 Cg_endo -56.96 141.6 93.72 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.76 2.306 . . . . 0.0 112.13 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.546 ' O ' ' N ' ' A' ' 70' ' ' ARG . 31.5 m-85 84.42 0.62 0.9 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.245 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.55 ' CG ' HD13 ' A' ' 102' ' ' ILE . 3.2 m-20 -52.97 80.33 0.0 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.976 0.417 . . . . 0.0 110.733 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.546 ' N ' ' O ' ' A' ' 68' ' ' TYR . 41.0 ttp180 -66.82 103.86 1.21 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.148 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.823 ' HA ' HG22 ' A' ' 102' ' ' ILE . 3.5 mp -63.2 107.39 1.04 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.809 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.668 HD22 ' HG2' ' A' ' 80' ' ' ARG . 8.2 mt -84.98 -67.23 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 0.0 111.155 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -116.21 112.85 22.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.073 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.607 HG23 ' OG1' ' A' ' 79' ' ' THR . 40.9 t -103.71 125.28 58.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.963 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.459 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 2.4 m120 45.69 36.9 2.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.398 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.459 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.4 OUTLIER 87.49 -22.66 0.14 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.736 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.0 t -83.39 134.9 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.321 . . . . 0.0 111.141 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -69.38 136.01 51.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.607 ' OG1' HG23 ' A' ' 74' ' ' VAL . 76.2 p -144.91 25.02 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.179 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.668 ' HG2' HD22 ' A' ' 72' ' ' LEU . 3.4 mtm180 -71.98 -48.45 44.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.883 0.373 . . . . 0.0 110.62 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -92.59 16.03 12.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.363 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.41 ' CG ' ' HA ' ' A' ' 79' ' ' THR . 3.3 m-85 -82.05 176.41 9.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.86 0.362 . . . . 0.0 110.818 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.87 160.46 18.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.559 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 6.4 p -51.62 -34.82 39.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.725 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 96.0 m -70.15 -21.69 63.05 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.223 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.609 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 0.5 OUTLIER -97.59 -32.32 11.85 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 111.014 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.543 HG11 HD13 ' A' ' 71' ' ' LEU . 46.3 t -79.92 -35.94 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.453 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.836 HG12 ' HD3' ' A' ' 89' ' ' PRO . 3.7 p -61.87 -41.2 75.53 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.606 -0.437 . . . . 0.0 111.439 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.836 ' HD3' HG12 ' A' ' 88' ' ' VAL . 72.3 Cg_endo -74.55 -45.55 0.32 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 121.806 1.67 . . . . 0.0 111.316 178.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 86' ' ' LEU . 36.3 mt -54.48 -29.38 49.84 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.347 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.939 HG23 ' CD1' ' A' ' 98' ' ' LEU . 62.2 mt -78.45 -47.12 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.55 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.63 -3.97 31.37 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -112.26 -0.64 15.41 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.764 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.418 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 16.5 m -64.79 -16.41 63.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.834 0.35 . . . . 0.0 111.139 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.91 -148.37 18.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.586 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -73.5 -8.52 56.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.616 0.246 . . . . 0.0 111.419 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.444 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -140.96 147.85 39.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.737 0.303 . . . . 0.0 110.863 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.939 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -132.13 97.45 4.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.219 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.551 ' OD1' HG23 ' A' ' 26' ' ' THR . 0.4 OUTLIER -93.53 118.3 31.18 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.077 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.752 HD23 HD22 ' A' ' 98' ' ' LEU . 1.9 pp -149.85 154.93 39.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.168 0.509 . . . . 0.0 112.096 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.838 HG12 HD22 ' A' ' 22' ' ' LEU . 23.5 t -111.53 109.16 27.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.954 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.823 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.7 pp -105.82 166.1 3.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.01 0.433 . . . . 0.0 111.596 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.7 p -134.12 129.09 35.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.551 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.468 ' HG3' ' HB2' ' A' ' 68' ' ' TYR . 6.0 ttp180 -127.74 135.78 50.61 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.033 0.444 . . . . 0.0 111.48 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -96.82 111.59 57.93 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.404 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.236 1.958 . . . . 0.0 112.356 -179.86 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.657 0.265 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.97 -18.92 45.42 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.682 2.255 . . . . 0.0 112.315 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.542 HG22 ' HD2' ' A' ' 19' ' ' PRO . 5.3 m -150.14 145.8 19.26 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.696 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.542 ' HD2' HG22 ' A' ' 18' ' ' THR . 52.8 Cg_exo -53.16 -171.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.394 2.062 . . . . 0.0 112.138 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 105' ' ' ASN . 35.2 m -45.51 129.77 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.929 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.54 122.05 45.22 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.727 HD13 ' CG1' ' A' ' 101' ' ' VAL . 4.4 pp -100.33 153.15 19.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.199 0.523 . . . . 0.0 112.264 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.829 ' CE1' HD11 ' A' ' 102' ' ' ILE . 54.1 p-80 -144.9 152.22 39.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.698 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -78.55 104.25 9.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.448 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.52 HG22 ' CD2' ' A' ' 23' ' ' HIS . 0.1 OUTLIER -99.22 144.62 11.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.364 -179.525 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.419 HG23 ' OD2' ' A' ' 99' ' ' ASP . 96.4 m -135.09 106.42 6.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.84 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.804 HD21 ' CD1' ' A' ' 65' ' ' LEU . 1.1 mp -105.36 175.18 5.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.033 0.444 . . . . 0.0 111.357 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.451 ' N ' ' CD1' ' A' ' 28' ' ' TYR . 1.5 m-85 -131.51 155.88 46.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.248 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -118.46 149.77 40.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.914 0.388 . . . . 0.0 111.322 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.15 152.85 31.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.741 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.2 m -63.62 -26.25 68.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.257 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.26 1.75 46.96 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.08 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 3.3 mmt -81.78 124.57 29.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.896 0.379 . . . . 0.0 110.976 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.03 -10.77 59.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.365 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -155.59 -167.92 2.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.641 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.526 ' CD2' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -105.46 17.49 23.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.559 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 91.19 7.15 65.91 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.531 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.571 ' CD2' HG22 ' A' ' 51' ' ' VAL . 25.6 p90 -173.62 145.79 1.24 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.26 0.53 . . . . 0.0 111.716 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.75 146.68 41.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.191 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.493 HG11 ' CD1' ' A' ' 71' ' ' LEU . 34.6 m -105.31 171.02 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.662 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -131.08 178.13 6.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.948 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -89.98 129.0 36.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.808 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.12 100.5 2.36 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.272 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.3 -24.05 17.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.964 0.411 . . . . 0.0 111.176 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.52 -10.98 57.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.32 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 47' ' ' LYS . 3.0 mt-10 -153.36 33.51 0.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.968 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 25.24 91.42 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.173 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 173.13 -162.76 34.19 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.42 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 82' ' ' PHE . 64.8 t -139.4 132.1 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.79 0.329 . . . . 0.0 110.749 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -131.87 163.39 28.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.74 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.571 HG22 ' CD2' ' A' ' 38' ' ' PHE . 66.7 t -72.37 122.57 25.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.747 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -87.39 -31.0 20.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.422 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -162.67 145.72 11.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.486 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.57 HG23 ' HB3' ' A' ' 38' ' ' PHE . 1.4 mt -127.48 133.59 67.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.943 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.08 144.49 99.07 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.814 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.23 144.03 45.32 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.516 2.144 . . . . 0.0 112.373 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 39.06 33.83 0.09 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.976 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -109.97 -168.14 19.85 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.39 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.406 ' O ' HD23 ' A' ' 27' ' ' LEU . 54.2 Cg_exo -52.2 -39.71 70.94 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.513 2.142 . . . . 0.0 112.152 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.39 -36.08 50.73 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.609 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -73.51 -32.83 64.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.027 0.441 . . . . 0.0 110.258 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.0 mt -77.28 -30.68 54.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.804 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.02 -47.81 29.54 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.369 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.46 35.27 1.01 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.554 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.804 ' CD1' HD21 ' A' ' 27' ' ' LEU . 13.2 mt -91.1 124.0 34.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.785 0.326 . . . . 0.0 110.998 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.24 156.1 35.66 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.831 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.447 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 53.6 Cg_exo -51.8 136.27 50.79 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.52 2.146 . . . . 0.0 112.227 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.448 ' O ' ' N ' ' A' ' 70' ' ' ARG . 9.9 m-85 85.5 7.49 0.4 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.004 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.778 ' OD1' HD13 ' A' ' 102' ' ' ILE . 3.8 m-20 -53.56 85.84 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.044 0.449 . . . . 0.0 110.993 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 68' ' ' TYR . 28.6 ttt85 -72.31 96.86 1.91 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.629 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.823 ' CD2' HD22 ' A' ' 100' ' ' LEU . 1.2 mp -53.33 107.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.104 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.736 HD11 ' HB2' ' A' ' 103' ' ' SER . 3.2 mp -82.17 -62.37 1.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.376 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -133.79 130.01 37.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.874 0.369 . . . . 0.0 111.281 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.927 ' O ' HG12 ' A' ' 77' ' ' VAL . 20.1 t -113.66 112.95 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.809 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 5.4 m-80 66.54 30.27 8.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.636 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.467 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 1.6 t-80 87.21 -12.12 0.53 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.892 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.927 HG12 ' O ' ' A' ' 74' ' ' VAL . 4.3 p -84.13 143.08 12.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.893 0.378 . . . . 0.0 111.06 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 mtp85 -70.08 125.47 26.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.527 HG23 HG13 ' A' ' 77' ' ' VAL . 52.8 p -146.39 19.69 1.36 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.348 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.504 ' HG3' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -66.23 -52.96 42.7 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.953 0.406 . . . . 0.0 110.623 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -94.77 29.33 2.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.239 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.855 ' O ' HG23 ' A' ' 49' ' ' VAL . 1.8 m-30 -80.97 171.79 14.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.858 0.361 . . . . 0.0 110.82 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.575 ' C ' HG21 ' A' ' 49' ' ' VAL . 2.4 m-20 -107.26 157.62 17.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.499 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.843 ' O ' HG23 ' A' ' 88' ' ' VAL . 5.7 p -51.49 -38.52 54.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.929 0.395 . . . . 0.0 110.445 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 18.9 m -65.67 -21.56 66.56 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.054 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.729 HD22 ' CE2' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -95.4 -32.12 13.07 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.094 0.474 . . . . 0.0 110.605 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.698 HG11 HD13 ' A' ' 71' ' ' LEU . 39.0 t -78.26 -35.79 20.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.303 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 84' ' ' CYS . 93.7 t -58.67 -51.01 84.92 Favored Pre-proline 0 C--N 1.331 -0.23 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.975 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.643 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.0 Cg_exo -68.01 -45.64 2.87 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.477 2.118 . . . . 0.0 111.634 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.618 HD11 ' HE2' ' A' ' 82' ' ' PHE . 36.6 mt -54.5 -30.25 52.82 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.998 0.428 . . . . 0.0 110.574 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.929 ' HA ' HD11 ' A' ' 98' ' ' LEU . 70.9 mt -79.17 -49.55 19.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.079 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.48 -2.59 29.56 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.431 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -102.07 -1.14 32.26 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.203 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.418 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -64.82 -30.87 71.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.185 0.516 . . . . 0.0 110.768 179.719 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.38 -63.09 0.84 Allowed Glycine 0 C--N 1.322 -0.248 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.252 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.432 ' HA ' ' CB ' ' A' ' 29' ' ' LYS . 18.8 p30 -162.71 18.29 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.528 0.204 . . . . 0.0 111.3 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.439 ' HE2' ' CE2' ' A' ' 28' ' ' TYR . 3.8 ttmt -161.8 116.77 1.97 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.929 HD11 ' HA ' ' A' ' 91' ' ' ILE . 1.0 OUTLIER -116.16 98.87 6.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.897 -179.141 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.419 ' OD2' HG23 ' A' ' 26' ' ' THR . 1.9 m-20 -98.52 117.98 34.18 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.844 HD23 HD22 ' A' ' 98' ' ' LEU . 1.2 pp -151.69 164.74 36.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.167 0.508 . . . . 0.0 112.097 -178.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.727 ' CG1' HD13 ' A' ' 22' ' ' LEU . 15.5 t -107.5 109.97 30.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.942 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.829 HD11 ' CE1' ' A' ' 23' ' ' HIS . 2.4 pp -100.44 153.75 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.22 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.736 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -119.53 127.3 52.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.496 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.21 129.88 11.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.996 0.427 . . . . 0.0 111.682 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 1.8 p-10 -62.78 158.23 53.58 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.785 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 122.531 2.154 . . . . 0.0 112.289 -179.951 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.413 ' CB ' ' HB2' ' A' ' 106' ' ' PRO . 9.7 t . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 120.765 0.317 . . . . 0.0 111.401 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.55 -68.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.745 2.296 . . . . 0.0 112.203 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.472 ' HB ' ' CD ' ' A' ' 19' ' ' PRO . 1.8 m -179.05 -61.67 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.665 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.472 ' CD ' ' HB ' ' A' ' 18' ' ' THR . 13.8 Cg_endo -56.79 126.57 22.67 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.567 2.178 . . . . 0.0 112.335 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.701 HG12 ' N ' ' A' ' 105' ' ' ASN . 19.6 m -45.86 144.71 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.171 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.42 ' HG3' ' NH1' ' A' ' 104' ' ' ARG . 11.3 pt-20 -106.92 124.51 49.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.793 HD22 ' CD1' ' A' ' 72' ' ' LEU . 4.7 pp -105.07 153.51 21.38 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -145.85 156.41 43.54 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.597 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.19 110.64 18.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.25 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.905 HG11 ' HG ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -111.75 146.14 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.596 -179.271 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.6 m -134.21 106.64 7.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.314 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.633 HD11 HD21 ' A' ' 65' ' ' LEU . 3.3 mp -93.53 174.76 7.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.947 0.403 . . . . 0.0 111.561 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.433 ' CD1' ' HG3' ' A' ' 97' ' ' LYS . 81.1 m-85 -132.3 141.44 48.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.171 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -116.25 163.14 16.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.878 0.37 . . . . 0.0 111.418 -179.69 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.75 140.13 52.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.749 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 90.3 p -61.75 84.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.055 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 123.86 19.67 2.69 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.075 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.79 167.88 18.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.778 0.323 . . . . 0.0 110.8 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -97.52 -18.36 19.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.207 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.62 -171.25 3.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.667 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.807 ' CD2' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -108.71 19.21 19.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.301 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 104.87 0.46 42.15 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.066 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.579 ' HB3' HG23 ' A' ' 54' ' ' ILE . 14.4 p90 -172.85 145.01 1.39 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.943 0.402 . . . . 0.0 111.453 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.1 m -98.19 138.5 35.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.172 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.49 HG23 ' SG ' ' A' ' 84' ' ' CYS . 35.8 m -93.74 171.07 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.698 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . . . -136.3 178.19 7.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.093 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.57 131.33 45.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.738 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.449 ' HA3' ' CZ ' ' A' ' 50' ' ' TYR . . . -104.0 108.96 3.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.528 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -94.48 -25.15 17.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.001 0.429 . . . . 0.0 111.069 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 45' ' ' LEU . 0.2 OUTLIER -83.94 -7.36 59.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.592 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 47' ' ' LYS . 5.2 mt-10 -153.17 25.22 0.54 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.168 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 27.38 80.86 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -170.22 -156.39 11.15 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.695 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.537 ' HB ' HG21 ' A' ' 87' ' ' VAL . 95.2 t -137.68 131.24 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.806 0.336 . . . . 0.0 111.044 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.449 ' CZ ' ' HA3' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -128.56 172.41 11.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.246 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.539 HG11 HG12 ' A' ' 54' ' ' ILE . 88.7 t -90.77 123.68 43.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.83 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 3.7 ptpp? -86.99 -30.73 21.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.362 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -161.76 144.9 12.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.652 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.597 HD12 ' O ' ' A' ' 65' ' ' LEU . 1.7 mt -126.08 135.84 62.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.996 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.6 mtt180 -65.37 143.87 98.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.724 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.09 143.22 35.65 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.501 2.134 . . . . 0.0 112.481 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 39.57 33.77 0.13 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.894 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.56 -159.24 13.3 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.265 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.79 -53.79 6.22 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.477 2.118 . . . . 0.0 112.033 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.22 -33.81 87.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.683 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -73.59 -32.61 64.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.982 0.42 . . . . 0.0 110.321 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 75.1 mt -75.12 -33.8 61.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.787 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.73 -54.1 10.6 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.392 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.26 33.23 1.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.701 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.905 ' HG ' HG11 ' A' ' 25' ' ' VAL . 1.7 mp -88.06 115.77 25.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.866 0.365 . . . . 0.0 110.884 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -81.37 159.86 66.39 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.552 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.426 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 13.0 Cg_endo -56.14 132.54 52.58 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.575 2.183 . . . . 0.0 112.332 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.427 ' O ' ' N ' ' A' ' 70' ' ' ARG . 0.3 OUTLIER 84.16 3.15 0.82 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.599 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.637 ' HB2' HD13 ' A' ' 102' ' ' ILE . 6.0 p-10 -54.43 87.61 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.174 0.512 . . . . 0.0 110.858 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 68' ' ' TYR . 4.2 ttp180 -66.99 109.55 3.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.862 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.004 HD23 HD13 ' A' ' 100' ' ' LEU . 4.0 mp -58.78 118.27 5.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.226 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.793 ' CD1' HD22 ' A' ' 22' ' ' LEU . 40.5 mt -82.77 -65.18 1.04 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.871 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -131.73 128.43 38.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.025 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.33 136.31 44.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.009 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.45 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 23.8 m120 50.18 32.01 5.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.332 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.45 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.3 OUTLIER 85.88 -14.79 0.52 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.77 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.2 t -83.75 136.94 21.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.843 0.354 . . . . 0.0 111.14 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -69.46 125.36 26.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.741 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.496 HG21 HD13 ' A' ' 90' ' ' LEU . 17.1 p -144.5 32.01 1.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.123 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.549 ' HG2' HD22 ' A' ' 72' ' ' LEU . 14.0 mtp180 -65.33 -52.03 56.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.43 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.69 28.54 2.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.049 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.695 ' HE2' HD11 ' A' ' 90' ' ' LEU . 1.8 m-30 -80.8 167.51 19.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.724 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -107.83 161.53 14.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.46 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.851 ' O ' HG23 ' A' ' 88' ' ' VAL . 0.8 OUTLIER -51.81 -40.66 60.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.924 0.393 . . . . 0.0 110.68 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.5 m -63.09 -23.03 67.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.205 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.51 ' O ' HD12 ' A' ' 90' ' ' LEU . 10.0 mp -94.17 -32.09 13.86 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.027 0.441 . . . . 0.0 110.864 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.537 HG21 ' HB ' ' A' ' 49' ' ' VAL . 52.9 t -78.44 -35.86 19.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.222 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 84' ' ' CYS . 97.3 t -57.41 -51.25 83.13 Favored Pre-proline 0 C--N 1.331 -0.199 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.788 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.651 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.9 Cg_exo -66.61 -48.38 2.26 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.475 2.117 . . . . 0.0 111.32 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.695 HD11 ' HE2' ' A' ' 82' ' ' PHE . 37.4 mt -54.94 -27.99 47.74 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.967 0.413 . . . . 0.0 110.427 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.955 ' HA ' HD11 ' A' ' 98' ' ' LEU . 27.8 mt -75.84 -48.12 30.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.799 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.2 -3.09 40.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.091 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -89.8 -11.41 42.21 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.428 ' HB2' ' HG ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -64.66 -27.01 68.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.005 0.431 . . . . 0.0 111.208 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.59 -59.6 3.31 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.423 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.413 ' HA ' ' CB ' ' A' ' 29' ' ' LYS . 9.0 p30 -164.24 20.41 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.523 0.201 . . . . 0.0 111.383 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.433 ' HG3' ' CD1' ' A' ' 28' ' ' TYR . 14.1 ttpt -165.55 113.03 0.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.7 0.286 . . . . 0.0 110.234 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.955 HD11 ' HA ' ' A' ' 91' ' ' ILE . 1.7 mt -109.03 102.19 11.2 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -97.32 118.12 33.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 1.004 HD13 HD23 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -152.67 159.16 43.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.267 0.556 . . . . 0.0 112.416 -178.403 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.625 ' CG1' HD13 ' A' ' 22' ' ' LEU . 15.5 t -105.99 109.33 27.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.455 178.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.705 HG23 HD12 ' A' ' 100' ' ' LEU . 2.6 pp -100.87 162.33 3.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.015 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.441 ' HB3' HD11 ' A' ' 72' ' ' LEU . 3.2 p -146.26 130.19 17.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.687 0.28 . . . . 0.0 111.145 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.42 ' NH1' ' HG3' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -144.96 145.8 31.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.958 0.408 . . . . 0.0 111.409 179.508 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.701 ' N ' HG12 ' A' ' 20' ' ' VAL . 3.3 p-10 -70.04 127.01 92.67 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.748 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.413 ' HB2' ' CB ' ' A' ' 16' ' ' SER . 51.7 Cg_exo . . . . . 0 C--O 1.248 1.001 0 C-N-CA 122.42 2.08 . . . . 0.0 112.247 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.427 ' N ' ' HD2' ' A' ' 17' ' ' PRO . 2.4 m . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 16' ' ' SER . 47.3 Cg_endo -68.56 -38.89 10.17 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.489 2.126 . . . . 0.0 112.114 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.545 HG22 ' HD2' ' A' ' 19' ' ' PRO . 2.9 m -54.42 145.43 37.85 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.989 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.545 ' HD2' HG22 ' A' ' 18' ' ' THR . 46.3 Cg_exo -56.49 -164.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.45 2.1 . . . . 0.0 112.182 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 m -54.15 167.13 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.478 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -135.23 122.38 21.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.613 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.047 HD21 HD12 ' A' ' 72' ' ' LEU . 16.0 mt -62.6 136.58 57.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.472 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 -142.86 119.72 11.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.87 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -75.34 110.93 10.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.28 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.71 HG11 ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -116.9 140.88 37.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.072 0.463 . . . . 0.0 111.508 -179.262 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.4 m -133.65 106.79 7.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.02 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.719 HD11 HD13 ' A' ' 65' ' ' LEU . 38.0 mt -98.3 179.56 4.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.172 0.511 . . . . 0.0 111.8 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.437 ' CD1' ' HG2' ' A' ' 97' ' ' LYS . 95.2 m-85 -135.69 136.1 40.61 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.366 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.451 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -99.33 165.14 11.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.968 0.413 . . . . 0.0 111.3 -179.662 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -119.8 131.1 55.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.784 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.82 84.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.126 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.26 -40.67 0.51 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.36 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.63 164.26 21.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 0.0 110.907 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.91 -28.52 9.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.072 0.463 . . . . 0.0 110.922 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -84.8 168.74 14.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.707 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.609 ' CD2' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -119.11 29.15 7.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.084 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.522 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 92.07 4.21 67.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.117 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.77 ' CE2' HD22 ' A' ' 65' ' ' LEU . 8.8 p90 -174.33 138.56 0.56 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.981 0.39 . . . . 0.0 111.545 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 52' ' ' LYS . 7.3 m -99.79 148.1 24.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.183 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.605 ' HB ' HG12 ' A' ' 49' ' ' VAL . 33.0 m -111.8 163.36 8.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.919 0.39 . . . . 0.0 111.588 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.782 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -135.08 172.22 13.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.908 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -84.18 163.62 19.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.935 0.397 . . . . 0.0 111.145 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.55 121.98 6.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.322 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.69 6.27 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.53 -38.77 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.072 0.463 . . . . 0.0 111.482 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 47' ' ' LYS . 11.8 mm-40 -88.85 18.14 5.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.561 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 46' ' ' GLU . 12.5 mmtt 27.76 78.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.971 0.415 . . . . 0.0 112.106 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.09 -163.51 35.84 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.473 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.782 HG13 ' O ' ' A' ' 41' ' ' ALA . 46.8 t -130.0 138.93 52.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 110.914 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -136.51 165.64 25.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.795 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.508 HG11 HD11 ' A' ' 54' ' ' ILE . 58.9 t -72.35 121.18 22.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.02 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 39' ' ' SER . 0.4 OUTLIER -87.53 -31.05 20.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.865 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -158.12 152.63 24.68 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.447 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.522 HG23 ' O ' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -133.21 141.53 44.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.029 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.12 117.22 37.43 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.749 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.64 134.2 52.5 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.512 2.141 . . . . 0.0 112.504 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 42.83 31.25 0.3 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.834 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -109.39 -160.88 19.22 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.749 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -50.64 -62.06 0.46 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.49 2.126 . . . . 0.0 111.785 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.9 -35.04 66.58 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.884 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -73.19 -32.83 65.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.051 0.453 . . . . 0.0 110.201 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 62' ' ' LEU . 27.5 mt -73.2 -27.41 61.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.56 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.54 -51.66 7.12 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.348 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 134.95 -8.02 4.48 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.021 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.77 HD22 ' CE2' ' A' ' 38' ' ' PHE . 4.0 mp -56.76 128.85 38.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.368 . . . . 0.0 111.114 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -116.6 167.24 10.93 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 69.7 Cg_exo -50.92 137.3 43.79 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.654 2.236 . . . . 0.0 112.368 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.437 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 10.8 m-85 85.02 4.1 0.62 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.232 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.528 ' CG ' HD13 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -52.5 89.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.947 0.403 . . . . 0.0 110.81 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.612 ' O ' HD23 ' A' ' 72' ' ' LEU . 9.3 ttt180 -77.85 95.59 4.76 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.787 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.018 HD23 HD13 ' A' ' 100' ' ' LEU . 1.2 mp -55.0 107.01 0.26 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.873 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.047 HD12 HD21 ' A' ' 22' ' ' LEU . 4.4 mt -83.98 -63.05 1.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.835 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -120.49 117.56 27.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.951 ' O ' HG12 ' A' ' 77' ' ' VAL . 24.6 t -108.15 109.62 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.163 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.491 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 1.7 m-80 64.24 33.59 11.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.669 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.491 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 3.3 t60 89.73 -17.94 0.21 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.92 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.951 HG12 ' O ' ' A' ' 74' ' ' VAL . 6.4 p -83.69 130.08 36.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.992 0.425 . . . . 0.0 111.125 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.78 89.24 0.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.415 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.687 HG23 HG13 ' A' ' 77' ' ' VAL . 17.3 p -96.76 26.26 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.809 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.652 ' HG2' HD22 ' A' ' 72' ' ' LEU . 10.5 mtp-105 -63.32 -53.03 59.13 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.985 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.35 24.16 4.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.402 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.693 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.3 m-85 -81.8 166.48 19.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.852 0.358 . . . . 0.0 110.76 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.557 ' C ' HG21 ' A' ' 49' ' ' VAL . 33.6 m-20 -106.08 160.9 14.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.554 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.841 ' O ' HG23 ' A' ' 88' ' ' VAL . 11.3 t -51.69 -41.98 61.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.69 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.3 m -63.07 -22.43 66.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.098 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.536 ' O ' HD12 ' A' ' 90' ' ' LEU . 6.6 mp -94.02 -32.93 13.61 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.99 0.424 . . . . 0.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.732 HG11 HD13 ' A' ' 71' ' ' LEU . 48.4 t -77.57 -36.79 23.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.134 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 84' ' ' CYS . 87.5 t -55.61 -52.19 73.97 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.793 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 48.7 Cg_endo -68.44 -45.81 2.36 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.191 1.927 . . . . 0.0 111.835 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.693 HD11 ' HE2' ' A' ' 82' ' ' PHE . 28.2 mt -54.78 -30.71 57.49 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.964 0.412 . . . . 0.0 110.725 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.809 HG23 ' CD1' ' A' ' 98' ' ' LEU . 61.3 mt -76.14 -48.37 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.367 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.69 -3.06 39.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.804 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -92.99 -4.55 52.45 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.433 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -63.52 -29.83 71.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.232 0.539 . . . . 0.0 110.903 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.8 -41.67 2.82 Favored Glycine 0 C--N 1.322 -0.227 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.761 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -166.23 -41.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 111.133 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.437 ' HG2' ' CD1' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -112.9 126.91 55.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.719 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.809 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.6 OUTLIER -115.85 97.48 6.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.626 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.27 118.16 31.18 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 1.018 HD13 HD23 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -148.59 156.44 42.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.142 0.496 . . . . 0.0 112.175 -178.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.899 HG12 HD22 ' A' ' 22' ' ' LEU . 17.1 t -114.32 109.04 27.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.794 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.883 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.4 pp -104.99 165.56 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.337 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.5 p -126.84 126.55 43.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.738 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -152.27 138.77 18.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.072 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -62.94 154.11 77.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.698 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo . . . . . 0 C--O 1.249 1.025 0 C-N-CA 122.61 2.207 . . . . 0.0 112.324 -179.855 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.9 t . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.749 0.309 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.89 163.97 35.4 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.496 2.13 . . . . 0.0 112.133 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.555 ' HB ' ' HD3' ' A' ' 19' ' ' PRO . 11.3 m -51.45 -58.73 9.74 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.202 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HD3' ' HB ' ' A' ' 18' ' ' THR . 58.0 Cg_endo -70.53 139.34 37.35 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.419 2.079 . . . . 0.0 112.321 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.719 HG21 ' HB3' ' A' ' 103' ' ' SER . 16.5 m -46.13 169.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.566 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -122.38 122.99 40.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.567 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.801 ' CD2' HD13 ' A' ' 72' ' ' LEU . 14.4 mt -60.33 147.52 40.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.057 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.67 ' CE1' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -157.55 116.57 3.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.368 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.31 121.02 20.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.79 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.877 HG11 HD22 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -118.24 145.54 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.296 -179.769 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.2 m -134.56 106.82 7.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.965 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.01 173.34 6.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.997 0.427 . . . . 0.0 111.692 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 28' ' ' TYR . 3.1 m-85 -123.19 156.05 35.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.519 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -111.22 160.37 17.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.912 0.387 . . . . 0.0 111.236 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.82 142.26 50.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.865 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.6 t -56.13 -30.46 62.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.022 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.29 38.17 3.4 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.399 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 5.4 mmt -157.25 110.85 2.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.785 0.326 . . . . 0.0 110.835 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -74.07 -28.81 61.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.087 0.47 . . . . 0.0 110.931 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -85.03 177.99 7.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.651 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.502 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -118.98 29.36 7.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.119 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.613 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 82.7 8.46 85.98 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.688 -0.767 . . . . 0.0 113.332 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.511 ' CE2' HG22 ' A' ' 51' ' ' VAL . 20.3 p90 -172.73 127.48 0.5 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 117.171 0.486 . . . . 0.0 111.395 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.06 149.89 20.83 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.013 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.757 HG11 HD11 ' A' ' 71' ' ' LEU . 31.6 m -122.15 150.74 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.303 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.761 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -107.67 178.11 4.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.08 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -94.87 168.18 10.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.015 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -96.88 109.78 3.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.065 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.554 ' O ' HD22 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -94.46 7.11 46.7 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.554 HD22 ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -150.15 0.47 0.45 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -179.304 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -158.17 31.45 0.25 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.642 0.258 . . . . 0.0 111.298 179.738 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER 28.59 90.77 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.97 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -175.35 -159.44 21.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.364 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 41' ' ' ALA . 99.6 t -150.53 137.56 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.94 0.4 . . . . 0.0 111.17 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.8 163.75 30.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.348 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.629 ' HA ' HG12 ' A' ' 40' ' ' VAL . 58.3 t -70.68 123.85 25.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.994 0.426 . . . . 0.0 111.262 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.99 -29.76 19.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.636 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -172.16 160.07 5.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.256 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.613 HG23 ' O ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -126.67 138.41 54.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.839 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -64.16 154.67 81.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.284 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.614 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 65.4 Cg_endo -73.71 102.4 1.5 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.684 2.256 . . . . 0.0 112.433 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 84.58 -6.51 0.99 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.686 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.84 175.87 6.08 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.518 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -46.68 -45.8 19.23 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.71 2.273 . . . . 0.0 112.536 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.425 ' HA2' HD21 ' A' ' 65' ' ' LEU . . . -57.08 -41.1 92.39 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.433 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.24 -32.72 64.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.035 0.445 . . . . 0.0 110.032 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.75 -32.13 69.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.515 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.25 -57.55 5.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.16 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.97 38.37 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.895 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.877 HD22 HG11 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -110.85 127.02 55.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.74 0.305 . . . . 0.0 110.825 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -96.76 162.06 24.44 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.565 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 9.2 Cg_endo -52.32 154.49 11.15 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.743 2.295 . . . . 0.0 112.208 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.472 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 8.0 m-85 90.29 -22.25 0.11 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.368 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.767 ' HB2' HD13 ' A' ' 102' ' ' ILE . 10.3 p-10 -55.26 87.75 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.203 0.525 . . . . 0.0 110.453 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -66.74 119.99 12.75 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.734 -179.624 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.757 HD11 HG11 ' A' ' 40' ' ' VAL . 1.3 mt -68.79 110.74 4.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.303 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.801 HD13 ' CD2' ' A' ' 22' ' ' LEU . 3.4 mp -82.74 -58.01 3.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.179 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -129.98 134.29 47.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.965 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.805 HG23 ' OG1' ' A' ' 79' ' ' THR . 28.2 t -117.28 108.51 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.005 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.443 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 33.2 m120 64.24 36.27 9.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 17.7 m80 86.35 -15.94 0.44 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.516 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.0 t -83.66 139.11 18.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.813 0.34 . . . . 0.0 111.013 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.87 122.82 20.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.631 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.805 ' OG1' HG23 ' A' ' 74' ' ' VAL . 28.0 p -143.08 28.22 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.95 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.594 ' HG3' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -72.29 -53.01 13.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.425 179.704 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -94.9 25.96 3.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.069 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.692 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.4 m-30 -80.85 171.4 15.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.778 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 87' ' ' VAL . 1.2 m-20 -108.01 159.94 16.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.479 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.878 ' O ' HG23 ' A' ' 88' ' ' VAL . 23.8 p -51.51 -42.11 61.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.88 0.371 . . . . 0.0 110.543 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.07 -21.73 66.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.191 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.603 ' O ' HD12 ' A' ' 90' ' ' LEU . 8.0 mp -95.31 -31.31 13.51 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.935 0.397 . . . . 0.0 110.819 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.656 HG11 ' CD1' ' A' ' 71' ' ' LEU . 48.1 t -79.37 -35.72 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.221 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 84' ' ' CYS . 88.8 t -58.18 -50.71 86.59 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.835 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 13.0 Cg_exo -69.62 -44.43 2.18 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.472 2.115 . . . . 0.0 111.626 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.692 HD11 ' HE2' ' A' ' 82' ' ' PHE . 15.5 mt -54.99 -33.32 62.46 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.694 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.9 HG23 ' CD1' ' A' ' 98' ' ' LEU . 80.4 mt -75.32 -45.87 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.629 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.66 -3.76 36.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.928 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -101.19 -12.12 18.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.659 0.266 . . . . 0.0 111.686 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.8 m -64.76 -15.67 61.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.502 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.97 -143.69 17.21 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.571 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -73.73 -7.52 52.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.547 0.213 . . . . 0.0 111.4 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.7 mtpt -137.49 151.73 48.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.612 0.244 . . . . 0.0 110.592 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.9 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -137.73 97.49 3.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.772 0.32 . . . . 0.0 111.382 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.7 118.17 31.3 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.74 HD23 HD22 ' A' ' 98' ' ' LEU . 1.4 pp -145.16 157.43 44.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.132 0.492 . . . . 0.0 112.079 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.776 HG12 HD22 ' A' ' 22' ' ' LEU . 16.7 t -110.53 109.25 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.919 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.767 HD13 ' HB2' ' A' ' 69' ' ' ASP . 2.6 pp -105.9 169.21 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.074 0.464 . . . . 0.0 111.641 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.791 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -131.84 114.51 14.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.488 179.589 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.422 ' HB3' ' HA ' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -140.82 131.99 26.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.923 0.392 . . . . 0.0 111.642 -179.561 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.408 ' N ' HG12 ' A' ' 20' ' ' VAL . 6.5 m-20 -65.65 119.86 63.74 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.595 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--O 1.25 1.078 0 C-N-CA 122.339 2.026 . . . . 0.0 112.376 -179.935 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.435 ' HA ' ' CG ' ' A' ' 106' ' ' PRO . 3.9 m . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.693 0.283 . . . . 0.0 111.294 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.82 146.42 48.04 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.633 2.222 . . . . 0.0 112.32 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.567 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 89.4 m -51.4 -51.1 72.19 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.635 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 18' ' ' THR . 37.6 Cg_endo -66.34 125.67 14.36 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.222 1.948 . . . . 0.0 112.448 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.5 m -45.63 150.77 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.946 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -111.08 122.36 47.68 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.578 HD13 ' CG1' ' A' ' 101' ' ' VAL . 4.4 pp -106.83 153.3 22.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.26 0.552 . . . . 0.0 112.37 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.677 ' NE2' HD11 ' A' ' 102' ' ' ILE . 28.7 p80 -149.28 143.46 25.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.561 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.51 112.26 14.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.486 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.803 HG11 ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -107.21 153.46 8.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.57 -179.462 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.857 HG23 ' OD1' ' A' ' 99' ' ' ASP . 98.4 m -134.09 122.1 22.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.824 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.705 HD21 ' CD1' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -108.2 175.16 5.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.293 0.568 . . . . 0.0 111.986 -178.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.465 ' CD1' ' HG2' ' A' ' 97' ' ' LYS . 27.7 m-85 -139.3 124.63 19.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.911 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.42 ' HG3' ' CE2' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -94.84 147.81 22.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.073 0.463 . . . . 0.0 111.431 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -123.41 153.82 39.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.682 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 p -64.64 -24.49 67.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.26 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.62 -0.22 55.43 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.156 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.94 130.42 35.07 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.824 0.345 . . . . 0.0 111.043 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -80.35 -10.74 59.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.16 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -155.93 -164.78 1.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.412 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.586 ' O ' HD22 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -106.01 25.59 10.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 111.482 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.606 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 91.48 -1.17 75.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.74 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.575 ' CD1' HG22 ' A' ' 51' ' ' VAL . 7.9 p90 -172.24 147.76 2.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.334 0.567 . . . . 0.0 111.895 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 p -108.89 137.71 46.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.242 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.749 ' HB ' HG12 ' A' ' 49' ' ' VAL . 22.6 m -99.23 161.12 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.519 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.772 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -125.19 171.11 10.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.153 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -82.01 136.01 35.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.968 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.26 103.43 2.07 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.337 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -94.31 -28.81 15.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.093 0.473 . . . . 0.0 111.287 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 45' ' ' LEU . 15.0 mt -83.85 -5.63 59.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.375 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 47' ' ' LYS . 11.9 mt-10 -153.07 28.1 0.52 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.941 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.4 OUTLIER 27.38 91.2 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.107 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.92 -153.16 21.73 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.582 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.772 HG13 ' O ' ' A' ' 41' ' ' ALA . 16.6 t -145.97 139.0 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.72 0.295 . . . . 0.0 110.931 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -136.93 156.19 48.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.118 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.575 HG22 ' CD1' ' A' ' 38' ' ' PHE . 87.6 t -67.63 117.94 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.536 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.4 tttt -87.39 -30.77 20.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.042 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.0 m120 -157.39 147.51 20.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.524 -179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 37' ' ' GLY . 1.3 mt -125.1 125.35 69.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.955 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.6 ttt85 -65.33 111.62 6.5 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.05 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.589 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 32.4 Cg_exo -58.34 123.48 13.71 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.476 2.117 . . . . 0.0 112.19 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 81.34 83.35 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.097 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 167.78 -152.54 21.02 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.531 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.55 ' C ' HD23 ' A' ' 27' ' ' LEU . 32.2 Cg_exo -59.61 -36.78 91.56 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.646 2.231 . . . . 0.0 112.2 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.09 -47.81 43.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.722 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.57 -32.95 64.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.056 0.455 . . . . 0.0 110.515 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.4 mt -71.26 -30.87 66.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.993 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.86 -38.66 15.38 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.663 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.44 29.24 6.38 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.803 ' HG ' HG11 ' A' ' 25' ' ' VAL . 1.2 mp -78.27 131.88 37.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.893 0.378 . . . . 0.0 110.784 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -98.4 165.05 15.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.841 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 28.1 Cg_endo -62.68 138.96 72.67 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.411 2.074 . . . . 0.0 112.115 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER 82.96 11.1 0.53 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.347 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.578 ' OD1' HD13 ' A' ' 102' ' ' ILE . 5.6 m-20 -53.74 88.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.931 0.396 . . . . 0.0 111.162 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.449 ' HB3' ' O ' ' A' ' 103' ' ' SER . 5.5 ttt85 -73.0 94.34 1.86 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.372 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.919 HD12 ' CG1' ' A' ' 87' ' ' VAL . 11.3 mt -50.86 107.51 0.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.998 0.428 . . . . 0.0 111.175 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.749 HD11 ' HB2' ' A' ' 103' ' ' SER . 16.0 mt -82.62 -65.33 1.02 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.946 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -133.79 138.86 45.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.49 ' O ' HG12 ' A' ' 77' ' ' VAL . 16.5 t -109.69 106.81 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.931 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 75.37 -59.37 0.54 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.078 0.466 . . . . 0.0 110.613 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.401 ' H ' ' H ' ' A' ' 77' ' ' VAL . 0.2 OUTLIER -167.29 -11.22 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.414 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 74' ' ' VAL . 12.9 p -85.41 125.3 40.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.712 0.292 . . . . 0.0 111.242 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 -69.55 123.8 22.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.424 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.639 HG21 HD13 ' A' ' 90' ' ' LEU . 14.2 p -143.17 32.75 1.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.91 0.386 . . . . 0.0 111.21 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.434 ' HG3' ' CA ' ' A' ' 72' ' ' LEU . 37.0 mtp180 -66.01 -52.49 48.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.636 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.24 30.35 1.95 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.112 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.699 ' HE2' HD11 ' A' ' 90' ' ' LEU . 1.6 m-30 -80.9 174.25 11.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.41 . . . . 0.0 110.742 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.09 158.47 17.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.439 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.848 ' O ' HG23 ' A' ' 88' ' ' VAL . 22.6 p -51.35 -41.66 60.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.914 0.388 . . . . 0.0 110.815 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.56 -22.47 66.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.131 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.55 ' O ' HD12 ' A' ' 90' ' ' LEU . 8.9 mp -93.02 -33.44 14.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.165 0.507 . . . . 0.0 110.875 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.919 ' CG1' HD12 ' A' ' 71' ' ' LEU . 59.7 t -77.18 -36.02 23.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.165 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 84' ' ' CYS . 78.5 t -55.45 -52.25 73.27 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.819 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 54.4 Cg_endo -69.19 -43.22 3.28 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.281 1.987 . . . . 0.0 111.904 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.699 HD11 ' HE2' ' A' ' 82' ' ' PHE . 15.9 mt -54.6 -31.61 57.3 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.967 0.413 . . . . 0.0 110.787 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.938 HG23 ' CD1' ' A' ' 98' ' ' LEU . 70.3 mt -78.8 -47.45 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.854 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.5 -3.96 30.9 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.08 -4.2 16.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.606 0.241 . . . . 0.0 111.593 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.6 p -64.08 -18.2 64.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.907 0.384 . . . . 0.0 111.133 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.85 -144.81 17.55 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.415 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -73.91 -8.24 55.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.615 0.245 . . . . 0.0 111.466 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.465 ' HG2' ' CD1' ' A' ' 28' ' ' TYR . 10.4 mtpt -144.33 147.57 33.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.678 0.275 . . . . 0.0 111.034 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.938 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -124.77 97.58 5.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 0.0 111.078 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.857 ' OD1' HG23 ' A' ' 26' ' ' THR . 6.0 m-20 -95.04 118.78 32.43 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.838 HD22 HD22 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -150.2 169.36 21.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.251 0.548 . . . . 0.0 112.333 -178.663 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.635 HG12 HD12 ' A' ' 72' ' ' LEU . 25.0 t -118.44 109.35 26.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.549 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.677 HD11 ' NE2' ' A' ' 23' ' ' HIS . 2.2 pp -102.58 154.56 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.429 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.749 ' HB2' HD11 ' A' ' 72' ' ' LEU . 3.4 t -130.15 125.72 35.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.452 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.42 126.23 10.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.005 0.431 . . . . 0.0 111.791 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.39 140.05 78.97 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.459 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.435 ' CG ' ' HA ' ' A' ' 16' ' ' SER . 74.1 Cg_endo . . . . . 0 C--O 1.249 1.028 0 C-N-CA 122.323 2.015 . . . . 0.0 112.302 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.756 0.312 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -71.23 -70.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.813 2.342 . . . . 0.0 112.116 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.596 HG22 ' HD2' ' A' ' 19' ' ' PRO . 1.9 m -75.73 145.28 78.14 Favored Pre-proline 0 N--CA 1.452 -0.337 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.004 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.596 ' HD2' HG22 ' A' ' 18' ' ' THR . 31.3 Cg_exo -58.67 -160.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.419 2.079 . . . . 0.0 112.095 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.447 HG12 ' OD1' ' A' ' 105' ' ' ASN . 27.5 m -52.5 146.22 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.462 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.39 122.55 47.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.629 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.793 HD22 HG12 ' A' ' 101' ' ' VAL . 14.1 mt -62.44 144.3 56.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.304 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.537 ' HB2' HD11 ' A' ' 102' ' ' ILE . 80.5 m-70 -152.41 110.59 3.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.806 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -72.99 106.26 4.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.112 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.594 HG11 ' CD2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -109.7 141.02 26.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.04 0.448 . . . . 0.0 111.57 -179.263 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.9 m -132.64 106.75 7.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.144 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.58 HD21 HD21 ' A' ' 65' ' ' LEU . 1.5 mp -101.06 177.6 4.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.046 0.45 . . . . 0.0 111.613 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.442 ' CD2' ' HG2' ' A' ' 97' ' ' LYS . 11.7 m-85 -138.89 133.51 32.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.437 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -94.84 161.88 13.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.971 0.415 . . . . 0.0 111.173 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -124.4 130.9 53.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.802 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 61.3 p -60.04 84.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.4 -13.49 1.4 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.893 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.94 174.64 11.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.769 0.319 . . . . 0.0 110.923 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.82 -10.73 13.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.48 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -155.66 -176.58 6.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.977 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.51 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -98.15 31.99 2.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.008 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.85 15.66 79.54 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.973 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.65 ' CD2' HD11 ' A' ' 65' ' ' LEU . 4.1 p90 -173.47 119.22 0.3 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 110.962 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -93.62 149.66 21.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.824 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.686 ' HB ' HG12 ' A' ' 49' ' ' VAL . 23.7 m -108.33 167.94 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.244 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.813 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -127.08 171.32 11.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.096 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -88.14 137.31 32.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.098 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.86 114.58 4.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.403 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tp -94.38 -31.05 14.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.068 0.461 . . . . 0.0 111.251 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.96 -54.88 4.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.892 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.7 mm-40 -90.55 17.99 6.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.473 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 29.83 89.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.79 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.1 -144.53 8.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.601 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.813 HG13 ' O ' ' A' ' 41' ' ' ALA . 38.8 t -146.7 140.74 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 0.0 111.021 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.1 159.99 40.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.608 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.792 HG11 HD11 ' A' ' 54' ' ' ILE . 59.8 t -62.97 123.63 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.982 0.42 . . . . 0.0 111.031 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.49 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 2.0 tptp -88.58 -35.38 16.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.98 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -162.55 143.59 10.14 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.273 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.792 HD11 HG11 ' A' ' 51' ' ' VAL . 1.2 mt -129.57 133.92 64.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.979 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.44 137.56 96.65 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.687 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.585 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 72.8 Cg_endo -75.03 107.59 2.52 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.498 2.132 . . . . 0.0 112.495 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 83.54 28.95 0.08 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.268 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -114.5 -161.64 13.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.305 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -50.65 -53.55 6.95 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.493 2.129 . . . . 0.0 112.199 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.01 -38.38 89.0 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.476 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.3 -32.81 64.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.05 0.452 . . . . 0.0 110.273 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.6 -30.8 67.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.687 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.99 -53.4 6.27 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.28 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.45 35.13 0.88 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.787 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.65 HD11 ' CD2' ' A' ' 38' ' ' PHE . 0.3 OUTLIER -113.64 141.87 46.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.843 0.354 . . . . 0.0 110.958 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -121.93 163.04 33.83 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.684 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.551 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 1.4 Cg_endo -44.51 144.28 3.31 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.824 2.35 . . . . 0.0 112.3 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.551 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 93.8 m-85 85.3 -7.82 0.86 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.41 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.708 ' CG ' HD13 ' A' ' 102' ' ' ILE . 5.4 m-20 -54.41 86.65 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.151 0.5 . . . . 0.0 110.591 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.613 ' O ' HD12 ' A' ' 72' ' ' LEU . 22.2 ttm180 -66.82 109.15 2.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.292 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.562 ' CD2' HD22 ' A' ' 100' ' ' LEU . 1.8 mp -66.61 107.92 2.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.796 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.719 HD11 ' HB3' ' A' ' 103' ' ' SER . 5.2 mp -83.75 -37.51 22.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.509 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.81 145.58 18.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.868 0.366 . . . . 0.0 111.087 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.812 HG12 ' OD1' ' A' ' 75' ' ' ASN . 21.5 t -115.11 109.75 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.791 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.812 ' OD1' HG12 ' A' ' 74' ' ' VAL . 1.0 OUTLIER 75.46 -57.46 0.59 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.072 0.463 . . . . 0.0 110.695 -179.699 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -167.19 -14.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.263 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.5 t -85.62 128.47 39.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-O 120.797 0.332 . . . . 0.0 111.098 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -69.31 127.07 31.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.515 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.784 HG21 HD13 ' A' ' 90' ' ' LEU . 16.8 p -142.69 32.44 1.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.031 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.444 ' CG ' ' HG ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -67.95 -48.39 66.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.303 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.15 24.21 4.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.077 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.613 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.1 m-30 -81.13 173.87 12.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.802 0.334 . . . . 0.0 110.823 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.32 159.59 16.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.327 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.853 ' O ' HG23 ' A' ' 88' ' ' VAL . 19.6 t -51.48 -42.1 61.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.824 0.345 . . . . 0.0 110.713 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.6 t -62.61 -21.64 65.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.18 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 90' ' ' LEU . 8.3 mp -95.64 -32.57 12.72 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.023 0.44 . . . . 0.0 110.978 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.619 HG12 HD11 ' A' ' 91' ' ' ILE . 50.9 t -78.29 -35.7 19.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.331 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 84' ' ' CYS . 91.9 t -58.27 -51.27 82.99 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.833 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.645 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.3 Cg_exo -67.55 -44.86 3.99 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.349 2.033 . . . . 0.0 111.47 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.784 HD13 HG21 ' A' ' 79' ' ' THR . 18.1 mt -54.74 -29.38 53.51 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.697 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.95 HG23 ' CD1' ' A' ' 98' ' ' LEU . 50.1 mt -78.08 -48.43 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.796 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.37 -4.32 32.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.97 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -99.3 -12.94 19.89 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.716 0.293 . . . . 0.0 111.576 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -15.97 62.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.383 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.03 -144.11 17.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.649 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -73.72 -7.1 50.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.442 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -138.58 141.67 39.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.772 0.32 . . . . 0.0 110.657 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.95 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -130.6 97.33 4.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.263 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -98.47 118.11 34.41 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.935 HD23 HD22 ' A' ' 98' ' ' LEU . 1.6 pp -145.91 163.2 35.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.12 0.486 . . . . 0.0 111.849 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.793 HG12 HD22 ' A' ' 22' ' ' LEU . 25.5 t -113.51 109.11 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.168 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.708 HD13 ' CG ' ' A' ' 69' ' ' ASP . 2.6 pp -103.75 168.95 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.088 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.719 ' HB3' HD11 ' A' ' 72' ' ' LEU . 54.2 p -142.39 120.24 11.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.716 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.5 ptt85 -128.34 130.32 47.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.176 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.447 ' OD1' HG12 ' A' ' 20' ' ' VAL . 14.8 m120 -65.85 157.42 79.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.852 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo . . . . . 0 C--O 1.249 1.054 0 C-N-CA 122.54 2.16 . . . . 0.0 112.224 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.552 0.215 . . . . 0.0 111.539 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.8 52.83 4.51 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.561 2.174 . . . . 0.0 112.563 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.467 ' HB ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -168.86 -52.05 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.963 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.467 ' HD3' ' HB ' ' A' ' 18' ' ' THR . 6.2 Cg_exo -78.36 84.63 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.841 2.361 . . . . 0.0 112.346 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.424 HG23 ' OG ' ' A' ' 103' ' ' SER . 30.2 m -46.08 168.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.476 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -125.55 122.69 37.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.675 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 1.081 HD21 HD12 ' A' ' 72' ' ' LEU . 15.1 mt -61.19 152.91 27.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.411 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.447 ' HB2' HD11 ' A' ' 102' ' ' ILE . 20.5 m-70 -157.15 109.9 2.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.024 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.545 ' CD ' HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -72.45 112.99 9.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.078 179.596 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.942 HG11 ' HG ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -121.92 143.4 34.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.142 0.496 . . . . 0.0 111.932 -178.898 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.1 m -134.0 106.4 7.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.811 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.538 HD11 HD11 ' A' ' 65' ' ' LEU . 4.4 mp -94.34 174.88 6.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.278 0.561 . . . . 0.0 112.04 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 96' ' ' ASN . 24.8 m-85 -137.4 121.63 18.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.222 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 6.1 tttm -112.04 152.98 27.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.958 0.408 . . . . 0.0 111.263 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.409 ' N ' ' HG2' ' A' ' 29' ' ' LYS . 19.6 t0 -102.52 138.86 38.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.867 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.0 m -51.35 -26.34 7.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.31 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.72 -38.15 21.06 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.615 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 9.2 mmm -81.76 158.14 24.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.91 0.386 . . . . 0.0 110.936 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.68 -30.89 8.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.114 0.483 . . . . 0.0 110.92 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.99 172.03 11.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.713 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.476 ' CD2' HG22 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -119.14 32.07 6.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.802 0.335 . . . . 0.0 111.105 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.401 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 77.1 6.59 86.24 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.283 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.481 ' HD2' HG13 ' A' ' 51' ' ' VAL . 14.1 p90 -172.5 123.15 0.46 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.159 0.479 . . . . 0.0 111.393 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -95.1 145.81 24.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.536 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.668 HG11 HD11 ' A' ' 71' ' ' LEU . 33.5 m -110.49 159.67 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.281 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.796 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -116.97 178.06 4.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -90.7 161.22 15.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.128 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.5 128.63 8.28 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.239 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.44 -58.07 2.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.289 0.566 . . . . 0.0 111.398 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.58 -43.51 15.59 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.61 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 47' ' ' LYS . 2.1 mt-10 -87.7 9.77 20.42 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.749 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER 27.71 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.73 -152.8 19.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.468 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.796 HG13 ' O ' ' A' ' 41' ' ' ALA . 59.7 t -142.65 138.39 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.761 0.315 . . . . 0.0 111.052 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.13 167.91 20.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.52 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.512 HG11 HD11 ' A' ' 54' ' ' ILE . 47.2 t -71.64 122.04 23.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.979 0.419 . . . . 0.0 111.368 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -89.52 -32.68 17.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.785 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -164.79 153.89 12.9 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.187 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.512 HD11 HG11 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -130.95 133.62 62.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.15 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.87 127.02 92.82 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.627 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 32.3 Cg_exo -58.34 114.22 1.89 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.418 2.079 . . . . 0.0 112.44 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 86.64 -14.67 0.48 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.951 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.63 -176.6 2.25 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.371 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.71 -32.48 97.0 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.521 2.148 . . . . 0.0 111.998 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.516 ' HA2' HD21 ' A' ' 27' ' ' LEU . . . -64.51 -38.87 96.32 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.321 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.58 -32.68 64.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.987 0.422 . . . . 0.0 110.019 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.4 mt -75.2 -34.99 61.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.833 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.42 -57.78 7.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.42 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 125.59 42.62 0.31 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.752 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.942 ' HG ' HG11 ' A' ' 25' ' ' VAL . 0.9 OUTLIER -104.56 122.83 46.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.857 0.361 . . . . 0.0 110.918 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.84 162.04 20.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.772 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 6.9 Cg_endo -49.15 137.46 29.63 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.972 2.448 . . . . 0.0 112.156 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 46.6 m-85 85.32 -1.52 0.82 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.17 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.608 ' CG ' HD13 ' A' ' 102' ' ' ILE . 0.9 OUTLIER -53.08 88.23 0.0 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.943 0.401 . . . . 0.0 110.735 179.507 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.57 ' O ' HD23 ' A' ' 72' ' ' LEU . 44.3 ttp180 -76.8 102.12 6.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.035 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.745 HD23 HD13 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -56.17 115.33 2.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.838 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.081 HD12 HD21 ' A' ' 22' ' ' LEU . 2.8 mt -82.49 -64.44 1.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 0.0 111.135 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -133.12 109.59 9.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.369 . . . . 0.0 111.174 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.553 HG13 ' HB3' ' A' ' 100' ' ' LEU . 23.4 t -89.41 123.69 41.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.903 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 4.4 m120 46.11 40.0 6.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.449 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.47 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 1.5 t-80 87.6 -21.92 0.16 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.823 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.0 t -82.37 129.52 37.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.721 0.296 . . . . 0.0 111.151 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -68.86 135.14 50.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.447 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 30.1 p -144.89 29.87 1.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.058 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.649 ' HG2' HD22 ' A' ' 72' ' ' LEU . 8.8 mtp-105 -72.83 -53.2 12.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.696 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.19 21.69 5.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.148 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.747 ' CE2' HD11 ' A' ' 90' ' ' LEU . 2.8 m-85 -81.27 169.44 17.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.872 0.367 . . . . 0.0 110.875 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -108.51 157.94 18.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.245 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.867 ' O ' HG23 ' A' ' 88' ' ' VAL . 8.0 p -51.39 -38.37 53.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.0 110.676 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -66.97 -21.45 65.96 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.222 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.63 HD23 ' CD2' ' A' ' 82' ' ' PHE . 1.0 OUTLIER -92.33 -32.31 15.03 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.003 0.43 . . . . 0.0 110.571 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.485 HG12 ' CD1' ' A' ' 91' ' ' ILE . 94.3 t -77.05 -35.68 23.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.982 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 84' ' ' CYS . 84.4 t -55.35 -52.64 69.9 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.817 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 49.3 Cg_endo -68.4 -43.22 4.48 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.205 1.937 . . . . 0.0 111.704 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.747 HD11 ' CE2' ' A' ' 82' ' ' PHE . 11.0 mt -53.97 -33.71 57.71 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.298 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.948 HG23 ' CD1' ' A' ' 98' ' ' LEU . 80.3 mt -78.92 -41.88 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.842 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.64 -5.55 38.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.36 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 4.5 pt-20 -98.38 -3.26 37.35 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.704 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.6 p -63.68 -31.03 72.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.232 0.539 . . . . 0.0 110.666 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.46 -48.9 1.88 Allowed Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.818 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 6.1 p30 -166.24 -39.48 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.744 0.307 . . . . 0.0 111.111 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -111.75 112.96 25.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.191 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.948 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -103.9 98.07 7.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.559 -179.111 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -95.94 118.5 32.69 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.745 HD13 HD23 ' A' ' 71' ' ' LEU . 1.4 pp -146.43 164.18 33.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.273 0.559 . . . . 0.0 111.978 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.892 HG12 HD22 ' A' ' 22' ' ' LEU . 26.0 t -119.22 109.36 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.147 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.733 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.5 pp -101.68 168.78 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.115 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.424 ' OG ' HG23 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -146.11 128.16 15.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.674 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.403 ' N ' ' HB ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -147.22 147.56 30.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.983 0.421 . . . . 0.0 111.329 -179.811 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -62.38 143.2 95.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.829 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo . . . . . 0 C--O 1.248 0.996 0 C-N-CA 122.514 2.142 . . . . 0.0 112.217 -179.958 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.416 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.613 0.244 . . . . 0.0 111.469 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 16' ' ' SER . 85.2 Cg_endo -83.38 50.93 3.41 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.512 2.141 . . . . 0.0 112.66 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.472 ' HB ' ' HD3' ' A' ' 19' ' ' PRO . 1.3 m 178.76 -61.93 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.479 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.472 ' HD3' ' HB ' ' A' ' 18' ' ' THR . 56.9 Cg_endo -70.46 107.19 1.94 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.425 2.083 . . . . 0.0 112.231 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.7 m -45.95 160.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.672 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.51 122.88 38.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.351 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.915 HD21 HD12 ' A' ' 72' ' ' LEU . 13.7 mt -60.53 147.0 42.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.584 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.468 ' HB2' HD11 ' A' ' 102' ' ' ILE . 15.1 m-70 -151.46 107.51 3.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.825 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.44 118.4 13.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.19 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.503 HG11 ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -126.25 141.58 45.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.076 0.465 . . . . 0.0 111.799 -179.223 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 95.9 m -134.38 106.64 7.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.778 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.929 HD11 HD11 ' A' ' 65' ' ' LEU . 17.1 mt -100.04 171.99 7.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.018 0.437 . . . . 0.0 111.774 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -123.52 137.25 54.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.34 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 1.5 tttt -95.24 162.91 13.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.033 0.444 . . . . 0.0 111.299 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -131.33 128.18 39.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.741 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.63 -27.16 6.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.248 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.08 26.93 20.6 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.504 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.87 140.09 13.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 110.892 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -96.57 -21.85 17.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.992 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -84.79 170.83 12.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.761 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -119.03 23.9 11.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.32 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 89.24 9.63 67.03 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.334 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.644 ' CD2' HD13 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -173.72 138.93 0.68 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.128 0.464 . . . . 0.0 111.627 179.781 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.8 m -99.35 154.69 18.0 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.596 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.639 ' HB ' HG12 ' A' ' 49' ' ' VAL . 35.0 m -116.34 159.23 16.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.42 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.825 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -117.98 178.31 4.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.047 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.09 144.8 26.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.194 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.2 115.45 5.05 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.242 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.29 -45.66 7.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.157 0.503 . . . . 0.0 111.343 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 45' ' ' LEU . 2.0 mm? -84.66 4.79 30.83 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.897 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.465 ' O ' ' C ' ' A' ' 47' ' ' LYS . 27.0 mt-10 -153.85 22.92 0.51 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.522 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 24.09 79.84 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -171.69 -157.4 13.51 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.365 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.825 HG13 ' O ' ' A' ' 41' ' ' ALA . 35.7 t -143.48 139.38 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.872 0.367 . . . . 0.0 111.15 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.81 168.57 19.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.359 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.513 HG22 ' CE2' ' A' ' 38' ' ' PHE . 72.2 t -74.21 121.54 25.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.793 0.33 . . . . 0.0 111.142 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -89.52 -31.55 17.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.29 -179.865 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -163.5 162.96 24.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.27 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -134.27 136.98 52.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.49 123.88 84.24 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.26 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.6 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 31.9 Cg_exo -58.5 105.99 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.525 2.15 . . . . 0.0 112.19 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 82.35 28.56 0.13 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.111 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.21 -173.39 24.23 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.276 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.444 ' C ' HD22 ' A' ' 27' ' ' LEU . 78.0 Cg_exo -49.87 -42.21 45.15 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.453 2.102 . . . . 0.0 112.171 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.583 ' HA2' HD21 ' A' ' 27' ' ' LEU . . . -64.23 -36.43 93.22 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.445 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.63 -32.96 64.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.062 0.458 . . . . 0.0 110.404 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.81 -34.43 75.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.992 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.05 -46.69 5.82 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.627 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.14 34.79 0.86 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.581 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.929 HD11 HD11 ' A' ' 27' ' ' LEU . 45.1 mt -75.81 133.49 40.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.738 0.304 . . . . 0.0 110.917 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -117.87 155.81 50.58 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.893 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.529 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 12.3 Cg_endo -55.69 146.42 65.77 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.621 2.214 . . . . 0.0 112.18 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.529 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 85.4 m-85 84.64 -5.39 0.99 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.384 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.531 ' CG ' HD13 ' A' ' 102' ' ' ILE . 7.0 m-20 -53.97 85.56 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.98 0.419 . . . . 0.0 110.774 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 68' ' ' TYR . 59.3 ttt180 -71.41 101.13 2.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.06 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.956 HD23 HD13 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -58.93 107.76 0.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.938 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.915 HD12 HD21 ' A' ' 22' ' ' LEU . 9.0 mt -82.39 -65.53 1.0 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.869 0.366 . . . . 0.0 110.881 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -119.56 127.5 53.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.892 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.9 104.68 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.101 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.468 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 1.2 m-20 64.71 36.94 7.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.725 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.468 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 2.8 t60 87.66 -14.68 0.42 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.503 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 79' ' ' THR . 21.4 t -83.63 114.06 23.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.8 0.333 . . . . 0.0 111.005 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -69.01 87.09 0.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.812 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 77' ' ' VAL . 15.8 p -95.95 32.08 1.98 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.115 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.73 ' HG2' HD22 ' A' ' 72' ' ' LEU . 36.2 mtp180 -66.28 -53.15 40.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.814 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -93.52 22.71 5.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.185 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.661 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.8 m-85 -82.01 167.94 18.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.951 0.405 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 87' ' ' VAL . 2.2 m-20 -106.99 160.87 15.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.383 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.873 ' O ' HG23 ' A' ' 88' ' ' VAL . 4.3 t -51.59 -41.35 61.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.666 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 10.0 p -62.56 -23.91 67.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.07 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.495 ' O ' HD12 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -94.12 -30.93 14.39 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.946 0.403 . . . . 0.0 110.972 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.517 HG12 ' CD1' ' A' ' 91' ' ' ILE . 41.3 t -78.89 -35.9 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.265 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 84' ' ' CYS . 91.6 t -57.76 -51.02 84.79 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.865 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.65 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 14.3 Cg_exo -68.96 -46.19 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.425 2.083 . . . . 0.0 111.517 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.661 HD11 ' HE2' ' A' ' 82' ' ' PHE . 33.3 mt -54.91 -33.09 61.74 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.986 0.422 . . . . 0.0 110.546 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.856 HG23 ' CD1' ' A' ' 98' ' ' LEU . 62.6 mt -73.25 -46.76 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.477 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.57 -3.9 36.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.848 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.18 -7.23 22.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.656 0.265 . . . . 0.0 111.497 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.408 ' OG ' ' HG ' ' A' ' 98' ' ' LEU . 4.8 p -64.52 -16.59 62.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.355 . . . . 0.0 111.347 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.26 -144.0 16.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.217 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -74.38 -8.81 57.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.569 0.223 . . . . 0.0 111.452 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -142.1 141.84 32.75 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.784 0.326 . . . . 0.0 110.959 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.894 HD22 HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -119.56 97.12 5.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.242 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -92.0 118.37 30.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.956 HD13 HD23 ' A' ' 71' ' ' LEU . 1.6 pp -151.85 162.17 41.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.324 0.583 . . . . 0.0 112.093 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.854 HG12 HD22 ' A' ' 22' ' ' LEU . 39.1 t -121.49 109.02 23.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.946 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.879 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.4 pp -100.95 169.3 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.349 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.58 128.26 16.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.579 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.0 151.74 35.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.012 0.434 . . . . 0.0 111.478 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -62.68 115.1 14.6 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.971 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.249 1.054 0 C-N-CA 122.508 2.139 . . . . 0.0 112.267 -179.992 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 121.013 0.435 . . . . 0.0 111.847 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -137.73 122.82 19.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.316 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.078 HD21 HD12 ' A' ' 72' ' ' LEU . 13.6 mt -60.03 137.5 58.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.102 0.477 . . . . 0.0 111.839 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.754 ' HD2' HD11 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -149.34 122.04 8.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.173 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.67 ' HD2' HG22 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -68.87 135.43 51.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.517 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.724 HG11 ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -137.37 143.05 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.143 0.496 . . . . 0.0 111.451 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.853 HG23 ' OD1' ' A' ' 99' ' ' ASP . 97.2 m -134.55 141.42 46.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.784 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.691 HD21 HD11 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -138.39 -179.63 5.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.08 0.467 . . . . 0.0 111.639 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.439 ' CD2' ' HG2' ' A' ' 97' ' ' LYS . 9.8 m-85 -138.96 125.35 20.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.391 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -94.87 164.94 12.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.997 0.427 . . . . 0.0 111.231 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.37 141.13 48.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.657 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.3 p -60.11 84.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 138.33 -3.68 3.03 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.217 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.6 151.34 29.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.864 0.364 . . . . 0.0 110.989 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -94.91 -10.53 30.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.388 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.83 175.87 13.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.68 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.861 ' CD2' HD12 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -94.15 2.1 56.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.619 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.33 18.23 5.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.382 -0.913 . . . . 0.0 113.25 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.69 ' HB3' HG23 ' A' ' 54' ' ' ILE . 39.4 p90 -174.04 134.45 0.45 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 117.035 0.418 . . . . 0.0 111.654 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.403 ' O ' ' N ' ' A' ' 52' ' ' LYS . 67.4 m -92.99 151.3 19.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.088 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.731 ' HB ' HG12 ' A' ' 49' ' ' VAL . 34.5 m -114.93 167.95 7.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.122 0.487 . . . . 0.0 111.837 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.506 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -133.85 140.69 47.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.782 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.13 121.75 18.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.817 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.422 ' HA3' ' CZ ' ' A' ' 50' ' ' TYR . . . -77.05 89.65 0.98 Allowed Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 pp -83.36 -2.47 55.82 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.54 ' H ' HD12 ' A' ' 45' ' ' LEU . 4.9 mp -77.17 -13.49 59.94 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.586 ' O ' ' CG ' ' A' ' 47' ' ' LYS . 0.6 OUTLIER -157.88 -83.78 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.001 179.334 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.586 ' CG ' ' O ' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -175.68 134.22 0.29 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.596 0.758 . . . . 0.0 110.233 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.62 -159.19 22.01 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.263 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.731 HG12 ' HB ' ' A' ' 40' ' ' VAL . 18.8 t -154.82 144.38 13.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.627 0.251 . . . . 0.0 110.852 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.422 ' CZ ' ' HA3' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -135.88 151.39 49.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.806 0.336 . . . . 0.0 111.028 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.623 HG22 ' CE1' ' A' ' 38' ' ' PHE . 44.7 t -60.49 123.59 13.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.02 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 39' ' ' SER . 0.1 OUTLIER -88.19 -27.54 21.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.169 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -169.68 140.34 2.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.738 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.69 HG23 ' HB3' ' A' ' 38' ' ' PHE . 2.7 mt -119.61 142.9 32.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.002 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -65.37 111.7 6.71 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.732 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.604 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 50.0 Cg_exo -55.53 109.17 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.464 2.109 . . . . 0.0 112.485 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 83.38 38.14 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.367 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.9 -170.41 13.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.171 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.415 ' HB2' ' O ' ' A' ' 36' ' ' PHE . 72.2 Cg_exo -49.77 -43.62 39.73 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.35 2.033 . . . . 0.0 111.817 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.46 ' HA2' HD12 ' A' ' 65' ' ' LEU . . . -64.85 -38.5 95.63 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.428 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -73.59 -32.84 64.32 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.007 0.432 . . . . 0.0 110.196 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 75.3 mt -73.01 -31.84 64.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.682 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.86 -40.92 34.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.362 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.34 8.4 6.49 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.031 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.724 ' HG ' HG11 ' A' ' 25' ' ' VAL . 1.2 mt -63.4 115.96 5.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.911 0.386 . . . . 0.0 110.988 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -107.33 141.56 23.23 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.512 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.598 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 4.1 Cg_exo -39.47 135.75 1.16 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.202 2.601 . . . . 0.0 112.727 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.598 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 78.2 m-85 85.44 -5.31 0.87 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.542 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.817 ' CB ' HD13 ' A' ' 102' ' ' ILE . 9.1 p-10 -56.22 85.1 0.01 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.062 0.458 . . . . 0.0 110.885 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.563 ' O ' HD23 ' A' ' 72' ' ' LEU . 42.4 ttt180 -66.66 102.61 0.94 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.476 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.92 HD22 HD22 ' A' ' 100' ' ' LEU . 3.2 mt -54.5 107.28 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.721 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.078 HD12 HD21 ' A' ' 22' ' ' LEU . 5.5 mt -82.98 -63.48 1.35 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.376 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -121.23 118.24 29.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.07 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.647 HG23 ' OG1' ' A' ' 79' ' ' THR . 27.1 t -100.55 120.21 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.249 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.442 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 0.4 OUTLIER 46.36 43.11 11.4 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.671 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.442 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.1 OUTLIER 86.59 -19.37 0.28 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.752 179.534 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.85 120.69 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.875 0.369 . . . . 0.0 111.087 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -70.13 85.94 0.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.671 HG21 HD13 ' A' ' 90' ' ' LEU . 27.9 p -96.51 30.93 2.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.138 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.664 ' HG2' HD22 ' A' ' 72' ' ' LEU . 4.6 mtp180 -68.4 -45.73 71.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.008 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -92.0 18.28 8.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.311 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.609 ' HE2' HD11 ' A' ' 90' ' ' LEU . 3.5 m-30 -82.16 171.81 13.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.883 0.373 . . . . 0.0 110.931 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.806 ' OD1' HD13 ' A' ' 86' ' ' LEU . 0.4 OUTLIER -114.07 166.87 11.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.33 179.357 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.809 ' O ' HG23 ' A' ' 88' ' ' VAL . 9.5 p -51.52 -44.62 62.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.256 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 26.2 p -61.13 -20.12 62.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.52 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.806 HD13 ' OD1' ' A' ' 83' ' ' ASP . 7.5 mp -99.45 -33.37 10.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.868 0.366 . . . . 0.0 111.165 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 83' ' ' ASP . 44.9 t -77.5 -35.9 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.963 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 84' ' ' CYS . 99.0 t -57.65 -52.36 74.9 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.735 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 45.7 Cg_endo -67.56 -44.8 4.04 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.149 1.899 . . . . 0.0 111.8 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.671 HD13 HG21 ' A' ' 79' ' ' THR . 13.1 mt -54.94 -31.64 60.58 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.045 0.45 . . . . 0.0 110.391 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.612 ' HA ' HD11 ' A' ' 98' ' ' LEU . 60.3 mt -72.57 -51.4 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.161 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.84 -3.06 42.7 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.976 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.97 -5.99 22.86 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.422 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 3.3 t -64.82 -14.73 60.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.741 0.305 . . . . 0.0 111.461 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.11 -142.97 16.34 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.663 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -74.65 -5.53 43.57 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.439 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 42.1 mtpt -146.23 151.3 37.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.874 0.369 . . . . 0.0 111.141 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.861 HD12 ' CD2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -129.67 97.86 4.65 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.285 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.853 ' OD1' HG23 ' A' ' 26' ' ' THR . 6.1 m-20 -99.21 117.9 34.71 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.92 HD22 HD22 ' A' ' 71' ' ' LEU . 2.3 pp -150.21 162.89 39.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.262 0.553 . . . . 0.0 112.253 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.916 HG12 HD22 ' A' ' 22' ' ' LEU . 15.1 t -114.1 109.53 28.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.895 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.848 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.6 pp -105.45 169.26 2.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.345 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.7 p -133.42 121.68 22.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.766 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.419 ' HB3' ' HA ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -136.44 147.68 47.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.171 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -74.57 122.67 88.04 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.779 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 C--O 1.25 1.11 0 C-N-CA 122.333 2.022 . . . . 0.0 112.385 -179.912 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.419 ' CG2' ' HB2' ' A' ' 103' ' ' SER . 28.9 m . . . . . 0 C--O 1.23 0.079 0 CA-C-O 121.063 0.458 . . . . 0.0 111.711 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -132.51 122.81 25.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.479 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.949 HD21 ' CD1' ' A' ' 72' ' ' LEU . 13.5 mt -60.01 148.67 34.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.033 0.444 . . . . 0.0 111.651 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.5 122.87 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.221 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -71.51 119.24 15.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.509 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.598 HG11 ' HB3' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -117.5 148.17 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.134 0.493 . . . . 0.0 111.493 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.3 m -134.59 106.89 7.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.848 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.099 HD11 HD21 ' A' ' 65' ' ' LEU . 13.8 mt -101.08 173.66 6.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.24 0.543 . . . . 0.0 112.017 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.443 ' CZ ' ' HD3' ' A' ' 97' ' ' LYS . 6.3 m-85 -132.53 166.15 22.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.329 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -134.08 161.02 36.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.98 0.419 . . . . 0.0 111.29 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.44 148.02 51.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.657 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.4 m -58.05 -25.21 60.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.149 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.77 -14.71 51.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.854 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 5.3 mmt -81.29 145.0 31.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.911 0.386 . . . . 0.0 111.013 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -91.73 -10.15 41.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.24 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -154.13 -167.52 2.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.607 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.526 ' CE2' ' HB2' ' A' ' 98' ' ' LEU . 1.1 m-85 -95.89 24.4 5.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.723 0.297 . . . . 0.0 111.564 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.631 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 80.6 16.81 74.76 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.568 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.507 ' CE2' HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -172.05 124.42 0.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.192 0.52 . . . . 0.0 111.696 179.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.4 m -89.51 154.04 20.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.807 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.678 ' HB ' HG12 ' A' ' 49' ' ' VAL . 30.8 m -106.39 165.47 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.554 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.782 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -124.25 178.15 5.49 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.144 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -103.81 139.08 39.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.077 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.07 118.51 5.44 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.33 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.53 -28.5 15.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.927 0.394 . . . . 0.0 111.263 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tp -84.7 -7.68 59.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.856 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 47' ' ' LYS . 8.9 mm-40 -150.12 25.44 0.81 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.13 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER 26.26 63.08 0.08 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.012 0.434 . . . . 0.0 112.082 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -149.24 -164.55 11.69 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.499 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.782 HG13 ' O ' ' A' ' 41' ' ' ALA . 19.1 t -132.39 132.51 60.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.638 0.256 . . . . 0.0 111.087 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.461 ' CE1' ' NH1' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -133.41 145.86 50.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.289 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.507 HG22 ' CE2' ' A' ' 38' ' ' PHE . 58.6 t -49.06 124.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.057 0.456 . . . . 0.0 111.512 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.714 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 5.9 tptt -88.29 -30.6 19.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.002 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -175.88 160.92 2.42 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.386 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -128.04 142.7 43.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.978 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -65.26 147.6 98.48 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.592 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 58.6 Cg_endo -71.78 100.08 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.526 2.151 . . . . 0.0 112.391 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 83.1 29.35 0.09 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.16 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.03 -179.52 32.95 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.401 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.83 -29.52 53.2 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.588 2.192 . . . . 0.0 112.146 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.656 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . -64.19 -47.3 86.4 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.201 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.25 -32.84 67.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.12 0.486 . . . . 0.0 109.951 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.3 mt -73.47 -29.14 62.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.358 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.444 ' HA3' HD23 ' A' ' 27' ' ' LEU . . . -71.46 -48.49 29.77 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.178 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.88 10.49 3.51 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.446 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.099 HD21 HD11 ' A' ' 27' ' ' LEU . 1.3 pp -111.44 152.16 27.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.098 0.449 . . . . 0.0 110.93 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.428 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -138.51 179.11 1.4 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.673 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.477 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 74.8 Cg_exo -49.73 144.9 18.95 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.362 2.041 . . . . 0.0 112.353 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.495 ' O ' ' N ' ' A' ' 70' ' ' ARG . 11.6 m-85 90.32 -17.21 0.2 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.433 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.653 ' CG ' HD13 ' A' ' 102' ' ' ILE . 1.6 m-20 -53.34 83.75 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.007 0.432 . . . . 0.0 110.847 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.569 ' HD2' HD21 ' A' ' 72' ' ' LEU . 24.6 ttm-85 -67.92 99.61 0.86 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.987 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.031 HD23 HD13 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -64.31 107.98 1.48 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.02 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.949 ' CD1' HD21 ' A' ' 22' ' ' LEU . 6.5 mt -83.51 -56.31 3.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.467 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -137.06 116.68 12.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.784 0.326 . . . . 0.0 111.516 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.59 HG23 ' OG1' ' A' ' 79' ' ' THR . 22.5 t -89.14 109.04 19.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.535 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 75.54 -59.11 0.54 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.18 0.514 . . . . 0.0 110.517 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -167.47 -14.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.221 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.81 129.24 38.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.775 0.321 . . . . 0.0 111.172 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.73 87.23 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.59 ' OG1' HG23 ' A' ' 74' ' ' VAL . 20.4 p -96.41 26.48 4.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.288 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.761 ' CG ' HD22 ' A' ' 72' ' ' LEU . 2.3 tmm_? -74.93 -46.37 36.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.797 0.332 . . . . 0.0 110.698 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -92.49 19.45 7.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.627 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.9 m-85 -82.01 171.14 14.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.959 0.409 . . . . 0.0 110.95 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.481 ' O ' HG23 ' A' ' 87' ' ' VAL . 7.0 t70 -105.27 158.74 16.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.378 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.898 ' O ' HG23 ' A' ' 88' ' ' VAL . 23.7 m -51.34 -41.32 60.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.88 0.372 . . . . 0.0 110.724 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 17.3 t -65.24 -21.63 66.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.274 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.729 ' O ' HD12 ' A' ' 90' ' ' LEU . 10.1 mp -94.56 -30.06 14.57 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.016 0.436 . . . . 0.0 110.739 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.61 HG12 ' CD1' ' A' ' 91' ' ' ILE . 48.7 t -78.59 -35.79 19.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.254 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 84' ' ' CYS . 58.1 t -58.92 -50.99 85.03 Favored Pre-proline 0 C--N 1.331 -0.209 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.87 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.652 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.8 Cg_exo -67.3 -48.04 1.92 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.445 2.097 . . . . 0.0 111.465 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.729 HD12 ' O ' ' A' ' 86' ' ' LEU . 11.0 mt -54.93 -29.96 57.48 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.886 0.374 . . . . 0.0 110.511 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.803 ' HA ' HD11 ' A' ' 98' ' ' LEU . 48.3 mt -74.19 -46.53 44.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.343 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.81 -3.79 52.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.966 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -94.87 -15.77 23.42 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.445 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 1.4 t -65.15 -16.04 63.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.382 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.08 -141.41 15.6 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.696 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -73.99 -20.38 60.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.683 0.277 . . . . 0.0 111.441 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.443 ' HD3' ' CZ ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -127.73 152.38 47.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.674 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.982 HD22 HD23 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -135.77 97.76 3.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.778 0.323 . . . . 0.0 111.575 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.97 118.06 30.41 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 1.031 HD13 HD23 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -146.6 162.99 37.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.157 0.503 . . . . 0.0 111.968 -178.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.881 HG12 HD22 ' A' ' 22' ' ' LEU . 24.5 t -112.91 109.17 27.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.272 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.653 HD13 ' CG ' ' A' ' 69' ' ' ASP . 2.4 pp -109.17 169.19 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.183 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.419 ' HB2' ' CG2' ' A' ' 20' ' ' VAL . 19.0 p -136.15 107.03 6.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.953 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.11 136.14 53.03 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 0.9 OUTLIER -93.54 131.37 32.59 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.128 178.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 105' ' ' ASN . 8.7 Cg_exo . . . . . 0 C--O 1.249 1.05 0 C-N-CA 122.24 1.96 . . . . 0.0 112.19 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.431 HG21 ' HB3' ' A' ' 103' ' ' SER . 27.4 m . . . . . 0 N--CA 1.462 0.128 0 CA-C-O 120.945 0.402 . . . . 0.0 111.629 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -120.32 122.75 41.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.601 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.723 HD22 HG12 ' A' ' 101' ' ' VAL . 14.1 mt -61.86 141.92 57.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.291 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.483 ' HB2' HD11 ' A' ' 102' ' ' ILE . 9.9 m-70 -144.15 108.51 4.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.839 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.95 102.5 4.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.607 HG23 HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -110.39 138.44 38.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.107 0.479 . . . . 0.0 111.828 -179.011 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.2 m -131.98 106.39 8.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.732 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.686 HD21 HD11 ' A' ' 65' ' ' LEU . 19.6 mt -98.81 177.1 5.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.978 0.418 . . . . 0.0 111.662 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -136.33 135.89 39.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.315 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -94.64 138.18 32.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.417 . . . . 0.0 111.097 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.54 131.04 54.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.795 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -60.59 84.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.838 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.77 -17.25 1.09 Allowed Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.882 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.09 167.94 19.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.848 0.356 . . . . 0.0 110.836 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -107.39 -10.52 15.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.37 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.44 -169.33 3.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.875 0.369 . . . . 0.0 110.896 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 1.6 m-85 -103.97 17.74 23.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.493 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.34 14.76 59.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.229 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.808 ' HB3' HD13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -173.31 130.62 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.112 0.482 . . . . 0.0 111.127 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.82 160.35 14.68 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.065 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.539 HG11 HD13 ' A' ' 71' ' ' LEU . 26.8 m -115.69 158.86 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.178 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' A' ' 52' ' ' LYS . . . -123.58 167.3 14.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.157 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.2 p30 -73.13 153.26 40.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.661 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -109.23 96.87 1.01 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.564 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.403 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -94.23 -17.97 22.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 0.0 111.302 179.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.691 HD12 ' HG2' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -85.02 -28.88 25.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.439 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.691 ' HG2' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -155.92 51.79 0.55 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.603 -179.734 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 21.62 96.44 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.643 179.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.34 -170.88 43.58 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.815 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 82' ' ' PHE . 93.7 t -133.08 131.58 58.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.678 0.275 . . . . 0.0 110.671 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.437 ' HB3' ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -138.59 157.11 46.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.876 0.37 . . . . 0.0 111.237 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.443 ' CG2' ' CD2' ' A' ' 38' ' ' PHE . 43.6 t -65.19 114.92 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.959 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -92.14 -28.32 17.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.26 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -142.8 156.49 44.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.603 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.808 HD13 ' HB3' ' A' ' 38' ' ' PHE . 1.2 mm -138.54 109.31 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.588 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -64.88 121.8 75.74 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.02 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.93 165.16 2.06 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.46 2.107 . . . . 0.0 112.267 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 35.77 75.34 0.06 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.983 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.93 -171.09 35.87 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.151 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.452 ' O ' HD22 ' A' ' 27' ' ' LEU . 46.8 Cg_exo -55.72 -29.75 72.67 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.387 2.058 . . . . 0.0 112.05 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.605 ' HA2' HD12 ' A' ' 65' ' ' LEU . . . -76.82 -43.83 16.72 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.578 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -73.77 -32.92 64.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.042 0.448 . . . . 0.0 110.357 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.2 mt -75.27 -32.93 61.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.037 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.4 -46.85 7.78 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.566 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 114.92 25.56 3.86 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.668 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.686 HD11 HD21 ' A' ' 27' ' ' LEU . 3.6 mt -73.73 141.95 46.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.857 0.361 . . . . 0.0 110.798 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -114.65 156.17 45.15 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.92 66.67 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.63 2.22 . . . . 0.0 112.04 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.437 ' O ' ' HB3' ' A' ' 50' ' ' TYR . 0.7 OUTLIER -178.16 -24.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.572 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.675 ' CB ' HD13 ' A' ' 102' ' ' ILE . 4.4 m-20 -44.0 94.96 0.01 OUTLIER 'General case' 0 C--O 1.231 0.082 0 CA-C-O 121.194 0.521 . . . . 0.0 111.277 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 50' ' ' TYR . 20.6 ttp180 -74.95 101.31 4.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.667 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.788 ' CD2' HD22 ' A' ' 100' ' ' LEU . 2.5 mp -53.98 107.05 0.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.278 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.693 HD11 ' HB2' ' A' ' 103' ' ' SER . 20.0 mt -85.12 -56.14 3.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.059 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -136.35 117.59 14.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.92 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.9 t -102.95 119.06 50.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.88 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 72.11 -61.58 0.49 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.128 0.489 . . . . 0.0 110.563 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.416 ' H ' ' H ' ' A' ' 77' ' ' VAL . 7.2 t-160 -168.07 -18.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.988 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.425 ' O ' HG23 ' A' ' 79' ' ' THR . 21.4 t -84.84 127.29 40.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.826 0.346 . . . . 0.0 111.198 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.69 93.61 0.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.745 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.49 HG21 HD13 ' A' ' 90' ' ' LEU . 14.5 p -95.75 34.41 1.51 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.198 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.52 ' HG2' HD22 ' A' ' 72' ' ' LEU . 3.3 mtt180 -67.99 -53.31 26.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.584 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -94.0 25.1 3.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.183 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.729 ' O ' HG23 ' A' ' 49' ' ' VAL . 2.5 m-30 -81.43 174.49 11.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.877 0.37 . . . . 0.0 110.805 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.51 ' C ' HG21 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -113.28 161.05 17.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.347 179.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.849 ' O ' HG23 ' A' ' 88' ' ' VAL . 42.0 t -51.82 -42.96 62.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.894 0.378 . . . . 0.0 110.664 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.4 t -63.54 -19.52 64.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.264 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.596 ' O ' HD12 ' A' ' 90' ' ' LEU . 3.2 mp -96.58 -32.77 12.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.042 0.449 . . . . 0.0 110.647 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.63 HG21 HG11 ' A' ' 49' ' ' VAL . 58.1 t -77.5 -36.01 22.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.9 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 84' ' ' CYS . 98.9 t -57.79 -52.2 76.14 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.839 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 41.5 Cg_endo -66.9 -45.4 4.29 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.336 2.024 . . . . 0.0 111.854 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.689 HD11 ' HE2' ' A' ' 82' ' ' PHE . 19.7 mt -54.64 -29.69 53.05 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.985 0.421 . . . . 0.0 110.681 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.913 HG23 ' CD1' ' A' ' 98' ' ' LEU . 70.2 mt -78.19 -48.18 23.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.839 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.19 -3.93 32.8 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.41 ' CG ' ' HA ' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -111.74 -4.21 14.74 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.489 ' OG ' HD23 ' A' ' 98' ' ' LEU . 2.4 t -64.73 -16.19 62.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.806 0.336 . . . . 0.0 111.367 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.46 -154.26 19.72 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.557 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -73.44 -9.25 58.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.612 0.244 . . . . 0.0 111.404 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -138.87 123.42 18.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.694 0.283 . . . . 0.0 110.743 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.913 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -107.3 97.4 7.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.19 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -98.62 118.23 34.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.788 HD22 ' CD2' ' A' ' 71' ' ' LEU . 1.9 pp -147.75 150.81 34.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.084 0.469 . . . . 0.0 111.965 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.723 HG12 HD22 ' A' ' 22' ' ' LEU . 11.6 t -105.43 108.85 25.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.792 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.768 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.5 pp -104.41 169.04 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.048 0.451 . . . . 0.0 111.503 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.693 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -137.71 123.87 20.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.382 179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.87 126.9 25.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.255 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -75.24 112.95 20.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.828 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 C--O 1.249 1.04 0 C-N-CA 122.413 2.075 . . . . 0.0 112.252 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 105' ' ' ASN . 29.1 m . . . . . 0 C--O 1.231 0.112 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -97.24 121.82 39.57 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.628 HD13 ' CG1' ' A' ' 101' ' ' VAL . 4.6 pp -100.34 153.14 19.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.266 0.555 . . . . 0.0 112.356 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -148.31 149.66 32.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.281 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.87 103.52 10.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.49 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.827 HG11 ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -100.4 138.7 23.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.197 -179.669 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.5 m -130.21 110.2 11.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.364 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.994 HD11 HD21 ' A' ' 65' ' ' LEU . 57.9 mt -106.78 174.87 5.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.027 0.442 . . . . 0.0 111.498 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -127.73 154.97 44.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.593 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -114.25 140.45 48.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.035 0.445 . . . . 0.0 111.321 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 32' ' ' GLY . 10.5 t70 -112.79 134.67 54.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.372 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.8 m -56.86 85.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.052 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 30' ' ' ASP . . . 148.65 -18.41 1.28 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.83 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.16 140.67 34.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 111.028 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.52 -10.58 59.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.263 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.58 -167.58 2.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.918 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 98' ' ' LEU . 4.0 m-85 -99.38 28.25 4.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.293 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.12 21.55 48.99 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.999 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.622 ' CD2' HD13 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -174.38 128.01 0.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.792 0.33 . . . . 0.0 110.833 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.7 m -90.06 150.02 22.26 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.792 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 35.5 m -110.48 171.0 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.697 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.61 144.38 26.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.112 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -72.49 168.24 18.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -105.35 122.59 7.27 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.314 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.15 -23.75 17.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.038 0.447 . . . . 0.0 111.322 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.4 mp -84.28 -39.61 19.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.949 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.538 ' O ' ' O ' ' A' ' 47' ' ' LYS . 7.0 pt-20 -156.2 59.95 0.57 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.058 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.538 ' O ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 32.85 -166.85 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.623 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.77 176.01 42.75 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.534 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.655 HG21 ' CG2' ' A' ' 87' ' ' VAL . 58.9 t -133.79 132.16 56.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.872 0.367 . . . . 0.0 111.226 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -126.1 -175.11 3.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.372 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.472 HG11 HD11 ' A' ' 54' ' ' ILE . 56.0 t -95.77 122.11 46.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.978 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.27 -29.69 19.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.448 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -157.37 154.11 28.38 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.558 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.601 ' CD1' HD12 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -138.25 139.05 42.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.768 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.04 133.42 94.76 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.889 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.606 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 61.1 Cg_endo -72.85 98.05 0.95 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.493 2.129 . . . . 0.0 112.306 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 82.99 28.77 0.1 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.082 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -106.47 -160.83 22.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.434 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.56 -53.61 6.57 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.586 2.191 . . . . 0.0 112.308 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.06 -39.04 89.05 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.421 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.56 -32.88 64.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.084 0.468 . . . . 0.0 110.21 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 45.3 mt -73.73 -31.41 63.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.686 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.74 -55.59 7.28 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.331 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 139.38 -11.65 3.25 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.04 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.994 HD21 HD11 ' A' ' 27' ' ' LEU . 3.3 pp -80.44 135.34 36.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.973 0.416 . . . . 0.0 111.025 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.587 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 6.7 ptmt -120.03 167.52 12.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.397 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.641 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 99.9 Cg_exo -44.62 146.99 1.91 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.459 2.106 . . . . 0.0 112.7 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.641 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 2.2 m-85 82.98 -10.13 1.05 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.671 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.614 ' CG ' HD13 ' A' ' 102' ' ' ILE . 7.7 m-20 -54.74 88.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.05 0.453 . . . . 0.0 110.854 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 50' ' ' TYR . 12.3 ttm180 -66.83 101.04 0.77 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.02 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.758 HD23 HD22 ' A' ' 100' ' ' LEU . 3.4 mp -56.14 107.89 0.41 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.006 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.625 HD22 ' CG ' ' A' ' 80' ' ' ARG . 27.8 mt -82.99 -56.55 3.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.437 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -139.48 137.02 35.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.099 0.475 . . . . 0.0 111.385 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.611 HG12 HD22 ' A' ' 75' ' ' ASN . 31.3 t -107.52 110.45 31.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.345 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.611 HD22 HG12 ' A' ' 74' ' ' VAL . 2.7 m-80 73.28 -58.84 0.58 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.678 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -167.47 -12.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.532 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.721 HG13 HG23 ' A' ' 79' ' ' THR . 12.2 p -84.22 133.15 29.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.924 0.393 . . . . 0.0 111.427 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.7 mmt-85 -72.07 89.79 1.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.943 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.721 HG23 HG13 ' A' ' 77' ' ' VAL . 37.7 p -96.28 21.01 9.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.333 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.625 ' CG ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -70.95 -42.53 69.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.885 0.374 . . . . 0.0 110.595 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.16 15.27 13.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.099 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.707 ' HE2' HD11 ' A' ' 90' ' ' LEU . 3.1 m-85 -81.92 172.24 13.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.927 0.394 . . . . 0.0 110.977 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.415 ' O ' HG23 ' A' ' 87' ' ' VAL . 20.3 t0 -111.88 162.53 15.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.383 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.894 ' O ' HG23 ' A' ' 88' ' ' VAL . 15.7 p -51.49 -43.67 62.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.759 0.314 . . . . 0.0 110.839 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.43 -22.22 64.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.332 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.55 ' O ' HD12 ' A' ' 90' ' ' LEU . 11.0 mp -95.99 -31.0 13.29 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.904 0.383 . . . . 0.0 111.127 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.655 ' CG2' HG21 ' A' ' 49' ' ' VAL . 59.4 t -78.95 -35.69 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.299 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.894 HG23 ' O ' ' A' ' 84' ' ' CYS . 62.1 t -58.73 -50.9 85.49 Favored Pre-proline 0 C--N 1.33 -0.26 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.913 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 14.0 Cg_exo -68.9 -44.57 2.62 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.444 2.096 . . . . 0.0 111.6 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.707 HD11 ' HE2' ' A' ' 82' ' ' PHE . 13.6 mt -54.62 -29.41 51.85 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.663 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.936 HG23 ' CD1' ' A' ' 98' ' ' LEU . 51.6 mt -78.07 -50.01 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.6 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.91 -4.05 26.06 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.931 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.14 -9.16 18.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.626 0.251 . . . . 0.0 111.581 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -64.8 -16.21 62.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.721 0.296 . . . . 0.0 111.374 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.83 -143.97 16.9 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.635 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -73.7 -10.15 59.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.584 0.231 . . . . 0.0 111.544 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -138.19 155.7 48.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.69 0.281 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.936 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -139.64 97.46 3.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.136 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -96.12 118.71 33.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.019 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.856 HD23 HD22 ' A' ' 98' ' ' LEU . 1.6 pp -150.04 163.92 36.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.142 0.496 . . . . 0.0 112.064 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.628 ' CG1' HD13 ' A' ' 22' ' ' LEU . 38.2 t -111.97 109.12 27.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.914 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.661 HG23 ' CD1' ' A' ' 100' ' ' LEU . 2.6 pp -100.67 168.65 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.999 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.578 ' HB3' HD11 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -142.46 129.72 21.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.545 179.321 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.419 ' NE ' ' CG ' ' A' ' 66' ' ' LYS . 10.2 ptt85 -139.7 124.88 18.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.919 0.39 . . . . 0.0 111.616 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.469 ' N ' HG12 ' A' ' 20' ' ' VAL . 4.1 p30 -69.13 133.94 89.6 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.662 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo . . . . . 0 C--O 1.249 1.065 0 C-N-CA 122.457 2.105 . . . . 0.0 112.337 179.939 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.812 0.339 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -112.35 122.2 47.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.408 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.122 HD21 HD12 ' A' ' 72' ' ' LEU . 14.2 mt -60.81 141.94 56.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.601 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.537 ' CD2' HD11 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -153.24 120.92 5.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.146 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.705 ' HD2' HG22 ' A' ' 101' ' ' VAL . 2.6 tptp -69.88 124.43 24.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.903 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.649 HG11 ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -126.4 139.92 50.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.039 0.447 . . . . 0.0 111.121 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 95.0 m -134.34 117.51 16.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.198 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 59' ' ' PRO . 2.6 mp -116.03 167.65 10.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.079 0.466 . . . . 0.0 111.572 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' A' ' 28' ' ' TYR . 2.9 m-85 -135.37 121.92 20.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.175 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -95.11 163.65 13.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.946 0.403 . . . . 0.0 111.262 -179.526 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.99 139.47 41.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.26 85.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.921 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.64 -23.58 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.831 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.91 156.7 27.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.932 0.396 . . . . 0.0 110.961 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -87.71 -10.54 50.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.434 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -155.35 -172.24 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.857 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -97.87 32.15 2.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.238 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.427 ' HA3' ' H ' ' A' ' 60' ' ' GLY . . . 96.93 -5.2 63.56 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.286 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.52 ' HD2' HG13 ' A' ' 51' ' ' VAL . 48.6 p90 -171.31 149.58 2.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.047 0.424 . . . . 0.0 111.739 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.9 m -104.5 133.83 48.71 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.433 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.659 ' HB ' HG12 ' A' ' 49' ' ' VAL . 33.1 m -93.46 170.8 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.751 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.744 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -139.38 162.31 35.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.148 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -83.25 130.31 35.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.709 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.516 ' HA3' ' CZ ' ' A' ' 50' ' ' TYR . . . -103.25 107.52 3.07 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.793 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 mp -94.67 -26.74 16.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.055 0.455 . . . . 0.0 111.03 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 tp -84.51 -6.09 59.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.714 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 47' ' ' LYS . 10.2 mt-10 -152.69 29.78 0.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.922 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 26.99 91.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.149 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.42 ' O ' ' HA3' ' A' ' 43' ' ' GLY . . . 157.9 160.4 10.2 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.273 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.744 HG13 ' O ' ' A' ' 41' ' ' ALA . 40.1 t -101.39 133.48 44.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.853 0.359 . . . . 0.0 111.361 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.516 ' CZ ' ' HA3' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -125.42 -177.46 3.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.454 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.867 HG11 HD11 ' A' ' 54' ' ' ILE . 37.2 t -89.62 162.2 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.649 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.516 ' N ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -144.9 -42.12 0.24 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.011 0.434 . . . . 0.0 110.833 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 67.1 m-80 -123.43 130.49 52.78 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.578 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.867 HD11 HG11 ' A' ' 51' ' ' VAL . 1.1 mt -136.49 117.78 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.746 0.308 . . . . 0.0 111.331 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.13 110.54 5.28 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.592 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.445 ' HA ' ' HB2' ' A' ' 61' ' ' ASP . 16.5 Cg_exo -68.11 55.06 0.72 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.589 2.193 . . . . 0.0 112.777 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -173.82 -43.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.927 0.394 . . . . 0.0 111.255 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.9 -152.47 0.96 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.705 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.733 ' O ' HD23 ' A' ' 27' ' ' LEU . 28.7 Cg_exo -62.14 -35.26 76.3 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.801 2.334 . . . . 0.0 112.079 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.522 ' O ' HD12 ' A' ' 65' ' ' LEU . . . -56.5 -49.92 66.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.716 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 6.2 t70 -73.67 -36.18 65.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.061 0.457 . . . . 0.0 110.201 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 33.1 mt -60.83 -29.6 69.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.974 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.92 -51.42 3.8 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.419 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.38 47.71 0.85 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.724 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.733 HD11 HD21 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -106.41 165.63 11.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.079 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 68' ' ' TYR . 12.2 mtmm -132.13 159.57 71.6 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.665 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.453 ' O ' ' CG ' ' A' ' 68' ' ' TYR . 36.7 Cg_endo -65.55 64.43 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.487 2.125 . . . . 0.0 112.254 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.453 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 6.2 m-85 -174.12 -30.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.396 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.709 ' HB2' HD13 ' A' ' 102' ' ' ILE . 4.4 p30 -50.25 96.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.453 0.644 . . . . 0.0 110.799 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.605 ' O ' HD23 ' A' ' 72' ' ' LEU . 27.6 ttp180 -74.3 104.16 4.96 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.537 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.05 HD23 HD13 ' A' ' 100' ' ' LEU . 1.1 mt -54.42 108.42 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.027 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.122 HD12 HD21 ' A' ' 22' ' ' LEU . 5.2 mt -82.9 -66.02 0.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.132 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.32 132.19 53.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.892 0.377 . . . . 0.0 111.163 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.518 HG23 ' OG1' ' A' ' 79' ' ' THR . 29.7 t -104.58 103.85 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.8 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 75.31 -58.61 0.56 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.138 0.494 . . . . 0.0 110.565 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -167.67 -13.76 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.286 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.63 141.04 15.05 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.741 0.305 . . . . 0.0 111.309 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -70.2 128.13 35.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.519 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.518 ' OG1' HG23 ' A' ' 74' ' ' VAL . 41.6 p -143.76 25.93 1.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.172 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.731 ' HE ' HD13 ' A' ' 72' ' ' LEU . 6.9 mtt180 -73.32 -52.78 12.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.59 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -93.74 25.33 3.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.108 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.699 ' CE2' HD11 ' A' ' 90' ' ' LEU . 2.2 m-85 -81.58 166.37 20.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.897 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.526 ' C ' HG21 ' A' ' 49' ' ' VAL . 15.6 t70 -106.03 161.16 14.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.549 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.863 ' O ' HG23 ' A' ' 88' ' ' VAL . 1.9 t -51.69 -42.2 62.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.645 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 23.0 m -62.74 -22.91 66.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.213 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.574 ' O ' HD12 ' A' ' 90' ' ' LEU . 7.9 mp -93.0 -32.93 14.33 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.012 0.434 . . . . 0.0 110.854 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.6 HG12 ' CD1' ' A' ' 91' ' ' ILE . 58.8 t -77.6 -36.03 22.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.0 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 84' ' ' CYS . 77.8 t -54.73 -52.41 70.54 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.732 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 50.3 Cg_endo -68.63 -45.96 2.1 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.233 1.956 . . . . 0.0 111.788 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.699 HD11 ' CE2' ' A' ' 82' ' ' PHE . 27.0 mt -55.48 -32.06 62.53 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.607 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.912 ' HA ' HD11 ' A' ' 98' ' ' LEU . 60.7 mt -75.17 -44.86 42.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.599 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.11 -3.7 43.66 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.949 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -85.03 -15.82 42.84 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.742 0.306 . . . . 0.0 111.723 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.407 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 2.0 m -65.02 -25.01 67.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.982 0.42 . . . . 0.0 111.269 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.92 -61.48 3.74 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.189 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 29' ' ' LYS . 24.3 p30 -163.12 16.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.84 105.69 2.21 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.912 HD11 ' HA ' ' A' ' 91' ' ' ILE . 0.9 OUTLIER -107.39 107.52 18.46 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.0 117.93 35.46 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 1.05 HD13 HD23 ' A' ' 71' ' ' LEU . 1.3 pp -150.49 155.96 40.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.262 0.553 . . . . 0.0 112.373 -178.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.871 HG12 HD22 ' A' ' 22' ' ' LEU . 18.5 t -105.44 109.24 27.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.618 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.862 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.8 pp -100.96 169.45 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.189 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.9 102.63 5.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.605 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.426 ' HB3' ' HA ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -111.56 124.3 52.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.073 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.1 148.09 88.66 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.675 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo . . . . . 0 C--O 1.248 1.022 0 C-N-CA 122.606 2.204 . . . . 0.0 112.42 -179.948 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 103' ' ' SER . 18.0 m . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.851 0.358 . . . . 0.0 111.432 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.58 122.21 28.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.734 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.84 HD22 HG12 ' A' ' 101' ' ' VAL . 14.7 mt -60.95 150.68 32.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.442 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.512 ' HB2' HD11 ' A' ' 102' ' ' ILE . 17.1 m-70 -156.67 110.56 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.986 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -71.4 113.56 8.56 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.792 HG11 ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -119.53 140.19 44.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.202 0.525 . . . . 0.0 112.099 -178.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.8 m -134.33 106.64 7.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.51 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.078 HD11 HD21 ' A' ' 65' ' ' LEU . 23.5 mt -102.79 173.54 6.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.222 0.534 . . . . 0.0 112.143 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 96' ' ' ASN . 8.5 m-85 -134.69 121.82 21.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.245 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.463 ' N ' ' CE1' ' A' ' 36' ' ' PHE . 5.2 tttt -104.26 152.05 22.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.928 0.394 . . . . 0.0 111.346 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -119.62 158.74 25.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.651 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.24 -27.94 64.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.173 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.13 -24.74 51.12 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.73 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 2.9 mmt -81.41 132.7 35.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.907 0.384 . . . . 0.0 111.043 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -78.67 -10.78 59.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.265 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -155.9 -168.82 2.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.639 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.463 ' CE1' ' N ' ' A' ' 29' ' ' LYS . 5.0 m-85 -97.02 29.72 2.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.334 . . . . 0.0 111.178 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.09 24.57 68.61 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.955 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.522 ' CD2' HD13 ' A' ' 65' ' ' LEU . 1.4 p90 -174.44 117.3 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.047 0.451 . . . . 0.0 111.427 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -88.9 146.44 24.93 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.872 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.721 ' HB ' HG12 ' A' ' 49' ' ' VAL . 34.4 m -108.62 171.07 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.656 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.693 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -137.81 156.89 47.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.14 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -72.38 144.34 48.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.693 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.438 ' HA3' ' CZ ' ' A' ' 50' ' ' TYR . . . -119.93 108.26 1.44 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.612 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 pp -94.14 -27.28 16.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.976 0.417 . . . . 0.0 110.985 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.4 -3.33 58.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.371 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 47' ' ' LYS . 7.2 mt-10 -152.97 27.6 0.53 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.675 -0.238 . . . . 0.0 110.981 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER 27.09 91.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.251 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.9 -154.37 25.3 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.479 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.721 HG12 ' HB ' ' A' ' 40' ' ' VAL . 21.3 t -142.11 139.31 30.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.36 . . . . 0.0 110.942 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.438 ' CZ ' ' HA3' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -126.68 177.73 6.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.509 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.502 HG11 HD11 ' A' ' 54' ' ' ILE . 61.4 t -86.46 123.29 39.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.182 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -88.13 -29.34 20.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.782 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -168.33 149.99 5.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.246 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.614 ' CD1' HD12 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -129.26 132.73 66.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.184 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -65.56 125.22 89.23 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.54 140.38 83.24 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.388 2.059 . . . . 0.0 112.547 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 40.8 32.34 0.15 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.991 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -101.66 -167.96 27.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.955 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.572 ' O ' HD22 ' A' ' 27' ' ' LEU . 18.0 Cg_endo -58.57 -34.27 98.72 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.313 2.009 . . . . 0.0 111.721 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.28 -44.67 42.34 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.427 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -71.98 -32.76 67.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.99 0.424 . . . . 0.0 109.942 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.1 mt -72.11 -29.24 63.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.443 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.37 -57.93 5.32 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.326 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.49 -20.83 1.69 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.449 -0.881 . . . . 0.0 113.091 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.078 HD21 HD11 ' A' ' 27' ' ' LEU . 3.1 pp -73.83 134.04 43.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.944 0.402 . . . . 0.0 111.0 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.488 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 15.1 mttt -120.74 167.63 12.51 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.607 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.677 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 99.9 Cg_exo -43.24 145.98 1.22 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.539 2.159 . . . . 0.0 112.606 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.677 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 4.3 m-85 83.21 -10.01 1.03 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.665 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.537 ' CG ' HD13 ' A' ' 102' ' ' ILE . 4.3 m-20 -54.61 87.06 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.972 0.415 . . . . 0.0 110.817 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.435 ' HD3' ' CE1' ' A' ' 50' ' ' TYR . 31.2 ttp180 -66.93 97.51 0.49 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.7 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.931 ' HA ' HG22 ' A' ' 102' ' ' ILE . 2.9 mt -55.58 107.39 0.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.127 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.788 HD12 HD21 ' A' ' 22' ' ' LEU . 23.8 mt -84.25 -65.92 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.121 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -122.57 140.97 52.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.027 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.555 HG12 ' OD1' ' A' ' 75' ' ' ASN . 41.3 t -124.69 112.63 32.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.055 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.555 ' OD1' HG12 ' A' ' 74' ' ' VAL . 5.1 m120 64.64 33.33 10.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.934 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.463 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 2.6 t-80 86.72 -14.89 0.47 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.611 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 36.7 t -83.27 138.65 18.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.828 0.346 . . . . 0.0 111.061 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -69.55 130.88 43.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.687 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.486 ' CG2' HD13 ' A' ' 90' ' ' LEU . 30.3 p -144.24 27.97 1.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.061 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.599 ' HG2' HD22 ' A' ' 72' ' ' LEU . 30.5 mtp180 -83.14 -42.5 17.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.627 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.11 10.31 27.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.041 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.617 ' CE2' HD11 ' A' ' 90' ' ' LEU . 3.1 m-85 -80.28 -176.45 5.63 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.959 0.409 . . . . 0.0 110.84 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -128.5 169.3 14.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.309 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.821 ' O ' HG23 ' A' ' 88' ' ' VAL . 53.3 t -51.18 -45.58 61.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.746 0.307 . . . . 0.0 110.755 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.28 -18.45 63.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.107 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.616 HD12 ' CD2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -95.5 -37.97 10.65 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.216 0.531 . . . . 0.0 111.04 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.48 HG11 HD13 ' A' ' 71' ' ' LEU . 46.6 t -77.03 -35.46 23.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.536 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 84' ' ' CYS . 89.8 t -57.53 -51.79 79.11 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.694 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.674 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 18.3 Cg_exo -65.67 -44.38 8.35 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.248 1.966 . . . . 0.0 111.181 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.617 HD11 ' CE2' ' A' ' 82' ' ' PHE . 52.7 mt -54.57 -32.08 57.88 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.04 0.447 . . . . 0.0 110.526 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.921 HG23 ' CD1' ' A' ' 98' ' ' LEU . 61.9 mt -73.29 -49.65 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.55 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.17 -2.69 32.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.796 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -93.32 -13.2 28.46 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.423 ' OG ' ' HG ' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -63.8 -27.63 69.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.05 0.453 . . . . 0.0 110.746 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.8 -53.3 0.82 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.865 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 6.7 m120 -165.6 -34.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.956 0.408 . . . . 0.0 110.403 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -104.71 108.7 20.3 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.248 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.921 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -101.93 97.35 7.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.708 -179.243 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -100.45 118.32 36.42 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.862 HD22 HD22 ' A' ' 71' ' ' LEU . 1.3 pp -148.1 159.51 43.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.226 0.536 . . . . 0.0 112.239 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.84 HG12 HD22 ' A' ' 22' ' ' LEU . 16.3 t -111.14 109.14 27.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.014 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.931 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.5 pp -104.19 169.6 2.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.38 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.714 ' OG ' HD21 ' A' ' 72' ' ' LEU . 9.0 p -143.19 125.4 15.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.332 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -144.99 137.16 25.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.986 0.422 . . . . 0.0 111.421 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -62.57 132.21 94.37 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.743 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 122.422 2.082 . . . . 0.0 112.284 -179.959 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 103' ' ' SER . 32.9 m . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.86 0.362 . . . . 0.0 111.531 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -116.0 122.39 45.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.647 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.83 HD22 HG12 ' A' ' 101' ' ' VAL . 15.4 mt -62.27 137.64 58.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.479 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.664 ' NE2' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -149.04 127.42 12.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.273 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -71.53 133.69 45.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.622 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.696 HG11 ' HG ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -135.87 147.72 28.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.949 0.404 . . . . 0.0 111.327 -179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.509 HG23 ' OD1' ' A' ' 99' ' ' ASP . 94.7 m -134.4 118.4 17.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.135 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.792 HD21 HD12 ' A' ' 65' ' ' LEU . 3.8 mt -110.11 168.77 9.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.959 0.409 . . . . 0.0 111.678 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -134.87 132.66 38.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.573 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -102.02 165.11 11.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.943 0.402 . . . . 0.0 111.254 -179.683 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.485 ' HB2' ' HE1' ' A' ' 33' ' ' MET . 13.3 t0 -144.14 141.68 30.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.687 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -55.87 -23.11 29.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.299 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.5 -13.11 56.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.996 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.485 ' HE1' ' HB2' ' A' ' 30' ' ' ASP . 0.1 OUTLIER -80.28 155.15 27.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.916 0.389 . . . . 0.0 111.197 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -100.99 -10.64 20.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.215 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -155.08 -174.62 5.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.588 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.684 ' CD2' HD12 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -97.46 32.55 2.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.27 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.99 1.08 90.2 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.009 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.469 ' O ' ' CD1' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -172.14 135.29 0.77 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.004 0.43 . . . . 0.0 111.43 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.9 m -96.32 148.23 22.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.51 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.527 ' HB ' HG12 ' A' ' 49' ' ' VAL . 33.9 m -104.15 169.07 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.674 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.757 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -141.42 167.01 23.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.999 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -80.58 153.28 28.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.839 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.01 115.48 2.45 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.505 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 44' ' ' LEU . 7.3 tt -94.31 -28.65 15.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.015 0.436 . . . . 0.0 111.148 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 mp -83.9 -55.9 3.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.781 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.4 mt-10 -89.78 17.11 6.95 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.431 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER 30.03 88.46 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.883 0.373 . . . . 0.0 111.934 -179.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.22 -141.99 7.26 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.515 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.757 HG13 ' O ' ' A' ' 41' ' ' ALA . 39.5 t -145.47 138.24 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.916 0.389 . . . . 0.0 110.988 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -131.1 179.44 6.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.416 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.461 HG11 HD11 ' A' ' 54' ' ' ILE . 47.9 t -87.65 123.6 40.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.017 0.437 . . . . 0.0 111.287 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.525 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -88.74 -31.33 18.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.225 -179.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -157.23 154.96 30.02 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.401 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.461 HD11 HG11 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -135.45 123.85 38.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.102 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -65.6 122.8 82.34 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.825 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.23 152.41 31.46 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.397 2.065 . . . . 0.0 112.439 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 38.65 33.94 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.007 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -118.79 -162.47 12.12 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.164 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.466 ' C ' HD23 ' A' ' 27' ' ' LEU . 71.8 Cg_exo -49.11 -54.33 5.61 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.5 2.133 . . . . 0.0 112.245 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.764 ' HA2' HD12 ' A' ' 65' ' ' LEU . . . -63.94 -33.15 86.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.717 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -73.71 -32.76 64.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.928 0.394 . . . . 0.0 110.409 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -74.1 -29.8 62.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.997 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -86.83 -34.83 10.67 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.463 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.2 32.83 3.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.518 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.792 HD12 HD21 ' A' ' 27' ' ' LEU . 11.4 mt -81.59 138.54 35.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.775 0.321 . . . . 0.0 111.042 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -126.32 160.58 56.96 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.715 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.436 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 78.1 Cg_exo -50.45 142.13 31.05 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.638 2.226 . . . . 0.0 112.332 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.436 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 18.4 m-85 85.44 -3.86 0.86 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.33 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.607 ' OD2' HD23 ' A' ' 65' ' ' LEU . 4.7 m-20 -53.19 89.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.056 0.455 . . . . 0.0 110.806 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 68' ' ' TYR . 69.0 ttt180 -76.99 111.64 12.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.999 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.858 ' HA ' HG22 ' A' ' 102' ' ' ILE . 0.9 OUTLIER -71.26 107.79 4.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.734 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.77 HD12 HD21 ' A' ' 22' ' ' LEU . 1.7 mt -83.48 -19.5 35.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.963 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.06 152.68 1.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.011 0.434 . . . . 0.0 111.528 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.483 HG12 ' OD1' ' A' ' 75' ' ' ASN . 40.2 t -124.0 112.6 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.611 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.483 ' OD1' HG12 ' A' ' 74' ' ' VAL . 8.3 m120 76.25 -58.19 0.54 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.107 0.48 . . . . 0.0 110.569 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.411 ' H ' ' H ' ' A' ' 77' ' ' VAL . 1.6 m-70 -167.06 -14.22 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.134 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.411 ' H ' ' H ' ' A' ' 76' ' ' HIS . 21.6 t -84.78 136.28 23.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-O 120.752 0.311 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -69.65 143.2 53.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.674 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.441 ' HA ' ' CG ' ' A' ' 82' ' ' PHE . 64.2 p -146.07 18.39 1.41 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.657 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.533 ' HG2' HD13 ' A' ' 72' ' ' LEU . 11.3 mtm180 -65.77 -51.66 57.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.895 0.379 . . . . 0.0 110.425 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -93.75 20.96 6.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.227 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.602 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.3 m-30 -81.32 169.18 17.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.797 0.332 . . . . 0.0 110.823 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 87' ' ' VAL . 2.4 t70 -109.76 160.33 16.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.668 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 24.8 p -51.87 -31.44 28.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.906 0.384 . . . . 0.0 110.713 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -21.67 62.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.196 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.618 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 5.7 mp -98.38 -30.23 12.69 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.084 0.469 . . . . 0.0 110.819 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.663 ' CG1' HD13 ' A' ' 71' ' ' LEU . 39.8 t -79.74 -35.98 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.451 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.77 HG12 ' HD3' ' A' ' 89' ' ' PRO . 5.0 p -64.22 -39.82 46.79 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.667 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.77 ' HD3' HG12 ' A' ' 88' ' ' VAL . 73.4 Cg_endo -74.37 -46.73 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.662 1.575 . . . . 0.0 111.227 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.602 HD11 ' HE2' ' A' ' 82' ' ' PHE . 81.5 mt -56.58 -28.35 60.04 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.108 0.48 . . . . 0.0 110.263 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.582 ' HA ' HD11 ' A' ' 98' ' ' LEU . 33.2 mt -75.92 -49.15 26.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.631 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.78 -2.56 47.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.064 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.64 -12.54 17.64 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.427 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -65.38 -14.3 60.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.698 0.285 . . . . 0.0 111.419 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.67 -145.15 17.77 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.609 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -73.56 -15.91 61.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.581 0.229 . . . . 0.0 111.393 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -125.98 139.68 53.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.798 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.684 HD12 ' CD2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -130.61 97.14 4.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.123 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.509 ' OD1' HG23 ' A' ' 26' ' ' THR . 2.5 m-20 -98.34 118.6 35.36 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.788 HD22 ' CD2' ' A' ' 71' ' ' LEU . 2.7 pp -146.86 158.79 44.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.224 0.535 . . . . 0.0 112.24 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.83 HG12 HD22 ' A' ' 22' ' ' LEU . 18.5 t -113.76 109.66 29.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.104 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.858 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.0 pp -108.78 169.56 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.372 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.415 ' N ' HD12 ' A' ' 102' ' ' ILE . 0.3 OUTLIER -130.54 127.84 39.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.859 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.03 141.43 34.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.934 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -71.42 135.78 84.06 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.766 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 C--O 1.248 1.003 0 C-N-CA 122.392 2.061 . . . . 0.0 112.252 -179.994 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.0 m . . . . . 0 N--CA 1.464 0.232 0 CA-C-O 120.927 0.394 . . . . 0.0 112.053 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -119.16 122.54 42.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.52 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.762 HD22 HG12 ' A' ' 101' ' ' VAL . 13.3 mt -60.72 135.46 57.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.499 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.533 ' HB2' HD11 ' A' ' 102' ' ' ILE . 40.2 m-70 -143.83 112.05 6.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.726 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 111.31 7.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.191 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.714 HG11 ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -117.66 139.55 44.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.122 0.487 . . . . 0.0 111.553 -179.185 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.5 m -133.02 106.74 7.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.97 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.917 HD21 HD21 ' A' ' 65' ' ' LEU . 2.4 mp -99.16 174.0 6.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.961 0.41 . . . . 0.0 111.902 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -131.33 140.16 49.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.332 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -109.22 165.21 11.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.952 0.406 . . . . 0.0 111.422 -179.559 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.65 137.22 53.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.681 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -59.25 85.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.138 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.06 14.36 2.75 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.163 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -81.68 166.88 19.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.89 0.345 . . . . 0.0 110.807 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -92.52 -24.29 18.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.152 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -157.79 -167.89 2.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.755 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -103.6 31.05 4.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.892 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.45 0.06 80.06 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.085 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.439 ' HB2' HG12 ' A' ' 54' ' ' ILE . 18.4 p90 -172.41 153.74 3.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.985 0.392 . . . . 0.0 111.461 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.9 p -119.03 148.01 43.48 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.552 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.725 HG11 ' CD1' ' A' ' 71' ' ' LEU . 30.5 m -113.35 157.6 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.474 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.505 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -114.14 177.54 4.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.208 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.79 160.86 21.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.27 115.29 2.49 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.389 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -94.61 -35.23 12.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.11 0.481 . . . . 0.0 111.191 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 tp -84.26 -53.78 5.25 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.055 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.4 mm-40 -90.53 16.37 9.09 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.558 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 46' ' ' GLU . 3.5 mmtt 29.05 82.91 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 174.97 -150.87 11.52 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.492 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 82' ' ' PHE . 88.8 t -138.38 139.83 40.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.824 0.345 . . . . 0.0 110.914 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -139.51 162.72 34.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.605 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.634 ' HA ' HG12 ' A' ' 40' ' ' VAL . 50.1 t -62.36 162.0 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.592 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.529 ' N ' HG12 ' A' ' 51' ' ' VAL . 16.8 pttt -147.0 -35.36 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 0.0 111.579 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.416 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 15.6 m-80 -144.49 139.03 28.02 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.981 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.646 HD11 HD12 ' A' ' 65' ' ' LEU . 1.0 OUTLIER -132.95 133.97 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.0 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.431 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -65.89 142.4 98.06 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.913 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 55' ' ' ARG . 34.7 Cg_exo -57.66 127.19 24.35 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.544 2.162 . . . . 0.0 112.531 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 43.28 30.79 0.33 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.875 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.92 -159.48 32.52 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.935 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -51.87 -55.92 3.44 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.312 2.008 . . . . 0.0 111.876 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.404 ' HA2' ' CD2' ' A' ' 27' ' ' LEU . . . -56.93 -38.66 86.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.671 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -73.37 -32.63 64.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.967 0.413 . . . . 0.0 110.183 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.6 mt -77.32 -30.39 54.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.842 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.28 -56.67 6.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.426 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.97 33.23 0.93 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.656 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.917 HD21 HD21 ' A' ' 27' ' ' LEU . 1.7 pp -118.5 132.06 56.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 110.905 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.469 ' CB ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -117.87 169.51 7.53 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.783 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 1.6 Cg_endo -44.63 146.14 2.35 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.646 2.231 . . . . 0.0 112.239 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.486 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 8.5 m-85 91.14 -21.13 0.11 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.095 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.684 ' CG ' HD13 ' A' ' 102' ' ' ILE . 7.2 m-20 -53.75 85.49 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.166 0.508 . . . . 0.0 110.669 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -68.49 105.91 2.37 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.195 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.725 ' CD1' HG11 ' A' ' 40' ' ' VAL . 1.9 mp -63.07 107.9 1.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.758 HD22 ' CG ' ' A' ' 80' ' ' ARG . 10.0 mt -83.38 -65.85 0.96 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.17 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -119.38 126.82 52.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.157 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.611 HG23 ' OG1' ' A' ' 79' ' ' THR . 43.1 t -109.62 107.1 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.712 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 74.65 -58.59 0.58 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.139 0.495 . . . . 0.0 110.537 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -167.22 -18.02 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.951 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 79' ' ' THR . 21.5 t -85.36 125.27 40.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-O 120.792 0.329 . . . . 0.0 111.129 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.65 84.36 0.45 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.649 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.611 ' OG1' HG23 ' A' ' 74' ' ' VAL . 17.7 p -94.62 43.94 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.17 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.758 ' CG ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -80.99 -47.02 14.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.646 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -92.93 21.29 5.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.055 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.591 ' HE2' HD11 ' A' ' 90' ' ' LEU . 3.2 m-85 -81.69 170.82 15.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.702 0.287 . . . . 0.0 110.954 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.423 ' C ' HG21 ' A' ' 49' ' ' VAL . 2.6 m-20 -106.26 160.26 15.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.404 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.885 ' O ' HG23 ' A' ' 88' ' ' VAL . 7.4 p -51.76 -42.12 62.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 110.694 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.7 m -63.44 -23.28 67.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.236 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.471 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -93.63 -31.13 14.6 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.906 0.384 . . . . 0.0 110.95 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.739 HG12 ' CD1' ' A' ' 91' ' ' ILE . 60.7 t -79.62 -35.95 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.359 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 84' ' ' CYS . 95.1 t -57.14 -50.84 85.86 Favored Pre-proline 0 C--N 1.331 -0.219 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.938 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.639 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 12.0 Cg_exo -70.43 -47.14 0.77 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.509 2.14 . . . . 0.0 111.512 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.591 HD11 ' HE2' ' A' ' 82' ' ' PHE . 44.8 mt -53.92 -30.75 47.62 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.517 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.942 HG23 ' CD1' ' A' ' 98' ' ' LEU . 63.9 mt -78.28 -42.04 26.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.505 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.41 -4.69 40.94 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.454 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 10.3 pt-20 -107.38 -3.44 19.58 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.432 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 6.9 t -64.38 -15.99 61.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.801 0.334 . . . . 0.0 111.411 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.5 -144.61 17.41 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.592 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.39 -10.67 59.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.55 0.214 . . . . 0.0 111.425 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -140.76 157.29 45.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.813 0.34 . . . . 0.0 110.97 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.942 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -138.33 97.2 3.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.033 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.14 118.23 31.25 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.825 HD23 HD22 ' A' ' 98' ' ' LEU . 1.1 pp -148.37 164.03 35.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.257 0.551 . . . . 0.0 112.025 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.762 HG12 HD22 ' A' ' 22' ' ' LEU . 48.4 t -115.79 108.93 26.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.103 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.684 HD13 ' CG ' ' A' ' 69' ' ' ASP . 2.5 pp -101.82 169.27 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.409 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.17 122.18 15.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.676 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.404 ' CG ' ' HB2' ' A' ' 68' ' ' TYR . 7.6 tmm_? -133.48 138.66 46.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.153 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -80.93 154.5 72.91 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.7 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo . . . . . 0 C--O 1.25 1.092 0 C-N-CA 122.497 2.131 . . . . 0.0 112.304 179.94 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.528 HG21 ' HB3' ' A' ' 103' ' ' SER . 11.4 m . . . . . 0 CA--C 1.527 0.074 0 CA-C-O 120.814 0.34 . . . . 0.0 111.748 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -123.45 122.38 38.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.597 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.939 HD21 HD12 ' A' ' 72' ' ' LEU . 15.5 mt -62.63 138.99 58.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.712 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.611 ' HB2' HD11 ' A' ' 102' ' ' ILE . 11.0 m-70 -145.09 120.82 10.52 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.677 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.13 113.2 11.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.465 HG21 HG12 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -117.42 139.84 42.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.144 0.497 . . . . 0.0 111.849 -179.041 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.7 m -134.03 106.43 7.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.955 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.053 HD21 HD21 ' A' ' 65' ' ' LEU . 2.3 mp -99.91 168.41 9.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.919 0.39 . . . . 0.0 111.483 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 96' ' ' ASN . 4.9 m-85 -124.92 143.95 50.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.748 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -104.83 159.45 15.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.113 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -129.97 140.97 50.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.92 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.7 p -57.97 -28.73 64.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.064 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.47 -22.53 46.99 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.683 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 18.0 mmm -81.0 162.44 23.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.369 . . . . 0.0 110.959 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.84 -10.56 15.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.325 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.63 -166.97 2.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.798 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.51 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 7.5 m-85 -97.46 32.75 2.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.201 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 48.39 40.63 23.44 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.209 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.902 ' HB2' HD13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -174.65 116.37 0.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.076 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.43 155.19 19.37 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 121.112 0.482 . . . . 0.0 112.155 -177.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.769 HG11 HD11 ' A' ' 71' ' ' LEU . 34.1 m -116.1 169.86 6.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.07 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.856 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . . . -129.51 176.74 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.87 0.367 . . . . 0.0 111.358 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.8 140.76 30.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.764 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.71 103.57 1.65 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.521 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 mp -94.17 -31.54 14.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.184 0.516 . . . . 0.0 110.828 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.498 HD12 ' HG3' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -84.28 -3.91 58.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.506 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.498 ' HG3' HD12 ' A' ' 45' ' ' LEU . 11.2 mt-10 -153.07 27.01 0.53 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.098 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 26.99 95.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 159.99 -155.46 26.58 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.435 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.744 HG13 ' O ' ' A' ' 41' ' ' ALA . 80.5 t -141.76 138.01 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.328 . . . . 0.0 111.042 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.462 ' CD1' ' HG3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -134.43 165.09 25.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.41 179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.08 HG11 HD11 ' A' ' 54' ' ' ILE . 3.8 t -63.84 162.76 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.625 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.856 ' HE2' ' HB2' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -145.4 -36.97 0.28 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.028 0.442 . . . . 0.0 111.325 -179.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.557 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 2.0 m-80 -140.24 145.21 37.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.326 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 1.08 HD11 HG11 ' A' ' 51' ' ' VAL . 5.0 mm -134.92 119.07 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.907 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.56 131.98 94.93 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.714 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.621 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 67.1 Cg_endo -74.0 121.82 7.22 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.491 2.127 . . . . 0.0 112.443 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 87.77 -20.8 0.19 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.73 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.16 -170.74 30.87 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.415 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.672 ' HA ' HD12 ' A' ' 62' ' ' LEU . 55.1 Cg_exo -51.93 -25.77 22.82 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.529 2.153 . . . . 0.0 112.247 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.406 ' HA3' HG23 ' A' ' 54' ' ' ILE . . . -65.47 -45.83 88.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.367 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -73.55 -33.03 64.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.947 0.403 . . . . 0.0 110.3 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.672 HD12 ' HA ' ' A' ' 59' ' ' PRO . 57.3 mt -62.07 -37.97 87.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.821 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.16 -52.05 5.45 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.38 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.35 44.99 1.91 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.611 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.053 HD21 HD21 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -111.56 126.21 54.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.928 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.8 mttp -75.12 164.69 59.58 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.107 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.62 64.78 3.83 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.767 2.311 . . . . 0.0 112.366 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.463 ' HB3' ' HG3' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -176.32 -25.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.527 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.727 ' CG ' HD13 ' A' ' 102' ' ' ILE . 71.1 m-20 -39.56 90.84 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.455 0.645 . . . . 0.0 111.852 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.574 ' O ' HD23 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -67.63 99.3 0.77 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.644 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.005 HD23 HD13 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -56.72 111.68 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.527 -179.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.939 HD12 HD21 ' A' ' 22' ' ' LEU . 6.5 mt -82.97 -44.82 14.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.693 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.6 142.37 32.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.762 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.599 HG23 ' OG1' ' A' ' 79' ' ' THR . 47.8 t -129.85 152.04 36.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.88 0.371 . . . . 0.0 111.492 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.0 m120 40.21 31.85 0.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.98 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 76.01 42.98 0.18 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.845 0.355 . . . . 0.0 110.898 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 72.8 t -152.15 152.95 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.05 129.06 38.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.73 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.599 ' OG1' HG23 ' A' ' 74' ' ' VAL . 66.8 p -144.47 28.14 1.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.017 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.694 ' CG ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -83.74 -44.95 13.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.736 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -92.28 15.77 13.03 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.34 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.555 ' CD2' HG22 ' A' ' 79' ' ' THR . 5.5 m-30 -81.85 167.53 18.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.872 0.368 . . . . 0.0 110.903 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.534 ' O ' HG23 ' A' ' 87' ' ' VAL . 0.9 OUTLIER -106.81 162.05 14.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.455 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.893 ' O ' HG23 ' A' ' 88' ' ' VAL . 22.9 p -51.8 -38.64 56.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.762 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 16.1 p -65.89 -24.6 66.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.4 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.727 ' O ' HD12 ' A' ' 90' ' ' LEU . 0.1 OUTLIER -93.4 -29.2 15.71 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.012 0.434 . . . . 0.0 110.913 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.661 HG21 ' HB ' ' A' ' 49' ' ' VAL . 45.0 t -78.0 -35.57 20.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.311 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 84' ' ' CYS . 94.1 t -58.79 -51.16 83.82 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.791 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.649 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 17.0 Cg_exo -67.11 -44.54 4.94 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.555 2.17 . . . . 0.0 111.428 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 86' ' ' LEU . 8.0 mt -54.07 -30.99 50.39 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.072 0.463 . . . . 0.0 110.431 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.628 HG23 HD12 ' A' ' 98' ' ' LEU . 71.6 mt -79.08 -48.86 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.128 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.5 -4.16 28.78 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.485 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -103.39 8.19 38.07 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.413 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 0.9 OUTLIER -64.41 -39.43 93.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.227 0.537 . . . . 0.0 110.238 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.59 -47.28 1.11 Allowed Glycine 0 C--N 1.32 -0.36 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.009 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.426 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -166.35 -36.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.682 0.277 . . . . 0.0 111.388 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -123.49 114.47 20.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.428 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.628 HD12 HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -100.99 97.58 8.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.548 -179.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -95.91 118.12 31.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 1.005 HD13 HD23 ' A' ' 71' ' ' LEU . 1.1 pp -146.44 156.04 43.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.993 0.425 . . . . 0.0 111.892 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.878 HG12 HD22 ' A' ' 22' ' ' LEU . 16.5 t -106.34 109.37 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.26 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.727 HD13 ' CG ' ' A' ' 69' ' ' ASP . 2.6 pp -106.28 170.12 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.46 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.528 ' HB3' HG21 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -142.5 130.78 22.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.787 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' A' ' 69' ' ' ASP . 0.6 OUTLIER -148.03 139.73 23.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.919 0.39 . . . . 0.0 111.123 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 1.4 p-10 -79.48 120.88 81.82 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.397 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 105' ' ' ASN . 20.9 Cg_exo . . . . . 0 C--O 1.248 0.999 0 C-N-CA 122.324 2.016 . . . . 0.0 112.232 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.442 HG21 ' OG ' ' A' ' 103' ' ' SER . 6.7 m . . . . . 0 C--O 1.231 0.098 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.76 122.32 38.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.324 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.917 HD21 ' CD1' ' A' ' 72' ' ' LEU . 14.0 mt -60.46 149.16 35.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.089 0.471 . . . . 0.0 111.759 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.5 117.91 3.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.193 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -70.73 131.97 44.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.903 HG11 ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -132.85 141.32 45.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 0.0 111.229 -179.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.1 m -134.63 109.48 8.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.237 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.767 HD21 HD11 ' A' ' 65' ' ' LEU . 8.1 mt -107.15 166.49 10.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.015 0.436 . . . . 0.0 111.726 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -121.03 147.08 46.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.491 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.14 155.1 17.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.939 0.4 . . . . 0.0 111.124 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.04 156.53 23.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.828 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.4 t -68.27 82.59 0.24 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.026 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.41 21.95 5.32 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.725 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.77 124.62 29.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 0.0 110.817 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -72.13 -10.9 60.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.343 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.33 -175.14 5.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.726 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.568 ' CD2' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -106.9 29.82 6.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.844 0.354 . . . . 0.0 111.115 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.3 7.47 72.86 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.623 -0.798 . . . . 0.0 113.114 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.484 ' HB2' HG12 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -171.6 148.69 2.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.038 0.419 . . . . 0.0 111.608 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 52' ' ' LYS . 2.4 m -117.84 144.57 45.28 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.594 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 51' ' ' VAL . 27.1 m -112.39 165.61 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.775 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.765 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . . . -129.6 161.59 30.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.051 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.4 p-10 -72.49 167.37 20.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.89 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.74 126.26 8.4 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.354 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.47 0.14 55.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.49 0.186 . . . . 0.0 111.422 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 93.0 mt -154.05 19.7 0.51 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.501 0.191 . . . . 0.0 111.355 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.463 ' O ' ' C ' ' A' ' 47' ' ' LYS . 81.8 mm-40 -155.36 22.24 0.42 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.196 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER 24.82 50.22 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.433 0.458 . . . . 0.0 112.129 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.25 -166.21 11.63 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.535 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.618 HG12 ' HB ' ' A' ' 40' ' ' VAL . 72.2 t -135.22 139.7 46.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.889 0.376 . . . . 0.0 111.219 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.51 153.99 47.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.507 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.711 ' HA ' HG12 ' A' ' 40' ' ' VAL . 51.4 t -57.07 162.21 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.616 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.765 ' HE2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -142.85 -34.13 0.44 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.876 0.369 . . . . 0.0 111.591 -179.419 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 37.2 m-80 -144.28 123.95 13.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.661 HD11 HG11 ' A' ' 51' ' ' VAL . 1.1 mt -123.57 123.25 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.268 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.95 117.36 44.84 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.411 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.418 ' HA ' ' HB2' ' A' ' 61' ' ' ASP . 58.1 Cg_endo -71.48 56.4 2.18 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.468 2.112 . . . . 0.0 112.599 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -173.04 -51.63 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.143 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.86 -170.48 0.29 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.654 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.509 ' HA ' HD12 ' A' ' 62' ' ' LEU . 50.0 Cg_exo -53.35 -31.87 58.99 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.626 2.217 . . . . 0.0 112.36 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.83 -51.58 56.14 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.575 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.418 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 7.5 t70 -73.48 -33.01 64.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.958 0.408 . . . . 0.0 110.396 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 59' ' ' PRO . 90.1 mt -59.38 -41.64 89.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.031 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.1 -50.93 6.47 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.543 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.26 42.56 0.35 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.442 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.903 ' CD2' HG11 ' A' ' 25' ' ' VAL . 19.3 mt -91.42 147.54 22.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.783 0.325 . . . . 0.0 110.845 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.23 161.88 55.01 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 50.9 Cg_exo -53.82 147.92 39.43 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.596 2.197 . . . . 0.0 112.154 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.465 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 4.8 m-85 88.62 -12.55 0.42 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.229 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.594 ' CG ' HD13 ' A' ' 102' ' ' ILE . 1.1 m-20 -52.88 85.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.93 0.395 . . . . 0.0 110.965 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.599 ' O ' HD23 ' A' ' 72' ' ' LEU . 21.2 ttm180 -74.04 95.12 2.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.462 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.973 HD23 HD13 ' A' ' 100' ' ' LEU . 1.7 mt -56.26 112.24 1.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.917 ' CD1' HD21 ' A' ' 22' ' ' LEU . 4.9 mt -81.2 -64.0 1.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.64 140.53 46.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.095 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.896 ' O ' HG12 ' A' ' 77' ' ' VAL . 24.3 t -118.6 116.16 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.002 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.461 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 0.2 OUTLIER 68.74 28.25 5.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.613 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.461 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER 85.81 -7.03 0.82 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.648 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.896 HG12 ' O ' ' A' ' 74' ' ' VAL . 4.6 p -83.97 134.61 26.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 120.818 0.342 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.4 mtt85 -70.56 118.2 13.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.95 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.692 HG23 HG13 ' A' ' 77' ' ' VAL . 30.6 p -145.47 35.94 1.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.668 ' CG ' HD22 ' A' ' 72' ' ' LEU . 1.6 ttp180 -75.87 -48.74 20.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.817 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -92.82 25.58 3.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.063 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.723 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.4 m-85 -81.75 170.08 16.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.957 0.408 . . . . 0.0 110.861 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.21 159.09 16.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.272 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.889 ' O ' HG23 ' A' ' 88' ' ' VAL . 6.5 p -51.38 -41.53 60.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 110.726 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.2 m -63.36 -24.57 67.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.164 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.615 ' O ' HD12 ' A' ' 90' ' ' LEU . 10.9 mp -91.09 -30.29 16.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.012 0.434 . . . . 0.0 110.847 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.464 HG12 ' CD1' ' A' ' 91' ' ' ILE . 65.7 t -79.3 -35.82 17.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.28 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 84' ' ' CYS . 68.0 t -55.3 -51.3 80.95 Favored Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.696 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.656 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 14.5 Cg_exo -68.33 -46.53 2.03 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.39 2.06 . . . . 0.0 111.294 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.723 HD11 ' HE2' ' A' ' 82' ' ' PHE . 15.4 mt -54.65 -29.38 52.2 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.008 0.433 . . . . 0.0 110.421 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.639 HG23 ' CD1' ' A' ' 98' ' ' LEU . 47.7 mt -73.91 -51.56 23.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.205 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.39 -2.74 36.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.884 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -92.15 -7.47 48.34 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.413 ' HB2' ' HG ' ' A' ' 98' ' ' LEU . 1.5 t -64.59 -16.51 62.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.873 0.368 . . . . 0.0 111.609 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.56 -52.68 3.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.687 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -165.98 -45.75 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.75 0.309 . . . . 0.0 110.985 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -101.04 107.22 18.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.475 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.639 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.9 OUTLIER -95.96 97.84 9.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.579 -179.428 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -101.34 118.2 36.49 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.973 HD13 HD23 ' A' ' 71' ' ' LEU . 1.3 pp -147.87 163.56 36.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.105 0.478 . . . . 0.0 112.088 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.892 HG12 HD22 ' A' ' 22' ' ' LEU . 21.7 t -114.85 109.4 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.217 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.808 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.4 pp -103.95 169.37 2.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.216 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.442 ' OG ' HG21 ' A' ' 20' ' ' VAL . 71.5 p -126.29 107.63 10.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.555 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.42 113.45 25.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.345 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.72 158.76 49.23 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.935 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 C--O 1.25 1.108 0 C-N-CA 122.578 2.185 . . . . 0.0 112.394 -179.908 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.499 ' HA ' ' N ' ' A' ' 105' ' ' ASN . 28.5 m . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 120.974 0.416 . . . . 0.0 111.493 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -139.45 122.5 16.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.91 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.825 HD22 HG12 ' A' ' 101' ' ' VAL . 11.9 mt -59.74 136.47 58.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.082 0.468 . . . . 0.0 111.667 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.716 ' HD2' HD11 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -152.47 119.07 5.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.127 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.16 130.45 42.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.68 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.448 HG13 ' CE1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -131.45 140.83 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.071 0.462 . . . . 0.0 111.343 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.9 m -134.41 106.92 7.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.944 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.016 HD11 HD11 ' A' ' 65' ' ' LEU . 2.6 mt -106.88 174.46 5.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.002 0.43 . . . . 0.0 111.543 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 96' ' ' ASN . 42.5 m-85 -123.07 165.67 16.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.693 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -128.34 120.68 27.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.852 0.358 . . . . 0.0 111.437 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.41 128.32 35.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.464 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.14 -29.22 0.87 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.751 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.32 -38.36 8.42 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.847 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.82 146.7 28.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.877 0.37 . . . . 0.0 111.206 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -103.04 -33.29 9.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.286 0.565 . . . . 0.0 110.603 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.35 152.64 23.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.285 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.518 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 0.8 OUTLIER -91.13 15.19 12.22 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.569 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.08 23.54 57.01 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.39 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.603 ' CD1' HG22 ' A' ' 51' ' ' VAL . 6.5 p90 -174.15 119.82 0.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.179 0.49 . . . . 0.0 111.549 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.1 m -91.88 154.14 19.06 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.631 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.712 ' HB ' HG12 ' A' ' 49' ' ' VAL . 24.1 m -112.17 170.93 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.011 0.434 . . . . 0.0 111.688 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.754 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -139.09 164.36 29.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.021 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -72.79 154.85 40.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.911 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.99 109.13 0.95 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.394 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.7 mt -94.28 -25.41 17.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.432 . . . . 0.0 111.182 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.9 tp -83.81 -6.71 59.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.532 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 47' ' ' LYS . 5.2 mt-10 -153.1 27.39 0.52 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.935 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER 26.54 78.48 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.127 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.02 -152.0 9.51 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.475 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 41' ' ' ALA . 23.8 t -144.49 138.42 23.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.875 0.369 . . . . 0.0 111.264 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -130.61 174.37 9.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.313 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.603 HG22 ' CD1' ' A' ' 38' ' ' PHE . 58.3 t -78.72 122.89 34.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.039 0.447 . . . . 0.0 111.255 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.558 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -89.1 -29.53 19.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.777 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.429 ' ND2' ' HG3' ' A' ' 52' ' ' LYS . 38.7 m-80 -157.59 155.3 29.92 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.35 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.539 HD13 ' CB ' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -137.85 130.7 41.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.561 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.407 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -64.38 127.4 92.14 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.873 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 55' ' ' ARG . 43.6 Cg_exo -56.49 140.02 88.46 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.454 2.103 . . . . 0.0 112.367 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 39.27 33.35 0.09 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.931 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.6 -161.75 21.32 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.259 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -57.6 -42.9 55.7 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.366 2.044 . . . . 0.0 112.147 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.661 ' HA2' HD12 ' A' ' 65' ' ' LEU . . . -65.87 -44.98 90.93 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.787 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.37 -32.62 64.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.028 0.442 . . . . 0.0 110.405 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.2 mt -67.54 -30.93 70.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.737 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.8 -38.6 13.46 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.395 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.53 31.52 1.64 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.565 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.016 HD11 HD11 ' A' ' 27' ' ' LEU . 28.4 mt -83.7 123.24 29.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.859 0.362 . . . . 0.0 111.021 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -113.88 138.59 22.83 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.55 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 77.6 Cg_exo -40.44 139.87 1.07 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.933 2.422 . . . . 0.0 113.144 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 48.9 m-85 88.7 -13.12 0.4 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.64 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.801 ' CB ' HD13 ' A' ' 102' ' ' ILE . 8.4 p-10 -55.99 85.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.064 0.459 . . . . 0.0 110.562 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.45 ' N ' ' O ' ' A' ' 68' ' ' TYR . 10.1 ttm180 -66.58 118.15 9.77 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.87 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.762 ' CD2' HD22 ' A' ' 100' ' ' LEU . 1.1 mt -72.5 112.07 8.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.286 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.618 HD23 ' HG3' ' A' ' 80' ' ' ARG . 5.0 mp -84.67 -67.07 0.82 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -115.5 110.42 19.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.456 ' HA ' ' HB3' ' A' ' 100' ' ' LEU . 46.6 t -102.75 143.05 15.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.874 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 0.5 OUTLIER 46.58 29.58 0.95 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.29 -179.687 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.456 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER 85.9 -19.1 0.32 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.773 179.658 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.0 t -83.98 136.0 23.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.818 0.342 . . . . 0.0 111.203 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -69.15 116.57 9.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.252 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.626 HG22 ' CE2' ' A' ' 82' ' ' PHE . 32.2 p -141.53 38.77 1.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.412 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.618 ' HG3' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -69.87 -46.57 65.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.589 179.679 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -94.38 27.81 2.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.44 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.626 ' CE2' HG22 ' A' ' 79' ' ' THR . 2.5 m-30 -81.09 176.3 9.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.811 0.338 . . . . 0.0 110.657 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.517 ' O ' HG23 ' A' ' 87' ' ' VAL . 3.6 t70 -108.26 158.79 17.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.511 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.841 ' O ' HG23 ' A' ' 88' ' ' VAL . 5.3 p -51.56 -41.88 61.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 110.654 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 37.3 m -63.15 -21.74 66.4 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.08 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.501 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 7.7 mp -96.48 -33.16 11.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.002 0.429 . . . . 0.0 111.022 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.642 HG21 ' HB ' ' A' ' 49' ' ' VAL . 37.8 t -77.61 -36.05 22.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.374 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 84' ' ' CYS . 93.3 t -58.54 -51.29 82.89 Favored Pre-proline 0 C--N 1.33 -0.241 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.79 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.666 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.5 Cg_exo -67.32 -40.93 10.01 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.334 2.023 . . . . 0.0 111.528 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.595 HD13 HG21 ' A' ' 79' ' ' THR . 25.3 mt -54.55 -33.88 60.89 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.027 0.441 . . . . 0.0 110.763 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.879 ' HA ' HD11 ' A' ' 98' ' ' LEU . 25.0 mt -78.34 -44.33 26.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.125 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.22 -2.75 49.95 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.423 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -104.81 6.66 34.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.445 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -63.39 -35.1 79.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.371 0.605 . . . . 0.0 110.253 179.481 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.85 -41.87 2.21 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.719 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 6.1 m-80 -166.82 -35.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.511 0.196 . . . . 0.0 111.328 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp -122.76 131.58 53.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.692 0.282 . . . . 0.0 110.942 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.879 HD11 ' HA ' ' A' ' 91' ' ' ILE . 0.5 OUTLIER -120.62 97.49 5.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.433 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -96.36 118.4 32.81 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.762 HD22 ' CD2' ' A' ' 71' ' ' LEU . 2.6 pp -150.22 162.52 40.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.342 0.592 . . . . 0.0 112.451 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.825 HG12 HD22 ' A' ' 22' ' ' LEU . 25.0 t -114.17 109.1 27.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.699 178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.801 HD13 ' CB ' ' A' ' 69' ' ' ASP . 2.6 pp -104.07 169.45 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.465 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.438 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -133.73 112.39 11.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.766 179.656 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.63 133.42 43.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.001 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.499 ' N ' ' HA ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -62.71 152.01 82.91 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.77 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 C--O 1.248 1.023 0 C-N-CA 122.568 2.179 . . . . 0.0 112.273 -179.927 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.7 m . . . . . 0 N--CA 1.461 0.122 0 CA-C-O 121.01 0.433 . . . . 0.0 112.139 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -121.53 122.45 39.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.393 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.838 HD22 HG12 ' A' ' 101' ' ' VAL . 13.7 mt -60.87 140.65 57.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.313 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.478 ' HB2' HD11 ' A' ' 102' ' ' ILE . 53.7 m-70 -146.52 106.62 4.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.936 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -71.44 109.49 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.047 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.429 HG11 ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -114.89 141.26 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.115 0.484 . . . . 0.0 111.8 -179.079 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.551 HG23 ' OD1' ' A' ' 99' ' ' ASP . 95.5 m -133.06 106.63 7.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.866 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 1.122 HD11 HD11 ' A' ' 65' ' ' LEU . 7.8 mt -105.21 -177.59 3.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.933 0.397 . . . . 0.0 111.608 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.444 ' CD2' ' HG2' ' A' ' 97' ' ' LYS . 16.2 m-85 -135.83 153.59 51.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.529 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -116.1 164.77 13.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.031 0.444 . . . . 0.0 111.423 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -106.16 152.9 22.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.672 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.25 -28.8 29.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.338 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.49 36.71 2.05 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.644 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.4 ttt -81.68 149.14 28.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.748 0.308 . . . . 0.0 110.926 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -96.04 -10.91 27.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.204 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -156.82 176.11 13.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.646 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -102.36 27.07 7.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.168 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 85.62 5.24 84.64 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.263 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.78 ' CD2' HD13 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -173.03 141.67 1.0 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.017 0.437 . . . . 0.0 111.475 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.5 m -107.72 153.42 22.96 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.352 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.742 HG11 ' CD1' ' A' ' 71' ' ' LEU . 32.6 m -118.58 164.97 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.393 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -132.73 141.66 48.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.08 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -55.98 164.88 1.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.112 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.79 140.56 16.42 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.339 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.72 -58.33 2.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.108 0.48 . . . . 0.0 111.423 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.13 -41.98 16.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.726 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 47' ' ' LYS . 18.0 mt-10 -88.4 10.68 19.17 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.616 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 26.36 78.2 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -169.54 -139.16 2.65 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.488 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.698 HG12 ' HB ' ' A' ' 40' ' ' VAL . 41.7 t -155.8 138.41 6.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.602 0.239 . . . . 0.0 111.109 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.76 156.48 47.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.829 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.468 ' CG2' ' HB2' ' A' ' 69' ' ' ASP . 62.0 t -64.03 121.17 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.989 0.423 . . . . 0.0 111.249 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.97 -30.64 17.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.181 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -160.34 154.99 23.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.503 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.455 HG23 ' HB3' ' A' ' 38' ' ' PHE . 1.1 mt -133.44 125.94 51.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.1 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.51 114.7 16.81 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.71 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.636 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 50.1 Cg_exo -53.62 125.07 17.4 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.293 1.996 . . . . 0.0 112.185 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 89.14 -28.88 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.586 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.86 -179.66 1.27 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.472 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.46 ' O ' HD22 ' A' ' 27' ' ' LEU . 58.4 Cg_exo -51.69 -34.6 54.42 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.601 2.201 . . . . 0.0 112.293 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.635 ' HA2' HD12 ' A' ' 65' ' ' LEU . . . -60.97 -46.71 94.04 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.592 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.42 -32.71 64.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.983 0.42 . . . . 0.0 110.357 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.4 mt -63.02 -32.76 74.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.897 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -86.44 -46.63 5.17 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.55 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.81 33.89 0.96 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.765 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.122 HD11 HD11 ' A' ' 27' ' ' LEU . 24.6 mt -73.85 145.94 44.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.775 0.321 . . . . 0.0 110.859 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.411 ' CD ' ' NH1' ' A' ' 104' ' ' ARG . 11.5 mttm -125.64 159.16 62.22 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.968 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.423 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 15.7 Cg_endo -56.96 141.6 93.72 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.76 2.306 . . . . 0.0 112.13 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.546 ' O ' ' N ' ' A' ' 70' ' ' ARG . 31.5 m-85 84.42 0.62 0.9 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.245 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.55 ' CG ' HD13 ' A' ' 102' ' ' ILE . 3.2 m-20 -52.97 80.33 0.0 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.976 0.417 . . . . 0.0 110.733 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.546 ' N ' ' O ' ' A' ' 68' ' ' TYR . 41.0 ttp180 -66.82 103.86 1.21 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.148 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.823 ' HA ' HG22 ' A' ' 102' ' ' ILE . 3.5 mp -63.2 107.39 1.04 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.809 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.668 HD22 ' HG2' ' A' ' 80' ' ' ARG . 8.2 mt -84.98 -67.23 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 0.0 111.155 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -116.21 112.85 22.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.073 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.607 HG23 ' OG1' ' A' ' 79' ' ' THR . 40.9 t -103.71 125.28 58.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.963 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.459 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 1.1 m-80 45.69 36.9 2.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.398 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.459 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.4 OUTLIER 87.49 -22.66 0.14 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.736 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.0 t -83.39 134.9 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.321 . . . . 0.0 111.141 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -69.38 136.01 51.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.607 ' OG1' HG23 ' A' ' 74' ' ' VAL . 76.2 p -144.91 25.02 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.179 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.668 ' HG2' HD22 ' A' ' 72' ' ' LEU . 3.4 mtm180 -71.98 -48.45 44.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.883 0.373 . . . . 0.0 110.62 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -92.59 16.03 12.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.363 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.41 ' CG ' ' HA ' ' A' ' 79' ' ' THR . 3.3 m-85 -82.05 176.41 9.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.86 0.362 . . . . 0.0 110.818 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.87 160.46 18.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.559 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 6.4 p -51.62 -34.82 39.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.725 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 96.0 m -70.15 -21.69 63.05 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.223 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.609 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 0.5 OUTLIER -97.59 -32.32 11.85 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 111.014 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.543 HG11 HD13 ' A' ' 71' ' ' LEU . 46.3 t -79.92 -35.94 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.453 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.836 HG12 ' HD3' ' A' ' 89' ' ' PRO . 3.7 p -61.87 -41.2 75.53 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.606 -0.437 . . . . 0.0 111.439 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.836 ' HD3' HG12 ' A' ' 88' ' ' VAL . 72.3 Cg_endo -74.55 -45.55 0.32 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 121.806 1.67 . . . . 0.0 111.316 178.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 86' ' ' LEU . 36.3 mt -54.48 -29.38 49.84 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.347 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.939 HG23 ' CD1' ' A' ' 98' ' ' LEU . 62.2 mt -78.45 -47.12 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.55 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.63 -3.97 31.37 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -112.26 -0.64 15.41 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.764 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.418 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 16.5 m -64.79 -16.41 63.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.834 0.35 . . . . 0.0 111.139 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.91 -148.37 18.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.586 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -73.5 -8.52 56.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.616 0.246 . . . . 0.0 111.419 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.444 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -140.96 147.85 39.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.737 0.303 . . . . 0.0 110.863 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.939 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -132.13 97.45 4.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.219 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.551 ' OD1' HG23 ' A' ' 26' ' ' THR . 0.4 OUTLIER -93.53 118.3 31.18 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.077 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.752 HD23 HD22 ' A' ' 98' ' ' LEU . 1.9 pp -149.85 154.93 39.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.168 0.509 . . . . 0.0 112.096 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.838 HG12 HD22 ' A' ' 22' ' ' LEU . 23.5 t -111.53 109.16 27.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.954 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.823 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.7 pp -105.82 166.1 3.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.01 0.433 . . . . 0.0 111.596 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.7 p -134.12 129.09 35.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.551 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.468 ' HG3' ' HB2' ' A' ' 68' ' ' TYR . 6.0 ttp180 -127.74 135.78 50.61 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.033 0.444 . . . . 0.0 111.48 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -96.82 111.59 57.93 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.404 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.236 1.958 . . . . 0.0 112.356 -179.86 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 105' ' ' ASN . 35.2 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.002 0.429 . . . . 0.0 111.929 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.54 122.05 45.22 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.727 HD13 ' CG1' ' A' ' 101' ' ' VAL . 4.4 pp -100.33 153.15 19.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.199 0.523 . . . . 0.0 112.264 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.855 ' CD2' HD11 ' A' ' 102' ' ' ILE . 20.9 p80 -144.9 152.22 39.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.698 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -78.55 104.25 9.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.448 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.67 HG22 ' CE1' ' A' ' 23' ' ' HIS . 0.1 OUTLIER -99.22 144.62 11.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.364 -179.525 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.419 HG23 ' OD2' ' A' ' 99' ' ' ASP . 96.4 m -135.09 106.42 6.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.84 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.804 HD21 ' CD1' ' A' ' 65' ' ' LEU . 1.1 mp -105.36 175.18 5.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.033 0.444 . . . . 0.0 111.357 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.451 ' N ' ' CD1' ' A' ' 28' ' ' TYR . 1.5 m-85 -131.51 155.88 46.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.248 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -118.46 149.77 40.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.914 0.388 . . . . 0.0 111.322 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.15 152.85 31.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.741 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.2 m -63.62 -26.25 68.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.257 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.26 1.75 46.96 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.08 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 3.3 mmt -81.78 124.57 29.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.896 0.379 . . . . 0.0 110.976 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.03 -10.77 59.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.365 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -155.59 -167.92 2.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.641 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.526 ' CD2' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -105.46 17.49 23.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.559 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 91.19 7.15 65.91 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.531 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.571 ' CD2' HG22 ' A' ' 51' ' ' VAL . 25.6 p90 -173.62 145.79 1.24 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.26 0.53 . . . . 0.0 111.716 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.75 146.68 41.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.191 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.493 HG11 ' CD1' ' A' ' 71' ' ' LEU . 34.6 m -105.31 171.02 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.662 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -131.08 178.13 6.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.948 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -89.98 129.0 36.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.808 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.12 100.5 2.36 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.272 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.3 -24.05 17.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.964 0.411 . . . . 0.0 111.176 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.52 -10.98 57.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.32 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 47' ' ' LYS . 3.0 mt-10 -153.36 33.51 0.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.968 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 25.24 91.42 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.173 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 173.13 -162.76 34.19 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.42 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 82' ' ' PHE . 64.8 t -139.4 132.1 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.79 0.329 . . . . 0.0 110.749 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -131.87 163.39 28.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.74 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.571 HG22 ' CD2' ' A' ' 38' ' ' PHE . 66.7 t -72.37 122.57 25.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.747 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -87.39 -31.0 20.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.422 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -162.67 145.72 11.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.486 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.57 HG23 ' HB3' ' A' ' 38' ' ' PHE . 1.4 mt -127.48 133.59 67.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.943 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.08 144.49 99.07 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.814 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.23 144.03 45.32 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.516 2.144 . . . . 0.0 112.373 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 39.06 33.83 0.09 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.976 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -109.97 -168.14 19.85 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.39 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.406 ' O ' HD23 ' A' ' 27' ' ' LEU . 54.2 Cg_exo -52.2 -39.71 70.94 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.513 2.142 . . . . 0.0 112.152 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.39 -36.08 50.73 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.609 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -73.51 -32.83 64.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.027 0.441 . . . . 0.0 110.258 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.0 mt -77.28 -30.68 54.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.804 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.02 -47.81 29.54 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.369 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.46 35.27 1.01 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.554 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.804 ' CD1' HD21 ' A' ' 27' ' ' LEU . 13.2 mt -91.1 124.0 34.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.785 0.326 . . . . 0.0 110.998 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.24 156.1 35.66 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.831 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.447 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 53.6 Cg_exo -51.8 136.27 50.79 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.52 2.146 . . . . 0.0 112.227 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.448 ' O ' ' N ' ' A' ' 70' ' ' ARG . 9.9 m-85 85.5 7.49 0.4 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.004 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.778 ' OD1' HD13 ' A' ' 102' ' ' ILE . 3.8 m-20 -53.56 85.84 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.044 0.449 . . . . 0.0 110.993 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 68' ' ' TYR . 28.6 ttt85 -72.31 96.86 1.91 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.629 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.823 ' CD2' HD22 ' A' ' 100' ' ' LEU . 1.2 mp -53.33 107.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.104 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.736 HD11 ' HB2' ' A' ' 103' ' ' SER . 3.2 mp -82.17 -62.37 1.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.376 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -133.79 130.01 37.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.874 0.369 . . . . 0.0 111.281 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.927 ' O ' HG12 ' A' ' 77' ' ' VAL . 20.1 t -113.66 112.95 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.809 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 5.4 m-80 66.54 30.27 8.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.636 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.467 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 1.6 t-80 87.21 -12.12 0.53 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.892 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.927 HG12 ' O ' ' A' ' 74' ' ' VAL . 4.3 p -84.13 143.08 12.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.893 0.378 . . . . 0.0 111.06 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 mtp85 -70.08 125.47 26.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.527 HG23 HG13 ' A' ' 77' ' ' VAL . 52.8 p -146.39 19.69 1.36 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.348 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.504 ' HG3' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -66.23 -52.96 42.7 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.953 0.406 . . . . 0.0 110.623 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -94.77 29.33 2.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.239 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.855 ' O ' HG23 ' A' ' 49' ' ' VAL . 1.8 m-30 -80.97 171.79 14.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.858 0.361 . . . . 0.0 110.82 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.575 ' C ' HG21 ' A' ' 49' ' ' VAL . 2.4 m-20 -107.26 157.62 17.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.499 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.843 ' O ' HG23 ' A' ' 88' ' ' VAL . 5.7 p -51.49 -38.52 54.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.929 0.395 . . . . 0.0 110.445 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 18.9 m -65.67 -21.56 66.56 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.054 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.729 HD22 ' CE2' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -95.4 -32.12 13.07 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.094 0.474 . . . . 0.0 110.605 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.698 HG11 HD13 ' A' ' 71' ' ' LEU . 39.0 t -78.26 -35.79 20.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.303 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 84' ' ' CYS . 93.7 t -58.67 -51.01 84.92 Favored Pre-proline 0 C--N 1.331 -0.23 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.975 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.643 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.0 Cg_exo -68.01 -45.64 2.87 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.477 2.118 . . . . 0.0 111.634 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.618 HD11 ' HE2' ' A' ' 82' ' ' PHE . 36.6 mt -54.5 -30.25 52.82 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.998 0.428 . . . . 0.0 110.574 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.929 ' HA ' HD11 ' A' ' 98' ' ' LEU . 70.9 mt -79.17 -49.55 19.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.079 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.48 -2.59 29.56 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.431 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -102.07 -1.14 32.26 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.203 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.418 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -64.82 -30.87 71.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.185 0.516 . . . . 0.0 110.768 179.719 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.38 -63.09 0.84 Allowed Glycine 0 C--N 1.322 -0.248 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.252 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.432 ' HA ' ' CB ' ' A' ' 29' ' ' LYS . 18.8 p30 -162.71 18.29 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.528 0.204 . . . . 0.0 111.3 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.439 ' HE2' ' CE2' ' A' ' 28' ' ' TYR . 3.8 ttmt -161.8 116.77 1.97 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.929 HD11 ' HA ' ' A' ' 91' ' ' ILE . 1.0 OUTLIER -116.16 98.87 6.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.897 -179.141 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.419 ' OD2' HG23 ' A' ' 26' ' ' THR . 1.9 m-20 -98.52 117.98 34.18 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.844 HD23 HD22 ' A' ' 98' ' ' LEU . 1.2 pp -151.69 164.74 36.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.167 0.508 . . . . 0.0 112.097 -178.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.727 ' CG1' HD13 ' A' ' 22' ' ' LEU . 15.5 t -107.5 109.97 30.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.942 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.855 HD11 ' CD2' ' A' ' 23' ' ' HIS . 2.4 pp -100.44 153.75 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.22 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.736 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -119.53 127.3 52.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.496 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.21 129.88 11.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.996 0.427 . . . . 0.0 111.682 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 3.4 p30 -62.78 158.23 53.58 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.785 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 122.531 2.154 . . . . 0.0 112.289 -179.951 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.701 HG12 ' N ' ' A' ' 105' ' ' ASN . 19.6 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 121.073 0.463 . . . . 0.0 112.171 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.42 ' HG3' ' NH1' ' A' ' 104' ' ' ARG . 11.3 pt-20 -106.92 124.51 49.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.793 HD22 ' CD1' ' A' ' 72' ' ' LEU . 4.7 pp -105.07 153.51 21.38 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -145.85 156.41 43.54 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.597 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.19 110.64 18.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.25 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.905 HG11 ' HG ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -111.75 146.14 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.596 -179.271 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.6 m -134.21 106.64 7.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.314 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.633 HD11 HD21 ' A' ' 65' ' ' LEU . 3.3 mp -93.53 174.76 7.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.947 0.403 . . . . 0.0 111.561 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.433 ' CD1' ' HG3' ' A' ' 97' ' ' LYS . 81.1 m-85 -132.3 141.44 48.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.171 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -116.25 163.14 16.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.878 0.37 . . . . 0.0 111.418 -179.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.75 140.13 52.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.749 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 90.3 p -61.75 84.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.055 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 123.86 19.67 2.69 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.075 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.79 167.88 18.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.778 0.323 . . . . 0.0 110.8 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -97.52 -18.36 19.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.207 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.62 -171.25 3.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.667 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.807 ' CD2' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -108.71 19.21 19.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.301 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 104.87 0.46 42.15 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.066 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.579 ' HB3' HG23 ' A' ' 54' ' ' ILE . 14.4 p90 -172.85 145.01 1.39 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.943 0.402 . . . . 0.0 111.453 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.1 m -98.19 138.5 35.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.172 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.49 HG23 ' SG ' ' A' ' 84' ' ' CYS . 35.8 m -93.74 171.07 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.698 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . . . -136.3 178.19 7.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.093 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.57 131.33 45.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.738 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.449 ' HA3' ' CZ ' ' A' ' 50' ' ' TYR . . . -104.0 108.96 3.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.528 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -94.48 -25.15 17.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.001 0.429 . . . . 0.0 111.069 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.42 ' HA ' HD22 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -83.94 -7.36 59.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.592 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 47' ' ' LYS . 5.2 mt-10 -153.17 25.22 0.54 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.168 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 27.38 80.86 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -170.22 -156.39 11.15 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.695 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.537 ' HB ' HG21 ' A' ' 87' ' ' VAL . 95.2 t -137.68 131.24 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.806 0.336 . . . . 0.0 111.044 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.449 ' CZ ' ' HA3' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -128.56 172.41 11.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.246 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.539 HG11 HG12 ' A' ' 54' ' ' ILE . 88.7 t -90.77 123.68 43.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.83 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 3.7 ptpp? -86.99 -30.73 21.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.362 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -161.76 144.9 12.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.652 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.597 HD12 ' O ' ' A' ' 65' ' ' LEU . 1.7 mt -126.08 135.84 62.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.996 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.6 mtt180 -65.37 143.87 98.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.724 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.09 143.22 35.65 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.501 2.134 . . . . 0.0 112.481 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 39.57 33.77 0.13 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.894 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.56 -159.24 13.3 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.265 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.79 -53.79 6.22 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.477 2.118 . . . . 0.0 112.033 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.22 -33.81 87.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.683 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -73.59 -32.61 64.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.982 0.42 . . . . 0.0 110.321 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 75.1 mt -75.12 -33.8 61.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.787 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.73 -54.1 10.6 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.392 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.26 33.23 1.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.701 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.905 ' HG ' HG11 ' A' ' 25' ' ' VAL . 1.7 mp -88.06 115.77 25.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.866 0.365 . . . . 0.0 110.884 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -81.37 159.86 66.39 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.552 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.426 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 13.0 Cg_endo -56.14 132.54 52.58 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.575 2.183 . . . . 0.0 112.332 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.427 ' O ' ' N ' ' A' ' 70' ' ' ARG . 0.3 OUTLIER 84.16 3.15 0.82 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.599 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.637 ' HB2' HD13 ' A' ' 102' ' ' ILE . 6.0 p-10 -54.43 87.61 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.174 0.512 . . . . 0.0 110.858 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 68' ' ' TYR . 4.2 ttp180 -66.99 109.55 3.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.862 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.004 HD23 HD13 ' A' ' 100' ' ' LEU . 4.0 mp -58.78 118.27 5.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.226 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.793 ' CD1' HD22 ' A' ' 22' ' ' LEU . 40.5 mt -82.77 -65.18 1.04 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.871 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -131.73 128.43 38.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.025 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.33 136.31 44.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.009 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.45 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 23.8 m120 50.18 32.01 5.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.332 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.45 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.3 OUTLIER 85.88 -14.79 0.52 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.77 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.2 t -83.75 136.94 21.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.843 0.354 . . . . 0.0 111.14 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -69.46 125.36 26.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.741 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.496 HG21 HD13 ' A' ' 90' ' ' LEU . 17.1 p -144.5 32.01 1.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.123 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.549 ' HG2' HD22 ' A' ' 72' ' ' LEU . 14.0 mtp180 -65.33 -52.03 56.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.43 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.69 28.54 2.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.049 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.695 ' HE2' HD11 ' A' ' 90' ' ' LEU . 1.8 m-30 -80.8 167.51 19.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.724 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -107.83 161.53 14.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.46 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.851 ' O ' HG23 ' A' ' 88' ' ' VAL . 0.8 OUTLIER -51.81 -40.66 60.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.924 0.393 . . . . 0.0 110.68 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.5 m -63.09 -23.03 67.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.205 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.51 ' O ' HD12 ' A' ' 90' ' ' LEU . 10.0 mp -94.17 -32.09 13.86 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.027 0.441 . . . . 0.0 110.864 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.537 HG21 ' HB ' ' A' ' 49' ' ' VAL . 52.9 t -78.44 -35.86 19.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.222 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 84' ' ' CYS . 97.3 t -57.41 -51.25 83.13 Favored Pre-proline 0 C--N 1.331 -0.199 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.788 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.651 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.9 Cg_exo -66.61 -48.38 2.26 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.475 2.117 . . . . 0.0 111.32 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.695 HD11 ' HE2' ' A' ' 82' ' ' PHE . 37.4 mt -54.94 -27.99 47.74 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.967 0.413 . . . . 0.0 110.427 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.955 ' HA ' HD11 ' A' ' 98' ' ' LEU . 27.8 mt -75.84 -48.12 30.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.799 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.2 -3.09 40.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.091 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -89.8 -11.41 42.21 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.428 ' HB2' ' HG ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -64.66 -27.01 68.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.005 0.431 . . . . 0.0 111.208 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.59 -59.6 3.31 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.423 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.413 ' HA ' ' CB ' ' A' ' 29' ' ' LYS . 9.0 p30 -164.24 20.41 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.523 0.201 . . . . 0.0 111.383 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.433 ' HG3' ' CD1' ' A' ' 28' ' ' TYR . 14.1 ttpt -165.55 113.03 0.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.7 0.286 . . . . 0.0 110.234 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.955 HD11 ' HA ' ' A' ' 91' ' ' ILE . 1.7 mt -109.03 102.19 11.2 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -97.32 118.12 33.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 1.004 HD13 HD23 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -152.67 159.16 43.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.267 0.556 . . . . 0.0 112.416 -178.403 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.625 ' CG1' HD13 ' A' ' 22' ' ' LEU . 15.5 t -105.99 109.33 27.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.455 178.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.705 HG23 HD12 ' A' ' 100' ' ' LEU . 2.6 pp -100.87 162.33 3.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.015 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.441 ' HB3' HD11 ' A' ' 72' ' ' LEU . 3.2 p -146.26 130.19 17.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.687 0.28 . . . . 0.0 111.145 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.42 ' NH1' ' HG3' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -144.96 145.8 31.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.958 0.408 . . . . 0.0 111.409 179.508 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.701 ' N ' HG12 ' A' ' 20' ' ' VAL . 6.1 p30 -70.04 127.01 92.67 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.748 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo . . . . . 0 C--O 1.248 1.001 0 C-N-CA 122.42 2.08 . . . . 0.0 112.247 179.989 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.886 0.374 . . . . 0.0 111.478 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -135.23 122.38 21.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.613 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.047 HD21 HD12 ' A' ' 72' ' ' LEU . 16.0 mt -62.6 136.58 57.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.472 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 -142.86 119.72 11.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.87 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -75.34 110.93 10.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.28 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.71 HG11 ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -116.9 140.88 37.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.072 0.463 . . . . 0.0 111.508 -179.262 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.4 m -133.65 106.79 7.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.02 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.719 HD11 HD13 ' A' ' 65' ' ' LEU . 38.0 mt -98.3 179.56 4.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.172 0.511 . . . . 0.0 111.8 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.437 ' CD1' ' HG2' ' A' ' 97' ' ' LYS . 95.2 m-85 -135.69 136.1 40.61 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.366 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.451 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -99.33 165.14 11.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.968 0.413 . . . . 0.0 111.3 -179.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -119.8 131.1 55.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.784 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.82 84.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.126 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.26 -40.67 0.51 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.36 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.63 164.26 21.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 0.0 110.907 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.91 -28.52 9.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.072 0.463 . . . . 0.0 110.922 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -84.8 168.74 14.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.707 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.609 ' CD2' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -119.11 29.15 7.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.084 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.522 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 92.07 4.21 67.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.117 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.77 ' CE2' HD22 ' A' ' 65' ' ' LEU . 8.8 p90 -174.33 138.56 0.56 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.981 0.39 . . . . 0.0 111.545 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 52' ' ' LYS . 7.3 m -99.79 148.1 24.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.183 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.605 ' HB ' HG12 ' A' ' 49' ' ' VAL . 33.0 m -111.8 163.36 8.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.919 0.39 . . . . 0.0 111.588 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.782 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -135.08 172.22 13.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.908 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -84.18 163.62 19.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.935 0.397 . . . . 0.0 111.145 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.55 121.98 6.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.322 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.69 6.27 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.53 -38.77 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.072 0.463 . . . . 0.0 111.482 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 47' ' ' LYS . 11.8 mm-40 -88.85 18.14 5.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.561 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 46' ' ' GLU . 12.5 mmtt 27.76 78.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.971 0.415 . . . . 0.0 112.106 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.09 -163.51 35.84 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.473 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.782 HG13 ' O ' ' A' ' 41' ' ' ALA . 46.8 t -130.0 138.93 52.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 110.914 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -136.51 165.64 25.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.795 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.508 HG11 HD11 ' A' ' 54' ' ' ILE . 58.9 t -72.35 121.18 22.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.02 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 39' ' ' SER . 0.4 OUTLIER -87.53 -31.05 20.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.865 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -158.12 152.63 24.68 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.447 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.522 HG23 ' O ' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -133.21 141.53 44.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.029 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.12 117.22 37.43 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.749 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.64 134.2 52.5 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.512 2.141 . . . . 0.0 112.504 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 42.83 31.25 0.3 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.834 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -109.39 -160.88 19.22 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.749 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -50.64 -62.06 0.46 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.49 2.126 . . . . 0.0 111.785 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.9 -35.04 66.58 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.884 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -73.19 -32.83 65.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.051 0.453 . . . . 0.0 110.201 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 62' ' ' LEU . 27.5 mt -73.2 -27.41 61.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.56 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.54 -51.66 7.12 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.348 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 134.95 -8.02 4.48 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.021 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.77 HD22 ' CE2' ' A' ' 38' ' ' PHE . 4.0 mp -56.76 128.85 38.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.368 . . . . 0.0 111.114 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -116.6 167.24 10.93 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 69.7 Cg_exo -50.92 137.3 43.79 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.654 2.236 . . . . 0.0 112.368 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.437 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 10.8 m-85 85.02 4.1 0.62 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.232 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.528 ' CG ' HD13 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -52.5 89.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.947 0.403 . . . . 0.0 110.81 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.612 ' O ' HD23 ' A' ' 72' ' ' LEU . 9.3 ttt180 -77.85 95.59 4.76 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.787 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.018 HD23 HD13 ' A' ' 100' ' ' LEU . 1.2 mp -55.0 107.01 0.26 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.873 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.047 HD12 HD21 ' A' ' 22' ' ' LEU . 4.4 mt -83.98 -63.05 1.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.835 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -120.49 117.56 27.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.951 ' O ' HG12 ' A' ' 77' ' ' VAL . 24.6 t -108.15 109.62 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.163 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.491 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 1.7 m-80 64.24 33.59 11.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.669 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.491 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 3.3 t60 89.73 -17.94 0.21 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.92 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.951 HG12 ' O ' ' A' ' 74' ' ' VAL . 6.4 p -83.69 130.08 36.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.992 0.425 . . . . 0.0 111.125 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.78 89.24 0.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.415 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.687 HG23 HG13 ' A' ' 77' ' ' VAL . 17.3 p -96.76 26.26 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.809 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.652 ' HG2' HD22 ' A' ' 72' ' ' LEU . 10.5 mtp-105 -63.32 -53.03 59.13 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.985 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.35 24.16 4.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.402 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.693 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.3 m-85 -81.8 166.48 19.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.852 0.358 . . . . 0.0 110.76 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.557 ' C ' HG21 ' A' ' 49' ' ' VAL . 33.6 m-20 -106.08 160.9 14.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.554 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.841 ' O ' HG23 ' A' ' 88' ' ' VAL . 11.3 t -51.69 -41.98 61.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.69 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.3 m -63.07 -22.43 66.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.098 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.536 ' O ' HD12 ' A' ' 90' ' ' LEU . 6.6 mp -94.02 -32.93 13.61 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.99 0.424 . . . . 0.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.732 HG11 HD13 ' A' ' 71' ' ' LEU . 48.4 t -77.57 -36.79 23.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.134 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 84' ' ' CYS . 87.5 t -55.61 -52.19 73.97 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.793 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 48.7 Cg_endo -68.44 -45.81 2.36 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.191 1.927 . . . . 0.0 111.835 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.693 HD11 ' HE2' ' A' ' 82' ' ' PHE . 28.2 mt -54.78 -30.71 57.49 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.964 0.412 . . . . 0.0 110.725 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.809 HG23 ' CD1' ' A' ' 98' ' ' LEU . 61.3 mt -76.14 -48.37 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.367 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.69 -3.06 39.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.804 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -92.99 -4.55 52.45 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.433 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -63.52 -29.83 71.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.232 0.539 . . . . 0.0 110.903 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.8 -41.67 2.82 Favored Glycine 0 C--N 1.322 -0.227 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.761 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -166.23 -41.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 111.133 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.437 ' HG2' ' CD1' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -112.9 126.91 55.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.719 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.809 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.6 OUTLIER -115.85 97.48 6.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.626 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.27 118.16 31.18 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 1.018 HD13 HD23 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -148.59 156.44 42.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.142 0.496 . . . . 0.0 112.175 -178.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.899 HG12 HD22 ' A' ' 22' ' ' LEU . 17.1 t -114.32 109.04 27.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.794 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.883 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.4 pp -104.99 165.56 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.337 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.5 p -126.84 126.55 43.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.738 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -152.27 138.77 18.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.072 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -62.94 154.11 77.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.698 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo . . . . . 0 C--O 1.249 1.025 0 C-N-CA 122.61 2.207 . . . . 0.0 112.324 -179.855 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.719 HG21 ' HB3' ' A' ' 103' ' ' SER . 16.5 m . . . . . 0 C--O 1.23 0.035 0 CA-C-O 120.969 0.414 . . . . 0.0 111.566 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -122.38 122.99 40.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.567 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.801 ' CD2' HD13 ' A' ' 72' ' ' LEU . 14.4 mt -60.33 147.52 40.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.057 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.717 ' HD2' HD11 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -157.55 116.57 3.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.368 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.31 121.02 20.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.79 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.877 HG11 HD22 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -118.24 145.54 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.296 -179.769 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.2 m -134.56 106.82 7.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.965 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.01 173.34 6.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.997 0.427 . . . . 0.0 111.692 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 28' ' ' TYR . 3.1 m-85 -123.19 156.05 35.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.519 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -111.22 160.37 17.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.912 0.387 . . . . 0.0 111.236 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.82 142.26 50.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.865 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.6 t -56.13 -30.46 62.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.022 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.29 38.17 3.4 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.399 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 5.4 mmt -157.25 110.85 2.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.785 0.326 . . . . 0.0 110.835 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -74.07 -28.81 61.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.087 0.47 . . . . 0.0 110.931 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -85.03 177.99 7.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.651 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.502 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -118.98 29.36 7.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.119 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.613 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 82.7 8.46 85.98 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.688 -0.767 . . . . 0.0 113.332 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.511 ' CE2' HG22 ' A' ' 51' ' ' VAL . 20.3 p90 -172.73 127.48 0.5 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 117.171 0.486 . . . . 0.0 111.395 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.06 149.89 20.83 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.013 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.757 HG11 HD11 ' A' ' 71' ' ' LEU . 31.6 m -122.15 150.74 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.303 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.761 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -107.67 178.11 4.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.08 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -94.87 168.18 10.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.015 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -96.88 109.78 3.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.065 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.554 ' O ' HD22 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -94.46 7.11 46.7 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.554 HD22 ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -150.15 0.47 0.45 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -179.304 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -158.17 31.45 0.25 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.642 0.258 . . . . 0.0 111.298 179.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER 28.59 90.77 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.97 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -175.35 -159.44 21.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.364 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 41' ' ' ALA . 99.6 t -150.53 137.56 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.94 0.4 . . . . 0.0 111.17 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.8 163.75 30.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.348 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.629 ' HA ' HG12 ' A' ' 40' ' ' VAL . 58.3 t -70.68 123.85 25.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.994 0.426 . . . . 0.0 111.262 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.99 -29.76 19.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.636 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -172.16 160.07 5.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.256 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.613 HG23 ' O ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -126.67 138.41 54.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.839 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -64.16 154.67 81.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.284 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.614 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 65.4 Cg_endo -73.71 102.4 1.5 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.684 2.256 . . . . 0.0 112.433 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 84.58 -6.51 0.99 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.686 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.84 175.87 6.08 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.518 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -46.68 -45.8 19.23 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.71 2.273 . . . . 0.0 112.536 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.425 ' HA2' HD21 ' A' ' 65' ' ' LEU . . . -57.08 -41.1 92.39 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.433 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.24 -32.72 64.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.035 0.445 . . . . 0.0 110.032 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.75 -32.13 69.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.515 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.25 -57.55 5.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.16 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.97 38.37 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.895 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.877 HD22 HG11 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -110.85 127.02 55.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.74 0.305 . . . . 0.0 110.825 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -96.76 162.06 24.44 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.565 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 9.2 Cg_endo -52.32 154.49 11.15 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.743 2.295 . . . . 0.0 112.208 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.472 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 8.0 m-85 90.29 -22.25 0.11 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.368 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.767 ' HB2' HD13 ' A' ' 102' ' ' ILE . 10.3 p-10 -55.26 87.75 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.203 0.525 . . . . 0.0 110.453 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -66.74 119.99 12.75 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.734 -179.624 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.757 HD11 HG11 ' A' ' 40' ' ' VAL . 1.3 mt -68.79 110.74 4.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.303 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.801 HD13 ' CD2' ' A' ' 22' ' ' LEU . 3.4 mp -82.74 -58.01 3.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.179 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -129.98 134.29 47.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.965 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.805 HG23 ' OG1' ' A' ' 79' ' ' THR . 28.2 t -117.28 108.51 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.005 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.443 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 33.2 m120 64.24 36.27 9.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 50.0 m-70 86.35 -15.94 0.44 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.516 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.0 t -83.66 139.11 18.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.813 0.34 . . . . 0.0 111.013 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.87 122.82 20.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.631 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.805 ' OG1' HG23 ' A' ' 74' ' ' VAL . 28.0 p -143.08 28.22 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.95 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.594 ' HG3' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -72.29 -53.01 13.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.425 179.704 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -94.9 25.96 3.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.069 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.692 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.4 m-30 -80.85 171.4 15.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.778 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 87' ' ' VAL . 1.2 m-20 -108.01 159.94 16.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.479 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.878 ' O ' HG23 ' A' ' 88' ' ' VAL . 23.8 p -51.51 -42.11 61.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.88 0.371 . . . . 0.0 110.543 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.07 -21.73 66.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.191 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.603 ' O ' HD12 ' A' ' 90' ' ' LEU . 8.0 mp -95.31 -31.31 13.51 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.935 0.397 . . . . 0.0 110.819 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.656 HG11 ' CD1' ' A' ' 71' ' ' LEU . 48.1 t -79.37 -35.72 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.221 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 84' ' ' CYS . 88.8 t -58.18 -50.71 86.59 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.835 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 13.0 Cg_exo -69.62 -44.43 2.18 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.472 2.115 . . . . 0.0 111.626 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.692 HD11 ' HE2' ' A' ' 82' ' ' PHE . 15.5 mt -54.99 -33.32 62.46 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.694 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.9 HG23 ' CD1' ' A' ' 98' ' ' LEU . 80.4 mt -75.32 -45.87 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.629 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.66 -3.76 36.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.928 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -101.19 -12.12 18.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.659 0.266 . . . . 0.0 111.686 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.8 m -64.76 -15.67 61.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.502 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.97 -143.69 17.21 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.571 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -73.73 -7.52 52.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.547 0.213 . . . . 0.0 111.4 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.7 mtpt -137.49 151.73 48.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.612 0.244 . . . . 0.0 110.592 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.9 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -137.73 97.49 3.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.772 0.32 . . . . 0.0 111.382 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.7 118.17 31.3 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.74 HD23 HD22 ' A' ' 98' ' ' LEU . 1.4 pp -145.16 157.43 44.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.132 0.492 . . . . 0.0 112.079 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.776 HG12 HD22 ' A' ' 22' ' ' LEU . 16.7 t -110.53 109.25 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.919 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.767 HD13 ' HB2' ' A' ' 69' ' ' ASP . 2.6 pp -105.9 169.21 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.074 0.464 . . . . 0.0 111.641 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.791 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -131.84 114.51 14.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.488 179.589 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.422 ' HB3' ' HA ' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -140.82 131.99 26.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.923 0.392 . . . . 0.0 111.642 -179.561 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.408 ' N ' HG12 ' A' ' 20' ' ' VAL . 1.1 m120 -65.65 119.86 63.74 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.595 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--O 1.25 1.078 0 C-N-CA 122.339 2.026 . . . . 0.0 112.376 -179.935 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.928 0.394 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -111.08 122.36 47.68 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.578 HD13 ' CG1' ' A' ' 101' ' ' VAL . 4.4 pp -106.83 153.3 22.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.26 0.552 . . . . 0.0 112.37 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.677 ' NE2' HD11 ' A' ' 102' ' ' ILE . 28.7 p80 -149.28 143.46 25.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.561 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.51 112.26 14.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.486 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.803 HG11 ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -107.21 153.46 8.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.57 -179.462 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.857 HG23 ' OD1' ' A' ' 99' ' ' ASP . 98.4 m -134.09 122.1 22.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.824 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.705 HD21 ' CD1' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -108.2 175.16 5.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.293 0.568 . . . . 0.0 111.986 -178.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.465 ' CD1' ' HG2' ' A' ' 97' ' ' LYS . 27.7 m-85 -139.3 124.63 19.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.911 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.42 ' HG3' ' CE2' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -94.84 147.81 22.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.073 0.463 . . . . 0.0 111.431 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -123.41 153.82 39.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.682 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 p -64.64 -24.49 67.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.26 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.62 -0.22 55.43 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.156 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.94 130.42 35.07 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.824 0.345 . . . . 0.0 111.043 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -80.35 -10.74 59.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.16 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -155.93 -164.78 1.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.412 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.586 ' O ' HD22 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -106.01 25.59 10.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 111.482 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.606 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 91.48 -1.17 75.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.74 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.575 ' CD1' HG22 ' A' ' 51' ' ' VAL . 7.9 p90 -172.24 147.76 2.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.334 0.567 . . . . 0.0 111.895 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 p -108.89 137.71 46.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.242 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.749 ' HB ' HG12 ' A' ' 49' ' ' VAL . 22.6 m -99.23 161.12 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.519 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.772 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -125.19 171.11 10.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.153 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -82.01 136.01 35.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.968 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.26 103.43 2.07 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.337 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -94.31 -28.81 15.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.093 0.473 . . . . 0.0 111.287 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 45' ' ' LEU . 15.0 mt -83.85 -5.63 59.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.375 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 47' ' ' LYS . 11.9 mt-10 -153.07 28.1 0.52 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.941 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.4 OUTLIER 27.38 91.2 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.107 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.92 -153.16 21.73 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.582 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.772 HG13 ' O ' ' A' ' 41' ' ' ALA . 16.6 t -145.97 139.0 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.72 0.295 . . . . 0.0 110.931 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -136.93 156.19 48.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.118 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.575 HG22 ' CD1' ' A' ' 38' ' ' PHE . 87.6 t -67.63 117.94 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.536 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.4 ' HG2' ' ND2' ' A' ' 53' ' ' ASN . 4.4 tttt -87.39 -30.77 20.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.042 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.4 ' ND2' ' HG2' ' A' ' 52' ' ' LYS . 71.2 m-80 -157.39 147.51 20.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.524 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 37' ' ' GLY . 1.3 mt -125.1 125.35 69.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.955 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.6 ttt85 -65.33 111.62 6.5 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.05 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.589 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 32.4 Cg_exo -58.34 123.48 13.71 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.476 2.117 . . . . 0.0 112.19 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 81.34 83.35 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.097 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 167.78 -152.54 21.02 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.531 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.55 ' C ' HD23 ' A' ' 27' ' ' LEU . 32.2 Cg_exo -59.61 -36.78 91.56 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.646 2.231 . . . . 0.0 112.2 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.09 -47.81 43.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.722 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.57 -32.95 64.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.056 0.455 . . . . 0.0 110.515 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.4 mt -71.26 -30.87 66.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.993 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.86 -38.66 15.38 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.663 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.44 29.24 6.38 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.803 ' HG ' HG11 ' A' ' 25' ' ' VAL . 1.2 mp -78.27 131.88 37.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.893 0.378 . . . . 0.0 110.784 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -98.4 165.05 15.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.841 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 28.1 Cg_endo -62.68 138.96 72.67 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.411 2.074 . . . . 0.0 112.115 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER 82.96 11.1 0.53 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.347 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.578 ' OD1' HD13 ' A' ' 102' ' ' ILE . 5.6 m-20 -53.74 88.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.931 0.396 . . . . 0.0 111.162 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.449 ' HB3' ' O ' ' A' ' 103' ' ' SER . 5.5 ttt85 -73.0 94.34 1.86 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.372 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.919 HD12 ' CG1' ' A' ' 87' ' ' VAL . 11.3 mt -50.86 107.51 0.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.998 0.428 . . . . 0.0 111.175 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.749 HD11 ' HB2' ' A' ' 103' ' ' SER . 16.0 mt -82.62 -65.33 1.02 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.946 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -133.79 138.86 45.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.49 ' O ' HG12 ' A' ' 77' ' ' VAL . 16.5 t -109.69 106.81 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.931 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 75.37 -59.37 0.54 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.078 0.466 . . . . 0.0 110.613 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.401 ' H ' ' H ' ' A' ' 77' ' ' VAL . 0.2 OUTLIER -167.29 -11.22 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.414 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 74' ' ' VAL . 12.9 p -85.41 125.3 40.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.712 0.292 . . . . 0.0 111.242 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 -69.55 123.8 22.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.424 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.639 HG21 HD13 ' A' ' 90' ' ' LEU . 14.2 p -143.17 32.75 1.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.91 0.386 . . . . 0.0 111.21 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.434 ' HG3' ' CA ' ' A' ' 72' ' ' LEU . 37.0 mtp180 -66.01 -52.49 48.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.636 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.24 30.35 1.95 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.112 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.699 ' HE2' HD11 ' A' ' 90' ' ' LEU . 1.6 m-30 -80.9 174.25 11.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.41 . . . . 0.0 110.742 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.09 158.47 17.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.439 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.848 ' O ' HG23 ' A' ' 88' ' ' VAL . 22.6 p -51.35 -41.66 60.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.914 0.388 . . . . 0.0 110.815 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.56 -22.47 66.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.131 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.55 ' O ' HD12 ' A' ' 90' ' ' LEU . 8.9 mp -93.02 -33.44 14.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.165 0.507 . . . . 0.0 110.875 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.919 ' CG1' HD12 ' A' ' 71' ' ' LEU . 59.7 t -77.18 -36.02 23.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.165 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 84' ' ' CYS . 78.5 t -55.45 -52.25 73.27 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.819 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 54.4 Cg_endo -69.19 -43.22 3.28 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.281 1.987 . . . . 0.0 111.904 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.699 HD11 ' HE2' ' A' ' 82' ' ' PHE . 15.9 mt -54.6 -31.61 57.3 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.967 0.413 . . . . 0.0 110.787 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.938 HG23 ' CD1' ' A' ' 98' ' ' LEU . 70.3 mt -78.8 -47.45 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.854 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.5 -3.96 30.9 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.08 -4.2 16.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.606 0.241 . . . . 0.0 111.593 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.6 p -64.08 -18.2 64.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.907 0.384 . . . . 0.0 111.133 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.85 -144.81 17.55 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.415 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -73.91 -8.24 55.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.615 0.245 . . . . 0.0 111.466 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.465 ' HG2' ' CD1' ' A' ' 28' ' ' TYR . 10.4 mtpt -144.33 147.57 33.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.678 0.275 . . . . 0.0 111.034 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.938 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -124.77 97.58 5.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 0.0 111.078 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.857 ' OD1' HG23 ' A' ' 26' ' ' THR . 6.0 m-20 -95.04 118.78 32.43 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.838 HD22 HD22 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -150.2 169.36 21.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.251 0.548 . . . . 0.0 112.333 -178.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.635 HG12 HD12 ' A' ' 72' ' ' LEU . 25.0 t -118.44 109.35 26.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.549 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.677 HD11 ' NE2' ' A' ' 23' ' ' HIS . 2.2 pp -102.58 154.56 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.429 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.749 ' HB2' HD11 ' A' ' 72' ' ' LEU . 3.4 t -130.15 125.72 35.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.452 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.42 126.23 10.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.005 0.431 . . . . 0.0 111.791 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.39 140.05 78.97 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.459 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo . . . . . 0 C--O 1.249 1.028 0 C-N-CA 122.323 2.015 . . . . 0.0 112.302 -179.902 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.447 HG12 ' OD1' ' A' ' 105' ' ' ASN . 27.5 m . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.808 0.337 . . . . 0.0 111.462 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.39 122.55 47.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.629 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.793 HD22 HG12 ' A' ' 101' ' ' VAL . 14.1 mt -62.44 144.3 56.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.304 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.537 ' HB2' HD11 ' A' ' 102' ' ' ILE . 80.5 m-70 -152.41 110.59 3.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.806 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -72.99 106.26 4.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.112 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.594 HG11 ' CD2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -109.7 141.02 26.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.04 0.448 . . . . 0.0 111.57 -179.263 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.9 m -132.64 106.75 7.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.144 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.58 HD21 HD21 ' A' ' 65' ' ' LEU . 1.5 mp -101.06 177.6 4.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.046 0.45 . . . . 0.0 111.613 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.442 ' CD2' ' HG2' ' A' ' 97' ' ' LYS . 11.7 m-85 -138.89 133.51 32.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.437 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -94.84 161.88 13.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.971 0.415 . . . . 0.0 111.173 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -124.4 130.9 53.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.802 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 61.3 p -60.04 84.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.4 -13.49 1.4 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.893 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.94 174.64 11.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.769 0.319 . . . . 0.0 110.923 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.82 -10.73 13.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.48 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -155.66 -176.58 6.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.977 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.51 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -98.15 31.99 2.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.008 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.85 15.66 79.54 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.973 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.65 ' CD2' HD11 ' A' ' 65' ' ' LEU . 4.1 p90 -173.47 119.22 0.3 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 110.962 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -93.62 149.66 21.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.824 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.686 ' HB ' HG12 ' A' ' 49' ' ' VAL . 23.7 m -108.33 167.94 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.244 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.813 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -127.08 171.32 11.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.096 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -88.14 137.31 32.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.098 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.86 114.58 4.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.403 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tp -94.38 -31.05 14.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.068 0.461 . . . . 0.0 111.251 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.96 -54.88 4.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.892 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.7 mm-40 -90.55 17.99 6.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.473 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 29.83 89.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.1 -144.53 8.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.601 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.813 HG13 ' O ' ' A' ' 41' ' ' ALA . 38.8 t -146.7 140.74 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 0.0 111.021 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.1 159.99 40.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.608 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.792 HG11 HD11 ' A' ' 54' ' ' ILE . 59.8 t -62.97 123.63 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.982 0.42 . . . . 0.0 111.031 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.49 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 2.0 tptp -88.58 -35.38 16.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.98 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -162.55 143.59 10.14 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.273 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.792 HD11 HG11 ' A' ' 51' ' ' VAL . 1.2 mt -129.57 133.92 64.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.979 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.44 137.56 96.65 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.687 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.585 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 72.8 Cg_endo -75.03 107.59 2.52 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.498 2.132 . . . . 0.0 112.495 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 83.54 28.95 0.08 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.268 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -114.5 -161.64 13.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.305 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -50.65 -53.55 6.95 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.493 2.129 . . . . 0.0 112.199 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.01 -38.38 89.0 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.476 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.3 -32.81 64.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.05 0.452 . . . . 0.0 110.273 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.6 -30.8 67.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.687 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.99 -53.4 6.27 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.28 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.45 35.13 0.88 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.787 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.65 HD11 ' CD2' ' A' ' 38' ' ' PHE . 0.3 OUTLIER -113.64 141.87 46.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.843 0.354 . . . . 0.0 110.958 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -121.93 163.04 33.83 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.684 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.551 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 1.4 Cg_endo -44.51 144.28 3.31 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.824 2.35 . . . . 0.0 112.3 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.551 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 93.8 m-85 85.3 -7.82 0.86 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.41 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.708 ' CG ' HD13 ' A' ' 102' ' ' ILE . 5.4 m-20 -54.41 86.65 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.151 0.5 . . . . 0.0 110.591 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.613 ' O ' HD12 ' A' ' 72' ' ' LEU . 22.2 ttm180 -66.82 109.15 2.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.292 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.562 ' CD2' HD22 ' A' ' 100' ' ' LEU . 1.8 mp -66.61 107.92 2.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.796 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.719 HD11 ' HB3' ' A' ' 103' ' ' SER . 5.2 mp -83.75 -37.51 22.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.509 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.81 145.58 18.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.868 0.366 . . . . 0.0 111.087 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.812 HG12 ' OD1' ' A' ' 75' ' ' ASN . 21.5 t -115.11 109.75 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.791 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.812 ' OD1' HG12 ' A' ' 74' ' ' VAL . 1.0 OUTLIER 75.46 -57.46 0.59 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.072 0.463 . . . . 0.0 110.695 -179.699 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -167.19 -14.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.263 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.5 t -85.62 128.47 39.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-O 120.797 0.332 . . . . 0.0 111.098 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -69.31 127.07 31.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.515 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.784 HG21 HD13 ' A' ' 90' ' ' LEU . 16.8 p -142.69 32.44 1.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.031 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.444 ' CG ' ' HG ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -67.95 -48.39 66.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.303 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.15 24.21 4.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.077 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.613 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.1 m-30 -81.13 173.87 12.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.802 0.334 . . . . 0.0 110.823 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.32 159.59 16.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.327 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.853 ' O ' HG23 ' A' ' 88' ' ' VAL . 19.6 t -51.48 -42.1 61.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.824 0.345 . . . . 0.0 110.713 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.6 t -62.61 -21.64 65.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.18 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 90' ' ' LEU . 8.3 mp -95.64 -32.57 12.72 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.023 0.44 . . . . 0.0 110.978 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.619 HG12 HD11 ' A' ' 91' ' ' ILE . 50.9 t -78.29 -35.7 19.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.331 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 84' ' ' CYS . 91.9 t -58.27 -51.27 82.99 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.833 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.645 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.3 Cg_exo -67.55 -44.86 3.99 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.349 2.033 . . . . 0.0 111.47 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.784 HD13 HG21 ' A' ' 79' ' ' THR . 18.1 mt -54.74 -29.38 53.51 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.697 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.95 HG23 ' CD1' ' A' ' 98' ' ' LEU . 50.1 mt -78.08 -48.43 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.796 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.37 -4.32 32.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.97 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -99.3 -12.94 19.89 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.716 0.293 . . . . 0.0 111.576 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -15.97 62.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.383 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.03 -144.11 17.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.649 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -73.72 -7.1 50.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.442 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -138.58 141.67 39.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.772 0.32 . . . . 0.0 110.657 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.95 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -130.6 97.33 4.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.263 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -98.47 118.11 34.41 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.935 HD23 HD22 ' A' ' 98' ' ' LEU . 1.6 pp -145.91 163.2 35.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.12 0.486 . . . . 0.0 111.849 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.793 HG12 HD22 ' A' ' 22' ' ' LEU . 25.5 t -113.51 109.11 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.168 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.708 HD13 ' CG ' ' A' ' 69' ' ' ASP . 2.6 pp -103.75 168.95 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.088 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.719 ' HB3' HD11 ' A' ' 72' ' ' LEU . 54.2 p -142.39 120.24 11.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.716 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.5 ptt85 -128.34 130.32 47.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.176 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . 0.447 ' OD1' HG12 ' A' ' 20' ' ' VAL . 14.8 m120 -65.85 157.42 79.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.852 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo . . . . . 0 C--O 1.249 1.054 0 C-N-CA 122.54 2.16 . . . . 0.0 112.224 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.424 HG23 ' OG ' ' A' ' 103' ' ' SER . 30.2 m . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.814 0.34 . . . . 0.0 111.476 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -125.55 122.69 37.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.675 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 1.081 HD21 HD12 ' A' ' 72' ' ' LEU . 15.1 mt -61.19 152.91 27.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.411 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.447 ' HB2' HD11 ' A' ' 102' ' ' ILE . 20.5 m-70 -157.15 109.9 2.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.024 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.545 ' CD ' HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -72.45 112.99 9.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.078 179.596 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.942 HG11 ' HG ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -121.92 143.4 34.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.142 0.496 . . . . 0.0 111.932 -178.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.1 m -134.0 106.4 7.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.811 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.538 HD11 HD11 ' A' ' 65' ' ' LEU . 4.4 mp -94.34 174.88 6.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.278 0.561 . . . . 0.0 112.04 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 96' ' ' ASN . 24.8 m-85 -137.4 121.63 18.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.222 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 6.1 tttm -112.04 152.98 27.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.958 0.408 . . . . 0.0 111.263 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.409 ' N ' ' HG2' ' A' ' 29' ' ' LYS . 19.6 t0 -102.52 138.86 38.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.867 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.0 m -51.35 -26.34 7.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.31 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.72 -38.15 21.06 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.615 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 9.2 mmm -81.76 158.14 24.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.91 0.386 . . . . 0.0 110.936 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.68 -30.89 8.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.114 0.483 . . . . 0.0 110.92 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.99 172.03 11.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.713 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.476 ' CD2' HG22 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -119.14 32.07 6.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.802 0.335 . . . . 0.0 111.105 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.401 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 77.1 6.59 86.24 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.283 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.481 ' HD2' HG13 ' A' ' 51' ' ' VAL . 14.1 p90 -172.5 123.15 0.46 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.159 0.479 . . . . 0.0 111.393 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -95.1 145.81 24.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.536 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.668 HG11 HD11 ' A' ' 71' ' ' LEU . 33.5 m -110.49 159.67 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.281 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.796 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -116.97 178.06 4.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -90.7 161.22 15.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.128 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.5 128.63 8.28 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.239 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.44 -58.07 2.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.289 0.566 . . . . 0.0 111.398 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.58 -43.51 15.59 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.61 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 47' ' ' LYS . 2.1 mt-10 -87.7 9.77 20.42 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.749 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER 27.71 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.73 -152.8 19.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.468 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.796 HG13 ' O ' ' A' ' 41' ' ' ALA . 59.7 t -142.65 138.39 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.761 0.315 . . . . 0.0 111.052 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.13 167.91 20.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.52 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.512 HG11 HD11 ' A' ' 54' ' ' ILE . 47.2 t -71.64 122.04 23.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.979 0.419 . . . . 0.0 111.368 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -89.52 -32.68 17.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.785 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -164.79 153.89 12.9 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.187 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.512 HD11 HG11 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -130.95 133.62 62.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.15 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.87 127.02 92.82 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.627 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 32.3 Cg_exo -58.34 114.22 1.89 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.418 2.079 . . . . 0.0 112.44 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 86.64 -14.67 0.48 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.951 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.63 -176.6 2.25 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.371 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.71 -32.48 97.0 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.521 2.148 . . . . 0.0 111.998 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.516 ' HA2' HD21 ' A' ' 27' ' ' LEU . . . -64.51 -38.87 96.32 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.321 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.58 -32.68 64.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.987 0.422 . . . . 0.0 110.019 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.4 mt -75.2 -34.99 61.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.833 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.42 -57.78 7.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.42 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 125.59 42.62 0.31 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.752 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.942 ' HG ' HG11 ' A' ' 25' ' ' VAL . 0.9 OUTLIER -104.56 122.83 46.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.857 0.361 . . . . 0.0 110.918 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.84 162.04 20.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.772 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 6.9 Cg_endo -49.15 137.46 29.63 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.972 2.448 . . . . 0.0 112.156 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 46.6 m-85 85.32 -1.52 0.82 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.17 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.608 ' CG ' HD13 ' A' ' 102' ' ' ILE . 0.9 OUTLIER -53.08 88.23 0.0 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.943 0.401 . . . . 0.0 110.735 179.507 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.57 ' O ' HD23 ' A' ' 72' ' ' LEU . 44.3 ttp180 -76.8 102.12 6.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.035 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.745 HD23 HD13 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -56.17 115.33 2.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.838 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.081 HD12 HD21 ' A' ' 22' ' ' LEU . 2.8 mt -82.49 -64.44 1.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 0.0 111.135 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -133.12 109.59 9.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.369 . . . . 0.0 111.174 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.553 HG13 ' HB3' ' A' ' 100' ' ' LEU . 23.4 t -89.41 123.69 41.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.903 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 14.8 m-80 46.11 40.0 6.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.449 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.47 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 1.5 t-80 87.6 -21.92 0.16 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.823 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.0 t -82.37 129.52 37.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.721 0.296 . . . . 0.0 111.151 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -68.86 135.14 50.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.447 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 30.1 p -144.89 29.87 1.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.058 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.649 ' HG2' HD22 ' A' ' 72' ' ' LEU . 8.8 mtp-105 -72.83 -53.2 12.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.696 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.19 21.69 5.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.148 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.747 ' CE2' HD11 ' A' ' 90' ' ' LEU . 2.8 m-85 -81.27 169.44 17.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.872 0.367 . . . . 0.0 110.875 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -108.51 157.94 18.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.245 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.867 ' O ' HG23 ' A' ' 88' ' ' VAL . 8.0 p -51.39 -38.37 53.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.0 110.676 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -66.97 -21.45 65.96 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.222 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.63 HD23 ' CD2' ' A' ' 82' ' ' PHE . 1.0 OUTLIER -92.33 -32.31 15.03 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.003 0.43 . . . . 0.0 110.571 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.485 HG12 ' CD1' ' A' ' 91' ' ' ILE . 94.3 t -77.05 -35.68 23.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.982 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 84' ' ' CYS . 84.4 t -55.35 -52.64 69.9 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.817 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 49.3 Cg_endo -68.4 -43.22 4.48 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.205 1.937 . . . . 0.0 111.704 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.747 HD11 ' CE2' ' A' ' 82' ' ' PHE . 11.0 mt -53.97 -33.71 57.71 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.298 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.948 HG23 ' CD1' ' A' ' 98' ' ' LEU . 80.3 mt -78.92 -41.88 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.842 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.64 -5.55 38.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.36 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 4.5 pt-20 -98.38 -3.26 37.35 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.704 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.6 p -63.68 -31.03 72.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.232 0.539 . . . . 0.0 110.666 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.46 -48.9 1.88 Allowed Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.818 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 6.1 p30 -166.24 -39.48 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.744 0.307 . . . . 0.0 111.111 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -111.75 112.96 25.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.191 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.948 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -103.9 98.07 7.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.559 -179.111 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -95.94 118.5 32.69 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.745 HD13 HD23 ' A' ' 71' ' ' LEU . 1.4 pp -146.43 164.18 33.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.273 0.559 . . . . 0.0 111.978 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.892 HG12 HD22 ' A' ' 22' ' ' LEU . 26.0 t -119.22 109.36 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.147 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.733 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.5 pp -101.68 168.78 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.115 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.424 ' OG ' HG23 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -146.11 128.16 15.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.674 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.403 ' N ' ' HB ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -147.22 147.56 30.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.983 0.421 . . . . 0.0 111.329 -179.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -62.38 143.2 95.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.829 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo . . . . . 0 C--O 1.248 0.996 0 C-N-CA 122.514 2.142 . . . . 0.0 112.217 -179.958 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.7 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.983 0.42 . . . . 0.0 111.672 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.51 122.88 38.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.351 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.915 HD21 HD12 ' A' ' 72' ' ' LEU . 13.7 mt -60.53 147.0 42.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.584 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.468 ' HB2' HD11 ' A' ' 102' ' ' ILE . 15.1 m-70 -151.46 107.51 3.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.825 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.44 118.4 13.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.19 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.503 HG11 ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -126.25 141.58 45.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.076 0.465 . . . . 0.0 111.799 -179.223 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 95.9 m -134.38 106.64 7.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.778 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.929 HD11 HD11 ' A' ' 65' ' ' LEU . 17.1 mt -100.04 171.99 7.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.018 0.437 . . . . 0.0 111.774 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -123.52 137.25 54.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.34 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 1.5 tttt -95.24 162.91 13.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.033 0.444 . . . . 0.0 111.299 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -131.33 128.18 39.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.741 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.63 -27.16 6.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.248 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.08 26.93 20.6 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.504 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.87 140.09 13.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 110.892 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -96.57 -21.85 17.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.992 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -84.79 170.83 12.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.761 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -119.03 23.9 11.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.32 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 89.24 9.63 67.03 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.334 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.644 ' CD2' HD13 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -173.72 138.93 0.68 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.128 0.464 . . . . 0.0 111.627 179.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.8 m -99.35 154.69 18.0 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.596 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.639 ' HB ' HG12 ' A' ' 49' ' ' VAL . 35.0 m -116.34 159.23 16.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.42 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.825 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -117.98 178.31 4.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.047 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.09 144.8 26.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.194 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.2 115.45 5.05 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.242 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.29 -45.66 7.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.157 0.503 . . . . 0.0 111.343 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 45' ' ' LEU . 2.0 mm? -84.66 4.79 30.83 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.897 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.465 ' O ' ' C ' ' A' ' 47' ' ' LYS . 27.0 mt-10 -153.85 22.92 0.51 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.522 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 24.09 79.84 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -171.69 -157.4 13.51 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.365 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.825 HG13 ' O ' ' A' ' 41' ' ' ALA . 35.7 t -143.48 139.38 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.872 0.367 . . . . 0.0 111.15 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.81 168.57 19.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.359 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.513 HG22 ' CE2' ' A' ' 38' ' ' PHE . 72.2 t -74.21 121.54 25.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.793 0.33 . . . . 0.0 111.142 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -89.52 -31.55 17.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.29 -179.865 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -163.5 162.96 24.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.27 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -134.27 136.98 52.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.49 123.88 84.24 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.26 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.6 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 31.9 Cg_exo -58.5 105.99 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.525 2.15 . . . . 0.0 112.19 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 82.35 28.56 0.13 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.111 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.21 -173.39 24.23 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.276 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.444 ' C ' HD22 ' A' ' 27' ' ' LEU . 78.0 Cg_exo -49.87 -42.21 45.15 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.453 2.102 . . . . 0.0 112.171 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.583 ' HA2' HD21 ' A' ' 27' ' ' LEU . . . -64.23 -36.43 93.22 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.445 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.63 -32.96 64.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.062 0.458 . . . . 0.0 110.404 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.81 -34.43 75.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.992 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.05 -46.69 5.82 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.627 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.14 34.79 0.86 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.581 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.929 HD11 HD11 ' A' ' 27' ' ' LEU . 45.1 mt -75.81 133.49 40.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.738 0.304 . . . . 0.0 110.917 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -117.87 155.81 50.58 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.893 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.529 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 12.3 Cg_endo -55.69 146.42 65.77 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.621 2.214 . . . . 0.0 112.18 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.529 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 85.4 m-85 84.64 -5.39 0.99 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.384 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.531 ' CG ' HD13 ' A' ' 102' ' ' ILE . 7.0 m-20 -53.97 85.56 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.98 0.419 . . . . 0.0 110.774 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 68' ' ' TYR . 59.3 ttt180 -71.41 101.13 2.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.06 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.956 HD23 HD13 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -58.93 107.76 0.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.938 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.915 HD12 HD21 ' A' ' 22' ' ' LEU . 9.0 mt -82.39 -65.53 1.0 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.869 0.366 . . . . 0.0 110.881 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -119.56 127.5 53.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.892 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.9 104.68 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.101 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.468 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 1.2 m-20 64.71 36.94 7.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.725 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.468 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 2.8 t60 87.66 -14.68 0.42 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.503 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 79' ' ' THR . 21.4 t -83.63 114.06 23.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.8 0.333 . . . . 0.0 111.005 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -69.01 87.09 0.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.812 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 77' ' ' VAL . 15.8 p -95.95 32.08 1.98 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.115 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.73 ' HG2' HD22 ' A' ' 72' ' ' LEU . 36.2 mtp180 -66.28 -53.15 40.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.814 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -93.52 22.71 5.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.185 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.661 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.8 m-85 -82.01 167.94 18.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.951 0.405 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 87' ' ' VAL . 2.2 m-20 -106.99 160.87 15.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.383 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.873 ' O ' HG23 ' A' ' 88' ' ' VAL . 4.3 t -51.59 -41.35 61.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.666 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 10.0 p -62.56 -23.91 67.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.07 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.495 ' O ' HD12 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -94.12 -30.93 14.39 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.946 0.403 . . . . 0.0 110.972 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.517 HG12 ' CD1' ' A' ' 91' ' ' ILE . 41.3 t -78.89 -35.9 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.265 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 84' ' ' CYS . 91.6 t -57.76 -51.02 84.79 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.865 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . 0.65 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 14.3 Cg_exo -68.96 -46.19 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.425 2.083 . . . . 0.0 111.517 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.661 HD11 ' HE2' ' A' ' 82' ' ' PHE . 33.3 mt -54.91 -33.09 61.74 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.986 0.422 . . . . 0.0 110.546 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.856 HG23 ' CD1' ' A' ' 98' ' ' LEU . 62.6 mt -73.25 -46.76 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.477 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.57 -3.9 36.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.848 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.18 -7.23 22.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.656 0.265 . . . . 0.0 111.497 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.408 ' OG ' ' HG ' ' A' ' 98' ' ' LEU . 4.8 p -64.52 -16.59 62.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.355 . . . . 0.0 111.347 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.26 -144.0 16.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.217 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -74.38 -8.81 57.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.569 0.223 . . . . 0.0 111.452 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -142.1 141.84 32.75 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.784 0.326 . . . . 0.0 110.959 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.894 HD22 HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -119.56 97.12 5.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.242 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -92.0 118.37 30.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.956 HD13 HD23 ' A' ' 71' ' ' LEU . 1.6 pp -151.85 162.17 41.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.324 0.583 . . . . 0.0 112.093 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.854 HG12 HD22 ' A' ' 22' ' ' LEU . 39.1 t -121.49 109.02 23.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.946 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.879 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.4 pp -100.95 169.3 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.349 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.58 128.26 16.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.579 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.0 151.74 35.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.012 0.434 . . . . 0.0 111.478 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -62.68 115.1 14.6 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.971 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.249 1.054 0 C-N-CA 122.508 2.139 . . . . 0.0 112.267 -179.992 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.431 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 16' ' ' SER . 28.0 Cg_exo -62.21 -13.47 32.35 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.498 2.132 . . . . 0.0 112.667 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.521 ' HB ' ' HD3' ' A' ' 19' ' ' PRO . 0.3 OUTLIER -163.0 -55.98 0.01 OUTLIER Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 116.651 -0.249 . . . . 0.0 111.476 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.521 ' HD3' ' HB ' ' A' ' 18' ' ' THR . 87.5 Cg_exo -47.72 95.7 0.03 OUTLIER 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 122.326 2.017 . . . . 0.0 112.559 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.4 m -50.0 170.3 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.847 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -137.73 122.82 19.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.316 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.078 HD21 HD12 ' A' ' 72' ' ' LEU . 13.6 mt -60.03 137.5 58.07 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.102 0.477 . . . . 0.0 111.839 -179.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.754 ' HD2' HD11 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -149.34 122.04 8.64 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.173 179.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.67 ' HD2' HG22 ' A' ' 101' ' ' VAL . 0.8 OUTLIER -68.87 135.43 51.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.517 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.724 HG11 ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -137.37 143.05 35.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.143 0.496 . . . . 0.0 111.451 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.853 HG23 ' OD1' ' A' ' 99' ' ' ASP . 97.2 m -134.55 141.42 46.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.784 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.691 HD21 HD11 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -138.39 -179.63 5.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.08 0.467 . . . . 0.0 111.639 -179.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.439 ' CD2' ' HG2' ' A' ' 97' ' ' LYS . 9.8 m-85 -138.96 125.35 20.4 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.391 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -94.87 164.94 12.71 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.997 0.427 . . . . 0.0 111.231 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -116.37 141.13 48.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.657 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.3 p -60.11 84.99 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 138.33 -3.68 3.03 Favored Glycine 0 CA--C 1.519 0.296 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.217 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.6 151.34 29.12 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.864 0.364 . . . . 0.0 110.989 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -94.91 -10.53 30.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.388 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.83 175.87 13.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.68 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.861 ' CD2' HD12 ' A' ' 98' ' ' LEU . 0.6 OUTLIER -94.15 2.1 56.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.619 -179.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 116.33 18.23 5.89 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.382 -0.913 . . . . 0.0 113.25 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.69 ' HB3' HG23 ' A' ' 54' ' ' ILE . 39.4 p90 -174.04 134.45 0.45 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 117.035 0.418 . . . . 0.0 111.654 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.403 ' O ' ' N ' ' A' ' 52' ' ' LYS . 67.4 m -92.99 151.3 19.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.088 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.731 ' HB ' HG12 ' A' ' 49' ' ' VAL . 34.5 m -114.93 167.95 7.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.122 0.487 . . . . 0.0 111.837 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.506 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -133.85 140.69 47.03 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.782 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -70.13 121.75 18.11 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.817 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.422 ' HA3' ' CZ ' ' A' ' 50' ' ' TYR . . . -77.05 89.65 0.98 Allowed Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.8 pp -83.36 -2.47 55.82 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.54 ' H ' HD12 ' A' ' 45' ' ' LEU . 4.9 mp -77.17 -13.49 59.94 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.586 ' O ' ' CG ' ' A' ' 47' ' ' LYS . 0.6 OUTLIER -157.88 -83.78 0.05 OUTLIER 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.001 179.334 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.586 ' CG ' ' O ' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -175.68 134.22 0.29 Allowed 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.596 0.758 . . . . 0.0 110.233 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 128.62 -159.19 22.01 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.212 -0.994 . . . . 0.0 113.263 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.731 HG12 ' HB ' ' A' ' 40' ' ' VAL . 18.8 t -154.82 144.38 13.35 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.627 0.251 . . . . 0.0 110.852 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.422 ' CZ ' ' HA3' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -135.88 151.39 49.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.806 0.336 . . . . 0.0 111.028 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.623 HG22 ' CE1' ' A' ' 38' ' ' PHE . 44.7 t -60.49 123.59 13.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.02 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 39' ' ' SER . 0.1 OUTLIER -88.19 -27.54 21.76 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.169 179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -169.68 140.34 2.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.738 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.69 HG23 ' HB3' ' A' ' 38' ' ' PHE . 2.7 mt -119.61 142.9 32.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.002 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -65.37 111.7 6.71 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.732 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.604 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 50.0 Cg_exo -55.53 109.17 0.38 Allowed 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.464 2.109 . . . . 0.0 112.485 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 83.38 38.14 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.367 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -123.9 -170.41 13.32 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.171 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.415 ' HB2' ' O ' ' A' ' 36' ' ' PHE . 72.2 Cg_exo -49.77 -43.62 39.73 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.35 2.033 . . . . 0.0 111.817 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.46 ' HA2' HD12 ' A' ' 65' ' ' LEU . . . -64.85 -38.5 95.63 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.428 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -73.59 -32.84 64.32 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.007 0.432 . . . . 0.0 110.196 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 75.3 mt -73.01 -31.84 64.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.682 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.86 -40.92 34.98 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.362 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 123.34 8.4 6.49 Favored Glycine 0 CA--C 1.518 0.264 0 C-N-CA 120.644 -0.789 . . . . 0.0 113.031 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.724 ' HG ' HG11 ' A' ' 25' ' ' VAL . 1.2 mt -63.4 115.96 5.09 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.911 0.386 . . . . 0.0 110.988 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.2 tttm -107.33 141.56 23.23 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.512 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.598 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 4.1 Cg_exo -39.47 135.75 1.16 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.202 2.601 . . . . 0.0 112.727 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.598 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 78.2 m-85 85.44 -5.31 0.87 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.542 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.817 ' CB ' HD13 ' A' ' 102' ' ' ILE . 9.1 p-10 -56.22 85.1 0.01 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.062 0.458 . . . . 0.0 110.885 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.563 ' O ' HD23 ' A' ' 72' ' ' LEU . 42.4 ttt180 -66.66 102.61 0.94 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.476 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.92 HD22 HD22 ' A' ' 100' ' ' LEU . 3.2 mt -54.5 107.28 0.27 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.721 -179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.078 HD12 HD21 ' A' ' 22' ' ' LEU . 5.5 mt -82.98 -63.48 1.35 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.376 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -121.23 118.24 29.1 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.07 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.647 HG23 ' OG1' ' A' ' 79' ' ' THR . 27.1 t -100.55 120.21 49.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.249 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.442 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 0.4 OUTLIER 46.36 43.11 11.4 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.671 179.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.442 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.1 OUTLIER 86.59 -19.37 0.28 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.752 179.534 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -81.85 120.69 33.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.875 0.369 . . . . 0.0 111.087 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.6 mmt180 -70.13 85.94 0.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.944 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.671 HG21 HD13 ' A' ' 90' ' ' LEU . 27.9 p -96.51 30.93 2.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.138 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.664 ' HG2' HD22 ' A' ' 72' ' ' LEU . 4.6 mtp180 -68.4 -45.73 71.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.008 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -92.0 18.28 8.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.311 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.609 ' HE2' HD11 ' A' ' 90' ' ' LEU . 3.5 m-30 -82.16 171.81 13.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.883 0.373 . . . . 0.0 110.931 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.806 ' OD1' HD13 ' A' ' 86' ' ' LEU . 0.4 OUTLIER -114.07 166.87 11.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.33 179.357 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.809 ' O ' HG23 ' A' ' 88' ' ' VAL . 9.5 p -51.52 -44.62 62.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.256 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 26.2 p -61.13 -20.12 62.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.52 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.806 HD13 ' OD1' ' A' ' 83' ' ' ASP . 7.5 mp -99.45 -33.37 10.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.868 0.366 . . . . 0.0 111.165 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 83' ' ' ASP . 44.9 t -77.5 -35.9 22.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.963 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.809 HG23 ' O ' ' A' ' 84' ' ' CYS . 99.0 t -57.65 -52.36 74.9 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.677 -0.238 . . . . 0.0 110.735 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 45.7 Cg_endo -67.56 -44.8 4.04 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.149 1.899 . . . . 0.0 111.8 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.671 HD13 HG21 ' A' ' 79' ' ' THR . 13.1 mt -54.94 -31.64 60.58 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 121.045 0.45 . . . . 0.0 110.391 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.612 ' HA ' HD11 ' A' ' 98' ' ' LEU . 60.3 mt -72.57 -51.4 28.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.161 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.84 -3.06 42.7 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.976 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -102.97 -5.99 22.86 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.422 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 3.3 t -64.82 -14.73 60.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.741 0.305 . . . . 0.0 111.461 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.11 -142.97 16.34 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.663 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.7 p30 -74.65 -5.53 43.57 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.439 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 42.1 mtpt -146.23 151.3 37.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.874 0.369 . . . . 0.0 111.141 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.861 HD12 ' CD2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -129.67 97.86 4.65 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.285 179.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.853 ' OD1' HG23 ' A' ' 26' ' ' THR . 6.1 m-20 -99.21 117.9 34.71 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.92 HD22 HD22 ' A' ' 71' ' ' LEU . 2.3 pp -150.21 162.89 39.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.262 0.553 . . . . 0.0 112.253 -178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.916 HG12 HD22 ' A' ' 22' ' ' LEU . 15.1 t -114.1 109.53 28.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.895 179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.848 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.6 pp -105.45 169.26 2.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.345 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 83.7 p -133.42 121.68 22.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.766 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.419 ' HB3' ' HA ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -136.44 147.68 47.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.171 -179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -74.57 122.67 88.04 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.779 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo . . . . . 0 C--O 1.25 1.11 0 C-N-CA 122.333 2.022 . . . . 0.0 112.385 -179.912 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.456 ' N ' ' HD2' ' A' ' 17' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.682 0 N-CA-C 111.492 0.182 . . . . 0.0 111.492 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 16' ' ' SER . 23.6 Cg_endo -61.79 -179.32 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.283 1.989 . . . . 0.0 112.128 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.522 ' CG2' ' HD2' ' A' ' 19' ' ' PRO . 24.8 m 59.03 146.06 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.156 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.522 ' HD2' ' CG2' ' A' ' 18' ' ' THR . 71.9 Cg_exo -50.72 178.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.597 2.198 . . . . 0.0 112.638 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.419 ' CG2' ' HB2' ' A' ' 103' ' ' SER . 28.9 m -46.07 170.11 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.711 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -132.51 122.81 25.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.479 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.949 HD21 ' CD1' ' A' ' 72' ' ' LEU . 13.5 mt -60.01 148.67 34.63 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.033 0.444 . . . . 0.0 111.651 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.5 122.87 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.221 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.1 tttm -71.51 119.24 15.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.509 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.598 HG11 ' HB3' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -117.5 148.17 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.134 0.493 . . . . 0.0 111.493 -179.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.3 m -134.59 106.89 7.21 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.848 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.099 HD11 HD21 ' A' ' 65' ' ' LEU . 13.8 mt -101.08 173.66 6.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.24 0.543 . . . . 0.0 112.017 -178.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.443 ' CZ ' ' HD3' ' A' ' 97' ' ' LYS . 6.3 m-85 -132.53 166.15 22.74 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.329 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -134.08 161.02 36.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.98 0.419 . . . . 0.0 111.29 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -129.44 148.02 51.31 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.657 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.4 m -58.05 -25.21 60.92 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.149 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.77 -14.71 51.93 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.854 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 5.3 mmt -81.29 145.0 31.12 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.911 0.386 . . . . 0.0 111.013 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 63.4 tt0 -91.73 -10.15 41.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.24 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -154.13 -167.52 2.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.607 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.526 ' CE2' ' HB2' ' A' ' 98' ' ' LEU . 1.1 m-85 -95.89 24.4 5.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.723 0.297 . . . . 0.0 111.564 -179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.631 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 80.6 16.81 74.76 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.683 -0.77 . . . . 0.0 113.568 179.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.507 ' CE2' HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -172.05 124.42 0.53 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.192 0.52 . . . . 0.0 111.696 179.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.4 m -89.51 154.04 20.32 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.807 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.678 ' HB ' HG12 ' A' ' 49' ' ' VAL . 30.8 m -106.39 165.47 4.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.554 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.782 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -124.25 178.15 5.49 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.144 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -103.81 139.08 39.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.077 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -108.07 118.51 5.44 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.33 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.53 -28.5 15.4 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.927 0.394 . . . . 0.0 111.263 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.8 tp -84.7 -7.68 59.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.856 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.456 ' O ' ' C ' ' A' ' 47' ' ' LYS . 8.9 mm-40 -150.12 25.44 0.81 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.674 -0.239 . . . . 0.0 111.13 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.456 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.3 OUTLIER 26.26 63.08 0.08 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 121.012 0.434 . . . . 0.0 112.082 179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -149.24 -164.55 11.69 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.499 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.782 HG13 ' O ' ' A' ' 41' ' ' ALA . 19.1 t -132.39 132.51 60.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.638 0.256 . . . . 0.0 111.087 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.461 ' CE1' ' NH1' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -133.41 145.86 50.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.289 179.901 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.507 HG22 ' CE2' ' A' ' 38' ' ' PHE . 58.6 t -49.06 124.3 2.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.057 0.456 . . . . 0.0 111.512 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.714 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 5.9 tptt -88.29 -30.6 19.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.002 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -175.88 160.92 2.42 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.386 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.631 HG23 ' O ' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -128.04 142.7 43.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.978 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -65.26 147.6 98.48 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.592 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 58.6 Cg_endo -71.78 100.08 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.526 2.151 . . . . 0.0 112.391 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 83.1 29.35 0.09 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.16 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -98.03 -179.52 32.95 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.401 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -53.83 -29.52 53.2 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.588 2.192 . . . . 0.0 112.146 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.656 ' HA2' HD22 ' A' ' 27' ' ' LEU . . . -64.19 -47.3 86.4 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.201 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.25 -32.84 67.04 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.12 0.486 . . . . 0.0 109.951 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.3 mt -73.47 -29.14 62.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.358 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.444 ' HA3' HD23 ' A' ' 27' ' ' LEU . . . -71.46 -48.49 29.77 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.178 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 127.88 10.49 3.51 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.555 -0.831 . . . . 0.0 113.446 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.099 HD21 HD11 ' A' ' 27' ' ' LEU . 1.3 pp -111.44 152.16 27.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 117.098 0.449 . . . . 0.0 110.93 179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.428 ' CB ' ' CD ' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -138.51 179.11 1.4 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.673 -179.596 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.477 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 74.8 Cg_exo -49.73 144.9 18.95 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.362 2.041 . . . . 0.0 112.353 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.495 ' O ' ' N ' ' A' ' 70' ' ' ARG . 11.6 m-85 90.32 -17.21 0.2 Allowed 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.433 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.653 ' CG ' HD13 ' A' ' 102' ' ' ILE . 1.6 m-20 -53.34 83.75 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.007 0.432 . . . . 0.0 110.847 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.569 ' HD2' HD21 ' A' ' 72' ' ' LEU . 24.6 ttm-85 -67.92 99.61 0.86 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.987 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.031 HD23 HD13 ' A' ' 100' ' ' LEU . 1.0 OUTLIER -64.31 107.98 1.48 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.02 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.949 ' CD1' HD21 ' A' ' 22' ' ' LEU . 6.5 mt -83.51 -56.31 3.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.467 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -137.06 116.68 12.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.784 0.326 . . . . 0.0 111.516 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.59 HG23 ' OG1' ' A' ' 79' ' ' THR . 22.5 t -89.14 109.04 19.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.535 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 75.54 -59.11 0.54 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.18 0.514 . . . . 0.0 110.517 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -167.47 -14.71 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.221 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.2 t -84.81 129.24 38.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 120.775 0.321 . . . . 0.0 111.172 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.73 87.23 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.895 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.59 ' OG1' HG23 ' A' ' 74' ' ' VAL . 20.4 p -96.41 26.48 4.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.288 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.761 ' CG ' HD22 ' A' ' 72' ' ' LEU . 2.3 tmm_? -74.93 -46.37 36.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.797 0.332 . . . . 0.0 110.698 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -92.49 19.45 7.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.142 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.627 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.9 m-85 -82.01 171.14 14.74 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.959 0.409 . . . . 0.0 110.95 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.481 ' O ' HG23 ' A' ' 87' ' ' VAL . 7.0 t70 -105.27 158.74 16.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.378 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.898 ' O ' HG23 ' A' ' 88' ' ' VAL . 23.7 m -51.34 -41.32 60.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.88 0.372 . . . . 0.0 110.724 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 17.3 t -65.24 -21.63 66.77 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.274 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.729 ' O ' HD12 ' A' ' 90' ' ' LEU . 10.1 mp -94.56 -30.06 14.57 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.016 0.436 . . . . 0.0 110.739 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.61 HG12 ' CD1' ' A' ' 91' ' ' ILE . 48.7 t -78.59 -35.79 19.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.254 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 84' ' ' CYS . 58.1 t -58.92 -50.99 85.03 Favored Pre-proline 0 C--N 1.331 -0.209 0 C-N-CA 120.87 -0.332 . . . . 0.0 110.87 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.652 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.8 Cg_exo -67.3 -48.04 1.92 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.445 2.097 . . . . 0.0 111.465 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.729 HD12 ' O ' ' A' ' 86' ' ' LEU . 11.0 mt -54.93 -29.96 57.48 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.886 0.374 . . . . 0.0 110.511 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.803 ' HA ' HD11 ' A' ' 98' ' ' LEU . 48.3 mt -74.19 -46.53 44.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.343 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.81 -3.79 52.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.966 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -94.87 -15.77 23.42 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.445 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 1.4 t -65.15 -16.04 63.07 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.382 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.08 -141.41 15.6 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.696 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -73.99 -20.38 60.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.683 0.277 . . . . 0.0 111.441 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.443 ' HD3' ' CZ ' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -127.73 152.38 47.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.674 -179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.982 HD22 HD23 ' A' ' 100' ' ' LEU . 0.3 OUTLIER -135.77 97.76 3.74 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.778 0.323 . . . . 0.0 111.575 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.97 118.06 30.41 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 178.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 1.031 HD13 HD23 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -146.6 162.99 37.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.157 0.503 . . . . 0.0 111.968 -178.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.881 HG12 HD22 ' A' ' 22' ' ' LEU . 24.5 t -112.91 109.17 27.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.272 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.653 HD13 ' CG ' ' A' ' 69' ' ' ASP . 2.4 pp -109.17 169.19 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.183 -179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.419 ' HB2' ' CG2' ' A' ' 20' ' ' VAL . 19.0 p -136.15 107.03 6.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.953 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.11 136.14 53.03 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -178.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.465 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 0.9 OUTLIER -93.54 131.37 32.59 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.128 178.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 105' ' ' ASN . 8.7 Cg_exo . . . . . 0 C--O 1.249 1.05 0 C-N-CA 122.24 1.96 . . . . 0.0 112.19 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.401 ' CB ' ' HD3' ' A' ' 17' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 120.543 0.211 . . . . 0.0 111.442 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.401 ' HD3' ' CB ' ' A' ' 16' ' ' SER . 69.6 Cg_exo -50.79 -32.19 35.95 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.405 2.07 . . . . 0.0 112.451 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.53 ' HB ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -169.14 -52.98 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.309 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.53 ' HD3' ' HB ' ' A' ' 18' ' ' THR . 51.1 Cg_exo -54.08 120.4 7.89 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.242 1.961 . . . . 0.0 112.344 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.431 HG21 ' HB3' ' A' ' 103' ' ' SER . 27.4 m -44.27 161.23 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.629 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -120.32 122.75 41.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.601 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.723 HD22 HG12 ' A' ' 101' ' ' VAL . 14.1 mt -61.86 141.92 57.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.291 -179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.483 ' HB2' HD11 ' A' ' 102' ' ' ILE . 9.9 m-70 -144.15 108.51 4.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.839 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.95 102.5 4.81 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.607 HG23 HD12 ' A' ' 100' ' ' LEU . 0.0 OUTLIER -110.39 138.44 38.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.107 0.479 . . . . 0.0 111.828 -179.011 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.2 m -131.98 106.39 8.01 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.732 179.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.686 HD21 HD11 ' A' ' 65' ' ' LEU . 19.6 mt -98.81 177.1 5.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.978 0.418 . . . . 0.0 111.662 -179.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -136.33 135.89 39.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.315 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -94.64 138.18 32.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.975 0.417 . . . . 0.0 111.097 -179.656 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.54 131.04 54.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.795 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -60.59 84.58 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.838 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.77 -17.25 1.09 Allowed Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.882 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.09 167.94 19.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.848 0.356 . . . . 0.0 110.836 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -107.39 -10.52 15.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.37 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -155.44 -169.33 3.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.875 0.369 . . . . 0.0 110.896 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 1.6 m-85 -103.97 17.74 23.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.493 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.34 14.76 59.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.229 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.808 ' HB3' HD13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -173.31 130.62 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.112 0.482 . . . . 0.0 111.127 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -102.82 160.35 14.68 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.065 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.539 HG11 HD13 ' A' ' 71' ' ' LEU . 26.8 m -115.69 158.86 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.178 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.463 ' HB2' ' HB2' ' A' ' 52' ' ' LYS . . . -123.58 167.3 14.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.157 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 37.2 p30 -73.13 153.26 40.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.661 179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 47' ' ' LYS . . . -109.23 96.87 1.01 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.564 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.403 ' O ' HD13 ' A' ' 44' ' ' LEU . 0.1 OUTLIER -94.23 -17.97 22.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.845 0.355 . . . . 0.0 111.302 179.881 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.691 HD12 ' HG2' ' A' ' 46' ' ' GLU . 0.4 OUTLIER -85.02 -28.88 25.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.439 -179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.691 ' HG2' HD12 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -155.92 51.79 0.55 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.603 -179.734 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.455 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 21.62 96.44 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.643 179.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 177.34 -170.88 43.58 Favored Glycine 0 CA--C 1.518 0.256 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.815 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 82' ' ' PHE . 93.7 t -133.08 131.58 58.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.678 0.275 . . . . 0.0 110.671 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.437 ' HB3' ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -138.59 157.11 46.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.876 0.37 . . . . 0.0 111.237 -179.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.443 ' CG2' ' CD2' ' A' ' 38' ' ' PHE . 43.6 t -65.19 114.92 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.959 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -92.14 -28.32 17.17 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.26 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -142.8 156.49 44.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.603 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.808 HD13 ' HB3' ' A' ' 38' ' ' PHE . 1.2 mm -138.54 109.31 5.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.588 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -64.88 121.8 75.74 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.02 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.93 165.16 2.06 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.46 2.107 . . . . 0.0 112.267 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 35.77 75.34 0.06 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.983 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.93 -171.09 35.87 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.151 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.452 ' O ' HD22 ' A' ' 27' ' ' LEU . 46.8 Cg_exo -55.72 -29.75 72.67 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.387 2.058 . . . . 0.0 112.05 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.605 ' HA2' HD12 ' A' ' 65' ' ' LEU . . . -76.82 -43.83 16.72 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.578 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -73.77 -32.92 64.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.042 0.448 . . . . 0.0 110.357 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 50.2 mt -75.27 -32.93 61.2 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.037 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.4 -46.85 7.78 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.566 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 114.92 25.56 3.86 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.668 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.686 HD11 HD21 ' A' ' 27' ' ' LEU . 3.6 mt -73.73 141.95 46.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.857 0.361 . . . . 0.0 110.798 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -114.65 156.17 45.15 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.92 66.67 0.56 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.63 2.22 . . . . 0.0 112.04 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.437 ' O ' ' HB3' ' A' ' 50' ' ' TYR . 0.7 OUTLIER -178.16 -24.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.572 -179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.675 ' CB ' HD13 ' A' ' 102' ' ' ILE . 4.4 m-20 -44.0 94.96 0.01 OUTLIER 'General case' 0 C--O 1.231 0.082 0 CA-C-O 121.194 0.521 . . . . 0.0 111.277 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 50' ' ' TYR . 20.6 ttp180 -74.95 101.31 4.4 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.667 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.788 ' CD2' HD22 ' A' ' 100' ' ' LEU . 2.5 mp -53.98 107.05 0.23 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.278 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.693 HD11 ' HB2' ' A' ' 103' ' ' SER . 20.0 mt -85.12 -56.14 3.7 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.059 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -136.35 117.59 14.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.92 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 24.9 t -102.95 119.06 50.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.88 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 72.11 -61.58 0.49 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.128 0.489 . . . . 0.0 110.563 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.416 ' H ' ' H ' ' A' ' 77' ' ' VAL . 7.2 t-160 -168.07 -18.41 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.988 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.425 ' O ' HG23 ' A' ' 79' ' ' THR . 21.4 t -84.84 127.29 40.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-O 120.826 0.346 . . . . 0.0 111.198 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.69 93.61 0.73 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.745 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.49 HG21 HD13 ' A' ' 90' ' ' LEU . 14.5 p -95.75 34.41 1.51 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.198 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.52 ' HG2' HD22 ' A' ' 72' ' ' LEU . 3.3 mtt180 -67.99 -53.31 26.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.584 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.2 p30 -94.0 25.1 3.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.183 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.729 ' O ' HG23 ' A' ' 49' ' ' VAL . 2.5 m-30 -81.43 174.49 11.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.877 0.37 . . . . 0.0 110.805 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.51 ' C ' HG21 ' A' ' 49' ' ' VAL . 0.6 OUTLIER -113.28 161.05 17.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.347 179.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.849 ' O ' HG23 ' A' ' 88' ' ' VAL . 42.0 t -51.82 -42.96 62.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.894 0.378 . . . . 0.0 110.664 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 8.4 t -63.54 -19.52 64.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.264 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.596 ' O ' HD12 ' A' ' 90' ' ' LEU . 3.2 mp -96.58 -32.77 12.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.042 0.449 . . . . 0.0 110.647 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.63 HG21 HG11 ' A' ' 49' ' ' VAL . 58.1 t -77.5 -36.01 22.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.9 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 84' ' ' CYS . 98.9 t -57.79 -52.2 76.14 Favored Pre-proline 0 C--N 1.331 -0.216 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.839 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 41.5 Cg_endo -66.9 -45.4 4.29 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.336 2.024 . . . . 0.0 111.854 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.689 HD11 ' HE2' ' A' ' 82' ' ' PHE . 19.7 mt -54.64 -29.69 53.05 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.985 0.421 . . . . 0.0 110.681 179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.913 HG23 ' CD1' ' A' ' 98' ' ' LEU . 70.2 mt -78.19 -48.18 23.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.839 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -74.19 -3.93 32.8 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.41 ' CG ' ' HA ' ' A' ' 90' ' ' LEU . 0.3 OUTLIER -111.74 -4.21 14.74 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 -179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.489 ' OG ' HD23 ' A' ' 98' ' ' LEU . 2.4 t -64.73 -16.19 62.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.806 0.336 . . . . 0.0 111.367 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 99.46 -154.26 19.72 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.557 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.8 p30 -73.44 -9.25 58.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.612 0.244 . . . . 0.0 111.404 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -138.87 123.42 18.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.694 0.283 . . . . 0.0 110.743 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.913 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -107.3 97.4 7.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.19 -179.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -98.62 118.23 34.87 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.788 HD22 ' CD2' ' A' ' 71' ' ' LEU . 1.9 pp -147.75 150.81 34.96 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.084 0.469 . . . . 0.0 111.965 -178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.723 HG12 HD22 ' A' ' 22' ' ' LEU . 11.6 t -105.43 108.85 25.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.792 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.768 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.5 pp -104.41 169.04 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.048 0.451 . . . . 0.0 111.503 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.693 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -137.71 123.87 20.42 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.382 179.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.87 126.9 25.99 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.255 -179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -75.24 112.95 20.93 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.828 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 C--O 1.249 1.04 0 C-N-CA 122.413 2.075 . . . . 0.0 112.252 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.67 0.272 . . . . 0.0 111.368 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -71.08 -47.62 0.53 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.448 2.099 . . . . 0.0 112.343 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.559 ' HB ' ' CD ' ' A' ' 19' ' ' PRO . 0.4 OUTLIER -167.49 -60.38 0.01 OUTLIER Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.216 179.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.559 ' CD ' ' HB ' ' A' ' 18' ' ' THR . 5.7 Cg_endo -47.69 125.41 11.09 Favored 'Trans proline' 0 C--N 1.349 0.572 0 C-N-CA 122.593 2.195 . . . . 0.0 112.333 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 105' ' ' ASN . 29.1 m -42.78 131.13 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.15 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -97.24 121.82 39.57 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.628 HD13 ' CG1' ' A' ' 101' ' ' VAL . 4.6 pp -100.34 153.14 19.56 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.266 0.555 . . . . 0.0 112.356 -178.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -148.31 149.66 32.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.281 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.87 103.52 10.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.49 179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.827 HG11 ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -100.4 138.7 23.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.197 -179.669 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.5 m -130.21 110.2 11.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.364 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.994 HD11 HD21 ' A' ' 65' ' ' LEU . 57.9 mt -106.78 174.87 5.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.027 0.442 . . . . 0.0 111.498 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 11.0 m-85 -127.73 154.97 44.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.593 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.1 OUTLIER -114.25 140.45 48.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.035 0.445 . . . . 0.0 111.321 -179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 32' ' ' GLY . 10.5 t70 -112.79 134.67 54.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.372 179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 69.8 m -56.86 85.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.052 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 30' ' ' ASP . . . 148.65 -18.41 1.28 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.83 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.16 140.67 34.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.85 0.357 . . . . 0.0 111.028 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -80.52 -10.58 59.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.263 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -155.58 -167.58 2.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.918 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 98' ' ' LEU . 4.0 m-85 -99.38 28.25 4.68 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.293 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 87.12 21.55 48.99 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.999 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.622 ' CD2' HD13 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -174.38 128.01 0.34 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.792 0.33 . . . . 0.0 110.833 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.7 m -90.06 150.02 22.26 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.792 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 50' ' ' TYR . 35.5 m -110.48 171.0 3.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.697 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.61 144.38 26.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.112 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -72.49 168.24 18.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -105.35 122.59 7.27 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.314 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.15 -23.75 17.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.038 0.447 . . . . 0.0 111.322 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.529 ' N ' HD12 ' A' ' 45' ' ' LEU . 4.4 mp -84.28 -39.61 19.01 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.949 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.538 ' O ' ' O ' ' A' ' 47' ' ' LYS . 7.0 pt-20 -156.2 59.95 0.57 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.058 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.538 ' O ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 32.85 -166.85 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.623 179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.77 176.01 42.75 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.534 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.655 HG21 ' CG2' ' A' ' 87' ' ' VAL . 58.9 t -133.79 132.16 56.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.872 0.367 . . . . 0.0 111.226 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -126.1 -175.11 3.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.372 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.472 HG11 HD11 ' A' ' 54' ' ' ILE . 56.0 t -95.77 122.11 46.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.978 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.27 -29.69 19.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.448 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -157.37 154.11 28.38 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.558 -179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.601 ' CD1' HD12 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -138.25 139.05 42.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.768 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.04 133.42 94.76 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.889 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.606 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 61.1 Cg_endo -72.85 98.05 0.95 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.493 2.129 . . . . 0.0 112.306 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 82.99 28.77 0.1 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.082 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -106.47 -160.83 22.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.434 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.56 -53.61 6.57 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.586 2.191 . . . . 0.0 112.308 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -57.06 -39.04 89.05 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.421 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.56 -32.88 64.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.084 0.468 . . . . 0.0 110.21 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 45.3 mt -73.73 -31.41 63.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.686 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.74 -55.59 7.28 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.331 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 139.38 -11.65 3.25 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.559 -0.829 . . . . 0.0 113.04 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.994 HD21 HD11 ' A' ' 27' ' ' LEU . 3.3 pp -80.44 135.34 36.13 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.973 0.416 . . . . 0.0 111.025 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.587 ' HB2' ' HD2' ' A' ' 67' ' ' PRO . 6.7 ptmt -120.03 167.52 12.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.397 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.641 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 99.9 Cg_exo -44.62 146.99 1.91 Allowed 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.459 2.106 . . . . 0.0 112.7 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.641 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 2.2 m-85 82.98 -10.13 1.05 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.671 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.614 ' CG ' HD13 ' A' ' 102' ' ' ILE . 7.7 m-20 -54.74 88.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.05 0.453 . . . . 0.0 110.854 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 50' ' ' TYR . 12.3 ttm180 -66.83 101.04 0.77 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.02 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.758 HD23 HD22 ' A' ' 100' ' ' LEU . 3.4 mp -56.14 107.89 0.41 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.006 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.625 HD22 ' CG ' ' A' ' 80' ' ' ARG . 27.8 mt -82.99 -56.55 3.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.437 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -139.48 137.02 35.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.099 0.475 . . . . 0.0 111.385 -179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.611 HG12 HD22 ' A' ' 75' ' ' ASN . 31.3 t -107.52 110.45 31.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.345 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.611 HD22 HG12 ' A' ' 74' ' ' VAL . 2.7 m-80 73.28 -58.84 0.58 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.678 -179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -167.47 -12.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.532 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.721 HG13 HG23 ' A' ' 79' ' ' THR . 12.2 p -84.22 133.15 29.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.924 0.393 . . . . 0.0 111.427 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.7 mmt-85 -72.07 89.79 1.15 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.943 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.721 HG23 HG13 ' A' ' 77' ' ' VAL . 37.7 p -96.28 21.01 9.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.333 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.625 ' CG ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -70.95 -42.53 69.66 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.885 0.374 . . . . 0.0 110.595 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.16 15.27 13.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.099 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.707 ' HE2' HD11 ' A' ' 90' ' ' LEU . 3.1 m-85 -81.92 172.24 13.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.927 0.394 . . . . 0.0 110.977 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.415 ' O ' HG23 ' A' ' 87' ' ' VAL . 20.3 t0 -111.88 162.53 15.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.383 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.894 ' O ' HG23 ' A' ' 88' ' ' VAL . 15.7 p -51.49 -43.67 62.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.759 0.314 . . . . 0.0 110.839 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.3 m -61.43 -22.22 64.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.332 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.55 ' O ' HD12 ' A' ' 90' ' ' LEU . 11.0 mp -95.99 -31.0 13.29 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.904 0.383 . . . . 0.0 111.127 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.655 ' CG2' HG21 ' A' ' 49' ' ' VAL . 59.4 t -78.95 -35.69 17.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.299 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.894 HG23 ' O ' ' A' ' 84' ' ' CYS . 62.1 t -58.73 -50.9 85.49 Favored Pre-proline 0 C--N 1.33 -0.26 0 C-N-CA 120.931 -0.307 . . . . 0.0 110.913 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 14.0 Cg_exo -68.9 -44.57 2.62 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.444 2.096 . . . . 0.0 111.6 179.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.707 HD11 ' HE2' ' A' ' 82' ' ' PHE . 13.6 mt -54.62 -29.41 51.85 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.663 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.936 HG23 ' CD1' ' A' ' 98' ' ' LEU . 51.6 mt -78.07 -50.01 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.6 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -71.91 -4.05 26.06 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.931 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -104.14 -9.16 18.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.626 0.251 . . . . 0.0 111.581 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -64.8 -16.21 62.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.721 0.296 . . . . 0.0 111.374 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 94.83 -143.97 16.9 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.635 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -73.7 -10.15 59.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.584 0.231 . . . . 0.0 111.544 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt -138.19 155.7 48.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.69 0.281 . . . . 0.0 110.882 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.936 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -139.64 97.46 3.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.136 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -96.12 118.71 33.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.019 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.856 HD23 HD22 ' A' ' 98' ' ' LEU . 1.6 pp -150.04 163.92 36.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.142 0.496 . . . . 0.0 112.064 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.628 ' CG1' HD13 ' A' ' 22' ' ' LEU . 38.2 t -111.97 109.12 27.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.914 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.661 HG23 ' CD1' ' A' ' 100' ' ' LEU . 2.6 pp -100.67 168.65 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.999 -179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.578 ' HB3' HD11 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -142.46 129.72 21.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.545 179.321 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.419 ' NE ' ' CG ' ' A' ' 66' ' ' LYS . 10.2 ptt85 -139.7 124.88 18.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.919 0.39 . . . . 0.0 111.616 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.469 ' N ' HG12 ' A' ' 20' ' ' VAL . 4.1 p30 -69.13 133.94 89.6 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.662 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo . . . . . 0 C--O 1.249 1.065 0 C-N-CA 122.457 2.105 . . . . 0.0 112.337 179.939 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.841 0.353 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.4 ' HD2' ' HG2' ' A' ' 106' ' ' PRO . 7.6 Cg_exo -72.82 -1.89 11.09 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.972 2.448 . . . . 0.0 112.647 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.506 ' CG2' ' HD2' ' A' ' 19' ' ' PRO . 21.8 m -157.14 143.86 13.34 Favored Pre-proline 0 N--CA 1.452 -0.329 0 CA-C-N 116.699 -0.228 . . . . 0.0 111.123 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.506 ' HD2' ' CG2' ' A' ' 18' ' ' THR . 1.7 Cg_endo -42.37 168.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.084 2.523 . . . . 0.0 112.538 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.7 m -48.98 144.52 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.634 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -112.35 122.2 47.03 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.408 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.122 HD21 HD12 ' A' ' 72' ' ' LEU . 14.2 mt -60.81 141.94 56.56 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.601 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.537 ' CD2' HD11 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -153.24 120.92 5.99 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.146 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.705 ' HD2' HG22 ' A' ' 101' ' ' VAL . 2.6 tptp -69.88 124.43 24.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.903 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.649 HG11 ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -126.4 139.92 50.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.039 0.447 . . . . 0.0 111.121 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 95.0 m -134.34 117.51 16.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.198 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 59' ' ' PRO . 2.6 mp -116.03 167.65 10.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.079 0.466 . . . . 0.0 111.572 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.444 ' N ' ' CD1' ' A' ' 28' ' ' TYR . 2.9 m-85 -135.37 121.92 20.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.175 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -95.11 163.65 13.21 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.946 0.403 . . . . 0.0 111.262 -179.526 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -136.99 139.47 41.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -59.26 85.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.921 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.64 -23.58 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.831 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.91 156.7 27.16 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.932 0.396 . . . . 0.0 110.961 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -87.71 -10.54 50.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.434 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -155.35 -172.24 4.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.857 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -97.87 32.15 2.45 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.238 -179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.427 ' HA3' ' H ' ' A' ' 60' ' ' GLY . . . 96.93 -5.2 63.56 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.286 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.52 ' HD2' HG13 ' A' ' 51' ' ' VAL . 48.6 p90 -171.31 149.58 2.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 117.047 0.424 . . . . 0.0 111.739 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.9 m -104.5 133.83 48.71 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.433 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.659 ' HB ' HG12 ' A' ' 49' ' ' VAL . 33.1 m -93.46 170.8 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.751 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.744 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -139.38 162.31 35.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.148 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -83.25 130.31 35.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.709 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.516 ' HA3' ' CZ ' ' A' ' 50' ' ' TYR . . . -103.25 107.52 3.07 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.793 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 mp -94.67 -26.74 16.2 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.055 0.455 . . . . 0.0 111.03 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.1 tp -84.51 -6.09 59.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.714 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 47' ' ' LYS . 10.2 mt-10 -152.69 29.78 0.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.788 -0.187 . . . . 0.0 110.922 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 26.99 91.23 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.149 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.42 ' O ' ' HA3' ' A' ' 43' ' ' GLY . . . 157.9 160.4 10.2 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.273 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.744 HG13 ' O ' ' A' ' 41' ' ' ALA . 40.1 t -101.39 133.48 44.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.853 0.359 . . . . 0.0 111.361 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.516 ' CZ ' ' HA3' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -125.42 -177.46 3.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.454 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.867 HG11 HD11 ' A' ' 54' ' ' ILE . 37.2 t -89.62 162.2 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.649 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.516 ' N ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -144.9 -42.12 0.24 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.011 0.434 . . . . 0.0 110.833 -179.253 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.51 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 67.1 m-80 -123.43 130.49 52.78 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.578 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.867 HD11 HG11 ' A' ' 51' ' ' VAL . 1.1 mt -136.49 117.78 18.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.746 0.308 . . . . 0.0 111.331 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.13 110.54 5.28 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.592 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.445 ' HA ' ' HB2' ' A' ' 61' ' ' ASP . 16.5 Cg_exo -68.11 55.06 0.72 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.589 2.193 . . . . 0.0 112.777 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -173.82 -43.65 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.927 0.394 . . . . 0.0 111.255 179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.9 -152.47 0.96 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.705 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.733 ' O ' HD23 ' A' ' 27' ' ' LEU . 28.7 Cg_exo -62.14 -35.26 76.3 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.801 2.334 . . . . 0.0 112.079 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.522 ' O ' HD12 ' A' ' 65' ' ' LEU . . . -56.5 -49.92 66.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.716 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.445 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 6.2 t70 -73.67 -36.18 65.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.061 0.457 . . . . 0.0 110.201 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 33.1 mt -60.83 -29.6 69.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.974 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.92 -51.42 3.8 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.419 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.38 47.71 0.85 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.724 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.733 HD11 HD21 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -106.41 165.63 11.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.867 0.365 . . . . 0.0 111.079 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 68' ' ' TYR . 12.2 mtmm -132.13 159.57 71.6 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.665 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.453 ' O ' ' CG ' ' A' ' 68' ' ' TYR . 36.7 Cg_endo -65.55 64.43 0.38 Allowed 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.487 2.125 . . . . 0.0 112.254 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.453 ' CG ' ' O ' ' A' ' 67' ' ' PRO . 6.2 m-85 -174.12 -30.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.396 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.709 ' HB2' HD13 ' A' ' 102' ' ' ILE . 4.4 p30 -50.25 96.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.453 0.644 . . . . 0.0 110.799 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.605 ' O ' HD23 ' A' ' 72' ' ' LEU . 27.6 ttp180 -74.3 104.16 4.96 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.537 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.05 HD23 HD13 ' A' ' 100' ' ' LEU . 1.1 mt -54.42 108.42 0.38 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.027 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.122 HD12 HD21 ' A' ' 22' ' ' LEU . 5.2 mt -82.9 -66.02 0.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.132 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.32 132.19 53.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.892 0.377 . . . . 0.0 111.163 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.518 HG23 ' OG1' ' A' ' 79' ' ' THR . 29.7 t -104.58 103.85 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.8 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 75.31 -58.61 0.56 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.138 0.494 . . . . 0.0 110.565 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -167.67 -13.76 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.286 179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.0 t -85.63 141.04 15.05 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.107 0 CA-C-O 120.741 0.305 . . . . 0.0 111.309 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.4 mmt180 -70.2 128.13 35.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.519 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.518 ' OG1' HG23 ' A' ' 74' ' ' VAL . 41.6 p -143.76 25.93 1.6 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.172 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.731 ' HE ' HD13 ' A' ' 72' ' ' LEU . 6.9 mtt180 -73.32 -52.78 12.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.59 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -93.74 25.33 3.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.108 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.699 ' CE2' HD11 ' A' ' 90' ' ' LEU . 2.2 m-85 -81.58 166.37 20.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.897 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.526 ' C ' HG21 ' A' ' 49' ' ' VAL . 15.6 t70 -106.03 161.16 14.73 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.549 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.863 ' O ' HG23 ' A' ' 88' ' ' VAL . 1.9 t -51.69 -42.2 62.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.894 0.378 . . . . 0.0 110.645 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 23.0 m -62.74 -22.91 66.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.213 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.574 ' O ' HD12 ' A' ' 90' ' ' LEU . 7.9 mp -93.0 -32.93 14.33 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.012 0.434 . . . . 0.0 110.854 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.6 HG12 ' CD1' ' A' ' 91' ' ' ILE . 58.8 t -77.6 -36.03 22.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.0 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.863 HG23 ' O ' ' A' ' 84' ' ' CYS . 77.8 t -54.73 -52.41 70.54 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.732 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 50.3 Cg_endo -68.63 -45.96 2.1 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.233 1.956 . . . . 0.0 111.788 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.699 HD11 ' CE2' ' A' ' 82' ' ' PHE . 27.0 mt -55.48 -32.06 62.53 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.607 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.912 ' HA ' HD11 ' A' ' 98' ' ' LEU . 60.7 mt -75.17 -44.86 42.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.599 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.11 -3.7 43.66 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.949 -179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -85.03 -15.82 42.84 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.742 0.306 . . . . 0.0 111.723 -179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.407 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 2.0 m -65.02 -25.01 67.67 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.982 0.42 . . . . 0.0 111.269 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.92 -61.48 3.74 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.189 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.415 ' HA ' ' HB3' ' A' ' 29' ' ' LYS . 24.3 p30 -163.12 16.76 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 111.73 0.271 . . . . 0.0 111.73 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.84 105.69 2.21 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.912 HD11 ' HA ' ' A' ' 91' ' ' ILE . 0.9 OUTLIER -107.39 107.52 18.46 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -178.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.0 117.93 35.46 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 1.05 HD13 HD23 ' A' ' 71' ' ' LEU . 1.3 pp -150.49 155.96 40.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.262 0.553 . . . . 0.0 112.373 -178.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.871 HG12 HD22 ' A' ' 22' ' ' LEU . 18.5 t -105.44 109.24 27.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.618 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.862 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.8 pp -100.96 169.45 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.189 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -134.9 102.63 5.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.605 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.426 ' HB3' ' HA ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -111.56 124.3 52.0 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.073 -179.726 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.1 148.09 88.66 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.675 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.4 ' HG2' ' HD2' ' A' ' 17' ' ' PRO . 90.4 Cg_endo . . . . . 0 C--O 1.248 1.022 0 C-N-CA 122.606 2.204 . . . . 0.0 112.42 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.46 ' CB ' ' HD2' ' A' ' 17' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.627 0.251 . . . . 0.0 111.093 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 16' ' ' SER . 1.3 Cg_endo -43.08 -41.06 9.27 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.137 2.558 . . . . 0.0 113.179 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.501 ' CB ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -86.48 -56.76 0.35 Allowed Pre-proline 0 C--N 1.33 -0.265 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.453 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.501 ' HD3' ' CB ' ' A' ' 18' ' ' THR . 7.0 Cg_exo -73.34 90.93 0.87 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.698 2.265 . . . . 0.0 112.561 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' A' ' 103' ' ' SER . 18.0 m -46.89 170.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.432 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -129.58 122.21 28.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.734 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.84 HD22 HG12 ' A' ' 101' ' ' VAL . 14.7 mt -60.95 150.68 32.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.442 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.512 ' HB2' HD11 ' A' ' 102' ' ' ILE . 17.1 m-70 -156.67 110.56 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.986 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 5.9 mtpt -71.4 113.56 8.56 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.792 HG11 ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -119.53 140.19 44.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.202 0.525 . . . . 0.0 112.099 -178.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.8 m -134.33 106.64 7.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.51 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.078 HD11 HD21 ' A' ' 65' ' ' LEU . 23.5 mt -102.79 173.54 6.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.222 0.534 . . . . 0.0 112.143 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 96' ' ' ASN . 8.5 m-85 -134.69 121.82 21.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.245 179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.463 ' N ' ' CE1' ' A' ' 36' ' ' PHE . 5.2 tttt -104.26 152.05 22.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.928 0.394 . . . . 0.0 111.346 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -119.62 158.74 25.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.651 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.24 -27.94 64.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.173 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.13 -24.74 51.12 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.73 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 2.9 mmt -81.41 132.7 35.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.907 0.384 . . . . 0.0 111.043 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -78.67 -10.78 59.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.265 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -155.9 -168.82 2.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.639 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.463 ' CE1' ' N ' ' A' ' 29' ' ' LYS . 5.0 m-85 -97.02 29.72 2.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.8 0.334 . . . . 0.0 111.178 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 76.09 24.57 68.61 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.955 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.522 ' CD2' HD13 ' A' ' 65' ' ' LEU . 1.4 p90 -174.44 117.3 0.21 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.047 0.451 . . . . 0.0 111.427 179.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.1 m -88.9 146.44 24.93 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.872 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.721 ' HB ' HG12 ' A' ' 49' ' ' VAL . 34.4 m -108.62 171.07 2.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.656 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.693 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -137.81 156.89 47.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.14 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -72.38 144.34 48.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.693 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.438 ' HA3' ' CZ ' ' A' ' 50' ' ' TYR . . . -119.93 108.26 1.44 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.612 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.2 pp -94.14 -27.28 16.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.976 0.417 . . . . 0.0 110.985 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.4 -3.33 58.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.371 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.439 ' O ' ' C ' ' A' ' 47' ' ' LYS . 7.2 mt-10 -152.97 27.6 0.53 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.675 -0.238 . . . . 0.0 110.981 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER 27.09 91.32 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.251 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 162.9 -154.37 25.3 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.479 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.721 HG12 ' HB ' ' A' ' 40' ' ' VAL . 21.3 t -142.11 139.31 30.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.855 0.36 . . . . 0.0 110.942 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.438 ' CZ ' ' HA3' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -126.68 177.73 6.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.509 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.502 HG11 HD11 ' A' ' 54' ' ' ILE . 61.4 t -86.46 123.29 39.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.182 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.3 tptm -88.13 -29.34 20.64 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.782 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -168.33 149.99 5.1 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.246 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.614 ' CD1' HD12 ' A' ' 65' ' ' LEU . 0.9 OUTLIER -129.26 132.73 66.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.184 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 9.8 ttt180 -65.56 125.22 89.23 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.879 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.54 140.38 83.24 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.388 2.059 . . . . 0.0 112.547 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 40.8 32.34 0.15 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.991 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -101.66 -167.96 27.48 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.663 -0.779 . . . . 0.0 111.955 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.572 ' O ' HD22 ' A' ' 27' ' ' LEU . 18.0 Cg_endo -58.57 -34.27 98.72 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.313 2.009 . . . . 0.0 111.721 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -72.28 -44.67 42.34 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.427 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -71.98 -32.76 67.55 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.99 0.424 . . . . 0.0 109.942 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 41.1 mt -72.11 -29.24 63.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.443 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.37 -57.93 5.32 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.326 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 146.49 -20.83 1.69 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.449 -0.881 . . . . 0.0 113.091 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.078 HD21 HD11 ' A' ' 27' ' ' LEU . 3.1 pp -73.83 134.04 43.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.944 0.402 . . . . 0.0 111.0 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.488 ' HB3' ' HD2' ' A' ' 67' ' ' PRO . 15.1 mttt -120.74 167.63 12.51 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.607 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.677 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 99.9 Cg_exo -43.24 145.98 1.22 Allowed 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.539 2.159 . . . . 0.0 112.606 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.677 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 4.3 m-85 83.21 -10.01 1.03 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.665 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.537 ' CG ' HD13 ' A' ' 102' ' ' ILE . 4.3 m-20 -54.61 87.06 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.972 0.415 . . . . 0.0 110.817 179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.435 ' HD3' ' CE1' ' A' ' 50' ' ' TYR . 31.2 ttp180 -66.93 97.51 0.49 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.7 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.931 ' HA ' HG22 ' A' ' 102' ' ' ILE . 2.9 mt -55.58 107.39 0.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.127 -179.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.788 HD12 HD21 ' A' ' 22' ' ' LEU . 23.8 mt -84.25 -65.92 0.95 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.121 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -122.57 140.97 52.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.027 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.555 HG12 ' OD1' ' A' ' 75' ' ' ASN . 41.3 t -124.69 112.63 32.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.055 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.555 ' OD1' HG12 ' A' ' 74' ' ' VAL . 5.1 m120 64.64 33.33 10.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.934 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.463 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 2.6 t-80 86.72 -14.89 0.47 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.611 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 36.7 t -83.27 138.65 18.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.828 0.346 . . . . 0.0 111.061 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -69.55 130.88 43.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.687 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.486 ' CG2' HD13 ' A' ' 90' ' ' LEU . 30.3 p -144.24 27.97 1.39 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.061 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.599 ' HG2' HD22 ' A' ' 72' ' ' LEU . 30.5 mtp180 -83.14 -42.5 17.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.627 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -91.11 10.31 27.42 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.041 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.617 ' CE2' HD11 ' A' ' 90' ' ' LEU . 3.1 m-85 -80.28 -176.45 5.63 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.959 0.409 . . . . 0.0 110.84 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -128.5 169.3 14.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.309 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.821 ' O ' HG23 ' A' ' 88' ' ' VAL . 53.3 t -51.18 -45.58 61.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.746 0.307 . . . . 0.0 110.755 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.28 -18.45 63.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.107 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.616 HD12 ' CD2' ' A' ' 82' ' ' PHE . 0.0 OUTLIER -95.5 -37.97 10.65 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 121.216 0.531 . . . . 0.0 111.04 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.48 HG11 HD13 ' A' ' 71' ' ' LEU . 46.6 t -77.03 -35.46 23.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.536 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 84' ' ' CYS . 89.8 t -57.53 -51.79 79.11 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.694 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.674 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 18.3 Cg_exo -65.67 -44.38 8.35 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.248 1.966 . . . . 0.0 111.181 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.617 HD11 ' CE2' ' A' ' 82' ' ' PHE . 52.7 mt -54.57 -32.08 57.88 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.04 0.447 . . . . 0.0 110.526 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.921 HG23 ' CD1' ' A' ' 98' ' ' LEU . 61.9 mt -73.29 -49.65 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.55 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -76.17 -2.69 32.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.796 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -93.32 -13.2 28.46 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 111.771 0.285 . . . . 0.0 111.771 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.423 ' OG ' ' HG ' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -63.8 -27.63 69.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.05 0.453 . . . . 0.0 110.746 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 101.8 -53.3 0.82 Allowed Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 115.659 -0.7 . . . . 0.0 112.865 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 6.7 m120 -165.6 -34.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.956 0.408 . . . . 0.0 110.403 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt -104.71 108.7 20.3 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.248 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.921 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.3 OUTLIER -101.93 97.35 7.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.708 -179.243 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -100.45 118.32 36.42 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.862 HD22 HD22 ' A' ' 71' ' ' LEU . 1.3 pp -148.1 159.51 43.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.226 0.536 . . . . 0.0 112.239 -178.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.84 HG12 HD22 ' A' ' 22' ' ' LEU . 16.3 t -111.14 109.14 27.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.014 178.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.931 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.5 pp -104.19 169.6 2.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.38 -179.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.714 ' OG ' HD21 ' A' ' 72' ' ' LEU . 9.0 p -143.19 125.4 15.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.332 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -144.99 137.16 25.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.986 0.422 . . . . 0.0 111.421 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.424 ' HB2' ' HA ' ' A' ' 17' ' ' PRO . 4.1 p30 -62.57 132.21 94.37 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.743 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo . . . . . 0 C--O 1.249 1.053 0 C-N-CA 122.422 2.082 . . . . 0.0 112.284 -179.959 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.441 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 59.0 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 120.663 0.268 . . . . 0.0 111.5 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.441 ' CD ' ' N ' ' A' ' 16' ' ' SER . 35.8 Cg_endo -67.8 -80.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.326 2.017 . . . . 0.0 112.593 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.943 HG22 ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -55.34 154.05 12.38 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.21 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.943 ' HD2' HG22 ' A' ' 18' ' ' THR . 32.1 Cg_exo -59.2 -144.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.792 2.328 . . . . 0.0 111.971 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 103' ' ' SER . 32.9 m -45.24 144.59 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 CA-C-O 120.86 0.362 . . . . 0.0 111.531 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -116.0 122.39 45.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.647 179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.83 HD22 HG12 ' A' ' 101' ' ' VAL . 15.4 mt -62.27 137.64 58.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.479 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.664 ' NE2' HG22 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -149.04 127.42 12.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.273 179.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -71.53 133.69 45.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.622 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.696 HG11 ' HG ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -135.87 147.72 28.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.949 0.404 . . . . 0.0 111.327 -179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.509 HG23 ' OD1' ' A' ' 99' ' ' ASP . 94.7 m -134.4 118.4 17.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.135 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.792 HD21 HD12 ' A' ' 65' ' ' LEU . 3.8 mt -110.11 168.77 9.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.959 0.409 . . . . 0.0 111.678 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -134.87 132.66 38.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.573 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -102.02 165.11 11.35 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.943 0.402 . . . . 0.0 111.254 -179.683 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.485 ' HB2' ' HE1' ' A' ' 33' ' ' MET . 13.3 t0 -144.14 141.68 30.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.687 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -55.87 -23.11 29.1 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.299 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -93.5 -13.11 56.24 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.996 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.485 ' HE1' ' HB2' ' A' ' 30' ' ' ASP . 0.1 OUTLIER -80.28 155.15 27.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.916 0.389 . . . . 0.0 111.197 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -100.99 -10.64 20.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.215 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -155.08 -174.62 5.06 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.588 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.684 ' CD2' HD12 ' A' ' 98' ' ' LEU . 0.1 OUTLIER -97.46 32.55 2.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.27 -179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.99 1.08 90.2 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.009 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.469 ' O ' ' CD1' ' A' ' 38' ' ' PHE . 0.1 OUTLIER -172.14 135.29 0.77 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.004 0.43 . . . . 0.0 111.43 179.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.9 m -96.32 148.23 22.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.51 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.527 ' HB ' HG12 ' A' ' 49' ' ' VAL . 33.9 m -104.15 169.07 2.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.674 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.757 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -141.42 167.01 23.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.999 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -80.58 153.28 28.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.839 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -125.01 115.48 2.45 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.505 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.547 HD23 ' O ' ' A' ' 44' ' ' LEU . 7.3 tt -94.31 -28.65 15.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.015 0.436 . . . . 0.0 111.148 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.5 mp -83.9 -55.9 3.98 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.781 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.43 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.4 mt-10 -89.78 17.11 6.95 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.431 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER 30.03 88.46 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 120.883 0.373 . . . . 0.0 111.934 -179.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 167.22 -141.99 7.26 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.515 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.757 HG13 ' O ' ' A' ' 41' ' ' ALA . 39.5 t -145.47 138.24 21.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.916 0.389 . . . . 0.0 110.988 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 0.0 OUTLIER -131.1 179.44 6.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.416 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.461 HG11 HD11 ' A' ' 54' ' ' ILE . 47.9 t -87.65 123.6 40.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.017 0.437 . . . . 0.0 111.287 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.525 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -88.74 -31.33 18.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.225 -179.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 -157.23 154.96 30.02 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.401 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.461 HD11 HG11 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -135.45 123.85 38.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.102 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -65.6 122.8 82.34 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.825 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.23 152.41 31.46 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.397 2.065 . . . . 0.0 112.439 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 38.65 33.94 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.007 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -118.79 -162.47 12.12 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.164 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.466 ' C ' HD23 ' A' ' 27' ' ' LEU . 71.8 Cg_exo -49.11 -54.33 5.61 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.5 2.133 . . . . 0.0 112.245 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.764 ' HA2' HD12 ' A' ' 65' ' ' LEU . . . -63.94 -33.15 86.47 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.717 179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -73.71 -32.76 64.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.928 0.394 . . . . 0.0 110.409 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.9 mt -74.1 -29.8 62.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.997 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -86.83 -34.83 10.67 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.463 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.2 32.83 3.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.518 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.792 HD12 HD21 ' A' ' 27' ' ' LEU . 11.4 mt -81.59 138.54 35.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.775 0.321 . . . . 0.0 111.042 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.3 mtpp -126.32 160.58 56.96 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.715 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.436 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 78.1 Cg_exo -50.45 142.13 31.05 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.638 2.226 . . . . 0.0 112.332 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.436 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 18.4 m-85 85.44 -3.86 0.86 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.33 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.607 ' OD2' HD23 ' A' ' 65' ' ' LEU . 4.7 m-20 -53.19 89.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.056 0.455 . . . . 0.0 110.806 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.406 ' N ' ' O ' ' A' ' 68' ' ' TYR . 69.0 ttt180 -76.99 111.64 12.77 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.999 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.858 ' HA ' HG22 ' A' ' 102' ' ' ILE . 0.9 OUTLIER -71.26 107.79 4.42 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.734 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.77 HD12 HD21 ' A' ' 22' ' ' LEU . 1.7 mt -83.48 -19.5 35.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.963 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -175.06 152.68 1.5 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.011 0.434 . . . . 0.0 111.528 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.483 HG12 ' OD1' ' A' ' 75' ' ' ASN . 40.2 t -124.0 112.6 33.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.611 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.483 ' OD1' HG12 ' A' ' 74' ' ' VAL . 8.3 m120 76.25 -58.19 0.54 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.107 0.48 . . . . 0.0 110.569 -179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.411 ' H ' ' H ' ' A' ' 77' ' ' VAL . 1.6 m-70 -167.06 -14.22 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.134 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.411 ' H ' ' H ' ' A' ' 76' ' ' HIS . 21.6 t -84.78 136.28 23.09 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 CA-C-O 120.752 0.311 . . . . 0.0 111.116 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 28.5 mtm180 -69.65 143.2 53.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.674 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.441 ' HA ' ' CG ' ' A' ' 82' ' ' PHE . 64.2 p -146.07 18.39 1.41 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.657 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.533 ' HG2' HD13 ' A' ' 72' ' ' LEU . 11.3 mtm180 -65.77 -51.66 57.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.895 0.379 . . . . 0.0 110.425 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -93.75 20.96 6.94 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.227 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.602 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.3 m-30 -81.32 169.18 17.58 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.797 0.332 . . . . 0.0 110.823 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 87' ' ' VAL . 2.4 t70 -109.76 160.33 16.42 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.668 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 24.8 p -51.87 -31.44 28.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.906 0.384 . . . . 0.0 110.713 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -71.34 -21.67 62.01 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.196 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.618 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 5.7 mp -98.38 -30.23 12.69 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.084 0.469 . . . . 0.0 110.819 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.663 ' CG1' HD13 ' A' ' 71' ' ' LEU . 39.8 t -79.74 -35.98 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.451 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.77 HG12 ' HD3' ' A' ' 89' ' ' PRO . 5.0 p -64.22 -39.82 46.79 Favored Pre-proline 0 CA--C 1.533 0.316 0 C-N-CA 120.577 -0.449 . . . . 0.0 111.667 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.77 ' HD3' HG12 ' A' ' 88' ' ' VAL . 73.4 Cg_endo -74.37 -46.73 0.27 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 121.662 1.575 . . . . 0.0 111.227 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.602 HD11 ' HE2' ' A' ' 82' ' ' PHE . 81.5 mt -56.58 -28.35 60.04 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 121.108 0.48 . . . . 0.0 110.263 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.582 ' HA ' HD11 ' A' ' 98' ' ' LEU . 33.2 mt -75.92 -49.15 26.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.631 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -80.78 -2.56 47.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.08 -0.509 . . . . 0.0 112.064 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.64 -12.54 17.64 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.427 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -65.38 -14.3 60.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.698 0.285 . . . . 0.0 111.419 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.67 -145.15 17.77 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.609 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -73.56 -15.91 61.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.581 0.229 . . . . 0.0 111.393 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 mtpp -125.98 139.68 53.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.798 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.684 HD12 ' CD2' ' A' ' 36' ' ' PHE . 0.4 OUTLIER -130.61 97.14 4.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.123 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.509 ' OD1' HG23 ' A' ' 26' ' ' THR . 2.5 m-20 -98.34 118.6 35.36 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.788 HD22 ' CD2' ' A' ' 71' ' ' LEU . 2.7 pp -146.86 158.79 44.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.224 0.535 . . . . 0.0 112.24 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.83 HG12 HD22 ' A' ' 22' ' ' LEU . 18.5 t -113.76 109.66 29.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.104 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.858 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.0 pp -108.78 169.56 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.372 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.415 ' N ' HD12 ' A' ' 102' ' ' ILE . 0.3 OUTLIER -130.54 127.84 39.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.859 179.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.03 141.43 34.31 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.934 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -71.42 135.78 84.06 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.766 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo . . . . . 0 C--O 1.248 1.003 0 C-N-CA 122.392 2.061 . . . . 0.0 112.252 -179.994 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.406 ' HA ' ' CG ' ' A' ' 106' ' ' PRO . 13.0 t . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.762 0.315 . . . . 0.0 111.232 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.36 109.65 2.65 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.449 2.099 . . . . 0.0 112.092 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.571 ' CG2' ' HD2' ' A' ' 19' ' ' PRO . 31.3 m 59.82 150.08 0.08 OUTLIER Pre-proline 0 N--CA 1.453 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.504 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.571 ' HD2' ' CG2' ' A' ' 18' ' ' THR . 72.6 Cg_exo -52.78 -147.94 0.0 OUTLIER 'Trans proline' 0 CA--C 1.531 0.358 0 C-N-CA 122.652 2.235 . . . . 0.0 112.572 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.0 m -36.98 153.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.927 0.394 . . . . 0.0 112.053 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -119.16 122.54 42.27 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.52 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.762 HD22 HG12 ' A' ' 101' ' ' VAL . 13.3 mt -60.72 135.46 57.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.499 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.533 ' HB2' HD11 ' A' ' 102' ' ' ILE . 40.2 m-70 -143.83 112.05 6.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.726 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.32 111.31 7.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.191 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.714 HG11 ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -117.66 139.55 44.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.122 0.487 . . . . 0.0 111.553 -179.185 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.5 m -133.02 106.74 7.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.97 179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.917 HD21 HD21 ' A' ' 65' ' ' LEU . 2.4 mp -99.16 174.0 6.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.961 0.41 . . . . 0.0 111.902 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -131.33 140.16 49.68 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.332 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -109.22 165.21 11.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.952 0.406 . . . . 0.0 111.422 -179.559 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -125.65 137.22 53.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.681 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.3 m -59.25 85.15 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.138 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 127.06 14.36 2.75 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.163 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -81.68 166.88 19.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.89 0.345 . . . . 0.0 110.807 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -92.52 -24.29 18.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.152 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -157.79 -167.89 2.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.755 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -103.6 31.05 4.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.892 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.45 0.06 80.06 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.739 -0.743 . . . . 0.0 113.085 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.439 ' HB2' HG12 ' A' ' 54' ' ' ILE . 18.4 p90 -172.41 153.74 3.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.985 0.392 . . . . 0.0 111.461 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.9 p -119.03 148.01 43.48 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.552 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.725 HG11 ' CD1' ' A' ' 71' ' ' LEU . 30.5 m -113.35 157.6 13.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.474 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.505 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -114.14 177.54 4.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.208 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.79 160.86 21.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.949 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.27 115.29 2.49 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.389 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 44' ' ' LEU . 0.4 OUTLIER -94.61 -35.23 12.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.11 0.481 . . . . 0.0 111.191 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 tp -84.26 -53.78 5.25 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.055 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.428 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.4 mm-40 -90.53 16.37 9.09 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.558 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 46' ' ' GLU . 3.5 mmtt 29.05 82.91 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 174.97 -150.87 11.52 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.492 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 82' ' ' PHE . 88.8 t -138.38 139.83 40.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.824 0.345 . . . . 0.0 110.914 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.482 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -139.51 162.72 34.39 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.605 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.634 ' HA ' HG12 ' A' ' 40' ' ' VAL . 50.1 t -62.36 162.0 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.592 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.529 ' N ' HG12 ' A' ' 51' ' ' VAL . 16.8 pttt -147.0 -35.36 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.869 0.366 . . . . 0.0 111.579 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.416 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 15.6 m-80 -144.49 139.03 28.02 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.981 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.646 HD11 HD12 ' A' ' 65' ' ' LEU . 1.0 OUTLIER -132.95 133.97 58.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.0 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.431 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 0.0 OUTLIER -65.89 142.4 98.06 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.913 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 55' ' ' ARG . 34.7 Cg_exo -57.66 127.19 24.35 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.544 2.162 . . . . 0.0 112.531 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 43.28 30.79 0.33 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.875 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.92 -159.48 32.52 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.713 -0.756 . . . . 0.0 111.935 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -51.87 -55.92 3.44 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.312 2.008 . . . . 0.0 111.876 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.404 ' HA2' ' CD2' ' A' ' 27' ' ' LEU . . . -56.93 -38.66 86.1 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 121.005 -0.617 . . . . 0.0 112.671 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -73.37 -32.63 64.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.967 0.413 . . . . 0.0 110.183 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 28.6 mt -77.32 -30.39 54.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.842 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.28 -56.67 6.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.426 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.97 33.23 0.93 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.656 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.917 HD21 HD21 ' A' ' 27' ' ' LEU . 1.7 pp -118.5 132.06 56.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.89 0.376 . . . . 0.0 110.905 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.469 ' CB ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -117.87 169.51 7.53 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.783 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.486 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 1.6 Cg_endo -44.63 146.14 2.35 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.646 2.231 . . . . 0.0 112.239 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.486 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 8.5 m-85 91.14 -21.13 0.11 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.095 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.684 ' CG ' HD13 ' A' ' 102' ' ' ILE . 7.2 m-20 -53.75 85.49 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.166 0.508 . . . . 0.0 110.669 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -68.49 105.91 2.37 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.195 -179.326 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.725 ' CD1' HG11 ' A' ' 40' ' ' VAL . 1.9 mp -63.07 107.9 1.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.758 HD22 ' CG ' ' A' ' 80' ' ' ARG . 10.0 mt -83.38 -65.85 0.96 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.17 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -119.38 126.82 52.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.157 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.611 HG23 ' OG1' ' A' ' 79' ' ' THR . 43.1 t -109.62 107.1 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.712 179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 74.65 -58.59 0.58 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.139 0.495 . . . . 0.0 110.537 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 26.2 p80 -167.22 -18.02 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.951 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 79' ' ' THR . 21.5 t -85.36 125.27 40.45 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-O 120.792 0.329 . . . . 0.0 111.129 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.65 84.36 0.45 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.649 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.611 ' OG1' HG23 ' A' ' 74' ' ' VAL . 17.7 p -94.62 43.94 1.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.17 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.758 ' CG ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -80.99 -47.02 14.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.646 179.766 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -92.93 21.29 5.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.055 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.591 ' HE2' HD11 ' A' ' 90' ' ' LEU . 3.2 m-85 -81.69 170.82 15.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.702 0.287 . . . . 0.0 110.954 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.423 ' C ' HG21 ' A' ' 49' ' ' VAL . 2.6 m-20 -106.26 160.26 15.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.404 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.885 ' O ' HG23 ' A' ' 88' ' ' VAL . 7.4 p -51.76 -42.12 62.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.927 0.394 . . . . 0.0 110.694 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.7 m -63.44 -23.28 67.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.236 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.471 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 0.1 OUTLIER -93.63 -31.13 14.6 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.906 0.384 . . . . 0.0 110.95 -179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.739 HG12 ' CD1' ' A' ' 91' ' ' ILE . 60.7 t -79.62 -35.95 17.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.359 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.885 HG23 ' O ' ' A' ' 84' ' ' CYS . 95.1 t -57.14 -50.84 85.86 Favored Pre-proline 0 C--N 1.331 -0.219 0 C-N-CA 121.035 -0.266 . . . . 0.0 110.938 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.639 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 12.0 Cg_exo -70.43 -47.14 0.77 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.509 2.14 . . . . 0.0 111.512 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.591 HD11 ' HE2' ' A' ' 82' ' ' PHE . 44.8 mt -53.92 -30.75 47.62 Favored 'General case' 0 N--CA 1.455 -0.183 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.517 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.942 HG23 ' CD1' ' A' ' 98' ' ' LEU . 63.9 mt -78.28 -42.04 26.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.505 179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.41 -4.69 40.94 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.454 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 10.3 pt-20 -107.38 -3.44 19.58 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.432 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 6.9 t -64.38 -15.99 61.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.801 0.334 . . . . 0.0 111.411 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.5 -144.61 17.41 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.592 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.39 -10.67 59.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.55 0.214 . . . . 0.0 111.425 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -140.76 157.29 45.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.813 0.34 . . . . 0.0 110.97 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.942 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -138.33 97.2 3.32 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.033 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.14 118.23 31.25 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.825 HD23 HD22 ' A' ' 98' ' ' LEU . 1.1 pp -148.37 164.03 35.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.257 0.551 . . . . 0.0 112.025 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.762 HG12 HD22 ' A' ' 22' ' ' LEU . 48.4 t -115.79 108.93 26.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.393 -0.821 . . . . 0.0 110.103 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.684 HD13 ' CG ' ' A' ' 69' ' ' ASP . 2.5 pp -101.82 169.27 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.409 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.17 122.18 15.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.676 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.404 ' CG ' ' HB2' ' A' ' 68' ' ' TYR . 7.6 tmm_? -133.48 138.66 46.26 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.153 -179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -80.93 154.5 72.91 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.7 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.406 ' CG ' ' HA ' ' A' ' 16' ' ' SER . 64.6 Cg_endo . . . . . 0 C--O 1.25 1.092 0 C-N-CA 122.497 2.131 . . . . 0.0 112.304 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.486 ' CB ' ' HD2' ' A' ' 106' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.602 0.239 . . . . 0.0 111.042 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.62 -23.36 25.44 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.304 2.003 . . . . 0.0 111.93 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.551 ' HB ' ' HD3' ' A' ' 19' ' ' PRO . 1.1 m 176.98 -50.95 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.624 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.551 ' HD3' ' HB ' ' A' ' 18' ' ' THR . 34.2 Cg_exo -58.17 92.73 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.405 2.07 . . . . 0.0 112.446 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.528 HG21 ' HB3' ' A' ' 103' ' ' SER . 11.4 m -47.34 170.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.748 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -123.45 122.38 38.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.597 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.939 HD21 HD12 ' A' ' 72' ' ' LEU . 15.5 mt -62.63 138.99 58.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.712 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.611 ' HB2' HD11 ' A' ' 102' ' ' ILE . 11.0 m-70 -145.09 120.82 10.52 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.677 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.13 113.2 11.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.465 HG21 HG12 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -117.42 139.84 42.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.144 0.497 . . . . 0.0 111.849 -179.041 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.7 m -134.03 106.43 7.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.955 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.053 HD21 HD21 ' A' ' 65' ' ' LEU . 2.3 mp -99.91 168.41 9.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.919 0.39 . . . . 0.0 111.483 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.426 ' HA ' ' O ' ' A' ' 96' ' ' ASN . 4.9 m-85 -124.92 143.95 50.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.748 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -104.83 159.45 15.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.113 -179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -129.97 140.97 50.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.92 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 89.7 p -57.97 -28.73 64.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.064 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.47 -22.53 46.99 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.683 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 18.0 mmm -81.0 162.44 23.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.876 0.369 . . . . 0.0 110.959 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -107.84 -10.56 15.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.325 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -155.63 -166.97 2.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.798 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.51 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 7.5 m-85 -97.46 32.75 2.17 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.201 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 48.39 40.63 23.44 Favored Glycine 0 C--N 1.335 0.484 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.209 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.902 ' HB2' HD13 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -174.65 116.37 0.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.076 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.43 155.19 19.37 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 121.112 0.482 . . . . 0.0 112.155 -177.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.769 HG11 HD11 ' A' ' 71' ' ' LEU . 34.1 m -116.1 169.86 6.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.07 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.856 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . . . -129.51 176.74 7.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.87 0.367 . . . . 0.0 111.358 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.8 140.76 30.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.764 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -110.71 103.57 1.65 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.521 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 mp -94.17 -31.54 14.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.184 0.516 . . . . 0.0 110.828 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.498 HD12 ' HG3' ' A' ' 46' ' ' GLU . 0.5 OUTLIER -84.28 -3.91 58.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.506 179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.498 ' HG3' HD12 ' A' ' 45' ' ' LEU . 11.2 mt-10 -153.07 27.01 0.53 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.098 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 26.99 95.47 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 159.99 -155.46 26.58 Favored Glycine 0 CA--C 1.517 0.176 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.435 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.744 HG13 ' O ' ' A' ' 41' ' ' ALA . 80.5 t -141.76 138.01 31.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.79 0.328 . . . . 0.0 111.042 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.462 ' CD1' ' HG3' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -134.43 165.09 25.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.41 179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.08 HG11 HD11 ' A' ' 54' ' ' ILE . 3.8 t -63.84 162.76 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.625 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.856 ' HE2' ' HB2' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -145.4 -36.97 0.28 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.028 0.442 . . . . 0.0 111.325 -179.403 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.557 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 2.0 m-80 -140.24 145.21 37.06 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.326 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 1.08 HD11 HG11 ' A' ' 51' ' ' VAL . 5.0 mm -134.92 119.07 26.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.907 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.56 131.98 94.93 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.714 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.621 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 67.1 Cg_endo -74.0 121.82 7.22 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.491 2.127 . . . . 0.0 112.443 -179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.621 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 87.77 -20.8 0.19 Allowed 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.73 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.16 -170.74 30.87 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.415 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.672 ' HA ' HD12 ' A' ' 62' ' ' LEU . 55.1 Cg_exo -51.93 -25.77 22.82 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.529 2.153 . . . . 0.0 112.247 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' HA3' HG23 ' A' ' 54' ' ' ILE . . . -65.47 -45.83 88.26 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.367 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -73.55 -33.03 64.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.947 0.403 . . . . 0.0 110.3 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.672 HD12 ' HA ' ' A' ' 59' ' ' PRO . 57.3 mt -62.07 -37.97 87.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.821 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -78.16 -52.05 5.45 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.38 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.35 44.99 1.91 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.611 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.053 HD21 HD21 ' A' ' 27' ' ' LEU . 0.5 OUTLIER -111.56 126.21 54.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.849 0.357 . . . . 0.0 110.928 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.8 mttp -75.12 164.69 59.58 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.107 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.62 64.78 3.83 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.767 2.311 . . . . 0.0 112.366 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.463 ' HB3' ' HG3' ' A' ' 104' ' ' ARG . 0.0 OUTLIER -176.32 -25.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.527 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.727 ' CG ' HD13 ' A' ' 102' ' ' ILE . 71.1 m-20 -39.56 90.84 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.455 0.645 . . . . 0.0 111.852 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.574 ' O ' HD23 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -67.63 99.3 0.77 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.644 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.005 HD23 HD13 ' A' ' 100' ' ' LEU . 0.5 OUTLIER -56.72 111.68 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.527 -179.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.939 HD12 HD21 ' A' ' 22' ' ' LEU . 6.5 mt -82.97 -44.82 14.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.693 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.6 142.37 32.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.762 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.599 HG23 ' OG1' ' A' ' 79' ' ' THR . 47.8 t -129.85 152.04 36.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.88 0.371 . . . . 0.0 111.492 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.0 m120 40.21 31.85 0.11 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.98 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 76.01 42.98 0.18 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.845 0.355 . . . . 0.0 110.898 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 72.8 t -152.15 152.95 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.86 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.05 129.06 38.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.73 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.599 ' OG1' HG23 ' A' ' 74' ' ' VAL . 66.8 p -144.47 28.14 1.34 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.017 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.694 ' CG ' HD22 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -83.74 -44.95 13.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.736 179.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -92.28 15.77 13.03 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.34 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.555 ' CD2' HG22 ' A' ' 79' ' ' THR . 5.5 m-30 -81.85 167.53 18.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.872 0.368 . . . . 0.0 110.903 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.534 ' O ' HG23 ' A' ' 87' ' ' VAL . 0.9 OUTLIER -106.81 162.05 14.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.455 179.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.893 ' O ' HG23 ' A' ' 88' ' ' VAL . 22.9 p -51.8 -38.64 56.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.762 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 16.1 p -65.89 -24.6 66.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.4 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.727 ' O ' HD12 ' A' ' 90' ' ' LEU . 0.1 OUTLIER -93.4 -29.2 15.71 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.012 0.434 . . . . 0.0 110.913 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.661 HG21 ' HB ' ' A' ' 49' ' ' VAL . 45.0 t -78.0 -35.57 20.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.311 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 84' ' ' CYS . 94.1 t -58.79 -51.16 83.82 Favored Pre-proline 0 CA--C 1.53 0.197 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.791 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.649 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 17.0 Cg_exo -67.11 -44.54 4.94 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.555 2.17 . . . . 0.0 111.428 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 86' ' ' LEU . 8.0 mt -54.07 -30.99 50.39 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 121.072 0.463 . . . . 0.0 110.431 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.628 HG23 HD12 ' A' ' 98' ' ' LEU . 71.6 mt -79.08 -48.86 20.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.128 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.5 -4.16 28.78 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.485 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -103.39 8.19 38.07 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 111.911 0.337 . . . . 0.0 111.911 -179.781 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.413 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 0.9 OUTLIER -64.41 -39.43 93.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.227 0.537 . . . . 0.0 110.238 179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 103.59 -47.28 1.11 Allowed Glycine 0 C--N 1.32 -0.36 0 CA-C-N 115.238 -0.892 . . . . 0.0 113.009 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.426 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -166.35 -36.12 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.682 0.277 . . . . 0.0 111.388 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -123.49 114.47 20.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.428 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.628 HD12 HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -100.99 97.58 8.14 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.548 -179.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -95.91 118.12 31.93 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.641 -0.504 . . . . 0.0 109.641 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 1.005 HD13 HD23 ' A' ' 71' ' ' LEU . 1.1 pp -146.44 156.04 43.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.993 0.425 . . . . 0.0 111.892 -178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.878 HG12 HD22 ' A' ' 22' ' ' LEU . 16.5 t -106.34 109.37 27.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.26 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.727 HD13 ' CG ' ' A' ' 69' ' ' ASP . 2.6 pp -106.28 170.12 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.46 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.528 ' HB3' HG21 ' A' ' 20' ' ' VAL . 0.1 OUTLIER -142.5 130.78 22.17 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.787 179.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' A' ' 69' ' ' ASP . 0.6 OUTLIER -148.03 139.73 23.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.919 0.39 . . . . 0.0 111.123 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 1.4 p-10 -79.48 120.88 81.82 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.397 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.486 ' HD2' ' CB ' ' A' ' 16' ' ' SER . 20.9 Cg_exo . . . . . 0 C--O 1.248 0.999 0 C-N-CA 122.324 2.016 . . . . 0.0 112.232 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.419 ' CB ' ' HD3' ' A' ' 17' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 120.557 0.218 . . . . 0.0 111.556 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.419 ' HD3' ' CB ' ' A' ' 16' ' ' SER . 5.5 Cg_exo -74.36 49.36 2.03 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.705 2.27 . . . . 0.0 112.55 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.433 ' HB ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -169.77 -51.91 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.136 179.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.433 ' HD3' ' HB ' ' A' ' 18' ' ' THR . 2.4 Cg_endo -85.72 24.28 0.77 Allowed 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 123.119 2.546 . . . . 0.0 112.875 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.442 HG21 ' OG ' ' A' ' 103' ' ' SER . 6.7 m -42.94 135.69 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.76 122.32 38.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.324 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.917 HD21 ' CD1' ' A' ' 72' ' ' LEU . 14.0 mt -60.46 149.16 35.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.089 0.471 . . . . 0.0 111.759 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.5 117.91 3.14 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.193 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.9 ttpt -70.73 131.97 44.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.903 HG11 ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -132.85 141.32 45.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.014 0.435 . . . . 0.0 111.229 -179.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.1 m -134.63 109.48 8.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.237 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.767 HD21 HD11 ' A' ' 65' ' ' LEU . 8.1 mt -107.15 166.49 10.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.015 0.436 . . . . 0.0 111.726 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -121.03 147.08 46.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.491 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.14 155.1 17.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.939 0.4 . . . . 0.0 111.124 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -114.04 156.53 23.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.828 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.4 t -68.27 82.59 0.24 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.026 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 114.41 21.95 5.32 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.725 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.77 124.62 29.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.78 0.324 . . . . 0.0 110.817 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -72.13 -10.9 60.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.343 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -156.33 -175.14 5.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.726 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.568 ' CD2' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -106.9 29.82 6.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.844 0.354 . . . . 0.0 111.115 -179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 88.3 7.47 72.86 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.623 -0.798 . . . . 0.0 113.114 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.484 ' HB2' HG12 ' A' ' 54' ' ' ILE . 0.1 OUTLIER -171.6 148.69 2.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.038 0.419 . . . . 0.0 111.608 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 52' ' ' LYS . 2.4 m -117.84 144.57 45.28 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.594 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.711 HG12 ' HA ' ' A' ' 51' ' ' VAL . 27.1 m -112.39 165.61 7.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.775 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.765 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . . . -129.6 161.59 30.2 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.051 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.4 p-10 -72.49 167.37 20.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.89 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.74 126.26 8.4 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.354 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.47 0.14 55.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.49 0.186 . . . . 0.0 111.422 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 93.0 mt -154.05 19.7 0.51 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.501 0.191 . . . . 0.0 111.355 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.463 ' O ' ' C ' ' A' ' 47' ' ' LYS . 81.8 mm-40 -155.36 22.24 0.42 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.743 -0.208 . . . . 0.0 111.196 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.463 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.2 OUTLIER 24.82 50.22 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.433 0.458 . . . . 0.0 112.129 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -145.25 -166.21 11.63 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.535 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.618 HG12 ' HB ' ' A' ' 40' ' ' VAL . 72.2 t -135.22 139.7 46.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.889 0.376 . . . . 0.0 111.219 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -139.51 153.99 47.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.507 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.711 ' HA ' HG12 ' A' ' 40' ' ' VAL . 51.4 t -57.07 162.21 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.616 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.765 ' HE2' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -142.85 -34.13 0.44 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.876 0.369 . . . . 0.0 111.591 -179.419 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.456 ' O ' ' HA ' ' A' ' 38' ' ' PHE . 37.2 m-80 -144.28 123.95 13.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.916 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.661 HD11 HG11 ' A' ' 51' ' ' VAL . 1.1 mt -123.57 123.25 66.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.268 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.95 117.36 44.84 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.411 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.418 ' HA ' ' HB2' ' A' ' 61' ' ' ASP . 58.1 Cg_endo -71.48 56.4 2.18 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.468 2.112 . . . . 0.0 112.599 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -173.04 -51.63 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.143 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.86 -170.48 0.29 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.654 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.509 ' HA ' HD12 ' A' ' 62' ' ' LEU . 50.0 Cg_exo -53.35 -31.87 58.99 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.626 2.217 . . . . 0.0 112.36 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.83 -51.58 56.14 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.575 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.418 ' HB2' ' HA ' ' A' ' 56' ' ' PRO . 7.5 t70 -73.48 -33.01 64.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.958 0.408 . . . . 0.0 110.396 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 59' ' ' PRO . 90.1 mt -59.38 -41.64 89.81 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.031 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -77.1 -50.93 6.47 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.543 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 124.26 42.56 0.35 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.442 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.903 ' CD2' HG11 ' A' ' 25' ' ' VAL . 19.3 mt -91.42 147.54 22.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.783 0.325 . . . . 0.0 110.845 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -139.23 161.88 55.01 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.465 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 50.9 Cg_exo -53.82 147.92 39.43 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.596 2.197 . . . . 0.0 112.154 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.465 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 4.8 m-85 88.62 -12.55 0.42 Allowed 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.229 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.594 ' CG ' HD13 ' A' ' 102' ' ' ILE . 1.1 m-20 -52.88 85.73 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.93 0.395 . . . . 0.0 110.965 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.599 ' O ' HD23 ' A' ' 72' ' ' LEU . 21.2 ttm180 -74.04 95.12 2.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.462 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.973 HD23 HD13 ' A' ' 100' ' ' LEU . 1.7 mt -56.26 112.24 1.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.917 ' CD1' HD21 ' A' ' 22' ' ' LEU . 4.9 mt -81.2 -64.0 1.28 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.923 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.64 140.53 46.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.095 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.896 ' O ' HG12 ' A' ' 77' ' ' VAL . 24.3 t -118.6 116.16 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.002 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.461 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 0.2 OUTLIER 68.74 28.25 5.61 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.613 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.461 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER 85.81 -7.03 0.82 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.648 -179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.896 HG12 ' O ' ' A' ' 74' ' ' VAL . 4.6 p -83.97 134.61 26.58 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 CA-C-O 120.818 0.342 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 14.4 mtt85 -70.56 118.2 13.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.95 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.692 HG23 HG13 ' A' ' 77' ' ' VAL . 30.6 p -145.47 35.94 1.08 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.668 ' CG ' HD22 ' A' ' 72' ' ' LEU . 1.6 ttp180 -75.87 -48.74 20.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.817 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -92.82 25.58 3.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.063 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.723 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.4 m-85 -81.75 170.08 16.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.957 0.408 . . . . 0.0 110.861 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.21 159.09 16.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.272 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.889 ' O ' HG23 ' A' ' 88' ' ' VAL . 6.5 p -51.38 -41.53 60.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.832 0.349 . . . . 0.0 110.726 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.2 m -63.36 -24.57 67.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.164 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.615 ' O ' HD12 ' A' ' 90' ' ' LEU . 10.9 mp -91.09 -30.29 16.82 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 121.012 0.434 . . . . 0.0 110.847 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.464 HG12 ' CD1' ' A' ' 91' ' ' ILE . 65.7 t -79.3 -35.82 17.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.28 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.889 HG23 ' O ' ' A' ' 84' ' ' CYS . 68.0 t -55.3 -51.3 80.95 Favored Pre-proline 0 C--N 1.331 -0.213 0 C-N-CA 120.903 -0.319 . . . . 0.0 110.696 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.656 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 14.5 Cg_exo -68.33 -46.53 2.03 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.39 2.06 . . . . 0.0 111.294 178.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.723 HD11 ' HE2' ' A' ' 82' ' ' PHE . 15.4 mt -54.65 -29.38 52.2 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.008 0.433 . . . . 0.0 110.421 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.639 HG23 ' CD1' ' A' ' 98' ' ' LEU . 47.7 mt -73.91 -51.56 23.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.205 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.39 -2.74 36.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.884 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -92.15 -7.47 48.34 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.413 ' HB2' ' HG ' ' A' ' 98' ' ' LEU . 1.5 t -64.59 -16.51 62.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.873 0.368 . . . . 0.0 111.609 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.56 -52.68 3.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.687 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -165.98 -45.75 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.75 0.309 . . . . 0.0 110.985 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.3 mtpt -101.04 107.22 18.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.475 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.639 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.9 OUTLIER -95.96 97.84 9.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.579 -179.428 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -101.34 118.2 36.49 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.973 HD13 HD23 ' A' ' 71' ' ' LEU . 1.3 pp -147.87 163.56 36.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.105 0.478 . . . . 0.0 112.088 -178.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.892 HG12 HD22 ' A' ' 22' ' ' LEU . 21.7 t -114.85 109.4 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.217 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.808 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.4 pp -103.95 169.37 2.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.216 -179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.442 ' OG ' HG21 ' A' ' 20' ' ' VAL . 71.5 p -126.29 107.63 10.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.555 179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.42 113.45 25.91 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.345 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.416 ' HB3' ' O ' ' A' ' 16' ' ' SER . 0.7 OUTLIER -62.72 158.76 49.23 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.935 179.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo . . . . . 0 C--O 1.25 1.108 0 C-N-CA 122.578 2.185 . . . . 0.0 112.394 -179.908 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.787 0.327 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -62.49 -66.62 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.593 2.195 . . . . 0.0 112.208 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.573 HG22 ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -67.82 147.91 98.52 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.096 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.573 ' HD2' HG22 ' A' ' 18' ' ' THR . 17.0 Cg_exo -67.04 -8.85 23.01 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.692 2.261 . . . . 0.0 112.682 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.499 ' HA ' ' N ' ' A' ' 105' ' ' ASN . 28.5 m -158.95 168.0 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-O 120.974 0.416 . . . . 0.0 111.493 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -139.45 122.5 16.78 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.91 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.825 HD22 HG12 ' A' ' 101' ' ' VAL . 11.9 mt -59.74 136.47 58.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.082 0.468 . . . . 0.0 111.667 -179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.716 ' HD2' HD11 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -152.47 119.07 5.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.127 179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.16 130.45 42.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.68 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.448 HG13 ' CE1' ' A' ' 23' ' ' HIS . 0.0 OUTLIER -131.45 140.83 47.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.071 0.462 . . . . 0.0 111.343 -179.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.9 m -134.41 106.92 7.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.944 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.016 HD11 HD11 ' A' ' 65' ' ' LEU . 2.6 mt -106.88 174.46 5.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.002 0.43 . . . . 0.0 111.543 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 96' ' ' ASN . 42.5 m-85 -123.07 165.67 16.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.693 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -128.34 120.68 27.51 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.852 0.358 . . . . 0.0 111.437 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -75.41 128.32 35.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.464 179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.14 -29.22 0.87 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.751 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -86.32 -38.36 8.42 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.847 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.82 146.7 28.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.877 0.37 . . . . 0.0 111.206 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -103.04 -33.29 9.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.286 0.565 . . . . 0.0 110.603 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.35 152.64 23.11 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.285 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.518 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 0.8 OUTLIER -91.13 15.19 12.22 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 -179.569 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.08 23.54 57.01 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.627 -0.797 . . . . 0.0 113.39 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.603 ' CD1' HG22 ' A' ' 51' ' ' VAL . 6.5 p90 -174.15 119.82 0.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 117.179 0.49 . . . . 0.0 111.549 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 46.1 m -91.88 154.14 19.06 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.631 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.712 ' HB ' HG12 ' A' ' 49' ' ' VAL . 24.1 m -112.17 170.93 3.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.011 0.434 . . . . 0.0 111.688 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.754 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -139.09 164.36 29.97 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.021 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -72.79 154.85 40.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.911 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -128.99 109.13 0.95 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.394 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.7 mt -94.28 -25.41 17.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.432 . . . . 0.0 111.182 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 28.9 tp -83.81 -6.71 59.49 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.532 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 47' ' ' LYS . 5.2 mt-10 -153.1 27.39 0.52 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.935 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER 26.54 78.48 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.127 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -177.02 -152.0 9.51 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.475 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 41' ' ' ALA . 23.8 t -144.49 138.42 23.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.875 0.369 . . . . 0.0 111.264 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.433 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -130.61 174.37 9.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.313 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.603 HG22 ' CD1' ' A' ' 38' ' ' PHE . 58.3 t -78.72 122.89 34.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.039 0.447 . . . . 0.0 111.255 -179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.558 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -89.1 -29.53 19.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.777 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.429 ' ND2' ' HG3' ' A' ' 52' ' ' LYS . 38.7 m-80 -157.59 155.3 29.92 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.35 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.539 HD13 ' CB ' ' A' ' 38' ' ' PHE . 0.9 OUTLIER -137.85 130.7 41.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.561 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.407 ' HA ' ' HD3' ' A' ' 56' ' ' PRO . 0.4 OUTLIER -64.38 127.4 92.14 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.873 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 55' ' ' ARG . 43.6 Cg_exo -56.49 140.02 88.46 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.454 2.103 . . . . 0.0 112.367 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 39.27 33.35 0.09 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.931 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.6 -161.75 21.32 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.259 179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -57.6 -42.9 55.7 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.366 2.044 . . . . 0.0 112.147 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.661 ' HA2' HD12 ' A' ' 65' ' ' LEU . . . -65.87 -44.98 90.93 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.787 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -73.37 -32.62 64.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.028 0.442 . . . . 0.0 110.405 179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 35.2 mt -67.54 -30.93 70.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.737 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -81.8 -38.6 13.46 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.395 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 117.53 31.52 1.64 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.565 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.016 HD11 HD11 ' A' ' 27' ' ' LEU . 28.4 mt -83.7 123.24 29.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.859 0.362 . . . . 0.0 111.021 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 11.2 mmtp -113.88 138.59 22.83 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.55 179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 77.6 Cg_exo -40.44 139.87 1.07 Allowed 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.933 2.422 . . . . 0.0 113.144 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.476 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 48.9 m-85 88.7 -13.12 0.4 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.64 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.801 ' CB ' HD13 ' A' ' 102' ' ' ILE . 8.4 p-10 -55.99 85.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.064 0.459 . . . . 0.0 110.562 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.45 ' N ' ' O ' ' A' ' 68' ' ' TYR . 10.1 ttm180 -66.58 118.15 9.77 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.87 -179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.762 ' CD2' HD22 ' A' ' 100' ' ' LEU . 1.1 mt -72.5 112.07 8.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.286 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.618 HD23 ' HG3' ' A' ' 80' ' ' ARG . 5.0 mp -84.67 -67.07 0.82 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.093 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -115.5 110.42 19.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.456 ' HA ' ' HB3' ' A' ' 100' ' ' LEU . 46.6 t -102.75 143.05 15.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.874 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.456 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 0.5 OUTLIER 46.58 29.58 0.95 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.29 -179.687 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.456 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.8 OUTLIER 85.9 -19.1 0.32 Allowed 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.773 179.658 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 43.0 t -83.98 136.0 23.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.818 0.342 . . . . 0.0 111.203 -179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -69.15 116.57 9.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.252 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.626 HG22 ' CE2' ' A' ' 82' ' ' PHE . 32.2 p -141.53 38.77 1.69 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.412 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.618 ' HG3' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -69.87 -46.57 65.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.589 179.679 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -94.38 27.81 2.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.44 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.626 ' CE2' HG22 ' A' ' 79' ' ' THR . 2.5 m-30 -81.09 176.3 9.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.811 0.338 . . . . 0.0 110.657 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.517 ' O ' HG23 ' A' ' 87' ' ' VAL . 3.6 t70 -108.26 158.79 17.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.511 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.841 ' O ' HG23 ' A' ' 88' ' ' VAL . 5.3 p -51.56 -41.88 61.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.004 0.431 . . . . 0.0 110.654 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 37.3 m -63.15 -21.74 66.4 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.08 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.501 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 7.7 mp -96.48 -33.16 11.96 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.002 0.429 . . . . 0.0 111.022 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.642 HG21 ' HB ' ' A' ' 49' ' ' VAL . 37.8 t -77.61 -36.05 22.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.374 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 84' ' ' CYS . 93.3 t -58.54 -51.29 82.89 Favored Pre-proline 0 C--N 1.33 -0.241 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.79 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.666 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.5 Cg_exo -67.32 -40.93 10.01 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.334 2.023 . . . . 0.0 111.528 179.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.595 HD13 HG21 ' A' ' 79' ' ' THR . 25.3 mt -54.55 -33.88 60.89 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 121.027 0.441 . . . . 0.0 110.763 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.879 ' HA ' HD11 ' A' ' 98' ' ' LEU . 25.0 mt -78.34 -44.33 26.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.125 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -81.22 -2.75 49.95 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.423 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -104.81 6.66 34.13 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 -178.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.445 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -63.39 -35.1 79.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.371 0.605 . . . . 0.0 110.253 179.481 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 97.85 -41.87 2.21 Favored Glycine 0 N--CA 1.451 -0.343 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.719 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 6.1 m-80 -166.82 -35.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.511 0.196 . . . . 0.0 111.328 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.1 mtpp -122.76 131.58 53.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.692 0.282 . . . . 0.0 110.942 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.879 HD11 ' HA ' ' A' ' 91' ' ' ILE . 0.5 OUTLIER -120.62 97.49 5.58 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.433 -179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -96.36 118.4 32.81 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.762 HD22 ' CD2' ' A' ' 71' ' ' LEU . 2.6 pp -150.22 162.52 40.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.342 0.592 . . . . 0.0 112.451 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.825 HG12 HD22 ' A' ' 22' ' ' LEU . 25.0 t -114.17 109.1 27.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.21 -0.904 . . . . 0.0 109.699 178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.801 HD13 ' CB ' ' A' ' 69' ' ' ASP . 2.6 pp -104.07 169.45 2.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.465 -179.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.438 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -133.73 112.39 11.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.766 179.656 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.63 133.42 43.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.001 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.499 ' N ' ' HA ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -62.71 152.01 82.91 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.77 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo . . . . . 0 C--O 1.248 1.023 0 C-N-CA 122.568 2.179 . . . . 0.0 112.273 -179.927 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.3 m . . . . . 0 N--CA 1.488 1.464 0 CA-C-O 120.755 0.312 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -69.74 -74.65 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.407 2.072 . . . . 0.0 112.559 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.544 ' HB ' ' CD ' ' A' ' 19' ' ' PRO . 1.3 m -167.99 -58.98 0.01 OUTLIER Pre-proline 0 CA--C 1.53 0.185 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.004 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.544 ' CD ' ' HB ' ' A' ' 18' ' ' THR . 11.4 Cg_endo -54.43 127.15 24.75 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.223 1.949 . . . . 0.0 112.22 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 19.7 m -40.48 160.3 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.139 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -121.53 122.45 39.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.393 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.838 HD22 HG12 ' A' ' 101' ' ' VAL . 13.7 mt -60.87 140.65 57.63 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.313 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.478 ' HB2' HD11 ' A' ' 102' ' ' ILE . 53.7 m-70 -146.52 106.62 4.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.936 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -71.44 109.49 5.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.047 179.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.429 HG11 ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -114.89 141.26 32.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.115 0.484 . . . . 0.0 111.8 -179.079 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.551 HG23 ' OD1' ' A' ' 99' ' ' ASP . 95.5 m -133.06 106.63 7.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.866 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 1.122 HD11 HD11 ' A' ' 65' ' ' LEU . 7.8 mt -105.21 -177.59 3.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.933 0.397 . . . . 0.0 111.608 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.444 ' CD2' ' HG2' ' A' ' 97' ' ' LYS . 16.2 m-85 -135.83 153.59 51.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.529 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -116.1 164.77 13.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.031 0.444 . . . . 0.0 111.423 -179.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -106.16 152.9 22.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.672 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.25 -28.8 29.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.338 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.49 36.71 2.05 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.644 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.4 ttt -81.68 149.14 28.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.748 0.308 . . . . 0.0 110.926 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -96.04 -10.91 27.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.204 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -156.82 176.11 13.18 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.646 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.506 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -102.36 27.07 7.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.168 -179.862 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 85.62 5.24 84.64 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.263 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.78 ' CD2' HD13 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -173.03 141.67 1.0 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.017 0.437 . . . . 0.0 111.475 179.89 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 21.5 m -107.72 153.42 22.96 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.352 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.742 HG11 ' CD1' ' A' ' 71' ' ' LEU . 32.6 m -118.58 164.97 14.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.393 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -132.73 141.66 48.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.08 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -55.98 164.88 1.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.112 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -113.79 140.56 16.42 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.339 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.72 -58.33 2.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.108 0.48 . . . . 0.0 111.423 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.13 -41.98 16.51 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.726 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' O ' ' C ' ' A' ' 47' ' ' LYS . 18.0 mt-10 -88.4 10.68 19.17 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.616 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 26.36 78.2 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -169.54 -139.16 2.65 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.488 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.698 HG12 ' HB ' ' A' ' 40' ' ' VAL . 41.7 t -155.8 138.41 6.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.602 0.239 . . . . 0.0 111.109 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.76 156.48 47.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.829 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.468 ' CG2' ' HB2' ' A' ' 69' ' ' ASP . 62.0 t -64.03 121.17 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.989 0.423 . . . . 0.0 111.249 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.97 -30.64 17.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.181 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -160.34 154.99 23.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.503 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.455 HG23 ' HB3' ' A' ' 38' ' ' PHE . 1.1 mt -133.44 125.94 51.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.1 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -65.51 114.7 16.81 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.71 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.636 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 50.1 Cg_exo -53.62 125.07 17.4 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.293 1.996 . . . . 0.0 112.185 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.636 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 89.14 -28.88 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.586 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -58.86 -179.66 1.27 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.472 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.46 ' O ' HD22 ' A' ' 27' ' ' LEU . 58.4 Cg_exo -51.69 -34.6 54.42 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.601 2.201 . . . . 0.0 112.293 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.635 ' HA2' HD12 ' A' ' 65' ' ' LEU . . . -60.97 -46.71 94.04 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.592 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.42 -32.71 64.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.983 0.42 . . . . 0.0 110.357 179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.4 mt -63.02 -32.76 74.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.897 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -86.44 -46.63 5.17 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.55 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.81 33.89 0.96 Allowed Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.765 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.122 HD11 HD11 ' A' ' 27' ' ' LEU . 24.6 mt -73.85 145.94 44.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.775 0.321 . . . . 0.0 110.859 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.411 ' CD ' ' NH1' ' A' ' 104' ' ' ARG . 11.5 mttm -125.64 159.16 62.22 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.968 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.423 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 15.7 Cg_endo -56.96 141.6 93.72 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.76 2.306 . . . . 0.0 112.13 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.546 ' O ' ' N ' ' A' ' 70' ' ' ARG . 31.5 m-85 84.42 0.62 0.9 Allowed 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.245 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.55 ' CG ' HD13 ' A' ' 102' ' ' ILE . 3.2 m-20 -52.97 80.33 0.0 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.976 0.417 . . . . 0.0 110.733 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.546 ' N ' ' O ' ' A' ' 68' ' ' TYR . 41.0 ttp180 -66.82 103.86 1.21 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.148 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.823 ' HA ' HG22 ' A' ' 102' ' ' ILE . 3.5 mp -63.2 107.39 1.04 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.809 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.668 HD22 ' HG2' ' A' ' 80' ' ' ARG . 8.2 mt -84.98 -67.23 0.81 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.853 0.359 . . . . 0.0 111.155 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -116.21 112.85 22.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.073 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.607 HG23 ' OG1' ' A' ' 79' ' ' THR . 40.9 t -103.71 125.28 58.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.963 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.459 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 1.1 m-80 45.69 36.9 2.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.398 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.459 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.4 OUTLIER 87.49 -22.66 0.14 Allowed 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.736 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.0 t -83.39 134.9 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.775 0.321 . . . . 0.0 111.141 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -69.38 136.01 51.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.814 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.607 ' OG1' HG23 ' A' ' 74' ' ' VAL . 76.2 p -144.91 25.02 1.46 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.179 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.668 ' HG2' HD22 ' A' ' 72' ' ' LEU . 3.4 mtm180 -71.98 -48.45 44.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.883 0.373 . . . . 0.0 110.62 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -92.59 16.03 12.97 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.363 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.41 ' CG ' ' HA ' ' A' ' 79' ' ' THR . 3.3 m-85 -82.05 176.41 9.55 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.86 0.362 . . . . 0.0 110.818 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.87 160.46 18.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.559 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 6.4 p -51.62 -34.82 39.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.725 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 96.0 m -70.15 -21.69 63.05 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.223 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.609 ' C ' ' HD2' ' A' ' 89' ' ' PRO . 0.5 OUTLIER -97.59 -32.32 11.85 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.915 0.388 . . . . 0.0 111.014 -179.823 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.543 HG11 HD13 ' A' ' 71' ' ' LEU . 46.3 t -79.92 -35.94 16.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.453 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.836 HG12 ' HD3' ' A' ' 89' ' ' PRO . 3.7 p -61.87 -41.2 75.53 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 120.606 -0.437 . . . . 0.0 111.439 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.836 ' HD3' HG12 ' A' ' 88' ' ' VAL . 72.3 Cg_endo -74.55 -45.55 0.32 Allowed 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 121.806 1.67 . . . . 0.0 111.316 178.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 86' ' ' LEU . 36.3 mt -54.48 -29.38 49.84 Favored 'General case' 0 N--CA 1.456 -0.127 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.347 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.939 HG23 ' CD1' ' A' ' 98' ' ' LEU . 62.2 mt -78.45 -47.12 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.55 179.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.63 -3.97 31.37 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -179.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 0.4 OUTLIER -112.26 -0.64 15.41 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.764 -179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.418 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 16.5 m -64.79 -16.41 63.01 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.834 0.35 . . . . 0.0 111.139 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.91 -148.37 18.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.586 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -73.5 -8.52 56.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.616 0.246 . . . . 0.0 111.419 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.444 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -140.96 147.85 39.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.737 0.303 . . . . 0.0 110.863 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.939 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -132.13 97.45 4.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.219 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.551 ' OD1' HG23 ' A' ' 26' ' ' THR . 0.4 OUTLIER -93.53 118.3 31.18 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.077 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.752 HD23 HD22 ' A' ' 98' ' ' LEU . 1.9 pp -149.85 154.93 39.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.168 0.509 . . . . 0.0 112.096 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.838 HG12 HD22 ' A' ' 22' ' ' LEU . 23.5 t -111.53 109.16 27.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.954 178.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.823 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.7 pp -105.82 166.1 3.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.01 0.433 . . . . 0.0 111.596 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.7 p -134.12 129.09 35.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.551 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.468 ' HG3' ' HB2' ' A' ' 68' ' ' TYR . 6.0 ttp180 -127.74 135.78 50.61 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.033 0.444 . . . . 0.0 111.48 -179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -96.82 111.59 57.93 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.404 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 C--O 1.249 1.046 0 C-N-CA 122.236 1.958 . . . . 0.0 112.356 -179.86 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.657 0.265 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.97 -18.92 45.42 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.682 2.255 . . . . 0.0 112.315 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.542 HG22 ' HD2' ' A' ' 19' ' ' PRO . 5.3 m -150.14 145.8 19.26 Favored Pre-proline 0 N--CA 1.45 -0.427 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.696 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.542 ' HD2' HG22 ' A' ' 18' ' ' THR . 52.8 Cg_exo -53.16 -171.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.394 2.062 . . . . 0.0 112.138 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 105' ' ' ASN . 35.2 m -45.51 129.77 2.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.929 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.54 122.05 45.22 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.727 HD13 ' CG1' ' A' ' 101' ' ' VAL . 4.4 pp -100.33 153.15 19.55 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.199 0.523 . . . . 0.0 112.264 -178.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.855 ' CD2' HD11 ' A' ' 102' ' ' ILE . 20.9 p80 -144.9 152.22 39.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.698 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.2 ttmm -78.55 104.25 9.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.448 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.67 HG22 ' CE1' ' A' ' 23' ' ' HIS . 0.1 OUTLIER -99.22 144.62 11.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.364 -179.525 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.419 HG23 ' OD2' ' A' ' 99' ' ' ASP . 96.4 m -135.09 106.42 6.78 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.84 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.804 HD21 ' CD1' ' A' ' 65' ' ' LEU . 1.1 mp -105.36 175.18 5.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.033 0.444 . . . . 0.0 111.357 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.451 ' N ' ' CD1' ' A' ' 28' ' ' TYR . 1.5 m-85 -131.51 155.88 46.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.248 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.435 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -118.46 149.77 40.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.914 0.388 . . . . 0.0 111.322 -179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -115.15 152.85 31.85 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.741 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.2 m -63.62 -26.25 68.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.257 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.26 1.75 46.96 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.08 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 3.3 mmt -81.78 124.57 29.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.896 0.379 . . . . 0.0 110.976 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.03 -10.77 59.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.365 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -155.59 -167.92 2.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.641 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.526 ' CD2' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -105.46 17.49 23.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.559 -179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.454 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 91.19 7.15 65.91 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.499 -0.858 . . . . 0.0 113.531 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.571 ' CD2' HG22 ' A' ' 51' ' ' VAL . 25.6 p90 -173.62 145.79 1.24 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 117.26 0.53 . . . . 0.0 111.716 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.75 146.68 41.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.191 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.493 HG11 ' CD1' ' A' ' 71' ' ' LEU . 34.6 m -105.31 171.02 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.662 -179.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -131.08 178.13 6.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.948 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -89.98 129.0 36.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.808 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -98.12 100.5 2.36 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.272 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.3 -24.05 17.58 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.964 0.411 . . . . 0.0 111.176 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.7 mp -83.52 -10.98 57.96 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.32 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 47' ' ' LYS . 3.0 mt-10 -153.36 33.51 0.46 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.968 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 25.24 91.42 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.173 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 173.13 -162.76 34.19 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.42 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.855 HG23 ' O ' ' A' ' 82' ' ' PHE . 64.8 t -139.4 132.1 36.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.79 0.329 . . . . 0.0 110.749 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 50' ' ' TYR . 0.0 OUTLIER -131.87 163.39 28.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.74 -179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.571 HG22 ' CD2' ' A' ' 38' ' ' PHE . 66.7 t -72.37 122.57 25.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.747 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -87.39 -31.0 20.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.422 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -162.67 145.72 11.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.486 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.57 HG23 ' HB3' ' A' ' 38' ' ' PHE . 1.4 mt -127.48 133.59 67.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.943 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.08 144.49 99.07 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.814 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.23 144.03 45.32 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.516 2.144 . . . . 0.0 112.373 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 39.06 33.83 0.09 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.976 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -109.97 -168.14 19.85 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.39 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.406 ' O ' HD23 ' A' ' 27' ' ' LEU . 54.2 Cg_exo -52.2 -39.71 70.94 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.513 2.142 . . . . 0.0 112.152 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -74.39 -36.08 50.73 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.609 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -73.51 -32.83 64.46 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.027 0.441 . . . . 0.0 110.258 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 93.0 mt -77.28 -30.68 54.42 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.804 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.02 -47.81 29.54 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.369 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.46 35.27 1.01 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.554 179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.804 ' CD1' HD21 ' A' ' 27' ' ' LEU . 13.2 mt -91.1 124.0 34.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.785 0.326 . . . . 0.0 110.998 -179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.24 156.1 35.66 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.831 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.447 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 53.6 Cg_exo -51.8 136.27 50.79 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.52 2.146 . . . . 0.0 112.227 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.448 ' O ' ' N ' ' A' ' 70' ' ' ARG . 9.9 m-85 85.5 7.49 0.4 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.004 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.778 ' OD1' HD13 ' A' ' 102' ' ' ILE . 3.8 m-20 -53.56 85.84 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 121.044 0.449 . . . . 0.0 110.993 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.448 ' N ' ' O ' ' A' ' 68' ' ' TYR . 28.6 ttt85 -72.31 96.86 1.91 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.629 -179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.823 ' CD2' HD22 ' A' ' 100' ' ' LEU . 1.2 mp -53.33 107.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.104 -179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.736 HD11 ' HB2' ' A' ' 103' ' ' SER . 3.2 mp -82.17 -62.37 1.64 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.376 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -133.79 130.01 37.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.874 0.369 . . . . 0.0 111.281 -179.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.927 ' O ' HG12 ' A' ' 77' ' ' VAL . 20.1 t -113.66 112.95 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.809 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.467 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 5.4 m-80 66.54 30.27 8.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.636 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.467 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 1.6 t-80 87.21 -12.12 0.53 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.892 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.927 HG12 ' O ' ' A' ' 74' ' ' VAL . 4.3 p -84.13 143.08 12.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-O 120.893 0.378 . . . . 0.0 111.06 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 16.6 mtp85 -70.08 125.47 26.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.527 HG23 HG13 ' A' ' 77' ' ' VAL . 52.8 p -146.39 19.69 1.36 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.348 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.504 ' HG3' HD23 ' A' ' 72' ' ' LEU . 0.0 OUTLIER -66.23 -52.96 42.7 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.953 0.406 . . . . 0.0 110.623 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -94.77 29.33 2.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.239 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.855 ' O ' HG23 ' A' ' 49' ' ' VAL . 1.8 m-30 -80.97 171.79 14.55 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.858 0.361 . . . . 0.0 110.82 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.575 ' C ' HG21 ' A' ' 49' ' ' VAL . 2.4 m-20 -107.26 157.62 17.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.499 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.843 ' O ' HG23 ' A' ' 88' ' ' VAL . 5.7 p -51.49 -38.52 54.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.929 0.395 . . . . 0.0 110.445 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 18.9 m -65.67 -21.56 66.56 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.054 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.729 HD22 ' CE2' ' A' ' 82' ' ' PHE . 0.1 OUTLIER -95.4 -32.12 13.07 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.094 0.474 . . . . 0.0 110.605 179.872 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.698 HG11 HD13 ' A' ' 71' ' ' LEU . 39.0 t -78.26 -35.79 20.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.303 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 84' ' ' CYS . 93.7 t -58.67 -51.01 84.92 Favored Pre-proline 0 C--N 1.331 -0.23 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.975 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.643 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.0 Cg_exo -68.01 -45.64 2.87 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.477 2.118 . . . . 0.0 111.634 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.618 HD11 ' HE2' ' A' ' 82' ' ' PHE . 36.6 mt -54.5 -30.25 52.82 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.998 0.428 . . . . 0.0 110.574 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.929 ' HA ' HD11 ' A' ' 98' ' ' LEU . 70.9 mt -79.17 -49.55 19.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.079 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.48 -2.59 29.56 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.915 0.709 . . . . 0.0 112.915 -178.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.431 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 0.6 OUTLIER -102.07 -1.14 32.26 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.203 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.418 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -64.82 -30.87 71.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.185 0.516 . . . . 0.0 110.768 179.719 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.38 -63.09 0.84 Allowed Glycine 0 C--N 1.322 -0.248 0 CA-C-N 115.468 -0.787 . . . . 0.0 112.252 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.432 ' HA ' ' CB ' ' A' ' 29' ' ' LYS . 18.8 p30 -162.71 18.29 0.08 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.528 0.204 . . . . 0.0 111.3 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.439 ' HE2' ' CE2' ' A' ' 28' ' ' TYR . 3.8 ttmt -161.8 116.77 1.97 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.929 HD11 ' HA ' ' A' ' 91' ' ' ILE . 1.0 OUTLIER -116.16 98.87 6.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.897 -179.141 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.419 ' OD2' HG23 ' A' ' 26' ' ' THR . 1.9 m-20 -98.52 117.98 34.18 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.844 HD23 HD22 ' A' ' 98' ' ' LEU . 1.2 pp -151.69 164.74 36.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.167 0.508 . . . . 0.0 112.097 -178.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.727 ' CG1' HD13 ' A' ' 22' ' ' LEU . 15.5 t -107.5 109.97 30.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.942 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.855 HD11 ' CD2' ' A' ' 23' ' ' HIS . 2.4 pp -100.44 153.75 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.22 -179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.736 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -119.53 127.3 52.88 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.496 179.241 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.21 129.88 11.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.996 0.427 . . . . 0.0 111.682 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 3.4 p30 -62.78 158.23 53.58 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.785 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 C--O 1.249 1.029 0 C-N-CA 122.531 2.154 . . . . 0.0 112.289 -179.951 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.413 ' CB ' ' HB2' ' A' ' 106' ' ' PRO . 9.7 t . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 120.765 0.317 . . . . 0.0 111.401 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.55 -68.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.745 2.296 . . . . 0.0 112.203 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.472 ' HB ' ' CD ' ' A' ' 19' ' ' PRO . 1.8 m -179.05 -61.67 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.665 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.472 ' CD ' ' HB ' ' A' ' 18' ' ' THR . 13.8 Cg_endo -56.79 126.57 22.67 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.567 2.178 . . . . 0.0 112.335 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.701 HG12 ' N ' ' A' ' 105' ' ' ASN . 19.6 m -45.86 144.71 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.171 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.42 ' HG3' ' NH1' ' A' ' 104' ' ' ARG . 11.3 pt-20 -106.92 124.51 49.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.793 HD22 ' CD1' ' A' ' 72' ' ' LEU . 4.7 pp -105.07 153.51 21.38 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -177.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 56.5 m-70 -145.85 156.41 43.54 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.597 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.19 110.64 18.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.25 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.905 HG11 ' HG ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -111.75 146.14 17.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.596 -179.271 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 91.6 m -134.21 106.64 7.25 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.314 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.633 HD11 HD21 ' A' ' 65' ' ' LEU . 3.3 mp -93.53 174.76 7.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.947 0.403 . . . . 0.0 111.561 -179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.433 ' CD1' ' HG3' ' A' ' 97' ' ' LYS . 81.1 m-85 -132.3 141.44 48.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.171 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -116.25 163.14 16.43 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.878 0.37 . . . . 0.0 111.418 -179.69 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -121.75 140.13 52.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.749 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 90.3 p -61.75 84.16 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.055 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 123.86 19.67 2.69 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.075 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -81.79 167.88 18.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.778 0.323 . . . . 0.0 110.8 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -97.52 -18.36 19.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.207 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.62 -171.25 3.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.667 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.807 ' CD2' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -108.71 19.21 19.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.301 179.885 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 104.87 0.46 42.15 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.5 -0.857 . . . . 0.0 113.066 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.579 ' HB3' HG23 ' A' ' 54' ' ' ILE . 14.4 p90 -172.85 145.01 1.39 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.943 0.402 . . . . 0.0 111.453 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 38.1 m -98.19 138.5 35.38 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.172 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.49 HG23 ' SG ' ' A' ' 84' ' ' CYS . 35.8 m -93.74 171.07 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.698 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.49 ' HB2' ' HB3' ' A' ' 52' ' ' LYS . . . -136.3 178.19 7.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.093 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.57 131.33 45.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.738 179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.449 ' HA3' ' CZ ' ' A' ' 50' ' ' TYR . . . -104.0 108.96 3.28 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.528 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -94.48 -25.15 17.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.001 0.429 . . . . 0.0 111.069 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.42 ' HA ' HD22 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -83.94 -7.36 59.44 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.592 -179.917 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 47' ' ' LYS . 5.2 mt-10 -153.17 25.22 0.54 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.168 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.443 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 27.38 80.86 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -170.22 -156.39 11.15 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.695 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.537 ' HB ' HG21 ' A' ' 87' ' ' VAL . 95.2 t -137.68 131.24 43.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.806 0.336 . . . . 0.0 111.044 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.449 ' CZ ' ' HA3' ' A' ' 43' ' ' GLY . 0.1 OUTLIER -128.56 172.41 11.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.246 179.546 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.539 HG11 HG12 ' A' ' 54' ' ' ILE . 88.7 t -90.77 123.68 43.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.83 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.49 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 3.7 ptpp? -86.99 -30.73 21.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.362 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -161.76 144.9 12.15 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.652 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.597 HD12 ' O ' ' A' ' 65' ' ' LEU . 1.7 mt -126.08 135.84 62.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.996 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.6 mtt180 -65.37 143.87 98.84 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.724 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.09 143.22 35.65 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.501 2.134 . . . . 0.0 112.481 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 39.57 33.77 0.13 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.894 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.56 -159.24 13.3 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.265 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.79 -53.79 6.22 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.477 2.118 . . . . 0.0 112.033 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.22 -33.81 87.87 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.683 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -73.59 -32.61 64.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.982 0.42 . . . . 0.0 110.321 179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 75.1 mt -75.12 -33.8 61.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.787 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -70.73 -54.1 10.6 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.392 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.26 33.23 1.25 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.701 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.905 ' HG ' HG11 ' A' ' 25' ' ' VAL . 1.7 mp -88.06 115.77 25.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.866 0.365 . . . . 0.0 110.884 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -81.37 159.86 66.39 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.552 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.426 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 13.0 Cg_endo -56.14 132.54 52.58 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.575 2.183 . . . . 0.0 112.332 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.427 ' O ' ' N ' ' A' ' 70' ' ' ARG . 0.3 OUTLIER 84.16 3.15 0.82 Allowed 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.599 179.781 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.637 ' HB2' HD13 ' A' ' 102' ' ' ILE . 6.0 p-10 -54.43 87.61 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 121.174 0.512 . . . . 0.0 110.858 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.427 ' N ' ' O ' ' A' ' 68' ' ' TYR . 4.2 ttp180 -66.99 109.55 3.02 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.862 -179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.004 HD23 HD13 ' A' ' 100' ' ' LEU . 4.0 mp -58.78 118.27 5.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.226 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.793 ' CD1' HD22 ' A' ' 22' ' ' LEU . 40.5 mt -82.77 -65.18 1.04 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.871 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -131.73 128.43 38.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.025 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.4 t -108.33 136.31 44.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.009 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.45 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 23.8 m120 50.18 32.01 5.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.332 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.45 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 0.3 OUTLIER 85.88 -14.79 0.52 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.77 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.2 t -83.75 136.94 21.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.843 0.354 . . . . 0.0 111.14 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -69.46 125.36 26.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.741 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.496 HG21 HD13 ' A' ' 90' ' ' LEU . 17.1 p -144.5 32.01 1.19 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.123 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.549 ' HG2' HD22 ' A' ' 72' ' ' LEU . 14.0 mtp180 -65.33 -52.03 56.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.43 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.69 28.54 2.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.049 179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.695 ' HE2' HD11 ' A' ' 90' ' ' LEU . 1.8 m-30 -80.8 167.51 19.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.724 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -107.83 161.53 14.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.46 179.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.851 ' O ' HG23 ' A' ' 88' ' ' VAL . 0.8 OUTLIER -51.81 -40.66 60.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.924 0.393 . . . . 0.0 110.68 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 3.5 m -63.09 -23.03 67.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.205 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.51 ' O ' HD12 ' A' ' 90' ' ' LEU . 10.0 mp -94.17 -32.09 13.86 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.027 0.441 . . . . 0.0 110.864 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.537 HG21 ' HB ' ' A' ' 49' ' ' VAL . 52.9 t -78.44 -35.86 19.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.222 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 84' ' ' CYS . 97.3 t -57.41 -51.25 83.13 Favored Pre-proline 0 C--N 1.331 -0.199 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.788 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.651 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.9 Cg_exo -66.61 -48.38 2.26 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.475 2.117 . . . . 0.0 111.32 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.695 HD11 ' HE2' ' A' ' 82' ' ' PHE . 37.4 mt -54.94 -27.99 47.74 Favored 'General case' 0 C--O 1.231 0.112 0 CA-C-O 120.967 0.413 . . . . 0.0 110.427 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.955 ' HA ' HD11 ' A' ' 98' ' ' LEU . 27.8 mt -75.84 -48.12 30.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.799 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -78.2 -3.09 40.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.243 -0.435 . . . . 0.0 112.091 -179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -89.8 -11.41 42.21 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.428 ' HB2' ' HG ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -64.66 -27.01 68.63 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.005 0.431 . . . . 0.0 111.208 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 90.59 -59.6 3.31 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.423 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.413 ' HA ' ' CB ' ' A' ' 29' ' ' LYS . 9.0 p30 -164.24 20.41 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.523 0.201 . . . . 0.0 111.383 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.433 ' HG3' ' CD1' ' A' ' 28' ' ' TYR . 14.1 ttpt -165.55 113.03 0.95 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.7 0.286 . . . . 0.0 110.234 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.955 HD11 ' HA ' ' A' ' 91' ' ' ILE . 1.7 mt -109.03 102.19 11.2 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -97.32 118.12 33.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 1.004 HD13 HD23 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -152.67 159.16 43.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.267 0.556 . . . . 0.0 112.416 -178.403 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.625 ' CG1' HD13 ' A' ' 22' ' ' LEU . 15.5 t -105.99 109.33 27.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.455 178.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.705 HG23 HD12 ' A' ' 100' ' ' LEU . 2.6 pp -100.87 162.33 3.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.728 -0.215 . . . . 0.0 111.015 -179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.441 ' HB3' HD11 ' A' ' 72' ' ' LEU . 3.2 p -146.26 130.19 17.26 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.687 0.28 . . . . 0.0 111.145 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.42 ' NH1' ' HG3' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -144.96 145.8 31.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.958 0.408 . . . . 0.0 111.409 179.508 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.701 ' N ' HG12 ' A' ' 20' ' ' VAL . 6.1 p30 -70.04 127.01 92.67 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.748 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.413 ' HB2' ' CB ' ' A' ' 16' ' ' SER . 51.7 Cg_exo . . . . . 0 C--O 1.248 1.001 0 C-N-CA 122.42 2.08 . . . . 0.0 112.247 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.427 ' N ' ' HD2' ' A' ' 17' ' ' PRO . 2.4 m . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 111.564 0.209 . . . . 0.0 111.564 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 16' ' ' SER . 47.3 Cg_endo -68.56 -38.89 10.17 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.489 2.126 . . . . 0.0 112.114 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.545 HG22 ' HD2' ' A' ' 19' ' ' PRO . 2.9 m -54.42 145.43 37.85 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.989 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.545 ' HD2' HG22 ' A' ' 18' ' ' THR . 46.3 Cg_exo -56.49 -164.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.45 2.1 . . . . 0.0 112.182 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 m -54.15 167.13 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.478 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -135.23 122.38 21.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.613 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.047 HD21 HD12 ' A' ' 72' ' ' LEU . 16.0 mt -62.6 136.58 57.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.472 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 -142.86 119.72 11.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.87 179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.1 tttp -75.34 110.93 10.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.28 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.71 HG11 ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -116.9 140.88 37.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.072 0.463 . . . . 0.0 111.508 -179.262 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 94.4 m -133.65 106.79 7.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.02 179.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.719 HD11 HD13 ' A' ' 65' ' ' LEU . 38.0 mt -98.3 179.56 4.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.172 0.511 . . . . 0.0 111.8 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.437 ' CD1' ' HG2' ' A' ' 97' ' ' LYS . 95.2 m-85 -135.69 136.1 40.61 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.366 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.451 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -99.33 165.14 11.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.968 0.413 . . . . 0.0 111.3 -179.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -119.8 131.1 55.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.784 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.82 84.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.126 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.26 -40.67 0.51 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.36 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.63 164.26 21.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 0.0 110.907 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.91 -28.52 9.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.072 0.463 . . . . 0.0 110.922 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -84.8 168.74 14.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.707 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.609 ' CD2' HD12 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -119.11 29.15 7.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.084 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.522 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 92.07 4.21 67.07 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.531 -0.842 . . . . 0.0 113.117 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.77 ' CE2' HD22 ' A' ' 65' ' ' LEU . 8.8 p90 -174.33 138.56 0.56 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.981 0.39 . . . . 0.0 111.545 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 52' ' ' LYS . 7.3 m -99.79 148.1 24.77 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.183 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.605 ' HB ' HG12 ' A' ' 49' ' ' VAL . 33.0 m -111.8 163.36 8.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.919 0.39 . . . . 0.0 111.588 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.782 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -135.08 172.22 13.32 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.908 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -84.18 163.62 19.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.935 0.397 . . . . 0.0 111.145 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.55 121.98 6.83 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.322 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 mt -94.69 6.27 49.4 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.618 0.229 . . . . 0.0 111.618 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.53 -38.77 0.08 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.072 0.463 . . . . 0.0 111.482 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 47' ' ' LYS . 11.8 mm-40 -88.85 18.14 5.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.561 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 46' ' ' GLU . 12.5 mmtt 27.76 78.79 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 CA-C-O 120.971 0.415 . . . . 0.0 112.106 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 172.09 -163.51 35.84 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.473 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.782 HG13 ' O ' ' A' ' 41' ' ' ALA . 46.8 t -130.0 138.93 52.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 110.914 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.4 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -136.51 165.64 25.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.795 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.508 HG11 HD11 ' A' ' 54' ' ' ILE . 58.9 t -72.35 121.18 22.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.02 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.408 ' N ' ' O ' ' A' ' 39' ' ' SER . 0.4 OUTLIER -87.53 -31.05 20.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.865 -179.834 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 61.0 m-80 -158.12 152.63 24.68 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.447 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.522 HG23 ' O ' ' A' ' 37' ' ' GLY . 1.0 OUTLIER -133.21 141.53 44.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.029 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.12 117.22 37.43 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.749 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.64 134.2 52.5 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.512 2.141 . . . . 0.0 112.504 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . 42.83 31.25 0.3 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.834 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -109.39 -160.88 19.22 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.849 -0.691 . . . . 0.0 111.749 179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -50.64 -62.06 0.46 Allowed 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.49 2.126 . . . . 0.0 111.785 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -56.9 -35.04 66.58 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.884 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -73.19 -32.83 65.05 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-O 121.051 0.453 . . . . 0.0 110.201 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 62' ' ' LEU . 27.5 mt -73.2 -27.41 61.61 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.56 179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.54 -51.66 7.12 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.348 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 134.95 -8.02 4.48 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.62 -0.8 . . . . 0.0 113.021 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.77 HD22 ' CE2' ' A' ' 38' ' ' PHE . 4.0 mp -56.76 128.85 38.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.368 . . . . 0.0 111.114 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.7 mtmt -116.6 167.24 10.93 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.859 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.437 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 69.7 Cg_exo -50.92 137.3 43.79 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.654 2.236 . . . . 0.0 112.368 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.437 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 10.8 m-85 85.02 4.1 0.62 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.232 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.528 ' CG ' HD13 ' A' ' 102' ' ' ILE . 1.0 OUTLIER -52.5 89.72 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.947 0.403 . . . . 0.0 110.81 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.612 ' O ' HD23 ' A' ' 72' ' ' LEU . 9.3 ttt180 -77.85 95.59 4.76 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.787 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.018 HD23 HD13 ' A' ' 100' ' ' LEU . 1.2 mp -55.0 107.01 0.26 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.873 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.047 HD12 HD21 ' A' ' 22' ' ' LEU . 4.4 mt -83.98 -63.05 1.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.835 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -120.49 117.56 27.99 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.951 ' O ' HG12 ' A' ' 77' ' ' VAL . 24.6 t -108.15 109.62 28.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.163 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.491 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 1.7 m-80 64.24 33.59 11.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.669 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.491 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 3.3 t60 89.73 -17.94 0.21 Allowed 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.92 179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.951 HG12 ' O ' ' A' ' 74' ' ' VAL . 6.4 p -83.69 130.08 36.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.992 0.425 . . . . 0.0 111.125 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.78 89.24 0.75 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.415 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.687 HG23 HG13 ' A' ' 77' ' ' VAL . 17.3 p -96.76 26.26 4.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.809 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.652 ' HG2' HD22 ' A' ' 72' ' ' LEU . 10.5 mtp-105 -63.32 -53.03 59.13 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.985 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.35 24.16 4.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.402 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.693 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.3 m-85 -81.8 166.48 19.97 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.852 0.358 . . . . 0.0 110.76 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.557 ' C ' HG21 ' A' ' 49' ' ' VAL . 33.6 m-20 -106.08 160.9 14.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.554 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.841 ' O ' HG23 ' A' ' 88' ' ' VAL . 11.3 t -51.69 -41.98 61.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.69 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 14.3 m -63.07 -22.43 66.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.098 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.536 ' O ' HD12 ' A' ' 90' ' ' LEU . 6.6 mp -94.02 -32.93 13.61 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.99 0.424 . . . . 0.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.732 HG11 HD13 ' A' ' 71' ' ' LEU . 48.4 t -77.57 -36.79 23.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.134 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.841 HG23 ' O ' ' A' ' 84' ' ' CYS . 87.5 t -55.61 -52.19 73.97 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.793 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 48.7 Cg_endo -68.44 -45.81 2.36 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.191 1.927 . . . . 0.0 111.835 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.693 HD11 ' HE2' ' A' ' 82' ' ' PHE . 28.2 mt -54.78 -30.71 57.49 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.964 0.412 . . . . 0.0 110.725 179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.809 HG23 ' CD1' ' A' ' 98' ' ' LEU . 61.3 mt -76.14 -48.37 28.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.367 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.69 -3.06 39.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.804 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -92.99 -4.55 52.45 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.433 ' CB ' ' HG ' ' A' ' 98' ' ' LEU . 0.4 OUTLIER -63.52 -29.83 71.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.232 0.539 . . . . 0.0 110.903 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 91.8 -41.67 2.82 Favored Glycine 0 C--N 1.322 -0.227 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.761 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -166.23 -41.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.76 0.314 . . . . 0.0 111.133 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.437 ' HG2' ' CD1' ' A' ' 28' ' ' TYR . 0.4 OUTLIER -112.9 126.91 55.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.719 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.809 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.6 OUTLIER -115.85 97.48 6.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.626 -179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.27 118.16 31.18 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 1.018 HD13 HD23 ' A' ' 71' ' ' LEU . 0.6 OUTLIER -148.59 156.44 42.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.142 0.496 . . . . 0.0 112.175 -178.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.899 HG12 HD22 ' A' ' 22' ' ' LEU . 17.1 t -114.32 109.04 27.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.794 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.883 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.4 pp -104.99 165.56 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.337 -178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.5 p -126.84 126.55 43.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.738 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.4 ppt_? -152.27 138.77 18.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.072 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -62.94 154.11 77.76 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.698 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo . . . . . 0 C--O 1.249 1.025 0 C-N-CA 122.61 2.207 . . . . 0.0 112.324 -179.855 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.9 t . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.749 0.309 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -68.89 163.97 35.4 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.496 2.13 . . . . 0.0 112.133 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.555 ' HB ' ' HD3' ' A' ' 19' ' ' PRO . 11.3 m -51.45 -58.73 9.74 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.202 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HD3' ' HB ' ' A' ' 18' ' ' THR . 58.0 Cg_endo -70.53 139.34 37.35 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.419 2.079 . . . . 0.0 112.321 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.719 HG21 ' HB3' ' A' ' 103' ' ' SER . 16.5 m -46.13 169.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.566 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -122.38 122.99 40.31 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.567 179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.801 ' CD2' HD13 ' A' ' 72' ' ' LEU . 14.4 mt -60.33 147.52 40.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.057 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.717 ' HD2' HD11 ' A' ' 102' ' ' ILE . 0.0 OUTLIER -157.55 116.57 3.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.368 179.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.31 121.02 20.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.79 -179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.877 HG11 HD22 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -118.24 145.54 24.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.296 -179.769 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 97.2 m -134.56 106.82 7.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.965 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.01 173.34 6.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.997 0.427 . . . . 0.0 111.692 -179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.434 ' CD1' ' N ' ' A' ' 28' ' ' TYR . 3.1 m-85 -123.19 156.05 35.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.519 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.416 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -111.22 160.37 17.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.912 0.387 . . . . 0.0 111.236 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.82 142.26 50.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.865 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 34.6 t -56.13 -30.46 62.15 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.022 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.29 38.17 3.4 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.399 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 5.4 mmt -157.25 110.85 2.58 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.785 0.326 . . . . 0.0 110.835 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -74.07 -28.81 61.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.087 0.47 . . . . 0.0 110.931 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -85.03 177.99 7.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.651 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.502 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -118.98 29.36 7.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.119 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.613 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 82.7 8.46 85.98 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.688 -0.767 . . . . 0.0 113.332 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.511 ' CE2' HG22 ' A' ' 51' ' ' VAL . 20.3 p90 -172.73 127.48 0.5 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 117.171 0.486 . . . . 0.0 111.395 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -94.06 149.89 20.83 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.013 -179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.757 HG11 HD11 ' A' ' 71' ' ' LEU . 31.6 m -122.15 150.74 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.303 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.761 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -107.67 178.11 4.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.08 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -94.87 168.18 10.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.015 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -96.88 109.78 3.91 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.065 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.554 ' O ' HD22 ' A' ' 45' ' ' LEU . 0.2 OUTLIER -94.46 7.11 46.7 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.554 HD22 ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -150.15 0.47 0.45 Allowed 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -179.304 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.429 ' O ' ' C ' ' A' ' 47' ' ' LYS . 0.5 OUTLIER -158.17 31.45 0.25 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.642 0.258 . . . . 0.0 111.298 179.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER 28.59 90.77 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.97 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -175.35 -159.44 21.41 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.364 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 41' ' ' ALA . 99.6 t -150.53 137.56 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.94 0.4 . . . . 0.0 111.17 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.8 163.75 30.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.348 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.629 ' HA ' HG12 ' A' ' 40' ' ' VAL . 58.3 t -70.68 123.85 25.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.994 0.426 . . . . 0.0 111.262 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -88.99 -29.76 19.26 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.636 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.7 p30 -172.16 160.07 5.06 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.256 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.613 HG23 ' O ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -126.67 138.41 54.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.839 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -64.16 154.67 81.88 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.284 -179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.614 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 65.4 Cg_endo -73.71 102.4 1.5 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.684 2.256 . . . . 0.0 112.433 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 84.58 -6.51 0.99 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.686 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.84 175.87 6.08 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.518 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -46.68 -45.8 19.23 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.71 2.273 . . . . 0.0 112.536 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.425 ' HA2' HD21 ' A' ' 65' ' ' LEU . . . -57.08 -41.1 92.39 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.433 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.24 -32.72 64.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.035 0.445 . . . . 0.0 110.032 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 17.8 mt -70.75 -32.13 69.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.515 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -72.25 -57.55 5.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.16 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 118.97 38.37 0.76 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.895 179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.877 HD22 HG11 ' A' ' 25' ' ' VAL . 0.4 OUTLIER -110.85 127.02 55.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.74 0.305 . . . . 0.0 110.825 179.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 5.3 mttm -96.76 162.06 24.44 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.565 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.472 ' O ' ' CB ' ' A' ' 68' ' ' TYR . 9.2 Cg_endo -52.32 154.49 11.15 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.743 2.295 . . . . 0.0 112.208 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.472 ' CB ' ' O ' ' A' ' 67' ' ' PRO . 8.0 m-85 90.29 -22.25 0.11 Allowed 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.368 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.767 ' HB2' HD13 ' A' ' 102' ' ' ILE . 10.3 p-10 -55.26 87.75 0.01 OUTLIER 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.203 0.525 . . . . 0.0 110.453 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.436 ' N ' ' O ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -66.74 119.99 12.75 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.734 -179.624 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.757 HD11 HG11 ' A' ' 40' ' ' VAL . 1.3 mt -68.79 110.74 4.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.303 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.801 HD13 ' CD2' ' A' ' 22' ' ' LEU . 3.4 mp -82.74 -58.01 3.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.179 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -129.98 134.29 47.34 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.965 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.805 HG23 ' OG1' ' A' ' 79' ' ' THR . 28.2 t -117.28 108.51 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.005 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.443 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 33.2 m120 64.24 36.27 9.49 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.443 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 50.0 m-70 86.35 -15.94 0.44 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.516 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.0 t -83.66 139.11 18.14 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.813 0.34 . . . . 0.0 111.013 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.87 122.82 20.01 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.631 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.805 ' OG1' HG23 ' A' ' 74' ' ' VAL . 28.0 p -143.08 28.22 1.55 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.95 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.594 ' HG3' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -72.29 -53.01 13.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.425 179.704 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -94.9 25.96 3.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.069 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.692 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.4 m-30 -80.85 171.4 15.06 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.778 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.409 ' O ' HG23 ' A' ' 87' ' ' VAL . 1.2 m-20 -108.01 159.94 16.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.479 179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.878 ' O ' HG23 ' A' ' 88' ' ' VAL . 23.8 p -51.51 -42.11 61.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.88 0.371 . . . . 0.0 110.543 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.07 -21.73 66.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.191 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.603 ' O ' HD12 ' A' ' 90' ' ' LEU . 8.0 mp -95.31 -31.31 13.51 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 120.935 0.397 . . . . 0.0 110.819 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.656 HG11 ' CD1' ' A' ' 71' ' ' LEU . 48.1 t -79.37 -35.72 17.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.221 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 84' ' ' CYS . 88.8 t -58.18 -50.71 86.59 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.835 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.626 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 13.0 Cg_exo -69.62 -44.43 2.18 Favored 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.472 2.115 . . . . 0.0 111.626 179.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.692 HD11 ' HE2' ' A' ' 82' ' ' PHE . 15.5 mt -54.99 -33.32 62.46 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.694 179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.9 HG23 ' CD1' ' A' ' 98' ' ' LEU . 80.4 mt -75.32 -45.87 39.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.629 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.66 -3.76 36.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.928 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -101.19 -12.12 18.99 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.659 0.266 . . . . 0.0 111.686 -179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.8 m -64.76 -15.67 61.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.502 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.97 -143.69 17.21 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.571 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -73.73 -7.52 52.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.547 0.213 . . . . 0.0 111.4 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.7 mtpt -137.49 151.73 48.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.612 0.244 . . . . 0.0 110.592 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.9 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -137.73 97.49 3.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.772 0.32 . . . . 0.0 111.382 -179.937 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.7 118.17 31.3 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.74 HD23 HD22 ' A' ' 98' ' ' LEU . 1.4 pp -145.16 157.43 44.09 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.132 0.492 . . . . 0.0 112.079 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.776 HG12 HD22 ' A' ' 22' ' ' LEU . 16.7 t -110.53 109.25 27.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.919 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.767 HD13 ' HB2' ' A' ' 69' ' ' ASP . 2.6 pp -105.9 169.21 2.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.074 0.464 . . . . 0.0 111.641 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.791 ' HB2' HD11 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -131.84 114.51 14.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.488 179.589 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.422 ' HB3' ' HA ' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -140.82 131.99 26.42 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.923 0.392 . . . . 0.0 111.642 -179.561 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.408 ' N ' HG12 ' A' ' 20' ' ' VAL . 1.1 m120 -65.65 119.86 63.74 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.595 179.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 C--O 1.25 1.078 0 C-N-CA 122.339 2.026 . . . . 0.0 112.376 -179.935 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.435 ' HA ' ' CG ' ' A' ' 106' ' ' PRO . 3.9 m . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.693 0.283 . . . . 0.0 111.294 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.82 146.42 48.04 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 122.633 2.222 . . . . 0.0 112.32 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.567 ' N ' ' HD2' ' A' ' 19' ' ' PRO . 89.4 m -51.4 -51.1 72.19 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.635 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 18' ' ' THR . 37.6 Cg_endo -66.34 125.67 14.36 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.222 1.948 . . . . 0.0 112.448 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.5 m -45.63 150.77 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.946 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -111.08 122.36 47.68 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.578 HD13 ' CG1' ' A' ' 101' ' ' VAL . 4.4 pp -106.83 153.3 22.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.26 0.552 . . . . 0.0 112.37 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.677 ' NE2' HD11 ' A' ' 102' ' ' ILE . 28.7 p80 -149.28 143.46 25.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.561 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.51 112.26 14.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.486 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.803 HG11 ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -107.21 153.46 8.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.57 -179.462 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.857 HG23 ' OD1' ' A' ' 99' ' ' ASP . 98.4 m -134.09 122.1 22.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.824 179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.705 HD21 ' CD1' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -108.2 175.16 5.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.293 0.568 . . . . 0.0 111.986 -178.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.465 ' CD1' ' HG2' ' A' ' 97' ' ' LYS . 27.7 m-85 -139.3 124.63 19.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.911 179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.42 ' HG3' ' CE2' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -94.84 147.81 22.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.073 0.463 . . . . 0.0 111.431 -179.326 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -123.41 153.82 39.87 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.682 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.9 p -64.64 -24.49 67.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.26 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -100.62 -0.22 55.43 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.156 -179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.94 130.42 35.07 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.824 0.345 . . . . 0.0 111.043 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -80.35 -10.74 59.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.16 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -155.93 -164.78 1.78 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.412 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.586 ' O ' HD22 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -106.01 25.59 10.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 111.482 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.606 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 91.48 -1.17 75.59 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.485 -0.864 . . . . 0.0 113.74 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.575 ' CD1' HG22 ' A' ' 51' ' ' VAL . 7.9 p90 -172.24 147.76 2.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.334 0.567 . . . . 0.0 111.895 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 2.4 p -108.89 137.71 46.38 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.242 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.749 ' HB ' HG12 ' A' ' 49' ' ' VAL . 22.6 m -99.23 161.12 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.519 -179.539 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.772 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -125.19 171.11 10.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.153 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -82.01 136.01 35.29 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.968 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -106.26 103.43 2.07 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.337 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -94.31 -28.81 15.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.093 0.473 . . . . 0.0 111.287 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.452 ' HA ' HD23 ' A' ' 45' ' ' LEU . 15.0 mt -83.85 -5.63 59.25 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.375 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.438 ' O ' ' C ' ' A' ' 47' ' ' LYS . 11.9 mt-10 -153.07 28.1 0.52 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.941 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.4 OUTLIER 27.38 91.2 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.107 179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.92 -153.16 21.73 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.582 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.772 HG13 ' O ' ' A' ' 41' ' ' ALA . 16.6 t -145.97 139.0 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.72 0.295 . . . . 0.0 110.931 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -136.93 156.19 48.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.118 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.575 HG22 ' CD1' ' A' ' 38' ' ' PHE . 87.6 t -67.63 117.94 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.536 179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.4 ' HG2' ' ND2' ' A' ' 53' ' ' ASN . 4.4 tttt -87.39 -30.77 20.5 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.042 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.4 ' ND2' ' HG2' ' A' ' 52' ' ' LYS . 71.2 m-80 -157.39 147.51 20.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.524 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 37' ' ' GLY . 1.3 mt -125.1 125.35 69.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.955 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 35.6 ttt85 -65.33 111.62 6.5 Favored Pre-proline 0 C--N 1.33 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.05 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.589 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 32.4 Cg_exo -58.34 123.48 13.71 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.476 2.117 . . . . 0.0 112.19 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 81.34 83.35 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.097 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 167.78 -152.54 21.02 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.531 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.55 ' C ' HD23 ' A' ' 27' ' ' LEU . 32.2 Cg_exo -59.61 -36.78 91.56 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.646 2.231 . . . . 0.0 112.2 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.09 -47.81 43.39 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.722 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.57 -32.95 64.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.056 0.455 . . . . 0.0 110.515 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.4 mt -71.26 -30.87 66.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.993 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.86 -38.66 15.38 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.663 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.44 29.24 6.38 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.497 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.803 ' HG ' HG11 ' A' ' 25' ' ' VAL . 1.2 mp -78.27 131.88 37.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.893 0.378 . . . . 0.0 110.784 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.5 mptt -98.4 165.05 15.93 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.841 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 28.1 Cg_endo -62.68 138.96 72.67 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.411 2.074 . . . . 0.0 112.115 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.428 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 0.2 OUTLIER 82.96 11.1 0.53 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.347 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.578 ' OD1' HD13 ' A' ' 102' ' ' ILE . 5.6 m-20 -53.74 88.44 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.931 0.396 . . . . 0.0 111.162 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.449 ' HB3' ' O ' ' A' ' 103' ' ' SER . 5.5 ttt85 -73.0 94.34 1.86 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.372 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.919 HD12 ' CG1' ' A' ' 87' ' ' VAL . 11.3 mt -50.86 107.51 0.18 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.998 0.428 . . . . 0.0 111.175 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.749 HD11 ' HB2' ' A' ' 103' ' ' SER . 16.0 mt -82.62 -65.33 1.02 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.946 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -133.79 138.86 45.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.855 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.49 ' O ' HG12 ' A' ' 77' ' ' VAL . 16.5 t -109.69 106.81 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.931 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 75.37 -59.37 0.54 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.078 0.466 . . . . 0.0 110.613 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.401 ' H ' ' H ' ' A' ' 77' ' ' VAL . 0.2 OUTLIER -167.29 -11.22 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.414 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 74' ' ' VAL . 12.9 p -85.41 125.3 40.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.712 0.292 . . . . 0.0 111.242 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 18.3 mtt-85 -69.55 123.8 22.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.424 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.639 HG21 HD13 ' A' ' 90' ' ' LEU . 14.2 p -143.17 32.75 1.35 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.91 0.386 . . . . 0.0 111.21 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.434 ' HG3' ' CA ' ' A' ' 72' ' ' LEU . 37.0 mtp180 -66.01 -52.49 48.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.636 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.24 30.35 1.95 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.112 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.699 ' HE2' HD11 ' A' ' 90' ' ' LEU . 1.6 m-30 -80.9 174.25 11.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.96 0.41 . . . . 0.0 110.742 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.09 158.47 17.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.439 179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.848 ' O ' HG23 ' A' ' 88' ' ' VAL . 22.6 p -51.35 -41.66 60.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.914 0.388 . . . . 0.0 110.815 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.56 -22.47 66.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.131 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.55 ' O ' HD12 ' A' ' 90' ' ' LEU . 8.9 mp -93.02 -33.44 14.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.165 0.507 . . . . 0.0 110.875 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.919 ' CG1' HD12 ' A' ' 71' ' ' LEU . 59.7 t -77.18 -36.02 23.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.165 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 84' ' ' CYS . 78.5 t -55.45 -52.25 73.27 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.819 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 54.4 Cg_endo -69.19 -43.22 3.28 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.281 1.987 . . . . 0.0 111.904 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.699 HD11 ' HE2' ' A' ' 82' ' ' PHE . 15.9 mt -54.6 -31.61 57.3 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.967 0.413 . . . . 0.0 110.787 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.938 HG23 ' CD1' ' A' ' 98' ' ' LEU . 70.3 mt -78.8 -47.45 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.854 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.5 -3.96 30.9 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.08 -4.2 16.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.606 0.241 . . . . 0.0 111.593 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.6 p -64.08 -18.2 64.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.907 0.384 . . . . 0.0 111.133 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 96.85 -144.81 17.55 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.415 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.7 m-80 -73.91 -8.24 55.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.615 0.245 . . . . 0.0 111.466 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.465 ' HG2' ' CD1' ' A' ' 28' ' ' TYR . 10.4 mtpt -144.33 147.57 33.64 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.678 0.275 . . . . 0.0 111.034 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.938 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -124.77 97.58 5.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 0.0 111.078 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.857 ' OD1' HG23 ' A' ' 26' ' ' THR . 6.0 m-20 -95.04 118.78 32.43 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.838 HD22 HD22 ' A' ' 98' ' ' LEU . 0.3 OUTLIER -150.2 169.36 21.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.251 0.548 . . . . 0.0 112.333 -178.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.635 HG12 HD12 ' A' ' 72' ' ' LEU . 25.0 t -118.44 109.35 26.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.549 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.677 HD11 ' NE2' ' A' ' 23' ' ' HIS . 2.2 pp -102.58 154.56 5.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.429 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.749 ' HB2' HD11 ' A' ' 72' ' ' LEU . 3.4 t -130.15 125.72 35.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.452 179.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.42 126.23 10.39 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.005 0.431 . . . . 0.0 111.791 -179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.39 140.05 78.97 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.459 179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.435 ' CG ' ' HA ' ' A' ' 16' ' ' SER . 74.1 Cg_endo . . . . . 0 C--O 1.249 1.028 0 C-N-CA 122.323 2.015 . . . . 0.0 112.302 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.756 0.312 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -71.23 -70.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.813 2.342 . . . . 0.0 112.116 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.596 HG22 ' HD2' ' A' ' 19' ' ' PRO . 1.9 m -75.73 145.28 78.14 Favored Pre-proline 0 N--CA 1.452 -0.337 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.004 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.596 ' HD2' HG22 ' A' ' 18' ' ' THR . 31.3 Cg_exo -58.67 -160.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.419 2.079 . . . . 0.0 112.095 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.447 HG12 ' OD1' ' A' ' 105' ' ' ASN . 27.5 m -52.5 146.22 2.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.462 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.39 122.55 47.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.629 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.793 HD22 HG12 ' A' ' 101' ' ' VAL . 14.1 mt -62.44 144.3 56.06 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.304 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.537 ' HB2' HD11 ' A' ' 102' ' ' ILE . 80.5 m-70 -152.41 110.59 3.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.806 179.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -72.99 106.26 4.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.112 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.594 HG11 ' CD2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -109.7 141.02 26.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.04 0.448 . . . . 0.0 111.57 -179.263 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 88.9 m -132.64 106.75 7.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.144 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.58 HD21 HD21 ' A' ' 65' ' ' LEU . 1.5 mp -101.06 177.6 4.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.046 0.45 . . . . 0.0 111.613 -179.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.442 ' CD2' ' HG2' ' A' ' 97' ' ' LYS . 11.7 m-85 -138.89 133.51 32.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.437 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -94.84 161.88 13.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.971 0.415 . . . . 0.0 111.173 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -124.4 130.9 53.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.802 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 61.3 p -60.04 84.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.852 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.4 -13.49 1.4 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.893 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.94 174.64 11.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.769 0.319 . . . . 0.0 110.923 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.82 -10.73 13.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.48 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -155.66 -176.58 6.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.869 0.366 . . . . 0.0 110.977 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.51 ' CZ ' ' HB2' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -98.15 31.99 2.57 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.008 -179.881 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.85 15.66 79.54 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.973 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.65 ' CD2' HD11 ' A' ' 65' ' ' LEU . 4.1 p90 -173.47 119.22 0.3 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 110.962 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.3 m -93.62 149.66 21.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.824 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.686 ' HB ' HG12 ' A' ' 49' ' ' VAL . 23.7 m -108.33 167.94 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.244 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.813 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -127.08 171.32 11.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.096 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -88.14 137.31 32.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.098 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.86 114.58 4.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.403 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 tp -94.38 -31.05 14.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.068 0.461 . . . . 0.0 111.251 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.96 -54.88 4.55 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.892 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.423 ' O ' ' C ' ' A' ' 47' ' ' LYS . 1.7 mm-40 -90.55 17.99 6.81 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.473 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 29.83 89.74 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 111.989 0.366 . . . . 0.0 111.989 -179.79 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 168.1 -144.53 8.94 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.601 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.813 HG13 ' O ' ' A' ' 41' ' ' ALA . 38.8 t -146.7 140.74 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.781 0.324 . . . . 0.0 111.021 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.1 159.99 40.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.608 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.792 HG11 HD11 ' A' ' 54' ' ' ILE . 59.8 t -62.97 123.63 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.982 0.42 . . . . 0.0 111.031 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.49 ' HB2' ' HB2' ' A' ' 41' ' ' ALA . 2.0 tptp -88.58 -35.38 16.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.98 -179.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -162.55 143.59 10.14 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.273 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.792 HD11 HG11 ' A' ' 51' ' ' VAL . 1.2 mt -129.57 133.92 64.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.979 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.44 137.56 96.65 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.687 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.585 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 72.8 Cg_endo -75.03 107.59 2.52 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.498 2.132 . . . . 0.0 112.495 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 83.54 28.95 0.08 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.268 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -114.5 -161.64 13.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.305 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -50.65 -53.55 6.95 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.493 2.129 . . . . 0.0 112.199 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -58.01 -38.38 89.0 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.476 179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.3 -32.81 64.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.05 0.452 . . . . 0.0 110.273 179.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.6 -30.8 67.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.687 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -74.99 -53.4 6.27 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.28 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 120.45 35.13 0.88 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.787 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.65 HD11 ' CD2' ' A' ' 38' ' ' PHE . 0.3 OUTLIER -113.64 141.87 46.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.843 0.354 . . . . 0.0 110.958 179.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.6 mmtt -121.93 163.04 33.83 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.684 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.551 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 1.4 Cg_endo -44.51 144.28 3.31 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.824 2.35 . . . . 0.0 112.3 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.551 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 93.8 m-85 85.3 -7.82 0.86 Allowed 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.41 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.708 ' CG ' HD13 ' A' ' 102' ' ' ILE . 5.4 m-20 -54.41 86.65 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 121.151 0.5 . . . . 0.0 110.591 179.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.613 ' O ' HD12 ' A' ' 72' ' ' LEU . 22.2 ttm180 -66.82 109.15 2.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.292 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.562 ' CD2' HD22 ' A' ' 100' ' ' LEU . 1.8 mp -66.61 107.92 2.28 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.796 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.719 HD11 ' HB3' ' A' ' 103' ' ' SER . 5.2 mp -83.75 -37.51 22.54 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.509 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.81 145.58 18.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.868 0.366 . . . . 0.0 111.087 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.812 HG12 ' OD1' ' A' ' 75' ' ' ASN . 21.5 t -115.11 109.75 29.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.791 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.812 ' OD1' HG12 ' A' ' 74' ' ' VAL . 1.0 OUTLIER 75.46 -57.46 0.59 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.072 0.463 . . . . 0.0 110.695 -179.699 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -167.19 -14.69 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.263 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.5 t -85.62 128.47 39.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.126 0 CA-C-O 120.797 0.332 . . . . 0.0 111.098 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -69.31 127.07 31.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.515 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.784 HG21 HD13 ' A' ' 90' ' ' LEU . 16.8 p -142.69 32.44 1.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.031 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.444 ' CG ' ' HG ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -67.95 -48.39 66.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.303 179.583 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.15 24.21 4.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.077 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.613 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.1 m-30 -81.13 173.87 12.13 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.802 0.334 . . . . 0.0 110.823 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.32 159.59 16.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.327 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.853 ' O ' HG23 ' A' ' 88' ' ' VAL . 19.6 t -51.48 -42.1 61.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.824 0.345 . . . . 0.0 110.713 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 6.6 t -62.61 -21.64 65.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.18 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 90' ' ' LEU . 8.3 mp -95.64 -32.57 12.72 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.023 0.44 . . . . 0.0 110.978 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.619 HG12 HD11 ' A' ' 91' ' ' ILE . 50.9 t -78.29 -35.7 19.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.331 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.853 HG23 ' O ' ' A' ' 84' ' ' CYS . 91.9 t -58.27 -51.27 82.99 Favored Pre-proline 0 CA--C 1.53 0.193 0 C-N-CA 120.969 -0.292 . . . . 0.0 110.833 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.645 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 16.3 Cg_exo -67.55 -44.86 3.99 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.349 2.033 . . . . 0.0 111.47 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.784 HD13 HG21 ' A' ' 79' ' ' THR . 18.1 mt -54.74 -29.38 53.51 Favored 'General case' 0 N--CA 1.455 -0.176 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.697 179.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.95 HG23 ' CD1' ' A' ' 98' ' ' LEU . 50.1 mt -78.08 -48.43 23.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.796 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -73.37 -4.32 32.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.97 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -99.3 -12.94 19.89 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.716 0.293 . . . . 0.0 111.576 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -65.09 -15.97 62.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.383 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.03 -144.11 17.84 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.649 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 20.7 p30 -73.72 -7.1 50.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.442 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -138.58 141.67 39.21 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.772 0.32 . . . . 0.0 110.657 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.95 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.1 OUTLIER -130.6 97.33 4.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.263 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -98.47 118.11 34.41 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.935 HD23 HD22 ' A' ' 98' ' ' LEU . 1.6 pp -145.91 163.2 35.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.12 0.486 . . . . 0.0 111.849 -178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.793 HG12 HD22 ' A' ' 22' ' ' LEU . 25.5 t -113.51 109.11 27.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.168 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.708 HD13 ' CG ' ' A' ' 69' ' ' ASP . 2.6 pp -103.75 168.95 2.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.088 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.719 ' HB3' HD11 ' A' ' 72' ' ' LEU . 54.2 p -142.39 120.24 11.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.716 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 3.5 ptt85 -128.34 130.32 47.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.176 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.447 ' OD1' HG12 ' A' ' 20' ' ' VAL . 14.8 m120 -65.85 157.42 79.95 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.852 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo . . . . . 0 C--O 1.249 1.054 0 C-N-CA 122.54 2.16 . . . . 0.0 112.224 179.985 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 120.552 0.215 . . . . 0.0 111.539 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.8 52.83 4.51 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.561 2.174 . . . . 0.0 112.563 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.467 ' HB ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -168.86 -52.05 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.963 179.62 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.467 ' HD3' ' HB ' ' A' ' 18' ' ' THR . 6.2 Cg_exo -78.36 84.63 1.98 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.841 2.361 . . . . 0.0 112.346 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.424 HG23 ' OG ' ' A' ' 103' ' ' SER . 30.2 m -46.08 168.41 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.476 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -125.55 122.69 37.25 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.675 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 1.081 HD21 HD12 ' A' ' 72' ' ' LEU . 15.1 mt -61.19 152.91 27.47 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.411 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.447 ' HB2' HD11 ' A' ' 102' ' ' ILE . 20.5 m-70 -157.15 109.9 2.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.024 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.545 ' CD ' HG22 ' A' ' 101' ' ' VAL . 0.0 OUTLIER -72.45 112.99 9.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.078 179.596 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.942 HG11 ' HG ' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -121.92 143.4 34.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.142 0.496 . . . . 0.0 111.932 -178.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 96.1 m -134.0 106.4 7.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.811 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.538 HD11 HD11 ' A' ' 65' ' ' LEU . 4.4 mp -94.34 174.88 6.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.278 0.561 . . . . 0.0 112.04 -178.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 96' ' ' ASN . 24.8 m-85 -137.4 121.63 18.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.222 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 6.1 tttm -112.04 152.98 27.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.958 0.408 . . . . 0.0 111.263 -179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.409 ' N ' ' HG2' ' A' ' 29' ' ' LYS . 19.6 t0 -102.52 138.86 38.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.867 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.0 m -51.35 -26.34 7.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.31 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -79.72 -38.15 21.06 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.615 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 9.2 mmm -81.76 158.14 24.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.91 0.386 . . . . 0.0 110.936 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.68 -30.89 8.7 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.114 0.483 . . . . 0.0 110.92 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -84.99 172.03 11.64 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.713 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.476 ' CD2' HG22 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -119.14 32.07 6.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.802 0.335 . . . . 0.0 111.105 179.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.401 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 77.1 6.59 86.24 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.704 -0.76 . . . . 0.0 113.283 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.481 ' HD2' HG13 ' A' ' 51' ' ' VAL . 14.1 p90 -172.5 123.15 0.46 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.159 0.479 . . . . 0.0 111.393 179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.2 m -95.1 145.81 24.73 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.536 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.668 HG11 HD11 ' A' ' 71' ' ' LEU . 33.5 m -110.49 159.67 10.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.281 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.796 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -116.97 178.06 4.48 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -90.7 161.22 15.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.128 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.5 128.63 8.28 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.239 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.44 -58.07 2.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.289 0.566 . . . . 0.0 111.398 -179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.2 mt -83.58 -43.51 15.59 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.61 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.442 ' O ' ' C ' ' A' ' 47' ' ' LYS . 2.1 mt-10 -87.7 9.77 20.42 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.749 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.1 OUTLIER 27.71 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 170.73 -152.8 19.57 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.468 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.796 HG13 ' O ' ' A' ' 41' ' ' ALA . 59.7 t -142.65 138.39 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.761 0.315 . . . . 0.0 111.052 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.13 167.91 20.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.52 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.512 HG11 HD11 ' A' ' 54' ' ' ILE . 47.2 t -71.64 122.04 23.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.979 0.419 . . . . 0.0 111.368 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -89.52 -32.68 17.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.785 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -164.79 153.89 12.9 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.187 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.512 HD11 HG11 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -130.95 133.62 62.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.15 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.87 127.02 92.82 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.627 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 32.3 Cg_exo -58.34 114.22 1.89 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.418 2.079 . . . . 0.0 112.44 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 86.64 -14.67 0.48 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.951 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -61.63 -176.6 2.25 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.371 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.71 -32.48 97.0 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.521 2.148 . . . . 0.0 111.998 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.516 ' HA2' HD21 ' A' ' 27' ' ' LEU . . . -64.51 -38.87 96.32 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.321 179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.58 -32.68 64.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.987 0.422 . . . . 0.0 110.019 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.4 mt -75.2 -34.99 61.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.833 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -69.42 -57.78 7.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.42 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 125.59 42.62 0.31 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.752 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.942 ' HG ' HG11 ' A' ' 25' ' ' VAL . 0.9 OUTLIER -104.56 122.83 46.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.857 0.361 . . . . 0.0 110.918 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.84 162.04 20.94 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.772 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.461 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 6.9 Cg_endo -49.15 137.46 29.63 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.972 2.448 . . . . 0.0 112.156 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 46.6 m-85 85.32 -1.52 0.82 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.17 -179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.608 ' CG ' HD13 ' A' ' 102' ' ' ILE . 0.9 OUTLIER -53.08 88.23 0.0 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.943 0.401 . . . . 0.0 110.735 179.507 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.57 ' O ' HD23 ' A' ' 72' ' ' LEU . 44.3 ttp180 -76.8 102.12 6.15 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.035 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.745 HD23 HD13 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -56.17 115.33 2.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.838 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.081 HD12 HD21 ' A' ' 22' ' ' LEU . 2.8 mt -82.49 -64.44 1.18 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.82 0.343 . . . . 0.0 111.135 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -133.12 109.59 9.59 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.874 0.369 . . . . 0.0 111.174 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.553 HG13 ' HB3' ' A' ' 100' ' ' LEU . 23.4 t -89.41 123.69 41.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.903 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 14.8 m-80 46.11 40.0 6.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.449 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.47 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 1.5 t-80 87.6 -21.92 0.16 Allowed 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.823 179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.0 t -82.37 129.52 37.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.721 0.296 . . . . 0.0 111.151 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 73.4 mtm180 -68.86 135.14 50.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.447 ' HA ' ' CD1' ' A' ' 82' ' ' PHE . 30.1 p -144.89 29.87 1.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.058 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.649 ' HG2' HD22 ' A' ' 72' ' ' LEU . 8.8 mtp-105 -72.83 -53.2 12.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.696 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.19 21.69 5.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.148 179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.747 ' CE2' HD11 ' A' ' 90' ' ' LEU . 2.8 m-85 -81.27 169.44 17.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.872 0.367 . . . . 0.0 110.875 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -108.51 157.94 18.0 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.245 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.867 ' O ' HG23 ' A' ' 88' ' ' VAL . 8.0 p -51.39 -38.37 53.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.908 0.385 . . . . 0.0 110.676 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -66.97 -21.45 65.96 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.222 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.63 HD23 ' CD2' ' A' ' 82' ' ' PHE . 1.0 OUTLIER -92.33 -32.31 15.03 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 121.003 0.43 . . . . 0.0 110.571 179.898 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.485 HG12 ' CD1' ' A' ' 91' ' ' ILE . 94.3 t -77.05 -35.68 23.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.982 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.867 HG23 ' O ' ' A' ' 84' ' ' CYS . 84.4 t -55.35 -52.64 69.9 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.817 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.542 ' HD2' ' N ' ' A' ' 88' ' ' VAL . 49.3 Cg_endo -68.4 -43.22 4.48 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.205 1.937 . . . . 0.0 111.704 179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.747 HD11 ' CE2' ' A' ' 82' ' ' PHE . 11.0 mt -53.97 -33.71 57.71 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.298 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.948 HG23 ' CD1' ' A' ' 98' ' ' LEU . 80.3 mt -78.92 -41.88 23.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.842 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -72.64 -5.55 38.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.36 -179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 90' ' ' LEU . 4.5 pt-20 -98.38 -3.26 37.35 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.704 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.6 p -63.68 -31.03 72.07 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.232 0.539 . . . . 0.0 110.666 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.46 -48.9 1.88 Allowed Glycine 0 N--CA 1.452 -0.251 0 CA-C-N 115.461 -0.791 . . . . 0.0 112.818 179.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.405 ' O ' ' HA ' ' A' ' 28' ' ' TYR . 6.1 p30 -166.24 -39.48 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.744 0.307 . . . . 0.0 111.111 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt -111.75 112.96 25.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.191 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.948 ' CD1' HG23 ' A' ' 91' ' ' ILE . 0.2 OUTLIER -103.9 98.07 7.97 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.559 -179.111 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -95.94 118.5 32.69 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 178.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.745 HD13 HD23 ' A' ' 71' ' ' LEU . 1.4 pp -146.43 164.18 33.28 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.273 0.559 . . . . 0.0 111.978 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.892 HG12 HD22 ' A' ' 22' ' ' LEU . 26.0 t -119.22 109.36 26.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.147 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.733 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.5 pp -101.68 168.78 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.115 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.424 ' OG ' HG23 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -146.11 128.16 15.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.674 179.742 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.403 ' N ' ' HB ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER -147.22 147.56 30.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.983 0.421 . . . . 0.0 111.329 -179.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -62.38 143.2 95.94 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.829 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo . . . . . 0 C--O 1.248 0.996 0 C-N-CA 122.514 2.142 . . . . 0.0 112.217 -179.958 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.416 ' N ' ' CD ' ' A' ' 17' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 120.613 0.244 . . . . 0.0 111.469 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 16' ' ' SER . 85.2 Cg_endo -83.38 50.93 3.41 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.512 2.141 . . . . 0.0 112.66 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.472 ' HB ' ' HD3' ' A' ' 19' ' ' PRO . 1.3 m 178.76 -61.93 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.479 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.472 ' HD3' ' HB ' ' A' ' 18' ' ' THR . 56.9 Cg_endo -70.46 107.19 1.94 Allowed 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.425 2.083 . . . . 0.0 112.231 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.7 m -45.95 160.49 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.672 -179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -124.51 122.88 38.84 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.351 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.915 HD21 HD12 ' A' ' 72' ' ' LEU . 13.7 mt -60.53 147.0 42.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.584 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.468 ' HB2' HD11 ' A' ' 102' ' ' ILE . 15.1 m-70 -151.46 107.51 3.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.825 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.44 118.4 13.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.19 179.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.503 HG11 ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -126.25 141.58 45.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 121.076 0.465 . . . . 0.0 111.799 -179.223 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 95.9 m -134.38 106.64 7.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.778 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.929 HD11 HD11 ' A' ' 65' ' ' LEU . 17.1 mt -100.04 171.99 7.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.018 0.437 . . . . 0.0 111.774 -179.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -123.52 137.25 54.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.34 179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 36' ' ' PHE . 1.5 tttt -95.24 162.91 13.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.033 0.444 . . . . 0.0 111.299 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -131.33 128.18 39.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.741 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.63 -27.16 6.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.248 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.08 26.93 20.6 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.504 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.87 140.09 13.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.848 0.356 . . . . 0.0 110.892 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -96.57 -21.85 17.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.992 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -84.79 170.83 12.81 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.761 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.484 ' CE1' ' HB2' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -119.03 23.9 11.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.32 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.567 ' O ' HG23 ' A' ' 54' ' ' ILE . . . 89.24 9.63 67.03 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.719 -0.753 . . . . 0.0 113.334 179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.644 ' CD2' HD13 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -173.72 138.93 0.68 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 117.128 0.464 . . . . 0.0 111.627 179.781 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.8 m -99.35 154.69 18.0 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.596 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.639 ' HB ' HG12 ' A' ' 49' ' ' VAL . 35.0 m -116.34 159.23 16.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.42 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.825 ' O ' HG13 ' A' ' 49' ' ' VAL . . . -117.98 178.31 4.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.047 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.09 144.8 26.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.194 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -104.2 115.45 5.05 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.242 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.29 -45.66 7.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.157 0.503 . . . . 0.0 111.343 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.473 HD13 ' HA ' ' A' ' 45' ' ' LEU . 2.0 mm? -84.66 4.79 30.83 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.897 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.465 ' O ' ' C ' ' A' ' 47' ' ' LYS . 27.0 mt-10 -153.85 22.92 0.51 Allowed 'General case' 0 C--N 1.332 -0.185 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.522 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.465 ' C ' ' O ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER 24.09 79.84 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -171.69 -157.4 13.51 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.365 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.825 HG13 ' O ' ' A' ' 41' ' ' ALA . 35.7 t -143.48 139.38 26.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.872 0.367 . . . . 0.0 111.15 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.81 168.57 19.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.359 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.513 HG22 ' CE2' ' A' ' 38' ' ' PHE . 72.2 t -74.21 121.54 25.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.793 0.33 . . . . 0.0 111.142 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -89.52 -31.55 17.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.29 -179.865 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -163.5 162.96 24.86 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.27 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -134.27 136.98 52.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.906 -179.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.49 123.88 84.24 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.26 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.6 ' O ' ' HB3' ' A' ' 57' ' ' ALA . 31.9 Cg_exo -58.5 105.99 0.25 Allowed 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.525 2.15 . . . . 0.0 112.19 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 56' ' ' PRO . . . 82.35 28.56 0.13 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.111 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -105.21 -173.39 24.23 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.276 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.444 ' C ' HD22 ' A' ' 27' ' ' LEU . 78.0 Cg_exo -49.87 -42.21 45.15 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.453 2.102 . . . . 0.0 112.171 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.583 ' HA2' HD21 ' A' ' 27' ' ' LEU . . . -64.23 -36.43 93.22 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.445 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.63 -32.96 64.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.062 0.458 . . . . 0.0 110.404 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.81 -34.43 75.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.992 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.05 -46.69 5.82 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.627 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 121.14 34.79 0.86 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.581 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.929 HD11 HD11 ' A' ' 27' ' ' LEU . 45.1 mt -75.81 133.49 40.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.738 0.304 . . . . 0.0 110.917 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 mtpp -117.87 155.81 50.58 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.893 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.529 ' O ' ' HB2' ' A' ' 68' ' ' TYR . 12.3 Cg_endo -55.69 146.42 65.77 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.621 2.214 . . . . 0.0 112.18 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.529 ' HB2' ' O ' ' A' ' 67' ' ' PRO . 85.4 m-85 84.64 -5.39 0.99 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.384 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.531 ' CG ' HD13 ' A' ' 102' ' ' ILE . 7.0 m-20 -53.97 85.56 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.98 0.419 . . . . 0.0 110.774 179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 68' ' ' TYR . 59.3 ttt180 -71.41 101.13 2.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.06 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.956 HD23 HD13 ' A' ' 100' ' ' LEU . 0.9 OUTLIER -58.93 107.76 0.57 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.938 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.915 HD12 HD21 ' A' ' 22' ' ' LEU . 9.0 mt -82.39 -65.53 1.0 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.869 0.366 . . . . 0.0 110.881 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -119.56 127.5 53.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.892 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.3 t -119.9 104.68 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.101 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.468 ' O ' ' CB ' ' A' ' 76' ' ' HIS . 1.2 m-20 64.71 36.94 7.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.725 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.468 ' CB ' ' O ' ' A' ' 75' ' ' ASN . 2.8 t60 87.66 -14.68 0.42 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.503 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 79' ' ' THR . 21.4 t -83.63 114.06 23.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.8 0.333 . . . . 0.0 111.005 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -69.01 87.09 0.37 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.812 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 77' ' ' VAL . 15.8 p -95.95 32.08 1.98 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.115 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.73 ' HG2' HD22 ' A' ' 72' ' ' LEU . 36.2 mtp180 -66.28 -53.15 40.08 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.814 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -93.52 22.71 5.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.185 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.661 ' HE2' HD11 ' A' ' 90' ' ' LEU . 2.8 m-85 -82.01 167.94 18.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.951 0.405 . . . . 0.0 110.895 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 87' ' ' VAL . 2.2 m-20 -106.99 160.87 15.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.383 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.873 ' O ' HG23 ' A' ' 88' ' ' VAL . 4.3 t -51.59 -41.35 61.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.666 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 10.0 p -62.56 -23.91 67.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.07 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.495 ' O ' HD12 ' A' ' 90' ' ' LEU . 0.6 OUTLIER -94.12 -30.93 14.39 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.946 0.403 . . . . 0.0 110.972 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.517 HG12 ' CD1' ' A' ' 91' ' ' ILE . 41.3 t -78.89 -35.9 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.265 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.873 HG23 ' O ' ' A' ' 84' ' ' CYS . 91.6 t -57.76 -51.02 84.79 Favored Pre-proline 0 C--N 1.331 -0.226 0 C-N-CA 121.074 -0.25 . . . . 0.0 110.865 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.65 ' HD3' ' HB ' ' A' ' 88' ' ' VAL . 14.3 Cg_exo -68.96 -46.19 1.69 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.425 2.083 . . . . 0.0 111.517 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.661 HD11 ' HE2' ' A' ' 82' ' ' PHE . 33.3 mt -54.91 -33.09 61.74 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-O 120.986 0.422 . . . . 0.0 110.546 179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.856 HG23 ' CD1' ' A' ' 98' ' ' LEU . 62.6 mt -73.25 -46.76 49.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.477 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -75.57 -3.9 36.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.848 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.18 -7.23 22.36 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.656 0.265 . . . . 0.0 111.497 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.408 ' OG ' ' HG ' ' A' ' 98' ' ' LEU . 4.8 p -64.52 -16.59 62.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.847 0.355 . . . . 0.0 111.347 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 93.26 -144.0 16.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.217 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 26.2 m-80 -74.38 -8.81 57.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.569 0.223 . . . . 0.0 111.452 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 52.8 mtpt -142.1 141.84 32.75 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.784 0.326 . . . . 0.0 110.959 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.894 HD22 HD23 ' A' ' 100' ' ' LEU . 0.2 OUTLIER -119.56 97.12 5.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.242 179.916 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -92.0 118.37 30.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.956 HD13 HD23 ' A' ' 71' ' ' LEU . 1.6 pp -151.85 162.17 41.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.324 0.583 . . . . 0.0 112.093 -178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.854 HG12 HD22 ' A' ' 22' ' ' LEU . 39.1 t -121.49 109.02 23.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.946 179.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.879 HG22 ' HA ' ' A' ' 71' ' ' LEU . 2.4 pp -100.95 169.3 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.349 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.58 128.26 16.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.579 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.0 151.74 35.07 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.012 0.434 . . . . 0.0 111.478 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -62.68 115.1 14.6 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.971 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo . . . . . 0 C--O 1.249 1.054 0 C-N-CA 122.508 2.139 . . . . 0.0 112.267 -179.992 . . . . . . . . 0 0 . 1 stop_ save_